Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6971542244343782,-2.60479868022149,0.0,0.0,0.0,65/87,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6919978746600358,-2.598313810860659,0.0,0.0,0.0,68/91,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;SEC62;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;SSR2;TRAM1;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,protein targeting to ER (GO:0045047),-0.6631878202199367,-2.541086659848893,0.0,0.0,0.0,70/99,19.90%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SPCS3;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;SEC62;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;SEC61G;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29;SPCS1;RPL28
prerank,cytoplasmic translation (GO:0002181),-0.6696409845388231,-2.5287773861163174,0.0,0.0,0.0,65/91,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;EIF3M;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;RPL18;RPL39;RPS11;RPL23A;DRG2;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5670485674219135,-2.186780504458041,0.0,0.0003864963623635937,0.002,66/110,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RNPS1;RPS18;RPL18;RPL39;RPS11;RPL23A;UPF1;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,response to glucocorticoid (GO:0051384),0.8642254544105517,2.0727286135573384,0.0,0.015251209376351237,0.01,7/26,3.51%,SLIT3;SLIT2;ANXA1;ISL1;ADAM9;FAM107A;IL10
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5659889985707643,-2.05954697361426,0.0,0.008052007549241536,0.042,41/69,27.08%,SDHA;COX4I1;COX7C;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;COX6C;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;CYCS;NDUFC1;UQCRC2;COA6;UQCRB;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6;NDUFA11
prerank,aerobic electron transport chain (GO:0019646),-0.5634033733387839,-2.0484114873962644,0.0,0.009800443474219695,0.06,40/68,27.08%,SDHA;COX4I1;COX7C;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;COX6C;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;CYCS;NDUFC1;UQCRC2;UQCRB;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6;NDUFA11
prerank,bicarbonate transport (GO:0015701),0.8372936000950577,2.0269522750840094,0.0,0.022876814064526855,0.031,3/25,0.04%,SLC4A10;SLC26A7;SLC4A4
prerank,regulation of multicellular organism growth (GO:0040014),-0.7511179007337885,-1.9642244869155534,0.0,0.04118601861437045,0.255,7/15,11.27%,IGF1;PTCH1;GHR;STAT5B;MFSD2A;PPIB;APP
prerank,regulation of BMP signaling pathway (GO:0030510),0.6873196900501686,1.9634534451391144,0.0,0.07185014195081027,0.158,16/73,5.45%,BMP4;BMPER;CRIM1;FSTL1;SMAD9;HTRA3;FOXD1;SULF1;VWC2;CCN1;SMAD6;SKIL;GDF5;BAMBI;BMPR1A;ZNF423
prerank,peptide biosynthetic process (GO:0043043),-0.46789339260220564,-1.942303591850292,0.0,0.05131812811383271,0.335,79/153,20.99%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;GGT5;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;RPL18;RPL39;RPS11;MRPL3;RPL23A;RPL7A;RPL35A;RPL26;PCSK1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;MRPS11;RPL31;SARS1;RPL19;GGT7;RPLP0;RPS15A;RPS28;RPL37;MRPL51;RPL29;MRPL35;RPL28;HBS1L;MRPL34;EIF4EBP2;GGT1;SRBD1
prerank,organic anion transport (GO:0015711),0.6752999999481276,1.9360527770697307,0.0,0.10497915787388434,0.281,9/76,2.82%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;LRRC8D;SLCO4A1;SLCO2A1;ABCG2
prerank,ion homeostasis (GO:0050801),0.7692000914125209,1.9176721968630905,0.0,0.12343312121926935,0.36,5/30,2.51%,SLC4A10;SLC4A4;FHL1;CAMK2D;WNK1
prerank,regulation of intracellular pH (GO:0051453),0.7516378248266742,1.9032280090135012,0.0014641288433382138,0.14522540483925567,0.466,12/34,13.01%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC9C1;SLC9A8;SLC4A8;SLC26A6;NOX1;SLC4A3;SLC9A1;SLC9A3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.78759577444784,-1.903081544638281,0.0,0.08850766698126294,0.537,6/12,6.10%,IL34;LYN;CSF1;PTK2;BST2;MAPK3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8346230026864259,1.8976499299997318,0.0,0.13929437897067462,0.508,3/18,1.59%,EGFR;BMP4;DDX5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.5560373773272052,-1.8900467884253838,0.003401360544217687,0.09750249141445202,0.603,14/41,10.33%,IL34;TGFA;DOCK3;GRM5;ACE;NEDD9;EPHA4;ADRA2A;GPRC5B;LRP8;GAS6;NTRK2;SRC;HBEGF
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5625401800850724,-1.88882223579096,0.003436426116838488,0.09066560500445968,0.611,15/46,8.91%,ATP1A2;SHANK3;CDH2;NRXN1;GRM3;DGKI;GRIK1;GRM5;GRM1;GRM7;MEF2C;OPHN1;GRM8;CACNG4;LRRK2
prerank,response to ketone (GO:1901654),0.7751023602077496,1.8756541882787547,0.001564945226917058,0.19496129319435665,0.653,4/24,1.44%,SLIT3;SLIT2;THBS1;TGFB3
prerank,positive regulation of blood coagulation (GO:0030194),0.8508140574304393,1.868679873179926,0.0,0.19758789036472824,0.692,7/17,9.56%,ST3GAL4;F3;THBS1;ANO6;THBD;HPSE;DMTN
prerank,cellular response to copper ion (GO:0071280),-0.7052811515120094,-1.8666132266119595,0.0025252525252525255,0.1148340153561062,0.722,10/16,14.55%,SNCA;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,regulation of cellular pH (GO:0030641),0.7596714812013758,1.8539484188189703,0.0030581039755351682,0.23222508143724152,0.786,12/29,13.01%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC9C1;SLC9A8;SLC4A8;SLC26A6;SLC4A3;ATP1A4;SLC9A1;SLC9A3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6929816859091898,-1.8505164749963392,0.0,0.13202991807170616,0.773,5/19,2.68%,TJP1;PRKCH;CLDN5;F11R;OCLN
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.8996019062465176,1.8453078907716336,0.0,0.24596041303315544,0.837,3/11,1.59%,EGFR;BMP4;DDX5
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6833671324633038,1.8437362769614758,0.0013351134846461949,0.23105582205172123,0.846,10/51,4.33%,BMPER;CRIM1;FSTL1;SMAD9;HTRA3;VWC2;SMAD6;SKIL;BAMBI;BMPR1A
prerank,cation transport (GO:0006812),0.5901898771970926,1.8436685800186978,0.0,0.2136733539291876,0.847,20/167,5.58%,SLC47A1;SLC4A4;PIEZO2;KCNB2;SLC9B2;SLC23A1;KCNK5;KCNJ2;SLC12A2;KCNMB3;KCNMB2;SLC5A6;ATP1B1;TRPM6;ANO6;KCNS3;TRPM4;KCNK7;SCN11A;SLC38A7
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.7912952367173457,1.8294567657646938,0.0015455950540958269,0.2549856958112819,0.901,4/23,2.43%,SLC12A7;SLC12A2;SLC12A8;ATP6V0A4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6338290909358466,1.8232203356266095,0.0,0.26543882630129534,0.923,21/79,11.02%,SLIT2;BMPER;CRIM1;THBS1;SMAD9;HTRA3;SULF1;VWC2;NEDD4;SMAD6;SKIL;BAMBI;BMPR1A;ATP2B4;FGF2;UBE2D3;AGTR2;SKI;SULF2;NIBAN2;NOG
prerank,neuron cell-cell adhesion (GO:0007158),-0.7310948520411569,-1.821465014676687,0.002506265664160401,0.17978522455946497,0.889,10/14,21.56%,NRXN1;NCAM2;NRXN3;ASTN2;CNTN4;ASTN1;NLGN1;CDK5R1;NLGN2;NINJ2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.7890691513912551,-1.81719631940645,0.0023584905660377358,0.1762785752717703,0.906,3/10,2.25%,ERRFI1;ENG;ENPP1
prerank,peptide cross-linking (GO:0018149),0.7574541739682208,1.811447092958818,0.0016313213703099511,0.3041345336467376,0.95,8/25,6.47%,THBS1;FN1;ANXA1;DSP;COL3A1;TGM3;SPRR1A;TGM1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.8187335042255083,1.803603758436897,0.001639344262295082,0.32601702866859056,0.959,7/15,11.02%,BMP4;SOX9;SMO;SIX1;GDNF;SIX4;NOG
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.6032330340141262,-1.8005228886644211,0.0,0.20381999344644805,0.954,12/26,18.18%,LYN;PICALM;MBP;EPHA4;GRIN2B;AIM2;GRIN1;PSME2;TTBK1;APH1B;PSENEN;VSIR
prerank,keratinocyte differentiation (GO:0030216),0.7317934544912148,1.7943992115559586,0.002962962962962963,0.3554661503902901,0.975,12/29,7.78%,CLIC4;ANXA1;DSP;ADAM9;TGM3;BCR;SPRR1A;WNT16;PIP5K1A;TGM1;JAG1;EXPH5
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.7356504749112586,-1.793732086595353,0.0,0.20849331547502745,0.965,8/12,21.67%,PCGF5;SMCHD1;YTHDC1;CDYL;METTL3;BRCA1;HNRNPU;RBM15B
prerank,positive regulation of nuclear division (GO:0051785),-0.5986335049141652,-1.7895900770061797,0.0028011204481792717,0.2081486330466038,0.976,8/25,11.16%,IGF1;TGFA;PDGFRB;INSR;IGF2;RGCC;EDN1;EDN3
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6838763446280551,-1.782345455364848,0.0072992700729927005,0.216389650878317,0.982,7/15,16.64%,ATP1A2;ADRA2A;TMBIM6;SLC30A1;TRIM27;CBARP;NOS1
prerank,cellular response to drug (GO:0035690),-0.6183178309299197,-1.7790154198275023,0.0,0.213033114017076,0.984,11/25,15.66%,PPM1E;PDE4B;ACER2;RAP2A;TFRC;MEF2C;AIM2;GAS6;KCNQ1;CERS1;PPM1F
prerank,collagen fibril organization (GO:0030199),0.605388923345706,1.7696017963752564,0.0,0.48846680416608457,0.996,21/88,5.75%,COL25A1;COL8A1;COL12A1;TLL1;ADAMTS2;COL6A2;COL6A1;COL5A2;CYP1B1;COL23A1;COL8A2;P3H2;BMP1;DDR2;COL3A1;P4HA2;PLOD2;P4HA1;COL6A3;TGFBR1;P3H4
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6501261894551273,-1.7685528351519686,0.015503875968992248,0.22825245400040864,0.989,5/18,9.17%,IGF1;IGFBP2;IGF2;RPS3;IL18
prerank,monosaccharide transmembrane transport (GO:0015749),0.8002713501910335,1.7666097208549634,0.0032258064516129032,0.4849376208033815,0.999,2/16,0.26%,SLC23A1;SLC23A2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7428762754204888,1.7658360767062027,0.012965964343598054,0.4660575919262127,0.999,9/21,8.00%,BMP4;CCN3;TGFB3;BMP6;GDF5;NUP93;BMPR1A;TGFBR1;WWTR1
prerank,endodermal cell differentiation (GO:0035987),0.7083400868109451,1.7652952017007988,0.004437869822485207,0.4494485187424721,0.999,13/31,12.61%,COL8A1;COL12A1;FN1;COL6A1;INHBA;ITGA5;ITGAV;MMP14;ITGB5;CTR9;SETD2;PAF1;RTF1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6604003210802596,1.7622848512636988,0.009776536312849162,0.4486065876846735,0.999,18/43,12.38%,BMP4;KLF5;SOX9;NFIB;FOXO3;DDX5;KLF4;IL10;JUN;FGF2;NFATC4;TEAD1;SMARCA4;ATOH8;GATA3;TGFB2;REST;STAT3
prerank,response to copper ion (GO:0046688),-0.639767651432365,-1.7511019225962126,0.00554016620498615,0.2648340291674015,0.995,11/20,14.55%,SNCA;MT2A;ATP5F1D;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.7007152959357235,1.749825589027879,0.004379562043795621,0.5090091129357226,0.999,4/27,3.21%,EGFR;BMP4;DDX5;EIF4G1
prerank,regulation of phagocytosis (GO:0050764),-0.49931864961836764,-1.7495989213562784,0.0,0.2573824213115057,0.995,15/53,9.28%,CAMK1D;MERTK;TGM2;CD47;IL15RA;DYSF;SYT7;CYBA;SCARB1;SIRPA;SYT11;GAS6;GATA2;CALR;SPHK1
prerank,ion transport (GO:0006811),0.5787897448075912,1.7446532755909503,0.0,0.5218353800212339,0.999,9/111,2.81%,SLC26A7;PIEZO2;SLC9A2;SLC12A7;SLC26A2;SLC12A2;SLC24A3;WNK1;ANO6
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8329724979907033,1.7412755259037989,0.008992805755395683,0.525423715847834,0.999,8/11,11.71%,BMP4;ZFPM2;ISL1;BMPR1A;JAG1;GATA4;GATA3;TGFB2
prerank,endoderm formation (GO:0001706),0.6815736011354531,1.7412533804100985,0.005865102639296188,0.5060388928380443,0.999,9/35,8.23%,COL8A1;COL12A1;FN1;COL6A1;INHBA;ITGA5;ITGAV;MMP14;ITGB5
prerank,aorta development (GO:0035904),-0.6926280878844692,-1.7406862521641573,0.00963855421686747,0.27170694274160634,0.997,7/14,10.16%,ROBO1;PDGFRB;ADAMTS9;TBX1;PDE2A;ROBO2;EFEMP2
prerank,B cell receptor signaling pathway (GO:0050853),-0.5506613279549839,-1.7386790170635964,0.013071895424836602,0.26720277359559985,0.997,21/32,39.25%,BCL2;RFTN1;TEC;MEF2C;VAV3;CD38;BMX;BLNK;NCKAP1L;LAT2;SYK;PIK3CD;BTK;PTPRC;PLEKHA1;PRKCB;ITK;LCK;CD79A;CTLA4;BLK
prerank,cellular response to chemokine (GO:1990869),0.6466699991082354,1.7368657617184426,0.002789400278940028,0.5160718753731043,0.999,4/46,2.51%,STK39;SLC12A2;PTK2B;WNK1
prerank,mesonephric tubule development (GO:0072164),0.798854310038299,1.7343661272603799,0.0033003300330033004,0.5165076242124286,0.999,5/15,2.36%,SLIT2;BMP4;SIX1;PKD1;WNT11
prerank,heart development (GO:0007507),0.5566349773460226,1.7316057492274,0.0,0.5181683114556312,0.999,29/150,6.07%,MICAL2;BMP4;PLCE1;SGCD;SOX9;ZFPM2;BMP5;NTRK3;PCSK5;FN1;CXADR;PKD1;AKAP13;CSRP3;PDLIM7;GPC3;HDAC9;ISL1;STRA6;CACNA1C;COL3A1;MEF2A;TCF25;FOXC2;PDLIM5;TGFBR1;FLRT2;TNNI3;TGFBR2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.733406605977442,-1.727284678138171,0.006666666666666667,0.2870093357551871,0.998,5/11,6.65%,PLCB1;IGF1;IGF1R;PIK3R1;GHR
prerank,positive regulation of coagulation (GO:0050820),0.8571560061779804,1.723439778976847,0.005084745762711864,0.5370332101647679,1.0,4/10,9.56%,ST3GAL4;THBS1;HPSE;DMTN
prerank,positive regulation of hemostasis (GO:1900048),0.8571560061779804,1.723439778976847,0.005084745762711864,0.5370332101647679,1.0,4/10,9.56%,ST3GAL4;THBS1;HPSE;DMTN
prerank,translation (GO:0006412),-0.3976981006359742,-1.722624538754931,0.0,0.29004481479160754,0.998,84/208,20.60%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;EEF1B2;RPS15;RPL22;RPS5;LARS2;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;FASTKD2;RPS18;RPL18;RPL39;RPS11;MRPL3;RPL23A;IARS1;DRG2;RPL7A;PPA1;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;MRPS11;RPL31;SARS1;RPL19;GARS1;RPLP0;MRPL2;RPS15A;RPS28;RPL37;MRPL51;RPL29;MRPL35;APEH;RPL28;RARS2;HBS1L;MRPL34;EIF4EBP2
prerank,acute inflammatory response (GO:0002526),0.7119486322148683,1.7187561095527562,0.015337423312883436,0.5520321583759296,1.0,5/23,5.80%,F3;LBP;ANO6;VNN1;PLSCR1
prerank,circulatory system development (GO:0072359),0.5668206273060962,1.7172714576271262,0.0011890606420927466,0.5454251133632749,1.0,24/118,6.07%,MICAL2;PLCE1;SOX9;NXN;ZFPM2;NTRK3;PCSK5;FN1;CXADR;PKD1;AKAP13;PDLIM7;HDAC9;ISL1;STRA6;CACNA1C;COL3A1;MEF2A;TCF25;FOXC2;PDLIM5;TGFBR1;TNNI3;TGFBR2
prerank,heterochromatin organization (GO:0070828),-0.6696500140517037,-1.7133084631377586,0.015,0.308830584719668,0.999,4/14,10.26%,MECOM;PRDM16;SMCHD1;HP1BP3
prerank,extracellular matrix organization (GO:0030198),0.5284244672634539,1.7127037914784784,0.0,0.561360704740212,1.0,51/276,6.42%,COL25A1;COL8A1;ADAMTSL3;COL12A1;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;TLL1;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;CYP1B1;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;P3H2;ITGA10;ADAMTSL5;BMP1;DDR2;COL3A1;P4HA2;GSN;CAPN2;ITGA5;PLOD2;P4HA1;PDGFA;COL6A3;TGFBR1;ADAM12;HTRA1;FLRT2;P3H4;ADAMTS5;MATN1;MMP16;ITGAV;MMP14
prerank,ganglioside biosynthetic process (GO:0001574),-0.6660855536271315,-1.7125040791661232,0.01240694789081886,0.30091962613025464,0.999,8/15,17.88%,ST6GALNAC3;ST3GAL1;ST8SIA4;ST8SIA6;ST3GAL5;ST6GALNAC4;B4GALT5;ST6GALNAC6
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6670698555192058,1.7110991358636252,0.0056657223796034,0.5563867124335544,1.0,7/39,3.36%,STK39;FHL1;PTPN3;ANK2;NEDD4;WWP2;FXYD5
prerank,positive regulation of cell junction assembly (GO:1901890),-0.48008260438935246,-1.7110178445777382,0.008620689655172414,0.29504633597853047,0.999,22/56,21.03%,TEK;CLDN5;NRXN1;CNTNAP2;IL1RAPL1;KDR;EPHB1;MAP4K4;GRID2;FLOT1;SRPX2;RAC1;MYOC;LRRC4B;ACE2;AGT;PPM1F;CLSTN3;CLSTN1;NLGN1;VEGFA;NLGN2
prerank,ureteric bud development (GO:0001657),0.762802271110536,1.7105279986059292,0.0032102728731942215,0.5451139466642874,1.0,5/17,2.57%,SLIT2;BMP4;SIX1;WNT11;GPC3
prerank,central nervous system neuron development (GO:0021954),-0.6583378743764611,-1.7083592350759766,0.02295918367346939,0.2937372353963312,0.999,8/15,17.55%,RAPGEF2;MAP2;LHX6;NTRK2;MAPT;HSP90AB1;ATP7A;B4GALT5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8198140791124979,1.707885621740796,0.01060070671378092,0.546742477888353,1.0,2/11,0.45%,SLIT2;CCN3
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5687812911567314,-1.7070500121027645,0.009009009009009009,0.28858395056481656,0.999,14/26,14.55%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;MT2A;SLC30A1;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6450373525679026,1.7070032384218803,0.005547850208044383,0.5377028946790501,1.0,6/45,5.37%,SLC38A2;EGFR;BMP4;DDX5;DXO;NFKB1
prerank,chloride transport (GO:0006821),0.6035654517343003,1.7068823817614847,0.002551020408163265,0.5250483014631853,1.0,8/74,4.47%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;SLC12A8;ANO6;GLRB
prerank,cGMP-mediated signaling (GO:0019934),-0.6885108423405552,-1.7058677691835413,0.017632241813602016,0.28342119278324407,0.999,7/13,12.07%,IRAG1;APOE;GUCY1B1;KCNC2;PDE9A;PDE2A;PDE3A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7886697611303543,1.703927472212924,0.010416666666666666,0.530469300438259,1.0,1/13,0.01%,SLC4A10
prerank,epidermal cell differentiation (GO:0009913),0.658957405221075,1.7037427362238067,0.004219409282700422,0.5190010759041177,1.0,11/41,6.86%,CLIC4;ANXA1;DSP;ADAM9;TGM3;BCR;SPRR1A;WNT16;PIP5K1A;TGM1;JAG1
prerank,negative regulation of leukocyte migration (GO:0002686),0.8419381096858496,1.7036215734734474,0.0070921985815602835,0.5076169967310208,1.0,2/10,1.04%,SLIT2;BMP5
prerank,cellular component maintenance (GO:0043954),-0.7013333333689575,-1.703562224483739,0.02040816326530612,0.28211473764239736,0.999,4/12,8.76%,IGF1R;ITGA3;INSR;CLDN1
prerank,sprouting angiogenesis (GO:0002040),0.616899424980172,1.7033532477781976,0.003973509933774834,0.49748982827797855,1.0,9/51,2.85%,RSPO3;SLIT2;BMP4;BMPER;THBS1;PTK2B;PARVA;PGF;SEMA3E
prerank,gland development (GO:0048732),0.6180114272247804,1.7030232916639498,0.00522875816993464,0.4884002101914198,1.0,15/59,7.89%,MET;SOX9;IGSF3;COBL;ANXA1;SIX1;TGFB3;EZR;WNT11;STRA6;RIPK3;TGFBR1;PRKCSH;FOXE1;HES1
prerank,regulation of acrosome reaction (GO:0060046),-0.7253873274219393,-1.699161134366279,0.011848341232227487,0.2860609881993876,0.999,2/10,9.15%,PLCB1;GLRA1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.700534774528633,1.6970715469264195,0.0015360983102918587,0.5125953574593646,1.0,7/26,2.62%,STK39;FHL1;ANK2;ATP1B1;NEDD4;ITGB1;WWP2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5925180906840019,-1.6946253152585034,0.011396011396011397,0.29036844953518903,0.999,4/23,2.27%,ENG;TGFBR3;NREP;ITGA3
prerank,cartilage development (GO:0051216),0.6405166524944156,1.6938596987221155,0.0028129395218002813,0.5203582841684434,1.0,18/49,11.54%,BMP4;CCN3;SOX9;ITGB8;NFIB;PKD1;CD44;ZBTB16;SULF1;GDF5;DDRGK1;SNX19;FGF2;SLC39A14;SULF2;HYAL3;WNT2B;TRIP11
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5861783378708887,-1.6913571768296904,0.008620689655172414,0.29203360011486007,0.999,8/25,13.14%,ERRFI1;PPARA;SLC6A9;CBLB;SOCS5;CNRIP1;ACE2;ZFYVE28
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7793925249979327,1.6903583533984863,0.01818181818181818,0.5303184415921245,1.0,3/14,2.51%,STK39;PTK2B;WNK1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4902499423548228,-1.6888686598536964,0.0038461538461538464,0.2917304273609817,0.999,12/49,10.04%,IGF1;LYN;IL31RA;KIT;PARP14;IL6ST;IL6R;ARL2BP;GHR;ERBB4;IL18;TNFRSF1A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4040177996729037,-1.686925785577901,0.0,0.2901138319991725,0.999,74/168,17.79%,RPLP1;RPS14;CNOT6L;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;AGO1;RPL5;RPS4X;RPS2;RPS13;NBDY;RPL34;RPL23;RPL17;RPS19;RPS8;CNOT8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;EXOSC8;RNPS1;LSM1;RPS18;RPL18;RPL39;RPS11;RPL23A;UPF1;RPL7A;RPL35A;RPL26;RPL32;RPL18A;TENT4B;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;DCP1B;CNOT9;RPL31;DCP2;RPL19;RPLP0;RPS15A;RPS28
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7799978260572756,1.685307165946166,0.013311148086522463,0.5483587893725635,1.0,3/13,1.77%,BMP4;NR3C2;ESR2
prerank,rRNA metabolic process (GO:0016072),-0.40047677048761965,-1.683942323594109,0.0,0.2914748176654223,0.999,60/160,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;MAPT;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;NIFK;RPL27;LAS1L;RPL11;DDX54;PIH1D1;RPL31;RPL19;RPLP0;RPS28;RPL37;NOB1;RPL29
prerank,zinc ion homeostasis (GO:0055069),-0.550024851076109,-1.6758224564656794,0.012269938650306749,0.307195590871492,1.0,14/28,14.55%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;MT2A;SLC30A1;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6851540836280416,1.67517445536033,0.017937219730941704,0.5981320967946603,1.0,11/25,7.87%,CXADR;ANK2;DSP;CAMK2D;CACNA1C;DSG2;DSC2;TRPM4;DLG1;FGF13;JUP
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.730517555163265,1.672789382770256,0.015025041736227046,0.6023729298123564,1.0,6/20,11.02%,SMOC2;THBS1;SULF1;FGF2;SULF2;NOG
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5593515395132826,1.6726768719095413,0.0036231884057971015,0.591570948309624,1.0,24/104,11.34%,BMPER;CRIM1;CCN3;SMAD9;CD109;HTRA3;VWC2;SMAD6;SKIL;IGSF1;BAMBI;BMPR1A;SPRED2;TGFBR1;TGFBR2;TGFB1I1;UBE2D3;IL17RD;PPM1A;SKI;NKX2-1;BCL9L;NOG;ACVR1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.6521863259893411,1.6725976939112042,0.006887052341597796,0.5808120944382515,1.0,8/40,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6;SLC38A7
prerank,digestive tract development (GO:0048565),0.6741251221447374,1.6718708486427034,0.01002865329512894,0.5745375344567675,1.0,13/32,11.91%,RARB;PCSK5;SMO;COBL;PKD1;GLI3;STRA6;CCDC40;CLMP;GATA4;AGR2;TGFB2;MEGF8
prerank,sodium ion import across plasma membrane (GO:0098719),0.7533486208148527,1.6698803188194937,0.013266998341625208,0.5772351670018999,1.0,4/17,5.12%,SLC9A2;SLC12A2;SLC9C1;TRPM4
prerank,regulation of smooth muscle contraction (GO:0006940),0.7134733821562503,1.6695071878837426,0.017628205128205128,0.5693058585772255,1.0,3/20,3.11%,KCNB2;PLCE1;ADRB2
prerank,transepithelial transport (GO:0070633),0.7782941552113012,1.666227960131185,0.013445378151260505,0.5790286638195761,1.0,5/15,2.82%,SLC23A1;SLC23A2;SLC12A2;CXADR;ABCG2
prerank,negative regulation of endocytosis (GO:0045806),-0.5629872809952802,-1.6647614044629169,0.02005730659025788,0.3332407589448892,1.0,7/24,9.48%,PRKD1;PICALM;MCTP1;NR1H3;SYT11;RAC1;CD300A
prerank,inorganic anion transport (GO:0015698),0.610223077529871,1.663050024947704,0.010825439783491205,0.5877325250125608,1.0,4/53,2.81%,SLC4A10;SLC26A7;CLIC4;ANO6
prerank,carbohydrate transport (GO:0008643),0.8146111268210667,1.6624559544373803,0.017094017094017096,0.5815622178799155,1.0,2/11,0.26%,SLC23A1;SLC23A2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6222695253728996,1.6624312714327163,0.009943181818181818,0.572072863706935,1.0,3/42,2.51%,STK39;PTK2B;WNK1
prerank,regulation of interleukin-1 production (GO:0032652),0.7533922297611467,1.6608046985120843,0.029459901800327332,0.5724120572706602,1.0,3/15,3.51%,FOXP1;ANXA1;IL10
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5183150075975741,-1.6596514173556909,0.01892744479495268,0.3416979203623589,1.0,24/38,30.60%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;NDUFS1;NDUFA2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7918134626053607,1.6580289442310787,0.01020408163265306,0.5798247418490867,1.0,6/12,11.02%,SOX9;SMO;SIX1;GDNF;SIX4;NOG
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6350552962952256,-1.6566575906142762,0.00997506234413965,0.3432517138191338,1.0,12/17,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;CYSLTR2;ADCY4;ADCY3;ADCY8
prerank,response to glucagon (GO:0033762),-0.6184080029010378,-1.6560570992280568,0.010666666666666666,0.3380162751714646,1.0,12/19,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;CYSLTR2;ADCY4;ADCY3;ADCY8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6253188105649956,-1.655343301248862,0.007772020725388601,0.33304473778139454,1.0,9/17,19.27%,COX4I1;COX7C;COX8A;COX6B1;COX6A1;COX5B;COX6C;COX10;CYCS
prerank,positive regulation of potassium ion transport (GO:0043268),0.650289341899019,1.654847729234501,0.005714285714285714,0.5888903480779686,1.0,5/38,1.46%,KCNJ2;FHL1;KCNMB3;KCNMB2;ANK2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7879719856821568,1.6539507361687225,0.017605633802816902,0.5855352333168516,1.0,1/12,0.11%,FZR1
prerank,rRNA processing (GO:0006364),-0.39135631584568403,-1.653898405118899,0.0,0.32966931908482155,1.0,62/172,18.75%,NSA2;RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RIOK1;RPL27;LAS1L;RPL11;TSR3;DDX54;PIH1D1;RPL31;RPL19;RPLP0;THUMPD1;RPS28;RPL37;NOB1;RPL29
prerank,response to interferon-alpha (GO:0035455),-0.6295690237658216,-1.6535274147134935,0.017811704834605598,0.3241836835335449,1.0,6/16,10.24%,IFNAR1;BST2;IFITM1;GAS6;IFNAR2;IFITM3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6967244046458682,1.653214398400292,0.013888888888888888,0.5806096303911848,1.0,7/26,8.85%,FOXP1;ISL1;CRY2;KANK2;PIAS2;STRN3;SMARCA4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.598755521663925,1.6525942838151493,0.00804289544235925,0.5752478882043752,1.0,12/56,5.78%,BMP4;BMPER;BMP5;TGFB3;INHBA;BMP6;SMAD6;GDF6;GDF5;BMPR1A;TGFBR1;BMP15
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.623388327419957,-1.6518298117479495,0.015544041450777202,0.32210606839381895,1.0,9/18,22.11%,CAMK1D;RPS6KA5;PRKD1;ADCY1;LRP8;CRTC2;ADCY8;VEGFA;CD200
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5618703109042649,1.6507508775304494,0.008684863523573201,0.5774365850542695,1.0,20/86,7.81%,BMP4;THBS1;BMP5;TGFB3;FOXD1;SULF1;CCN1;INHBA;BMP6;GDF6;GDF5;NUP93;GIPC1;BMPR1A;TGFBR1;ZNF423;BMP15;EP300;TGFB1I1;CREBBP
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6773779008879132,1.6490412882484031,0.01078582434514638,0.5785890176738113,1.0,7/25,5.45%,BMP4;FOXD1;SULF1;CCN1;GDF5;BMPR1A;ZNF423
prerank,sodium ion transport (GO:0006814),0.563907448022123,1.6483621535634894,0.004860267314702308,0.5736959755067466,1.0,17/85,8.73%,SLC4A4;SLC9B2;SLC23A1;SLC12A2;SLC24A3;SLC5A6;ATP1B1;SLC6A7;ANO6;SLC6A19;NALCN;SCN11A;SLC38A7;SLC4A8;FGF13;PKD2L1;SLC6A16
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6263279038559195,1.6478628891094806,0.023255813953488372,0.5684779357825093,1.0,11/39,7.71%,SLIT2;BMP4;MET;SIX1;PKD1;SEMA3E;LRP6;GDNF;TGFBR2;FGF2;NRP1
prerank,embryonic skeletal system development (GO:0048706),0.6464026022535413,1.6461342071494636,0.013043478260869565,0.5702663472160178,1.0,7/35,2.75%,KIAA1217;PCSK5;WNT9A;SIX1;SULF1;WNT11;HOXA3
prerank,sulfate transport (GO:0008272),0.7460251483016012,1.6457674337359587,0.031932773109243695,0.5645065692774451,1.0,2/14,0.36%,SLC26A7;SLC26A2
prerank,transition metal ion transport (GO:0000041),-0.5161970335193471,-1.6433417213012775,0.013029315960912053,0.3404767709821638,1.0,15/35,14.74%,CP;SLC30A10;FTH1;TRPC3;TFRC;SLC39A8;ATOX1;ATP2C1;COX17;TTYH1;SLC31A1;SLC30A1;TRPC4;TRPC6;SLC11A2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7494154033564865,1.6428884878274788,0.027210884353741496,0.572359085033587,1.0,6/14,10.39%,THBS1;SULF1;FGF2;FUZ;SULF2;GATA3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5457018736802646,-1.6416310335919937,0.0273224043715847,0.3389461608593419,1.0,4/26,8.48%,ATP1A2;CALM1;ADRA2A;CALM3
prerank,positive regulation of chemotaxis (GO:0050921),0.6190462460162662,1.6414391659915732,0.013888888888888888,0.5732943344398697,1.0,5/43,1.07%,SMOC2;F3;THBS1;MET;NTRK3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.716918500467868,-1.6395261807714288,0.024553571428571428,0.3392599437369865,1.0,6/10,11.07%,DCN;BCL2;KDR;LRRK2;SRC;MYOC
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.6315459901766509,1.639406788246742,0.016597510373443983,0.5773904520428227,1.0,11/38,9.48%,KCNJ2;ANK2;DSP;CAMK2D;ISL1;CACNA1C;DSG2;DSC2;TRPM4;JUP;CACNB2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5919020596833596,-1.6386847008384635,0.0056022408963585435,0.33558978130227773,1.0,6/21,9.74%,PLTP;APOE;PTCH1;NR1H3;GPS2;EEPD1
prerank,embryonic digestive tract development (GO:0048566),0.7279352241044488,1.631149742005278,0.01951219512195122,0.6167508802273407,1.0,4/18,2.71%,RARB;PCSK5;GLI3;STRA6
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7639654067846154,1.6292180351998315,0.02146690518783542,0.619859326193988,1.0,3/12,1.04%,SLIT2;CCN3;BMP5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7293195691327741,1.6287525134050755,0.028286189683860232,0.6144673152066846,1.0,3/17,1.69%,SLIT2;FSTL1;SULF1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6783340702674243,1.627299823899631,0.01791044776119403,0.6151449817317163,1.0,3/24,2.81%,SLIT2;CCN3;ANO6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.7599743076960197,1.6271215767250298,0.038869257950530034,0.6084215793872386,1.0,2/12,1.91%,BMP4;NEDD4
prerank,negative regulation of cartilage development (GO:0061037),0.7552067120977536,1.6269293046571638,0.04262877442273535,0.6018767394128934,1.0,6/13,5.26%,SOX9;WNT9A;WNT11;EFEMP1;GDF5;TGFBR1
prerank,positive regulation of phagocytosis (GO:0050766),-0.476489143075319,-1.6253281935134425,0.01079136690647482,0.36903375399134764,1.0,25/47,28.51%,CAMK1D;MERTK;CD47;IL15RA;MYO18A;CYBA;SIRPA;GAS6;C4B;GATA2;CALR;APPL2;RAB27A;NCKAP1L;LMAN2;LYAR;C3;CCL2;TREM2;PTPRC;DOCK2;IL2RG;AHSG;C2;PLA2G5
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5433639531535565,-1.6239182741991383,0.006230529595015576,0.36691272971704547,1.0,9/27,16.31%,PLTP;APOE;PTCH1;NR1H3;GPS2;ABCA5;EEPD1;ABCB4;SCP2
prerank,vesicle transport along actin filament (GO:0030050),-0.5972147056417778,-1.621856276289311,0.02535211267605634,0.36656128683115563,1.0,7/19,18.01%,MYO1B;MYO6;FNBP1L;MYO5A;MYO5C;WASL;MYO1F
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5594801671056161,1.6216654764768774,0.0112079701120797,0.6246796165695735,1.0,13/76,7.28%,EGFR;NR3C2;CCN3;RASSF2;EZR;TCIM;NFAT5;PDCD4;EP300;TRIP6;DLG1;TRIM44;IFI35
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5914985166860995,1.6207699439546175,0.011857707509881422,0.622433092065689,1.0,29/59,19.21%,STK39;CAMK2D;WNK1;CIT;PRKCD;HIPK1;GSK3B;TGFBR1;TGFBR2;MARK2;DYRK2;CDC42BPG;DYRK3;CAD;TAF1;CHEK1;ACVR1;CSNK2A2;CSNK2A1;NLK;MAPK1;PRKCA;WNK3;MAP3K12;PRKDC;MAPK8;CDC42BPA;PRKD2;ULK1
prerank,metal ion homeostasis (GO:0055065),0.6193855498491843,1.6196206651324256,0.009790209790209791,0.6216562399682724,1.0,6/40,3.44%,SLC12A7;SLC12A2;SLC12A8;CNNM2;CNNM4;CLDN16
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6113685373436479,-1.6194843115733573,0.014742014742014743,0.36773796132818815,1.0,9/16,17.68%,APOE;NOS3;GUCY1B1;NDNF;KCNC2;GUCY1A1;AGT;NOS1;DDAH2
prerank,response to UV-A (GO:0070141),0.7452691674664481,1.6171888881334369,0.04047217537942664,0.6290555685434787,1.0,1/14,0.19%,EGFR
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6332088460389869,-1.6171329205544325,0.009411764705882352,0.3691204030217389,1.0,9/15,25.15%,IL31RA;NR1H3;GRN;CD300A;HAVCR2;CD84;LRFN5;CD200;GPER1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7301962091793192,1.6159747369451598,0.024429967426710098,0.628728150879348,1.0,5/16,7.51%,BMP4;SIX1;FOXD1;GDNF;FGF2
prerank,regulation of histone acetylation (GO:0035065),-0.519304290463364,-1.615500685422033,0.022727272727272728,0.36823440924191386,1.0,14/33,18.30%,RPS6KA5;RAPGEF3;SNCA;MAPK3;PPARGC1A;ARRB1;SET;MYOCD;NOC2L;RUVBL2;NOS1;FLCN;PARK7;BRCA1
prerank,carnitine shuttle (GO:0006853),-0.6731126699573953,-1.6154965607552796,0.017543859649122806,0.36219777958221033,1.0,5/11,11.01%,PRKAG2;CPT1A;ACACA;ACACB;PRKAA2
prerank,pharyngeal system development (GO:0060037),0.7283602095352383,1.6141790309619042,0.040336134453781515,0.6314935621847809,1.0,10/15,11.71%,BMP4;BMP5;ISL1;BMPR1A;TGFBR1;HES1;SIX4;GATA3;NOG;TGFB2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7201192827292611,1.612877367840475,0.04317789291882556,0.6315964852713942,1.0,5/15,7.51%,SMOC2;THBS1;MET;P2RX4;FGF2
prerank,organic acid transport (GO:0015849),0.5498996338393461,1.612736542649245,0.010817307692307692,0.6251967672885377,1.0,11/94,3.42%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;SLC16A1;ABCG2;SLC7A2;SLC6A19
prerank,regulation of membrane depolarization (GO:0003254),0.7163250214085289,1.6126640678860364,0.024752475247524754,0.6186003494969369,1.0,3/18,2.02%,FHL1;PTPN3;CAMK2D
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6271511881005689,-1.6122789381802107,0.031331592689295036,0.3655663375791458,1.0,4/15,9.53%,PLTP;APOE;SCARB1;ABCA5
prerank,peptidyl-threonine modification (GO:0018210),0.5810316084789857,1.6121088481297876,0.012953367875647668,0.6147187087678333,1.0,31/66,19.21%,STK39;CAMK2D;WNK1;CIT;PRKCD;HIPK1;GSK3B;GALNT13;TGFBR1;TGFBR2;MARK2;DYRK2;CDC42BPG;DYRK3;CAD;TAF1;CHEK1;ACVR1;CSNK2A2;CSNK2A1;NLK;MAPK1;GALNT11;PRKCA;WNK3;MAP3K12;PRKDC;MAPK8;CDC42BPA;PRKD2;ULK1
prerank,response to chemokine (GO:1990868),0.7571393782003455,1.6092698027391241,0.028523489932885907,0.6242496823356519,1.0,3/13,2.51%,STK39;SLC12A2;WNK1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7012812296278311,-1.6090585250769558,0.017817371937639197,0.36856722555394916,1.0,3/10,5.83%,SEMA6A;DCN;DAB2IP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7552730471634722,1.6080055089309264,0.03904923599320883,0.6245561563030948,1.0,7/12,7.87%,DSP;CACNA1C;DSG2;DSC2;TRPM4;DLG1;JUP
prerank,epiboly involved in wound healing (GO:0090505),0.7331289750165724,1.6068566405942972,0.038834951456310676,0.6239367104010246,1.0,3/16,1.95%,TMEFF2;CD44;CCN1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7410484637072499,1.6068270332550532,0.03372681281618887,0.6174438737761959,1.0,2/14,2.42%,ME1;NMNAT2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7095336055712882,-1.6066595999569564,0.02877697841726619,0.36934558628370917,1.0,4/10,8.08%,LYN;RAPGEF2;CXCL12;GAS6
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7404454286400041,1.6064295206455168,0.0338409475465313,0.6132998481641466,1.0,6/13,5.26%,BMP4;TGFB3;BMP6;NUP93;BMPR1A;TGFBR1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.5860877446636277,-1.6054855076979895,0.017948717948717947,0.3671864094901202,1.0,11/19,22.80%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,external encapsulating structure organization (GO:0045229),0.5047333973618915,1.605272829500971,0.0,0.6135283760938768,1.0,41/205,7.51%,COL8A1;ADAMTSL3;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;ITGA10;ADAMTSL5;DDR2;COL3A1;TGM3;ITGA5;PDGFA;COL6A3;ADAM12;ADAMTS5;MATN1;MMP16;ITGAV;MMP14;TGM1;SMOC1;LOXL1;FGF2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5684872064607525,-1.60473487527369,0.02349869451697128,0.36374578103355487,1.0,9/21,9.60%,ITGA1;PDGFRB;CALM1;MEF2C;BMP2;CALM3;PLEK;CD300A;HSP90AB1
prerank,axon extension (GO:0048675),0.6711110385975176,1.6045051765320846,0.014469453376205787,0.6111066222352657,1.0,6/23,9.26%,SLIT3;SLIT2;ALCAM;ULK2;NRP1;SPG11
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7640708376935729,1.6042453139498818,0.03571428571428571,0.6062586806029562,1.0,2/11,1.47%,KCNJ2;ATP1B1
prerank,regulation of fibrinolysis (GO:0051917),0.7620526486928453,1.6037683166519403,0.03460207612456748,0.6026667897158954,1.0,2/13,4.13%,THBS1;THBD
prerank,postsynaptic membrane organization (GO:0001941),-0.6191178545350356,-1.6014807510793678,0.02040816326530612,0.3678060905119811,1.0,6/17,11.54%,SHANK3;APOE;NRXN1;GPHN;LRRC4;MUSK
prerank,regulation of response to stress (GO:0080134),0.7726000547823487,1.6010418381401754,0.040780141843971635,0.6109745211019862,1.0,3/10,3.51%,SLC38A2;EIF4G1;IL10
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6650527940440246,-1.6008059408211661,0.03644646924829157,0.36417335555207875,1.0,6/11,18.14%,PARP14;PARP8;PARP11;TIPARP;PARP12;PARP16
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7281485420047464,1.600702996614505,0.033444816053511704,0.6068386434075234,1.0,4/16,6.68%,NT5E;DPYSL3;NT5C1A;UPP2
prerank,lymphocyte mediated immunity (GO:0002449),0.7568536449492834,1.5999166327790528,0.04088586030664395,0.6053298779136638,1.0,5/12,10.17%,CD55;GNL1;KLRC2;JAG1;CD46
prerank,renal water homeostasis (GO:0003091),-0.5672276718411255,-1.5986989838556493,0.01643835616438356,0.365281072907766,1.0,12/23,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;AQP4;PRKAR1B;PRKAR1A;ADCY4;ADCY3;ADCY8
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7322544113240399,1.598211609839348,0.039723661485319514,0.6087090060254854,1.0,4/14,12.58%,THBS1;IL10;CMKLR1;PIBF1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.7021358757259817,-1.5976025080878145,0.031476997578692496,0.3629891014669794,1.0,6/10,21.35%,SNCA;SET;KLF15;NOC2L;BRCA1;CTBP1
prerank,carboxylic acid transport (GO:0046942),0.5784926361375927,1.5957947307905418,0.02216427640156454,0.6160132924990225,1.0,7/55,2.03%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC6A7;SLC16A1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6658227621771446,-1.595737057794732,0.025522041763341066,0.3633610167291532,1.0,4/12,5.83%,SEMA6A;ADAMTS12;DCN;DAB2IP
prerank,positive regulation of organelle organization (GO:0010638),0.6413734566192925,1.5953758613098696,0.032116788321167884,0.612427180038537,1.0,12/32,15.88%,SORBS3;ANXA1;ATL3;ANXA2;ADRB2;GSK3B;RAB3GAP2;SMCR8;C2CD5;KATNBL1;SYNJ1;FYCO1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6648580841533402,-1.5948380122726664,0.026845637583892617,0.3612130586589752,1.0,7/11,24.97%,UQCR10;UQCRH;UQCR11;CYCS;UQCRC2;UQCRB;UQCRFS1
prerank,cellular response to BMP stimulus (GO:0071773),0.5694875633736648,1.5947721823097316,0.012853470437017995,0.6097918126533258,1.0,13/66,5.78%,BMP4;SMAD9;SOX9;BMP5;TGFB3;DDX5;BMP6;SMAD6;GDF6;GDF5;PDCD4;BMPR1A;BMP15
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7514782728844618,1.5941061360086264,0.032490974729241874,0.6075818214388619,1.0,4/11,4.42%,EGLN3;P3H2;P4HA2;P4HA1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5963785835385296,1.5939936696482315,0.013157894736842105,0.6026606332644041,1.0,7/54,2.62%,STK39;KCNJ2;FHL1;KCNMB3;KCNMB2;NEDD4;WWP2
prerank,extracellular structure organization (GO:0043062),0.5015894704057939,1.593713653986688,0.0,0.5987347506439563,1.0,40/204,7.51%,COL8A1;ADAMTSL3;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;ITGA10;ADAMTSL5;DDR2;COL3A1;ITGA5;PDGFA;COL6A3;TGFBR1;ADAM12;ADAMTS5;MATN1;MMP16;ITGAV;MMP14;SMOC1;LOXL1;FGF2
prerank,spinal cord development (GO:0021510),0.7810090768146194,1.5933484875827633,0.028764805414551606,0.5953742384649116,1.0,2/12,1.38%,VIT;PKD1
prerank,response to zinc ion (GO:0010043),-0.5369975251006688,-1.591840219766968,0.024725274725274724,0.36566262009098077,1.0,13/25,14.55%,PAM;CRIP1;GLRA1;MT2A;SLC30A4;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,regulation of protein import into nucleus (GO:0042306),0.6258660494368892,1.5891951229033376,0.01702127659574468,0.6106202954056626,1.0,8/36,7.87%,CDH1;BMP4;PRKCD;ZIC1;MDFIC;HCLS1;MAVS;JUP
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.6867718455925829,1.5886660184941725,0.03924914675767918,0.6081498469251939,1.0,5/17,12.71%,BMP4;SOX9;FGF2;ATOH8;SFN
prerank,ureteric bud morphogenesis (GO:0060675),0.7228066258073883,1.588395498520219,0.03236797274275979,0.6042332940520723,1.0,6/16,10.39%,BMP4;SIX1;WNT11;GDNF;FGF2;GATA3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6710656795395352,1.5873497239439744,0.026397515527950312,0.6042573361314351,1.0,8/23,11.02%,BMP4;SOX9;SMO;SIX1;GDNF;FGF2;SIX4;NOG
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7059146491872492,-1.5871501427900454,0.01818181818181818,0.3751103884453148,1.0,2/10,6.13%,ATP1A2;ADRA2A
prerank,response to nitric oxide (GO:0071731),-0.6362373592087359,-1.5860324094935856,0.0399002493765586,0.37363891670896476,1.0,9/13,30.00%,FOXO1;GUCY1B1;KCNC2;EGLN1;CCL19;TXN;MMP3;MT3;AQP1
prerank,negative regulation of potassium ion transport (GO:0043267),0.7581564148846731,1.5851362502260467,0.04674457429048414,0.6107495800828472,1.0,2/13,1.57%,STK39;PTK2B
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.6030484817151642,-1.584560524860274,0.025,0.3727909979350425,1.0,11/17,22.80%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,aortic valve morphogenesis (GO:0003180),0.6346227006736045,1.584472670294597,0.027607361963190184,0.6091098390924279,1.0,5/30,3.02%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,positive regulation of heart contraction (GO:0045823),-0.5635718341215316,-1.584201380567831,0.013157894736842105,0.3689659916421021,1.0,10/19,22.16%,ATP1A2;KCNQ1;EDN1;RYR2;ADM;EDN3;GSK3A;ATP2A2;SCN3B;CHGA
prerank,potassium ion transmembrane transport (GO:0071805),0.520495374067712,1.5833739087053136,0.0033975084937712344,0.6094624528859185,1.0,14/135,4.01%,SLC9A2;KCNB2;KCNK5;SLC12A7;KCNJ2;SLC12A2;SLC24A3;KCNQ5;ATP1B1;SLC12A8;KCNS3;SLC9C1;NALCN;KCNB1
prerank,negative regulation of histone acetylation (GO:0035067),-0.6593480934343595,-1.5831673574023375,0.046189376443418015,0.36717154424541393,1.0,6/11,24.24%,SNCA;SET;NOC2L;BRCA1;CTBP1;SPI1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6076926302735106,1.5823952929319427,0.013831258644536652,0.6096724348789462,1.0,7/44,2.81%,KCNJ2;KCNMB3;KCNMB2;ANK2;ATP1B1;WNK1;ANO6
prerank,purine-containing compound catabolic process (GO:0072523),0.7363250581749654,1.5815066172732555,0.042735042735042736,0.6090401006563908,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,membrane repolarization during action potential (GO:0086011),0.7447411924574485,1.5808111848921573,0.03767123287671233,0.6077627943651417,1.0,2/13,1.47%,KCNJ2;ATP1B1
prerank,nucleosome assembly (GO:0006334),0.6319425216607492,1.579392701567375,0.03186646433990895,0.6104484067753964,1.0,6/31,6.93%,SOX9;CHAF1B;UBN1;KAT6B;CABIN1;NAP1L2
prerank,mesenchyme development (GO:0060485),0.7150154632486126,1.5793597670375703,0.03571428571428571,0.6056094051705261,1.0,5/15,8.03%,BMP4;WNT11;ISL1;TGFBR1;GATA4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6363715078518251,1.5788093112770765,0.03829160530191458,0.603570710856567,1.0,10/27,7.87%,ANK2;DSP;CAMK2D;CACNA1C;DSG2;DSC2;TRPM4;DLG1;FGF13;JUP
prerank,skin development (GO:0043588),0.5579465600260848,1.5771487112523872,0.012690355329949238,0.6069899992004452,1.0,16/65,6.86%,CLIC4;MET;ANXA1;PKD1;COL5A2;DSP;COL3A1;ADAM9;TGM3;BCR;SPRR1A;WNT16;PDGFA;PIP5K1A;TGM1;JAG1
prerank,negative regulation of viral transcription (GO:0032897),-0.6325510742119024,-1.5761901415638142,0.024630541871921183,0.3823500880964652,1.0,7/13,21.39%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27;LARP7;TRIM32
prerank,negative regulation of myotube differentiation (GO:0010832),0.7560738912349141,1.5754330211138843,0.058823529411764705,0.6104034296638694,1.0,2/12,1.51%,CCN3;HDAC4
prerank,amino acid transmembrane transport (GO:0003333),0.5958690400327118,1.5750417493836804,0.020804438280166437,0.6076386039137441,1.0,8/45,5.72%,SLC47A1;SLC38A2;SLC38A1;LRRC8D;SLC38A6;SFXN1;SLC38A7;SFXN2
prerank,positive regulation of wound healing (GO:0090303),0.6244662672211068,1.5749039502301094,0.028985507246376812,0.603574554407317,1.0,7/36,5.00%,SMOC2;ST3GAL4;THBS1;ANXA1;ITGB1;PLPP3;FOXC2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5810324368869085,-1.5726029950155258,0.0316622691292876,0.3883805321301162,1.0,7/18,7.31%,FLT1;COL4A3;AKT3;ITGA4;IGF2;MEF2C;MDK
prerank,negative regulation of T cell differentiation (GO:0045581),0.7694944088503349,1.5725162174003873,0.045787545787545784,0.610355763770162,1.0,2/10,1.61%,BMP4;GLI3
prerank,basement membrane organization (GO:0071711),-0.6372675735697267,-1.5719345704879994,0.024213075060532687,0.38553012145768467,1.0,6/14,8.45%,NID1;NID2;COL4A1;RAMP2;LAMB1;CTSS
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7750894547042502,1.5711595767257749,0.04639175257731959,0.6120818696375631,1.0,1/11,0.08%,STK39
prerank,regulation of viral life cycle (GO:1903900),-0.5692677928696568,-1.5709828847970364,0.02072538860103627,0.38368012362563947,1.0,10/21,18.10%,PPIA;TRIM14;TRIM62;HS3ST5;NECTIN2;TRIM21;TRIM27;KPNA2;TYRO3;TRIM6
prerank,glycine transport (GO:0015816),-0.6880031814983653,-1.5708282597251957,0.035,0.37944163960478827,1.0,6/10,23.33%,SLC6A9;SLC38A5;SLC6A17;SLC25A38;SLC7A8;SLC36A2
prerank,regulation of T cell chemotaxis (GO:0010819),0.7695992706875509,1.5692672458563488,0.037800687285223365,0.6164826002820369,1.0,2/11,2.51%,STK39;WNK1
prerank,AMP metabolic process (GO:0046033),0.7542875727525228,1.5678113143307053,0.03508771929824561,0.6191220743698785,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.49716667457285935,-1.566211613093572,0.006756756756756757,0.3886013871943239,1.0,15/35,8.84%,IRAG1;KSR1;APOE;RAPGEF3;PDE7B;ADCY1;RAPGEF2;AHR;RIMS2;ADCY2;GUCY1B1;CAP2;PDE4D;PDE9A;PDE2A
prerank,response to estradiol (GO:0032355),0.6247493516792223,1.5657105860198945,0.033873343151693665,0.6246344940966951,1.0,11/31,15.32%,EGFR;ANXA1;MYOG;SOCS2;STRN3;KAT5;FOXA1;CYP19A1;STAT3;LCOR;NRIP1
prerank,regulation of sensory perception of pain (GO:0051930),0.7562278351390496,1.5648342966329212,0.04671280276816609,0.6240931454797342,1.0,4/11,8.56%,CCN3;MGLL;SCN11A;ACP3
prerank,chemical homeostasis (GO:0048878),0.5606127081891747,1.5641268255973912,0.02564102564102564,0.6230552089271155,1.0,7/61,6.88%,SLC4A10;SLC4A4;WNK1;PNPLA3;RBP1;HNF4A;SLC4A8
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.556611857468182,-1.5634225424079042,0.028423772609819122,0.39229380779904754,1.0,10/22,14.88%,SLC16A2;KDM2B;MDK;NES;GATA2;LRRK2;TOX;TAFA1;PROX1;APPL2
prerank,detection of mechanical stimulus (GO:0050982),0.6870673969783553,1.5631910092106065,0.03937007874015748,0.6231838529335834,1.0,7/19,11.00%,PIEZO2;PKD1;CSRP3;PKD2L2;JUP;PKD2L1;PKD1L2
prerank,response to alcohol (GO:0097305),0.633845423260821,1.5629192447851965,0.036753445635528334,0.6199189874484763,1.0,5/27,6.07%,SLIT3;SLIT2;ADH7;TGFBR1;TGFBR2
prerank,organic cation transport (GO:0015695),0.6797291186030096,1.559360182879106,0.03482587064676617,0.6333746208924688,1.0,1/20,0.02%,SLC47A1
prerank,nucleotide biosynthetic process (GO:0009165),0.6929669491800232,1.5581170218292022,0.046104928457869634,0.6348087317633775,1.0,5/18,11.64%,ME1;NMNAT2;RRM2;PRPS2;NMNAT1
prerank,response to estrogen (GO:0043627),0.6216585494833308,1.5562572811224271,0.027941176470588237,0.6395703589182722,1.0,12/31,17.97%,KRT19;SERPINB9;EP300;CYP27B1;BCAS3;GATA3;TRIM25;KMT2D;CITED2;ASH2L;NCOA4;AR
prerank,ventricular septum morphogenesis (GO:0060412),0.6400853990702796,1.555167381392189,0.04,0.6403921523853431,1.0,11/27,11.71%,SLIT3;SLIT2;BMP4;ZFPM2;BMPR1A;TGFBR1;TGFBR2;HES1;NOG;ACVR1;TGFB2
prerank,entry into host (GO:0044409),0.7368021609755735,1.5547041261362455,0.04584040747028863,0.6381020080759012,1.0,5/13,9.97%,CDH1;MET;ITGAV;CTNND1;CXCR4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6872000372289042,-1.5545391017392058,0.030660377358490566,0.4138769331508052,1.0,2/10,2.57%,LYN;KIT
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7431929553595159,1.5541689824726392,0.05317324185248713,0.6360856378681279,1.0,3/12,8.85%,FOXP1;PIAS2;SMARCA4
prerank,ncRNA processing (GO:0034470),-0.36209228063210164,-1.553380822133113,0.0,0.41242937978080607,1.0,69/200,19.94%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;AGO1;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;LIN28B;RPL27A;RPL3;RPL24;EXOSC8;IMP3;AGO4;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;SMAD1;RPL32;RPL18A;RPS25;RPL36;SMAD3;RPL12;RPL27;LAS1L;RPL11;METTL3;DDX54;PIH1D1;RPL31;TARBP2;SARS1;RPL19;RPLP0;RPS28;RPL37;NOB1;RPL29;EXOSC3;RPL28;INTS4
prerank,regulation of cell growth (GO:0001558),0.4840731846380486,1.553319245438651,0.0021691973969631237,0.6360884029151529,1.0,39/204,12.86%,SLIT3;SLIT2;EGFR;PLCE1;CCN3;FHL1;NDRG3;OSGIN2;ESR2;CAMK2D;AGTR1;WNT11;INHBA;EIF4G1;FAM107A;IP6K2;SGK3;SOCS2;TGFBR1;KLHL22;HNF4A;MMP14;BAP1;ADAM10;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2;MTOR;PAK4;CDC42;LTBP4;RB1;CSNK2A1;TGFB2;USP47;ST7L;WFDC1
prerank,regulation of integrin activation (GO:0033623),-0.5893708868657235,-1.552249984123866,0.036585365853658534,0.41104766538191734,1.0,5/15,9.09%,PIEZO1;RASIP1;JAM3;PLEK;SRC
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7224654138789774,1.5516348303850007,0.04377104377104377,0.6396672754704669,1.0,3/15,3.22%,ANXA1;ISL1;FAM107A
prerank,urogenital system development (GO:0001655),0.7535766937708195,1.551210257864043,0.042328042328042326,0.6373751995256487,1.0,2/11,1.33%,SOX9;ANXA1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5782591485495493,1.550828405385981,0.03292181069958848,0.6350382251568872,1.0,10/45,5.78%,BMP4;BMP5;TGFB3;INHBA;BMP6;GDF6;GDF5;BMPR1A;TGFBR1;BMP15
prerank,regulation of cell communication (GO:0010646),0.5991202595691408,1.5504910148704323,0.025525525525525526,0.6322450676193606,1.0,7/35,4.79%,GRK5;CXADR;ANXA1;ANK2;CAMK2D;MGLL;SOCS2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7261568389135618,1.55029746150828,0.054385964912280704,0.6291209165336475,1.0,3/13,1.27%,BMP4;SOX9;NFIB
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5691298345461521,1.5500813914795444,0.028532608695652172,0.6262282136235385,1.0,10/53,9.20%,EGFR;EYA2;DDX5;PRKCD;SPRED2;BCLAF1;EYA4;EYA3;ATM;RNF168
prerank,skeletal system development (GO:0001501),0.507767121395232,1.5473286787658163,0.004449388209121246,0.6351909868912662,1.0,37/148,11.71%,KIAA1217;TNFRSF11B;SOX9;CDH11;EXT1;TLL1;BMP5;ITGB8;PCSK5;PKD1;CD44;ZBTB16;SULF1;AKAP13;DSPP;WNT11;FGFR1;HHIP;BMP6;BMP1;DDRGK1;PAPSS2;TGFBR1;PHEX;MMP16;MMP14;SLC10A7;UFD1;P3H1;SULF2;HYAL3;NOG;EIF2AK3;EBP;TRIP11;NPR3;TGFB2
prerank,cellular response to zinc ion (GO:0071294),-0.5900710656499903,-1.547219683626578,0.04819277108433735,0.4214764544853773,1.0,10/15,14.55%,GLRA1;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,chordate embryonic development (GO:0043009),0.5598776553058776,1.545965781156057,0.01984126984126984,0.6377748061351793,1.0,18/55,11.02%,KIAA1217;MBNL1;BMP5;PCSK5;PKD1;TGFB3;FUT8;SULF1;WNT11;FGFR1;ISL1;TGFBR1;STIL;ADAM10;SIX4;SULF2;GATA3;NOG
prerank,metanephros development (GO:0001656),0.6473902546746735,1.5459309908394998,0.03599374021909233,0.6338123509711877,1.0,6/26,5.17%,BMP4;SIX1;PKD1;FOXD1;GDF6;GDNF
prerank,regulation of cellular senescence (GO:2000772),-0.5009205799092548,-1.5453327743563665,0.03389830508474576,0.4223653719929483,1.0,13/28,22.31%,SLC30A10;B2M;AKT3;NUAK1;CDK6;YPEL3;YBX1;ABI3;CGAS;VASH1;ING2;RBL1;NEK4
prerank,aorta morphogenesis (GO:0035909),-0.5879620330527902,-1.5444619730177718,0.03640776699029126,0.4203891202939396,1.0,10/17,15.98%,ENG;MYLK;PDGFRB;ADAMTS9;TBX1;RBPJ;HEY2;EFEMP2;PROX1;HEY1
prerank,potassium ion transport (GO:0006813),0.5121980387082844,1.543942055475535,0.0045871559633027525,0.6394020014121696,1.0,12/120,4.01%,SLC9A2;KCNB2;KCNK5;KCNJ2;KCNMB3;KCNMB2;SLC24A3;KCNQ5;KCNS3;SLC9C1;NALCN;KCNB1
prerank,cGMP biosynthetic process (GO:0006182),0.7436863689086982,1.5438631707090638,0.047619047619047616,0.6356900857861599,1.0,1/10,0.09%,GUCY2C
prerank,response to hexose (GO:0009746),0.6324135051686344,1.5428857888249832,0.03840245775729647,0.6362296178167858,1.0,7/25,16.64%,THBS1;TCF7L2;HNF4A;EIF2B2;SELENOT;EIF2B3;IRS2
prerank,BMP signaling pathway (GO:0030509),0.5555315924116617,1.5417795360120459,0.019430051813471502,0.6378826416780655,1.0,20/62,14.78%,BMP4;SMAD9;BMP5;TGFB3;DDX5;BMP6;SMAD6;GDF6;GDF5;PDCD4;BMPR1A;BMP15;NOG;RGMB;ACVR1;TGFB2;MEGF8;CHRD;SMURF1;AMHR2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.770990714154616,1.5414843593929206,0.044563279857397504,0.6351453018758934,1.0,2/10,2.51%,STK39;WNK1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4806936077550653,-1.5412446622486347,0.011494252873563218,0.4261437473614894,1.0,15/37,8.98%,PLCB1;GRM3;GRIK1;GRIN2A;GRM5;GRM1;GRM7;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRM8;GRIN3A;GRIK2
prerank,secretion (GO:0046903),-0.610440627786009,-1.5402936547422192,0.025404157043879907,0.4245330070574946,1.0,5/14,3.88%,FBLN5;RIMS1;NPR1;SLC22A6;SLC22A4
prerank,kidney development (GO:0001822),0.5459718554309034,1.5398991915794509,0.03129074315514994,0.6387155329719457,1.0,14/65,6.52%,BMP4;PCSK5;SIX1;PKD1;ZBTB16;SULF1;AGTR1;STRA6;GDF6;GDNF;TGFBR1;KANK2;TFAP2A;ARL3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4359129574950038,-1.5398753544288015,0.020242914979757085,0.4212193600248761,1.0,13/57,10.04%,IGF1;LYN;IL31RA;KIT;PARP14;IL6ST;INPP5F;IL6R;ARL2BP;GHR;ERBB4;IL18;TNFRSF1A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6018484416491535,1.5397145289880312,0.03812316715542522,0.6356195694417317,1.0,11/35,13.71%,NR3C2;DDX5;ESR2;NEDD4;RBFOX2;TADA3;CALCOCO1;UBR5;ZMIZ1;PLPP1;DDX17
prerank,positive regulation of DNA replication (GO:0045740),0.6923768354814605,1.5394563406732145,0.03826955074875208,0.6328462491114524,1.0,8/16,21.13%,EGFR;BCAR3;STN1;DHX9;FAF1;ATAD5;GLI2;EGF
prerank,melanocyte differentiation (GO:0030318),-0.6593750509800239,-1.5391790349336074,0.03482587064676617,0.41889086010380544,1.0,6/11,10.91%,LRMDA;ENPP1;KIT;MEF2C;SLC24A5;MITF
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5945819074734889,-1.5390604494634552,0.032418952618453865,0.4149602090501625,1.0,8/16,18.10%,TRIM14;TRIM62;HS3ST5;NECTIN2;TRIM21;TRIM27;FUCA2;TRIM6
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5751066074734714,1.5389672838126576,0.025885558583106268,0.6312745438239343,1.0,11/46,11.25%,CDH1;TCF7L2;NEDD4;PRKCD;ZIC1;GSK3B;HCLS1;MAVS;JUP;NRDE2;UBR5
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5715214978886168,-1.5376619293596994,0.04568527918781726,0.41503533345049304,1.0,6/17,9.60%,ITGA1;PDGFRB;CALM1;CALM3;CD300A;HSP90AB1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6867508944057761,1.5370711630025857,0.05555555555555555,0.6363964766514759,1.0,2/17,1.38%,EGFR;PKD1
prerank,pancreas development (GO:0031016),0.737541693822534,1.5359161667138632,0.059027777777777776,0.6377671381116374,1.0,4/12,4.71%,MET;TCF7L2;ISL1;CCDC40
prerank,activation of phospholipase C activity (GO:0007202),0.6233213452003805,1.535660790710533,0.022590361445783132,0.6350911689552582,1.0,2/29,0.48%,EGFR;EDNRA
prerank,substantia nigra development (GO:0021762),-0.48137538267539426,-1.535607785166415,0.01384083044982699,0.41657800526082134,1.0,15/37,16.89%,MBP;CALM1;PLP1;MAOB;GNB4;ACTB;ATP5PF;CALM3;COX6B1;DYNLL1;BASP1;PADI2;NDUFS3;TTBK1;CNP
prerank,peptidyl-lysine acetylation (GO:0018394),0.7525569911114941,1.5354712686671925,0.05128205128205128,0.6322024410437131,1.0,5/10,12.88%,EP300;KAT2A;CREBBP;KAT5;KAT2B
prerank,neutral amino acid transport (GO:0015804),0.6286282674848394,1.535010186450598,0.0547945205479452,0.6305172636461824,1.0,4/28,4.52%,SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5028510529604214,-1.5349705390096775,0.022364217252396165,0.4141074282506292,1.0,15/30,9.04%,TJP1;GJB6;PECAM1;CLDN5;ESAM;MBP;F11R;OCLN;LAMA2;ACTB;SLC1A1;JAM3;GJA1;CLDN1;MFSD2A
prerank,regulation of activated T cell proliferation (GO:0046006),-0.5071063740935793,-1.5347844306278373,0.04013377926421405,0.41069103464755463,1.0,6/30,9.17%,IGF1;IGFBP2;IGF2;RPS3;PRKAR1A;IL18
prerank,cellular response to reactive oxygen species (GO:0034614),0.5554747532036314,1.5345666706668402,0.027061855670103094,0.6287916272122082,1.0,11/59,7.13%,EGFR;MAP3K5;ANXA1;CYP1B1;PRKCD;ABL1;RIPK3;NFE2L2;ANKZF1;CHUK;JUN
prerank,protein hydroxylation (GO:0018126),0.7058783271719669,1.534288004080204,0.04567699836867863,0.6262982829536649,1.0,7/15,16.92%,EGLN3;P3H2;PLOD2;P3H4;P3H1;VIPAS39;JMJD4
prerank,modulation by symbiont of host process (GO:0044003),-0.6707716002315448,-1.533970112036014,0.05043859649122807,0.4088060038742843,1.0,5/10,13.94%,B2M;RPS27A;UBC;UBB;MRC1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7299530692999707,1.5315809867068266,0.07964601769911504,0.6349168176371351,1.0,3/11,4.74%,RSPO3;MLLT3;PLEKHA4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6295773067244271,1.5312438462944393,0.036163522012578615,0.632844919595543,1.0,7/26,6.74%,EYA2;FGFR1;INHBA;GATA1;GDNF;EYA4;EYA3
prerank,blood vessel morphogenesis (GO:0048514),-0.4455055864306848,-1.5301395154251551,0.011450381679389313,0.4166677082981045,1.0,20/54,11.66%,FLT1;EFNB2;ENG;TGFBR3;LAMA1;CCBE1;CDH2;KDR;RASIP1;COL4A1;TBX1;RAMP2;SOX17;SLC1A1;RBPJ;HEY2;FLT4;AGGF1;ADM;SOX18
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5884683441142078,1.528843290765446,0.035211267605633804,0.6400719767681922,1.0,8/45,3.14%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;EFEMP1;GAREM1
prerank,gene expression (GO:0010467),-0.32889627781704844,-1.5276141795583564,0.0,0.4201646983957038,1.0,129/348,23.94%,RBPMS;RBMS1;ATXN1;RPLP1;NOVA1;RPS14;PTMA;RPL37A;RPL38;RPL30;SETX;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;TSPAN5;RPLP2;RPS21;APOBEC1;RPS23;ANGPT2;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;ADARB2;RPL34;RPL23;RPL17;CELF2;RPS19;RPS8;RPS20;RPS27A;RPS17;ADARB1;ELAVL4;RPL13A;RPS12;BCL3;RPS7;RPS3;RPL27A;RPL3;RPL24;FASTKD2;RNPS1;RPS18;HNRNPH3;RPL18;DTX1;RPL39;RPS11;NUP160;EIF4E;PABPN1;MRPL3;SRSF9;RPL23A;UPF1;RPL7A;RPL35A;YTHDC1;RPL26;PWP1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;XAB2;SLBP;RPL27;WDR33;RPL11;POLR2K;NUP210;TOPORS;MRPS11;DDX54;HHEX;RPL31;SARS1;RPL19;RPLP0;RPS15A;RPS28;POM121;RPL37;NUP205;MRPL51;RPL29;RNASEL;MRPL35;POLR2C;RPL28;HBS1L;TSPAN33;MRPL34;THOC7;EIF4EBP2;SRBD1;POLR2G;TESC;HNRNPU;RBM15B;SRSF1;NUP62;MRPL44;POLR2L;NUFIP1;TFIP11;GSPT2;NOX4;MRPL11;HARS2;RPL7
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5488196004573654,1.5272429554082487,0.04183535762483131,0.6437832273932618,1.0,20/61,19.95%,EGFR;SMOC2;EYA2;EYA4;EYA3;FGF2;USP7;APLF;RNF168;ERCC8;DHX9;PML;STPG4;ATRX;UBE2N;WRN;NBN;PRKD2;USP9X;MRE11
prerank,nucleotide metabolic process (GO:0009117),0.6492806147199119,1.5256597659361149,0.05555555555555555,0.6474985669670897,1.0,6/23,12.71%,ME1;FHIT;NMNAT2;CTPS2;NMNAT1;REXO2
prerank,positive regulation of histone acetylation (GO:0035066),-0.5354381519452744,-1.5243366896076087,0.03551912568306011,0.4261308210617449,1.0,11/23,25.64%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;RUVBL2;PIH1D1;NOS1;BRCA1;SPHK2;TADA2B;SMARCB1
prerank,aortic valve development (GO:0003176),0.6000694369007394,1.5240938036345202,0.05247376311844078,0.6511191556564978,1.0,8/34,8.32%,SLIT3;SLIT2;BMP4;SOX9;SMAD6;JAG1;GATA4;TNFRSF1B
prerank,regulation of DNA repair (GO:0006282),0.580984900873706,1.5240745522945438,0.04195804195804196,0.6475293774910824,1.0,13/44,16.77%,EGFR;EYA2;EYA4;EYA3;TRIP12;RNF168;RAD52;UBR5;ERCC8;DHX9;PML;USP1;UBE2N
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4888781697455897,-1.5238048596519662,0.016025641025641024,0.4238024636260225,1.0,12/32,25.57%,CEMIP;CALM1;SNCA;CALM3;JPH2;PLCG1;APLNR;HTT;HAP1;CASQ1;GPER1;AKAP6
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7595983590327665,1.5236591489349856,0.05419580419580419,0.6457436726301875,1.0,3/10,6.68%,NT5E;NT5C1A;UPP2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6542898562968755,1.523163287632906,0.06356589147286822,0.6443778763094318,1.0,3/20,2.02%,STK39;NEDD4;CAMK2D
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6901612901596506,1.5221438545737092,0.04222972972972973,0.6453618829470757,1.0,5/18,12.11%,ANXA1;ISL1;FAM107A;KLF9;REST
prerank,xenobiotic transport (GO:0042908),0.6791985314642516,1.5218673251915584,0.04936305732484077,0.6430474732676212,1.0,2/17,2.82%,SLC47A1;ABCG2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6883038545692614,1.5202203022412009,0.06634304207119741,0.64731974677121,1.0,2/15,1.47%,KCNJ2;ATP1B1
prerank,muscle tissue development (GO:0060537),0.7018453976467217,1.5199314601063392,0.0727580372250423,0.6451149835724952,1.0,5/13,4.15%,BMP4;SMO;CSRP3;STRA6;CSRP2
prerank,dopaminergic neuron differentiation (GO:0071542),0.660465367703361,1.5197752706176326,0.075,0.6422453726263465,1.0,6/19,10.12%,LRP6;PITX3;PHOX2A;NR4A2;CDNF;FOXA1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5211146569624865,-1.5195549406733164,0.030211480362537766,0.4323836899140259,1.0,12/24,16.96%,RAPGEF2;PRKAR2B;PEX5L;PRKAR1B;PDE4D;PDE2A;PRKAR1A;PDE11A;PDE3A;CGAS;PDE3B;RNF157
prerank,protein K11-linked ubiquitination (GO:0070979),0.6111912636501022,1.5187451205942144,0.05604719764011799,0.6437889128989773,1.0,5/27,8.72%,FZR1;UBE2B;ANAPC5;UBE2D3;CDC16
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.6263022492204309,-1.5173892712815562,0.05442176870748299,0.43507931632425095,1.0,2/12,2.13%,SERINC3;SERINC5
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6605553548567848,1.5172635995900765,0.059375,0.6470964479931427,1.0,5/16,12.88%,NAA40;EP300;CREBBP;NAA35;KAT2B
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4958719997732154,1.5169777963178794,0.016355140186915886,0.6449402995878308,1.0,40/128,14.78%,BMP4;SMAD9;BMP5;TGFB3;DDX5;ITGB1;INHBA;BMP6;SMAD6;COL3A1;ADAM9;GDF6;GDF5;GCNT2;BAMBI;PDCD4;BMPR1A;LTBP2;TGFBR1;BMP15;TGFBR2;ID1;JUN;TGFB1I1;ITGB5;SKI;PARD3;RGMB;ACVR1;TGFB2;RHOA;ZMIZ1;MEGF8;NLK;RNF111;INHBB;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5230563104345305,1.5169659731767113,0.03959131545338442,0.6415294810394591,1.0,13/74,6.74%,BMP4;THBS1;EYA2;TCF7L2;BMP5;GSK3B;GATA1;BIRC6;GDNF;TGFBR1;ITGAV;EYA4;EYA3
prerank,regulation of cell junction assembly (GO:1901888),-0.5280646207685047,-1.5166306285800581,0.025,0.4333948330003982,1.0,9/27,8.81%,TJP1;PRKCH;CLDN5;RAPGEF2;F11R;OCLN;MEF2C;RAPGEF1;FLOT1
prerank,lung epithelium development (GO:0060428),0.7477536678696796,1.516089288085347,0.08103130755064457,0.6421137723563142,1.0,3/10,2.71%,BMP4;PKD1;STRA6
prerank,positive regulation of synapse assembly (GO:0051965),-0.5045737851533302,-1.5153538581486086,0.02147239263803681,0.43331029102511054,1.0,19/27,36.75%,NRXN1;IL1RAPL1;EPHB1;GRID2;SRPX2;LRRC4B;CLSTN3;SEMA4A;CLSTN1;NLGN1;NLGN2;AGRN;VSTM5;CUX2;WNT7A;NLGN3;EPHB2;CLSTN2;BDNF
prerank,sodium ion transmembrane transport (GO:0035725),0.5249099316672446,1.5148615491773394,0.02342786683107275,0.6441013399049502,1.0,12/84,5.51%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;SLC6A7;ANO6;SLC6A19;SLC9C1;NALCN;TRPM4;SCN11A
prerank,positive regulation of protein catabolic process (GO:0045732),0.5207624624633116,1.5148218025399254,0.024783147459727387,0.640903979708099,1.0,25/84,14.53%,FZR1;WWP1;EZR;NEDD4;GPC3;WWP2;ADAM9;ASB9;GSK3B;STX5;VCP;ASB11;PLK3;IDE;TNFRSF1B;NSF;CDKN1B;RDX;SEC22B;CSNK2A1;SH3D19;ADAM8;AMER1;SMURF1;VIP
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.586756353787828,1.514753275673204,0.025495750708215296,0.6378572119762341,1.0,10/39,7.87%,STK39;PTPN3;SLMAP;NEDD4;CAMK2D;WNK1;FXYD5;DMD;FGF13;FXYD7
prerank,negative chemotaxis (GO:0050919),0.5992114587252201,1.5142806174992172,0.02848575712143928,0.6365473513454597,1.0,9/33,6.37%,SLIT3;SLIT2;NTN1;SEMA3D;SEMA3C;UNC5C;SEMA3E;PDGFA;ITGAV
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6056846860410408,1.5129175990601076,0.048600883652430045,0.6394497565840724,1.0,8/33,6.81%,MAP3K5;ANXA1;CYP1B1;PRKCD;ABL1;RIPK3;NFE2L2;ANKZF1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6898447312013543,1.512325411639409,0.06372549019607843,0.6389732632149026,1.0,3/15,2.61%,F3;NTRK3;PGF
prerank,maintenance of protein localization in organelle (GO:0072595),-0.5635566753400062,-1.5122596897822962,0.042105263157894736,0.43863823524973666,1.0,9/19,16.11%,TAPT1;ARL2BP;TAF3;BCL3;HK2;CHCHD10;AKT1;TOPORS;HK1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.609936251611128,1.5119130637197125,0.042232277526395176,0.6377404000105628,1.0,6/30,8.85%,FOXP1;DDX5;EP300;PIAS2;KDM1A;SMARCA4
prerank,cellular response to osmotic stress (GO:0071470),0.6452583929640532,1.5114154564262485,0.06623586429725363,0.6369247409652318,1.0,3/21,3.72%,STK39;LRRC8D;YBX3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.7023328437253651,1.5108403998365734,0.08547008547008547,0.6361586519525134,1.0,3/13,6.17%,BMP4;SOX9;PRICKLE1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7035978270622706,1.5104995919529143,0.0706713780918728,0.6344913907548684,1.0,3/12,3.96%,ANK2;PTK2B;DIAPH1
prerank,purine nucleotide catabolic process (GO:0006195),0.700457791067628,1.5102149996016245,0.06587837837837837,0.6324883454329221,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,regulation of protein catabolic process (GO:0042176),0.49982225001773567,1.51012690704337,0.019161676646706587,0.6296563465755783,1.0,16/99,8.98%,FZR1;EGFR;WWP1;NEDD4;GPC3;WWP2;ASB9;GSK3B;STX5;VCP;ASB11;IDE;NSF;MDM4;CHEK2;CDKN1B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5524898365176157,1.509848100998304,0.04353741496598639,0.6277630467741099,1.0,9/50,7.28%,EGFR;NR3C2;TCIM;NFAT5;PDCD4;EP300;TRIP6;TRIM44;IFI35
prerank,embryonic organ development (GO:0048568),0.5429336821536966,1.509836762454278,0.02454780361757106,0.6246905427358336,1.0,18/61,11.71%,PBX3;RARB;PCSK5;COBL;GLI3;PBX1;STRA6;BMPR1A;PDGFA;GDNF;TGFBR2;STIL;FOXE1;TEAD1;ERCC3;GATA3;IFT122;TGFB2
prerank,nucleoside catabolic process (GO:0009164),0.7329165729739183,1.5091983178243396,0.0706713780918728,0.6241125444887932,1.0,4/11,10.50%,NT5E;NT5C1A;UPP2;DERA
prerank,positive regulation of neuron migration (GO:2001224),-0.6404129610395873,-1.506017322377502,0.04428904428904429,0.45393301369761974,1.0,4/11,7.31%,SEMA6A;RAPGEF2;DAB2IP;MDK
prerank,response to hydrogen peroxide (GO:0042542),0.5701648038834045,1.5059478570325147,0.04755434782608696,0.6354321689605059,1.0,9/45,6.81%,MAP3K5;ANXA1;CYP1B1;PRKCD;ADAM9;ABL1;RIPK3;NFE2L2;ANKZF1
prerank,regulation of cholesterol efflux (GO:0010874),-0.4849078240958308,-1.5053546389541184,0.03987730061349693,0.4520540823993291,1.0,7/30,9.74%,PLTP;APOE;PTCH1;NR1H3;GPS2;ABCA5;EEPD1
prerank,sulfur compound transport (GO:0072348),0.6127479402513718,1.5046676426573573,0.054252199413489736,0.6378576534193182,1.0,4/27,2.82%,SLC26A7;SLC5A6;LRRC8D;ABCG2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.7346337186660093,1.5043592377568853,0.07312925170068027,0.6360840156560731,1.0,4/11,11.97%,RNF185;VCP;UFD1;UGGT2
prerank,vitamin transport (GO:0051180),0.6140097043135929,1.5031747442092083,0.05045871559633028,0.6382324135086399,1.0,3/29,2.82%,SLC23A1;SLC5A6;ABCG2
prerank,regulation of cell killing (GO:0031341),0.6762087970664317,1.5023456805013309,0.05314009661835749,0.6387177157567099,1.0,7/16,11.71%,CFH;CD55;IL10;FZD7;CR1L;NOX1;TGFB2
prerank,regulation of myotube differentiation (GO:0010830),0.6177211090374877,1.5019088960924265,0.07727272727272727,0.6373983907203483,1.0,5/24,6.42%,CCN3;HDAC4;HDAC9;MYOG;MMP14
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6376424996383118,-1.501139469837032,0.06937799043062201,0.46092256453201663,1.0,6/11,10.71%,EFNB2;SOX6;MEF2C;BMP2;FRS2;MYOCD
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5556331974227782,-1.5001936925283361,0.03535353535353535,0.46010866295850184,1.0,6/18,8.98%,UNC13C;CDH8;GRIK1;GRIA2;GRID2;GRIK2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6112809003479742,1.500136405641464,0.0625,0.6421485395509412,1.0,12/27,13.50%,KAT6B;SGF29;CPA4;TRRAP;ATAT1;EP300;KAT2A;CREBBP;TAF6L;KAT5;KAT2B;BRD8
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5138692541381316,1.5000513694159843,0.01240694789081886,0.639509952977276,1.0,12/92,5.00%,SMOC2;BMP4;FOXP1;DOCK5;THBS1;SOX9;MAPRE2;ANXA3;PTK2B;ADAM9;ABL1;FOXC2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.42481564854278997,-1.499790571245753,0.012048192771084338,0.4533918857718268,1.0,30/56,30.80%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;TIMMDC1;NDUFAF8;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.42481564854278997,-1.499790571245753,0.012048192771084338,0.4533918857718268,1.0,30/56,30.80%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;TIMMDC1;NDUFAF8;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6797715124445013,1.4993708558262542,0.06506849315068493,0.6394669028259169,1.0,5/15,7.51%,SMOC2;MET;FGFR1;P2RX4;FGF2
prerank,base conversion or substitution editing (GO:0016553),-0.6286411431795101,-1.4986515756655732,0.059496567505720827,0.45265495977587455,1.0,4/11,16.22%,APOBEC1;ADARB2;ADARB1;METTL3
prerank,activation of protein kinase A activity (GO:0034199),-0.5860733426842697,-1.4957616307958164,0.04600484261501211,0.4578917391315634,1.0,11/16,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;ADCY4;ADCY3;ADCY8
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6890755884139191,1.4953519012598628,0.0840630472854641,0.6538448839830081,1.0,5/14,5.26%,SOX9;WNT9A;EFEMP1;GDF5;TGFBR1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7376927241237826,1.4950231887966816,0.06690140845070422,0.6523099038399199,1.0,3/10,2.02%,STK39;NEDD4;CAMK2D
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6888906657175238,1.4948715028366772,0.07439446366782007,0.6499805338056494,1.0,2/15,1.74%,GLI3;CD55
prerank,positive regulation of embryonic development (GO:0040019),-0.5383237687176333,-1.494651180567863,0.03316326530612245,0.45767340254172945,1.0,8/19,17.55%,PLCB1;WNT4;TENM4;OSR1;NR2C2;CFL1;RBM19;B4GALT5
prerank,limb morphogenesis (GO:0035108),0.6413681917975124,1.4946506714906387,0.06351791530944625,0.6479551618157028,1.0,8/20,12.08%,MBNL1;PCSK5;GLI3;LRP6;SKI;TGFB2;MEGF8;IQCE
prerank,positive regulation of cellular senescence (GO:2000774),-0.6318263314653338,-1.4940347490132457,0.06502242152466367,0.45568726323422615,1.0,4/10,13.66%,B2M;YPEL3;ABI3;CGAS
prerank,cellular response to estradiol stimulus (GO:0071392),0.6664657370578689,1.493833674573272,0.07986688851913477,0.6485160951707449,1.0,5/18,15.32%,EGFR;MYOG;KAT5;LCOR;NRIP1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6310257522007003,1.492456124454457,0.05573248407643312,0.6516697183184404,1.0,6/25,5.06%,STK39;ANK2;ATP1B1;WNK1;DMD;COA8
prerank,T cell migration (GO:0072678),0.6981101588155699,1.4920907450685879,0.07419898819561552,0.6500032937429014,1.0,1/13,0.48%,SLC12A2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6101889685110689,1.4919439312884584,0.07530120481927711,0.6476957543206426,1.0,9/25,7.87%,CXADR;PARVA;DSP;ITGB1;DSG2;ITGA5;DSC2;ITGAV;JUP
prerank,positive regulation of catabolic process (GO:0009896),0.5285816719335015,1.491902022469434,0.029831387808041506,0.6449444302937551,1.0,15/65,11.42%,FZR1;WWP1;NEDD4;GPC3;WWP2;ASB9;GSK3B;STX5;VCP;ASB11;IDE;NSF;CDKN1B;SEC22B;CSNK2A1
prerank,negative regulation of complement activation (GO:0045916),0.7289446284613409,1.491868135177588,0.072992700729927,0.6421904133132786,1.0,4/10,11.05%,CD55;CR1L;CD46;SERPING1
prerank,histone modification (GO:0016570),0.4970795444859768,1.4905097161534615,0.021660649819494584,0.6450053323899195,1.0,37/109,17.91%,EYA2;HDAC4;CCNA2;HDAC9;PRKCD;RCOR3;KAT6B;UBE2B;CTCFL;SGF29;CPA4;TRRAP;EYA4;EP300;EYA3;TBL1X;HDAC10;KAT2A;CREBBP;TAF6L;KAT5;USP22;USP3;USP21;BAZ2A;EHMT2;EHMT1;BRD8;CARM1;UFL1;PRMT6;PRMT2;MAP3K12;UBE2N;MORF4L2;HUWE1;BRMS1L
prerank,androgen receptor signaling pathway (GO:0030521),0.7198722783320219,1.4902710547324627,0.0775716694772344,0.6432242944980231,1.0,8/11,21.00%,DDX5;ZMIZ1;PLPP1;DDX17;AR;ARID1A;PMEPA1;RNF14
prerank,atrioventricular valve morphogenesis (GO:0003181),0.647532436846095,1.4900399075054271,0.07479674796747968,0.6412964084873737,1.0,8/19,11.71%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;MDM4;ACVR1;TGFB2
prerank,detection of calcium ion (GO:0005513),0.6922313676529669,1.4898815451413672,0.07528641571194762,0.6391966303783503,1.0,2/13,0.60%,KCNMB3;KCNMB2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5447432404441371,1.4895551950583419,0.034993270524899055,0.6375946122536266,1.0,2/55,0.56%,FBXL7;FHL1
prerank,L-serine metabolic process (GO:0006563),-0.6596312073278678,-1.48750526752773,0.055299539170506916,0.47214842812210406,1.0,2/10,2.13%,SERINC3;SERINC5
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7115864649591412,1.4870830397817685,0.08626760563380281,0.6451306160376037,1.0,4/11,5.33%,MAP3K5;CYP1B1;PRKCD;DIABLO
prerank,regulation of microtubule-based movement (GO:0060632),-0.6290039804587584,-1.4830430631020817,0.06422018348623854,0.48177405169215987,1.0,7/11,23.67%,MAP2;LAMP1;NEFH;DYNLT2B;IGBP1;DRC1;HAP1
prerank,negative regulation of cell growth (GO:0030308),0.48355719044942796,1.4830296111970005,0.015476190476190477,0.6597757535155149,1.0,18/121,9.66%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;ESR2;WNT11;INHBA;IP6K2;ULK2;HNF4A;FGF13;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6868764357980333,1.4829926667795972,0.08374384236453201,0.657057465056403,1.0,5/14,12.08%,NT5E;NT5C1A;UPP2;CAD;ERH
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5871161617091138,1.4823302893890318,0.06017191977077364,0.6570344241428083,1.0,5/32,11.29%,FZR1;FOXN3;ATM;MRNIP;CHEK1
prerank,alcohol catabolic process (GO:0046164),-0.6485358689552291,-1.4817042831520773,0.06726457399103139,0.4819185435349468,1.0,2/10,2.17%,APOE;CYP27A1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6701473435024178,1.4812314619299798,0.10508474576271186,0.6588653926526634,1.0,1/15,0.19%,EGFR
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7038409230074374,1.4811658709601403,0.09849749582637729,0.6563300135792516,1.0,5/12,6.10%,SORBS1;ZBTB7B;C1QTNF12;ERFE;IRS1
prerank,mesonephros development (GO:0001823),0.7232955843780549,1.4808192898540937,0.08571428571428572,0.6550937561379906,1.0,2/11,1.62%,BMP4;ZBTB16
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6318650861022324,1.4795396542988397,0.07419354838709677,0.6575196571185391,1.0,2/20,1.38%,EGFR;PKD1
prerank,establishment of endothelial barrier (GO:0061028),-0.4897621662918853,-1.477893805807232,0.05740181268882175,0.4894945260273432,1.0,13/29,11.66%,TJP1;PECAM1;RAPGEF3;RAPGEF2;F11R;PPP1R16B;RAPGEF1;ROBO4;PDE4D;PDE2A;MYADM;RAB1B;SOX18
prerank,primary neural tube formation (GO:0014020),0.5959436012492768,1.4777574091454335,0.05652173913043478,0.6620446592244402,1.0,10/30,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5354549025421778,-1.4775504110850899,0.07197943444730077,0.48662210999750616,1.0,10/20,25.42%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;PRKAA2;RUVBL2;NOS1;BRCA1;TADA2B;DIP2A
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.6212659846610825,-1.4771373233406904,0.06345177664974619,0.4841480424893477,1.0,9/12,31.50%,ACLY;IDH3A;ACO2;ASS1;IDH2;ACO1;GLUD1;IDH3B;IDH1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5684124224538885,1.4767255706533389,0.055632823365785816,0.6637643785987173,1.0,11/43,10.61%,BMP4;FOXP1;THBS1;IL10;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;NOX1;HTR1B
prerank,inorganic cation import across plasma membrane (GO:0098659),0.5166386544647708,1.4766005817204624,0.03176620076238882,0.6614966424264299,1.0,17/75,13.16%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;SLC9C1;TRPM4;ATP2B4;SLC39A14;KCNJ15;ATP1A3;ATP1A4;ATP1A1;SLC9A1;SLC9A3;KCNJ9
prerank,positive regulation of nervous system development (GO:0051962),-0.4482372517928718,-1.4763286274786218,0.030303030303030304,0.4827933005217827,1.0,15/42,21.39%,TGM2;NRXN1;IL1RAPL1;EPHB1;GRID2;SRPX2;FAIM;LRRC4B;CX3CR1;NUMBL;CLSTN3;CLSTN1;NLGN1;NLGN2;TRIM32
prerank,ventricular septum development (GO:0003281),0.5782030402141144,1.475933971281259,0.06051873198847262,0.6614898321750646,1.0,14/37,11.71%,SLIT3;SLIT2;ZFPM2;STRA6;BMPR1A;TGFBR1;TGFBR2;HES1;GATA4;MDM4;GATA3;NOG;ACVR1;TGFB2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6887895234442509,1.4757506662717856,0.07807308970099668,0.6594877121157215,1.0,3/15,2.90%,PIEZO2;TMEM120A;TMC1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6076961227293766,1.4755362908121004,0.04918032786885246,0.6576583052925346,1.0,10/28,16.59%,CDH1;PRKCD;ZIC1;HCLS1;MAVS;JUP;UBR5;RAN;DMAP1;FLNA
prerank,sulfation (GO:0051923),0.7100440509500582,1.4742419689636614,0.10084033613445378,0.6605118119188855,1.0,3/11,4.37%,UST;SULT1A1;CHST5
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5847238390092523,-1.4742122468414234,0.05778894472361809,0.48555115273341937,1.0,7/15,22.29%,ABHD12;GGT5;ALDH4A1;SARDH;GGT7;GGT1;HOGA1
prerank,regulation of neutrophil migration (GO:1902622),-0.6332561135483468,-1.4739803519210324,0.09049773755656108,0.48248378259013347,1.0,5/10,16.06%,JAM3;RHOH;RHOG;RAC1;NCKAP1L
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3857455006610206,-1.4729509199228383,0.005952380952380952,0.48222853827211454,1.0,31/91,16.91%,CP;SLC30A10;FTH1;SLC39A10;TFRC;SLC40A1;SLC39A8;SLC39A7;ATOX1;FTL;MT2A;ATP6AP1;CAND1;APP;SLC22A17;SLC31A1;SLC30A1;ATP6V1A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;SLC11A2;BOLA2;NUBP1;GLRX3;ATP7A
prerank,cAMP metabolic process (GO:0046058),-0.6069749671371211,-1.4726115985875052,0.07459207459207459,0.4794915176437499,1.0,8/13,15.58%,ADCY5;ADCY1;ADCY7;ADCY2;PDE4D;ADCY4;ADCY3;ADCY8
prerank,tube closure (GO:0060606),0.5900747647126282,1.4721863583983414,0.0536231884057971,0.666237261395619,1.0,10/31,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,muscle cell migration (GO:0014812),0.7061606151254847,1.471007549044274,0.11293260473588343,0.6686571892284703,1.0,2/10,1.37%,CCN3;SIX1
prerank,positive regulation of protein import (GO:1904591),0.5966501232299252,1.4695676334359333,0.05522388059701493,0.6720201599838599,1.0,7/30,7.87%,CDH1;PRKCD;ZIC1;ARHGEF5;HCLS1;MAVS;JUP
prerank,potassium ion homeostasis (GO:0055075),0.6360226072500388,1.4694412029117028,0.07739938080495357,0.6698463417903774,1.0,5/23,1.56%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4915279911948668,-1.469033567922694,0.06948640483383686,0.48671457632419896,1.0,6/27,8.17%,GPCPD1;ENPP2;ENPP6;ABHD12;INPP5F;PNPLA8
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5366391512444403,-1.4687646313563307,0.07455012853470437,0.4837960950917066,1.0,11/19,23.67%,IGF1;APOE;PICALM;RTN1;NTRK2;CHRNA7;GGA3;BIN1;RTN4;PIN1;HAP1
prerank,response to fatty acid (GO:0070542),0.6477705461388095,1.4686685188307946,0.07142857142857142,0.6703163795018655,1.0,7/17,13.00%,SOX9;FOXO3;PID1;IRS1;SCD;CD36;PPP5C
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5513787401064324,-1.4684238291126932,0.04871794871794872,0.4812745001790242,1.0,11/18,22.80%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,regulation of cell death (GO:0010941),0.5034126308464704,1.4664012498649852,0.03026634382566586,0.6771618958849285,1.0,23/94,12.74%,BMP4;CCN3;ACER3;LRPAP1;CCN1;WNT11;EIF4G1;WNT16;CCN5;BECN1;CLU;CELF1;RIPK2;FGF2;TNFRSF1B;SPEF1;SRGAP2;CDKN1B;AGR2;SRSF6;CD36;BNIP3;HTR2B
prerank,positive regulation of transporter activity (GO:0032411),0.6907831132073667,1.4656598479407847,0.09135399673735727,0.6776069451027058,1.0,1/13,0.08%,STK39
prerank,integrin-mediated signaling pathway (GO:0007229),0.5127926544207936,1.465470289265231,0.04419191919191919,0.6757139821448673,1.0,20/73,11.05%,ITGBL1;ITGB8;FN1;PTK2B;ITGB1;ITGA10;PLPP3;COL3A1;ADAM9;ITGA5;ABL1;ITGAV;PRAM1;NRP1;ITGB5;ADAM10;PTPRA;CDH17;CDC42;ITGB4
prerank,cAMP biosynthetic process (GO:0006171),-0.6535589841100098,-1.4638355046032767,0.06726457399103139,0.49197408258863584,1.0,7/10,15.58%,ADCY5;ADCY1;ADCY7;ADCY2;ADCY4;ADCY3;ADCY8
prerank,negative regulation of growth (GO:0045926),0.47823081991512467,1.4633988198060364,0.018823529411764704,0.6820389442536549,1.0,17/121,9.66%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;ESR2;WNT11;INHBA;IP6K2;NOTCH2;HNF4A;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2
prerank,response to amyloid-beta (GO:1904645),-0.4347576538518517,-1.4630540612452207,0.028985507246376812,0.490772228363786,1.0,16/44,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;ITGA4;EPHA4;GJA1;MMP2;APP;CACNA1B;CACNA2D1;GRIN1;CHRNA7;CACNB1
prerank,cGMP metabolic process (GO:0046068),0.67703619125942,1.4625582045057597,0.08514492753623189,0.6829112295851414,1.0,1/12,0.09%,GUCY2C
prerank,ERBB signaling pathway (GO:0038127),0.5279579425343432,1.4618949291466838,0.04533333333333334,0.6832823114085287,1.0,8/64,3.14%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;EFEMP1;GAREM1
prerank,negative regulation of coagulation (GO:0050819),-0.583361988650175,-1.4616472505448888,0.08177570093457943,0.4915697712411998,1.0,6/14,10.01%,VTN;APOE;TFPI;CD34;HS3ST5;EDN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6620635175607662,1.4609596584702569,0.10066006600660066,0.6845551362409328,1.0,5/13,7.26%,MET;IL10;NFE2L2;NR4A3;PYCR1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5496892250662603,-1.4604113626843442,0.07591623036649214,0.4918236228533679,1.0,9/17,16.02%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;ATP5F1D;VPS9D1;ATP5MC2;ATP5F1A
prerank,purine nucleotide metabolic process (GO:0006163),0.6143616054459746,1.460345150726376,0.06933744221879815,0.6846457283147438,1.0,3/24,2.14%,NT5E;NT5C1A;FHIT
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6083546066639751,-1.4598338583604777,0.08409090909090909,0.48998840989721204,1.0,4/11,4.54%,MECOM;WNT5A;ETV6;CD34
prerank,endocardial cushion morphogenesis (GO:0003203),0.6231216999893687,1.459806376314673,0.09884678747940692,0.6841954656392322,1.0,9/18,11.71%,BMP4;SOX9;ISL1;BMPR1A;TGFBR2;MDM4;NOG;ACVR1;TGFB2
prerank,negative regulation of heart contraction (GO:0045822),-0.610622662394993,-1.4593179492979942,0.06483790523690773,0.48804137985387136,1.0,1/11,0.02%,ATP1A2
prerank,regulation of endothelial cell migration (GO:0010594),0.4961041916173389,1.459302468244425,0.030562347188264057,0.6837843128897005,1.0,9/85,2.11%,SLIT2;SMOC2;BMP4;FOXP1;BMPER;THBS1;ANXA3;PTK2B;RHOJ
prerank,eye development (GO:0001654),0.5326631637137236,1.4586535760765618,0.05906040268456376,0.6840462971366715,1.0,16/54,14.54%,PBX3;COL5A2;PBX1;STRA6;HIPK1;EFEMP1;CACNA1C;RAB18;SMOC1;TSKU;SKI;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5729736242020701,1.458189876543957,0.0744047619047619,0.6833719500171095,1.0,12/33,12.38%,KLF5;FOXO3;KLF4;IL10;JUN;FGF2;TEAD1;SMARCA4;ATOH8;GATA3;TGFB2;STAT3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5980482401706881,1.4577843341913228,0.08099688473520249,0.6824173188280894,1.0,14/27,24.24%,CRY2;USP2;BHLHE40;FBXL6;PER2;PER3;PML;RBM4B;FBXL17;FBXL8;MTA1;CRTC1;FBXL3;RBM4
prerank,positive regulation of cell cycle (GO:0045787),0.5160686963357863,1.4568519171173393,0.05006765899864682,0.6836593207438407,1.0,13/62,11.71%,EGFR;SMOC2;PKD1;LRP6;CDC25B;TGM1;USP2;CDKN1B;FOXA1;PKN2;CHEK1;USP22;TGFB2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6450456739526041,1.4564662399397879,0.09634551495016612,0.6825983392502039,1.0,7/14,15.61%,THBS1;KLF4;MEOX2;RHOA;MAP2K5;STARD13;ITGB1BP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6256808355271741,-1.4563088762901315,0.06896551724137931,0.4939820971804902,1.0,6/10,16.65%,PDE4B;CALM1;CALM3;CACNA2D1;NOS1AP;NIPSNAP2
prerank,regulation of cholesterol storage (GO:0010885),-0.5661656862385895,-1.4560228604338281,0.0678391959798995,0.49142876384262496,1.0,8/15,20.74%,PPARA;ABCA1;PPARD;NR1H3;SCARB1;MSR1;ABCG1;LPL
prerank,smoothened signaling pathway (GO:0007224),0.5897881780311974,1.455493680518919,0.07291666666666667,0.6841665464516175,1.0,8/32,9.50%,SMO;GLI3;HIPK1;STIL;DYRK2;PKD2L1;TMEM231;EVC2
prerank,protein localization to centrosome (GO:0071539),0.6657242466869403,1.4551976680734116,0.07881773399014778,0.6827034419441671,1.0,11/17,24.51%,GOLGB1;CEP131;STIL;PCM1;PIBF1;CSNK1D;NUDCD3;CEP192;C2CD3;CCDC14;CEP83
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6663961506295957,1.4551685765695341,0.09899328859060402,0.6802384692253627,1.0,4/13,10.66%,CYFIP2;PERP;RIPK2;TBC1D10A
prerank,outflow tract septum morphogenesis (GO:0003148),0.6066304114857746,1.4547521137193926,0.07278481012658228,0.6794891571944437,1.0,9/24,7.71%,BMP4;ZFPM2;PARVA;SEMA3C;ISL1;SMAD6;BMPR1A;TGFBR2;NRP1
prerank,negative regulation of transmembrane transport (GO:0034763),0.7133420825766533,1.4538451870160474,0.1033210332103321,0.6808056088672786,1.0,1/10,0.45%,THBS1
prerank,vasculogenesis (GO:0001570),-0.4687536936870713,-1.4536226093195492,0.04437869822485207,0.4954586060607145,1.0,13/32,11.66%,ENG;TGFBR3;PDGFRB;KDR;RASIP1;NOTCH1;RAMP2;SOX17;HEY2;AGGF1;ADM;SPRED1;SOX18
prerank,regulation of synapse maturation (GO:0090128),-0.6411829545043908,-1.4529614719574513,0.09324009324009325,0.4941181532654978,1.0,5/10,15.19%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;ADGRL1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5404046356475282,1.4526159020050504,0.049723756906077346,0.68322382939511,1.0,15/50,12.24%,SMO;GLI3;HHIP;GPC3;ZIC1;VCP;CREBBP;GLIS2;FUZ;ARMC9;IFT122;HERC4;MEGF8;TTC23;KIF7
prerank,positive regulation of T cell migration (GO:2000406),0.6279936498498411,1.4525161931127695,0.10542635658914729,0.6811564300719667,1.0,5/20,12.15%,STK39;WNK1;ADAM10;RHOA;TNFRSF14
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5699843536272992,1.4522063208694616,0.05563480741797432,0.6798537252292157,1.0,4/41,1.46%,KCNJ2;KCNMB3;KCNMB2;ANK2
prerank,phosphatidylserine metabolic process (GO:0006658),-0.45537747288881647,-1.4516338941269062,0.045454545454545456,0.49483529097234025,1.0,6/32,6.30%,OSBPL8;SERINC5;PLA1A;ABHD12;OSBPL10;SERINC1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7144168406989462,1.4515504265080565,0.099644128113879,0.6799750762487442,1.0,4/10,11.12%,DDIT3;NFE2L2;QRICH1;EIF2AK3
prerank,thymus development (GO:0048538),0.6866032409636718,1.45068905383658,0.10696095076400679,0.6809777127786242,1.0,5/13,7.89%,SIX1;RIPK3;TGFBR1;FOXE1;HES1
prerank,amino sugar metabolic process (GO:0006040),-0.627530319900433,-1.4492114016263495,0.06621004566210045,0.49888473951528106,1.0,3/10,6.31%,ST3GAL1;ST6GAL1;CSGALNACT1
prerank,action potential (GO:0001508),0.5429258473216306,1.4481577906290586,0.05782792665726375,0.6889896776037786,1.0,6/44,5.51%,KCNJ2;KCNMB3;KCNMB2;KCNB1;DMD;SCN11A
prerank,photoperiodism (GO:0009648),0.5902745936027559,1.4480104252645416,0.08166409861325115,0.6871022345917462,1.0,14/28,24.24%,CRY2;USP2;BHLHE40;FBXL6;PER2;PER3;PML;RBM4B;FBXL17;FBXL8;MTA1;CRTC1;FBXL3;RBM4
prerank,negative regulation of histone modification (GO:0031057),-0.5735367574603106,-1.4476950226819143,0.07481296758104738,0.5000461014763671,1.0,9/14,27.60%,JARID2;SNCA;SET;NOC2L;BRCA1;CTBP1;SPHK2;TWIST1;AASS
prerank,positive regulation of cartilage development (GO:0061036),0.654771754320587,1.44760028577101,0.0805921052631579,0.6862045958380696,1.0,6/17,3.54%,BMP4;SOX9;ZBTB16;BMP1;GDF6;GDF5
prerank,retina homeostasis (GO:0001895),-0.5030830352192709,-1.4468466387038348,0.06043956043956044,0.4992658161998496,1.0,8/23,18.77%,B2M;ATP1B2;ACTB;POTEF;CDH3;WHRN;PRDX1;ACTG1
prerank,regulation of muscle cell differentiation (GO:0051147),0.5834382442673272,1.446655021879308,0.07102272727272728,0.6879105879474214,1.0,10/31,10.90%,CDON;BOC;CTNNA1;HDAC9;MYOG;MEF2A;ABL1;TCF3;TCF23;CDC42
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6287677494051311,-1.446606216783304,0.06753812636165578,0.4967580678882276,1.0,4/10,13.40%,SLC1A3;SLC1A1;SLC1A2;SLC25A18
prerank,epithelial tube morphogenesis (GO:0060562),0.5803714549887999,1.4456164398542617,0.06461086637298091,0.6894904748211662,1.0,4/32,1.38%,SLIT2;BMP4;MET;PKD1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6265307912077316,-1.4450025569802387,0.08274231678486997,0.4987606724181388,1.0,5/11,22.16%,NOS3;CALM1;QDPR;AKT1;PTS
prerank,integrated stress response signaling (GO:0140467),0.6830433608101636,1.442793381103364,0.09215017064846416,0.6989515878886648,1.0,6/14,11.64%,DDIT3;NFE2L2;EIF2AK4;QRICH1;EIF2AK3;OMA1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4880523253818659,-1.4427594455777424,0.06043956043956044,0.502592446839797,1.0,16/27,27.34%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT9;ARL8B;SDF4;PPP3CB;SYT13;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5943664753768869,1.4423455103072973,0.07946026986506746,0.6983049553829561,1.0,3/27,3.15%,SLC47A1;SLC38A1;SLC7A2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.41596234489374034,-1.441315385402011,0.02952029520295203,0.5034432962189067,1.0,19/57,17.07%,ADCY5;ADCY1;ADCY7;ADCY2;GRM7;ADRA2A;GPR37;GRM8;LPAR1;PDE2A;CHRM3;PSAP;ADCY4;CHRM2;P2RY12;GPR37L1;ADCY3;ADCY8;NPY1R
prerank,neurotransmitter secretion (GO:0007269),-0.43428087207095456,-1.4409615856306834,0.03333333333333333,0.5011885263649862,1.0,20/44,27.22%,NRXN1;LIN7A;HSPA8;RIMS1;RIMS2;SNCA;PIP5K1C;SYN1;CPLX1;SNAP25;UNC13A;LIN7C;PPFIA3;SYT1;SNAPIN;SLC32A1;CDK5;STXBP3;SYN2;RAB3A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6240619529729117,1.4402682750766167,0.09693053311793215,0.7047002854359475,1.0,1/21,0.11%,FZR1
prerank,early endosome to Golgi transport (GO:0034498),0.6805281537591057,1.4401301257754997,0.09930313588850175,0.7027894776697692,1.0,5/11,16.76%,EHD3;STX5;RAB6A;RBSN;SNX2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6066803394665837,1.4401047413131565,0.10291858678955453,0.7004018755200925,1.0,5/22,3.75%,CD44;WNK1;KLF4;IL10;GCNT2
prerank,lipid catabolic process (GO:0016042),-0.5267310578086448,-1.4376322017231762,0.08226221079691516,0.50799801913585,1.0,7/18,29.67%,PLA1A;ACADL;LIPE;HSD11B1;LPL;HSD17B14;MT3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5814253871623769,-1.43739056663091,0.08616780045351474,0.5054998390978034,1.0,3/13,4.75%,ERRFI1;CBLB;SOCS5
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5530413838024624,1.4369830536572308,0.08776978417266187,0.7109362927212625,1.0,7/37,7.56%,MAPRE2;EFNA5;PHLDB2;FAM107A;GAS2L2;GSK3B;MARK2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5421683604339168,1.4367673502614704,0.07650273224043716,0.709338760228633,1.0,12/43,19.95%,FZR1;FOXN3;ATM;RAD17;MRNIP;CHEK1;INTS3;TAOK3;CLSPN;NBN;CHFR;MRE11
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6732093955910257,1.436594865370985,0.12666666666666668,0.7075847643755566,1.0,5/13,6.10%,SORBS1;ZBTB7B;C1QTNF12;ERFE;IRS1
prerank,histone H3 deacetylation (GO:0070932),0.6443467644660288,1.436217989179952,0.0975609756097561,0.706806455612593,1.0,4/15,10.68%,HDAC4;HDAC9;PER2;HDAC8
prerank,motor neuron axon guidance (GO:0008045),0.65683836088683,1.436002579515487,0.08576329331046312,0.705310865212025,1.0,5/15,8.92%,SLIT2;NTN1;NTN5;NTN3;TMEFF1
prerank,positive regulation of protein metabolic process (GO:0051247),0.47589519326257546,1.4357404974560501,0.03739445114595899,0.7039598150124567,1.0,21/110,8.98%,FZR1;WWP1;NEDD4;AGTR1;INHBA;GPC3;WWP2;ISL1;KLF4;EIF4G1;ASB9;GSK3B;STX5;VCP;ASB11;CD80;CLU;IDE;NSF;BCL10;CDKN1B
prerank,mesenchymal to epithelial transition (GO:0060231),0.7158599029580307,1.4349532855572174,0.10185185185185185,0.7050139793668174,1.0,2/10,4.04%,BMP4;FZD7
prerank,histone H4 deacetylation (GO:0070933),0.6919040200578204,1.4348681193908792,0.09874326750448834,0.7029194750931685,1.0,4/10,12.11%,HDAC4;HDAC9;HDAC8;REST
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5824665221779217,-1.4339453953892243,0.08755760368663594,0.513148247261202,1.0,3/11,5.11%,PICALM;NEDD4L;GPM6B
prerank,activation of protein kinase B activity (GO:0032148),-0.4575730549563307,-1.4335864486785472,0.05934718100890208,0.5109814248083135,1.0,15/29,18.39%,IGF1;OSBPL8;WNT5A;PPIA;CCDC88A;INSR;RICTOR;ADRA2A;GAS6;IL18;FGF1;AKT1;NTF3;PARK7;TXN
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6420628793495196,-1.4332538015299732,0.08275862068965517,0.5087931068975675,1.0,8/10,26.41%,APOD;LRCH1;RIPOR2;PADI2;AKT1;WASL;CD200;MIA3
prerank,positive regulation of integrin activation (GO:0033625),-0.5959444425704734,-1.4332471623570222,0.1026252983293556,0.5055992272372426,1.0,5/11,13.38%,PIEZO1;RASIP1;PLEK;SRC;P2RY12
prerank,negative regulation of insulin secretion (GO:0046676),0.6367154826878337,1.4327138039753515,0.10490693739424704,0.7094520192137729,1.0,6/17,12.79%,CCN3;KCNB1;KLF7;IRS1;REST;INHBB
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48688880535707113,1.4325139171660664,0.055,0.7078650357390859,1.0,14/84,7.71%,SMOC2;BMP4;FOXP1;THBS1;MET;ANXA3;PTK2B;FGFR1;PLPP3;ABL1;FOXC2;P2RX4;FGF2;NRP1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.47151739876460796,1.4311923040274066,0.04028436018957346,0.7110429592837029,1.0,16/113,7.71%,EGFR;BMP4;F3;SOX9;TCF7L2;BMP5;NRAS;BMP6;PGF;NOTCH2;FZD7;TGFBR1;NR4A3;TGM1;FGF2;NRP1
prerank,odontogenesis (GO:0042476),0.5668612739687139,1.4310738915181016,0.06843575418994413,0.7091743193520893,1.0,6/35,4.61%,BMP4;EDA;TGFB3;INHBA;LRP6;AQP6
prerank,protein localization to mitochondrion (GO:0070585),-0.6010274216480577,-1.4305310356209744,0.0855106888361045,0.5109059180050373,1.0,6/11,18.87%,LRRK2;HK2;AKT1;HK1;COX18;RALA
prerank,atrioventricular valve development (GO:0003171),0.6579090533403776,1.430470390429185,0.1135593220338983,0.7093552893502774,1.0,6/14,11.71%,SLIT3;BMPR1A;TGFBR2;MDM4;ACVR1;TGFB2
prerank,ribosome biogenesis (GO:0042254),-0.33658936824301616,-1.4302028130818811,0.0,0.5085727988051753,1.0,61/187,18.75%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;NOC2L;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RIOK1;RPL27;LAS1L;RPL11;DDX54;PIH1D1;RPL31;RPL19;DDX31;RPLP0;RPS28;RPL37;NOB1;RPL29
prerank,non-motile cilium assembly (GO:1905515),0.5693287999207421,1.430021235121103,0.0953757225433526,0.7088446102077914,1.0,22/30,31.16%,ARL13A;RPGRIP1;FUZ;PCM1;DISC1;IFT122;TOGARAM1;PIBF1;IFT88;CSNK1D;GORAB;CEP89;DCTN1;C2CD3;TMEM80;TMEM17;BBS10;VANGL2;BBS1;BBS4;TMEM107;TMEM216
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5011504716129889,1.4287594988304104,0.05867014341590613,0.7117607615368264,1.0,9/68,9.02%,SLC23A1;SLC23A2;AOX1;SLC5A6;VNN1;RFK;MMACHC;FPGS;CD320
prerank,atrial septum development (GO:0003283),0.6622218987248927,1.4283808230154396,0.09499136442141623,0.7109895449420476,1.0,6/13,11.71%,ANK2;ISL1;NOTCH2;GATA4;MDM4;TGFB2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6807422131737774,1.427648307248406,0.1254355400696864,0.7115190746728501,1.0,4/13,8.83%,GLI3;ZBTB7B;TGFBR2;CBFB
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6017559240218703,1.426518217937137,0.09880239520958084,0.7138243819660217,1.0,6/24,4.13%,CDON;BOC;CTNNA1;MYOG;MEF2A;ABL1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6059525059990104,1.4260058958602195,0.11446740858505565,0.713496500668835,1.0,5/21,10.42%,RASSF2;DMD;NCK2;DMTN;CNKSR3
prerank,regulation of ion transmembrane transport (GO:0034765),0.560679161627516,1.42561232543829,0.09544159544159544,0.7127196512441615,1.0,5/33,2.81%,KCNJ2;NEDD4;WNK1;WWP2;ANO6
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5394593721462941,1.4253001749732164,0.08776978417266187,0.7115251237339698,1.0,10/43,7.07%,SORBS1;GRB10;PRKCD;PID1;ZBTB7B;C1QTNF12;ERFE;SIK2;IRS1;PTPN2
prerank,inorganic anion transmembrane transport (GO:0098661),0.5131322573017859,1.424511737102091,0.05229591836734694,0.7125090766427601,1.0,11/63,9.37%,SLC12A7;SLC26A2;SLC12A2;SLC5A6;SLC12A8;ANO6;GLRB;SLC4A8;GABRA3;SLC25A14;ANO9
prerank,positive regulation of DNA repair (GO:0045739),0.5372295869001801,1.4244507642560524,0.07458563535911603,0.7103829979632122,1.0,11/46,16.77%,EGFR;EYA2;EYA4;EYA3;HDAC10;RNF168;ERCC8;DDX11;FOXM1;DHX9;UBE2N
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5834769356119115,-1.423751057372202,0.09839816933638444,0.5250982523112045,1.0,7/12,26.17%,APOE;PICALM;CHRNA7;RANBP9;TMED10;FKBP1A;ABCA2
prerank,response to progesterone (GO:0032570),0.6186068524089313,1.423384745904695,0.1020066889632107,0.7123942903504266,1.0,2/18,1.44%,THBS1;TGFB3
prerank,regulation of DNA replication (GO:0006275),0.5265494872439156,1.4229910289912893,0.06420765027322405,0.7117827180774496,1.0,17/49,21.73%,EGFR;CCNA2;BCAR3;RAD17;WAPL;STN1;GTPBP4;EHMT2;ORC5;DHX9;FAF1;ATAD5;GLI2;ZBTB38;USP37;EGF;ATR
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6591792128913387,1.4224258162309067,0.10927152317880795,0.7115283377030567,1.0,4/13,14.48%,BMP4;VNN1;ADAM8;CAMK4
prerank,sensory perception of sound (GO:0007605),-0.3712469400963694,-1.4223469383769718,0.031746031746031744,0.5263167565211103,1.0,19/88,10.36%,COL4A3;CEMIP;CACNA1D;DCDC2;ADGRV1;KIT;USP53;ALDH7A1;COL1A1;GRM7;TBX1;RIPOR2;EPS8L2;PCDH15;CLIC5;KCNQ1;CCDC50;GRAP;GSDME
prerank,connective tissue development (GO:0061448),0.5624837379994707,1.4217424839585378,0.08695652173913043,0.712042277327784,1.0,7/35,4.86%,SOX9;ITGB8;PKD1;CD44;ZBTB16;SULF1;DDRGK1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5937931957528046,1.4209865245649511,0.08398133748055987,0.7130711143487956,1.0,4/25,2.89%,SLIT2;LIMK2;PRKCD;ARHGAP44
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.6095438339316052,-1.420550889532817,0.08616780045351474,0.5284218329882371,1.0,2/11,3.93%,IL34;CSF1
prerank,chondrocyte differentiation (GO:0002062),0.5722445986274125,1.4204752933122715,0.0858806404657933,0.7129719706781202,1.0,10/32,11.12%,BMP4;CCN3;SOX9;NFIB;SULF1;SNX19;SLC39A14;SULF2;WNT2B;EIF2AK3
prerank,nucleotide catabolic process (GO:0009166),0.6412101173060791,1.419481185255526,0.11655405405405406,0.7146332174718358,1.0,4/16,10.50%,NT5E;NT5C1A;VCP;DERA
prerank,endocardial cushion development (GO:0003197),0.5973534571989645,1.4184257456663125,0.0993485342019544,0.7169107892934162,1.0,9/21,11.71%,BMP4;SOX9;ISL1;BMPR1A;GATA4;MDM4;NOG;ACVR1;TGFB2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.686755253700793,1.4180692626117326,0.10314685314685315,0.7161916114355343,1.0,4/11,8.89%,C1QTNF12;ERFE;EP300;CLK2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4707292814724283,-1.4179870798122203,0.07861635220125786,0.5330897478037124,1.0,19/28,34.42%,PRKAG2;CD47;SIRPA;RAC1;MITF;PRKAA2;NOS1AP;CX3CR1;NR1H4;SIRT5;FGFR4;MED1;C3;ADIPOR2;MFSD12;PRKAB2;CCL5;PDK4;STC2
prerank,positive regulation of macrophage activation (GO:0043032),0.6224250518579068,1.417783419499358,0.10737179487179487,0.7151542228682559,1.0,4/17,11.44%,THBS1;LBP;TLR6;TLR4
prerank,regulation of mRNA metabolic process (GO:1903311),0.6767062240320256,1.4168747312476124,0.113345521023766,0.716694226273282,1.0,1/11,0.68%,SLTM
prerank,vesicle transport along microtubule (GO:0047496),0.5996644901919662,1.4166679038307903,0.1,0.7152961530720494,1.0,6/23,7.44%,KIF13A;NDEL1;DYNC1I1;PAFAH1B1;FBXW11;KIF1C
prerank,negative regulation of macrophage activation (GO:0043031),-0.538006860183683,-1.415651166671021,0.06265060240963856,0.5369505487246504,1.0,4/16,7.47%,IL31RA;NR1H3;GRN;SYT11
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5704464285683524,1.4147181831876106,0.10061919504643962,0.7210081172336917,1.0,1/29,0.01%,SLC4A10
prerank,positive regulation of protein maturation (GO:1903319),-0.6107391091014948,-1.4144538875271704,0.09558823529411764,0.5373398752854686,1.0,2/11,5.41%,CCBE1;NKD2
prerank,regulation of T cell mediated immunity (GO:0002709),0.6840056960189942,1.414263443206366,0.13479052823315119,0.7206762175292376,1.0,3/10,8.32%,RIPK3;TRPM4;TNFRSF1B
prerank,regulation of interleukin-12 production (GO:0032655),0.518280874877869,1.4133202081256357,0.08469945355191257,0.7224815615106255,1.0,9/47,12.58%,FOXP1;THBS1;ISL1;IL10;RIPK2;TLR4;IL16;CMKLR1;PIBF1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6545316871926019,1.4133129363080037,0.1234991423670669,0.7202720168168006,1.0,2/12,5.15%,SOAT1;ACSL3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4843299075834859,1.4129944034143618,0.0460772104607721,0.7192287201070717,1.0,15/93,10.42%,EGFR;RASSF2;NGF;NTRK3;CD44;DOCK7;EIF4G1;DMD;NCK2;HCLS1;RIPK2;ATP2B4;BCAR3;DMTN;CNKSR3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6666813405362954,1.4124709840919532,0.11478260869565217,0.7192243698528091,1.0,2/12,2.19%,FUT8;GMDS
prerank,negative regulation of cell death (GO:0060548),0.4801529016253377,1.411750141219798,0.060225846925972396,0.7199794688118603,1.0,19/88,10.36%,BMP4;CCN3;LRPAP1;CCN1;WNT11;EIF4G1;GSK3B;WNT16;CCN5;KANK2;BECN1;CLU;FGF2;GATA4;TNFRSF1B;SPEF1;SRGAP2;AGR2;SRSF6
prerank,import into cell (GO:0098657),0.5420891907837609,1.4117137829108912,0.0921595598349381,0.7179393407488649,1.0,5/41,1.63%,SLC47A1;SLC12A7;SLC38A1;SLC5A6;LRRC8D
prerank,positive regulation of dendrite extension (GO:1903861),-0.5333975629630592,-1.4098496347595997,0.09405940594059406,0.5489398632355779,1.0,11/17,27.34%,NEDD4L;RIMS1;RIMS2;RNF157;UNC13A;CPNE5;SYT1;CPNE9;ITSN2;SYT17;SYT2
prerank,renal system development (GO:0072001),0.5115473309170457,1.4098313451910607,0.08618331053351573,0.7233907472311415,1.0,10/52,6.52%,BMP4;PCSK5;SIX1;PKD1;SULF1;AGTR1;STRA6;TGFBR1;TFAP2A;ARL3
prerank,regulation of dendrite extension (GO:1903859),-0.5241181524385026,-1.4095528622146138,0.08080808080808081,0.5466179174575997,1.0,11/18,27.34%,NEDD4L;RIMS1;RIMS2;RNF157;UNC13A;CPNE5;SYT1;CPNE9;ITSN2;SYT17;SYT2
prerank,mammary gland epithelium development (GO:0061180),-0.5578830391804503,-1.409462900576705,0.1026252983293556,0.5437264928351244,1.0,7/14,31.00%,WNT4;ERBB4;AKT1;CSF1R;WNT2;WNT3;EPHA2
prerank,positive regulation of vasoconstriction (GO:0045907),0.6689998641565535,1.4093493942542539,0.12458471760797342,0.7231249767645013,1.0,2/13,5.12%,ADRA1B;TRPM4
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.6012513564493739,1.4091918369555136,0.12131147540983607,0.721527895948708,1.0,9/20,16.09%,MCUB;MICU1;PARL;PMPCB;SPG7;MCU;STOML2;SLC8B1;YME1L1
prerank,catecholamine biosynthetic process (GO:0042423),-0.6083755458873534,-1.4082352484718992,0.08505747126436781,0.5444569736190653,1.0,3/11,6.97%,MOXD1;SNCA;DDC
prerank,response to interferon-gamma (GO:0034341),-0.39108575492126896,-1.4081172006140383,0.04065040650406504,0.5416510575978973,1.0,26/67,24.48%,WNT5A;CD47;GBP7;SNCA;GBP4;BST2;AQP4;IFITM1;GAPDH;SIRPA;DAPK1;RPL13A;IFITM3;TRIM21;SP100;GBP5;GBP2;CCL19;CD74;CD40;CASP1;STAT1;KYNU;AIF1;GBP3;CCL2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.631240639849269,1.4078617281103776,0.12685337726523888,0.7249346381879618,1.0,2/16,2.50%,ST3GAL4;NFAT5
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4441328568229057,-1.4062954694867584,0.06918238993710692,0.5437422956870708,1.0,8/35,6.83%,FLT1;PTPRM;NR2F2;COL4A3;APOE;SPARC;MEF2C;RGCC
prerank,endothelial cell proliferation (GO:0001935),0.6313458201621098,1.4058019782365287,0.10613598673300166,0.7312508143362525,1.0,2/17,0.36%,BMP4;BMPER
prerank,negative regulation of cell motility (GO:2000146),0.47465040729093755,1.4057805731825879,0.04529201430274136,0.7291122474884403,1.0,24/108,11.60%,CDH1;SLIT2;TMEFF2;CLIC4;DPYSL3;FOXO3;CYP1B1;SULF1;PTPRU;WNT11;CCDC125;IGFBP5;ZMYND8;VCL;JAG1;RAP2C;DUSP10;SRGAP2;SRGAP3;FUZ;GATA3;NKX2-1;NOG;GTPBP4
prerank,regulation of mononuclear cell migration (GO:0071675),0.5948334222517095,1.40503106119232,0.12202380952380952,0.7299847430873917,1.0,3/23,1.04%,SLIT2;THBS1;BMP5
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6675852068161591,1.404449386986535,0.116751269035533,0.730177220239868,1.0,3/12,3.75%,CD44;IL10;GCNT2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6699260147939342,1.4042081330452154,0.12417218543046357,0.7289956315753167,1.0,3/12,7.36%,TMEFF2;IL10;AP2A1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6559587800610749,1.403790689891567,0.1352253756260434,0.7285404079420353,1.0,5/12,7.65%,NFIB;EPHB6;PAFAH1B1;MYCBP2;TSKU
prerank,"wound healing, spreading of cells (GO:0044319)",0.5851200855007627,1.4036628777170115,0.11094452773613193,0.7269470793036179,1.0,4/24,4.00%,TMEFF2;CD44;CCN1;ITGA5
prerank,positive regulation of angiogenesis (GO:0045766),0.4618710305034319,1.4031818924234916,0.036470588235294116,0.7267178639924279,1.0,16/108,5.38%,SMOC2;F3;BMPER;THBS1;ITGB8;ANXA3;CYP1B1;PTGIS;ITGB1;PGF;ISL1;KLF4;HIPK1;ITGA5;FOXC2;ADAM12
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.499494940103504,1.4023518746577435,0.07069408740359898,0.7279730121293397,1.0,18/67,15.10%,VIT;DOCK5;FN1;PTK2B;GSK3B;ABL1;NRP1;JUP;LIMS2;DMTN;AGR2;CDC42;TRIOBP;CD36;RSU1;S100A10;ILK;EMP2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6066732578008174,1.4020469527782198,0.11507293354943274,0.7269833113697196,1.0,3/19,2.50%,PLCE1;PPP3CA;NFAT5
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6228321556464158,1.4016162751561148,0.12351945854483926,0.726391179129921,1.0,4/17,11.55%,UBASH3A;EZR;PTPN2;PHPT1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5028468995833959,1.4011885351855837,0.07170294494238157,0.7259814196232164,1.0,9/66,6.47%,EGFR;FHL1;ANXA1;PKD1;KLF4;EIF4G1;FAM107A;KANK2;DLG1
prerank,regulation of tissue remodeling (GO:0034103),-0.5212847657766918,-1.399274150185231,0.08539944903581267,0.5632795763843552,1.0,6/18,9.17%,LEPR;CST3;SYT7;MDK;FLT4;IL18
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6125549444985383,1.3987503986861416,0.137987012987013,0.7338001960092146,1.0,5/18,12.79%,CCN3;KCNB1;IRS1;REST;INHBB
prerank,regulation of transport (GO:0051049),-0.4445752649556848,-1.398680486180446,0.06646525679758308,0.561904975734008,1.0,11/36,18.77%,LEPR;EPB41;MYO6;SNCA;ACTB;ICA1;LRRK2;FES;SCFD1;CLDN10;ACTG1
prerank,regulation of ossification (GO:0030278),0.546504635353254,1.3975086693228127,0.08761329305135952,0.7366941805730447,1.0,7/36,3.02%,BMP4;SOX9;ZBTB16;DDR2;SGMS2;LRP6;SMAD6
prerank,epithelial cell-cell adhesion (GO:0090136),0.6763345230207445,1.3974173382471806,0.15789473684210525,0.734904351349632,1.0,5/11,8.23%,CCN3;DSP;VCL;JUP;ITGB5
prerank,cellular response to unfolded protein (GO:0034620),-0.4766267720408811,-1.3968349817684431,0.07605633802816901,0.5644603692155574,1.0,7/26,14.06%,HSPA8;ERN1;DAB2IP;TMBIM6;HSPA9;OPTN;PACRG
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5925252536282588,1.3964291551296406,0.11129032258064517,0.7366673044541566,1.0,8/21,10.19%,EXT1;HS3ST4;SULF1;GLCE;HS6ST2;SGSH;HPSE;SULF2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6183219661073449,1.395055486161542,0.13131313131313133,0.7401714583669992,1.0,6/17,7.33%,ANXA1;KLF4;IL10;ANXA4;OTUD7B;TLR6
prerank,potassium ion import across plasma membrane (GO:1990573),0.5493617327099002,1.3945790283786104,0.08321579689703808,0.7399165982968238,1.0,5/41,1.56%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5911748169280683,1.393897898549408,0.12044374009508717,0.7405397092256923,1.0,3/21,4.90%,NT5E;NT5C1A;NUDT4
prerank,regulation of response to biotic stimulus (GO:0002831),0.5550285698485273,1.3937331062818958,0.11343283582089553,0.7391228414187565,1.0,7/28,12.39%,FOXP1;CD55;RNF135;ERAP1;IRF1;CD36;BIRC3
prerank,regulation of neuron projection development (GO:0010975),-0.33782439869864506,-1.3935991201601892,0.02631578947368421,0.5715724382564314,1.0,51/163,13.88%,EFNB2;CAMK1D;LYN;SHANK3;CDH2;APOE;ITGA6;PRKD1;IL1RAPL1;CTNNA2;RAPGEF2;PPFIA2;CHN1;LRRC4C;WNT5A;PTK7;FUT9;SERPINI1;PAK1;SETX;ATP1B2;DCC;CCDC88A;CSMD3;ROR2;TENM3;NDNF;DAB2IP;EPHA4;RAPGEF1;DENND5A;MDK;RIT2;LPAR1;CDKL5;LRRK2;MFSD2A;NTRK2;SPOCK1;PLK5;TOX;ABI3;CRMP1;LRRC7;MAG;CIB1;BRSK2;MINAR1;CAMK2B;ABL2;FES
prerank,sarcomere organization (GO:0045214),0.581482217661343,1.3933121262972392,0.11609907120743033,0.7387976321130756,1.0,9/27,19.67%,KRT19;CSRP3;CSRP2;FHOD3;SIX4;WDR1;TPM1;MYLK3;MYOM2
prerank,secretory granule organization (GO:0033363),-0.6109607686330449,-1.3929953309524958,0.09501187648456057,0.5701907008802231,1.0,2/10,4.30%,ABCA1;SRGN
prerank,vasculature development (GO:0001944),-0.5297281647223461,-1.3928909156980946,0.10617283950617284,0.5672913716463288,1.0,11/16,22.79%,ERRFI1;PDGFRB;ACVR2B;NOTCH4;PDGFRA;FLT4;SOX18;BMPR2;ACVRL1;APLNR;FOXF1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6195136674797502,1.392448325490058,0.11735537190082644,0.7402789298768413,1.0,4/17,5.09%,ADRA1B;AKAP13;ADRB2;ADCY9
prerank,potassium ion export across plasma membrane (GO:0097623),0.6507936431571609,1.3913890009499554,0.12478031634446397,0.7423815012601396,1.0,1/13,0.26%,KCNK5
prerank,cellular response to alkaloid (GO:0071312),-0.5395162593995931,-1.3911410076110857,0.08072916666666667,0.5698888863051188,1.0,7/17,15.89%,TGM2;SLC8A1;RYR2;CASP3;BLM;RYR3;CASQ2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5333498824970292,-1.3886586529283926,0.10617283950617284,0.5744382260842108,1.0,5/15,6.57%,PPARA;LPGAT1;PPARD;NR1H3;PPARGC1A
prerank,regulation of cartilage development (GO:0061035),0.6057936545805314,1.388397759967776,0.11993517017828201,0.7525312504892417,1.0,5/18,2.72%,BMP4;SOX9;ZBTB16;WNT11;BMP1
prerank,autonomic nervous system development (GO:0048483),0.6194434725954658,1.3881714367712028,0.13001605136436598,0.7513130609234392,1.0,5/17,10.39%,FN1;PHOX2A;GDNF;NRP1;GATA3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6549721792222356,1.387730331100973,0.1456140350877193,0.7509495011533877,1.0,3/11,10.17%,THBS1;BMPR1A;CD46
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5879119851226672,1.3874098694092625,0.11235955056179775,0.7479557626211233,1.0,5/21,6.74%,EYA2;GATA1;GDNF;EYA4;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5879119851226672,1.3874098694092625,0.11235955056179775,0.7479557626211233,1.0,5/21,6.74%,EYA2;GATA1;GDNF;EYA4;EYA3
prerank,myoblast differentiation (GO:0045445),0.6406542028085178,1.3871427902584703,0.1445993031358885,0.7469570899881999,1.0,8/14,13.71%,TCF7L2;MBNL1;DDX5;PLEKHM3;JAG1;RB1;REST;DDX17
prerank,neural tube closure (GO:0001843),0.551384843711945,1.386550748756587,0.09649122807017543,0.7473064272760525,1.0,10/34,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,negative regulation of nuclear division (GO:0051784),0.6788927582801275,1.3861320971013298,0.15641476274165203,0.7469477492930304,1.0,3/11,11.40%,BMP4;CHEK1;NANOS2
prerank,cardiac muscle tissue development (GO:0048738),0.5076628641910397,1.3855968784898107,0.08719346049046321,0.746912136537782,1.0,7/50,4.33%,BMP4;SGCD;BMP5;AKAP13;CSRP3;NOTCH2;BMPR1A
prerank,embryonic eye morphogenesis (GO:0048048),0.6668968916990035,1.3852920962226294,0.12585034013605442,0.7460790513920685,1.0,4/11,6.12%,MFAP5;EFEMP1;LRP6;RARG
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5396444617320286,1.3843003613313394,0.09734513274336283,0.7480038967094081,1.0,9/32,7.56%,THBS1;ANXA1;RHOJ;HDAC9;KLF4;MEOX2;FOXC2;FGF2;MAP3K3
prerank,acidic amino acid transport (GO:0015800),-0.5170456989637922,-1.3830328523384716,0.10606060606060606,0.5892795362212835,1.0,7/17,7.25%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;SLC1A2;SLC6A6;GJA1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6563623815064912,1.3821547347363272,0.12479740680713128,0.7544767691957376,1.0,2/12,3.07%,SOX9;MUC6
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6414585583374054,1.3815354812954281,0.15025906735751296,0.7549251144978215,1.0,3/14,4.05%,THBS1;ANO6;PDCD4
prerank,cellular response to amyloid-beta (GO:1904646),-0.4313633827341436,-1.3812530139733743,0.04276315789473684,0.5916720747281686,1.0,13/35,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;ITGA4;EPHA4;GJA1;APP;CACNA2D1;GRIN1;CACNB1
prerank,regulation of protein localization to membrane (GO:1905475),0.552929709249733,1.381238129404937,0.1125,0.75405423874281,1.0,6/28,7.41%,GPC6;GPC3;GSN;MMP14;STX8;GPC4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5983777956178007,1.3807857940282136,0.14426229508196722,0.7537255720507711,1.0,7/17,14.03%,BMP4;NOTCH2;BMPR1A;JAG1;NOG;ACVR1;GALNT11
prerank,pulmonary valve morphogenesis (GO:0003184),0.6153360347728628,1.3797634830608407,0.1163575042158516,0.7558024148076787,1.0,6/17,6.86%,SLIT2;BMP4;STRA6;SMAD6;NOTCH2;JAG1
prerank,peripheral nervous system development (GO:0007422),0.5798661987257745,1.3791967168857417,0.10920436817472699,0.7560411623343736,1.0,5/23,5.17%,NGF;PMP22;EGR2;ADGRG6;GDNF
prerank,positive regulation of cytokinesis (GO:0032467),0.5555260997626448,1.3786057989209626,0.10650887573964497,0.756229155952136,1.0,9/32,12.45%,CIT;GIPC1;CDC25B;PKP4;PKN2;CDC42;DRD3;RHOA;PRKCE
prerank,regulation of MAPK cascade (GO:0043408),-0.33556594674924545,-1.3781990212846962,0.0,0.5989275763132464,1.0,36/157,9.06%,FLT1;IGF1;KSR1;LYN;IGF1R;PHLPP1;TGFBR3;TEK;EPHA7;KIT;JCAD;KDR;PAK1;TNIK;NRK;ROR2;TBX1;INSR;EPHB1;PAK5;PELI2;FAS;DAB2IP;IGF2;MAPK3;ADRA2A;MAP4K4;GPR37;LBH;BMP2;EPHA8;RIT2;LPAR1;FLT4;DUSP3;NTRK2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5766507134297213,1.3777724902738748,0.10381679389312977,0.7575123596223706,1.0,3/26,3.14%,EGFR;SOX9;GAREM1
prerank,histone deubiquitination (GO:0016578),0.6063974854909429,1.3776864287937767,0.13543307086614173,0.7557657543893166,1.0,7/18,11.86%,TRRAP;USP49;KAT2A;USP7;USP22;USP3;USP21
prerank,autophagy of peroxisome (GO:0030242),0.6473281409907391,1.3771222766891293,0.15070921985815602,0.7559475226250636,1.0,4/12,13.47%,ATM;SQSTM1;RB1CC1;ACBD5
prerank,skeletal muscle organ development (GO:0060538),0.5719019142194728,1.3769665077067585,0.10676691729323308,0.754527077782425,1.0,6/26,3.49%,SIX1;DISP1;CSRP3;STRA6;LARGE1;MYOG
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5305832027726389,-1.3765911207680048,0.11842105263157894,0.601059295637361,1.0,11/16,28.37%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;ATP5F1D;ATP5MC2;ATP5F1A;ATP5MF;ATP5MG;ATP5MC3
prerank,ceramide transport (GO:0035627),-0.5716658601017448,-1.3757362291646495,0.09644670050761421,0.6006122302068765,1.0,4/12,14.05%,PLTP;CERT1;PSAP;ABCB4
prerank,retinol metabolic process (GO:0042572),0.6222261745551309,1.3748892519027056,0.152428810720268,0.7608848692807467,1.0,2/14,2.45%,CYP1B1;ADH7
prerank,vascular transport (GO:0010232),0.4752180998635312,1.3747647186611918,0.07547169811320754,0.7594155829124738,1.0,11/81,3.15%,SLC4A4;SLC38A2;SLC12A2;SLCO3A1;SLC38A1;SLC24A3;SLC5A6;SLC2A13;SLC16A1;ABCG2;SLC7A2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.6839069941692766,1.3746158732450888,0.15488215488215487,0.7580349994393979,1.0,5/10,13.44%,SOX9;PDGFA;TGFBR2;CHRD;LRP5
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4154694786859023,-1.3741900403535168,0.06907894736842106,0.6023711153473982,1.0,17/39,18.62%,RPS14;RPS24;RPS27;RPS15;RPS5;RPS16;RPS19;RPS17;RPS7;EMG1;SNU13;RPS25;RIOK1;TSR3;MRPS11;RPS28;NOB1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6106865755327825,1.3727422894251147,0.14729950900163666,0.763189883807697,1.0,2/16,1.44%,BMP4;TGFB3
prerank,SNARE complex assembly (GO:0035493),0.6660927749314847,1.3726297195321073,0.15771230502599654,0.7615946930259196,1.0,1/10,0.71%,STXBP6
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5242704781871839,1.3722567010598805,0.10460251046025104,0.7610754826414434,1.0,6/46,5.36%,BMP4;FOXP1;THBS1;TCF7L2;IGFBP5;NR4A3
prerank,endothelial cell migration (GO:0043542),0.5311408602854066,1.3710767296516666,0.10227272727272728,0.763745339677247,1.0,13/37,16.82%,CCN3;FSTL1;CYP1B1;GIPC1;ABL1;ID1;NRP1;RHOA;S100A2;EMP2;STARD13;LGALS8;NR4A1
prerank,regulation of interleukin-8 production (GO:0032677),0.4891203223144615,1.3707458231333975,0.07874015748031496,0.7631087670953155,1.0,11/69,8.66%,F3;ANXA1;LBP;KLF4;IL10;ANXA4;DDIT3;OTUD7B;MAVS;TLR6;BCL10
prerank,organelle disassembly (GO:1903008),0.5477982026237885,1.3702455644130929,0.11278195488721804,0.7630887526584486,1.0,19/33,22.13%,ULK2;STX5;VCP;DDRGK1;PLK3;MRRF;EIF2D;KLC1;DYRK3;GFM2;KIF9;RB1CC1;UFL1;ATG2A;GBF1;MTIF2;ULK1;UBA5;CDK1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4601065264975192,1.3700144698048609,0.05889423076923077,0.7619514795542701,1.0,17/101,11.21%,THBS1;CYFIP2;SAMD4A;PERP;EZR;AGTR1;INHBA;KLF4;EIF4G1;NIBAN1;LARP4B;FBXW11;PLD1;RDX;MTOR;TBC1D10A;IST1
prerank,metal ion transport (GO:0030001),-0.353157872340489,-1.3697389582317814,0.025380710659898477,0.6139535832779979,1.0,25/86,14.09%,ITPR1;CACNA1D;TRPC3;CACNA1E;CALCRL;SLC41A1;TPT1;RAMP2;SLC39A8;NDFIP2;GRIN3A;ATP2C1;SELENOK;MMGT1;CAMK2A;SLC8A1;RYR2;CACNG7;CACNA1B;SLC3A2;CACNA2D1;SLC30A1;TRPC4;CHRNA7;RYR3
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4456110061477977,-1.369466314593533,0.096045197740113,0.6116816172978424,1.0,9/29,7.73%,FLT1;TEK;PDGFRB;PRKD1;KIT;PTK2;CD81;PDGFRA;EPHA8
prerank,pulmonary valve development (GO:0003177),0.5985552368227579,1.369073156559323,0.12561174551386622,0.7638228200005741,1.0,7/18,8.32%,SLIT2;BMP4;STRA6;SMAD6;NOTCH2;JAG1;TNFRSF1B
prerank,regulation of RNA metabolic process (GO:0051252),0.4905661159281979,1.3674248211002322,0.10695187165775401,0.768463398042502,1.0,21/59,19.41%,AHNAK2;MBNL1;AHNAK;CLK1;MBNL2;SON;HNRNPH1;CELF1;FUS;TNFRSF1B;CLK2;PCBP4;METTL4;HNRNPL;SNRNP70;FAM50A;TRA2B;YTHDF2;RC3H2;ZNF326;GRSF1
prerank,carboxylic acid metabolic process (GO:0019752),0.5465580067375525,1.3670604664320405,0.11587982832618025,0.7678438765791197,1.0,9/33,10.98%,SLC23A1;SLC23A2;PTGIS;PON3;LIPT2;CARNMT1;CYP2S1;GNE;GNMT
prerank,inorganic cation transmembrane transport (GO:0098662),0.42862851462119694,1.3669205864907141,0.00944386149003148,0.7664230603331533,1.0,35/268,8.98%,SLC4A4;SLC9A2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC24A3;PKD1;KCNQ5;ATP1B1;SLC6A7;ATP2C2;ATP6V0A4;TRPM6;ANO6;KCNS3;CACNA1C;SLC39A11;SLC6A19;SLC9C1;NALCN;KCNB1;MCOLN3;TRPM4;KCNK7;SCN11A;ITGAV;SLC9A8;SLC4A8;P2RX4;ATP2B4;SLC39A14;PKD2L1;SLC6A16;SLC25A14
prerank,signal release from synapse (GO:0099643),-0.4168547748200828,-1.3668698298089301,0.06020066889632107,0.6170312715565729,1.0,19/43,27.22%,NRXN1;LIN7A;HSPA8;RIMS1;SNCA;PIP5K1C;SYN1;CPLX1;SNAP25;UNC13A;LIN7C;PPFIA3;SYT1;SNAPIN;SLC32A1;CDK5;STXBP3;SYN2;RAB3A
prerank,cellular response to peptide (GO:1901653),-0.38451795558871704,-1.3665135192828863,0.06611570247933884,0.6150502780078974,1.0,17/56,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;VIM;NOD1;ITGA4;EPHA4;RPL23;GJA1;SRC;APP;CACNA2D1;GRIN1;CACNB1
prerank,regulation of intracellular protein transport (GO:0033157),0.5379492329440783,1.3659001967582014,0.12464183381088825,0.7684649215992546,1.0,7/32,12.48%,BMP4;NDEL1;PLK3;CEP131;PCM1;BCAS3;PTPN14
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6043051566631931,1.365784832470285,0.15332197614991483,0.7669403033051294,1.0,2/15,2.57%,RSPO3;GPC3
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5161063841560344,-1.3656603937804328,0.1309823677581864,0.6147053538232535,1.0,10/17,23.67%,IGF1;APOE;RTN1;NTRK2;CHRNA7;GGA3;BIN1;RTN4;PIN1;HAP1
prerank,regulation of microtubule-based process (GO:0032886),0.526608916381738,1.3654935631918326,0.10848400556328233,0.7662035965816315,1.0,7/36,7.56%,EFNA5;PHLDB2;FAM107A;GSK3B;DIAPH1;MEMO1;MARK2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5456133729429403,1.3654157133623774,0.11808669656203288,0.7645446822823424,1.0,1/31,0.11%,FZR1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6444883640160611,1.3647256529471496,0.15206611570247933,0.7653985649474783,1.0,3/13,4.69%,USP13;NFE2L2;RNF185
prerank,regulation of RNA splicing (GO:0043484),0.48128702150979186,1.3644450730410265,0.09536082474226804,0.7645500935940707,1.0,11/69,8.89%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK1;MBNL2;SON;HNRNPH1;CELF1;FUS;CLK2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.558328725272029,1.3639013273874707,0.1375186846038864,0.7648333494722991,1.0,8/27,10.56%,PTPN3;SLMAP;CAMK2D;FXYD5;DLG1;ATP2B4;FXYD7;COMMD1
prerank,sulfur compound catabolic process (GO:0044273),-0.42653691903761737,-1.3638081504398227,0.0979020979020979,0.6179936654166062,1.0,18/38,23.60%,FMOD;OGN;DCN;LUM;GGT5;IDS;OMD;PRELP;NCAN;CSPG5;CSPG4;GGT7;HEXB;GGT1;VCAN;TXN2;BGN;GALNS
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.521653607619994,-1.363672625481142,0.12169312169312169,0.6152215227865745,1.0,8/16,16.10%,ACE;ADM;KLK2;BMPR2;GPR37L1;GSK3A;PRCP;KLK1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.43502262625333277,-1.363475555414035,0.07166123778501629,0.6127552969564963,1.0,8/34,11.16%,IGF1;TGFA;PDGFRB;INSR;IGF2;RGCC;EDN1;EDN3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6140083424314899,1.3632402224442806,0.125,0.7635234335069839,1.0,6/15,19.11%,TNRC6C;CNOT7;TOB1;NANOS2;ZFP36L1;PABPC1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6140083424314899,1.3632402224442806,0.125,0.7635234335069839,1.0,6/15,19.11%,TNRC6C;CNOT7;TOB1;NANOS2;ZFP36L1;PABPC1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5953633003348859,-1.3627527499999637,0.125,0.6119755794782116,1.0,3/10,14.05%,APOE;DBI;ABCB4
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6213731928964967,1.3626246206455288,0.13388429752066117,0.7640447154922119,1.0,7/17,12.38%,CD55;GNL1;IL18BP;JAG1;CD46;TLR4;STAT3
prerank,negative regulation of hemostasis (GO:1900047),-0.5646686068224064,-1.362415821302116,0.12155963302752294,0.6101688701410931,1.0,5/12,10.01%,VTN;APOE;TFPI;CD34;EDN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.48628990166234687,1.3622983510720839,0.09138381201044386,0.7633020063160612,1.0,2/65,0.56%,FBXL7;FHL1
prerank,neuromuscular junction development (GO:0007528),-0.4705448775498903,-1.3621131635085728,0.12607449856733524,0.6079900100272148,1.0,11/24,14.71%,UNC13C;PDZRN3;PPFIBP2;GPHN;ANK3;ZC4H2;PPFIBP1;LRRK2;MUSK;CACNB4;CACNB1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5284088899163527,-1.3617449204463126,0.1141552511415525,0.6060612556560774,1.0,5/15,7.12%,GRM3;GRM5;GRM1;GRM7;GRM8
prerank,stem cell development (GO:0048864),-0.5222466900903778,-1.3605406503453579,0.11734693877551021,0.6070456803418489,1.0,10/16,35.51%,CDH2;TAPT1;NOLC1;NRG1;PTPRC;SHH;WNT7A;KBTBD8;SNAI2;CYP26C1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.595352932188589,1.3595579356584555,0.14790996784565916,0.7721763563293512,1.0,2/17,1.44%,BMP4;TGFB3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6436889058571109,1.3594468163672064,0.1721170395869191,0.7707121958574571,1.0,2/12,4.47%,BDH2;GCLC
prerank,actin filament-based transport (GO:0099515),-0.4891701013989681,-1.359338033160391,0.10355029585798817,0.6078809018652178,1.0,7/21,18.01%,MYO1B;MYO6;FNBP1L;MYO5A;MYO5C;WASL;MYO1F
prerank,ganglioside metabolic process (GO:0001573),-0.4968875603428668,-1.3593222273261405,0.12299465240641712,0.6049337742905228,1.0,8/20,18.17%,ST6GALNAC3;ST8SIA4;ST8SIA6;GM2A;ST3GAL5;ST6GALNAC4;ST6GALNAC6;HEXB
prerank,regulation of autophagosome maturation (GO:1901096),0.6373987804035862,1.3585293524856739,0.15807560137457044,0.7725433085204572,1.0,8/13,23.77%,ADRB2;TBC1D25;SMCR8;CLEC16A;FYCO1;CLN3;TMEM39A;PHF23
prerank,protein import into peroxisome membrane (GO:0045046),0.5763680003048078,1.3585244042882516,0.15082956259426847,0.7706465111750814,1.0,8/22,19.53%,ABCD3;PXMP2;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6019339433570857,1.3580747255346028,0.15865384615384615,0.7704251601213734,1.0,7/17,10.90%,BAIAP2L1;NTRK3;ABL1;HCLS1;NRP1;BCAS3;CDC42
prerank,cellular protein metabolic process (GO:0044267),-0.2943741360725927,-1.3579225959152463,0.0,0.6062614306725774,1.0,131/396,18.78%,CP;IGF1;LTBP1;IGFBP2;CDH2;ST3GAL1;APOE;ST3GAL6;IGFBP7;SPARCL1;ST8SIA4;RPLP1;RPS14;MSRA;IGFBP3;CTSH;RPL37A;ITIH2;RPL38;RPL30;CST3;IGFBP4;RPL8;CSF1;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;VWA1;RPS21;PAPPA;RPS23;RPS9;RPS29;TNC;RPS15;RPL22;RPS5;DAB2IP;RPS16;IGF2;RPL5;RPS4X;RPS2;UBE2I;RPS13;LGALS1;RPL34;NOTUM;RPL23;RPL17;PLAT;RPS19;LAMB1;RPS8;RPS20;RPS27A;RPS17;GAS6;RPL13A;SCG3;RPS12;SERPIND1;SPP1;RPS7;RPS3;GATA6;MMP2;RPN2;RPL27A;LCMT1;RPL3;RPL24;F5;CHRM3;ADORA2A;RPS18;SPCS3;RPL18;RPL39;RPS11;SFTPA2;SFTPA1;APP;HSP90B1;MRPL3;PDIA6;CSF2RA;RPL23A;SDC2;ABL2;RPL7A;RPL35A;RPL26;RPL32;ERO1A;PENK;RPL18A;ICMT;RPS25;RPL36;MSRB1;APLP2;RPL12;UBL5;RPS10;VGF;RPL27;RPL11;MRPS11;RPL31;QSOX1;SARS1;FUCA2;RPL19;RPLP0;APH1B;RPS15A;PNPLA2;RPS28;PSENEN;MATN3;RPL37;MRPL51;RPL29;MRPL35
prerank,protein localization to microtubule organizing center (GO:1905508),0.6305327052347349,1.3578327757210853,0.15307820299500832,0.7694768608886479,1.0,9/15,24.51%,CEP131;STIL;PCM1;PIBF1;CSNK1D;CEP192;C2CD3;CCDC14;CEP83
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.44311490251049124,-1.3569355784882782,0.09477124183006536,0.6065577286843647,1.0,10/34,7.73%,FLT1;PIK3R1;TEK;PDGFRB;PRKD1;KIT;PTK2;DAB2IP;PDGFRA;EPHA8
prerank,regulation of glycogen metabolic process (GO:0070873),0.6389857312159584,1.356604964152487,0.15517241379310345,0.7725050587081187,1.0,2/12,2.78%,PPP1R3B;PPP1R3C
prerank,visual system development (GO:0150063),0.5230785060613298,1.3564862003899505,0.11869436201780416,0.7710766641924974,1.0,11/37,16.20%,PBX3;PBX1;HIPK1;RAB18;SMOC1;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18;PAX6
prerank,metal ion export (GO:0070839),0.543803536136878,1.3564163025285385,0.13670133729569092,0.7694484333136787,1.0,3/31,1.47%,SLC4A4;KCNK5;ATP1B1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.33381584937271563,-1.3557247271483626,0.015267175572519083,0.6073884601949329,1.0,29/121,10.14%,IGF1;IL34;VTN;LYN;IL31RA;PECAM1;ENPP2;KIT;PARP14;TNK2;GRM5;ACE;IL6ST;TEC;IL6R;NEDD9;ARL2BP;CD81;EPHA4;IGF2;GHR;GPRC5B;LRP8;GAS6;ERBB4;SRC;IL18;TNFRSF1A;FGF7
prerank,transport across blood-brain barrier (GO:0150104),0.4701450626450831,1.3554019043449033,0.0832282471626734,0.7715968414472337,1.0,11/83,3.15%,SLC4A4;SLC38A2;SLC12A2;SLCO3A1;SLC38A1;SLC24A3;SLC5A6;SLC2A13;SLC16A1;ABCG2;SLC7A2
prerank,actin polymerization or depolymerization (GO:0008154),0.5107875089677347,1.3549779843610676,0.11946308724832215,0.7712325792548139,1.0,11/50,10.81%,MICAL2;COBL;VILL;ABI1;FAM107A;GSN;DIAPH1;MSRB2;TTC17;WDR1;WASHC5
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.47580233807547134,1.354265954690326,0.08987341772151898,0.7720649532334486,1.0,10/73,8.42%,EGFR;NGF;NTRK3;CD44;DOCK7;EIF4G1;HCLS1;RIPK2;ATP2B4;BCAR3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6414528938226335,1.3536579959481339,0.13769363166953527,0.7726168892396705,1.0,2/12,2.79%,FOXP1;KLF4
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.33809036775593543,-1.3532033798788419,0.022727272727272728,0.612634258264972,1.0,27/124,11.27%,PTPRM;LYN;FRYL;APOE;CNTNAP2;RAPGEF2;GPM6A;MAP2;ATP1B2;PLP1;GPM6B;CNTN4;STMN4;STMN3;OPHN1;SH3GL2;LAMB1;MICALL1;EPHA8;ARMC2;PLEK;RASGRF1;MAPT;RAC1;UHMK1;MYOC;APP
prerank,regulation of blood coagulation (GO:0030193),0.5663025581843555,1.3518468499490477,0.13793103448275862,0.7777772121840231,1.0,6/27,9.56%,ST3GAL4;THBS1;THBD;SERPINE2;HPSE;DMTN
prerank,positive regulation of RNA splicing (GO:0033120),0.5448410031626795,1.3508297719871658,0.13549337260677466,0.7798942910040815,1.0,1/29,0.04%,SLC38A2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5857691049637366,1.35074380508861,0.15544871794871795,0.7783384267908473,1.0,8/16,18.23%,DDX5;ESR2;RBFOX2;TADA3;DDX17;NCOA4;AR;ARID1A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5527190741281156,-1.3502201916570964,0.14105793450881612,0.6192110501128324,1.0,2/12,9.17%,IL1R1;IL18
prerank,cardiac muscle cell contraction (GO:0086003),0.5930859406652644,1.349106548082146,0.1386748844375963,0.782841644363229,1.0,4/19,3.65%,KCNJ2;CAMK2D;CACNA1C;GSN
prerank,phospholipid catabolic process (GO:0009395),-0.46094544374903135,-1.3490461952121697,0.11470588235294117,0.6199596758648812,1.0,4/24,4.59%,GPCPD1;ENPP2;ENPP6;ABHD12
prerank,blood vessel diameter maintenance (GO:0097746),0.5226223691948922,1.3486013928673495,0.12078651685393259,0.7830782828706386,1.0,7/34,9.73%,EDNRA;KCNMB2;AGTR1;GCLC;SCPEP1;AGTR2;PER2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4359851817911405,-1.3485380366062505,0.08333333333333333,0.6186530768665868,1.0,11/33,16.70%,IGF1;IGF1R;PIK3R1;NYAP2;EDN1;HTR2A;PIK3C2A;MYO16;AKT1;PIK3R5;TYRO3
prerank,organophosphate catabolic process (GO:0046434),-0.571765988078401,-1.3480435083611617,0.1425233644859813,0.617322112490908,1.0,2/11,4.59%,ENPP2;ABHD12
prerank,regulation of interleukin-13 production (GO:0032656),-0.5443298848084438,-1.3476185870748654,0.11270983213429256,0.6157702175112008,1.0,3/13,9.17%,LEF1;TNFRSF21;IL18
prerank,cell-cell junction assembly (GO:0007043),-0.37699907904753066,-1.3468945669056689,0.044897959183673466,0.6152037616962013,1.0,18/63,7.25%,TJP1;TLN2;GJB6;CDH2;CLDN5;EPB41L3;CDH8;GJB2;GJC1;GJD3;CDH10;ARVCF;TLN1;ACTB;RAMP2;PIP5K1C;JAM3;GJA1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5601677144527516,1.3464334597258938,0.13213213213213212,0.7893704895107266,1.0,6/27,7.72%,DDX5;CD44;SMYD2;SPRED2;ATM;KDM1A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.43419867964553477,-1.3459568494239962,0.08231707317073171,0.6154500936412103,1.0,10/34,9.28%,FLT1;SEMA6A;PRKD1;KDR;NOTCH1;ERN1;RAMP2;DAB2IP;FLT4;SPHK1
prerank,lipoprotein catabolic process (GO:0042159),-0.5595400531168491,-1.3457451090907326,0.11564625850340136,0.6131837031209135,1.0,4/11,12.64%,APOE;NOTUM;ABHD17C;CTSD
prerank,eye photoreceptor cell development (GO:0042462),0.6131378581777285,1.34549094149135,0.15980230642504117,0.7911895488847364,1.0,2/15,5.71%,RP1;RPGRIP1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5512216429668813,1.3451864894512964,0.13249211356466878,0.7905549109172643,1.0,5/25,8.66%,EGFR;THBS1;FZD7;NRP1;BCL10
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.5884356474426728,1.3450319412636595,0.15875613747954173,0.7893219337580764,1.0,4/20,4.05%,THBS1;ANO6;GSN;PDCD4
prerank,endothelial tube morphogenesis (GO:0061154),0.6578384917555945,1.344642096191579,0.18592057761732853,0.7889934890494655,1.0,1/10,0.27%,BMP4
prerank,calcium ion transmembrane transport (GO:0070588),0.45799403880085915,1.3444193216573797,0.09102244389027432,0.7879551145324794,1.0,27/86,16.09%,SLC35G1;SLC24A3;PKD1;ATP2C2;TRPM6;ANO6;CACNA1C;NALCN;MCOLN3;TRPM4;GRIN2C;ITGAV;P2RX4;ATP2B4;MCUB;MICU1;PARL;PMPCB;TRPC5;SPG7;MCU;TRPM7;STOML2;SLC8B1;TRPC7;TRPM2;YME1L1
prerank,cellular response to organic substance (GO:0071310),0.44808502943298767,1.3441117651232153,0.07384987893462469,0.7872741423761588,1.0,17/116,7.07%,SLIT3;SLIT2;DPYSL3;CYP1B1;RAMP1;SHC1;NFAT5;KLF4;PID1;BMPR1A;IGFBP5;SOCS2;TGFBR1;TGFBR2;HCLS1;IL18BP;PTPN2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6051270780334557,1.3440427693716073,0.15763546798029557,0.7856992448313767,1.0,2/15,3.93%,TCF7L2;GSK3B
prerank,axonal transport of mitochondrion (GO:0019896),-0.570259270242197,-1.3434674396550559,0.14532019704433496,0.6176166929132741,1.0,6/11,23.67%,HIF1A;MAPT;SYBU;TRAK2;NEFL;HAP1
prerank,dendritic spine organization (GO:0097061),-0.4579280785571832,-1.343361646261886,0.10115606936416185,0.6151241700492522,1.0,6/26,5.10%,DOCK10;IGF1R;SHANK3;ITGA3;INSR;EPHB1
prerank,cellular response to organonitrogen compound (GO:0071417),0.45375483463840366,1.3411987643214418,0.08262454434993925,0.7946787042757087,1.0,17/99,11.08%,CDH1;SLIT2;SOX9;EZR;CTNNA1;RAP1A;CAPN2;DIAPH1;IGFBP5;GOLPH3;P2RX4;JUP;DMTN;SLC26A6;MTOR;HTR1B;TAF1
prerank,establishment of epithelial cell polarity (GO:0090162),0.5972477505469558,1.340460725916852,0.16585365853658537,0.7957773885365471,1.0,7/19,12.11%,CYTH3;EZR;GOLPH3;PARD3;CDC42;RHOA;MYO9A
prerank,negative regulation of cell differentiation (GO:0045596),0.42440233296250424,1.3403263966657275,0.058305830583058306,0.7944454738408308,1.0,41/181,13.60%,EGFR;BMP4;CRIM1;SOX9;ZFPM2;BMP5;WNT9A;PTK2B;ZBTB16;COL5A2;EFEMP1;SMAD6;GDF5;BAMBI;PDCD4;SPRED2;TRPM4;TGFBR1;TRIO;TWIST2;ITGAV;JAG1;TSKU;HES1;WWTR1;EIF2AK4;IL17RD;CTR9;SKI;FOXA1;GATA3;TCF23;NKX2-1;NOG;RB1;PAF1;REST;ITGB3;CHRD;LRP5;LDLRAD4
prerank,negative regulation of peptidase activity (GO:0010466),-0.4029840415365694,-1.3388153605826816,0.08582089552238806,0.6269211444583199,1.0,9/47,9.45%,VTN;TIMP3;SPOCK2;SERPINI1;CST3;GAPDH;SPOCK3;SERPIND1;SPOCK1
prerank,mitochondrial protein processing (GO:0034982),0.630475034729581,1.3387914025942238,0.17731629392971246,0.798542420760338,1.0,6/11,16.09%,PMPCB;OMA1;IMMP1L;SPG7;STOML2;YME1L1
prerank,cellular response to purine-containing compound (GO:0071415),-0.5845225235132689,-1.3380455383524428,0.1331877729257642,0.626505284634105,1.0,5/10,15.89%,P2RY1;SLC8A1;RYR2;RYR3;CASQ2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4958413067058932,1.3377800118885832,0.10744985673352435,0.8003834680709129,1.0,13/49,10.77%,GPC6;EXT1;HS3ST1;GPC3;B3GNT2;GCNT2;HS6ST2;HEXA;GPC4;B4GAT1;B3GNT6;NDST1;B4GALT7
prerank,positive regulation of vasculature development (GO:1904018),0.444422463528185,1.3363010494749616,0.08994082840236686,0.8042400306522679,1.0,11/94,2.80%,SMOC2;F3;THBS1;ITGB8;ANXA3;CYP1B1;PTGIS;ITGB1;PGF;ISL1;HIPK1
prerank,cell-cell junction maintenance (GO:0045217),-0.5629320163645676,-1.3357557500225248,0.1388888888888889,0.6309156030281868,1.0,5/11,24.62%,TJP1;MYADM;CSF1R;NLGN2;PRTN3
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5009829954793971,1.3355675076469926,0.1440443213296399,0.8053556447574067,1.0,11/44,14.68%,THBS1;NGF;CD44;KLF4;CAST;CSNK2A1;USP47;DNAJB6;SFN;MAP2K5;CDKN2D
prerank,osteoclast differentiation (GO:0030316),0.5674248098939919,1.3348705431008836,0.15262321144674085,0.806217202416503,1.0,4/22,7.52%,FOXP1;ANXA2;TNFSF11;GAB2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4835458032426433,1.3346596535237574,0.11506849315068493,0.8051842020577054,1.0,8/55,6.43%,THBS1;CYP1B1;AGTR1;PID1;COQ7;ARF4;TGFBR2;TFAP2A
prerank,cell-matrix adhesion (GO:0007160),0.4534851617241923,1.3343986824227443,0.09891435464414958,0.804431758437172,1.0,19/95,8.36%,MSLN;ITGBL1;ITGB8;FN1;PKD1;SORBS1;CD44;ITGB1;ITGA10;COL3A1;ADAM9;BCR;PIP5K1A;VCL;ITGAV;TRIP6;ITGB5;MKLN1;PPFIA1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5553041049965325,-1.3343543288141233,0.1367713004484305,0.6324178489297835,1.0,3/11,2.59%,TJP1;RAPGEF2;F11R
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5504489352613876,-1.3342908541165361,0.13194444444444445,0.6297048821509198,1.0,5/12,13.99%,PIK3R1;ERN1;DAB2IP;TMEM33;BOK
prerank,lipid phosphorylation (GO:0046834),-0.5744080205393616,-1.3340871005118429,0.1367713004484305,0.6275952305704506,1.0,5/10,15.24%,DGKB;DGKI;DGKD;DGKG;DGKE
prerank,cAMP-mediated signaling (GO:0019933),-0.4752601261437844,-1.3330618025056045,0.11143695014662756,0.6279222683561617,1.0,11/24,8.84%,KSR1;RAPGEF3;PDE7B;ADCY1;RAPGEF2;AHR;RIMS2;ADCY2;CAP2;PDE4D;PDE2A
prerank,positive regulation of leukocyte activation (GO:0002696),0.5890648784268524,1.3329213824671842,0.15912897822445563,0.8080878939940916,1.0,4/18,11.44%,THBS1;LBP;TLR6;TLR4
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.4840893731182728,1.332602487322926,0.10649350649350649,0.8075742213430032,1.0,12/57,18.02%,FZR1;FOXN3;ATM;CHEK2;RAD17;MRNIP;CHEK1;PRKDC;TAOK3;ATF2;CLSPN;NBN
prerank,calcium-mediated signaling (GO:0019722),0.44546191825976694,1.3315643075149939,0.08935128518971848,0.8098810020195283,1.0,23/93,15.73%,EGFR;PLCE1;ANK2;ATP1B1;PPP3CA;AGTR1;CACNA1C;NUDT4;TRPM4;TNNI3;TNFSF11;P2RX4;DMTN;RCAN1;CXCR4;EIF2AK3;SLC9A1;HTR2B;PPP3CC;MCU;PRKAA1;PRKACA;TRPM2
prerank,fatty acid oxidation (GO:0019395),0.47870943783538084,1.3314269505044294,0.12916111850865514,0.8085549664644806,1.0,10/57,7.54%,ABCD3;BDH2;EHHADH;ADH7;ACADM;AUH;HACL1;ECHDC1;PECR;DECR1
prerank,polyol biosynthetic process (GO:0046173),0.5786067446405946,1.3312483509585666,0.16478190630048464,0.8074151999091307,1.0,6/16,8.58%,ACER3;IP6K2;FGF2;IP6K3;PPIP5K2;CYP27B1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5977422390882986,1.3311065996042757,0.17224080267558528,0.8061537971453093,1.0,3/16,7.77%,SOX9;WDTC1;ERLIN1
prerank,neuron differentiation (GO:0030182),0.4304381431874246,1.3302959775912417,0.061016949152542375,0.8074169669833008,1.0,26/165,11.87%,VSX1;PBX3;MET;WNT9A;PBX1;WNT11;WNK1;INHBA;LRP6;PITX3;LHX2;PHOX2A;WNT16;FZD7;NR4A2;ACSL3;TGFBR1;CDNF;ITM2C;FZD2;ERCC3;ATOH8;FOXA1;WNT2B;TGFB2;THOC2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5696492273844124,1.3293821435162467,0.15838509316770186,0.8090393613804647,1.0,5/21,13.70%,LRP6;GSK3B;FZD2;CSNK1A1;AMER1
prerank,muscle organ development (GO:0007517),0.48737621533525693,1.3276800837322384,0.12287581699346405,0.8139176569081668,1.0,8/54,5.24%,MKX;SGCD;FHL1;MRAS;LARGE1;MEF2A;DMD;COL6A3
prerank,protein localization to plasma membrane (GO:0072659),0.4329565055996632,1.3275981642544565,0.0811764705882353,0.8124564853510089,1.0,21/129,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;NECTIN3;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;PIP5K1A;GAK;DLG1;PRAM1;FGF13;JUP
prerank,protein localization to cell surface (GO:0034394),0.55014091713899,1.3273415456912807,0.16408668730650156,0.8115717917446433,1.0,11/26,16.59%,ANK2;PTPRU;WNT11;VCL;PIGU;RIC3;GGA2;SMURF1;USP4;EMP2;FLNA
prerank,hexose transmembrane transport (GO:0008645),-0.4619796209002507,-1.3272684508338628,0.12903225806451613,0.6435768333920027,1.0,7/21,20.34%,SLC2A1;PPARD;SLC5A3;SLC2A12;SLC50A1;SLC45A1;SLC2A8
prerank,regulation of axon regeneration (GO:0048679),-0.5499982266613541,-1.3271497989767895,0.13901345291479822,0.6410986938685979,1.0,9/12,37.44%,INPP5F;EPHA4;GRN;CERS2;PTN;RTN4R;RTN4RL1;KLK8;CNTF
prerank,positive regulation of protein processing (GO:0010954),-0.49270706190402863,-1.326297739975834,0.125,0.6411948999198588,1.0,4/19,5.87%,CCBE1;CLEC3B;NKD2;MYH9
prerank,regulation of heart contraction (GO:0008016),-0.34441056650228435,-1.325865510610512,0.050761421319796954,0.6396812756868197,1.0,28/90,17.33%,ATP1A2;ITPR1;ATP1B3;CALM1;NPR1;ATP1B2;DMPK;ABCC9;ATP2B1;CELF2;PDE4D;CALM3;DES;FXYD6;KCNQ1;SLC8A1;RYR2;ACE2;AGT;RYR3;KCNJ12;STIM1;GSK3A;CASQ2;NOS1;FXYD1;CORIN;ATP2A2
prerank,negative regulation of wound healing (GO:0061045),0.5317630664880268,1.3251755374772087,0.15269461077844312,0.8180221001708166,1.0,6/28,7.51%,SLC12A2;CD109;PHLDB2;THBD;SERPINE2;FGF2
prerank,actin filament depolymerization (GO:0030042),0.6455049289094505,1.32471374842216,0.17109634551495018,0.818043551499654,1.0,2/11,3.65%,MICAL2;GSN
prerank,regulation of muscle contraction (GO:0006937),0.5562845507237315,1.324357556551265,0.15535444947209653,0.8175916329250731,1.0,2/26,0.44%,KCNB2;PLCE1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5732254487406567,1.3229346153026234,0.1497584541062802,0.821739680074657,1.0,4/20,5.09%,ADRA1B;AKAP13;ADRB2;ADCY9
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.48527854596356357,-1.3226931131096247,0.13624678663239073,0.646932189695746,1.0,6/18,7.31%,IL34;DAAM2;TENM4;NOTCH1;TNFRSF21;MDK
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6014494613106005,1.322477939238791,0.17474048442906576,0.8216603141687885,1.0,3/15,4.13%,EGFR;PTK2B;ABL1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5572551952258159,-1.3224300357304049,0.1473429951690821,0.645005888923968,1.0,3/10,6.10%,LYN;FAS;MAPK3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.607449229694857,1.3223879893746373,0.16013628620102216,0.820227136011093,1.0,4/15,6.43%,SIX1;TGFBR1;TGFBR2;TFAP2A
prerank,protein localization to cell periphery (GO:1990778),0.4287796536494586,1.322070123483004,0.08139534883720931,0.8195678958889299,1.0,22/133,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;RABEP1;PIP5K1A;GAK;DLG1;ARL3;PRAM1;FGF13;JUP
prerank,regulation of cardiac conduction (GO:1903779),-0.38054984464078756,-1.3217600111971768,0.07865168539325842,0.6446549271853892,1.0,20/54,17.33%,ATP1A2;ITPR1;ATP1B3;NPR1;ATP1B2;DMPK;ABCC9;ATP2B1;FXYD6;SLC8A1;RYR2;ACE2;AGT;RYR3;STIM1;CASQ2;NOS1;FXYD1;CORIN;ATP2A2
prerank,regulation of gene expression (GO:0010468),0.39353914133861145,1.3213143072670641,0.0,0.8206785502457102,1.0,158/903,13.00%,SLC38A2;BNC2;CDH1;BMP4;F3;FOXP1;VSX1;AHNAK2;SLC24A3;SOX9;TCF7L1;ZFHX3;MBNL1;PRRX2;NGF;ITGB8;NTRK3;FN1;PRDM6;SMO;FOXN3;SIX1;HOXA5;ANK2;ATP1B1;FOXD1;HDAC4;EZR;AHNAK;ESR2;NFIA;USP13;WNT11;KRAS;INHBA;BMP6;WWP2;KLF4;EFEMP1;PID1;COQ7;CLK1;IL10;PITX3;GSN;IGSF1;KAT6B;YBX3;GCNT2;ZBTB7B;GSK3B;WNT16;NOTCH2;FZD7;ZNF148;ABL1;ZFP64;BMPR1A;DDIT3;NFE2L2;CTCFL;TNRC6C;AFF3;DDRGK1;CRABP2;GDNF;TGFBR1;JMJD1C;NFKB1;ZNF423;TRRAP;SERPINB9;TOB2;PLSCR1;MBNL2;MOV10;CLU;EP300;TFAP2A;ERC1;SON;HCLS1;FGF22;TRIM44;HNRNPH1;TRIM26;CNOT7;CELF1;ATM;TLR6;ATP2B4;HDAC10;FGF2;TADA3;TSKU;NELL1;CREBBP;BHLHE40;FUS;SMCR8;WWTR1;GATA4;ADAM10;TOB1;TAF6L;CALCOCO1;CAVIN4;ZNF462;CLK2;CHEK2;PCBP4;NFYA;CTR9;HMG20A;RDX;BCL6;TCF3;NFKB2;ATOH8;GON4L;BRCA2;AGR2;CD46;FOXK2;GPBP1L1;GCFC2;GATA3;TCF23;ZNHIT3;MTOR;PHF12;NKX2-1;ZC3H7A;NOG;TAF1;EIF2AK3;GNB3;UBR5;RB1;RBL2;TLR4;ZBTB11;ZNF507;TGFB2;MEGF8;REST;NLK;CD36;NFIL3;STAT3;FOXC1;METTL4;SNX12;BAZ2A;RBMS3;ASCC1;MAPK1;ZBTB4
prerank,negative regulation of cell migration (GO:0030336),0.4352894843699314,1.3210668939468466,0.07542857142857143,0.8198133970859128,1.0,24/137,8.97%,CDH1;SLIT2;TMEFF2;CLIC4;DPYSL3;FOXO3;CYP1B1;SULF1;ARHGDIB;PHLDB2;PTPRU;WNT11;COL3A1;BMPR1A;IGFBP5;ZMYND8;VCL;JAG1;RAP2C;FGF2;DUSP10;SRGAP2;SRGAP3;FUZ
prerank,reverse cholesterol transport (GO:0043691),-0.5289374868686062,-1.3209771088799158,0.1386861313868613,0.6444743185191633,1.0,4/13,9.53%,APOE;ABCA1;SCARB1;ABCA5
prerank,embryonic limb morphogenesis (GO:0030326),0.5320564870624979,1.320776393724727,0.14723032069970846,0.8191638608099672,1.0,12/34,11.91%,MBNL1;GLI3;LRP6;CACNA1C;AFF3;RARG;TFAP2A;CREBBP;SKI;NOG;TGFB2;MEGF8
prerank,epithelial structure maintenance (GO:0010669),0.6438153484943124,1.3192431839243373,0.16843971631205673,0.8233561723067192,1.0,2/11,3.07%,CXADR;MUC6
prerank,in utero embryonic development (GO:0001701),0.5502555160089044,1.3181040950239296,0.1676829268292683,0.8262292730262596,1.0,7/25,8.30%,MBNL1;PKD1;TGFB3;FUT8;TGFBR1;STIL;ADAM10
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.40391925197799655,-1.317847086939776,0.09968847352024922,0.65164619440579,1.0,13/39,9.70%,ROBO1;EPN2;NOS3;MAML2;MAML3;NOTCH1;TSPAN5;IL6ST;NOTCH4;RBPJ;JAG2;SRC;ROBO2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5376595964460014,1.3171766511124574,0.1340941512125535,0.8280996891252023,1.0,11/29,11.39%,TCF7L1;TCF7L2;TRRAP;EP300;CREBBP;SMARCA4;KAT5;TLE4;BCL9L;TLE3;TLE2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5003438664841112,-1.317151307333037,0.1523809523809524,0.6510348757920915,1.0,4/16,7.45%,APOD;PPARA;ADCY7;SIRPA
prerank,negative regulation of cell division (GO:0051782),-0.5515191814414171,-1.316882976284735,0.15955056179775282,0.6491156855080867,1.0,7/11,30.61%,TXNIP;BLM;CHMP4C;ORC6;E2F7;VPS4A;E2F8
prerank,regulation of ruffle assembly (GO:1900027),-0.4649157785843874,-1.3155752785985202,0.1318051575931232,0.6507200776636921,1.0,8/23,15.78%,EPS8;ARHGAP24;EVL;EPS8L2;ABI3;P2RY12;PFN1;PLEKHM1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5837511665429898,1.3153747006394285,0.1791044776119403,0.8332973461612385,1.0,3/18,4.04%,CCN3;HDAC4;FZD7
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5247629981355861,-1.315235081973669,0.14388489208633093,0.6490805170266135,1.0,4/14,11.59%,ZEB1;OSR1;NOTCH4;SPRED1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.4215789467140784,-1.3150914021075568,0.10130718954248366,0.6468187856720344,1.0,13/32,19.51%,ITGA1;PDGFRB;PPIA;CALM1;PPP1R16B;CALM3;CD300A;HSP90AB1;PPP2R5A;DUSP26;PPP1R7;PPP1R15B;CDCA2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5928095072549359,1.3141291740551797,0.18357487922705315,0.8361698850049405,1.0,5/17,13.86%,SOX9;DSPP;KLF7;GATA3;CEBPB
prerank,Rac protein signal transduction (GO:0016601),-0.48460644123473595,-1.31405267020274,0.13541666666666666,0.6476331167748444,1.0,9/18,20.94%,EPS8;ELMO1;RHOH;RHOG;RAC1;CDH13;HACE1;ABI2;HACD3
prerank,protein kinase B signaling (GO:0043491),-0.4609625304925902,-1.3136485632828627,0.10275689223057644,0.6462170664531541,1.0,7/23,17.50%,IGF1;KDR;SETX;GAS6;AKT1;TYRO3;THEM4
prerank,atrial septum morphogenesis (GO:0060413),0.6533288573823717,1.3131659938929048,0.1881720430107527,0.8380660593649263,1.0,5/10,11.71%,ISL1;NOTCH2;GATA4;ACVR1;TGFB2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3865767668436138,-1.3127618868279216,0.07835820895522388,0.6463990620380119,1.0,14/47,8.28%,LEF1;WNT4;ENG;TGFBR3;TBX3;WNT5A;HIF1A;NOTCH1;BMP7;LOXL3;NOTCH4;RBPJ;BMP2;HEY2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.36200115282111733,-1.3126787610932242,0.07555555555555556,0.6440336428244384,1.0,10/67,6.13%,ITPR1;CHD7;RAPGEF4;CACNA1D;SLC2A1;RAPGEF3;CACNA1E;KCNC2;SYT7;ADRA2A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.43295224017715367,1.3121126642506566,0.08624708624708624,0.840533786503106,1.0,31/122,18.20%,EGFR;SMOC2;THBS1;SAMD4A;SORBS1;KLF4;NIBAN1;NFKB1;LARP4B;IRS1;FGF2;DYRK2;BCAR3;PLD1;NOX1;MTOR;STN1;TLR4;TGFB2;CIITA;FXR2;NAMPT;DHX9;PRKDC;IRS2;LDB1;FAF1;ATAD5;YTHDF3;AR;ZCCHC4
prerank,positive regulation of gene expression (GO:0010628),0.39480766259076144,1.3119125806726342,0.025329280648429583,0.8394454089595209,1.0,52/442,7.74%,SLC38A2;EGFR;BMP4;F3;THBS1;SLC24A3;SOX9;SAMD4A;NGF;ITGB8;NTRK3;FN1;SMO;HOXA5;ANK2;FOXD1;DDX5;EZR;WNT11;KRAS;INHBA;BMP6;KLF4;PID1;IL10;GSN;ZBTB7B;GSK3B;WNT16;POLR1G;NFE2L2;CTCFL;NIBAN1;TNRC6C;DDRGK1;TGFBR1;SERPINB9;PLSCR1;LARP4B;MOV10;CLU;HILPDA;EP300;TFAP2A;FGF22;CELF1;TAF1C;ATM;TLR6;FGF2;TADA3;KAT2A
prerank,mesenchymal cell development (GO:0014031),-0.48148904738781073,-1.3107886317521829,0.14358974358974358,0.64766089813015,1.0,4/18,8.28%,CDH2;NOTCH1;TAPT1;HEY2
prerank,regulation of T cell migration (GO:2000404),-0.47667595205852137,-1.3107751764599915,0.15064935064935064,0.6450393662446967,1.0,5/18,11.27%,APOD;CXCL12;LRCH1;RIPOR2;APP
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39509144339871255,1.3106652011977311,0.011077542799597181,0.8426079991485788,1.0,107/572,12.61%,FOXP2;BMP4;FOXP1;KLF12;RARB;SOX9;ZFHX3;ZFPM2;TCF7L2;PRDM6;NFIB;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;ESR2;NEDD4;NR2F1;BMP6;WWP2;HDAC9;ISL1;CRY2;KLF4;CUX1;SMYD2;FOXP4;SKIL;ZBTB7B;MEF2A;ZNF148;DDIT3;TLE6;GATA1;KLF7;NR4A2;TCF25;FOXC2;NR4A3;NFKB1;ZNF8;ID4;KANK2;BPTF;GLIS1;ID1;RARG;EP300;TFAP2A;DLG1;PLK3;USP2;OTUD7B;TBL1X;E2F6;JUN;FOXE1;NR6A1;KLF10;HDAC10;ZMYM5;KDM1A;RNF2;CREBBP;GLIS2;BHLHE40;HES1;NFATC4;ETV5;JDP2;UBE2D3;MDM4;CBFB;SMARCA4;TCERG1;KAT5;CTR9;DCAF1;BCL6;TCF3;MXD1;PHF21A;PER2;FRK;PPM1A;SKI;GATA3;TCF23;PHF12;NKX2-1;HDAC8;NOG;TAF1;RB1;PEX2;PAF1;REST;MTDH;CBX2;NFIL3;RXRA;STAT3;FOXC1;GATAD2B;RTF1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5920797235554249,1.3101583576929976,0.17560975609756097,0.8428158671709708,1.0,5/16,14.16%,PTK2B;GSN;SHTN1;BCAS3;CYRIB
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.536767011542872,1.3093811787815588,0.17004680187207488,0.8440156431783655,1.0,7/26,11.63%,SMOC2;CDC25B;USP2;HES1;FOXA1;PKN2;USP22
prerank,mitochondrial transcription (GO:0006390),0.6415920712122284,1.30845347141663,0.1735985533453888,0.8457534261749148,1.0,1/10,1.55%,FOXO3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5520663603249194,-1.3083758626272874,0.174496644295302,0.6497336491643879,1.0,2/10,6.10%,KCNAB1;ANK3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3345632698789815,-1.3082610424092493,0.0759493670886076,0.6474957783315555,1.0,32/110,15.58%,ADGRL3;ADGRL4;ADCY5;ADCY1;RAPGEF2;ABCA1;GNG2;ADGRE5;GNAS;LGR4;ADCY7;CALCRL;ADCY2;RAMP2;S1PR1;ADRA2A;PTGFR;PTH1R;LPAR1;S1PR3;ADORA2A;ADGRG1;ADM;ADCY4;LPAR2;IAPP;ADGRB1;TBXA2R;ADGRL1;ADGRE1;ADCY3;ADCY8
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5631860927714936,-1.3081694992267157,0.16393442622950818,0.6451347004623529,1.0,9/11,25.22%,KDR;CD34;NDNF;MCAM;GATA2;PRCP;SRF;VEGFA;ADIPOR2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4798238396585387,-1.3078851694084657,0.12566844919786097,0.6434342932988487,1.0,7/19,5.83%,ROBO1;SEMA6A;CCBE1;DCN;JCAD;TSPAN12;DAB2IP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.5646954849915092,-1.3076250966209424,0.1697674418604651,0.6416501957792125,1.0,3/10,10.33%,TGFA;ADRA2A;HBEGF
prerank,cytosolic transport (GO:0016482),0.4376144803159735,1.3073855455363663,0.1097708082026538,0.8481016514148706,1.0,48/108,23.38%,VPS13A;VPS13C;EHD3;EEA1;STX5;VPS54;RAB6A;ANKRD27;BECN1;GAK;ERC1;STX8;DOP1B;AP2A1;VPS53;TMEM87B;RBSN;RGP1;VTI1A;TBC1D10A;WASHC1;STX16;RAB5A;SNX32;EMP2;HOOK2;TMEM87A;SNX2;GBF1;SPAG9;TBC1D5;ARL1;VPS51;AP4M1;CORO7;MON2;RAB7A;CLN3;VPS50;DCTN1;VPS29;BET1L;VPS26A;ARFRP1;RILP;TBC1D17;PIKFYVE;WDR81
prerank,regulation of myeloid cell differentiation (GO:0045637),0.469537747694732,1.3073831183337772,0.1352405721716515,0.8463036696924461,1.0,17/62,14.91%,THBS1;HOXA5;PTK2B;ZBTB16;GATA1;TNRC6C;NR4A3;MOV10;EP300;CREBBP;CBFB;CTR9;PAF1;KAT2B;KMT2C;KMT2D;PRMT6
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4635454685334553,-1.3071016977468102,0.12849162011173185,0.640753537612463,1.0,5/22,13.96%,APOD;ADRA2A;PPP2R5A;ASXL3;PDE3B
prerank,positive regulation of calcium ion import (GO:0090280),-0.5441034611791672,-1.3070899086862082,0.16441441441441443,0.6382214431710022,1.0,7/12,32.75%,PDGFRB;CXCL12;SPHK2;STC1;CCL2;ATP2A1;RAMP3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.575881927026892,1.3064914144664765,0.14193548387096774,0.8478852107580657,1.0,6/20,8.89%,FMNL2;DLG1;NCKAP1;RHOQ;FMNL3;FHOD3
prerank,protein K63-linked ubiquitination (GO:0070534),0.4939429114811103,1.3059756845543125,0.1381294964028777,0.8481524961282878,1.0,13/41,17.17%,TRAF3IP2;NEDD4;WWP2;RNF115;UBE2B;RNF135;RNF168;ARIH2;BFAR;TRAF5;UBE2S;UBE2N;UBE2G1
prerank,sensory organ development (GO:0007423),0.4742041365073551,1.305733365833267,0.13517241379310344,0.847391156178848,1.0,13/51,14.54%,PBX3;PBX1;STRA6;HIPK1;RAB18;SMOC1;SIX4;GATA3;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18
prerank,mesenchymal cell differentiation (GO:0048762),-0.37515445429463723,-1.3057272478735618,0.10305343511450382,0.6398978518949275,1.0,15/51,8.28%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;HIF1A;NOTCH1;BMP7;LOXL3;NOTCH4;RBPJ;MEF2C;BMP2;HEY2
prerank,regulation of plasminogen activation (GO:0010755),0.6156239074708085,1.305648941390912,0.18584070796460178,0.8458844109025638,1.0,2/12,6.41%,THBS1;SERPINE2
prerank,skeletal system morphogenesis (GO:0048705),0.5095427237529894,1.3052315625600446,0.1534090909090909,0.8457196946801928,1.0,13/42,15.27%,SIX1;FGFR1;HHIP;HOXA3;LRP6;TGFBR1;TFAP2A;FUZ;SKI;MEGF8;LRP5;HOXB3;ANKRD11
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4190531984518673,1.304896433919233,0.11273957158962795,0.8452309949370187,1.0,22/140,12.51%,PLCE1;EDNRA;PTGDR;GPR4;ADRA1B;CD55;AGTR1;CACNA1C;LPAR4;P2RX2;ABL1;TRPM4;P2RX4;PTGER1;BDKRB1;PTGER2;CXCR4;FPR3;SELENOT;DRD3;CD36;CMKLR1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5849931658227193,1.304635679206776,0.18867924528301888,0.8446015306884749,1.0,3/18,3.13%,SLIT2;PTK2B;MTUS1
prerank,epithelial cell differentiation (GO:0030855),0.44980373560051323,1.3042205049117324,0.11014851485148515,0.8444064987175958,1.0,7/88,4.04%,BMP4;FSTL1;ANXA1;SIX1;BDH2;ANXA4;FZD7
prerank,actin crosslink formation (GO:0051764),0.6226125170723036,1.3041255413047237,0.20287539936102236,0.8429938824429032,1.0,3/12,3.53%,DPYSL3;BAIAP2L1;GAS2L2
prerank,regulation of B cell differentiation (GO:0045577),0.573704220665721,1.303074721062099,0.19504132231404958,0.8452071960727142,1.0,3/17,6.42%,PPP2R3C;INHBA;MMP14
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5715925591089079,1.3029688831191317,0.17491749174917492,0.8438114717292998,1.0,2/19,1.44%,BMP4;TGFB3
prerank,nuclear migration (GO:0007097),0.6127375706904431,1.3027409348680667,0.1692573402417962,0.8428940520374214,1.0,6/13,11.89%,DOCK7;SYNE2;PAFAH1B1;FBXW11;PCM1;TMEM201
prerank,artery development (GO:0060840),-0.45170365366678,-1.3026887341642757,0.12466124661246612,0.6466720634368243,1.0,7/23,10.16%,ROBO1;ENG;TBX1;ACVR2B;PDE2A;ROBO2;EFEMP2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4169678316043256,-1.302160369049223,0.10979228486646884,0.645785008940561,1.0,17/34,20.49%,IGF1;APOE;PICALM;RTN1;EPHA4;NTRK2;LRRTM3;CASP3;CHRNA7;GSAP;GSK3A;GGA3;ABCG1;RELA;BIN1;RTN4;TMED10
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.614353833319764,1.3017604154830227,0.19071310116086235,0.8449822565224143,1.0,4/12,5.36%,DOCK5;DOCK7;IGFBP5;NR4A3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6131471008233444,1.3017221049110452,0.19283276450511946,0.8434443964508472,1.0,6/13,21.44%,TNRC6C;CNOT7;TOB1;TNRC6A;PABPC1;EIF4ENIF1
prerank,transport along microtubule (GO:0010970),0.5973769549538329,1.3015841605327263,0.19148936170212766,0.8422126612924026,1.0,4/13,10.90%,ARHGAP21;DYNC1I1;SPG11;CDC42
prerank,protein targeting to peroxisome (GO:0006625),0.5293525854941129,1.3011809880609733,0.1757754800590842,0.8420613203279492,1.0,13/29,24.26%,ABCD3;PXMP2;HACL1;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16;LONP2;PEX7;PXMP4;PEX13
prerank,glycolipid biosynthetic process (GO:0009247),0.5096876037438691,1.3009468507335133,0.1676056338028169,0.8412153712192945,1.0,9/38,12.98%,ST3GAL4;LARGE1;A4GALT;PIGB;PIGL;PIGU;PIGN;DPM1;ST3GAL2
prerank,regulation of vasoconstriction (GO:0019229),0.537829225071798,1.3003817876867996,0.168141592920354,0.8416667417139149,1.0,4/27,5.12%,KCNMB2;ADRA1B;AGTR1;TRPM4
prerank,fat cell differentiation (GO:0045444),0.46787223004656836,1.300356356019535,0.13674033149171272,0.8400619791507746,1.0,13/57,9.73%,TCF7L2;BBS9;TMEM120A;KLF4;PID1;SMAD6;GDF6;EGR2;NR4A2;NR4A3;EP300;ERAP1;PER2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.52235641907316,1.3003481682640081,0.15499254843517138,0.838372466882102,1.0,9/31,15.93%,FHL1;KLF4;FAM107A;KANK2;DLG1;RB1;RBL2;CDKN2D;PRMT2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5161710439252912,1.2997956663829615,0.17138599105812222,0.8387792418678484,1.0,7/33,12.06%,PKD1;TCIM;DDRGK1;ATP2B4;CDKN1B;TAF1;PAF1
prerank,fatty acid beta-oxidation (GO:0006635),0.47426274178173683,1.2990758923571706,0.16137931034482758,0.8397299350142703,1.0,11/51,13.35%,ABCD3;BDH2;EHHADH;ACADM;AUH;ECHDC1;ACOT8;DECR1;SLC25A17;PEX2;ACOX3
prerank,response to calcium ion (GO:0051592),0.43719032783664136,1.2988279160509455,0.10859188544152745,0.8390165653692986,1.0,10/102,4.30%,THBS1;CLIC4;KCNMB3;KCNMB2;NEDD4;PPP3CA;CAMK2D;ADAM9;MEF2A;SYT8
prerank,positive regulation of chemokine production (GO:0032722),-0.391744857078559,-1.2985902269040726,0.1079136690647482,0.654449421144763,1.0,14/44,20.74%,MBP;WNT5A;HIF1A;IL6R;IL18;TLR3;EGR1;APP;TLR7;SYK;TIRAP;CD74;CSF1R;LPL
prerank,positive regulation of protein sumoylation (GO:0033235),0.6328596159907179,1.2985431988663187,0.21100917431192662,0.8384028189267613,1.0,2/10,5.61%,HDAC4;PIAS3
prerank,triglyceride homeostasis (GO:0070328),-0.4425702540253055,-1.298208247178818,0.10614525139664804,0.6530386527336158,1.0,8/26,15.24%,APOE;NR1H3;C1QTNF3;SCARB1;PNPLA8;IL18;NR1H4;MTLN
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4366698782304358,-1.2974225633078569,0.13333333333333333,0.653182626773012,1.0,8/27,7.73%,FLT1;TEK;PDGFRB;PRKD1;KIT;PTK2;PDGFRA;EPHA8
prerank,cellular response to superoxide (GO:0071451),-0.5535546240731203,-1.297353080279211,0.18244803695150116,0.6508628819740845,1.0,5/10,19.30%,NOS3;SOD3;ATP7A;PRDX1;SOD2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5426767097835233,-1.296879535811978,0.17422434367541767,0.6498419506612759,1.0,10/12,41.64%,MAOA;DDC;ATP7A;SMS;SRM;SLC22A3;SLC29A4;AMD1;ODC1;TRH
prerank,Wnt signaling pathway (GO:0016055),0.43825796960500074,1.2961234490040783,0.12285012285012285,0.8459666113005407,1.0,23/92,13.70%,TCF7L1;NXN;TCF7L2;WNT9A;WNT11;PLPP3;LRP6;STRN;GSK3B;WNT16;FZD7;NR4A2;RARG;GPC4;FZD2;CSNK1G3;CSNK1E;BCL9L;WNT2B;USP34;CSNK1A1;LRP5;AMER1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5665050577375785,1.2951884535394345,0.1924342105263158,0.8479344430253947,1.0,2/20,1.51%,ST3GAL4;FUT8
prerank,canonical Wnt signaling pathway (GO:0060070),0.4531645273983411,1.2951254568462633,0.13727959697732997,0.8465045163480542,1.0,23/68,16.85%,TCF7L1;TCF7L2;WNT9A;WNT11;PLPP3;LRP6;GSK3B;WNT16;FZD7;NR4A2;RARG;FZD2;GATA3;CSNK1E;BCL9L;WNT2B;CSNK1A1;LRP5;AMER1;RAB5A;FRZB;FZD9;FZD3
prerank,glial cell differentiation (GO:0010001),0.5270550207946322,1.295124423272475,0.17272727272727273,0.8448067497435234,1.0,4/28,5.16%,SOX9;NFIB;EGR2;ADGRG6
prerank,negative regulation of cellular process (GO:0048523),0.3904121832277251,1.2945853245544676,0.025278058645096056,0.8452287476174714,1.0,96/521,12.88%,SLIT3;SLIT2;ZBTB7C;BMP4;CCN3;FHL1;TES;NDRG3;NGF;BMP5;WNT9A;OSGIN2;TGFB3;PTK2B;CYP1B1;ESR2;ARHGDIB;LRPAP1;ABI1;CCN1;PTPRU;WNT11;P3H2;INHBA;CD9;KLF4;SMAD6;SMYD2;VPS13C;MYOG;IL10;STRN;IP6K2;LMNA;WNT16;PDCD4;CCN5;KANK2;NCK2;PLSCR1;BECN1;HNF4A;RARG;CLU;TDRD9;TFAP2A;PLXNA2;SSTR3;CNOT7;CELF1;PTPN2;IFI35;KLF10;FGF2;TGFB1I1;BAP1;ADAM10;TOB1;TNFRSF1B;SPEF1;SRGAP2;CYP27B1;MDM4;SMARCA4;FUZ;CDKN1B;BCL6;CGREF1;FABP3;AGTR2;P3H1;FRK;SKI;AGR2;DIS3L2;SRSF6;GATA3;NIBAN2;PIM2;EIF2AK3;IRF1;RB1;GTPBP4;TGFB2;ZBTB49;REST;IGFBP6;BNIP3;CASK;PTPN14;PLPP1;ST7L;SLURP1;HTR2B;WFDC1;KAT2B
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.44293075736617793,-1.2942144495534713,0.12893982808022922,0.6559581939964122,1.0,14/27,22.61%,DCN;UGDH;CSGALNACT1;CHST3;CHSY3;PXYLP1;XYLT2;NCAN;CSPG5;B3GAT2;CSPG4;CHSY1;VCAN;BGN
prerank,cellular response to mechanical stimulus (GO:0071260),0.4853340439755917,1.2940128084777238,0.1564625850340136,0.8456571914782575,1.0,10/46,12.40%,PIEZO2;SOX9;NFKB1;CRADD;BCL10;IRF1;CHEK1;TLR4;SLC9A1;BNIP3
prerank,regulation of transferase activity (GO:0051338),0.5837666520930654,1.2933632225801521,0.19117647058823528,0.8464715472053189,1.0,10/17,18.57%,SPTSSB;SMG6;ATM;PPP1R3F;EMP2;FEM1B;LDB2;LDB1;FEM1A;PINX1
prerank,supramolecular fiber organization (GO:0097435),0.3981260427435955,1.293353469564239,0.04653567735263702,0.8448258567643425,1.0,40/333,6.56%,COL25A1;COL8A1;COL12A1;TLL1;SNCAIP;ADAMTS2;COL6A2;CLIP4;COL6A1;COL5A2;CYP1B1;COL23A1;COL8A2;DSP;SHROOM3;P3H2;TMOD3;BMP1;DDR2;COL3A1;P4HA2;GSN;RIPK3;HDGFL3;TNXB;PLOD2;P4HA1;TLE6;LTBP2;LTBP3;FAT1;COL6A3;TGFBR1;MAP7D3;P3H4;CLIP1;MPRIP;DLG1;PLK3;SLAIN2
prerank,anion transport (GO:0006820),0.5117037631891717,1.2932859780735202,0.1744868035190616,0.8434151242256532,1.0,3/33,2.82%,SLC26A7;LRRC8D;ABCG2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4317883056179331,1.2932693403753452,0.12318840579710146,0.8418082542581977,1.0,17/108,10.19%,RSPO3;TRABD2B;TCF7L1;NXN;CTNND2;SULF1;GRB10;GPC3;MDFIC;FZD7;TSKU;TMEM237;CBFB;SMARCA4;SKI;DISC1;SULF2
prerank,cellular response to heat (GO:0034605),0.4965419952304845,1.2930710089371433,0.1625544267053701,0.8408661171706219,1.0,3/35,4.82%,THBS1;TCIM;VCP
prerank,regulation of protein localization to nucleus (GO:1900180),0.48564110518839304,1.2928972804252827,0.15940054495912806,0.8399397602370494,1.0,6/43,8.00%,BMP4;LIMK2;CTNNA1;GSK3B;OTUD7B;WWTR1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.6257330517550963,1.2918814936782705,0.2206405693950178,0.8420873536339438,1.0,9/11,31.40%,UBN1;CABIN1;HIRA;ATRX;RBBP4;ASF1B;NASP;HAT1;IPO4
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5416328536281653,1.291398356028279,0.17540983606557378,0.8422110105946319,1.0,9/23,12.24%,GLI3;HHIP;GPC3;VCP;GLIS2;IFT122;HERC4;MEGF8;KIF7
prerank,peptidyl-serine phosphorylation (GO:0018105),0.41280142216494736,1.2913230812738783,0.08823529411764706,0.8408979512160383,1.0,52/153,17.86%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;HIPK1;MKNK2;GSK3B;SGK3;ULK2;TLK1;TGFBR1;TGFBR2;CHUK;ATM;MARK2;DYRK2;SMG1;DYRK3;CSNK1G3;MARK3;MTOR;CSNK1E;PKN2;PAK2;TAF1;EIF2AK3;CSNK2A2;CSNK2A1;IKBKE;NLK;PRKCE;CSNK1A1;MAPK1;MORC3;CAB39;VRK3;CAMK4;PRKCA;PRKACA;MAP2K2;CSNK1D;MAP3K12;PRKDC;MAP4K1;TOP1;MAPK8;VRK2;MAPKAPK2;TLK2;CLSPN
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.45286191006626625,-1.2909208474519986,0.14560439560439561,0.6642274455224249,1.0,6/23,11.48%,ACSL1;ELOVL7;ELOVL6;FAR2;ACOT7;HSD17B12
prerank,peptidyl-lysine modification (GO:0018205),0.43179324631345994,1.2902712991440795,0.11298076923076923,0.8432244142524047,1.0,34/99,21.10%,HDAC4;HDAC9;NUP93;EGR2;PLOD2;TRPM4;PIAS3;P3H4;EP300;PIAS2;LIPT2;LOXL1;HDAC10;KAT5;NUP188;RANBP2;METTL21C;KAT2B;VIPAS39;NSMCE2;LOXL4;SAE1;EEF1AKMT1;NUP107;AAAS;RNF212B;SENP3;RAE1;LIPT1;NUP54;PIAS1;METTL21A;SUMO1;NUP98
prerank,regulation of protein phosphorylation (GO:0001932),0.4017742766062,1.2902004625249388,0.059009483667017915,0.841880685619681,1.0,21/256,5.02%,SLIT2;EGFR;BMP4;BMPER;PLCE1;SLCO3A1;SOX9;CARD14;NTRK3;FN1;EFNA5;CCN1;LIMK2;KRAS;PLPP3;PGF;PID1;LRP6;ABL1;NIBAN1;PDGFA
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5411768540078208,1.2897996810083938,0.16535433070866143,0.8416800891264923,1.0,7/24,5.26%,SOX9;WNT9A;ZBTB16;EFEMP1;GDF6;GDF5;TGFBR1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3923064906493415,1.2896494067041206,0.038183694530443756,0.8406240664402189,1.0,53/348,11.44%,SLC38A2;BMP4;F3;SLC24A3;SOX9;NGF;ITGB8;NTRK3;FN1;SMO;HOXA5;ANK2;FOXD1;EZR;WNT11;KRAS;INHBA;BMP6;ANXA2;KLF4;PID1;GSN;ZBTB7B;GSK3B;WNT16;NFE2L2;CTCFL;TNRC6C;DDRGK1;TGFBR1;SERPINB9;PLSCR1;MOV10;CLU;TFAP2A;FGF22;CELF1;ATM;TLR6;FGF2;TADA3;NSF;CALCOCO1;RDX;AGR2;CD46;TCF23;MTOR;NKX2-1;NOG;EIF2AK3;UBR5;TLR4
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.28554798111216856,-1.2882300553543684,0.0,0.6701639607328274,1.0,95/306,18.78%,RBMS1;APOE;RPLP1;RPS14;FUT9;PTMA;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;EEF1B2;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;SET;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;BCL3;RPS7;RPS3;RPL27A;RPL3;RPL24;RNPS1;RPS18;RPL18;DTX1;ALAS1;RPL39;RPS11;MRPL3;ORC4;POLA2;RPL23A;GAL3ST2;UPF1;RPL7A;BLM;RPL35A;RPL26;PWP1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;XAB2;RPL27;RPL11;POLR2K;TOPORS;MRPS11;RPL31;SARS1;RPL19;ORC6;CDC7;RPLP0;RPS15A;B4GALT5;RPS28;DONSON;BRCA1;PCLAF;RPL37;MRPL51;RPL29;MRPL35
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4104793872084159,-1.2876799273552568,0.12624584717607973,0.6694205506754777,1.0,16/34,18.67%,GRIN2A;GABRG3;GRIN2B;MEF2C;GRID2;GABRA1;GABRA2;LRRK2;GLRA1;GRIN1;GABRA4;AKT1;GSK3A;GABRG1;INSYN2A;ARRB2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5873333187334169,1.2874222203939203,0.21926910299003322,0.8472531444918134,1.0,9/14,25.54%,TNKS2;BRCA2;XRCC5;ATRX;ACD;TPP1;PINX1;ATR;TERT
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.290114847216614,-1.2872861250267018,0.014705882352941176,0.6681353798771937,1.0,62/224,15.46%,SLC1A3;UNC13C;DTNA;PDE7B;NRXN1;GRM3;NOVA1;MBP;CACNA1E;PRKAR2B;SLC6A1;CALM1;GRIK1;GRIN2A;GRM5;PLP1;GABRG3;GRM1;SNCA;PRKACB;GRM7;GRIA4;GRIA2;SLC1A1;SLC1A2;GRIA3;GRIN2B;PRKAR1B;SDCBP;SYN1;GABRA1;GABRA2;ATXN3;APBA2;RIT2;GRIK2;PRKAR1A;GLRA1;GABRB2;GABARAP;GABRB1;CHRM3;APBA1;KCND2;SLC12A5;HTR2A;RPS6KA1;CACNA1B;KCNQ3;CPLX1;CHRM2;SST;GRIN1;CHRFAM7A;CHRNA7;HRH1;CACNB4;PENK;GABRA4;CACNB1;KCNMB4;SNAP25
prerank,smooth muscle tissue development (GO:0048745),0.6303296777581269,1.2871534982646526,0.1989342806394316,0.8466247400466927,1.0,3/10,2.71%,BMP4;SMO;STRA6
prerank,organelle transport along microtubule (GO:0072384),0.5060791475030448,1.2868837544959568,0.1674074074074074,0.8459416285035669,1.0,15/31,23.90%,ARHGAP21;NDEL1;DYNC1I1;RAB6A;PAFAH1B1;FBXW11;CDC42;TMEM201;BORCS5;CLN3;LRPPRC;UXT;RHOT2;TRAK1;RHOT1
prerank,visual perception (GO:0007601),0.4372236662542148,1.2867886954094554,0.11313868613138686,0.8446692041717901,1.0,17/84,19.44%,SLC4A10;PITPNA;EFEMP1;EYA4;EYA3;CRYBG3;MYO9A;DNAJC19;IMPG2;PAX6;POU6F2;ATF6;ARR3;WFS1;TULP2;COL11A1;OAT
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5836977457802386,1.2861303749121429,0.19536423841059603,0.84545677841749,1.0,4/15,7.51%,BMPER;KLF4;ITGA5;FGF2
prerank,positive regulation of metabolic process (GO:0009893),-0.32902218355700646,-1.2860600574812764,0.08875739644970414,0.6695207677160021,1.0,22/103,9.98%,LEPR;CAMK1D;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;GNAS;PRDM16;ELOVL6;INSR;EBF2;PPARGC1A;ACLY;GJA1;ACACA;ACACB;MFN2;ACADL;IL18;LPIN1;IL4R
prerank,positive regulation of dendrite development (GO:1900006),0.6290331536632479,1.2858174757631111,0.22702702702702704,0.8450521739452944,1.0,2/10,1.31%,BMP5;COBL
prerank,neuron projection fasciculation (GO:0106030),-0.5520466528290383,-1.2857773738928417,0.16853932584269662,0.6679021760852676,1.0,6/10,20.67%,CNTN4;EPHA4;NRCAM;RTN4;CDK5R1;AMIGO1
prerank,regulation of bone mineralization (GO:0030500),0.46839994147544955,1.285693422883491,0.1489071038251366,0.8438572359265275,1.0,14/55,8.58%,BMP4;TGFB3;PTK2B;CCN1;BMP6;DDR2;ANO6;SGMS2;BMPR1A;TRPM4;TFAP2A;TXLNG;NELL1;CYP27B1
prerank,linoleic acid metabolic process (GO:0043651),-0.49695965650652063,-1.285646160718114,0.1569620253164557,0.6657981039250289,1.0,4/17,12.75%,ACSL1;PNPLA8;FADS2;ALOX12
prerank,endochondral bone morphogenesis (GO:0060350),0.6150531304599972,1.285493866860021,0.22242647058823528,0.8430201119880782,1.0,1/11,0.27%,BMP4
prerank,regulation of platelet activation (GO:0010543),-0.44968454891101606,-1.2850262103736971,0.1335149863760218,0.6654142849895229,1.0,7/21,8.53%,LYN;APOE;NOS3;TEC;PRKCQ;PDGFRA;PLEK
prerank,positive regulation of phospholipase C activity (GO:0010863),0.49674822023018805,1.2849438229320347,0.15759312320916904,0.8434210953884232,1.0,4/40,2.40%,EGFR;EDNRA;NTRK3;FGFR1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5156046717838512,-1.2845127026978942,0.1524547803617571,0.6645033400267872,1.0,5/14,7.40%,LYN;PIK3R1;PTK2;GHR;STAT5B
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5147987575568967,-1.28441420128186,0.15625,0.6623240172511434,1.0,7/15,25.29%,OSBPL8;PPARA;PLIN2;PNPLA2;LPL;PLIN3;TREM2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3245696498746535,-1.284111353751035,0.059880239520958084,0.6608121555511542,1.0,35/107,15.92%,ATP1A2;CDH2;GRM3;MCTP1;LRRC4C;NRG3;DGKI;RIMS1;RIMS2;GRIK1;GRM5;GRM1;GRM7;MEF2C;OPHN1;GRID2;GRM8;LRP8;SYN1;LRRK2;GRIK2;LRRC4;CAMK2A;MCTP2;APP;CACNA1B;CPLX1;DLGAP2;NPTXR;CX3CR1;CHRNA7;TMEM108;ABR;KCNMB4;CLSTN3
prerank,negative regulation of protein processing (GO:0010955),0.604817336787092,1.2840341342086627,0.21390374331550802,0.8452649875286816,1.0,2/12,6.41%,THBS1;SERPINE2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5216992425612591,1.28325795073973,0.19756838905775076,0.8463994325240993,1.0,4/28,6.42%,EGFR;TCIM;WWP2;MMP14
prerank,cellular component disassembly (GO:0022411),0.4753476578510718,1.2820968756421218,0.1509933774834437,0.8492067046903181,1.0,15/53,12.46%,TLL1;CD44;BMP1;GSN;CAPN2;HTRA1;ADAMTS5;MMP16;MMP14;TIMP2;ADAM10;DYRK3;WASHC1;ADAM8;KIF9
prerank,embryonic appendage morphogenesis (GO:0035113),0.6027548530900442,1.281671233402696,0.20950704225352113,0.8491424929475396,1.0,5/12,11.91%,MBNL1;LRP6;SKI;TGFB2;MEGF8
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6236009194713144,1.281193095427428,0.20526315789473684,0.8477034262134419,1.0,3/10,3.51%,WNK1;KLF4;IL10
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6236009194713144,1.281193095427428,0.20526315789473684,0.8477034262134419,1.0,3/10,3.51%,WNK1;KLF4;IL10
prerank,negative regulation of chemotaxis (GO:0050922),0.5139541282990552,1.2805372770783128,0.17787742899850523,0.8485476906296856,1.0,5/31,2.85%,SLIT2;THBS1;SEMA3D;SEMA3C;SEMA3E
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4375388248001975,1.2804579020943736,0.13017031630170317,0.8472094768341025,1.0,21/87,20.59%,FBXL7;FHL1;KLF4;FAM107A;KANK2;DLG1;RB1;RBL2;USP47;PSMC6;CDKN2D;PRMT2;PSMD8;ZFP36L1;PINX1;PSMB1;PSMD13;PSMD1;AURKA;PSMD7;PSMA8
prerank,mitochondrion disassembly (GO:0061726),0.4929183975076506,1.2799813124014412,0.1586608442503639,0.8473736600436889,1.0,13/34,19.48%,WIPI2;ULK2;BECN1;ATG3;MARK2;SQSTM1;BNIP3;RB1CC1;AMBRA1;ATG2A;ATG7;ULK1;FIS1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.47972288575035826,1.279918964796759,0.1591549295774648,0.8459796150404916,1.0,16/45,21.05%,BMP4;PTPN3;IL10;CDKN1B;BCL6;CHEK1;FOXC1;HECA;BTG3;PRCC;FZD3;ZFP36L1;CHFR;NME6;GAS1;TGFB1
prerank,clathrin coat assembly (GO:0048268),-0.4914534411918494,-1.2796706575750818,0.1726027397260274,0.6721756477696875,1.0,9/15,22.21%,SGIP1;PICALM;NSG1;HIP1;PIK3C2A;HIP1R;EPS15;AP2S1;NSG2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4098659314660628,1.2795899515396985,0.09731543624161074,0.8456685912565229,1.0,19/159,6.07%,CDH1;PCDHB16;GPC6;HMCN1;CDH11;CXADR;PKD1;ALCAM;NECTIN3;FAT2;MPZL2;ITGB1;PCDHB13;CLDN16;DSG2;CLDN11;PVR;SDK1;TGFBR2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6214361080448506,1.2795728238937212,0.20173913043478262,0.844149678928177,1.0,3/10,6.07%,CD55;ZBTB7B;TGFBR2
prerank,T cell differentiation in thymus (GO:0033077),0.590076561480632,1.2794817983849802,0.22144112478031636,0.8429101113375312,1.0,2/14,4.22%,GLI3;RIPK3
prerank,negative regulation of lipid storage (GO:0010888),-0.46273662150293376,-1.2791483412739642,0.17737789203084833,0.6713669165057012,1.0,5/19,5.06%,OSBPL8;PPARA;ABCA1;PPARD;NR1H3
prerank,amino acid transport (GO:0006865),0.47248092676834996,1.27914033294008,0.15517241379310345,0.8426160396272822,1.0,6/49,5.58%,SLC38A2;SLC38A1;SLC7A2;SLC6A19;SLC38A6;SLC38A7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5982555210493748,1.2790843237972451,0.2171799027552674,0.8412533011080534,1.0,3/14,4.77%,SLIT2;BMPR1A;IGFBP5
prerank,ganglion development (GO:0061548),0.6078017845899314,1.2789137767089511,0.2140468227424749,0.8403491960963715,1.0,3/11,16.85%,UNC5C;NRP1;FZD3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4065024633729068,-1.278778734719671,0.14329268292682926,0.6701216920156685,1.0,13/32,13.35%,SLC6A9;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;MEF2C;DAPK1;CAMK2A;APP;LRRC7;GRIN1;CAMK2B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5649410992617232,-1.2785914037613368,0.17330210772833723,0.6682402206759962,1.0,5/10,13.96%,SHANK3;APP;SYP;CAMK2B;NETO1
prerank,respiratory tube development (GO:0030323),0.5206813760147299,1.2784149093668855,0.18484848484848485,0.8406047836632985,1.0,5/28,7.51%,BMP4;PCSK5;STRA6;CCDC40;FGF2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.46323419317226594,1.2777969847472288,0.16317991631799164,0.8413677982554855,1.0,4/48,5.09%,GUCY2C;SLC26A2;PAPSS2;ADCY9
prerank,DNA double-strand break processing (GO:0000729),0.5638646333647922,1.2776090153770316,0.2057877813504823,0.8405380323707583,1.0,9/18,19.95%,RNF138;ATM;KAT5;RAD52;EXD2;RBBP8;UBE2N;NBN;MRE11
prerank,negative regulation of protein catabolic process (GO:0042177),0.48273994888005933,1.276696586697284,0.16138328530259366,0.8423751312204667,1.0,12/40,17.79%,EGFR;PTPN3;IL10;NELL1;TIMP2;MDM4;RGP1;SNX12;SNRNP70;FLNA;HMGCR;AZIN1
prerank,anterior/posterior pattern specification (GO:0009952),0.4718609483677803,1.276154238900854,0.15844155844155844,0.8428535454617997,1.0,21/53,20.19%,PCSK5;HOXA5;HOXA3;HOXB6;DDIT3;HOXA6;TGFBR1;HOXB5;BHLHE40;HES1;GATA4;SKI;TIFAB;HES7;LRP5;HOXB3;HOXC5;HOXC6;HEYL;CELSR2;HOXD3
prerank,cell-cell junction organization (GO:0045216),0.43958526849900187,1.2761001283519693,0.15279503105590062,0.8415004295062348,1.0,18/79,11.79%,CDH1;CDH11;CXADR;TGFB3;CTNND2;NECTIN3;DSP;CTNNA1;DSG2;PVR;SDK1;PKP4;JUP;LIMS2;CTNND1;CDH17;TGFB2;CSK
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.44907423092069926,-1.2758908072031268,0.15363128491620112,0.6742885809861139,1.0,7/23,11.27%,CEMIP;PRKAG2;CALM1;BMP7;CALM3;SPHK1;APP
prerank,protein localization to cilium (GO:0061512),0.5138387404831504,1.275775789683616,0.18115942028985507,0.8410925371597644,1.0,10/32,15.74%,BBS9;RABEP1;ZNF423;ARL3;IFT122;EHD1;TTC21A;INVS;MAPK15;CSNK1D
prerank,regulation of cell morphogenesis (GO:0022604),0.5204509654258627,1.2755304545358188,0.1815519765739385,0.8404626779812099,1.0,7/30,12.11%,FMNL2;CD44;EFNA5;MOV10;BCL9L;SH3D19;MYO9A
prerank,positive regulation of leukocyte migration (GO:0002687),-0.42509134682654154,-1.2747679489450152,0.11076923076923077,0.6754339010860073,1.0,10/27,26.41%,CSF1;IL6R;JAM3;MDK;EDN3;NCKAP1L;VEGFA;PTN;AIF1;MIA3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4381843849186638,-1.2740738584557125,0.15775401069518716,0.6750849639075002,1.0,7/23,13.72%,IGF1;EFNB2;PIEZO1;MEF2C;EDN1;MYOCD;PROX1
prerank,negative regulation of cation channel activity (GO:2001258),-0.433558341569921,-1.2739191778575913,0.1557632398753894,0.6731988078550335,1.0,10/26,27.30%,KCNAB1;SLC6A9;CALM1;CALM3;CBARP;CASQ2;GPR35;FKBP1A;SRI;CRHR1
prerank,positive regulation of cell division (GO:0051781),0.4933523141318505,1.273679018000644,0.20140845070422536,0.8458296556111977,1.0,10/38,12.74%,CIT;GIPC1;CDC25B;PKP4;PKN2;CDC42;DRD3;RHOA;PRKCE;HTR2B
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.4143286624229118,-1.2735925442853147,0.15229885057471265,0.6717902453276448,1.0,8/31,14.06%,HSPA8;ERN1;DAB2IP;ATXN3;TMBIM6;HSPA9;OPTN;PACRG
prerank,regulation of keratinocyte migration (GO:0051547),0.589637590733105,1.2731191626367024,0.24414715719063546,0.8463289423130462,1.0,3/12,10.44%,MAPRE2;ADAM9;MTOR
prerank,striated muscle tissue development (GO:0014706),0.5145627329116442,1.272896927632717,0.2065378900445765,0.8455263070254286,1.0,5/29,3.49%,SGCD;BMP5;SIX1;CSRP3;MYOG
prerank,regulation of developmental growth (GO:0048638),-0.4239248370863607,-1.272848718292288,0.14201183431952663,0.6718928682257033,1.0,11/29,12.84%,PLCB1;IGF1;APOE;INSR;GHR;STAT5B;SPAAR;MFSD2A;APP;MUSK;OLFM1
prerank,actin filament bundle organization (GO:0061572),0.5104442248075397,1.272770724938884,0.19692737430167598,0.8444659333786065,1.0,7/33,5.31%,DPYSL3;BAIAP2L1;CALD1;EZR;PAWR;FAM107A;ESPN
prerank,regulation of hippo signaling (GO:0035330),0.5665737071202711,1.2716806440419277,0.21963394342762063,0.8467862644345221,1.0,4/17,12.34%,MOB3B;CIT;MARK3;NEK8
prerank,microvillus assembly (GO:0030033),0.5922198233234379,1.2715980257729451,0.21222410865874364,0.8455082601032171,1.0,6/14,7.01%,EZR;RAP1A;FXYD5;RAPGEF6;ESPN;RAP2C
prerank,ceramide biosynthetic process (GO:0046513),-0.3875208398143114,-1.2715666555001466,0.12542372881355932,0.6733736311859447,1.0,7/40,5.20%,ST6GALNAC3;CERS4;ST8SIA4;SGMS1;DEGS2;ST8SIA6;SPTSSA
prerank,DNA geometric change (GO:0032392),0.5340921579287259,1.2714711151059563,0.18995290423861852,0.8444444785565829,1.0,10/24,24.03%,ANXA1;DDX11;DDX1;DHX9;WRN;MCM9;NBN;MRE11;RECQL5;HMGB2
prerank,positive regulation of vacuole organization (GO:0044090),0.6210179153313028,1.2714353264005103,0.2341880341880342,0.843028492296036,1.0,3/10,7.19%,ANXA2;RAB3GAP2;LRSAM1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5515333637617805,-1.2706683024926253,0.1746031746031746,0.6740147068229575,1.0,7/10,28.37%,ATP5MC1;ATP5F1D;VPS9D1;ATP5MC2;ATP5F1A;ATP5MG;ATP5MC3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.45710518641406783,-1.270645095765638,0.17587939698492464,0.6716979007112589,1.0,7/17,6.53%,NOTCH3;MAML2;MAML3;NOTCH1;PLXND1;NOTCH4;RBPJ
prerank,nitrogen compound transport (GO:0071705),0.4093852787064002,1.2704935733332094,0.10593713620488941,0.8448986796788359,1.0,9/141,3.42%,SLC38A2;SLC23A1;SLC12A2;SLC38A1;LRRC8D;RAMP1;ABCG2;SLC7A2;SLC6A19
prerank,ceramide catabolic process (GO:0046514),0.5888699752026934,1.2697905657222104,0.209106239460371,0.8460580971298158,1.0,3/14,5.93%,ACER3;NAGA;HEXA
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5326176357997848,-1.2696482970677314,0.15456674473067916,0.672632956267669,1.0,6/12,18.14%,PARP8;PARP11;PARP1;TIPARP;PARP12;PARP16
prerank,positive regulation of defense response to virus by host (GO:0002230),0.5359780703208532,1.2692212328215144,0.20247295208655333,0.8465489062341145,1.0,5/24,8.41%,TRAF3IP2;ZDHHC11;TRIM44;MAVS;EIF2AK4
prerank,respiratory electron transport chain (GO:0022904),-0.5045064925818786,-1.269179467166647,0.19174757281553398,0.6717442390637982,1.0,7/14,28.34%,SDHA;GPD2;PPARGC1A;SLC25A18;UQCRFS1;NDUFA5;ETFRF1
prerank,negative regulation of phosphorylation (GO:0042326),0.4414984265093554,1.2690995118973547,0.15433673469387754,0.8454818590563902,1.0,9/85,4.57%,SLIT2;BMP4;NTRK3;HDAC4;PLPP3;INHBA;PID1;LRP6;NIBAN1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5812386551955193,1.2685426765288237,0.21070811744386875,0.8460319656213199,1.0,2/14,6.39%,FOXO3;EARS2
prerank,peptidyl-serine modification (GO:0018209),0.4028161470390404,1.2681819850230043,0.10067114093959731,0.8459174061601407,1.0,54/166,18.28%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;HIPK1;MKNK2;GSK3B;GALNT13;SGK3;ULK2;TLK1;TGFBR1;TGFBR2;CHUK;ATM;MARK2;DYRK2;SMG1;POGLUT3;DYRK3;CSNK1G3;MARK3;MTOR;CSNK1E;PKN2;PAK2;TAF1;EIF2AK3;CSNK2A2;CSNK2A1;IKBKE;PRKCE;CSNK1A1;MAPK1;MORC3;CAB39;VRK3;CAMK4;PRKCA;PRKACA;CSNK1D;MAP3K12;PRKDC;MAP4K1;TOP1;MAPK8;VRK2;MAPKAPK2;TLK2;CLSPN;POGLUT2;CSNK1G1
prerank,myeloid cell development (GO:0061515),0.5658301576025162,1.2681499587062148,0.21475409836065573,0.8445508979294756,1.0,3/18,4.55%,FOXP1;ANXA2;GATA1
prerank,type I interferon signaling pathway (GO:0060337),-0.3870689366787158,-1.267935893405909,0.13468013468013468,0.6709516250157052,1.0,17/41,22.60%,IFNAR1;IRF2;SAMHD1;BST2;IFITM1;IFIT2;IFNAR2;IFITM3;EGR1;OAS2;IFIT3;SP100;GBP2;RNASEL;PSMB8;STAT1;IRF7
prerank,cellular response to type I interferon (GO:0071357),-0.3870689366787158,-1.267935893405909,0.13468013468013468,0.6709516250157052,1.0,17/41,22.60%,IFNAR1;IRF2;SAMHD1;BST2;IFITM1;IFIT2;IFNAR2;IFITM3;EGR1;OAS2;IFIT3;SP100;GBP2;RNASEL;PSMB8;STAT1;IRF7
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4221781325300888,1.2677974900449398,0.1374233128834356,0.8443706334674553,1.0,21/95,10.77%,ST3GAL4;GPC6;EXT1;UST;DSE;HS3ST1;GLCE;GPC3;B3GNT2;GCNT2;CHST13;CHST5;HS6ST2;HEXA;GPC4;SLC10A7;B4GAT1;B4GALT1;NDST1;ABCC5;B4GALT7
prerank,regulation of endopeptidase activity (GO:0052548),-0.3657473542101102,-1.267470386384952,0.12096774193548387,0.6702289783799922,1.0,16/59,19.64%,VTN;TIMP3;SPOCK2;PICALM;SERPINI1;GAPDH;SPOCK3;SERPIND1;SPOCK1;AGT;PSME2;AKT1;APH1B;PSENEN;VSIR;PSMB8
prerank,negative regulation of vascular permeability (GO:0043116),0.6054029909033186,1.2673325671820932,0.2061328790459966,0.8445720638677529,1.0,1/12,0.15%,SLIT2
prerank,cell differentiation in hindbrain (GO:0021533),-0.5287881210788515,-1.2664217799935105,0.19483568075117372,0.671360229717425,1.0,9/11,26.47%,OPHN1;GRID2;FAIM2;PROX1;ATP7A;KNDC1;LHX1;CBLN1;CEND1
prerank,neuronal action potential (GO:0019228),0.5365173505042962,1.2663153285437048,0.20970266040688576,0.8467557977434612,1.0,3/22,5.51%,KCNMB3;KCNMB2;SCN11A
prerank,L-amino acid transport (GO:0015807),0.5200382644927,1.2663072141623233,0.17925925925925926,0.8452823086537995,1.0,3/28,5.40%,SLC38A2;SLC7A2;SFXN1
prerank,response to cholesterol (GO:0070723),0.5456600553033977,1.2658947767603983,0.2251655629139073,0.8452493285116519,1.0,5/17,9.05%,SMO;LRP6;TGFBR1;TGFBR2;GRAMD1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5673708420141836,1.2657062153165015,0.1865546218487395,0.8429622669804954,1.0,5/16,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5673708420141836,1.2657062153165015,0.1865546218487395,0.8429622669804954,1.0,5/16,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.4462364865253451,-1.2651626970540921,0.165374677002584,0.6729701316396435,1.0,9/23,10.95%,PDE4B;TGM2;GNG2;SNCA;MAPK3;APLP1;LRRK2;KCNQ1;RYR2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3874569756970749,-1.2646493539186074,0.1245674740484429,0.67213178397842,1.0,14/40,20.96%,VTN;SGIP1;B2M;INSR;ARRB1;DGKD;CD63;HIP1;WASL;CCL19;NTF3;ARRB2;GREM1;VEGFA
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4968098198994486,1.2645207290043492,0.19014084507042253,0.8459087301122927,1.0,3/35,3.05%,PCDHB16;CDH11;PCDHB13
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4793461515763476,-1.2640480875871745,0.1867007672634271,0.6717525174796347,1.0,7/17,10.95%,ATP1A2;GJC1;GJD3;ATP1B2;GJA1;SLC8A1;RYR2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.608494881047481,1.263893754675839,0.24436741767764297,0.8467756848498771,1.0,3/10,10.44%,MAPRE2;ADAM9;MTOR
prerank,central nervous system development (GO:0007417),0.39619841471366396,1.2637597377652123,0.08993576017130621,0.8458055404281187,1.0,26/250,7.85%,SLC23A1;VIT;WWP1;PBX3;DCLK1;SOX9;ZFHX3;PDGFC;SMO;NFIB;ZIC4;PKD1;ZBTB16;PBX1;ADGRL2;GSN;ZIC1;EGR2;NR4A2;BPTF;GRIN2C;TGFBR2;RAB18;ECRG4;NCKAP1;GLIS2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.381633143614581,1.2637204224002079,0.042988741044012284,0.8444655067713512,1.0,119/476,16.33%,CDH1;EGFR;BMP4;SOX9;MAP3K5;ZFHX3;NFIB;SIX1;TGFB3;MLLT3;HDAC4;FOXO3;GLI3;ZBTB16;ESR2;WNT11;SHC1;INHBA;KLF4;LRP6;FOXK1;GDF6;IL10;PITX3;LHX2;KAT6B;ELF1;ZIC1;BAMBI;MDFIC;FZD7;EGR2;DDIT3;GATA1;CTCFL;FOXC2;TGFBR1;NFKB1;ZNF423;CD80;HNF4A;HNF1A;EP300;TFAP2A;FBXW11;TRIM44;TBL1X;CHUK;JUN;TASP1;FOXE1;HIVEP3;FGF2;TRIM45;TADA3;TGFB1I1;KAT2A;CREBBP;GLIS2;HES1;GATA4;TEAD1;CALCOCO1;BCL10;SMARCA4;CHEK2;NFYA;KAT5;FZD2;TCF3;SIX4;PPM1A;ATOH8;MED14;BRCA2;FOXK2;GATA3;QRICH1;NKX2-1;MYRFL;NIBAN2;PIM2;RNF10;IRF1;RGMB;ACVR1;USP22;USP21;ZMIZ1;REST;NFIL3;RXRA;STAT3;FOXC1;EHF;RNF111;CIITA;LRP5;ZXDC;FOXM1;CEBPB;TFE3;TRIM16;LBHD1;TFEB;CAMK4;ILK;TAF15;HCFC1;ELF4;XPC;MAP2K2;JMJD6;PML;PRMT2;ZNF711;MAP3K12;PAX6;ZNF496
prerank,organic substance transport (GO:0071702),0.4115056880176211,1.2631241106444144,0.12339930151338765,0.8451192842513598,1.0,7/121,2.82%,SLC47A1;SLC23A1;ABCD3;DISP1;RAMP1;SLCO2A1;ABCG2
prerank,cognition (GO:0050890),0.4831537237746149,1.2630870909609937,0.1844380403458213,0.8437709445757008,1.0,5/42,3.22%,ST3GAL4;SOBP;STRA6;MGAT3;FAM107A
prerank,regulation of cell cycle (GO:0051726),0.38825982496072053,1.262442643063148,0.07684210526315789,0.8446323102081666,1.0,59/271,17.21%,BMP4;THBS1;SOX9;GRK5;TCF7L2;PLAGL1;PKD1;INHBA;LRP6;NEK7;MYOG;BIRC7;NOTCH2;PDCD4;ABL1;TTC28;TGFBR1;EP300;TGM1;SON;JUN;ATM;TXLNG;BAP1;IQGAP1;ADAM10;CDKN1B;FBXL6;PER2;GATA3;UHRF2;PIM2;IRF1;CHEK1;RB1;CSNK2A2;CSNK2A1;TGFB2;ZBTB49;STAT3;BIRC3;KAT2B;FOXM1;THAP1;CDKN2D;STK11;PUM1;TMEM8B;HCFC1;PRKACA;PML;PRCC;CDKN3;NR4A1;FZD9;CITED2;GBF1;WHAMM;GADD45G
prerank,response to laminar fluid shear stress (GO:0034616),0.621726781669921,1.2622898402389162,0.23649906890130354,0.8437149075997086,1.0,3/10,4.43%,KLF4;SMAD6;NFE2L2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.43564513173071273,1.2618765756920174,0.15308641975308643,0.8437539956152668,1.0,12/86,6.29%,PLCE1;ARHGEF28;NGF;STK19;ARHGDIB;AKAP13;SHC1;ARHGAP44;BCR;NOTCH2;KANK2;SHOC2
prerank,electron transport chain (GO:0022900),-0.4838269247833249,-1.2617172945170143,0.19023136246786632,0.6773414705432621,1.0,8/15,28.34%,SDHA;PDIA5;PPARGC1A;CYB561;POR;UQCRFS1;NDUFA5;ETFRF1
prerank,positive regulation of ossification (GO:0045778),0.48463033344810086,1.2613199558003052,0.18373071528751753,0.8443347445128837,1.0,9/39,7.70%,BMP4;TGFB3;ZBTB16;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.49833578376891924,1.2609312112656421,0.1754636233951498,0.8442584843645239,1.0,9/32,15.85%,DDX5;FHIT;HIPK1;EP300;DYRK2;CDIP1;STK11;SNW1;PML
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4606070540713482,1.2603193427749801,0.16920943134535368,0.8449748488647344,1.0,14/54,11.46%,GPC6;EXT1;HS3ST1;GPC3;GCNT2;HS6ST2;HEXA;NAGLU;GPC4;SGSH;HPSE;NDST1;B4GALT7;GLB1
prerank,glucose transmembrane transport (GO:1904659),-0.46231442696256575,-1.2602460608410078,0.18469656992084432,0.6797340446385025,1.0,6/18,20.34%,SLC2A1;SORT1;PPARD;SLC5A3;SLC45A1;SLC2A8
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6050080793179394,1.2596717791868415,0.22795341098169716,0.8458759968954398,1.0,5/11,13.44%,SOX9;PDGFA;TGFBR2;CHRD;LRP5
prerank,ether lipid biosynthetic process (GO:0008611),0.6011591584052013,1.2595478460600718,0.24452554744525548,0.8448471199109062,1.0,7/10,23.44%,PEDS1;GNPAT;DHRS7B;AGPS;PLA2G4A;PEX7;FAR1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5474925958947746,-1.2590925876560113,0.205607476635514,0.6811965632729324,1.0,6/10,17.15%,GABRG3;GABRA1;GABRA2;GABRB2;GABRA4;GABRG1
prerank,nerve growth factor signaling pathway (GO:0038180),0.6150549572983586,1.2587160352917757,0.23036649214659685,0.8464325284319111,1.0,3/10,7.53%,NGF;RAP1A;KIDINS220
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3736932019029256,1.2573905636500349,0.001,0.8497813691984345,1.0,349/1646,16.82%,BNC2;CDH1;FOXP2;EGFR;ZBTB7C;BMP4;FOXP1;MKX;KLF12;NR3C2;WWP1;VSX1;PBX3;KLF5;SLTM;TFCP2L1;SMAD9;SOX9;TCF7L1;MAP3K5;ZFHX3;ZFPM2;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;FOXN3;ZIC4;ZFHX4;SIX1;HOXA5;TGFB3;MLLT3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;PBX1;ESR2;RBFOX2;CAMK2D;TCIM;GRHL1;NFIA;USP13;WNT11;KLF3;SHC1;NFAT5;NR2F1;INHBA;WWP2;HDAC9;ISL1;CRY2;HOXA3;KLF4;EFEMP1;CUX1;LRP6;SMAD6;PURG;FOXK1;FOXP4;SP140;GDF6;MYOG;NOBOX;IL10;PITX3;BARHL2;LHX2;PHOX2A;RCOR3;IGSF1;KAT6B;HOXB6;L3MBTL3;ELF1;ZBTB7B;ZIC1;BTAF1;ANXA4;BAMBI;MDFIC;MEF2A;FZD7;PDCD4;ZNF148;ABL1;MEOX2;EGR2;HDGFL3;DDIT3;NFE2L2;ARID4A;GCLC;GATA1;KLF7;CTCFL;NR4A2;E2F5;ATP8B1;TCF20;FOXC2;HOXA6;CRABP2;ATF1;TGFBR1;JMJD1C;NR4A3;NFKB1;ZNF8;ZNF423;TRRAP;ID4;CD80;PIAS3;BPTF;SCMH1;FOXO6;GLIS1;TWIST2;HNF4A;HNF1A;ID1;BCLAF1;BAZ2B;FOXD2;PRICKLE1;PRRX1;EP300;TFAP2A;HOXB5;ERC1;PIAS2;MBTD1;FBXW11;HCLS1;LBX1;TRIM44;CAMTA2;CNOT7;TBL1X;CHUK;E2F6;JUN;TASP1;FOXE1;HIVEP3;RRM2;NR6A1;KLF10;ATP2B4;HDAC10;FGF2;TRIM45;TADA3;TGFB1I1;KDM1A;KAT2A;BAP1;CREBBP;KLF9;GLIS2;BHLHE40;HES1;NFATC4;FUS;CREB3L3;PHC2;WWTR1;ETV5;GATA4;HIF3A;JDP2;TNFRSF4;TEAD1;TAF6L;CALCOCO1;CCNL2;BCL10;MDM4;CBFB;SMARCA4;CHEK2;CDKN1B;MNAT1;CARF;NFYA;KAT5;FZD2;CTR9;HMG20A;BCL6;TOX4;TCF3;MXD1;NFKB2;SIX4;E2F3;PER2;BCL11B;ZNF585B;ZNF585A;PPM1A;ZKSCAN1;ATOH8;MBD1;ARID4B;MED14;GON4L;BRCA2;FOXA1;FOXK2;GPBP1L1;GCFC2;PRDM15;GATA3;TCF23;ZNHIT3;QRICH1;PHF12;NKX2-1;SETD5;BRD9;MYRFL;EBF4;NIBAN2;PIM2;ZNF383;ZFP62;RNF10;IRF1;RB1;RGMB;ACVR1;TLE2;HSF5;ZBTB11;USP22;ZBTB49;BAZ1A;USP21;ZBTB37;ZMIZ1;USP47;REST;NLK;MTDH;KLF16;NFIL3;SPINDOC;RXRA;STAT3;WIZ;FOXC1;METTL4;EHF;RNF111;KDM3B;PGBD1;BAZ2A;RFX5;HIVEP2;STAT5A;ASCC1;ZBTB4;CIITA;XRCC5;CIPC;HES7;EHMT1;LRP5;REL;DDX17;ZXDC;FOXM1;MGA;CEBPB;TGFBRAP1;SOX21;ZNF76;TFE3;THAP1;KMT2D;TRIM16;BRD3;GTF2IRD1;LCOR;CARM1;LBHD1;TFEB;CAMK4;ZBTB32;MYNN;ILK;HOXB3;HTATIP2;FOXL1;ATF7;ZXDB;PRMT6;BRWD1;TAF15;FBXL19;RBBP8;ERN2;CDK18;AATF;HCFC1;ZFX;SBNO2;ELF4;XPC;ELP4;ZNF25;SNW1;MAP2K2;JMJD6;DHX9;PML;SRCAP;HOXC5;PCGF1;PRMT2;ZNF711;MAP3K12;ZBTB18;CREBRF;PAX6;MED27;ZNF496;NFIX;ZIC5;ELOA;HIRA;ATRX;MED17;DMAP1;CSRNP2;SERTAD3;SAP30;MAEL;RORA;NR4A1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5025862932710556,1.2572023970153454,0.19730941704035873,0.8490065830011468,1.0,10/33,15.93%,FHL1;KLF4;FAM107A;KANK2;DLG1;PLK3;RB1;RBL2;CDKN2D;PRMT2
prerank,sodium-independent organic anion transport (GO:0043252),0.6067760013017749,1.2570715968737438,0.2522361359570662,0.8480453191888303,1.0,3/10,2.33%,SLCO3A1;SLCO4A1;SLCO2A1
prerank,negative regulation of programmed cell death (GO:0043069),0.38124233373538374,1.2568858978431685,0.06597938144329897,0.8472934513822099,1.0,42/355,7.24%,EGFR;BMP4;THBS1;MET;FSTL1;SOX9;GRK5;CARD14;NGF;ARHGAP10;ANXA1;PTK2B;CD44;TCIM;WNT11;SHC1;TAX1BP1;SMAD6;IL10;BIRC7;ANXA4;GSK3B;NOTCH2;RIPK3;ARF4;GCLC;GATA1;SOCS2;DDRGK1;BIRC6;GDNF;NFKB1;DNAJC3;GOLPH3;KANK2;SERPINB9;TFAP2A;ERC1;PLK3;SON;STIL;RIPK2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5261333814171563,-1.256372379222075,0.2111368909512761,0.6875293694650146,1.0,5/11,16.54%,LYN;MFHAS1;CYBA;TNFAIP3;TIRAP
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5291363945463737,-1.2558481903830276,0.20544554455445543,0.6867565372089064,1.0,6/11,22.48%,PTPRT;BCL3;NF2;LEPROT;SH2B3;SOCS1
prerank,bile acid and bile salt transport (GO:0015721),-0.43137196135502803,-1.2555389500029814,0.15625,0.6854571350062985,1.0,3/24,1.56%,SLCO2B1;NCOA1;SLCO1C1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3916598924137622,-1.2554902846601146,0.1609907120743034,0.6833262149738207,1.0,11/35,16.62%,VTN;SGIP1;B2M;PICALM;TNK2;FLOT1;RAC1;HIP1;HIP1R;SNAP91;CCL19
prerank,sensory perception (GO:0007600),-0.3777216083987938,-1.2554058076600707,0.16091954022988506,0.6812996835594444,1.0,12/45,17.99%,RETREG1;ADGRV1;GNAS;PCDH15;TTC8;ADORA2A;CHRNA7;PENK;KCNA2;P2RX7;NTSR2;WHRN
prerank,liver development (GO:0001889),0.5015130925168176,1.254524819107041,0.19794721407624633,0.8544723489978991,1.0,5/32,5.75%,MET;COBL;ANXA1;CCDC40;PRKCSH
prerank,regulation of lipid storage (GO:0010883),0.5361641462453528,1.2544267694367086,0.2169230769230769,0.8534324737966091,1.0,8/22,16.86%,FTO;NFKB1;HILPDA;ITGAV;PTPN2;IKBKE;ITGB3;ALKBH7
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.530748713340086,1.2539819712244769,0.21060842433697347,0.853617943646604,1.0,2/22,2.57%,BMP4;INHBA
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4733218492165564,-1.253677364816457,0.18,0.6842526463120778,1.0,4/17,11.01%,PPARA;PRKAG2;PPARD;PRKAA2
prerank,neuron projection development (GO:0031175),-0.30281991102498323,-1.2530732177606558,0.03225806451612903,0.6839257898308485,1.0,56/168,17.99%,PTPRM;DOCK10;LYN;FRYL;SHANK3;APOE;ADGRV1;CNTNAP2;RAPGEF2;EPB41L3;GPM6A;PAK1;MAP2;TNIK;PLP1;NRK;BMP7;GRM7;EPHB1;GPM6B;CNTN4;STMN4;SGK1;DAB2IP;EPHA4;NYAP2;STMN3;MAP4K4;OPHN1;SH3GL2;LAMB1;MICALL1;EPHA8;LRRK2;RASGRF1;MAPT;UHMK1;MYOC;APP;CNTNAP1;UBB;SLC9A6;MYO16;TMEM108;ALS2;BLOC1S6;ATXN10;NCKAP1L;WASL;BLOC1S5;ATP7A;OMG;PRMT1;NTF3;STX3;WHRN
prerank,extracellular matrix assembly (GO:0085029),-0.4421282776741962,-1.2528827639661178,0.1620879120879121,0.6823095806963828,1.0,14/23,25.17%,FBLN5;GPM6B;RAMP2;MYH11;LAMB1;MFAP4;GAS6;EFEMP2;QSOX1;ATP7A;HAS2;EMILIN1;HAS3;LAMB2
prerank,intestinal absorption (GO:0050892),-0.5106260367520584,-1.2524371895429995,0.17942583732057416,0.6814890752528,1.0,4/13,9.07%,F11R;UGCG;ADRA2A;KCNQ1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.42759193845688165,-1.2519698244831448,0.16666666666666666,0.6806834541816923,1.0,15/26,24.17%,SHANK3;NRXN1;RIMS1;RIMS2;LRRK2;APP;GRIN1;CHRNA7;TMEM108;PRKCZ;NLGN1;NLGN2;MTMR2;STX1B;CBLN1
prerank,regulation of signal transduction (GO:0009966),0.3938213798362519,1.2518687235272137,0.1184939091915836,0.859695103064394,1.0,36/190,12.33%,RSPO3;PLCE1;TCF7L1;GRK5;SULF1;CD55;HHIP;GDF5;ELF1;ZIC1;MDFIC;MGLL;IGFBP5;SOCS2;GDNF;FRMPD1;CD80;NCK2;PLSCR1;SIK2;CLU;PTPN2;CREBBP;WWTR1;CASTOR2;TMEM237;CBFB;FUZ;USP33;CD46;GATA3;KCTD8;ACVR1;CSK;CD36;IGFBP6
prerank,regulation of lamellipodium assembly (GO:0010591),0.4904132170591604,1.2517805841566285,0.19703703703703704,0.8585743887472397,1.0,2/34,0.44%,SLIT2;PLCE1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5199069274221682,1.2517789294698076,0.22390317700453857,0.8571333981914553,1.0,5/26,8.63%,ST3GAL4;LARGE1;GOLPH3;RRM2;B3GNT6
prerank,ATP transport (GO:0015867),-0.5549751037377875,-1.2515083791295158,0.20898876404494382,0.6798420491575303,1.0,6/10,26.03%,CD47;ABCC6;SLC25A4;SLC25A24;SLC25A42;SLC17A9
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5703701206905856,1.2510087352161303,0.22682119205298013,0.8584222791332942,1.0,3/15,11.71%,TGFB3;IL10;TGFB2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5219843459184236,1.2508293992564217,0.21353383458646616,0.8576289038252846,1.0,3/26,3.21%,EGFR;ANXA1;EIF4G1
prerank,actin filament bundle assembly (GO:0051017),0.5105135659248496,1.2507178677862079,0.19219653179190752,0.856575474268425,1.0,7/33,5.31%,DPYSL3;BAIAP2L1;CALD1;EZR;PAWR;FAM107A;ESPN
prerank,neuron maturation (GO:0042551),-0.4600968535162405,-1.249920476156859,0.2014218009478673,0.6825437633134662,1.0,9/18,36.32%,EPHA8;C1QA;APP;B4GALT5;ACTL6B;C3;RND1;SRRM4;CX3CL1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4221732553108269,1.2496785618342785,0.154126213592233,0.8587682653189669,1.0,17/86,7.71%,EGFR;PTK2B;CD44;EFNA5;BMP6;PRKCD;ITGA5;ABL1;GATA1;PDGFA;CD80;IL5;HCLS1;CNOT7;RAP2C;RIPK2;NRP1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5000661927084246,-1.2496739506852552,0.18811881188118812,0.6810680785423008,1.0,8/13,39.09%,LCMT1;CDK5RAP2;ANAPC15;XRCC3;GEN1;NDC80;CCNB1;PCID2
prerank,endothelial cell development (GO:0001885),-0.44200740154035867,-1.249379965860824,0.1910828025477707,0.6797551677968049,1.0,12/25,9.47%,COL22A1;PECAM1;RAPGEF3;COL18A1;COL15A1;RAPGEF2;PPP1R16B;RAPGEF1;ROBO4;PDE4D;PDE2A;MYADM
prerank,extracellular matrix disassembly (GO:0022617),0.4610762626804745,1.2493407296904324,0.18872870249017037,0.8586719920757986,1.0,14/53,12.46%,TLL1;CD44;BMP1;GSN;CAPN2;HTRA1;ADAMTS5;MMP16;MMP14;TIMP2;ADAM10;WASHC1;ADAM8;KIF9
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.40679355826510305,1.2491733781364271,0.11504424778761062,0.8578393652798153,1.0,20/150,7.52%,EGFR;F3;THBS1;MET;TCF7L2;TNFAIP8L3;ITGB1;FGFR1;STRN;GCNT2;PDGFA;TGFBR1;CD80;IRS1;HCLS1;FGF22;P2RX4;PIK3AP1;FGF2;GAB2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.427697355851688,1.2491459019465925,0.16020025031289112,0.8565197806276226,1.0,27/87,14.78%,SMAD9;TGFB3;ITGB1;SMAD6;COL3A1;ADAM9;GDF5;GCNT2;BAMBI;BMPR1A;LTBP2;TGFBR1;TGFBR2;ID1;JUN;ITGB5;SKI;PARD3;ACVR1;TGFB2;RHOA;ZMIZ1;NLK;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.48359786401249766,-1.249104127330682,0.20286396181384247,0.6783354019157359,1.0,7/14,17.03%,NOS3;ACE;ENPEP;EDN1;EDN3;ACE2;CORIN
prerank,response to acidic pH (GO:0010447),0.5758531113422862,1.2490927669956162,0.2376068376068376,0.8552570318079571,1.0,3/13,12.17%,GPR4;PKD2L1;SLC9A1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.563204421675894,1.2485152485224134,0.21833333333333332,0.8558073425349874,1.0,3/16,7.51%,THBS1;AGTR1;FGF2
prerank,nucleosome organization (GO:0034728),0.4562906732577427,1.2484624116825649,0.18457300275482094,0.8545938032763793,1.0,16/55,20.04%,SOX9;CHAF1B;KAT6B;BPTF;NAP1L2;SMARCA4;SETD2;PAF1;SRCAP;VPS72;ATRX;DMAP1;INO80;ARID1A;SMARCD2;ZNHIT1
prerank,regulation of fibroblast migration (GO:0010762),0.5429370006919231,1.247822164982366,0.22756410256410256,0.8555103615475825,1.0,6/20,12.45%,THBS1;ITGB1;DDR2;FGF2;DMTN;PRKCE
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5260334097751831,1.2476870185307007,0.2286158631415241,0.8546021476191051,1.0,10/25,19.74%,RNF185;VCP;UFD1;OMA1;UGGT2;UBE2W;YME1L1;LONP1;FBXL17;CLPP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4593151251876221,1.2475185801731152,0.18342391304347827,0.8538110215515129,1.0,2/48,0.15%,SLIT3;SLIT2
prerank,cell junction maintenance (GO:0034331),-0.49044232149057343,-1.2471568460066862,0.20971867007672634,0.6823276375367179,1.0,9/14,34.66%,CLDN1;MYADM;CHCHD10;CSF1R;NLGN2;CBLN1;PRTN3;PARD6A;F2R
prerank,neuron migration (GO:0001764),-0.3790043825366471,-1.2469598359887035,0.13978494623655913,0.6807105243609183,1.0,18/48,12.49%,ADGRL3;AUTS2;DCDC2;SH3RF1;RAPGEF2;GPM6A;NAV1;ASTN2;NDNF;MEF2C;ASTN1;CDKL5;DCX;NTRK2;RAC1;SPOCK1;MDGA1;TUBB2A
prerank,carbohydrate biosynthetic process (GO:0016051),0.5388829918995192,1.244947720380396,0.2245557350565428,0.8616204656663301,1.0,2/21,1.51%,ST3GAL4;FUT8
prerank,negative regulation of phagocytosis (GO:0050765),-0.4752875361968566,-1.2449252047397612,0.1934673366834171,0.6847900564727736,1.0,5/17,9.48%,CD47;DYSF;SIRPA;SYT11;CD300A
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.41491912640989953,1.2447688599571276,0.15456674473067916,0.8608488274902641,1.0,18/114,15.37%,TNFRSF11B;CARD14;EDA;FOXO3;PTK2B;TNFRSF13B;TNFSF11;CHUK;TNFRSF4;TNFRSF1B;CDIP1;TNFRSF14;BIRC3;TRADD;TRAF5;PSMC6;ILK;TNFRSF13C
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.566150299472237,1.2447521749225474,0.24390243902439024,0.8594920468341548,1.0,8/15,21.20%,BMP4;CYP27B1;FOXC1;SFN;TRIM16;SULT2B1;SFRP4;NCOA3
prerank,mitochondrion localization (GO:0051646),0.5290102417376614,1.2444006082980166,0.21169036334913113,0.859304807027636,1.0,4/19,7.56%,MARK1;MEF2A;TLE6;MARK2
prerank,chromatin assembly (GO:0031497),0.48369088615773337,1.2442233903035906,0.19208211143695014,0.8584825050511696,1.0,4/38,6.93%,SOX9;CHAF1B;KAT6B;NAP1L2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5114337378223354,-1.2442014481044033,0.18159203980099503,0.6846893838483203,1.0,4/13,15.27%,NOS3;CALM1;QDPR;AKT1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.44810253005440315,1.2428104468028194,0.18075422626788037,0.8622415758525374,1.0,18/63,12.74%,MET;PTPN3;EIF4G3;DAPL1;EIF4G1;FOXK1;IL10;KLHL22;TAB3;NELL1;TIMP2;RGP1;FOXK2;MTOR;WASHC1;NRDE2;STAT3;HTR2B
prerank,polyamine metabolic process (GO:0006595),0.5841180005104557,1.2426474437019939,0.24013722126929674,0.8613922863161225,1.0,2/13,7.47%,SMOX;HDAC10
prerank,gliogenesis (GO:0042063),0.568823590693374,1.2419658298566978,0.20729684908789386,0.8624699657244864,1.0,3/15,2.75%,NFIB;ANXA1;CD9
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.42472836278077125,-1.2413429990284304,0.17341040462427745,0.6914450596999163,1.0,8/26,13.14%,ERRFI1;TGFA;CBLB;SOCS5;ADRA2A;HBEGF;APP;ZFYVE28
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4320377139523476,1.2408310402392602,0.16728167281672818,0.8649560139594253,1.0,18/76,13.67%,BAIAP2L1;NTRK3;SORBS3;PTK2B;CDC42EP5;ABL1;NCK2;FCHSD1;HCLS1;NRP1;NCKAP1;WDR1;BCAS3;CDC42;PRKCE;CTTN;FCHSD2;KATNBL1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.501948444533347,1.240495618863612,0.22254335260115607,0.8646990064169114,1.0,11/30,17.63%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;CSNK2A2;RNF31;HSPA1L;SAE1;HUWE1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.48355150208344844,1.2402733091947094,0.20422535211267606,0.8641099584564887,1.0,12/38,17.63%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;PARL;CSNK2A2;RNF31;HSPA1L;SAE1;HUWE1
prerank,lung development (GO:0030324),0.49290574316810404,1.2401269294721375,0.22026431718061673,0.8632135150350152,1.0,6/33,7.51%,BMP4;PKD1;WNT11;STRA6;CCDC40;FGF2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.44360745229321513,1.239847269744708,0.19176319176319176,0.8627453921877063,1.0,11/63,11.34%,BMP4;THBS1;TCF7L2;FGFR1;BIRC6;TGFBR1;ITGAV;BCL10;AGTR2;PAK2;ACVR1
prerank,positive regulation of bone mineralization (GO:0030501),0.4837177156039209,1.2396723006898298,0.20625889046941678,0.8619852346314784,1.0,8/35,7.70%,BMP4;TGFB3;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4457562942537265,-1.2392884852946107,0.1801566579634465,0.6958065880567427,1.0,3/21,4.94%,OSBPL8;PLA1A;OSBPL10
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5220777650458641,-1.239154395423616,0.21709006928406466,0.6917981036966845,1.0,5/11,25.82%,CALM1;CALM3;CASQ2;FKBP1A;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5220777650458641,-1.239154395423616,0.21709006928406466,0.6917981036966845,1.0,5/11,25.82%,CALM1;CALM3;CASQ2;FKBP1A;SRI
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5810825133811,1.238672313987601,0.234006734006734,0.864058372377279,1.0,2/14,1.47%,ANK2;ATP1B1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4929078807813558,1.238524094814595,0.19630156472261737,0.8632135467756356,1.0,10/34,16.59%,DOCK5;ABL1;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;FLNA
prerank,regulation of osteoblast differentiation (GO:0045667),0.42538592859365604,1.2361844292906614,0.17596034696406443,0.8701006711338046,1.0,15/82,8.00%,BMP4;CRIM1;SOX9;DDX5;CCN1;BMP6;DDR2;SMAD6;BAMBI;BMPR1A;TRPM4;TWIST2;SMOC1;NELL1;WWTR1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.49145684230692604,1.2358856198583439,0.2171945701357466,0.8697816848219867,1.0,5/27,7.51%,SMOC2;PDGFA;SMG6;ATM;FGF2
prerank,regulation of dendritic spine development (GO:0060998),-0.44754333268289564,-1.2358202341930509,0.20618556701030927,0.7001763254229492,1.0,6/19,13.35%,SHANK3;APOE;PPFIA2;MEF2C;GRIN3A;CAMK2B
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45203199826272755,-1.2356858323673934,0.2071611253196931,0.6984200633108304,1.0,4/19,19.13%,IGF1;CX3CR1;TNFAIP3;GIT1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4990375954928903,-1.23563115690322,0.20544554455445543,0.6964249056505306,1.0,6/13,24.10%,ELOVL7;ELOVL6;ELOVL4;TECRL;HACD3;HACD2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5762355074779677,1.2356174856782192,0.24319419237749546,0.8693709919133585,1.0,3/13,4.37%,MGAT3;LARGE1;CHST5
prerank,regulation of membrane repolarization (GO:0060306),0.5860410824098797,1.2353524734223567,0.24288107202680068,0.8688852738659198,1.0,1/13,0.42%,KCNJ2
prerank,protein ADP-ribosylation (GO:0006471),-0.4085298213062852,-1.2352048940768936,0.1534090909090909,0.6956214342987487,1.0,10/28,18.92%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP;PARP12;SIRT5;PARP16;HPF1
prerank,sensory perception of light stimulus (GO:0050953),0.4191510492473541,1.2349230824402686,0.15571776155717762,0.8690286668838795,1.0,17/87,19.44%,SLC4A10;PITPNA;EFEMP1;EYA4;EYA3;CRYBG3;MYO9A;DNAJC19;IMPG2;PAX6;POU6F2;ATF6;ARR3;WFS1;TULP2;COL11A1;OAT
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.37329505698485793,1.2348183459779294,0.06038894575230297,0.8679751442415777,1.0,80/417,13.37%,FOXP2;BMP4;FOXP1;WWP1;SOX9;ZFPM2;TCF7L2;FOXN3;FOXD1;HDAC4;GLI3;ZBTB16;RBFOX2;WNT11;SHC1;WWP2;HDAC9;CRY2;KLF4;FOXK1;RCOR3;KAT6B;L3MBTL3;BTAF1;MDFIC;PDCD4;ZNF148;DDIT3;ARID4A;GCLC;ATP8B1;ZNF423;ID4;SCMH1;TWIST2;HNF4A;ID1;BCLAF1;PRICKLE1;TFAP2A;MBTD1;FBXW11;CNOT7;JUN;FOXE1;KLF10;HDAC10;KDM1A;BAP1;GLIS2;BHLHE40;HES1;PHC2;TNFRSF4;SMARCA4;CDKN1B;KAT5;BCL6;SIX4;PER2;ATOH8;MBD1;FOXK2;GCFC2;GATA3;PHF12;NKX2-1;NIBAN2;IRF1;RB1;TLE2;USP47;REST;NFIL3;SPINDOC;ZBTB4;CIITA;XRCC5;CIPC;EHMT1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5110729400552297,-1.2345965378297843,0.19907407407407407,0.69534943459447,1.0,4/12,5.83%,UNC13C;RIMS1;RIMS2;SYT7
prerank,regulation of chromatin binding (GO:0035561),0.6184616943864386,1.2343934299565105,0.2517857142857143,0.8681744875799,1.0,4/10,13.66%,BTAF1;WAPL;KDM4D;DDX11
prerank,glial cell development (GO:0021782),-0.4264052692214117,-1.2341344522257909,0.18384401114206128,0.6946824779732861,1.0,10/25,21.00%,CDK6;MDK;APP;MYRF;EIF2B5;NRROS;CSPG5;TPPP;SOX10;DLL1
prerank,axoneme assembly (GO:0035082),0.4938054905059998,1.2336935357587833,0.21726618705035972,0.8693495982592323,1.0,7/30,11.55%,RP1;DNAAF3;CCDC40;SPEF1;SPAG17;RSPH6A;TOGARAM1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4812935421985548,1.2334777571118032,0.22413793103448276,0.8687308001231913,1.0,6/39,3.51%,CDH1;WNK1;BMP6;KLF4;FXYD5;IL10
prerank,regulation of sprouting angiogenesis (GO:1903670),0.48030846010504646,1.233373206524118,0.1985611510791367,0.8677165922010875,1.0,5/33,4.00%,BMPER;THBS1;RHOJ;KLF4;ITGA5
prerank,heart process (GO:0003015),0.5671708014359383,1.2333180531671233,0.24787775891341257,0.8665176591331837,1.0,2/14,5.96%,SGCD;TNNI3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5479174379885615,1.2330213810862447,0.26517571884984026,0.8661901111614568,1.0,3/19,4.98%,SLC26A2;SULT1A1;PAPSS2
prerank,sphingosine metabolic process (GO:0006670),0.5416343193575673,1.2320563730406944,0.25870646766169153,0.868334210697012,1.0,2/17,2.52%,ACER3;PLPP3
prerank,negative regulation of cellular senescence (GO:2000773),-0.5066848254758008,-1.2319952885138827,0.19948186528497408,0.6992967875712738,1.0,4/13,9.25%,SLC30A10;AKT3;CDK6;YBX1
prerank,regulation of myoblast differentiation (GO:0045661),0.4843520777249592,1.2318489910836594,0.2342606149341142,0.867693097980768,1.0,4/32,3.49%,BMP4;BOC;SOX9;MYOG
prerank,inner ear morphogenesis (GO:0042472),0.525583164092921,1.2316851373460842,0.2303120356612184,0.8668911909186422,1.0,6/22,10.99%,SOX9;SIX1;ZIC1;TFAP2A;MYO3B;TIFAB
prerank,stress fiber assembly (GO:0043149),0.5665921337580075,1.2314555600163695,0.24570446735395188,0.8650100899041688,1.0,5/15,11.89%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.5665921337580075,1.2314555600163695,0.24570446735395188,0.8650100899041688,1.0,5/15,11.89%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.47062516487731315,-1.2313629243379873,0.20437956204379562,0.699010088983647,1.0,10/16,24.93%,ARHGAP24;AUTS2;STMN3;RASGRF1;GABARAP;ALS2;KBTBD7;ARF6;PIK3CG;PIK3CB
prerank,cellular response to metal ion (GO:0071248),0.4016055953055642,1.2312512098868975,0.1511216056670602,0.8643670574076365,1.0,16/123,9.56%,CDH1;EGFR;SLC12A2;CLIC4;CAMK2D;BMP6;MEF2A;SYT8;TFAP2A;CHUK;JUN;P2RX4;IQGAP1;CDKN1B;CARF;DMTN
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5816762388598302,1.231178650220107,0.2556131260794473,0.8632596916212705,1.0,3/12,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,ether lipid metabolic process (GO:0046485),0.5673865569139199,1.2307922540247829,0.24067796610169492,0.8632564599460317,1.0,6/14,13.64%,NCEH1;PAFAH1B1;PEDS1;GNPAT;DHRS7B;AGPS
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3464790683556924,-1.2301966457236253,0.14912280701754385,0.7004182816384089,1.0,13/66,6.83%,ROBO1;MCC;PTPRM;MTSS1;NR2F2;TGFBR3;APOE;B2M;SPARC;CDK6;DAB2IP;AQP11;RGCC
prerank,T-helper cell differentiation (GO:0042093),0.5731102942684299,1.2299685816402206,0.25252525252525254,0.8647032496236566,1.0,1/14,0.32%,FOXP1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4297031817514683,-1.2298574827433704,0.1878453038674033,0.6993315849337296,1.0,3/23,4.75%,ERRFI1;CBLB;SOCS5
prerank,carbohydrate derivative transport (GO:1901264),-0.45147796344999275,-1.2296260265303876,0.19464720194647203,0.6979754254577856,1.0,8/18,16.99%,PLTP;NPC2;SLC29A1;SCARB1;MFSD2A;SLC25A19;SLC15A2;ABCG1
prerank,neuron remodeling (GO:0016322),-0.5416287391911632,-1.2278615707668366,0.23636363636363636,0.7015231057201193,1.0,6/10,36.32%,EPHA8;C1QA;APP;C3;RND1;CX3CL1
prerank,cellular response to ketone (GO:1901655),-0.39216179515935373,-1.227755557704016,0.16615384615384615,0.699736484443846,1.0,8/35,9.09%,ADCY5;ADCY1;GNG2;AHR;ADCY2;PTGFR;SPP1;SRC
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5256218499518157,1.2275244082544259,0.2422360248447205,0.8718087022767107,1.0,3/22,3.65%,SLIT2;PRKCD;GSN
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6030768946236219,1.2272709006480624,0.2636986301369863,0.8713240546925083,1.0,4/10,15.67%,RARB;RARG;RXRA;SNW1
prerank,Golgi to endosome transport (GO:0006895),0.5498040925082035,1.2268519311644202,0.26666666666666666,0.8714862115739231,1.0,8/16,18.72%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;AP4M1;CORO7;MON2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4897158762702251,1.226389814037574,0.2319277108433735,0.8717610137277393,1.0,10/31,13.44%,CRIM1;SOX9;SMAD6;BAMBI;TRPM4;TWIST2;SKI;NOG;CHRD;LRP5
prerank,heart looping (GO:0001947),0.47436061425662984,1.2260310570450919,0.20926966292134833,0.871736847378868,1.0,6/39,8.03%,MICAL2;SMO;CCDC40;TGFBR2;STIL;GATA4
prerank,peroxisomal membrane transport (GO:0015919),0.5034721558767575,1.2258832563744424,0.2277526395173454,0.8709310037327874,1.0,11/27,24.26%,ABCD3;PXMP2;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16;PEX7;PXMP4;PEX13
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.424841562859387,1.2255586789912551,0.19848293299620734,0.8707642798329178,1.0,19/74,13.60%,BMP5;TGFB3;PHLDB2;GCNT2;BAMBI;SPRED2;TGFBR1;TGFBR2;TGFB1I1;WWTR1;IL17RD;FOXA1;GATA3;MTOR;NKX2-1;BCL9L;TGFB2;FOXC1;LDLRAD4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4199117124154791,1.2255509125981068,0.18444165621079048,0.8694579367699412,1.0,13/77,11.42%,BMP4;THBS1;TCF7L2;NR4A2;BIRC6;TGFBR1;CLU;ITGAV;GATA4;RB1;ACVR1;CSNK2A2;CSNK2A1
prerank,muscle cell differentiation (GO:0042692),-0.3941613304394465,-1.2255489166400404,0.18023255813953487,0.704366337494254,1.0,13/32,10.71%,WNT5B;MRTFB;SGCZ;TMEM204;SPEG;TBX1;TBX18;MEF2C;HEY2;GATA6;MEGF10;NINJ1;MYOCD
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5353812637727504,1.2254194671779224,0.24874791318864775,0.868540779699587,1.0,3/20,1.62%,HOXA5;PTK2B;ZBTB16
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.39563149256509234,-1.2251602675543807,0.16981132075471697,0.7033363307714783,1.0,12/34,18.94%,LYN;MFHAS1;LGR4;DAB2IP;GPS2;TLR3;CD300A;LRRC14;TNFAIP3;TYRO3;GRAMD4;SMPDL3B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.40140191462143104,1.2247749581346241,0.14864864864864866,0.8694497258341147,1.0,45/144,21.35%,CDH1;TCF7L2;ABLIM3;NPEPPS;PRKCD;ZIC1;GSK3B;KCNB1;PLK3;CEP131;HCLS1;MAVS;BAP1;JUP;UBE2D3;PCM1;BCAS3;HPS4;SAR1B;ARIH2;UBR5;CSNK2A2;SFN;C2CD5;PPP3CC;RNF31;HSPA1L;RAN;SAE1;ITGB1BP1;DMAP1;FLNA;TCAF2;MAPK8;HUWE1;NMT1;CHP1;MIEF1;FIS1;BBC3;PIK3R2;EFCAB7;TGFB1;SH3GLB1;PRNP
prerank,negative regulation of autophagy (GO:0010507),0.4512465443391514,1.224451539349774,0.2147562582345191,0.8692194362460994,1.0,15/54,12.74%,MET;EIF4G3;DAPL1;EIF4G1;FOXK1;IL10;KLHL22;TAB3;SMG1;SMCR8;FOXK2;MTOR;WASHC1;STAT3;HTR2B
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6051318829300837,1.224316538393639,0.2831541218637993,0.8684030857464687,1.0,4/10,3.54%,SOX9;ZBTB16;GDF6;GDF5
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4510511219324306,1.224128749613557,0.20367936925098554,0.8677953634340375,1.0,9/56,11.30%,EGFR;ANXA1;EIF4G1;CDC25B;ANAPC5;CDC16;RDX;RAD51C;RB1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4755426676833173,-1.2241033751915797,0.2075,0.7043925133444935,1.0,8/16,18.96%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST3GAL5;ST6GALNAC4;ST8SIA1;ST6GALNAC6;ST8SIA5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4522958204303268,-1.2234874020890019,0.2041343669250646,0.7043434715882627,1.0,11/18,33.77%,RUVBL1;CCT5;RUVBL2;DCP2;CCT2;SHQ1;EXOSC10;NOP10;DKC1;NHP2;CCT8
prerank,erythrocyte differentiation (GO:0030218),-0.35988572441176664,-1.2221478859686339,0.17465753424657535,0.7062789664647393,1.0,19/44,24.11%,LYN;TGFBR3;MFHAS1;RPS14;KIT;RPS19;HSPA9;TAL1;ALAS1;CASP3;IKZF1;NCKAP1L;SLC25A38;KMT2E;JAK3;VEGFA;SH2B3;LYAR;MED1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3699953082765439,-1.2219144218402918,0.14963503649635038,0.7048913775546348,1.0,8/47,9.45%,VTN;TIMP3;SPOCK2;SERPINI1;GAPDH;SPOCK3;SERPIND1;SPOCK1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5058898790071337,-1.221615103150733,0.23950617283950618,0.7037178256949612,1.0,2/12,8.53%,PLEKHH2;PLEK
prerank,positive chemotaxis (GO:0050918),0.5528707077703361,1.221545966241876,0.25252525252525254,0.8752677572671088,1.0,2/17,7.71%,MET;NRP1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5813882144901333,1.2215056587970472,0.26501766784452296,0.8727533494314599,1.0,2/11,2.47%,PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.5813882144901333,1.2215056587970472,0.26501766784452296,0.8727533494314599,1.0,2/11,2.47%,PTK2B;SHC1
prerank,response to prostaglandin E (GO:0034695),-0.5326304848391489,-1.221171526656054,0.2532467532467532,0.7031355024176791,1.0,2/10,2.79%,TGFBR3;GNG2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3653238303738292,1.2209635378710855,0.02404809619238477,0.87333354572826,1.0,209/834,18.18%,EGFR;MICAL2;BMP4;KLF5;MET;SMAD9;RARB;SOX9;ZFHX3;ZFPM2;TCF7L2;BMP5;PLAGL1;NFIB;SIX1;PKD1;HOXA5;TGFB3;HDAC4;FOXO3;GLI3;PBX1;PPP3CA;CCN1;GRHL1;NFIA;CSRP3;NFAT5;NR2F1;INHBA;BMP6;ISL1;KLF4;PID1;LRP6;MYOG;IL10;PHOX2A;KAT6B;ELF1;DCAF6;MEF2A;ABL1;MEOX2;ZFP64;EGR2;BMPR1A;DDIT3;CEBPZ;ARF4;NFE2L2;GATA1;KLF7;CTCFL;ZBED4;NR4A2;E2F5;DDRGK1;TCF20;FOXC2;GDNF;ATF1;NR4A3;NFKB1;NCK2;BPTF;PLSCR1;TNFSF11;GLIS1;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;HCLS1;MLLT10;JAG1;CAMTA2;TBL1X;MAVS;CHUK;JUN;RIPK2;ATM;KLF10;FGF2;KDM1A;KAT2A;CREBBP;GLIS2;JUP;HES1;CREB3L3;WWTR1;ETV5;GATA4;TEAD1;TAF6L;RHOQ;CALCOCO1;ZNF462;SMARCA4;TCERG1;KAT5;PAXBP1;THAP3;TCF3;NFKB2;E2F3;BCL11B;ATOH8;MED14;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;NKX2-1;HDAC8;GABPB1;GABPB2;SLC30A9;BCL9L;PPP1R12A;RBMX;RNF10;IRF1;ACVR1;TLR4;ASXL2;SQSTM1;ZNF507;TGFB2;ZBTB49;ZMIZ1;TAF9;MYSM1;REST;SLC9A1;RXRA;STAT3;FOXC1;EHF;RNF111;GALR1;RFX5;KAT2B;LPIN2;CIITA;LRP5;BRD8;KMT2C;REL;DDX17;FOXM1;GLYR1;CEBPB;ZNF76;COPS5;MAP2K5;TFE3;KMT2D;TFEB;HOXB3;HTATIP2;CDK12;NRIP1;AATF;NAMPT;HCFC1;SBNO2;ELF4;ITGB1BP1;SNW1;JMJD6;DHX9;ZBTB18;CREBRF;PAX6;PRKDC;NFIX;ATRX;MED17;EAF2;CSRNP2;RORA;NR4A1;CITED2;LDB2;LDB1;ZNF513;STAT6;EPC1;KDM6B;ATF2;YY1;AR;E2F2;ATF6;ZMIZ2;ELF3;CSRNP1;INO80;TNIP1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5092102419208779,1.2205135091464423,0.2539432176656151,0.8722401630757687,1.0,9/23,16.96%,THBS1;GIPC1;EP300;TGFB1I1;CREBBP;RNF111;STK11;SNW1;CITED2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5092102419208779,1.2205135091464423,0.2539432176656151,0.8722401630757687,1.0,9/23,16.96%,THBS1;GIPC1;EP300;TGFB1I1;CREBBP;RNF111;STK11;SNW1;CITED2
prerank,protein localization to organelle (GO:0033365),0.39441410776422636,1.2203775103886283,0.1630558722919042,0.8714137712552478,1.0,24/133,12.85%,BMP4;SIX1;ANK2;BBS9;CSRP3;CNTLN;LMNA;STX5;TOR1AIP1;DDRGK1;RAB6A;ZNF423;GAK;ARL3;CNEP1R1;VAPA;SIX4;IFT122;RPA1;FAM83H;EHD1;PAF1;XPA;COG3
prerank,response to ethanol (GO:0045471),-0.48003656853019483,-1.2203571523551846,0.2179176755447942,0.7036052601428526,1.0,7/14,13.31%,ADCY7;GRIN2A;GRIN2B;GRIN3A;GLRA1;SDF4;GRIN1
prerank,keratan sulfate catabolic process (GO:0042340),-0.5215879437947806,-1.220247895791161,0.23556581986143188,0.7018904283870872,1.0,6/11,18.17%,FMOD;OGN;LUM;OMD;PRELP;HEXB
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4902720998428908,1.220030375312316,0.2336182336182336,0.8712590230343337,1.0,4/33,4.86%,EGFR;ANXA1;EIF4G1;DDRGK1
prerank,regulation of JNK cascade (GO:0046328),-0.31260878819899707,-1.2190803214691703,0.10734463276836158,0.7032651646165624,1.0,24/101,11.27%,PLCB1;MECOM;IGF1R;PHLPP1;TGFBR3;TNFRSF19;MFHAS1;SH3RF1;TPD52L1;RAP2A;CCN2;MTURN;EPHB1;DAB2IP;MAP4K4;SDCBP;GPS2;SIRPA;SH3RF3;FLT4;DUSP3;ANKRD6;MAP3K10;APP
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.4185706686801907,-1.2188108179140702,0.22905027932960895,0.7020599375237232,1.0,6/24,16.03%,LPGAT1;CDS2;PNPLA8;GPAM;PGS1;SLC27A1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3722485593451601,1.2183501347664245,0.09710743801652892,0.8758551670418855,1.0,46/348,7.98%,EGFR;BMP4;SLCO3A1;SOX9;CARD14;RASSF2;NGF;PDGFC;BMP5;NTRK3;TGFB3;PTK2B;CD44;EFNA5;CCN1;LIMK2;KRAS;INHBA;BMP6;PGF;DDR2;DOCK7;EIF4G1;RAP1A;GDF6;GDF5;ITGA5;ABL1;BMPR1A;GATA1;NIBAN1;DDRGK1;PDGFA;TGFBR1;CD80;IL5;BMP15;HCLS1;FGF22;RAP2C;MAVS;RIPK2;ATP2B4;FGF2;NRP1;IQGAP1
prerank,presynapse organization (GO:0099172),-0.527112872133197,-1.2182538512020662,0.2336244541484716,0.7016088689633183,1.0,6/10,33.52%,WNT5A;LRRTM3;NLGN1;NLGN2;WNT7A;NLGN3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.29553060150627103,-1.2182134897970838,0.08695652173913043,0.6996928493954484,1.0,40/152,15.59%,ADGRL3;ADGRL4;ADCY5;CACNA1D;ADCY1;ABCA1;ADGRE5;GNAS;LGR4;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;S1PR1;ADRA2A;GPR37;PTGFR;GRM8;PTH1R;LPAR1;PDE2A;S1PR3;ADORA2A;ADGRG1;ADM;PSAP;ADCY4;CHRM2;P2RY12;LPAR2;IAPP;GPR37L1;ADGRB1;TBXA2R;ADGRL1;ADGRE1;ADCY3;ADCY8;VIPR2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4069814943313833,1.2179956171204125,0.16627634660421545,0.8758331396981558,1.0,31/108,15.22%,CLIC4;SORBS3;EFNA5;EZR;PHLDB2;PRKCD;ARHGAP44;FAM107A;CAPN2;GSK3B;DIAPH1;ABL1;CAPN6;PDGFA;ARHGEF5;MARK2;IQGAP1;SPEF1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;PAK2;RHOA;MAPK1;KATNBL1;LRP1;ARHGAP17;RND3;PRKAA1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5353354198262953,1.2178349473775603,0.25196850393700787,0.8750383285129971,1.0,2/18,2.02%,STK39;CAMK2D
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.31885593113888716,-1.2174812629888834,0.1261682242990654,0.6998404688593093,1.0,44/87,30.80%,NDUFA8;NDUFB3;COX17;NDUFS4;NDUFA6;IMMP2L;SCO1;PET100;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;COX20;NDUFB8;NDUFA3;UQCC2;NDUFB9;COX18;NDUFB4;TIMMDC1;SDHAF3;NDUFAF8;COA3;SLC25A33;NDUFS5;NDUFC1;CHCHD4;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;NDUFS6;NDUFA11;SDHAF1;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,regulation of regulated secretory pathway (GO:1903305),-0.394052244724558,-1.2173177008878993,0.19420289855072465,0.6983192884915642,1.0,18/34,27.34%,RIMS1;RIMS2;SYT7;SYN1;SYT11;SYT12;SYT9;LRRK2;SYT13;RAB27A;RAB15;SYT15;SYT1;SNAPIN;SYT5;SYT17;RAB3A;SYT2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.395580513443045,-1.2172438877987026,0.1861198738170347,0.6965652903132487,1.0,9/33,5.83%,MCC;PTPRG;PTPRM;NR2F2;APOE;DCN;ADAMTS9;EVL;DAB2IP
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33890825213929926,-1.2172002911631021,0.15079365079365079,0.6946967567641326,1.0,18/57,17.79%,RPL38;RPL14;RPS24;RPS15;RPS16;RPL5;RPS19;RPS17;RPS7;NOC2L;EMG1;RPL35A;RPL26;RPS25;RIOK1;RPL11;DDX31;RPS28
prerank,protein localization to Golgi apparatus (GO:0034067),0.49583277605712367,1.216852312452705,0.23219814241486067,0.8771089234328754,1.0,10/27,17.61%,VPS13A;VPS13C;RAB6A;GOLPH3;GAK;ZDHHC15;VPS13D;CSNK1D;GBF1;ARL1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4677876255388485,1.2161269104897579,0.2270861833105335,0.8782264918167235,1.0,10/44,13.61%,BAIAP2L1;PTK2B;CDC42EP5;GSN;NCK2;FCHSD1;NCKAP1;PRKCE;CTTN;FCHSD2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.36616963769107225,1.2159463629783738,0.06415478615071284,0.8776092187130162,1.0,86/497,12.32%,FOXP2;BMP4;FOXP1;WWP1;SOX9;SAMD4A;ZFPM2;TCF7L2;FOXN3;FOXD1;HDAC4;GLI3;ZBTB16;RBFOX2;WNT11;SHC1;WWP2;HDAC9;CRY2;KLF4;FOXK1;RCOR3;KAT6B;L3MBTL3;BTAF1;GSK3B;MDFIC;PDCD4;ZNF148;DDIT3;ARID4A;GCLC;IGFBP5;ATP8B1;SYNCRIP;ZNF423;ID4;SCMH1;TWIST2;HNF4A;ID1;BCLAF1;PRICKLE1;TFAP2A;MBTD1;FBXW11;CNOT7;PAIP2;JUN;FOXE1;KLF10;HDAC10;KDM1A;BAP1;GLIS2;BHLHE40;HES1;PHC2;TNFRSF4;TOB1;SMARCA4;CDKN1B;KAT5;BCL6;SIX4;RAD17;PER2;ATOH8;MBD1;FOXK2;GCFC2;GATA3;WAPL;PHF12;NKX2-1;NIBAN2;EIF2AK3;IRF1;RB1;TLE2;NANOS2;GTPBP4;USP47;REST;NFIL3;SPINDOC
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5086606536698149,-1.2159080853734876,0.22037914691943128,0.6965409835633658,1.0,4/11,12.62%,FOXO1;FAS;ATP6AP1;ATP6V1A
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.507486817210339,-1.2157505689218637,0.24170616113744076,0.6950107521272165,1.0,6/12,28.49%,MAP2;SNCA;TUBB4A;STMN2;STMN1;ARHGEF7
prerank,histone acetylation (GO:0016573),0.4291641597598194,1.215642324761227,0.19770408163265307,0.8773816950175014,1.0,26/69,18.84%,KAT6B;NAA40;SGF29;CPA4;TRRAP;EP300;TADA3;KAT2A;CREBBP;TAF6L;BRD1;KAT5;BRCA2;ZZZ3;TAF9;KAT2B;BRD8;TRIM16;TAF12;DMAP1;KAT14;EPC1;MORF4L2;ATF2;YEATS2;TADA1
prerank,histone methylation (GO:0016571),0.4908223229596881,1.2153287250556168,0.2526158445440957,0.8771866218287097,1.0,11/26,24.46%,SMYD2;CTCFL;CREBBP;EHMT2;EHMT1;CARM1;PRMT6;PRMT2;PRMT8;SIRT7;EZH2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4351616382394522,1.214952940999788,0.19590268886043533,0.877188528274845,1.0,19/66,21.05%,CDH1;LIMK2;PRKCD;ZIC1;HCLS1;MAVS;JUP;WWTR1;EIF2AK3;UBR5;RAN;TCP1;DMAP1;FLNA;PINX1;PIK3R2;MEPCE;EFCAB7;TGFB1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5181501285137583,-1.2145930749244005,0.23842592592592593,0.696412642928753,1.0,4/11,10.02%,APOE;UGCG;WIPI1;PORCN
prerank,negative regulation of signal transduction (GO:0009968),0.37583609581715843,1.2138790127822312,0.14301075268817204,0.8795950213236037,1.0,45/249,12.24%,EGFR;THBS1;TRABD2B;NXN;NTN1;BMP5;GLI3;SULF1;LRPAP1;NEDD4;TCIM;GRB10;HHIP;GPC3;WWP2;PRKCD;PALM;PID1;IL10;NR4A2;IGFBP5;VCP;KANK2;IRS1;MMP14;PTPN2;FGF2;TSKU;GLIS2;GATA4;AGTR2;GPR108;SULF2;GATA3;IFT122;NIBAN2;HERC4;NOG;RB1;ACVR1;CSNK2A2;CSNK2A1;MEGF8;NLK;KIF7
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5506875657399669,1.2135392074094895,0.2567783094098884,0.8794683318621791,1.0,6/16,15.86%,DDX5;RSRC1;SRSF6;DDX17;DHX9;SCNM1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4956655138377036,1.2129547320611163,0.2526475037821483,0.8801271386510797,1.0,8/29,13.60%,BMP5;SPRED2;IL17RD;FUZ;FOXA1;GATA3;NKX2-1;LDLRAD4
prerank,protein methylation (GO:0006479),0.4661456464748735,1.212541914050804,0.21678321678321677,0.8802913948856614,1.0,16/40,20.93%,CTCFL;RAB6A;METTL22;ETF1;METTL21C;EHMT2;EHMT1;SNRPD3;CARM1;PRMT6;PRMT2;GSPT1;EEF1AKMT1;CAMKMT;PRMT8;METTL21A
prerank,regulation of osteoblast proliferation (GO:0033688),0.5491633640700092,1.212129601368828,0.2671118530884808,0.8805016550340707,1.0,5/17,11.89%,CCN1;NELL1;HPSE;NPR3;RHOA
prerank,regulation of cellular response to stress (GO:0080135),0.39876628768296046,1.2115439285583247,0.16706443914081145,0.8814075955512138,1.0,23/115,14.82%,SLC38A2;CAMK2D;EIF4G1;NUP93;GSK3B;ABL1;EP300;ATM;CREBBP;SMG1;DYRK3;SEC13;MLST8;NUP188;MTOR;AIFM2;RPA1;RANBP2;DNAJB6;MAPK1;CEBPB;HSPA1L;ARMT1
prerank,acylglycerol homeostasis (GO:0055090),-0.43088142747332997,-1.2115253940922905,0.21614583333333334,0.7039188174733254,1.0,5/20,9.17%,APOE;NR1H3;SCARB1;PNPLA8;IL18
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3909403155228745,1.2114374163404231,0.1678082191780822,0.8804837168454729,1.0,24/136,11.30%,TCF7L2;PKD1;HDAC4;CYP1B1;PTGIS;TAX1BP1;WWP2;KLF4;ANXA4;DDIT3;ID1;CHUK;KDM1A;RNF2;GLIS2;BHLHE40;HES1;USP7;TNFRSF4;EIF2AK4;ACOD1;COMMD1;TAF1;RB1
prerank,positive regulation of ion transport (GO:0043270),0.445260328648277,1.2113962173288029,0.23098201936376211,0.8793371052709453,1.0,11/48,12.42%,FHL1;ANK2;ANO6;STIM2;GDNF;DLG1;P2RX4;CACNB2;CNKSR3;CRACR2A;SNX4
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.587652516482234,1.211365083107112,0.26548672566371684,0.8781565853985512,1.0,2/10,2.99%,BMP5;LRP6
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5676824956044447,1.2110259756055883,0.2738301559792028,0.8754431670444124,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5676824956044447,1.2110259756055883,0.2738301559792028,0.8754431670444124,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5676824956044447,1.2110259756055883,0.2738301559792028,0.8754431670444124,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4536124664173995,1.210444685516706,0.22070844686648503,0.8762108803801093,1.0,7/49,12.38%,F3;LBP;DDIT3;MAVS;BCL10;TLR4;STAT3
prerank,sphingosine biosynthetic process (GO:0046512),0.5852094966750606,1.2103670649139353,0.2669039145907473,0.8739356765151718,1.0,1/11,0.61%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.5852094966750606,1.2103670649139353,0.2669039145907473,0.8739356765151718,1.0,1/11,0.61%,ACER3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3944845698397438,-1.2103480944041116,0.19705882352941176,0.7054841475355293,1.0,3/33,3.93%,IL34;LEF1;CSF1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4708772811999968,-1.2101727693868753,0.22727272727272727,0.7040385075150797,1.0,6/15,14.28%,APOE;PFDN2;APP;PFDN5;CHRNA7;IAPP
prerank,cation transmembrane transport (GO:0098655),-0.3515120416479773,-1.2101347027562581,0.15087719298245614,0.7021884367708736,1.0,6/44,6.22%,ATP1A2;TRPM3;SLC6A9;SLC7A5;ABCC9;SLC38A5
prerank,regulation of mast cell degranulation (GO:0043304),-0.4840416240799576,-1.210028439251257,0.25,0.7005165371125353,1.0,5/14,16.35%,LYN;CD300A;CD84;FES;SYK
prerank,O-glycan processing (GO:0016266),0.4404180085044688,1.209782459517066,0.22913907284768212,0.8746505860704779,1.0,11/54,14.64%,ST3GAL4;MUC6;B3GNT2;GALNT15;GALNT13;B3GNT6;GXYLT2;GCNT4;ST3GAL2;GALNT11;GALNT14
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3599541875160061,1.2091148717388736,0.003,0.8756109792865152,1.0,350/1668,16.55%,FOXP2;EGFR;ZBTB7C;BMP4;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;SLTM;MET;TFCP2L1;SMAD9;RARB;SOX9;TCF7L1;ZFHX3;ZFPM2;TCF7L2;PRRX2;BMP5;TBX15;PRDM6;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;PKD1;HOXA5;TGFB3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;PBX1;ESR2;PPP3CA;CCN1;CAMK2D;GRHL1;NFIA;CSRP3;KLF3;NFAT5;NR2F1;INHBA;BMP6;WWP2;HDAC9;ISL1;CRY2;HOXA3;KLF4;CUX1;PID1;LRP6;SMAD6;SMYD2;PURG;FOXK1;FOXP4;SP140;SKIL;MYOG;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;RCOR3;KAT6B;HOXB6;ELF1;ZBTB7B;ZIC1;DCAF6;ANXA4;MEF2A;ZNF148;ABL1;MEOX2;ZFP64;EGR2;HDGFL3;BMPR1A;DDIT3;CEBPZ;ARF4;TLE6;NFE2L2;ARID4A;GATA1;KLF7;CTCFL;TNRC6C;ZBED4;NR4A2;E2F5;DDRGK1;TCF25;TCF20;FOXC2;HOXA6;GDNF;ATF1;MED15;JMJD1C;NR4A3;NFKB1;ZNF8;ID4;KANK2;PIAS3;NCK2;BPTF;PLSCR1;TNFSF11;FOXO6;GLIS1;TWIST2;MOV10;HNF4A;HNF1A;ID1;BCLAF1;RARG;BAZ2B;FOXD2;PRRX1;EP300;TFAP2A;HOXB5;DLG1;PLK3;PIAS2;HCLS1;LBX1;MLLT10;USP2;OTUD7B;JAG1;CAMTA2;TBL1X;MAVS;CHUK;E2F6;JUN;RIPK2;FOXE1;HIVEP3;ATM;NR6A1;KLF10;ATP2B4;HDAC10;FGF2;TADA3;ZMYM5;KDM1A;KAT2A;RNF2;CREBBP;KLF9;GLIS2;JUP;BHLHE40;HES1;NFATC4;FUS;CREB3L3;WWTR1;ETV5;GATA4;HIF3A;JDP2;TEAD1;TAF6L;RHOQ;CALCOCO1;UBE2D3;CCNL2;ZNF462;MDM4;CBFB;SMARCA4;TCERG1;MNAT1;CARF;NFYA;KAT5;CTR9;PAXBP1;THAP3;DCAF1;BCL6;TOX4;TCF3;MXD1;NFKB2;PHF21A;SIX4;E2F3;PER2;FRK;BCL11B;ZNF585B;ZNF585A;PPM1A;ZKSCAN1;ATOH8;ARID4B;MED14;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;TCF23;PHF12;NKX2-1;BRD9;HDAC8;GABPB1;GABPB2;SLC30A9;EBF4;BCL9L;NOG;ZNF383;TAF1;PPP1R12A;ZFP62;RBMX;RNF10;IRF1;RB1;ACVR1;TLR4;HSF5;ASXL2;SQSTM1;ZNF507;ZBTB49;BAZ1A;ZBTB37;ZMIZ1;TAF9;PEX2;PAF1;MYSM1;REST;SLC9A1;MTDH;CBX2;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;GATAD2B;EHF;RNF111;KDM3B;RTF1;PGBD1;GALR1;RFX5;HIVEP2;STAT5A;KAT2B;ZBTB4;LPIN2;EHMT2;CIITA;HES7;LRP5;BRD8;KMT2C;REL;DDX17;ZXDC;FOXM1;MGA;NCOA5;GLYR1;CEBPB;SOX21;ZNF76;COPS5;MAP2K5;TFE3;THAP1;KMT2D;BRD3;GTF2IRD1;LCOR;TFEB;ZBTB32;MYNN;PER3;HOXB3;HTATIP2;FOXL1;ATF7;ZXDB;CDK12;BRWD1;FBXL19;RBBP8;NRIP1;AATF;NAMPT;HCFC1;ZFX;SBNO2;ELF4;ELP4;ITGB1BP1;ZNF25;SNW1;JMJD6;DHX9;SRCAP;HOXC5;PCGF1;ZBTB18;CREBRF;PAX6;DUSP22;VPS72;MED27;ZNF496;PRKDC;NFIX;ZIC5;ELOA;HIRA;ATRX;MED17;DMAP1;EAF2
prerank,positive regulation of binding (GO:0051099),0.415157922395586,1.208768975026065,0.21508034610630408,0.8755518454909229,1.0,20/84,14.62%,BMP4;MET;TCF7L2;NGF;PKD1;GSK3B;BAMBI;RIPK2;IDE;HES1;USP33;SKI;MARK3;TAF1;KDM4D;FOXC1;ADD1;DDX11;LRP1;RAN
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3573295925315377,-1.2086204268551253,0.18326693227091634,0.7028835801129645,1.0,15/49,17.43%,CPEB2;F11R;MAP2;CST3;GPSM1;GMIP;LRCH1;DAB2IP;LRRK2;CAMK2A;EGLN1;SH3BP4;RASA4;NOS1;SH2D4A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5159454000483173,1.2085993657618679,0.27689873417721517,0.8748214179890567,1.0,6/19,15.85%,HIPK1;EP300;DYRK2;CDIP1;SNW1;PML
prerank,positive regulation of phosphorylation (GO:0042327),0.37532188580973264,1.208381441687912,0.14423076923076922,0.8743219766812997,1.0,21/240,4.57%,SLC4A4;EGFR;BMP4;THBS1;SLCO3A1;MET;SOX9;CARD14;NTRK3;EFNA5;CCN1;LMO4;LIMK2;FGFR1;KRAS;PGF;DDR2;FZD7;ABL1;PFKFB2;NIBAN1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.30854826483704045,-1.2081718360177847,0.13855421686746988,0.7022821924708061,1.0,29/102,15.73%,TBC1D4;PIK3R1;ADCY5;SLC30A10;FOXO1;ADCY1;ENPP1;CPEB2;PRKAR2B;ADCY7;ADCY2;PRKACB;INSR;PRKAR1B;LPIN3;PARP1;MYO5A;PRKAR1A;SRC;INSIG2;LPIN1;CYSLTR2;ADCY4;RPS6KB1;PDE3B;AKT1;ADCY3;ADCY8;GSK3A
prerank,regulation of cytokinesis (GO:0032465),0.42056840172638316,1.2079650914320055,0.2147239263803681,0.8744173214481497,1.0,18/78,12.45%,KIF13A;CIT;GIPC1;KLHL13;CDC25B;BIRC6;BECN1;PKP4;PLK3;RAB11FIP3;ENTR1;ZFYVE26;PKN2;CDC42;DRD3;SETD2;RHOA;PRKCE
prerank,regulation of feeding behavior (GO:0060259),-0.5152196515661669,-1.2077973653590162,0.2524271844660194,0.7014372176395942,1.0,2/11,1.35%,LEPR;SGIP1
prerank,response to purine-containing compound (GO:0014074),-0.4596349523022818,-1.2076944127261224,0.1989795918367347,0.699831425773957,1.0,7/17,15.51%,TRPC3;ABCC9;P2RY1;NDUFS4;RYR2;VGF;P2RX7
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.49624228117738106,1.2066488651407168,0.2590759075907591,0.8775450783679173,1.0,4/23,7.08%,SLC4A4;PFKFB2;NFKB1;GAPDHS
prerank,chemical synaptic transmission (GO:0007268),-0.26924473163167423,-1.2063392177047891,0.044444444444444446,0.701845897801762,1.0,65/284,13.64%,SLC1A3;UNC13C;APOE;DTNA;PDE7B;NRXN1;GRM3;NOVA1;MBP;CACNA1E;CDH8;LIN7A;PRKAR2B;SLC6A1;CALM1;HSPA8;RIMS1;GRIK1;GRIN2A;GRM5;PLP1;GABRG3;GRM1;SNCA;PRKACB;GRM7;GRIA4;GRIA2;SLC1A1;SLC1A2;GRIA3;GRIN2B;PRKAR1B;SDCBP;GRID2;SYN1;GABRA1;GABRA2;ATXN3;APBA2;RIT2;GRIK2;PRKAR1A;GLRA1;GABRB2;GABARAP;GABRB1;CHRM3;NSG1;APBA1;KCND2;SLC12A5;HTR2A;RPS6KA1;CACNA1B;KCNQ3;CPLX1;DLGAP2;CHRM2;SST;GRIN1;CHRFAM7A;CHRNA7;HRH1;CACNB4
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4772871923131004,-1.206142297516886,0.21678321678321677,0.7005086858599489,1.0,5/14,20.07%,MOXD1;ALDH9A1;SLC22A2;NOS1;DAGLA
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5461237266428395,1.2059625204947229,0.2706896551724138,0.8786697956798007,1.0,3/15,4.37%,MGAT3;LARGE1;CHST5
prerank,regulation of histone deacetylation (GO:0031063),0.5660187820826134,1.2058909193017675,0.2736842105263158,0.8776294212829219,1.0,2/13,3.83%,CAMK2D;ZBTB7B
prerank,phosphate ion homeostasis (GO:0055062),-0.5268261165498884,-1.2057201116191472,0.24780701754385964,0.6999539375676113,1.0,3/10,17.46%,ENPP1;XPR1;FGFR4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.46100956261992904,1.2055085618688621,0.2316715542521994,0.8776859780678525,1.0,13/40,12.50%,TCF7L2;TGFB3;GCNT2;BAMBI;TGFBR1;TGFBR2;JAG1;TGFB1I1;WWTR1;MTOR;BCL9L;TGFB2;FOXC1
prerank,positive regulation of cell communication (GO:0010647),-0.3946186870273861,-1.2053981298976233,0.22255192878338279,0.6990077909235044,1.0,11/28,21.52%,WLS;RIMS1;RIMS2;ANK3;GRIK2;EDN1;EDN3;CLSTN3;CLSTN1;PTPN23;SYT1
prerank,relaxation of muscle (GO:0090075),0.5751705103895257,1.2052206225188031,0.28130360205831906,0.8774092755632523,1.0,5/13,7.14%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4
prerank,development of primary male sexual characteristics (GO:0046546),0.469194396637334,1.2048947733155881,0.2510948905109489,0.8772568258083785,1.0,9/34,11.71%,SOX9;LHFPL2;INHBA;GATA1;GATA4;SIX4;GATA3;WNT2B;TGFB2
prerank,regulation of B cell apoptotic process (GO:0002902),0.570561316477667,1.2043801950750566,0.2876480541455161,0.8776545217355098,1.0,2/12,3.51%,FOXP1;IL10
prerank,pre-miRNA processing (GO:0031054),-0.4717685464980619,-1.204052082183903,0.21287128712871287,0.7011529773731019,1.0,5/14,22.47%,AGO1;LIN28B;AGO4;TARBP2;MRPL44
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.38707493219206623,1.203793584331571,0.18764044943820224,0.878394345463627,1.0,17/151,8.03%,EGFR;BMPER;PDGFC;NTRK3;TNFAIP8L3;PTK2B;CD44;SHC1;GAREM1;RAP1A;GCNT2;NOTCH2;PDGFA;TNFSF11;FGF2;NRP1;GATA4
prerank,maintenance of protein location in nucleus (GO:0051457),-0.44144401796935095,-1.203747832633296,0.2196969696969697,0.7001665947589355,1.0,9/20,21.42%,ARL2BP;TAF3;BCL3;CHCHD10;SP100;TOPORS;SUN1;PARK7;HNRNPU
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.36681957583591107,1.2032958215559684,0.11558307533539731,0.8787733825974173,1.0,85/327,19.19%,BNC2;VSX1;TCF7L1;ZFHX3;PRRX2;FOXN3;SIX1;ESR2;NFIA;USP13;EFEMP1;PITX3;IGSF1;KAT6B;FZD7;ABL1;DDIT3;CRABP2;TGFBR1;JMJD1C;ZNF423;TRRAP;EP300;ERC1;HCLS1;HDAC10;CREBBP;BHLHE40;FUS;WWTR1;GATA4;TAF6L;CHEK2;NFYA;CTR9;HMG20A;TCF3;NFKB2;GON4L;BRCA2;FOXK2;GPBP1L1;GCFC2;ZNHIT3;PHF12;RB1;ZBTB11;ZMIZ1;REST;NLK;NFIL3;STAT3;FOXC1;BAZ2A;ASCC1;ZBTB4;CEBPB;TGFBRAP1;SOX21;THAP1;KMT2D;GTF2IRD1;CARM1;TFEB;ATF7;HCFC1;SBNO2;PML;PCGF1;ATRX;SERTAD3;SAP30;RORA;LDB1;ACTR8;ATF2;CREBL2;POU6F2;SRRT;REXO4;CREM;SPIN4;NUP107;ZFAT;SP3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5635521992724906,1.2028810038672964,0.28825622775800713,0.8789274852077843,1.0,2/12,1.76%,UST;DSE
prerank,epithelial cell migration (GO:0010631),0.45816794674441474,1.2028559076122987,0.24671532846715327,0.8777687534341522,1.0,10/37,12.41%,FSTL1;CYP1B1;FAT2;GIPC1;ABL1;KANK2;NRP1;PKN2;RHOA;S100A2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4436943551450629,1.2028349722039784,0.22612359550561797,0.8766133041867911,1.0,11/50,14.68%,THBS1;NGF;CD44;KLF4;PAK2;CSNK2A1;USP47;DNAJB6;SFN;MAP2K5;CDKN2D
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.43682903435066434,-1.2028342596334034,0.21505376344086022,0.7009316332525349,1.0,11/21,22.61%,DCN;UGDH;CSGALNACT1;CHST3;CHSY3;NCAN;CSPG5;CSPG4;CHSY1;VCAN;BGN
prerank,cellular response to alcohol (GO:0097306),0.4605038044620722,1.2026282188944364,0.23661971830985915,0.8760536269093003,1.0,9/42,9.05%,CDH1;SMO;CTNNA1;LRP6;GOLPH3;KLF9;JUP;PTGER2;GRAMD1C
prerank,calcineurin-mediated signaling (GO:0097720),0.5963794368955069,1.2025400106700441,0.28888888888888886,0.8738821077698907,1.0,4/10,13.75%,PPP3CA;NFAT5;NFATC4;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5963794368955069,1.2025400106700441,0.28888888888888886,0.8738821077698907,1.0,4/10,13.75%,PPP3CA;NFAT5;NFATC4;PPP3CC
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4296388397886301,-1.202360589640029,0.22865013774104684,0.7005141826278518,1.0,7/19,7.31%,IL34;CAMK1D;CSF1;PTK2;MAPK3;JAM3;MDK
prerank,myelination in peripheral nervous system (GO:0022011),0.5633242003532719,1.2020805554989509,0.27318718381112983,0.8742351224134303,1.0,4/13,10.75%,ADGRG6;ARHGEF10;SKI;PARD3
prerank,activin receptor signaling pathway (GO:0032924),0.55106557512263,1.201024926720551,0.2878787878787879,0.8766907098233371,1.0,6/15,14.78%,INHBA;GDF6;TGFBR1;ACVR1;INHBB;AMHR2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5947503230769531,1.2010228726234309,0.2915194346289753,0.8754665427259148,1.0,3/10,2.02%,STK39;NEDD4;CAMK2D
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4680533285455783,-1.2002950165044821,0.25061425061425063,0.7048544606272488,1.0,3/14,9.61%,TFRC;RIF1;NECTIN2
prerank,regulation of cellular component movement (GO:0051270),0.4501575796482271,1.1997979283961324,0.24147339699863574,0.8781117308068203,1.0,8/49,6.13%,EGFR;ARAP1;CD9;DIAPH1;ABL1;TGFBR1;MYCBP2;MEMO1
prerank,autophagy of mitochondrion (GO:0000422),0.4585647011606189,1.1995286279296966,0.23219373219373218,0.8778317009928075,1.0,13/38,19.48%,WIPI2;ULK2;BECN1;ATG3;MARK2;SQSTM1;BNIP3;RB1CC1;AMBRA1;ATG2A;ATG7;ULK1;FIS1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4907489276815205,-1.1993395013335353,0.22843822843822845,0.7059027901282239,1.0,4/12,9.53%,PPARA;ABCA1;NR1H3;ABCA5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4000407992492644,-1.1991814920420028,0.20396600566572237,0.7044701404831418,1.0,13/26,22.96%,SLC30A10;PPARA;SNCA;CYBA;SLC5A3;GRIN1;ADGRB1;RAB27A;PARK7;SLC25A33;ABCB7;SLC18A2;SPHK2
prerank,positive regulation of locomotion (GO:0040017),0.4951697599448581,1.1991109255158476,0.2644230769230769,0.8780288325807061,1.0,2/27,0.98%,THBS1;NTN1
prerank,positive regulation of lipid transport (GO:0032370),-0.49806109142477145,-1.1990208028129525,0.24703087885985747,0.7030866199366783,1.0,4/12,14.05%,APOE;SPP1;DBI;ABCB4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3639872079594013,1.1989669713644506,0.11475409836065574,0.8772839282501541,1.0,93/366,19.19%,BNC2;VSX1;TCF7L1;ZFHX3;PRRX2;FOXN3;SIX1;FOXO3;ESR2;CCNA2;NFIA;USP13;EFEMP1;PITX3;IGSF1;KAT6B;FZD7;ABL1;DDIT3;GATA1;PDGFA;CRABP2;TGFBR1;JMJD1C;ZNF423;TRRAP;EP300;ERC1;HCLS1;HDAC10;CREBBP;BHLHE40;FUS;WWTR1;GATA4;TAF6L;CHEK2;NFYA;CTR9;HMG20A;TCF3;NFKB2;GON4L;BRCA2;FOXK2;GPBP1L1;GCFC2;ZNHIT3;PHF12;RB1;ZBTB11;REST;NLK;NFIL3;STAT3;FOXC1;BAZ2A;ASCC1;ZBTB4;EHMT2;CEBPB;TGFBRAP1;SOX21;THAP1;KMT2D;GTF2IRD1;CARM1;TFEB;ATF7;ORC5;HCFC1;SBNO2;PML;PCGF1;ATRX;SERTAD3;SAP30;RORA;LDB1;ACTR8;ATF2;CREBL2;POU6F2;CYFIP1;SRRT;REXO4;ATXN2;CREM;SPIN4;NUP107;RBM4B;ZFAT;SP3
prerank,regulation of protein neddylation (GO:2000434),-0.5134640881961444,-1.1988067480612319,0.2411504424778761,0.701831923892008,1.0,5/10,16.53%,HIF1A;RPL5;DCUN1D3;RPL11;EPAS1
prerank,regulation of actin filament polymerization (GO:0030833),0.42494670618746805,1.1985555669388517,0.22123893805309736,0.8774259696918718,1.0,15/69,14.16%,SLIT2;BAIAP2L1;PTK2B;CDC42EP5;PRKCD;NCK2;FCHSD1;HCLS1;NCKAP1;SSH3;WASHC5;PRKCE;CTTN;FCHSD2;CYRIB
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3406576232916723,-1.1985285372150778,0.1422924901185771,0.7008390071587358,1.0,13/55,11.16%,IGF1;TGFA;PDGFRB;OBSL1;BMP7;INSR;IGF2;RGCC;LCMT1;EDN1;RCC1;CDK5RAP2;EDN3
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.41068789771346603,1.1985198208724601,0.23414634146341465,0.876325711053152,1.0,35/80,24.44%,SGSM2;EHD3;STX5;VPS54;RAB6A;ERC1;VPS53;TMEM87B;RAB7B;RBSN;RGP1;VTI1A;TBC1D10A;WASHC1;SNX12;STX16;SNX32;TMEM87A;SNX2;GBF1;SPAG9;TBC1D5;ARL1;VPS51;RAB7A;VPS50;DCTN1;VPS29;BET1L;VPS26A;ARFRP1;TBC1D17;PIKFYVE;TRAPPC10;VPS52
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3212478673859229,-1.1982746993566975,0.14953271028037382,0.6998436625285192,1.0,16/75,8.47%,PTPRM;SEMA6A;WNT4;TEK;COL4A3;CLDN5;HSPG2;DCN;NPR1;SPARC;DAB2IP;AGO1;STAB1;RGCC;ECSCR;THBS2
prerank,synaptic membrane adhesion (GO:0099560),0.5523452931279624,1.1980046577803383,0.28097731239092494,0.8769282768399803,1.0,3/14,9.14%,GPC6;GPC4;PTPRF
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.4223332917084279,-1.1978704304564436,0.21983914209115282,0.6992406071981768,1.0,4/22,9.28%,SASH1;MFHAS1;BMP2;SPHK1
prerank,negative regulation of immune system process (GO:0002683),0.5479866720023616,1.1977383159617685,0.2652027027027027,0.8766042112272608,1.0,2/16,3.09%,SOX9;COL3A1
prerank,regulation of cell migration (GO:0030334),0.36768718401884937,1.1976394052181454,0.10319917440660474,0.8757338906658921,1.0,53/382,8.45%,CDH1;SLIT2;EGFR;F3;THBS1;TMEFF2;CLIC4;DPYSL3;PDGFC;NTRK3;PHACTR1;SMO;ANXA1;FOXO3;PTK2B;SEMA3D;CYP1B1;SULF1;SEMA3C;PPP3CA;CCN1;PTPRU;LMO4;ITGB1;WNT11;SEMA3E;MGAT3;ADAM9;FAM107A;GCNT2;LMNA;SGK3;IGFBP5;DDRGK1;PDGFA;ZMYND8;TGFBR1;SYNE2;TWIST2;VCL;SERPINE2;MMP14;TRIP6;PLXNA2;FGF22;JAG1;RAP2C;ATM;FGF2;DUSP10;ADAM10;SRGAP2;SRGAP3
prerank,Golgi localization (GO:0051645),0.5695691311345806,1.1970396153336054,0.2764811490125673,0.8766093786756004,1.0,3/11,15.49%,ARHGAP21;CDC42;ARCN1
prerank,neurotransmitter uptake (GO:0001504),-0.488008447295878,-1.196621436904075,0.2375296912114014,0.7009310914507847,1.0,2/12,0.19%,ATP1A2;SLC1A3
prerank,response to ATP (GO:0033198),-0.44487587336013246,-1.1965504060461545,0.22395833333333334,0.6992626798752405,1.0,7/18,15.51%,TRPC3;ABCC9;P2RY1;HSP90B1;P2RY12;RYR3;P2RX7
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3857197096301315,1.1965150129181097,0.18089887640449437,0.8771716548907061,1.0,21/142,12.81%,SLC35G1;PLCE1;EDNRA;PTGDR;ADRA1B;CD55;AGTR1;CACNA1C;ABL1;TRPM4;ATP2B4;PTGER1;BDKRB1;PTGER2;CXCR4;FPR3;SELENOT;DRD3;CD36;CMKLR1;TRPC5
prerank,positive regulation of programmed cell death (GO:0043068),0.37234937809610186,1.1965135859234346,0.14360587002096437,0.8759657092198172,1.0,42/272,12.40%,SLIT2;BMP4;MAP3K5;RASSF2;NGF;HOXA5;TGFB3;FOXO3;CYP1B1;AKAP13;PAWR;ITGB1;ANO6;IP6K2;ABL1;TIAM2;ARHGEF6;CALHM2;DIABLO;TRIO;CRADD;ARHGEF5;BCLAF1;RARG;CLU;VAV2;JUN;ATM;BCL10;UNC13B;BCL6;MOAP1;GNA13;ERCC3;FOXA1;QRICH1;UBE2Z;AIFM2;OMA1;SQSTM1;REST;BNIP3
prerank,cell projection assembly (GO:0030031),0.5133523215949917,1.1961565544545174,0.26033690658499237,0.8759369075138139,1.0,7/22,10.90%,PARVA;RHOJ;GSN;PDGFA;NCKAP1;RHOQ;CDC42
prerank,monoacylglycerol metabolic process (GO:0046462),0.5632993030506964,1.195628680856204,0.28717948717948716,0.8765145922826627,1.0,4/13,8.51%,MOGAT3;MGLL;DGAT2L6;ABHD6
prerank,relaxation of cardiac muscle (GO:0055119),0.5719028142268786,1.1953712116004054,0.27241379310344827,0.8761494623377701,1.0,5/13,7.14%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4
prerank,determination of heart left/right asymmetry (GO:0061371),0.45771618571234135,1.1953653271512639,0.2510402219140083,0.8749571333762266,1.0,6/42,8.03%,MICAL2;SMO;CCDC40;TGFBR2;STIL;GATA4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41340268103083627,1.1953558060927836,0.2121982210927573,0.8737945751368592,1.0,13/78,11.08%,FZR1;GSK3B;RNF19A;NFE2L2;VCP;DDRGK1;CLU;PRICKLE1;PLK3;ARIH1;CSNK1E;ARIH2;TAF1
prerank,NAD biosynthetic process (GO:0009435),0.5184230987090461,1.1950849283934855,0.2737341772151899,0.8734875983482231,1.0,3/20,3.69%,PTGIS;NMNAT2;QPRT
prerank,lipid oxidation (GO:0034440),-0.4904908294623136,-1.1950610346843773,0.2543640897755611,0.7017833127009213,1.0,5/12,29.45%,PPARGC1A;ALOX12;ACOX1;ADIPOR2;ALOX5
prerank,regulation of establishment of protein localization (GO:0070201),-0.4792600317599465,-1.1945797844952404,0.2403846153846154,0.7013438058984718,1.0,8/13,33.73%,CORO2B;CEP120;CTSD;SCFD1;TREM2;DNAJA1;CEP135;PTP4A3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.45407554406256656,-1.194496385568582,0.24634146341463414,0.69975824056807,1.0,9/16,15.26%,MCTP1;RIMS1;MEF2C;SYN1;FLOT1;CAMK2A;MCTP2;CPLX1;KCNMB4
prerank,heart trabecula morphogenesis (GO:0061384),-0.44614992853721963,-1.1942493079773155,0.22395833333333334,0.6986476770607857,1.0,8/18,6.53%,ENG;TGFBR3;TEK;RBP4;NOTCH1;BMP7;S1PR1;RBPJ
prerank,synaptic vesicle endocytosis (GO:0048488),-0.37853443977922435,-1.1941592341875487,0.19420289855072465,0.6971201673420999,1.0,17/33,25.16%,DNAJC6;DNM3;PICALM;SNCA;PIP5K1C;OPHN1;SNAP91;ITSN1;NLGN1;DNM1;NLGN2;SYT1;ITSN2;PACSIN1;CANX;SYT5;CDK5
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.39291201960441474,-1.1937127897429616,0.20658682634730538,0.6966822806101262,1.0,8/29,17.01%,ACSL1;ELOVL7;ELOVL6;ACLY;ACACA;HSD17B12;GCDH;ACSL5
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.35591099528251113,1.1936229081856038,0.028028028028028028,0.8769591435814594,1.0,259/1082,17.41%,CDH1;EGFR;BMP4;KLF5;MET;RARB;SOX9;MAP3K5;ZFHX3;ZFPM2;TCF7L2;BMP5;PLAGL1;NFIB;SIX1;PKD1;HOXA5;TGFB3;MLLT3;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;PPP3CA;CCN1;GRHL1;NFIA;CSRP3;WNT11;SHC1;NFAT5;NR2F1;INHBA;BMP6;ISL1;KLF4;PID1;LRP6;FOXK1;GDF6;MYOG;IL10;PITX3;LHX2;PHOX2A;KAT6B;ELOF1;ELF1;ZIC1;DCAF6;BAMBI;MDFIC;MEF2A;FZD7;ABL1;MEOX2;ZFP64;EGR2;BMPR1A;DDIT3;CEBPZ;ARF4;NFE2L2;GATA1;KLF7;CTCFL;ZBED4;NR4A2;E2F5;DDRGK1;TCF20;FOXC2;GDNF;ATF1;TGFBR1;NR4A3;NFKB1;ZNF423;CD80;NCK2;BPTF;PLSCR1;TNFSF11;GLIS1;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;FBXW11;HCLS1;MLLT10;TRIM44;JAG1;CAMTA2;TBL1X;MAVS;CHUK;JUN;TASP1;RIPK2;FOXE1;HIVEP3;ATM;KLF10;FGF2;TRIM45;TADA3;TGFB1I1;KDM1A;KAT2A;CREBBP;GLIS2;JUP;HES1;CREB3L3;WWTR1;ETV5;GATA4;TEAD1;TAF6L;RHOQ;CALCOCO1;BCL10;ZNF462;SMARCA4;TCERG1;CHEK2;SCAF8;NFYA;KAT5;FZD2;PAXBP1;THAP3;TCF3;NFKB2;SIX4;E2F3;BCL11B;PPM1A;ATOH8;MED14;BRCA2;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;MTOR;QRICH1;NKX2-1;HDAC8;GABPB1;GABPB2;SLC30A9;MYRFL;NIBAN2;BCL9L;WDR43;PIM2;EIF2AK3;PPP1R12A;RBMX;RNF10;IRF1;CHEK1;RGMB;ACVR1;TLR4;ASXL2;USP22;SQSTM1;ZNF507;ZBTB49;USP21;ZMIZ1;TAF9;MYSM1;REST;SLC9A1;NFIL3;RXRA;STAT3;FOXC1;EHF;RNF111;GALR1;RFX5;KAT2B;LPIN2;CIITA;LRP5;BRD8;KMT2C;REL;DDX17;ZXDC;FOXM1;GLYR1;CEBPB;ZNF76;COPS5;MAP2K5;TFE3;KMT2D;TRIM16;LBHD1;TFEB;CAMK4;ILK;THOC5;HOXB3;HTATIP2;TAF15;WDR75;NRIP1;AATF;NAMPT;HCFC1;SBNO2;ELF4;XPC;ITGB1BP1;SNW1;MAP2K2;JMJD6;DHX9;PML;PRMT2;ZNF711;MAP3K12;ZBTB18;CREBRF;PAX6;ZNF496;PRKDC;NFIX;ATRX;MED17;EAF2;CSRNP2;SERTAD3;RORA;NR4A1;CITED2;LDB2;LDB1;ZNF513;STAT6;EPC1;KDM6B;ATF2
prerank,macromolecule catabolic process (GO:0009057),0.490550533943503,1.1934798249453116,0.27071005917159763,0.8762819866017153,1.0,9/26,21.06%,NEDD4;BECN1;LRSAM1;IDE;MTOR;SMURF1;TPP1;TGFB1;SH3GLB1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5619624226613356,1.193455474300283,0.27652173913043476,0.8751628039474793,1.0,2/13,1.47%,SLC4A4;ATP1B1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5008984450335535,1.1933731151978688,0.2633279483037157,0.874230904338355,1.0,4/22,11.55%,UBASH3A;EZR;PTPN2;PHPT1
prerank,heart morphogenesis (GO:0003007),-0.3473284302092156,-1.193360190955206,0.18518518518518517,0.6959162383700797,1.0,13/50,8.28%,ENG;TGFBR3;CHD7;NOS3;TBX3;EPHB4;PTK2;NOTCH1;TBX1;INSR;SOX17;BMP2;HEY2
prerank,neurogenesis (GO:0022008),0.4536582168228268,1.1932773583599137,0.2426367461430575,0.8733485737185341,1.0,11/43,13.62%,ANXA1;SIX1;CIT;NTN5;DAGLB;BTBD3;SIX4;CXCR4;TGFB2;THOC2;BTBD2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5862294129501632,1.193273254468911,0.30017452006980805,0.8721757733098371,1.0,1/12,0.28%,F3
prerank,chloride transmembrane transport (GO:1902476),0.44945806134400557,1.1932447713220193,0.2523489932885906,0.8710944483794166,1.0,8/48,9.37%,SLC12A7;SLC12A2;SLC12A8;ANO6;GLRB;SLC4A8;GABRA3;ANO9
prerank,positive regulation of cell population proliferation (GO:0008284),0.36187557437144063,1.1930031615944914,0.10344827586206896,0.8706704643886239,1.0,52/423,8.30%,EGFR;BMP4;FOXP1;THBS1;ACER3;SOX9;GRK5;ZFPM2;TCF7L2;PDGFC;BMP5;NTRK3;FN1;TGFB3;HDAC4;PTK2B;CCN1;FGFR1;SHC1;KRAS;BMP6;PGF;DDR2;PID1;GAREM1;GCNT2;BAMBI;CDC25B;BMPR1A;DDRGK1;PDGFA;TRPM4;GDNF;TGFBR1;NR4A3;TGFBR2;IRS1;HILPDA;ITGAV;CEP131;HCLS1;FGF22;CNOT7;CLCF1;FGF2;GAB2;MAP3K3;KDM1A;MVD;HES1;WWTR1;ADAM10
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.415323689307664,1.1929654990708427,0.22165605095541402,0.8696188680238783,1.0,21/76,18.89%,HDAC4;TANK;FAM107A;BIRC7;PIAS3;MYCBP2;PRICKLE1;RIPK2;DCUN1D4;BCL10;FBXO4;COMMD1;BIRC3;AMER1;TSPYL5;SAE1;CENPX;HUWE1;TNIP1;WFS1;ANGPT1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4566706803713947,1.1923372281845852,0.23554301833568406,0.8704414784214329,1.0,9/43,11.91%,MICAL2;SMO;CCDC40;TGFBR2;STIL;HES1;GATA4;ACVR1;MEGF8
prerank,regulation of organelle organization (GO:0033043),0.41220613342197754,1.1923148766280272,0.21843434343434343,0.869323050837817,1.0,24/80,15.17%,CLIC4;EZR;CAPN2;EHD3;DIAPH1;CAPN6;STX5;GOLPH3;ARHGEF5;TBC1D25;EP300;MAVS;MARK2;SPEF1;RDX;RBSN;SAR1B;PAK2;PARL;SQSTM1;MAPK1;CLEC16A;PRMT6;MAPK15
prerank,positive regulation of apoptotic process (GO:0043065),0.3708372561934625,1.192199060546656,0.14600840336134455,0.868541986049829,1.0,47/293,12.40%,SLIT2;BMP4;MAP3K5;RASSF2;NGF;HOXA5;TGFB3;FOXO3;CYP1B1;AKAP13;PAWR;PTGIS;ITGB1;ANO6;IP6K2;ABL1;DDIT3;TIAM2;ARHGEF6;CALHM2;TGFBR1;DIABLO;TRIO;CRADD;ARHGEF5;BCLAF1;RARG;CLU;TFAP2A;VAV2;JUN;ATM;BCL10;UNC13B;BCL6;MOAP1;GNA13;ERCC3;FOXA1;QRICH1;UBE2Z;AIFM2;OMA1;SQSTM1;TGFB2;REST;BNIP3
prerank,embryonic organ morphogenesis (GO:0048562),0.4533316445101727,1.191771474462,0.24653739612188366,0.8687551391839132,1.0,10/42,11.91%,SIX1;MFAP5;HOXA3;EFEMP1;RARG;FOXE1;HES1;FUZ;ACVR1;MEGF8
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3571556252000125,1.1915805201939618,0.04609218436873747,0.8682160916234619,1.0,148/807,13.22%,FOXP2;BMP4;FOXP1;KLF12;WWP1;RARB;SOX9;ZFHX3;ZFPM2;TCF7L2;PRDM6;FOXN3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;ESR2;RBFOX2;WNT11;SHC1;NR2F1;BMP6;WWP2;HDAC9;ISL1;CRY2;KLF4;CUX1;SMYD2;FOXK1;FOXP4;SKIL;RCOR3;KAT6B;L3MBTL3;ZBTB7B;BTAF1;MDFIC;MEF2A;PDCD4;ZNF148;DDIT3;TLE6;ARID4A;GCLC;GATA1;KLF7;NR4A2;TCF25;ATP8B1;FOXC2;NR4A3;NFKB1;ZNF8;ZNF423;ID4;KANK2;BPTF;SCMH1;GLIS1;TWIST2;HNF4A;ID1;BCLAF1;RARG;PRICKLE1;EP300;TFAP2A;DLG1;PLK3;MBTD1;FBXW11;USP2;OTUD7B;CNOT7;TBL1X;E2F6;JUN;FOXE1;NR6A1;KLF10;HDAC10;ZMYM5;KDM1A;RNF2;BAP1;CREBBP;GLIS2;BHLHE40;HES1;PHC2;ETV5;JDP2;TNFRSF4;UBE2D3;MDM4;CBFB;SMARCA4;TCERG1;CDKN1B;KAT5;CTR9;DCAF1;BCL6;TCF3;MXD1;PHF21A;SIX4;PER2;FRK;PPM1A;ATOH8;MBD1;SKI;FOXK2;GCFC2;GATA3;TCF23;PHF12;NKX2-1;HDAC8;NIBAN2;NOG;TAF1;IRF1;RB1;TLE2;PEX2;PAF1;USP47;REST;MTDH;CBX2;NFIL3;SPINDOC;RXRA;STAT3;FOXC1;GATAD2B;RTF1;ZBTB4;EHMT2;CIITA;XRCC5;CIPC
prerank,response to X-ray (GO:0010165),0.5537421080296263,1.1915287293615784,0.2685025817555938,0.8672049189420459,1.0,3/14,13.21%,ANXA1;ATM;XRCC5
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5516192362359913,1.1912641446415493,0.27164685908319186,0.8669678767063363,1.0,3/14,4.50%,ATP1B1;WNK1;DMD
prerank,regulation of viral entry into host cell (GO:0046596),-0.39686504172010995,-1.1911330950329504,0.1925287356321839,0.7007218997596383,1.0,12/30,18.10%,LY6E;TRIM14;TRIM62;IFITM1;LGALS1;HS3ST5;NECTIN2;IFITM3;TRIM21;TRIM27;CD74;TRIM6
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5189794786855463,1.1910170513219247,0.26517571884984026,0.8665572473637013,1.0,1/21,0.15%,SLIT2
prerank,acylglycerol biosynthetic process (GO:0046463),0.5014365101624717,1.190842184924633,0.2768,0.8659764456947614,1.0,8/23,15.95%,PLCE1;PNPLA3;MOGAT3;DGAT2L6;GPAT3;LPIN2;PLA2G4A;PLA2G15
prerank,regulation of angiogenesis (GO:0045765),0.37456918552305113,1.1908185667289024,0.16210295728368018,0.8649098620840286,1.0,17/192,2.85%,SMOC2;F3;BMPER;THBS1;ITGB8;ANXA3;HOXA5;CYP1B1;SULF1;RHOJ;PTGIS;ITGB1;PGF;ISL1;KLF4;HIPK1;SEMA3E
prerank,phospholipid metabolic process (GO:0006644),0.4223090651603857,1.190497464911472,0.22661396574440051,0.8648032208135648,1.0,16/71,18.17%,PLPPR2;TNFAIP8L3;PLPP3;PNPLA3;PIP5K1A;PLA2G4F;PLCD1;PLPP1;FDFT1;GNPAT;LCAT;AGPAT4;PLA2G4A;PLA2G15;AGPAT5;MBOAT1
prerank,cardiac conduction system development (GO:0003161),0.4943321439024095,1.1903456669181485,0.26993865030674846,0.8641295970761169,1.0,4/24,8.03%,BMP4;NOTCH2;BMPR1A;GATA4
prerank,copper ion transport (GO:0006825),-0.5043024827413307,-1.190046739296413,0.24186046511627907,0.7020960434119221,1.0,9/11,29.01%,ATOX1;COX17;STEAP3;SLC31A1;SLC11A2;ATP7A;ATP7B;STEAP4;STEAP2
prerank,regulation of protein kinase B signaling (GO:0051896),0.3800816700583716,1.1899623348784165,0.16379310344827586,0.8642473665113563,1.0,24/193,8.03%,EGFR;F3;THBS1;MET;TCF7L2;NTRK3;TNFAIP8L3;ITGB1;FGFR1;STRN;GCNT2;DDIT3;PDGFA;TGFBR1;CD80;PHLPP2;IRS1;HCLS1;FGF22;P2RX4;PIK3AP1;FGF2;GAB2;GATA4
prerank,positive regulation of response to wounding (GO:1903036),-0.41855279081949087,-1.1885462987465698,0.23822714681440443,0.7047771103339265,1.0,9/24,10.33%,VTN;MYLK;OCLN;PTK2;GRN;ADRA2A;MDK;CLDN1;HBEGF
prerank,aminoglycan catabolic process (GO:0006026),0.47988992720872276,1.1883124855628184,0.271513353115727,0.8684952746273572,1.0,8/28,12.99%,GPC6;GPC3;NAGLU;GPC4;SGSH;HPSE;GLB1;SDC4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.47961480003784934,-1.1877889075641386,0.2635135135135135,0.705184910999436,1.0,5/13,15.58%,SHANK3;ADCY1;APP;CHRNA7;ADCY8
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4629801263319911,1.187580817919085,0.24585635359116023,0.8696641430815826,1.0,5/37,5.21%,HMCN1;CXADR;ALCAM;NECTIN3;PVR
prerank,microvillus organization (GO:0032528),0.5627463572752587,1.1873568276427724,0.2789115646258503,0.8692192797505768,1.0,5/13,7.01%,EZR;RAP1A;FXYD5;RAPGEF6;RAP2C
prerank,peptidyl-proline modification (GO:0018208),0.5077411819703334,1.186783250638925,0.2727272727272727,0.8698837940585521,1.0,2/25,2.38%,FKBP5;P3H2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3793622719612398,1.1862188027173777,0.17581187010078386,0.8706405716185841,1.0,28/166,12.28%,EGFR;SMOC2;THBS1;SAMD4A;SORBS1;KLF4;GIPC1;NIBAN1;LARP4B;IRS1;CLU;PTPN2;P2RX4;TLR6;FGF2;CNEP1R1;DYRK2;BCAR3;PLD1;STARD4;FABP3;AGTR2;MTOR;STN1;SLC45A3;TLR4;ELOVL5;CD36
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4028185675384716,1.1859492041044857,0.2196029776674938,0.8703920186649565,1.0,7/85,3.54%,EGFR;BMP4;SOX9;TCF7L2;BMP5;BMP6;GDF5
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4760447963267439,-1.1857910002312704,0.28117359413202936,0.7090577254492404,1.0,3/14,7.47%,IGF1;GRN;SYT11
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5758565092070257,1.1856885694859087,0.29326047358834245,0.8700557078518443,1.0,2/11,9.37%,EZR;RDX
prerank,cytosolic calcium ion transport (GO:0060401),0.4720735932392108,1.1855931089021179,0.2526964560862866,0.8692052192943898,1.0,4/28,11.04%,SLC35G1;CACNA1C;MCUB;MICU1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4428021694484492,1.184788878706563,0.23769338959212377,0.8706670264590934,1.0,9/47,12.28%,THBS1;AGTR1;PRKCD;PID1;TGFBR2;TLR6;ACOD1;TLR4;CD36
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4897751292343046,1.1847447445139048,0.2413793103448276,0.8696778649264071,1.0,9/31,14.75%,SIX1;HOXA3;TGFBR1;TGFBR2;TFAP2A;FUZ;NOG;MEGF8;HOXB3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.48647193354587137,1.1842675237251254,0.28325508607198746,0.8701024828236497,1.0,4/27,4.50%,ANK2;AHNAK;CAMK2D;DMD
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.516425419914764,-1.1842097428858365,0.26277372262773724,0.7117202338111528,1.0,4/10,10.88%,CST3;NOTCH1;TNFRSF1A;DPP4
prerank,regulation of dephosphorylation (GO:0035303),-0.45998246610319204,-1.1841195184473359,0.24647887323943662,0.7101723140735474,1.0,9/15,26.84%,PPP1R16B;SRC;MTMR9;MTMR2;INPP5K;MTMR1;IGBP1;SMG7;SMG5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.504204051753374,-1.184014625370861,0.25295508274231676,0.7086690376178301,1.0,8/11,27.95%,MERTK;CXCL12;GAS6;CCL19;IRF7;AXL;SELENOS;LILRB1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.36253373616294504,1.1837289561264528,0.15015641293013557,0.8707668677680301,1.0,75/314,20.59%,FBXL7;FZR1;WWP1;NEDD4;UBE4B;WWP2;UBE2B;DDIT3;NFE2L2;RNF185;VCP;KLHL22;ANAPC5;FBXW11;NPLOC4;ANKZF1;TBL1X;ECRG4;ANAPC16;ERLIN1;OS9;UBE2D3;CDC16;FBXO4;UFD1;KAT5;FBXL6;FBXL20;TRIM25;TAF1;FBXO17;RB1;ERCC8;UBXN4;CUL4A;FAF2;UBE2W;BFAR;ECPAS;APPBP2;RAD23B;SMURF1;PSMC6;UBE4A;FBXL14;FBXL19;PML;UBE3D;TMUB1;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;FEM1C;FEM1A;HUWE1;PPP2R5C;PCNP;WFS1;PSMB1;SEL1L2;FBXL17;PSMD13;FBXL8;PSMD1;AURKA;PSMD7;KCTD17;PSMA8
prerank,positive regulation of cell migration (GO:0030335),0.36846421996814743,1.1826893365769735,0.1639871382636656,0.8730948547865055,1.0,29/253,6.45%,EGFR;F3;DOCK5;THBS1;SOX9;PDGFC;NTRK3;FN1;SMO;PTK2B;SEMA3D;SEMA3C;PPP3CA;CCN1;ITGB1;WNT11;DDR2;SEMA3E;ADAM9;FAM107A;GCNT2;DDRGK1;PDGFA;TGFBR1;SYNE2;TWIST2;SHTN1;MMP14;TRIP6
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3827173006901318,1.181702396150079,0.19955156950672645,0.8751592583211193,1.0,27/152,12.09%,RSPO3;EGFR;SULF1;WNK1;GPC3;TMEM198;BAMBI;UBE2B;PLEKHA4;VCP;TRPM4;NFKB1;TNKS2;TBL1X;JUP;SMARCA4;CSNK1G3;PPM1A;SKI;DISC1;SULF2;PRDM15;CSNK1E;UBR5;CSNK2A1;USP34;USP47
prerank,myotube differentiation (GO:0014902),-0.44249552519545143,-1.1814861471966491,0.2639593908629442,0.7144654338036978,1.0,4/17,6.59%,IGF1;SORT1;ADAMTS15;MEF2C
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.49588048293235876,1.181419064197826,0.2672811059907834,0.8749435221429253,1.0,2/26,1.68%,ACER3;CYP1B1
prerank,artery morphogenesis (GO:0048844),0.4673600374939722,1.1812081535135597,0.27492447129909364,0.8745099059767317,1.0,9/30,11.71%,BMP4;STRA6;BMPR1A;TGFBR1;JAG1;NRP1;HES1;NOG;TGFB2
prerank,detection of visible light (GO:0009584),0.521274193898754,1.1809735877107599,0.285,0.8741765801606217,1.0,1/16,1.09%,RP1
prerank,iron ion transport (GO:0006826),-0.352218594141875,-1.180941662559558,0.1760299625468165,0.7143448297412571,1.0,11/47,14.74%,CP;FTH1;TFRC;SLC40A1;ATP6V1D;STEAP3;TTYH1;ATP6AP1;ATP6V1A;ATP6V0B;SLC11A2
prerank,response to UV (GO:0009411),0.40015598869571345,1.1808347522156526,0.2272159800249688,0.8734915597013079,1.0,22/95,18.17%,EGFR;SCARA3;NEDD4;UBE4B;PRKCD;UBE2B;EP300;KDM1A;CREBBP;EIF2AK4;ERCC3;TAF1;ERCC8;USP47;XPA;REV1;CDKN2D;USP1;MAPK8;WRN;YY1;INO80
prerank,protein insertion into membrane (GO:0051205),0.47190921146302206,1.1806957301492782,0.2661764705882353,0.8728096349465472,1.0,2/32,4.54%,EGFR;STX5
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.37195115990180116,-1.1804495667344974,0.22530864197530864,0.7140033523430158,1.0,6/32,10.80%,RPL30;DEFA6;PGLYRP1;RPS19;GAPDH;RPL39
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4344251660298727,1.1802743417390427,0.24726775956284153,0.8730474468651855,1.0,15/52,15.77%,EGFR;SORBS1;ITGB1;CNST;ACSL3;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;LRP1;PTPN9;WNK3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.40956638027736103,-1.1802639809656674,0.2336448598130841,0.7127313383792656,1.0,10/26,18.77%,SHANK3;SYNPO;SYNPO2;FHOD1;PLEK;RAC1;PFN1;LIMK1;ALMS1;ACTG1
prerank,regulation of filopodium assembly (GO:0051489),0.4587457846390855,1.1800226324087009,0.28111273792093705,0.8727308910817968,1.0,15/38,15.73%,DPYSL3;TGFB3;ARAP1;PRKCD;ARHGAP44;PALM;NRP1;RHOQ;DMTN;BCAS3;CDC42;FXR2;RAB5A;RAB17;TRPM2
prerank,response to glucose (GO:0009749),0.4338540359463683,1.1796283953432005,0.2496513249651325,0.8727658916788548,1.0,13/46,17.85%,THBS1;TCF7L2;KCNB1;HNF4A;SLC39A14;UNC13B;EIF2B2;SELENOT;PRKAA1;EIF2B3;PRKACA;IRS2;TRA2B
prerank,somite development (GO:0061053),0.5649419091813888,1.179468716463727,0.31551724137931036,0.8721094137933968,1.0,2/11,4.20%,SMO;MEOX2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4289731708772956,1.1794347111772774,0.246684350132626,0.8710890705231074,1.0,10/59,5.92%,CDH1;HMCN1;PKD1;NECTIN3;FAT2;MPZL2;ITGB1;DSG2;PVR;SDK1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4462844693586224,1.179388682856886,0.22282608695652173,0.8701367813726743,1.0,12/47,16.59%,DOCK5;EFNA5;ABL1;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;ITGB1BP1;FLNA
prerank,cellular defense response (GO:0006968),0.4524889883111564,1.1793571939258363,0.2638888888888889,0.8691019935131623,1.0,6/40,5.88%,PTK2B;LBP;ITGB1;KLRC2;ZNF148;BECN1
prerank,negative regulation of cell junction assembly (GO:1901889),0.4848137417101674,1.1784144698739145,0.2619047619047619,0.8710117730109531,1.0,5/25,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,regulation of calcium ion import (GO:0090279),-0.4105424684466865,-1.1780405977788526,0.25196850393700787,0.7175949127884055,1.0,7/21,24.48%,PDGFRB;CXCL12;SLC30A1;TRIM27;SPHK2;STC1;CCL2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3798883917367941,-1.177770119474042,0.22282608695652173,0.7165835806402209,1.0,5/29,7.23%,ENG;TGFBR3;NOTCH1;S1PR1;BMP2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.35868767560341563,1.1775723017961266,0.14285714285714285,0.872572525785642,1.0,86/341,20.59%,FBXL7;FZR1;WWP1;NEDD4;FBXO10;UBE4B;WWP2;RNF115;UBE2B;RNF19A;DDIT3;NFE2L2;UBR4;RNF185;VCP;BIRC6;KLHL22;ANAPC5;FBXW11;NPLOC4;ARIH1;OTUD7B;TRIP12;TBL1X;TGFB1I1;ANAPC16;UBAP1;OS9;UBE2D3;CDC16;UFD1;KAT5;RNF168;USP33;TRIM25;ARIH2;TAF1;ERCC8;SQSTM1;RNF111;CUL4A;UBE2W;BFAR;TSG101;APPBP2;RAD23B;SMURF1;PSMC6;UBE4A;FBXL14;RNF146;FBXL19;PML;UBE3D;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;RNF114;ZRANB1;FEM1C;FEM1A;VPS37A;HUWE1;PPP2R5C;RNF144A;PCNP;NUB1;RC3H2;PSMB1;FBXL17;NTAN1;USP9X;CHFR;PSMD13;PSMD1;AURKA;PSMD7;KCTD17;PSMA8
prerank,regulation of mitotic cell cycle (GO:0007346),0.3757988912898723,1.176248430268838,0.20112994350282487,0.8756290165559193,1.0,49/171,23.72%,FZR1;SMOC2;PTPN3;NEK7;IL10;CDC25B;TTC28;ANAPC5;USP2;ANAPC16;IQGAP1;CDC16;CDKN1B;ERCC3;FOXA1;PKN2;PIM2;RB1;USP22;FOXC1;HECA;BTG3;THAP1;PSMC6;TMEM8B;XPC;PRKCA;UBE2S;PSMD8;GBF1;CKS1B;PSMB1;PSMD13;PSMD1;GAS1;PSMD7;PSMA8;TGFB1;PDXP;PSMD3;CUL7;PSMD2;CDK1;NEK6;ANGEL2;PSMC2;PKMYT1;ERCC2;PSMB2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.4804267010607281,-1.1757598873146733,0.2698019801980198,0.7208663169528007,1.0,6/13,20.14%,EPS8;EPS8L2;P2RY12;PFN1;PLEKHM1;NLGN1
prerank,protein polyglutamylation (GO:0018095),-0.5056023847021582,-1.1751917904188978,0.275626423690205,0.7207171688500368,1.0,5/11,13.10%,TTLL7;TTLL4;TTLL11;TTLL5;CEP41
prerank,negative regulation of ossification (GO:0030279),0.49894601215914586,1.1750857570790245,0.2714285714285714,0.8783084367221052,1.0,4/23,5.12%,SOX9;PTK2B;SMAD6;TRPM4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4946024614565231,1.1748218267265091,0.2936746987951807,0.8779736224463485,1.0,3/24,2.36%,NT5E;EZR;ITGB1
prerank,dermatan sulfate metabolic process (GO:0030205),0.5421561915193831,1.1745170876862052,0.3188908145580589,0.877782318158659,1.0,2/13,1.76%,UST;DSE
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5645655785115288,1.1734673756082539,0.2967032967032967,0.8801327218900805,1.0,4/11,18.04%,DDIT3;CREB3L3;CEBPB;ATF6
prerank,positive regulation of protein modification process (GO:0031401),0.37449225726627217,1.1726023565141994,0.20588235294117646,0.8818006069942099,1.0,17/203,4.92%,EGFR;BMP4;TRABD2B;SLCO3A1;SOX9;CARD14;NTRK3;EFNA5;RAMP1;CCN1;LIMK2;KRAS;PGF;PRKCD;ABL1;NIBAN1;RAB3GAP2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.46249401137758994,1.17245943521635,0.2659732540861813,0.8811827087597743,1.0,6/31,5.96%,ZFPM2;DSP;ISL1;BMPR1A;TGFBR1;TNNI3
prerank,membrane lipid catabolic process (GO:0046466),0.5749629225361679,1.1721215884393017,0.2934027777777778,0.8811508794588853,1.0,3/10,5.11%,CYP1B1;PDXDC1;NAGA
prerank,adherens junction organization (GO:0034332),0.435377792494622,1.1718357426719324,0.25312934631432543,0.880885884630485,1.0,11/48,11.79%,CDH1;CDH11;NECTIN3;CTNNA1;PVR;VCL;JUP;CTNND1;CDH17;PAK2;CSK
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.44839626340399863,1.1717478046195746,0.2683982683982684,0.8800655672193229,1.0,9/39,12.43%,THBS1;EFNA5;SEMA3E;GCNT2;FZD7;JAG1;DMTN;RHOA;CASK
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4458114650215556,1.1713807689563547,0.26943699731903487,0.8800686912168267,1.0,8/40,7.70%,BMP4;TGFB3;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3695905197037337,1.1707731711775393,0.19629225736095965,0.8808626107745923,1.0,36/199,11.66%,EGFR;BMP4;SOX9;BMP5;NFIB;ARHGDIB;LRPAP1;WNT11;HDAC9;SMAD6;DOCK7;IL10;GSK3B;DDIT3;KLF7;SPRED2;FOXC2;ZNF423;ADAMTS5;ID1;RAB11FIP3;ATP2B4;DUSP10;ABHD6;IL17RD;ASB1;BRCA2;FOXA1;SRSF6;GATA3;NKX2-1;TIFAB;RB1;TLE3;TLR4;NPR3
prerank,regulation of apoptotic process (GO:0042981),0.350962503889757,1.1706369177880762,0.08844221105527639,0.8801992844114755,1.0,71/676,7.31%,SLIT2;EGFR;BMP4;THBS1;FSTL1;SOX9;MAP3K5;GRK5;CARD14;RASSF2;NGF;EGLN3;ARHGAP10;PERP;NDRG1;ANXA1;HOXA5;TGFB3;FOXO3;PTK2B;CD44;CYP1B1;AKAP13;PAWR;TCIM;FBXO10;ITGB1;WNT11;SHC1;TAX1BP1;ANO6;SMAD6;IL10;BIRC7;IP6K2;ANXA4;GSK3B;NOTCH2;ABL1;RIPK3;ARF4;GCLC;TIAM2;GATA1;ARHGEF6;SOCS2;VCP;DDRGK1;BIRC6;GDNF;CALHM2;DIABLO;NFKB1;TRIO;DNAJC3;GOLPH3;SERPINB9;CRADD;ARHGEF5;BCLAF1;RARG;CLU;TFAP2A;ERC1;PLK3;SON;VAV2;JUN;STIL;RIPK2;ATM
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.36502291326346004,1.170355166168744,0.1799163179916318,0.8799448400275843,1.0,70/259,17.20%,NTN1;ABLIM3;PKD1;BBS9;EZR;PARVA;EXOC4;ITGB1;ANO6;RAP1A;FXYD5;GSN;RAPGEF6;EHD3;EMP1;PMP22;ARF4;CFAP70;ARHGEF6;PDE6D;GOLPH3;DZIP1;EXOC5;CEP164;PIP5K1A;ATAT1;SHTN1;VCL;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;RAP2C;ABLIM2;OCRL;MKS1;FGD6;NRP1;SPEF1;SRGAP2;TMEM237;FUZ;TMEM231;DMTN;PCM1;PTPDC1;DISC1;KIF27;ARMC9;IFT122;EHD1;DNAH5;PIBF1;POC1B;CCDC66;GALNT11;ATP6V0D1;EMP2;IFT88;RAB17;DYNC2I2;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;WHAMM;NUDCD3
prerank,tRNA wobble base modification (GO:0002097),0.5365293829541523,1.1701001799636097,0.29037800687285226,0.8796782464812403,1.0,8/14,23.15%,CTU2;MOCS3;MTO1;ELP4;GTPBP3;ALKBH8;KTI12;URM1
prerank,ameboidal-type cell migration (GO:0001667),0.43663300890023576,1.1696485073456575,0.25069637883008355,0.8800560924099442,1.0,8/51,5.17%,CCN3;SEMA3D;SEMA3C;FAT2;GPC3;SEMA3E;PDXDC1;GDNF
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.44132139466437825,-1.169318421787978,0.2544987146529563,0.7363690774870888,1.0,10/18,30.67%,APOE;TMCC2;NSG1;ABCG1;APH1B;PSENEN;ADAM19;APH1A;NCSTN;ACHE
prerank,estrogen metabolic process (GO:0008210),0.5310651018073267,1.1693007050243243,0.29304635761589404,0.8801370235788677,1.0,3/15,10.46%,CYP1B1;SULT1A1;CYP19A1
prerank,protein localization to nucleus (GO:0034504),0.3930879531787321,1.1686022049051927,0.24179829890643986,0.8813287840411173,1.0,26/102,19.24%,BMP4;SIX1;NUP93;LMNA;TOR1AIP1;IPO7;PRICKLE1;CNEP1R1;SEC13;SIX4;E2F3;NUP188;TNPO2;PAF1;XPA;STAT3;MORC3;HEATR3;FAM53A;RAN;PML;WRN;ZBTB7A;PINX1;NUP107;IPO8
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4498997511803126,1.1684562457025132,0.28205128205128205,0.8807322091200633,1.0,11/33,15.61%,THBS1;KLF4;MEOX2;ATP2B4;FGF2;JUP;AGTR2;RHOA;MAP2K5;STARD13;ITGB1BP1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.44004296114571667,-1.1682473290763224,0.26804123711340205,0.7377871154821868,1.0,9/19,28.43%,IGF1;IL18;SPHK1;DAGLA;NUPR1;PTGS2;CD200;TREM2;MMP3
prerank,glucose import (GO:0046323),-0.4740966009067253,-1.1681279598345085,0.28095238095238095,0.7363185143429085,1.0,2/13,1.73%,SLC2A1;SORT1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5468108116219024,1.168106007198495,0.30578512396694213,0.8807662380230867,1.0,5/15,12.58%,VCP;NPLOC4;OS9;UFD1;FAF2
prerank,glycoprotein catabolic process (GO:0006516),-0.4397302551207362,-1.1678346377570128,0.26463104325699743,0.7354402241007393,1.0,3/17,4.27%,ADAMTS12;ADAMTS9;STT3B
prerank,regulation of blood circulation (GO:1903522),0.4569306480443692,1.1678179846160837,0.2818590704647676,0.8805869315917516,1.0,3/34,2.21%,KCNMB2;CAMK2D;AGTR1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5460417631392074,1.1677325169728547,0.31841652323580033,0.8797386925454729,1.0,3/13,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,negative regulation of cell population proliferation (GO:0008285),0.35677985386682626,1.1676134636833155,0.15336134453781514,0.8790786955041514,1.0,69/351,12.88%,ZBTB7C;BMP4;CCN3;SOX9;TES;NGF;BMP5;WNT9A;TGFB3;PTK2B;CYP1B1;ABI1;PTPRU;P3H2;INHBA;KLF4;SMAD6;SMYD2;MYOG;IL10;GDF5;STRN;LMNA;IGFBP5;KANK2;NCK2;HNF4A;RARG;TFAP2A;SSTR3;CNOT7;CELF1;PTPN2;IFI35;KLF10;TGFB1I1;DUSP10;NELL1;BAP1;HES1;TOB1;CYP27B1;MDM4;FUZ;CDKN1B;CGREF1;FABP3;P3H1;E2F3;PER2;FRK;SKI;DIS3L2;GATA3;B4GALT7;NIBAN2;PIM2;NOG;IRF1;GTPBP4;TGFB2;ZBTB49;PEX2;REST;IGFBP6;PTPN14;PLPP1;SLURP1;KAT2B
prerank,cilium assembly (GO:0060271),0.3598754250205003,1.167393334743445,0.16510903426791276,0.8787086715680577,1.0,85/296,20.91%,RP1;ABLIM3;PKD1;BBS9;PARVA;EXOC4;DNAAF3;SFI1;ARL13A;GSN;EHD3;ARF4;CCDC40;CFAP70;PDE6D;DZIP1;EXOC5;CEP164;RPGRIP1;PAFAH1B1;ATAT1;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;OCRL;MKS1;TMEM237;FUZ;TMEM231;PCM1;PTPDC1;DISC1;HAUS5;KIF27;ARMC9;CSNK1E;IFT122;CEP70;RSPH6A;TRIP11;TOGARAM1;CEP63;EHD1;CEP57;DNAH5;PIBF1;POC1B;CCDC66;CEP97;GALNT11;ATP6V0D1;IFT88;RAB17;PRKACA;CFAP46;CSNK1D;GORAB;DYNC2I2;DCTN3;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;NUDCD3;DZIP1L;CNTRL;AKAP9;CDC14A;EHD2;NPHP1;TEKT2;CEP192;HYLS1;DCTN1;TRAF3IP1;EXOC7;EXOC1;ODF2;C2CD3;LZTFL1;RSPH9
prerank,regulation of phosphorylation (GO:0042325),0.38466679423692424,1.1667398115430179,0.22807017543859648,0.8796720742663436,1.0,34/120,21.17%,EGFR;BMP4;THBS1;FN1;INHBA;NUP93;FZD7;EP300;MCM7;NRP1;BCL10;SEC13;CDKN1B;RAD17;NUP188;RANBP2;KDM4D;ILK;CDKN2D;EMP2;PML;LDB2;LDB1;ZBTB7A;AR;NUP107;AAAS;DSCAM;BTBD10;RAE1;NUP54;NUP98;EGF;EIF6
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3703581165003656,1.1665186311532987,0.21882086167800455,0.8792404201215824,1.0,25/170,12.11%,CDH1;FOXP1;PRDM6;ATP1B1;COQ7;IL10;YBX3;ZFP64;AFF3;GDNF;TOB2;TRIM44;TRIM26;TSKU;NELL1;TOB1;MKLN1;CAVIN4;ZNF462;PCBP4;HMG20A;GNB3;ZNF507;MEGF8;REST
prerank,signal peptide processing (GO:0006465),0.5615202149971718,1.1657315575900948,0.30742049469964666,0.8806732424982558,1.0,2/11,11.06%,PCSK5;PARL
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3513332970662667,-1.165494987106249,0.21908127208480566,0.7406011008445774,1.0,10/38,13.28%,IL34;GRM5;ACE;NEDD9;EPHA4;GPRC5B;LRP8;GAS6;APP;AGT
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5040434921490057,1.1650242630761207,0.3125,0.8819011821875103,1.0,2/20,1.84%,MET;MRAP
prerank,regulation of cell population proliferation (GO:0042127),0.3502287804768953,1.1645514838720012,0.09346733668341708,0.8823041421385851,1.0,119/691,12.88%,EGFR;ZBTB7C;BMP4;THBS1;ACER3;SOX9;TES;GRK5;TCF7L2;NGF;PDGFC;EGLN3;BMP5;NTRK3;FN1;WNT9A;SIX1;TGFB3;HDAC4;PTK2B;CYP1B1;ABI1;RBFOX2;PTPRU;AGTR1;P3H2;FGFR1;SHC1;KRAS;INHBA;BMP6;PGF;KLF4;SMAD6;SMYD2;GAREM1;MYOG;IL10;BIRC7;STRN;GCNT2;LMNA;BAMBI;CDC25B;BMPR1A;SGK3;DDRGK1;BIRC6;PDGFA;TRPM4;GDNF;TGFBR1;NR4A3;KANK2;NCK2;HNF4A;TGFBR2;IRS1;RARG;CLU;HILPDA;ITGAV;TFAP2A;CEP131;HCLS1;FGF22;JAG1;SSTR3;CNOT7;CELF1;PTPN2;JUN;CLCF1;IFI35;ECRG4;KLF10;FGF2;GAB2;TGFB1I1;BAP1;MVD;JUP;HES1;WWTR1;ADAM10;TOB1;CYP27B1;MDM4;FUZ;CDKN1B;BCL6;CGREF1;FABP3;SIX4;P3H1;FRK;SKI;NOX1;DIS3L2;GATA3;NIBAN2;PIM2;IRF1;CSNK2A1;BEX4;GTPBP4;NPR3;TGFB2;ZBTB49;RHOA;REST;IGFBP6;STAT3;PTPN14;PLPP1;SLURP1;HTR2B;STAT5A;KAT2B
prerank,endocrine system development (GO:0035270),0.505597854657414,1.1638465048135098,0.29310344827586204,0.8834567427817195,1.0,6/21,10.60%,SIX1;WNT11;STRA6;TGFBR1;FOXE1;NKX2-1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4810833607044471,1.1637373028473343,0.2867981790591806,0.8827134203523029,1.0,8/24,11.12%,CYP1B1;SULF1;ISL1;GATA4;HPSE;NOX1;SULF2;EIF2AK3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5505982843643189,1.163536978054194,0.2982758620689655,0.8822461500186422,1.0,2/12,6.15%,DPYSL3;CTPS2
prerank,regulation of peptidase activity (GO:0052547),-0.43680133586189784,-1.1634433035132006,0.23743016759776536,0.7450191032061163,1.0,4/19,19.64%,CTSH;CST3;RCN3;PSMB8
prerank,positive regulation of protein transport (GO:0051222),0.40786564471271736,1.1634120767267073,0.2704485488126649,0.8815836831485254,1.0,17/67,12.29%,TGFB3;EZR;BMP6;ADAM9;CNST;ACSL3;GOLPH3;ARHGEF5;PLK3;CEP131;EXPH5;SYTL4;UNC13B;PCM1;BCAS3;TGFB2;ADAM8
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.36082937778919055,1.1630257353469653,0.17984832069339113,0.8816947724946813,1.0,60/234,17.62%,SLCO3A1;CARD14;ANXA3;EDA;SMO;HDAC4;ESR2;PLPP3;DDR2;LRP6;IL10;RIPK3;DDIT3;DDRGK1;NFKB1;ARHGEF5;TNFSF11;TAB3;CLU;EP300;ERC1;HCLS1;IL18RAP;TRIM26;MAVS;CHUK;RIPK2;TLR6;KDM1A;JUP;BCL10;SMARCA4;FZD2;TCF3;RAB7B;NFKB2;FOXA1;TRIM25;TAF1;TLR4;IKBKE;MTDH;CD36;ADAM8;STAT3;TRADD;TRAF5;COPS5;RNF31;TRIM41;TAF12;PRDX3;DHX9;MYD88;UBE2N;ROR1;CARD16;ATF2;ZBTB7A;EDA2R
prerank,positive regulation of signal transduction (GO:0009967),0.36132964507637055,1.1627763896532197,0.20770877944325483,0.8813864148853495,1.0,49/238,13.07%,RSPO3;SMOC2;F3;CCN3;NTRK3;SMO;PTK2B;SORBS1;SULF1;GRB10;PTGIS;BMP6;ZBTB7B;C1QTNF12;ITGA5;ERFE;TGFBR1;CD80;CRADD;TNFSF11;IRS1;ITGAV;EP300;TRIM44;JAG1;NRP1;CREBBP;SLC39A14;LIMS2;CYP27B1;SMARCA4;DMTN;SKI;DISC1;SULF2;GATA3;ARMC9;CSNK2A1;DRD3;ASXL2;TGFB2;ZMIZ1;TTC23;KIF7;STAT3;AAK1;ZDHHC5;KAT2B;ITGB3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.539639587431116,1.162608219714405,0.32318104906937395,0.8807835077748807,1.0,2/13,7.72%,CD44;KDM1A
prerank,establishment of skin barrier (GO:0061436),0.5174773043011428,1.1623551966510939,0.285,0.87944538944706,1.0,1/15,0.68%,MET
prerank,regulation of water loss via skin (GO:0033561),0.5174773043011428,1.1623551966510939,0.285,0.87944538944706,1.0,1/15,0.68%,MET
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4433254378848638,-1.1620750555935189,0.2775,0.7472987489504974,1.0,9/15,33.77%,RUVBL1;CCT5;RUVBL2;CCT2;SHQ1;NOP10;DKC1;NHP2;CCT8
prerank,phospholipid dephosphorylation (GO:0046839),0.4554083183083093,1.1620716345728936,0.28888888888888886,0.879277843822561,1.0,9/37,15.59%,PLPPR2;PLPP3;MTMR12;OCRL;PLPP1;INPP5B;MTMR11;SYNJ1;PIP4P2
prerank,cell differentiation in spinal cord (GO:0021515),-0.5164727492276762,-1.161720008029537,0.3002309468822171,0.7464682335174174,1.0,4/10,11.33%,SOX13;SOX6;ZC4H2;MDGA1
prerank,actomyosin structure organization (GO:0031032),0.40702297935288023,1.1614976009677598,0.263681592039801,0.8799265845507753,1.0,17/75,10.68%,PHACTR1;SORBS1;EPB41L5;KRT19;CSRP3;ITGB1;CIT;TMOD3;EPB41L2;CSRP2;ITGB5;FRMD6;CDC42BPG;FHOD3;SIX4;WDR1;EPB41L1
prerank,positive regulation of axonogenesis (GO:0050772),0.4411378660181746,1.1614003085880702,0.26265389876880985,0.8791668936043345,1.0,9/43,11.89%,SLIT2;NTN1;NGF;TIAM2;SHTN1;PLXNA2;ISLR2;ZFYVE27;RHOA
prerank,response to cadmium ion (GO:0046686),0.47018087275269826,1.1610029719389188,0.2852852852852853,0.8793441617022499,1.0,3/26,7.13%,EGFR;CHUK;JUN
prerank,positive regulation of transferase activity (GO:0051347),-0.27707012684689347,-1.1604253307570613,0.12142857142857143,0.7486509769418305,1.0,29/142,9.60%,FLT1;IGF1R;TEK;MERTK;PDGFRB;EPHA7;SERINC5;TIE1;KIT;KDR;EPHB4;ROR2;INSR;EPHB1;EPHA4;IGF2;MAPK3;RPS2;SERINC1;UBE2I;PRKCQ;PDGFRA;EPHA8;ERBB4;FLT4;NTRK2;PTGES3;DBI;HSP90AB1
prerank,neuromuscular process (GO:0050905),0.5349581667951229,1.16031266632815,0.30664395229982966,0.8804339713705327,1.0,10/16,20.89%,STRA6;PAFAH1B1;MYCBP2;TIFAB;SHANK1;AGTPBP1;TPP1;CLN3;DCTN1;UBA5
prerank,dicarboxylic acid transport (GO:0006835),0.48076651649281094,1.159881453570422,0.3004484304932735,0.8807844876498406,1.0,2/28,3.93%,SLC26A7;GIPC1
prerank,activation of protein kinase activity (GO:0032147),-0.2958001197929133,-1.1598219227823428,0.14136125654450263,0.748728820813269,1.0,27/106,9.21%,IGF1;OSBPL8;ADCY5;ADCY1;WNT5A;PRKAR2B;PPIA;PAK1;ADCY7;TNIK;CCDC88A;CARD10;NRK;ADCY2;PRKACB;INSR;RICTOR;PAK5;ADRA2A;MAP4K4;GHR;PRKAR1B;MALT1;GAS6;PRKAR1A;IL18;TLR3
prerank,response to nutrient levels (GO:0031667),0.5116878194731929,1.159401853389088,0.293354943273906,0.8812105642922154,1.0,7/17,21.74%,EIF4G1;FAM107A;KCNB1;MTOR;PRKAA1;ULK1;SCTR
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.40123286490879767,-1.159298960926687,0.24054054054054055,0.74843897579858,1.0,7/22,13.39%,AEBP1;APOE;MAP2;HSPA8;MAPT;EFEMP2;CHRNA7
prerank,protein O-linked glycosylation (GO:0006493),0.3946670255274178,1.1592969811328946,0.23179611650485438,0.8804440700729618,1.0,19/96,14.64%,ST3GAL4;TMTC1;MUC6;B3GNT2;LARGE1;GALNT15;GALNT13;PLOD2;POGLUT3;POMGNT2;B4GAT1;B3GNT6;GXYLT2;GCNT4;DPM1;LARGE2;ST3GAL2;GALNT11;GALNT14
prerank,V(D)J recombination (GO:0033151),0.5530594523514027,1.159257388823686,0.31866197183098594,0.8794790307266007,1.0,6/11,26.80%,DCAF1;TCF3;PRKDC;HMGB2;LIG4;LIG3
prerank,regulation of lipase activity (GO:0060191),0.5380035422977834,1.1592296649440519,0.304270462633452,0.8785040428364896,1.0,3/13,12.64%,PCSK5;RHOA;LMF1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3854711176923563,-1.1592125546300096,0.23303834808259588,0.7468925506914863,1.0,11/27,16.99%,PRKCH;PPARA;ABCA1;CSF1;NR1H3;IL18;ABCA5;AGT;MAPK9;MSR1;ABCG1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.44958825527083596,1.1588771335020178,0.29260935143288086,0.8785996663660415,1.0,5/32,7.08%,SLC4A4;PID1;PFKFB2;VCP;GAPDHS
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4775569747048452,1.1586969390305046,0.3012232415902141,0.8780997110632401,1.0,5/24,4.65%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,positive regulation of protein polymerization (GO:0032273),0.4158185331066061,1.157322502349557,0.26666666666666666,0.8813877615108516,1.0,13/65,13.61%,MET;BAIAP2L1;PTK2B;CDC42EP5;NCK2;FCHSD1;CLIP1;SLAIN2;NCKAP1;TOGARAM1;PRKCE;CTTN;FCHSD2
prerank,cellular response to cadmium ion (GO:0071276),0.4773548827228429,1.1571286730247796,0.2872503840245776,0.8809944195787561,1.0,3/24,7.13%,EGFR;CHUK;JUN
prerank,regulation of protein binding (GO:0043393),0.38357232427302534,1.1571158381053979,0.2485207100591716,0.8799722001932605,1.0,24/114,15.65%,BMP4;TCF7L2;PKD1;HDAC4;LRPAP1;PRKCD;GSK3B;BAMBI;SLPI;RIPK2;IDE;MARK2;KDM1A;USP33;DISC1;MARK3;CSNK1E;TAF1;ADD1;DDX11;LRP1;RAN;ITGB1BP1;PRKACA
prerank,B cell homeostasis (GO:0001782),-0.5049898540607639,-1.1568505023142015,0.32186732186732187,0.7522336791438512,1.0,4/10,6.59%,DOCK10;LYN;DOCK11;MEF2C
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.48729409377815003,1.1567756375949365,0.3132328308207705,0.8789445480344602,1.0,3/20,7.08%,SLC4A4;PFKFB2;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),0.48729409377815003,1.1567756375949365,0.3132328308207705,0.8789445480344602,1.0,3/20,7.08%,SLC4A4;PFKFB2;GAPDHS
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.37619539307942385,-1.1562525643743622,0.24836601307189543,0.7524159742813996,1.0,5/32,7.78%,CDK14;CDK17;TFDP2;BACH1;CDK15
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5683093819178038,1.1557271699249803,0.31956912028725315,0.8811866618120234,1.0,1/11,1.33%,ANXA1
prerank,regulation of interleukin-4 production (GO:0032673),-0.4066778204159339,-1.1556587964576195,0.26582278481012656,0.7523703169032305,1.0,6/21,17.76%,LEF1;SLC7A5;PRKCQ;HAVCR2;SYK;PRKCZ
prerank,peroxisome organization (GO:0007031),0.4847308587648011,1.1555134919233367,0.27980922098569155,0.8808359966660536,1.0,9/25,20.64%,ABCD3;TMEM135;ACOT8;PEX2;PEX12;FIS1;PEX16;LONP2;PEX7
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.48772074369878393,1.1554384149427437,0.2953846153846154,0.8799741548770894,1.0,6/24,7.67%,PPP1R3B;SORBS1;PPP1R3C;GSK3B;IRS1;DYRK2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3789242645143043,1.1553529765715902,0.23321956769055746,0.8792088923161764,1.0,23/140,8.54%,SLIT2;PLCE1;ARHGAP21;ARHGAP10;ARHGAP20;ARHGDIB;ARAP1;AKAP13;RHOJ;ARHGAP44;ARHGAP31;ARAP2;BCR;TIAM2;ARHGEF6;TRIO;ARHGEF5;ITGAV;VAV2;OCRL;SRGAP2;SRGAP3;RHOQ
prerank,lamellipodium assembly (GO:0030032),0.47833674027823503,1.1550271581033082,0.2943786982248521,0.879175331114848,1.0,9/26,9.56%,ABLIM3;ITGB1;ARHGEF6;GOLPH3;VCL;ABLIM2;SPEF1;SRGAP2;DMTN
prerank,homeostasis of number of cells (GO:0048872),0.5448730553931592,1.1549617635769838,0.31123388581952116,0.8783318370204469,1.0,1/12,0.45%,CCN3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5019681211545131,-1.1549103073288158,0.29550827423167847,0.7527756362987663,1.0,2/10,2.30%,ZEB2;RAPGEF2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5124313726808102,1.1548353440263235,0.31518151815181517,0.8776702696893005,1.0,6/18,7.56%,ANXA1;RHOJ;HDAC9;FOXC2;FGF2;MAP3K3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4235800131314757,-1.1544795477987515,0.28717948717948716,0.7523880409699159,1.0,9/18,17.95%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;HPGDS;MIF;CD74;CBR1
prerank,gluconeogenesis (GO:0006094),-0.35451885871196287,-1.1541612666922394,0.2125,0.7515490783367643,1.0,11/39,15.19%,RBP4;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,negative regulation of telomere maintenance (GO:0032205),0.5343857258179568,1.1539647125365893,0.33993399339933994,0.879336850235332,1.0,6/15,18.57%,SMG6;TNKS2;ATM;ERCC1;NBN;PINX1
prerank,protein maturation (GO:0051604),0.3880804717757163,1.153919880612734,0.26570048309178745,0.8784154496179628,1.0,18/95,15.15%,F3;PCSK5;DDI2;NAA40;PHEX;MMP16;MMP14;LIPT2;TASP1;ADAM10;DNAJB11;CCS;NAA35;LMF1;PITRM1;CPE;NFU1;XPNPEP3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4019022359050506,-1.1536708592267593,0.2647887323943662,0.7511960741727511,1.0,4/22,4.40%,APOE;PPARA;ZBTB20;PPARD
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.5016642140087721,-1.1535978460255258,0.3333333333333333,0.7496357970466718,1.0,3/10,4.67%,APOE;ABCA1;PRKACB
prerank,protein-containing complex assembly (GO:0065003),0.3606314790324973,1.1532212150589238,0.2051009564293305,0.8795959032317772,1.0,57/259,16.17%,FBXL7;REPS2;SOX9;TCF7L1;TCF7L2;FN1;PTK2B;ANO6;SEC24B;GSK3B;DMD;STX5;TRRAP;CNIH2;SAMM50;MATN1;EP300;BIN2;MAGI1;CREBBP;HES1;ADAM10;NSF;TEAD1;MDM4;SMARCA4;SEC13;MNAT1;KAT5;TLE4;DMTN;SEC22B;SAR1B;TUBGCP4;PARD3;BCL9L;TLE3;TLE2;SLC9A1;CSNK1A1;TRADD;CAPZA1;SPG7;AMER1;TRAPPC4;MCU;KMT2D;CAPZA2;STOML2;SEC24A;ITGB1BP1;PPP6R3;SHANK1;CSNK1D;DHX9;PML;ANKRD28
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5015617619057645,-1.1530210294883483,0.3047619047619048,0.7496750245675682,1.0,7/10,20.17%,PDE4D;PDE2A;PDE11A;PDE3A;PDE3B;RNF157;APLNR
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3584069845344167,-1.1527387779459208,0.22145328719723184,0.7487250374464685,1.0,9/39,6.87%,TJP1;APOE;RAPGEF2;TIE1;HSPA8;NOTCH1;GFAP;DAB2IP;RAPGEF1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4449193298247627,-1.1520582414246066,0.28835978835978837,0.7491277111052423,1.0,8/16,14.32%,RANBP3L;PLCB1;IGFBP3;RIPOR2;MEF2C;BTG1;AKIRIN1;LRRC8A
prerank,cellular potassium ion homeostasis (GO:0030007),0.5513305831978357,1.1520524258707432,0.31551724137931036,0.8823431547838976,1.0,3/13,1.47%,KCNJ2;SLC12A2;ATP1B1
prerank,negative regulation of catabolic process (GO:0009895),0.42565498650801936,1.151711549651776,0.275177304964539,0.882345784050774,1.0,11/47,18.50%,EGFR;HDAC4;MDM4;SNX12;PRKAA1;BSCL2;FLNA;HMGCR;PFKFB1;AZIN1;ZDHHC7
prerank,cochlea morphogenesis (GO:0090103),0.5680185978893485,1.1511985520921557,0.3316239316239316,0.8829215264626105,1.0,3/10,10.99%,SOX9;MYO3B;TIFAB
prerank,negative regulation of apoptotic process (GO:0043066),0.34777767271687204,1.1510332339244447,0.15682281059063136,0.8823665925717964,1.0,75/444,13.02%,EGFR;BMP4;THBS1;FSTL1;SOX9;GRK5;CARD14;NGF;ARHGAP10;ANXA1;SIX1;TGFB3;PTK2B;CD44;TCIM;ITGB1;WNT11;SHC1;TAX1BP1;ISL1;PRKCD;KLF4;SMAD6;IL10;BIRC7;ANXA4;GSK3B;ITGA5;NOTCH2;ARF4;GCLC;GATA1;NR4A2;SOCS2;DDRGK1;BIRC6;GDNF;NFKB1;DNAJC3;GOLPH3;SERPINB9;TFAP2A;ERC1;PLK3;SON;HCLS1;STIL;CLCF1;RIPK2;NFATC4;GATA4;FATE1;ADAM10;SIX4;UBE2Z;PAK2;NIBAN2;PIM2;NAA35;RB1;CSNK2A2;CSNK2A1;SQSTM1;TAF9;USP47;MTDH;DNAJB6;ADAM8;BIRC3;BNIP3;SFN;APIP;HTR2B;MAPK1;BFAR
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.44222739116428356,1.15078401045113,0.29454022988505746,0.882085691916632,1.0,15/40,20.05%,PTK2B;XPO1;CLU;CCDC22;COMMD1;TAF1;CSNK2A2;CSNK2A1;RAD23B;SMURF1;UFL1;PML;DESI1;NUB1;HFE
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40413375701967263,1.1507610991319877,0.2636363636363636,0.8811244338525476,1.0,11/72,5.58%,MET;ARHGEF28;GPR4;ARHGDIB;AKAP13;CCDC125;COL3A1;LPAR4;BCR;ABL1;KANK2
prerank,fatty acid elongation (GO:0030497),-0.46382891107872004,-1.150702071721917,0.3026634382566586,0.7513589083878447,1.0,3/13,9.35%,ELOVL7;ELOVL6;ELOVL4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.44077982295159307,-1.1505993932488656,0.2621359223300971,0.7498934573559486,1.0,5/16,7.23%,IGF1;IGFBP2;IGFBP3;IGFBP4;BMP2
prerank,positive regulation of cell motility (GO:2000147),0.3624773553211814,1.1501446299621971,0.21420765027322405,0.8819912812726367,1.0,25/205,6.45%,EGFR;F3;THBS1;NTN1;PDGFC;NTRK3;SMO;PTK2B;SEMA3D;SEMA3C;PPP3CA;CCN1;ITGB1;WNT11;SEMA3E;ADAM9;FAM107A;GCNT2;DDRGK1;PDGFA;TGFBR1;SYNE2;TWIST2;MMP14;TRIP6
prerank,mitochondrion transport along microtubule (GO:0047497),-0.46059082733024526,-1.1500381611634884,0.28535353535353536,0.7497916551243213,1.0,5/13,18.56%,HIF1A;MAPT;UBB;SYBU;NEFL
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.49376966701964015,-1.1497896281250901,0.31662870159453305,0.7488412066990706,1.0,4/10,32.19%,SNCA;AOC3;MT3;HP
prerank,cellular response to hormone stimulus (GO:0032870),0.406851208300565,1.1495772952704446,0.25851197982345525,0.8827798103791119,1.0,13/69,12.38%,SLIT3;SLIT2;RAMP1;GATA1;SOCS2;NR4A3;SERPINB9;KLF9;RDX;BCAS3;ATP1A3;ATP1A1;STAT3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5294194904881744,1.149530108149072,0.3254637436762226,0.8818782637034748,1.0,6/15,21.44%,TNRC6C;CNOT7;TOB1;TNRC6A;PABPC1;EIF4ENIF1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.535160018387035,1.1494789586255725,0.3144758735440932,0.8810204471431157,1.0,5/14,18.44%,PKD1;IL10;CCDC22;FAF1;MDFI
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4960097066843997,1.1491354929484607,0.3139717425431711,0.8810531009184515,1.0,6/23,12.58%,VCP;NPLOC4;OS9;SEC13;UFD1;FAF2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.39097049475378814,1.1489048362268857,0.25857843137254904,0.8807250120050537,1.0,25/88,23.72%,FBXL7;FBXW11;FBXO4;FBXL6;FBXL20;FBXO17;CUL4A;PSMC6;FBXL14;FBXL4;FBXW5;PSMD8;PSMB1;FBXL17;PSMD13;FBXL8;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;DMAC2;FBXL3;PSMB2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4452454959507589,1.1483141972465318,0.2818696883852691,0.8815222719934086,1.0,3/38,3.93%,THBS1;BMP5;GSK3B
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.37006277315319774,-1.148226195068823,0.24778761061946902,0.7518118252409126,1.0,11/32,12.04%,MCTP1;RIMS1;RIMS2;MEF2C;SYN1;SYT11;LRRK2;CAMK2A;MCTP2;SLC30A1;CPLX1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5631027733154701,1.1480817100684642,0.3392857142857143,0.8812003189859602,1.0,6/10,28.14%,SMYD2;SETD2;EHMT1;METTL18;KMT5A;SETD4
prerank,transition metal ion homeostasis (GO:0055076),-0.3749844112621117,-1.1480225157624688,0.27627627627627627,0.7507108955767711,1.0,4/28,4.23%,CP;B2M;PICALM;SLC40A1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3067348605539758,-1.1477073718413342,0.1875,0.7499930598302843,1.0,24/85,10.51%,CAMK1D;LYN;APOE;ITGA6;PRKD1;RAPGEF2;WNT5A;PTK7;FUT9;SERPINI1;SETX;ATP1B2;BMP7;ROR2;TENM3;NDNF;DAB2IP;RAPGEF1;MDK;LRP8;RIT2;NTRK2;PLK5;TOX
prerank,stabilization of membrane potential (GO:0030322),0.5187838811868176,1.1476070815945825,0.3140350877192982,0.8816239412108626,1.0,2/16,5.22%,KCNK5;KCNK7
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5048859982859688,1.1474026908483703,0.3327974276527331,0.8812388498561932,1.0,1/20,0.29%,FKBP5
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3314855346627779,-1.1470631382878747,0.24904214559386972,0.7502648641574806,1.0,11/47,6.57%,IGF1R;PHLPP1;TGFBR3;FOXO1;PPIA;RAP2A;EPHB1;FAS;DAB2IP;MAPK3;MAP4K4
prerank,central nervous system myelination (GO:0022010),-0.4832889188078774,-1.146756622211596,0.29411764705882354,0.7494422724168066,1.0,6/11,20.67%,TENM4;PLP1;CNTNAP1;MYRF;B4GALT5;SOX10
prerank,camera-type eye development (GO:0043010),0.48299208942036526,1.1467519984813015,0.29793510324483774,0.8823031040432716,1.0,7/25,10.78%,CYP1B1;STRA6;EFEMP1;CACNA1C;TSKU;SKI;IFT122
prerank,macrophage chemotaxis (GO:0048246),-0.48382020572392226,-1.146618565775092,0.3057471264367816,0.748150337849748,1.0,5/10,34.83%,EDNRB;TAFA4;CCL2;CCL5;CXCL17
prerank,regulation of cellular protein localization (GO:1903827),0.42187715069183135,1.1464497886484282,0.2767475035663338,0.8821879155271759,1.0,16/45,21.13%,GPC6;GPC3;NDEL1;VCP;GPC4;KDM1A;CSNK1E;SETD2;CCDC66;PRKAA1;GBF1;PTPN1;VCPIP1;MAP1A;HFE;EGF
prerank,pyroptosis (GO:0070269),-0.4450968811180189,-1.1464218271017719,0.29411764705882354,0.7469995146689156,1.0,7/15,26.53%,CASP4;AIM2;GSDME;GSDMD;CASP1;TREM2;ZBP1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5680994717020671,1.1463543926010398,0.3420138888888889,0.8804338042680342,1.0,3/10,10.90%,CDC42EP5;WASHC1;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.5680994717020671,1.1463543926010398,0.3420138888888889,0.8804338042680342,1.0,3/10,10.90%,CDC42EP5;WASHC1;CDC42
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.45782492861123136,1.146001324819536,0.3169642857142857,0.880449147299427,1.0,5/30,5.46%,BMP4;MLLT3;INHBA;TNFRSF13B;PRRC2C
prerank,actin cytoskeleton reorganization (GO:0031532),0.41688392876540853,1.1459018849768186,0.270481144343303,0.8797772416583488,1.0,15/63,9.56%,CXADR;PHACTR1;ANXA1;EZR;PARVA;SIPA1L1;GSN;ANTXR1;PIP5K1A;NRP1;CAPN10;MKLN1;CDC42BPG;GAB1;DMTN
prerank,regulation of neuron apoptotic process (GO:0043523),0.3811950477324625,1.1448985100954423,0.2536945812807882,0.8818631127324618,1.0,13/96,7.90%,NGF;EGLN3;SIX1;TGFB3;FOXO3;PTK2B;ISL1;KCNB1;DDIT3;GDNF;TFAP2A;CLCF1;NFATC4
prerank,inositol phosphate biosynthetic process (GO:0032958),0.540161407793732,1.1441935549365676,0.3291592128801431,0.8830397578011935,1.0,4/11,8.07%,IP6K2;FGF2;IP6K3;PPIP5K2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3609276729179258,1.1441234879377755,0.24259055982436883,0.8822456491579072,1.0,38/175,20.76%,TNFRSF11B;CARD14;EDA;FOXO3;PTK2B;TANK;PID1;YBX3;TNFRSF13B;NFE2L2;TNFSF11;CHUK;TNFRSF4;TNFRSF1B;CDIP1;ACOD1;GATA3;HYAL3;TNFRSF14;BIRC3;TRADD;TRAF5;PSMC6;ERBIN;ILK;TNFRSF13C;DHX9;PSMD8;NPNT;EDA2R;ZFP36L1;ADAMTS7;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;CCL15
prerank,regulation of cell cycle phase transition (GO:1901987),0.39139037557462075,1.1436707030455455,0.27238805970149255,0.882621864574707,1.0,24/91,23.72%,FZR1;TCIM;ANAPC5;ATP2B4;ANAPC16;CDC16;CDKN1B;ERCC3;TAF1;PSMC6;XPC;UBE2S;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;CDK1;PSMC2;ERCC2;PSMB2
prerank,amide transport (GO:0042886),0.46914600544104074,1.1435153789264214,0.30074074074074075,0.8820865753290119,1.0,3/26,2.82%,SLC5A6;DISP1;ABCG2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3613241122590488,1.143407413729438,0.24746906636670415,0.8813894601470571,1.0,44/166,18.62%,NR3C2;RARB;ESR2;NR2F1;HDAC9;NOTCH2;POLR1G;NR4A2;NR4A3;HNF4A;RARG;TBL1X;TAF1C;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;MNAT1;E2F3;ERCC3;TAF1;POLR1A;TAF9;CRCP;RXRA;KAT2B;POLR1H;GTF2F2;TAF15;POLR1F;RRN3;TAF12;SNW1;TAF1D;MED27;MED17;RORA;NR4A1;GTF2E1;AR;E2F2;BRF1;POLR2H
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.36690062060122813,1.1432668241011175,0.252262443438914,0.8807800263494892,1.0,35/145,22.13%,FBXL7;FHL1;SFI1;CDC25B;CEP164;PAFAH1B1;CEP131;PCM1;HAUS5;RAD51C;CSNK1E;CEP70;CEP63;USP47;CEP57;PSMC6;PRKACA;CSNK1D;DCTN3;PSMD8;CNTRL;AKAP9;PINX1;PSMB1;CEP192;PSMD13;PSMD1;DCTN1;AURKA;PSMD7;PSMA8;ODF2;PSMD3;PSMD2;CDK1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5122698726621245,1.1432313131706446,0.3489583333333333,0.8798919442893859,1.0,2/15,1.76%,UST;DSE
prerank,defense response to symbiont (GO:0140546),-0.2989987458989126,-1.1429203669808068,0.1945945945945946,0.755222294153296,1.0,21/92,13.66%,SERINC3;SERINC5;BCL2;ABCC9;IRF2;SAMHD1;BST2;IFITM1;BCL2L1;NLRC5;IFIT2;AGBL4;TLR3;IFNAR2;IFITM3;MLKL;OAS2;RTP4;IFIT3;TLR7;CGAS
prerank,regulation of protein autophosphorylation (GO:0031952),-0.35874401497640207,-1.1421963445798766,0.2225705329153605,0.7556753934226542,1.0,7/36,3.48%,ERRFI1;ENG;PDGFD;EPHA7;ENPP1;CALM1;RAP2A
prerank,macrophage differentiation (GO:0030225),0.543607307319615,1.142187278378533,0.3310696095076401,0.882114165210384,1.0,1/13,0.27%,BMP4
prerank,protein localization to membrane (GO:0072657),0.35902533209015697,1.1421402303887298,0.22797356828193832,0.8812497741093395,1.0,23/187,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;RABEP1;FRMPD1;PIP5K1A;GAK;DLG1;ARL3;PRAM1;FGF13;JUP
prerank,dendrite self-avoidance (GO:0070593),-0.4445644185090284,-1.1417883810504805,0.275,0.7551205694743832,1.0,5/16,10.98%,BSG;CNTN4;CNTN2;ROBO4;PALLD
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5671308314676182,1.141730673938909,0.34574468085106386,0.8815025315551785,1.0,6/10,14.54%,CD9;PRKCD;SERPINE2;RDX;C1QTNF1;ADAMTS18
prerank,positive regulation of filopodium assembly (GO:0051491),0.47455422571294575,1.1417005735220924,0.308411214953271,0.880601474934154,1.0,8/24,10.90%,DPYSL3;TGFB3;ARAP1;PALM;NRP1;RHOQ;BCAS3;CDC42
prerank,cellular component assembly (GO:0022607),0.35644727645472585,1.1414393703817436,0.22736842105263158,0.880377216644525,1.0,46/253,13.30%,REPS2;SOX9;DPYSL3;BAIAP2L1;RP1;CALD1;PTK2B;EZR;BSN;PAWR;PARVA;RHOJ;CHAF1B;FAM107A;KRT14;GSN;CCDC40;PDGFA;ESPN;P3H4;MATN1;NCKAP1;MAGI1;CREBBP;HES1;TEAD1;SPEF1;LIMS2;RHOQ;MDM4;MNAT1;SPAG17;DMTN;ZFYVE27;TUBGCP4;PARD3;CDC42;RSPH6A;TOGARAM1;PLS1;RHOA;MYO9A;TLCD2;CAPZA1;SPG7;ADD1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.49132217736733225,1.1412724426052183,0.32436708860759494,0.8798880283202479,1.0,3/21,6.99%,SAMD4A;PAN3;CNOT7
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.40870827784888,1.1406773402084294,0.2909090909090909,0.8807175707568854,1.0,9/62,4.00%,NGF;STK19;MAPRE2;GPR4;AKAP13;SHC1;COL3A1;LPAR4;NOTCH2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.497435927732259,1.1406768532960436,0.3284552845528455,0.8797213070836519,1.0,8/21,21.16%,BMP4;KLF7;CBFB;SFN;SULT2B1;ZFP36L1;SFRP4;MAFG
prerank,apical junction assembly (GO:0043297),0.4157027928981497,1.1406394675409657,0.2787794729542302,0.8788480648956909,1.0,15/53,11.89%,CTNNA1;MPP7;CLDN16;STRN;PDCD6IP;CLDN11;VCL;DLG1;POF1B;WDR1;PATJ;PARD3;PKN2;PAK2;RHOA
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4272428134303656,-1.140638196880018,0.2727272727272727,0.7568894416293905,1.0,3/18,4.19%,ACSL1;ELOVL7;ELOVL6
prerank,negative regulation of GTPase activity (GO:0034260),-0.4063228713410023,-1.1406362033864272,0.29971181556195964,0.755179712108049,1.0,9/22,16.16%,CPEB2;F11R;GPSM1;GMIP;LRCH1;DAB2IP;LRRK2;SH3BP4;RASA4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.33381965143300374,-1.1404819242637778,0.2217573221757322,0.7539455369145517,1.0,16/51,9.42%,LIMCH1;PPM1E;RAPGEF3;CD47;PAK1;CCDC88A;CCN2;EVL;ARHGEF15;SYNPO;RGCC;SYNPO2;FHOD1;LPAR1;PLEK;RAC1
prerank,sodium ion homeostasis (GO:0055078),-0.3969425858647035,-1.1404485661047727,0.2872628726287263,0.7523461413968612,1.0,4/21,3.55%,ATP1A2;ATP1B3;NEDD4L;ATP1B2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3475248545448812,-1.1398313885198017,0.25170068027210885,0.7523730567463592,1.0,17/40,28.48%,IGF1;TNFSF10;PDCD5;BCL2L1;BMF;AKT1;BIK;MLLT11;DNM1L;BAD;PLAUR;GPER1;TRIAP1;GHITM;HRK;PMAIP1;TP53
prerank,positive regulation of synaptic transmission (GO:0050806),-0.31301949123157147,-1.1393586037098187,0.19736842105263158,0.752067637962592,1.0,27/72,25.15%,SHANK3;NRXN1;ADCY1;RIMS1;RIMS2;GRIN2A;SLC24A2;GRIN2B;CACNG4;FLOT1;GRIK2;CACNG7;APP;CHRNA7;ADCY8;CLSTN3;PRKCZ;CLSTN1;NLGN1;NLGN2;SYT1;BAIAP3;HAP1;STX1B;LGMN;CCL2;GPER1
prerank,small GTPase mediated signal transduction (GO:0007264),0.38662926515922147,1.1391973902097976,0.2641277641277641,0.8822712609687048,1.0,17/103,7.51%,PLCE1;NTN1;CCNA2;MRAS;SHC1;NRAS;KRAS;ARHGAP31;BCR;RAPGEF6;TIAM2;SHTN1;SHOC2;ARL3;JUN;RAB18;FGF2
prerank,zymogen activation (GO:0031638),0.43863527446963324,1.1388182929419772,0.2967189728958631,0.8824436960500137,1.0,7/39,11.64%,CYFIP2;PERP;MMP14;RIPK2;TBC1D10A;PRSS12;OMA1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4857492090302943,-1.1385776751000634,0.3310344827586207,0.7526453377579111,1.0,3/11,10.71%,EFNB2;MEF2C;MYOCD
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.4873206852683392,1.138390054408919,0.3338533541341654,0.8827842449776874,1.0,4/22,7.01%,RASSF2;PDGFC;PDGFA;RAP2C
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2899533970068872,-1.1376977431952873,0.19576719576719576,0.7534344524303986,1.0,23/101,11.16%,FLT1;ROBO1;IL34;CEMIP;PDGFRB;PDGFD;RAPGEF2;KIT;WNT5A;TPD52L1;CALM1;SNCA;CCNY;DAB2IP;ADRA2A;RGCC;PIK3R6;CALM3;LRRK2;SRC;EDN1;ETAA1;EDN3
prerank,innate immune response in mucosa (GO:0002227),-0.48249137333524716,-1.137547168801328,0.3119266055045872,0.7521732527076795,1.0,8/10,48.54%,DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4483491308055086,-1.1372465697493506,0.3148614609571788,0.7514384509775561,1.0,6/15,18.00%,RPL5;RPL23;RPS7;LIMK1;RPL11;PARK7
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5036886395826109,1.137090098619114,0.3247863247863248,0.8857197094600425,1.0,2/17,2.63%,PCSK5;HDAC9
prerank,B cell differentiation (GO:0030183),0.4260835854605061,1.1370797973909212,0.30991735537190085,0.8847519917691921,1.0,8/46,9.43%,HDAC4;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3
prerank,negative regulation of synaptic transmission (GO:0050805),-0.39356114243318663,-1.137052060639307,0.2801047120418848,0.7503096826604706,1.0,11/23,34.72%,SLC24A2;SYT11;LRRK2;SLC30A1;GRIK3;MTMR2;CBLN1;ATAD1;ACHE;PLK2;SLC24A1
prerank,sphingolipid catabolic process (GO:0030149),0.5187726821696012,1.1368566129607929,0.3288364249578415,0.8844067788140784,1.0,2/15,3.32%,ACER3;PDXDC1
prerank,monocyte differentiation (GO:0030224),0.5703486220631366,1.1367967944226238,0.3421516754850088,0.8835967594963084,1.0,1/10,0.27%,BMP4
prerank,microglial cell activation (GO:0001774),-0.41170113615926174,-1.1363436459722884,0.25,0.7507220501885534,1.0,10/21,25.29%,SNCA;GRN;MAPT;C1QA;APP;CX3CR1;ITGB2;TYROBP;AIF1;TREM2
prerank,cell-substrate junction assembly (GO:0007044),0.46609082706270505,1.1362205403488654,0.30994152046783624,0.8844071451033481,1.0,9/33,13.08%,FN1;SORBS1;KRT14;BCR;PIP5K1A;TRIP6;ITGB4;PLEC;CTTN
prerank,autophagy of nucleus (GO:0044804),0.510760446295114,1.1360024429810416,0.3233333333333333,0.8841135753356568,1.0,7/16,19.21%,WIPI2;ULK2;ATG3;RB1CC1;ATG2A;ATG7;ULK1
prerank,lipid droplet organization (GO:0034389),0.48319768209093394,1.1356779765239629,0.31789137380191695,0.8841311455569869,1.0,7/22,16.58%,PNPLA3;ZFYVE1;HILPDA;RAB18;CDS1;FAF2;BSCL2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.47999186354231954,1.1350854808900066,0.3094867807153966,0.8849438978607606,1.0,5/22,17.51%,NEDD4;RNF115;UBAP1;TSG101;VPS37A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3500134931951995,-1.134834421396409,0.2607260726072607,0.7533215990276863,1.0,8/36,10.01%,WNT5A;HIF1A;PARP14;CSF1;CASP4;NLRC5;GAS6;EDN1
prerank,oligodendrocyte development (GO:0014003),-0.453581167701653,-1.1347692651775316,0.3213429256594724,0.7518527388144634,1.0,7/15,20.67%,PLP1;CNTNAP1;MYRF;EIF2B5;B4GALT5;TPPP;SOX10
prerank,cellular protein modification process (GO:0006464),0.3383233477590182,1.1346253101663528,0.10510510510510511,0.8853928467151169,1.0,211/983,16.97%,STK39;FBXL7;MSLN;ST3GAL4;BMP4;DCLK1;THBS1;FSTL1;MAP3K5;GRK5;EGLN3;STK19;UST;FN1;ANXA1;PTPN3;PTP4A2;MARK1;PTK2B;ZBTB16;PPP3CA;CCN1;DSP;FBXO40;CAMK2D;PTPRU;FBXO10;LIMK2;WNT11;FGFR1;WNK1;GPC3;WWP2;PRKCD;HIPK1;MKNK2;COL3A1;NEK7;B3GNT2;LARGE1;ASB9;TGM3;ASB16;BCR;SPRR1A;GCNT2;WIPI2;DCAF6;GSK3B;PPM1H;ABL1;KLHL13;CDC25B;RIPK3;PLOD2;BMPR1A;CHST5;SGK3;ARF4;SIK3;IGFBP5;SOCS2;FBXW8;BIRC6;PHKA2;TLK1;DUSP16;MPI;ASB11;TGFBR1;DNAJC3;KLHL22;PRKCSH;BMP15;PHEX;TGFBR2;SIK2;PPEF2;TGM1;ATG3;FBXW11;WDTC1;UBE2F;TNKS2;CHUK;PTPN21;ATM;LOXL1;MARK2;DYRK2;DUSP10;BAP1;IP6K3;KTN1;LRRC41;HIF3A;ADAM10;ASB14;FBXO32;EIF2AK4;UBE2D3;B3GNT6;FBXO4;CDC42BPG;DYRK3;CLK2;CHEK2;PIGU;PTPRF;MACROD2;DAPP1;PRSS23;PTPRA;ASB1;CSNK1G3;P3H1;FRK;PPM1A;CCDC22;DUSP5;FBXL20;MARK3;MTOR;COMMD1;PAK4;CSNK1E;B4GALT7;PKN2;PAK2;GNMT;PIM2;TAF1;EIF2AK3;FBXO17;PPP1R12A;CHEK1;FBXW2;TRIOBP;ACVR1;CSNK2A1;ERCC8;PHPT1;GOLM1;TGFB2;CSK;USP25;IKBKE;NLK;PRKCE;AAK1;PTPN14;CUL4A;CSNK1A1;YES1;COG3;MAPK1;ST3GAL2;PPP5C;SRPK1;MORC3;METAP1D;DUSP11;PPP2R1B;COPS7B;PPP3CC;KLHL11;COPS5;DUSP12;PSMC6;CAMK4;ILK;FBXL14;UFL1;RAB5A;CPE;AMHR2;WSB2;CDK12;STK11;PPP4R1;MBTPS1;FBXL19;FAM20A;AMELX;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;PTPN9;CSNK1D;NPC1;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;PPP4R2;CHM;FBXL4;UBE2S;MAP4K1;FBXW5;PSMD8;PIGH;TAOK3;FEM1B;JMJD4;PPP2CB;COP1
prerank,phospholipid biosynthetic process (GO:0008654),0.4461177921683435,1.1340459560888103,0.31176470588235294,0.886191045307984,1.0,18/36,27.94%,DHDDS;SGMS2;PIP5K1A;MVD;FDPS;GNPAT;CPNE3;AGPAT4;AGPAT5;MBOAT1;CLN3;AGK;FADS1;FAR1;CPNE1;SRD5A3;HDHD5;DOLK
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4289333317201842,1.1337575466767933,0.3111432706222865,0.886032991824975,1.0,9/41,11.71%,BMP4;ISL1;BMPR1A;TNNI3;TGFBR2;JAG1;GATA4;GATA3;TGFB2
prerank,inflammatory response (GO:0006954),0.3569384628964251,1.133751947692478,0.23026315789473684,0.8850598563726771,1.0,31/195,13.86%,THBS1;PTGDR;TRAF3IP2;ANXA1;HDAC4;CD44;AGTR1;HDAC9;MGLL;VNN1;NFKB1;CDO1;CHUK;RIPK2;TLR6;PTGER1;NFATC4;TNFRSF4;PTGER2;AGTR2;CXCR4;NOX1;FPR3;HYAL3;TLR4;ADAM8;STAT3;CMKLR1;CIITA;REL;CEBPB
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3487581239544161,-1.1336025240769736,0.26666666666666666,0.7536679066090077,1.0,12/41,16.62%,ITPR1;GRIN2A;SLC24A2;GRIN2B;SLC8A1;RYR2;HTR2A;CACNA2D1;GRIN1;RYR3;ERO1A;CCL19
prerank,protein polymerization (GO:0051258),0.4183549190451933,1.1334429764654548,0.2891891891891892,0.8850502744939236,1.0,10/55,8.14%,COBL;FAM107A;GSN;DIAPH1;HDGFL3;MAP7D3;MSRB2;RNF135;FGF13;TTC17
prerank,negative regulation of viral life cycle (GO:1903901),-0.44675481716953547,-1.1333274765453065,0.30295566502463056,0.7528184640543624,1.0,5/15,10.24%,LY6E;PPIA;BST2;IFITM1;IFITM3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4623995554330046,1.1328211286105843,0.3068862275449102,0.8859254307289266,1.0,8/26,11.12%,CYP1B1;SULF1;ISL1;GATA4;HPSE;NOX1;SULF2;EIF2AK3
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5666543201841915,1.132802999400196,0.34789915966386553,0.8849962308309041,1.0,4/10,12.11%,EZR;CDC42;RHOA;MYO9A
prerank,hepaticobiliary system development (GO:0061008),0.489831222892747,1.1327062176805027,0.33548387096774196,0.884323557275886,1.0,3/20,5.75%,MET;COBL;PRKCSH
prerank,negative regulation of immune effector process (GO:0002698),-0.45964397119545425,-1.1324745990037273,0.29156626506024097,0.753610694976421,1.0,6/13,10.99%,CD47;GRN;RPS19;ENPP3;CD300A;HAVCR2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5247161389791288,1.1323917923890563,0.3431542461005199,0.8842754670690353,1.0,4/11,16.84%,YBX3;RIPK3;BIRC3;FZD9
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4249329898126528,1.132121197880086,0.30398899587345257,0.8840746901757036,1.0,17/49,21.17%,THBS1;GATA1;TNRC6C;NR4A3;MOV10;EP300;CBFB;RAB7B;KAT2B;KMT2C;KMT2D;PRMT6;ASH2L;TNRC6A;KMT2A;THPO;EIF6
prerank,positive regulation of endocytosis (GO:0045807),-0.3386141648898468,-1.1314242545252686,0.2491349480968858,0.755090839059066,1.0,6/45,4.67%,VTN;APOE;SGIP1;B2M;NEDD4L;SNCA
prerank,regulation of receptor binding (GO:1900120),-0.4866564937361698,-1.131296460346039,0.30288461538461536,0.7538409017056987,1.0,4/10,18.19%,B2M;GREM2;ATP2A2;ADAM15
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4464763287113539,1.1312754231195723,0.3163265306122449,0.885677792368067,1.0,12/35,11.55%,BAIAP2L1;NTRK3;PTK2B;ARHGDIB;SEMA3E;NOTCH2;ABL1;HCLS1;NRP1;BCAS3;CDC42;PHPT1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3962460494095054,-1.1302434442118587,0.2677165354330709,0.7552488367186758,1.0,9/22,16.54%,LYN;MFHAS1;NR1H3;DAB2IP;FLOT1;NINJ1;APPL2;TNFAIP3;TIRAP
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3874369947927846,1.1302370672046653,0.2811004784688995,0.8878255287625081,1.0,24/94,16.35%,MAP3K5;DDX5;CYP1B1;TMEM117;FHIT;PRKCD;ABL1;DDIT3;DIABLO;ATM;TNFRSF1B;CHEK2;MOAP1;QRICH1;IKBKE;BNIP3;CUL4A;SFN;CEBPB;ARL6IP5;STK11;ERN2;PML;PRKDC
prerank,protein import (GO:0017038),0.38857533045184617,1.1299416400512732,0.28136419001218027,0.8876987693054293,1.0,24/84,19.53%,ABCD3;NUP93;PXMP2;IPO7;SAMM50;CLU;PRICKLE1;SEC13;E2F3;SLC25A17;NUP188;TNPO2;PEX2;STAT3;HEATR3;ACBD5;FAM53A;RAN;PEX12;NUP107;HSPA4;IPO8;FIS1;PEX16
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4642398130220935,1.1297645895680843,0.32370820668693007,0.8872546251267395,1.0,7/29,15.85%,THBS1;INHBA;BCL10;AGTR2;PAK2;PPP2R1B;PML
prerank,protein localization to synapse (GO:0035418),0.5315679105349119,1.1295502236354886,0.3274956217162872,0.8869757008823853,1.0,6/12,20.34%,BSN;NPHS1;ZDHHC15;SHANK1;PCLO;DLG4
prerank,diol biosynthetic process (GO:0034312),0.5157075156734872,1.1290548818000352,0.3293918918918919,0.8874831080780811,1.0,1/15,0.61%,ACER3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4716179471856883,-1.1289863416459722,0.3333333333333333,0.7573816325256317,1.0,2/12,2.19%,NKD1;PROM1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3882671829343993,1.1288479193193521,0.29015544041450775,0.887137653710955,1.0,16/78,12.47%,EGFR;SORBS1;MRAP;ITGB1;PID1;MMP14;DLG1;STX8;ATP2B4;PPFIA1;RHOQ;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5
prerank,cilium organization (GO:0044782),0.3586296719377546,1.1288410739284165,0.24262295081967214,0.8861871395212861,1.0,59/209,20.73%,ABLIM3;PKD1;BBS9;PARVA;EXOC4;GSN;EHD3;ARF4;CFAP70;PDE6D;DZIP1;EXOC5;CEP164;ATAT1;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;FAM161B;OCRL;MKS1;TTC17;TMEM237;FUZ;TMEM231;PCM1;PTPDC1;DISC1;KIF27;ARMC9;IFT122;EHD1;DNAH5;PIBF1;POC1B;CCDC66;GALNT11;ATP6V0D1;IFT88;RAB17;DYNC2I2;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;NUDCD3;DZIP1L;CDC14A;EHD2;TEKT2;HYLS1;TRAF3IP1;EXOC7;EXOC1;ODF2;LZTFL1
prerank,epidermis development (GO:0008544),0.41055182069300034,1.1285860045844263,0.31309041835357626,0.8859684494582823,1.0,7/56,5.07%,DSP;GRHL1;KRT14;SPRR1A;KRTDAP;EMP1;CRABP2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3540824991347379,1.1285465256027118,0.2552255225522552,0.8851179650467719,1.0,43/193,19.48%,FBXL7;FZR1;NEDD4;FBXO10;UBE4B;UBE2B;RNF19A;UBR4;RNF185;BIRC6;ANAPC5;NPLOC4;ARIH1;TRIP12;ANAPC16;OS9;CDC16;UFD1;RNF168;USP33;TRIM25;ARIH2;TAF1;SQSTM1;RNF111;BFAR;SMURF1;UBE4A;FBXL14;RNF146;FBXL4;UBE2S;UBE2G1;RNF114;FEM1C;FEM1A;RNF144A;NUB1;RC3H2;LONP1;NTAN1;CHFR;PSMD13
prerank,sympathetic nervous system development (GO:0048485),0.519417108587737,1.1284415697974677,0.35323383084577115,0.8844824549243884,1.0,4/15,16.85%,GDNF;NRP1;GATA3;FZD3
prerank,regulation of viral transcription (GO:0046782),-0.3490019709578627,-1.1284014150732447,0.2755102040816326,0.757518198461838,1.0,15/39,22.66%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27;NELFCD;NELFA;POLR2K;TARBP2;LARP7;POLR2C;POLR2G;TRIM32;SUPT4H1;POLR2L
prerank,regulation of presynapse organization (GO:0099174),0.4990290664227553,1.1282318939515166,0.34035656401944897,0.8831723931941702,1.0,3/18,7.41%,GPC6;EIF4G1;GPC4
prerank,regulation of presynapse assembly (GO:1905606),0.4990290664227553,1.1282318939515166,0.34035656401944897,0.8831723931941702,1.0,3/18,7.41%,GPC6;EIF4G1;GPC4
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3804383098093319,-1.1282259098382077,0.281767955801105,0.7563721262872334,1.0,6/24,8.46%,TEK;KDR;RAMP2;NDNF;GAS6;GATA2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4688701405777351,1.127739310716015,0.335,0.8837967963235426,1.0,2/21,5.09%,GUCY2C;ADCY9
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.39638300174838015,1.1276463560797343,0.3034300791556728,0.883106911856322,1.0,15/60,18.85%,SMOC2;KLF4;NEK7;TNKS2;ATM;FGF2;FBXO4;RFC5;MAPK1;XRCC5;MAPK15;TCP1;POLG2;ACD;PRKD2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.4542352022823989,-1.1275345109697499,0.32098765432098764,0.7568191458485811,1.0,6/14,28.57%,BCL2L1;TMBIM6;LRRK2;PARK7;SELENOS;XBP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3815019007340423,-1.127521928544905,0.2677595628415301,0.7552338832496187,1.0,6/26,5.58%,DNAJC6;SGIP1;PICALM;FNBP1L;INPP5F;PIP5K1C
prerank,modified amino acid transport (GO:0072337),-0.44458831236106644,-1.126803016559485,0.3472906403940887,0.7557603896030943,1.0,2/15,0.33%,SLC6A13;SLC16A12
prerank,actin filament capping (GO:0051693),0.49570792980928824,1.1267980414088437,0.3258426966292135,0.88375740765264,1.0,7/18,14.38%,VILL;ADD3;GSN;TRIOBP;CAPZA1;ADD1;CAPZA2
prerank,barbed-end actin filament capping (GO:0051016),0.49570792980928824,1.1267980414088437,0.3258426966292135,0.88375740765264,1.0,7/18,14.38%,VILL;ADD3;GSN;TRIOBP;CAPZA1;ADD1;CAPZA2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5234708824724398,1.1261054156443884,0.3508137432188065,0.8848444342678599,1.0,5/13,18.86%,DDRGK1;BFAR;UFL1;WFS1;PTPN1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.37219106422276416,-1.1258843920379282,0.2814207650273224,0.7568506958591584,1.0,11/28,18.42%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;LACC1;TAB2;UBB;AAMP;TNFAIP3;RELA
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4859490026143708,-1.1256558029114692,0.31002331002331,0.7558962609037913,1.0,2/10,8.17%,ENPP2;PNPLA8
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4631994190704898,-1.1253486922706195,0.32367149758454106,0.7551874649567618,1.0,9/13,31.54%,IL6ST;OAS2;IL27;STAT1;CANX;OASL;TYK2;CRLF1;IL27RA
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4144811439225407,1.1253110647926692,0.31456043956043955,0.8862108042309792,1.0,14/52,15.77%,EGFR;SORBS1;ITGB1;EPB41L2;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;LRP1;PTPN9;WNK3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.45931416654866786,1.1251122478545728,0.3248,0.8857759511570822,1.0,3/27,3.28%,GPR4;AGTR1;LPAR4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.48099519560053255,-1.124875806281052,0.3170731707317073,0.7549885045209216,1.0,3/10,7.40%,LYN;GHR;STAT5B
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4035607688276171,-1.124763889653905,0.2912371134020619,0.7537172465701604,1.0,11/20,27.76%,PLCB1;CHRM3;CHRM2;CHRNA7;CDK5R1;GRK2;LYPD1;AGRN;LY6H;RGS8;LY6G6D
prerank,negative regulation of cell projection organization (GO:0031345),-0.33491104668076466,-1.1246507371292422,0.24475524475524477,0.7524001000700442,1.0,15/48,16.35%,EFNB2;APOE;RAPGEF2;DCC;EPHA4;GRIN2B;DENND5A;LPAR1;SPOCK1;CRMP1;MAG;CIB1;MINAR1;HDAC2;MYLIP
prerank,regulation of interferon-alpha production (GO:0032647),0.4677094846274793,1.124363377904475,0.32445141065830724,0.8870922480715309,1.0,7/23,15.78%,IL10;MAVS;CHUK;RIPK2;TLR4;SETD2;DHX9
prerank,regulation of leukocyte activation (GO:0002694),-0.4587807088545964,-1.1242615670469296,0.31234866828087166,0.7519053358039491,1.0,3/14,5.24%,LYN;MFHAS1;MYO18A
prerank,vesicle organization (GO:0016050),-0.3401131384362924,-1.1238452524518743,0.2867383512544803,0.7515229743654465,1.0,12/46,18.35%,SORT1;FNBP1L;SRGN;CD34;AKTIP;ALS2;DNAJC13;HOOK1;WASL;EPS15;EXOC8;LAMTOR1
prerank,morphogenesis of an epithelium (GO:0002009),0.4711185822404427,1.1237873525185877,0.32222222222222224,0.8879077511733726,1.0,3/25,6.28%,SOX9;LRP6;VCL
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.36190216737891606,-1.1235991512789492,0.283987915407855,0.7506468749158491,1.0,9/33,16.65%,IGF1;TFRC;BCL2L1;MAPT;TMEM14A;VAT1;IAPP;AKT1;FLCN
prerank,regulation of response to cytokine stimulus (GO:0060759),0.481543610582807,1.1232432205973002,0.32100840336134456,0.8885527692653715,1.0,8/19,18.44%,KLF4;ELF1;MAVS;CBFB;TAF9;MAP2K5;DHX9;IRAK1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5064198050101346,1.1223195087217825,0.324459234608985,0.8903171191017999,1.0,5/16,7.71%,PDGFC;ABL1;PDGFA;NR4A3;NRP1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.48573251684776236,1.1222978022439842,0.326984126984127,0.8894231989123592,1.0,3/21,3.13%,THBS1;PTK2B;MTUS1
prerank,cellular metal ion homeostasis (GO:0006875),0.37275887580757483,1.1220731433848259,0.29488703923900117,0.8891526053065795,1.0,9/102,3.80%,KCNJ2;SLC12A2;SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;CLDN16;STIM2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4079160669305199,-1.1220368657965756,0.3249370277078086,0.7536231543986287,1.0,7/19,20.47%,MAOB;CYBA;PRDX4;CAT;PARK7;PRDX1;ACOX1
prerank,cellular response to misfolded protein (GO:0071218),0.49409037747658163,1.1214755813894473,0.3523809523809524,0.8899091580406654,1.0,5/20,12.68%,RNF185;VCP;UFD1;UGGT2;UBE2W
prerank,extracellular transport (GO:0006858),0.5255504470747318,1.121438474241921,0.34590163934426227,0.8890675887084147,1.0,4/12,13.59%,WWP2;CCDC40;SPAG17;TSG101
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.36011274513687186,1.1212875647889238,0.28738317757009346,0.8885467796493433,1.0,35/138,17.98%,NR3C2;RARB;ESR2;NR2F1;HDAC9;NOTCH2;NR4A2;NR4A3;HNF4A;RARG;TBL1X;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;MNAT1;E2F3;ERCC3;TAF1;TAF9;RXRA;KAT2B;GTF2F2;TAF15;TAF7L;TAF12;SNW1;MED27;MED17;RORA;NR4A1;GTF2E1;AR;E2F2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3921159983683386,1.1212383844859006,0.3005181347150259,0.8877367407413084,1.0,9/75,7.71%,BMP4;F3;AGTR1;FGFR1;NRAS;PGF;TGFBR1;FGF2;NRP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.37574734253643766,1.1211797936923207,0.29890643985419196,0.8869773147669754,1.0,19/95,11.03%,THBS1;CD109;HTRA3;SMAD6;SKIL;GIPC1;BAMBI;SPRED2;TGFBR1;TGFBR2;EP300;TGFB1I1;CREBBP;IL17RD;PPM1A;SKI;NKX2-1;BCL9L;LTBP4
prerank,regulation of gluconeogenesis (GO:0006111),0.4553741444885455,1.1206905319885716,0.33540372670807456,0.887519470550885,1.0,7/27,10.98%,C1QTNF12;ERFE;EP300;PTPN2;USP7;CLK2;GNMT
prerank,vasoconstriction (GO:0042310),0.5454603967760989,1.12044949943928,0.3546617915904936,0.8872724370035845,1.0,1/11,0.48%,EDNRA
prerank,regulation of chromosome segregation (GO:0051983),0.5058277039314314,1.1196717320725813,0.3587140439932318,0.8885884070868482,1.0,8/16,20.49%,IHO1;KIF2C;CSNK2A2;CSNK2A1;PUM2;PUM1;SMC5;RMI2
prerank,macrophage activation (GO:0042116),0.4430524341072338,1.1196579752281703,0.33097595473833097,0.8876852844669456,1.0,4/34,7.28%,FOXP1;LBP;CLU;IFI35
prerank,cell projection organization (GO:0030030),0.45239447951931405,1.1192723988595807,0.312316715542522,0.8878915903478832,1.0,8/30,10.90%,PARVA;RHOJ;ITGB1;GSN;PDGFA;NCKAP1;RHOQ;CDC42
prerank,histone deacetylation (GO:0016575),0.4186188339010388,1.1192021490830273,0.3157894736842105,0.8871627414873949,1.0,9/43,12.66%,HDAC4;HDAC9;RCOR3;TBL1X;HDAC10;PER2;HDAC8;REST;BAZ2A
prerank,protein polyubiquitination (GO:0000209),0.34520913538173625,1.1191504998589055,0.23645833333333333,0.8863782935720367,1.0,77/297,22.27%,FBXL7;FZR1;WWP1;TRAF3IP2;NEDD4;FBXO40;FBXO10;UBE4B;NPEPPS;WWP2;RNF115;UBE2B;RNF19A;FBXW8;ANAPC5;FBXW11;ARIH1;TRIP12;TNKS2;LRSAM1;RNF135;FBXO32;UBE2D3;CDC16;FBXO4;CBFB;RNF168;MKRN1;FBXL20;ARIH2;TAF1;FBXO17;UBR5;FBXW2;ERCC8;UBE2W;BFAR;TRAF5;RNF31;SMURF1;PSMC6;UBE4A;PPIL2;FBXL14;RNF146;FBXL19;HERC6;UBE3D;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;UBE2N;UBE2G1;RNF114;HUWE1;RNF144A;RC3H2;PSMB1;FBXL17;UNKL;CHFR;PSMD13;FBXL8;PSMD1;PSMD7;FBXW9;PSMA8;RNF14;FBXO11;PSMD3;TRAF3;RNF26;PSMD2;UBE2Q2;MIB2
prerank,ERBB2 signaling pathway (GO:0038128),0.44227518415014644,1.1188864449099474,0.34135338345864663,0.8862115875493859,1.0,2/31,2.47%,EGFR;SHC1
prerank,eosinophil chemotaxis (GO:0048245),-0.4432860554360057,-1.118036587982796,0.31890660592255127,0.7620500971093249,1.0,10/14,44.82%,CCL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;SCG2;CCL1;CCL3
prerank,eosinophil migration (GO:0072677),-0.4432860554360057,-1.118036587982796,0.31890660592255127,0.7620500971093249,1.0,10/14,44.82%,CCL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;SCG2;CCL1;CCL3
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.36026169429854765,-1.1180180734246015,0.29194630872483224,0.7605164927789232,1.0,13/35,20.93%,PAM;ACSS3;FAR2;GGT5;ACLY;ACACA;ALOX12;GCDH;BDH1;GGT7;HMGCS2;AWAT2;GGT1
prerank,intracellular sterol transport (GO:0032366),-0.4491843628474473,-1.1179909806369794,0.33253588516746413,0.7590195498728417,1.0,5/13,16.99%,ABCA1;NPC2;OSBP;RELCH;ABCG1
prerank,negative regulation of inflammatory response (GO:0050728),-0.2623999994815353,-1.117980810570375,0.13541666666666666,0.7574463111514892,1.0,47/182,16.70%,IGF1;LYN;TEK;ADCY5;APOE;MFHAS1;PPARA;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PPARD;PRKACB;NR1H3;RAMP2;C1QTNF3;MYH9;GGT5;GRN;PRKAR1B;GPS2;RPS19;MDK;SIRPA;PTH1R;ENPP3;CYSLTR1;PRKAR1A;SRC;TNFRSF1A;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;NR1H4;PLCG1;ADCY3;ADCY8;VIPR2;TNFAIP3;LRFN5;SYK;METRNL;TYRO3
prerank,mesenchyme morphogenesis (GO:0072132),0.4905060798014583,1.1178197568160655,0.3441226575809199,0.8885273888432726,1.0,7/17,11.71%,SOX9;ISL1;BMPR1A;MDM4;NOG;ACVR1;TGFB2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.34590244849434704,-1.1177833703766227,0.26973684210526316,0.7564260121470804,1.0,10/35,11.52%,ITGA1;PDGFRB;CALM1;NUAK1;PPP4R4;CALM3;CD300A;HSP90AB1;TIPRL;HSP90B1
prerank,androgen metabolic process (GO:0008209),-0.410012647911961,-1.11768184827241,0.31839622641509435,0.7551152633186887,1.0,8/18,28.33%,SPP1;HSD17B4;HSD17B7;HSD17B11;HSD17B10;SRD5A1;MED1;SHH
prerank,positive regulation of kinase activity (GO:0033674),0.3705681119599159,1.117564284224901,0.30760095011876487,0.8883071737791521,1.0,10/107,3.35%,EGFR;MET;RASSF2;NTRK3;PTK2B;CCN1;LMO4;FGFR1;DDR2;RAP1A
prerank,early endosome to late endosome transport (GO:0045022),0.4791312614456293,1.1175352337801552,0.36468646864686466,0.887461485387718,1.0,10/20,23.38%,EEA1;ANKRD27;BECN1;STX8;RAB5A;EMP2;HOOK2;RAB7A;RILP;WDR81
prerank,toxin transport (GO:1901998),0.5495488034194358,1.116307764062838,0.3607142857142857,0.8901622539330338,1.0,3/10,8.30%,ANTXR1;ANTXRL;ADAM10
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3836638762892322,-1.1156916218776125,0.31958762886597936,0.7593213161330216,1.0,9/24,15.94%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;TAB2;UBB;AAMP;TNFAIP3
prerank,chromatin organization (GO:0006325),0.3624462793413333,1.115094969075585,0.2830409356725146,0.892831617344427,1.0,38/132,19.60%,SOX9;TCF7L1;HDAC4;BPTF;BAZ2B;HDAC10;KAT2A;TAF6L;SMARCA4;HMG20A;FOXA1;SETD5;HDAC8;RB1;SETD2;BAZ1A;MYSM1;KDM4D;CHD1L;BAZ2A;KAT2B;EHMT1;DDX11;BRWD1;PBRM1;LRWD1;HCFC1;ATRX;TOP1;KDM6B;ZBTB7A;FAM50A;INO80;ARID1A;SMARCD2;RBBP4;HMGN2;PWWP3A
prerank,monocarboxylic acid transport (GO:0015718),0.41411524430658864,1.1147494339687858,0.308,0.8928989095383203,1.0,12/51,12.35%,SLCO3A1;SLC5A6;SLC16A9;SLC16A1;SLCO2A1;ABCG2;ATP8B1;ABCC4;SLC26A6;SLC16A13;CD36;RXRA
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3667262507763464,-1.1146202884117793,0.30340557275541796,0.7607350405075981,1.0,4/30,2.27%,ENG;TGFBR3;NREP;ITGA3
prerank,microtubule bundle formation (GO:0001578),0.42397628046785957,1.1145057377381762,0.3190883190883191,0.8926656333059555,1.0,12/42,19.08%,RP1;GAS2L2;CAPN6;CCDC40;CLIP1;SPEF1;RSPH6A;TOGARAM1;CCDC66;CFAP46;AAAS;CHP1
prerank,negative regulation of protein polymerization (GO:0032272),0.45825771936470777,1.1143204327794527,0.34194528875379937,0.8922459450740186,1.0,2/27,2.77%,SLIT2;PRKCD
prerank,photoreceptor cell development (GO:0042461),0.5158409353807815,1.1142393865105695,0.3670668953687822,0.89155187969118,1.0,2/14,6.52%,RP1;ARL3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.48049165692916956,-1.1139825463526332,0.34,0.7610950119641183,1.0,3/10,4.54%,RAPGEF2;KDR;CD34
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4944026593093232,1.113847615493006,0.3688394276629571,0.8917694393795425,1.0,4/18,11.87%,NUP93;DDX19B;NXF1;THOC2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4868088480104412,1.1137114612335821,0.34833333333333333,0.8912359603662661,1.0,4/18,5.95%,AGTR1;ABL1;GDNF;RFK
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3749712829102189,-1.1135870463189586,0.3149171270718232,0.7606801117018903,1.0,6/25,10.27%,ITPR1;RIT2;PLEK;LRRK2;MAPT;CDH13
prerank,regulation of protein kinase C signaling (GO:0090036),-0.43642158882074555,-1.1131716181144065,0.33414634146341465,0.7603046126259799,1.0,9/14,22.96%,ADGRV1;WNT5A;DGKD;FLT4;MYADM;DGKG;CD40;VEGFA;SPHK2
prerank,cortical cytoskeleton organization (GO:0030865),0.42722777392105316,1.1130946761046876,0.3347050754458162,0.8921563974184353,1.0,10/41,11.89%,FMNL2;EZR;PPP2R3C;DLG1;NCKAP1;RHOQ;FMNL3;FHOD3;RHOBTB1;RHOA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.31223832416445374,-1.1130672402195698,0.2683982683982684,0.7589980716063579,1.0,25/57,22.39%,GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;MEF2C;CACNG4;DAPK1;CAMK2A;CACNG7;APP;LRRC7;DLGAP2;NPTXR;GRIN1;CAMK2B;NETO1;GSG1L;NEFL;NLGN1;LYNX1;SHISA9;NLGN2;SHISA6;MAPK8IP2
prerank,spindle assembly (GO:0051225),0.3964396384553372,1.1129160887704117,0.32591623036649214,0.8917458086230687,1.0,22/67,19.71%,MAPRE2;NEK7;ARHGEF10;CHEK2;HAUS5;MISP;TUBGCP4;TOGARAM1;CEP63;RHOA;TUBGCP5;PIBF1;SMC1A;CSNK1D;FLNA;STAG2;INO80;KIF2A;SPICE1;AAAS;CEP192;TUBGCP6
prerank,Rap protein signal transduction (GO:0032486),-0.47193790660193574,-1.112660398877527,0.3340857787810384,0.7585801252022382,1.0,4/10,6.87%,RAPGEF3;RAPGEF2;RAP2A;RAPGEF1
prerank,regulation of protein transport (GO:0051223),0.4543220963721581,1.1121963147295773,0.3328220858895706,0.8929620236153453,1.0,13/27,24.48%,DISP1;WWP2;NDEL1;ARFIP1;P3H1;GAPVD1;SNX12;PTPN1;CHP1;LLGL1;RHBDF1;DNAJC1;STXBP5L
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3567299300174376,1.11215811002678,0.2876404494382023,0.8921326656553801,1.0,48/173,20.30%,ANK2;CD55;ATL3;SPTAN1;ERGIC1;GOLGB1;SEC24B;ARF4;STX5;ERGIC2;DYNC1I1;TMED5;CNIH2;DCTN6;ATL2;TRAPPC3L;NSF;SEC13;LMAN2L;DYNC1LI2;VAPA;SEC22B;VTI1A;SAR1B;TRIP11;TRAPPC12;COG3;CAPZA1;TRAPPC4;CAPZA2;GOPC;SEC24A;ARCN1;DCTN3;BCAP29;COG5;TICAM2;GBF1;WHAMM;AREG;USO1;COPA;GOLT1A;DCTN1;SEC23A;VAPB;BET1L;TRAPPC6B
prerank,positive regulation of protein binding (GO:0032092),0.40661061274041466,1.1120637720625668,0.3129973474801061,0.8914607249535483,1.0,14/56,14.62%,BMP4;TCF7L2;PKD1;GSK3B;BAMBI;ABL1;RIPK2;IDE;USP33;MARK3;TAF1;ADD1;LRP1;RAN
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4149061947654306,1.1114676673597021,0.33288948069241014,0.8924142275131632,1.0,13/48,16.59%,DOCK5;CUX1;ABL1;FBXW8;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;PRKDC;FLNA
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.34760841354256833,1.1111518814942423,0.294940796555436,0.8924081873997523,1.0,24/214,8.03%,EGFR;BMPER;PDGFC;NTRK3;FN1;TNFAIP8L3;PTK2B;CD44;EZR;CCN1;SHC1;GAREM1;RAP1A;GCNT2;NOTCH2;SPRED2;PDGFA;ARHGEF5;DLG1;PTPN2;FGF2;DUSP10;NRP1;GATA4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3952279505233877,1.1110632796170379,0.3272490221642764,0.8917475561745425,1.0,14/65,10.94%,CD109;HTRA3;SMAD6;SKIL;BAMBI;SPRED2;TGFBR1;TGFBR2;TGFB1I1;IL17RD;PPM1A;SKI;NKX2-1;BCL9L
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2900254481100338,-1.1109763106677426,0.24434389140271492,0.7618434878251273,1.0,33/82,21.45%,EFNB2;LYN;EPHA7;CHN1;PAK1;EPHB4;PTK2;ACTB;EPHB1;EPHA4;GRIN2B;SDCBP;EPHA8;VAV3;MMP2;SRC;RAC1;EFNB3;SDC2;EFNB1;GRIN1;WASL;APH1B;PSENEN;ARPC3;ITSN1;ACTG1;GIT1;RASA1;AP2S1;CDK5R1;DNM1;AP2M1
prerank,transcription by RNA polymerase I (GO:0006360),0.42782996611011836,1.1109692192164997,0.33185840707964603,0.8911093898956869,1.0,12/34,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TTF1;TAF1;POLR1A;POLR1H;POLR1F;RRN3;TAF1D;POLR2H
prerank,bile acid biosynthetic process (GO:0006699),-0.3840183410100481,-1.1109576068352922,0.31024930747922436,0.7603489409787856,1.0,12/24,26.94%,CYP7B1;CYP27A1;OSBP;HSD17B4;OSBPL1A;SCP2;CH25H;HSD17B10;SLC27A2;CYP46A1;OSBPL6;OSBPL7
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5252338394062093,1.1109221047704514,0.3546099290780142,0.8903176634931729,1.0,5/13,12.11%,BMP5;NFKB1;ERLIN1;CYP27B1;REST
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.394556917154556,-1.11084144990075,0.2864721485411141,0.7591648746895753,1.0,6/21,8.89%,LIMCH1;PEAK1;PTK2;GPM6B;MACF1;DUSP3
prerank,sulfur compound biosynthetic process (GO:0044272),0.37421038481026375,1.1103471549369264,0.31072749691738594,0.8910863782830986,1.0,13/104,8.62%,ST3GAL4;SLC26A2;UST;DSE;GLCE;B3GNT2;CHST13;CHST5;GCLC;PAPSS2;CDO1;SLC10A7;B4GAT1
prerank,response to unfolded protein (GO:0006986),-0.32460387941685326,-1.109790465062395,0.25806451612903225,0.7607001020864953,1.0,10/48,14.06%,HSPA8;ERN1;STT3B;DAB2IP;TMBIM6;HSPA9;HSP90AB1;OPTN;DNAJB5;PACRG
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.40837416047007563,1.1094142695762963,0.3254847645429363,0.8929501602868012,1.0,9/48,7.56%,THBS1;ANXA1;RHOJ;FGFR1;HDAC9;FOXC2;P2RX4;FGF2;MAP3K3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.47682710202290823,1.1093677696844184,0.34782608695652173,0.8921631873946005,1.0,7/22,12.29%,PTPN3;ADAM9;IL10;TIMP2;TNFRSF1B;SH3D19;ADAM8
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3825977418682474,-1.109184593555626,0.3342618384401114,0.7609499205618399,1.0,8/24,20.27%,DACH1;RPS3;DFFA;BLM;BMPR2;TERF2IP;ACVRL1;H1-0
prerank,positive regulation of cell development (GO:0010720),0.4396302166934859,1.1089926733129203,0.34332833583208394,0.8923515658259653,1.0,2/31,3.49%,BMP4;MYOG
prerank,positive regulation of type I interferon production (GO:0032481),0.38643012976651386,1.1089367491290583,0.3148831488314883,0.8916160977409378,1.0,24/73,19.95%,POLR3D;NFKB1;EP300;MAVS;CHUK;RIPK2;RNF135;CREBBP;NFKB2;IRF1;TLR4;SETD2;CRCP;POLR3GL;XRCC5;POLR3B;DHX9;PRKDC;MYD88;STAT6;IRAK1;POLR2H;PTPN11;MRE11
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5066260893326731,1.1084369861969265,0.3605220228384992,0.8922130258907122,1.0,5/17,12.58%,VCP;NPLOC4;OS9;UFD1;FAF2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4404699566225744,1.1082618870046888,0.3549848942598187,0.8918149913002928,1.0,7/32,10.01%,THBS1;PHLDB2;SEMA3E;FAM107A;JAG1;DMTN;BCAS3
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3818456179807198,-1.1079245736976875,0.3092485549132948,0.7631956275418192,1.0,9/24,19.61%,TTLL7;TTLL4;TTLL11;TTLL5;PARP1;AGBL4;CEP41;VKORC1;AGBL5
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5069912705433232,1.1077498142475528,0.34782608695652173,0.8924460167348164,1.0,4/14,17.64%,PAICS;RFK;PFAS;GMPS
prerank,negative regulation of cell aging (GO:0090344),-0.4263289013678132,-1.1074543578216114,0.34210526315789475,0.762966027262039,1.0,4/16,9.25%,SLC30A10;AKT3;CDK6;YBX1
prerank,protein modification by small protein conjugation (GO:0032446),0.336651105996122,1.1070628288608355,0.25622406639004147,0.8935956028473953,1.0,99/361,21.69%,FBXL7;WWP1;NEDD4;FBXO10;WWP2;ASB9;BIRC7;NUP93;RNF138;KLHL13;EGR2;UBE2B;NFE2L2;VCP;DDRGK1;FBXW8;BIRC6;TRPM4;ASB11;PIAS3;HERC2;MYCBP2;PIAS2;ATG3;FBXW11;ARIH1;TRIM44;UBE2F;TRIM26;RNF135;TRIM7;ANAPC16;DCUN1D4;USP7;HIF3A;OS9;FBXO32;UBE2D3;BCL10;CDC16;FBXO4;CTR9;RNF168;ASB1;MOCS3;MKRN1;CCDC22;NUP188;UHRF2;COMMD1;UBE2Z;ARIH2;RANBP2;PEX2;PAF1;RNF111;CUL4A;RTF1;UBE2W;NSMCE2;SMURF1;TRIM41;UFL1;SAE1;FBXO25;PRKDC;UBE2S;FBXW5;UBE2N;UBE2G1;HUWE1;RNF144A;GAN;PCNP;NUB1;DTX3;TRIM47;PEX12;NUP107;AAAS;FBXL17;VCPIP1;RNF212B;ATG7;USP9X;CHFR;RAE1;UVSSA;NUP54;KLHL18;PIAS1;UBA5;RNF14;SUMO1;NUP98;FBXO11;CUL7;RNF38;RNF26
prerank,actin filament network formation (GO:0051639),0.5444447518483135,1.1070198365953945,0.3754152823920266,0.8927885903989717,1.0,3/11,11.58%,COBL;FHOD3;PLS1
prerank,hexose biosynthetic process (GO:0019319),-0.33495435229441217,-1.1069630644771642,0.2721311475409836,0.7628345582616451,1.0,11/42,15.19%,RBP4;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.35516329285262627,-1.106608625954745,0.3037542662116041,0.7623136284498319,1.0,11/36,13.43%,SGMS1;PPIA;BCL2;TPD52L1;FAS;DAB2IP;DAPK2;TMBIM6;RPS3;CX3CR1;TRAF7
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4718962042359089,1.1060932281193177,0.35668789808917195,0.8945698951127704,1.0,4/22,7.53%,NGF;NTRK3;RAP1A;KIDINS220
prerank,regulation of defense response to virus by host (GO:0050691),0.44379195552646555,1.1060751021792514,0.3402061855670103,0.8936958930621638,1.0,5/30,8.41%,TRAF3IP2;ZDHHC11;TRIM44;MAVS;EIF2AK4
prerank,negative regulation of neuron projection development (GO:0010977),-0.3132589215998439,-1.1057620969418593,0.2992125984251969,0.7632218798149292,1.0,21/56,21.05%,EFNB2;APOE;DCC;EPHA4;ARHGDIA;DENND5A;LINGO1;LPAR1;SPOCK1;EFNB3;CRMP1;MAG;CIB1;MINAR1;HDAC2;MYLIP;OMG;TRPV4;RTN4;NLGN1;PTPRO
prerank,thyroid hormone generation (GO:0006590),0.544710094083515,1.1050704623985987,0.36493738819320215,0.8957606017511424,1.0,3/10,12.93%,CPQ;FOXE1;DUOX1
prerank,regulation of stress fiber assembly (GO:0051492),0.38641924064002015,1.104237537474063,0.3278061224489796,0.8973807442817114,1.0,19/74,12.17%,TMEFF2;MET;SORBS3;TGFB3;ARAP1;PHLDB2;WNT11;ABL1;RHPN2;TGFBR1;ARHGEF10;ARHGEF5;NRP1;PPFIA1;PAK2;CDC42;ASAP3;RHOA;SLC9A1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.43156626089647604,1.1042140487274585,0.3313521545319465,0.8965511619153177,1.0,10/30,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TTF1;POLR1A;POLR1H;POLR1F;TAF1D;POLR2H
prerank,protein depolymerization (GO:0051261),0.4528279821261208,1.1040794980567683,0.3551263001485884,0.8960715145690696,1.0,2/27,3.65%,MICAL2;GSN
prerank,histone H2A monoubiquitination (GO:0035518),-0.4127260639643658,-1.1039582520225348,0.34005037783375314,0.766764335847698,1.0,6/17,16.28%,PCGF5;KDM2B;BCOR;DDB1;RYBP;DDB2
prerank,inhibitory synapse assembly (GO:1904862),-0.47454363960552465,-1.1037024951377281,0.3756218905472637,0.765955173697922,1.0,4/11,9.37%,WNT5A;GABRA1;GABRA2;GABRB2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.37558957127543036,1.103306926994674,0.31389578163771714,0.8973726695540054,1.0,6/88,2.61%,BMP4;F3;THBS1;SULF1;NRAS;PGF
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34363854975858776,-1.1032392346817055,0.2894736842105263,0.7657362940194645,1.0,6/36,8.89%,MECOM;FOXO1;PPIA;GPS2;SIRPA;DUSP3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.47256216055621597,1.103223802518095,0.35333333333333333,0.896703879819825,1.0,6/20,5.96%,ANK2;ATP1B1;CAMK2D;CACNA1C;DMD;TNNI3
prerank,regulation of neuron projection arborization (GO:0150011),-0.42986503425267636,-1.1030084935778817,0.3381995133819951,0.7648843691330683,1.0,4/15,9.04%,WNT5A;GRIP1;MACF1;MFSD2A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5437522881766165,1.1026926588466717,0.3709677419354839,0.8973301156839654,1.0,2/10,7.65%,FN1;TSKU
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4047584844475609,-1.1024737383926668,0.32545931758530183,0.7649522200458732,1.0,6/19,15.19%,VCAM1;KDR;GRM5;PTGFR;RYR2;ADGRL1
prerank,fatty acid catabolic process (GO:0009062),0.385668048259599,1.1024084772999072,0.3276089828269485,0.8972098093995001,1.0,15/67,13.69%,ABCD3;BDH2;EHHADH;ACADM;AUH;HACL1;ECHDC1;ACOT8;PECR;DECR1;SLC25A17;PEX2;LPIN2;ACBD5;NUDT7
prerank,natural killer cell mediated immunity (GO:0002228),0.49819013692393,1.1023462018831318,0.3547351524879615,0.8964844422147383,1.0,2/15,3.48%,RAET1E;KLRC2
prerank,negative regulation of protein secretion (GO:0050709),0.42635692937311725,1.1022163138961953,0.3484848484848485,0.895970693248708,1.0,7/38,12.79%,CCN3;KCNB1;IRS1;RAB11FIP3;DRD3;REST;INHBB
prerank,DNA dealkylation (GO:0035510),0.5474506321380339,1.1019113794947877,0.40319715808170514,0.8950552860211191,1.0,3/10,12.84%,MPG;FTO;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5474506321380339,1.1019113794947877,0.40319715808170514,0.8950552860211191,1.0,3/10,12.84%,MPG;FTO;ASCC1
prerank,actin filament polymerization (GO:0030041),0.4530460677654031,1.101759881777429,0.3416422287390029,0.8945958883355732,1.0,7/29,10.81%,COBL;FAM107A;GSN;DIAPH1;MSRB2;TTC17;WASHC5
prerank,proteolysis (GO:0006508),0.33990826489179066,1.1013689192471057,0.28281750266808964,0.8948145653300783,1.0,38/252,13.54%,F3;TRABD2B;PCSK5;CAPN5;HTRA3;NPEPPS;BMP1;CPA5;CAPN2;DDI2;CAPN6;CPQ;CPA4;CPA3;HTRA1;PHEX;TMPRSS2;MMP16;MMP14;TBL1X;TASP1;IDE;NLN;CPB1;CAPN10;SPPL2A;ADAM10;ERAP1;FBXL6;LAP3;PARL;XPNPEP1;FBXW2;USP25;PGPEP1;SPG7;PITRM1;NAPSA
prerank,secondary palate development (GO:0062009),-0.43980731359313974,-1.1013179840357934,0.3424657534246575,0.7667743426594562,1.0,5/14,7.14%,LEF1;TGFBR3;CHD7;WNT5A;LRRC32
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4143742215642715,-1.101159673400533,0.3472906403940887,0.7657631040359394,1.0,5/17,17.76%,SLC7A5;PRKCQ;HAVCR2;SYK;PRKCZ
prerank,response to exogenous dsRNA (GO:0043330),-0.41037544753392163,-1.1011425891602546,0.3495702005730659,0.7642870275709895,1.0,5/18,13.66%,RFTN1;FLOT1;TLR3;SLC3A2;CGAS
prerank,long-chain fatty acid import into cell (GO:0044539),-0.47484829905408626,-1.1007402262975134,0.3585746102449889,0.7639427754549137,1.0,2/10,1.27%,ACSL1;SLC2A1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.35881302544829824,1.1000598150318872,0.3162684869169511,0.8977704345244758,1.0,14/138,5.86%,GUCY2C;EGFR;MET;NGF;NTRK3;PTK2B;ABI1;PTPRU;FGFR1;SHC1;DDR2;POLR1G;TRIO;EPHB6
prerank,regulation of epithelial cell migration (GO:0010632),0.4052352929897948,1.0999692458604018,0.34864864864864864,0.8971182184109285,1.0,4/51,2.11%,DOCK5;BMPER;SOX9;RHOJ
prerank,protein localization to chromosome (GO:0034502),0.43501209717594697,1.099719928730917,0.35778443113772457,0.8968907888275771,1.0,12/34,18.57%,TNKS2;WAPL;MRNIP;RB1;RPA1;IFFO1;XRCC5;ATRX;MCM9;ACD;TPP1;PINX1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4696981619593068,1.0996808098051083,0.37285491419656785,0.8960803362850029,1.0,7/19,14.55%,CLIC4;DLG1;MARK2;PATJ;PARD3;DLG2;ERBIN
prerank,"phototransduction, visible light (GO:0007603)",0.5041722554300679,1.099569974477074,0.3611111111111111,0.8955032397065995,1.0,1/14,1.09%,RP1
prerank,positive regulation of transport (GO:0051050),-0.2883413088981758,-1.0994606808556344,0.2849462365591398,0.7660771734104359,1.0,16/85,9.03%,CAMK1D;MERTK;APOE;NEDD4L;CD47;IL15RA;SNCA;ACTB;NR1H3;SGK1;CYBA;SIRPA;GAS6;GATA2;FLOT1;CALR
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.461045038982368,1.0991595509558072,0.34762633996937214,0.8957533442309841,1.0,4/23,7.89%,PTK2B;CYP1B1;IL10;HES1
prerank,respiratory system development (GO:0060541),0.4397740779461149,1.0989345143259077,0.35893648449039883,0.895531250153032,1.0,5/32,7.51%,BMP4;DISP1;STRA6;CCDC40;FGF2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3593946292821258,-1.098788150258989,0.30857142857142855,0.7663900785368093,1.0,15/30,30.55%,DACH1;SRC;CERS1;BMPR2;TENT4B;DCP2;ACVRL1;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;TP53;PIF1
prerank,magnesium ion transport (GO:0015693),0.5244931557255295,1.0986372730998328,0.3838209982788296,0.8954531055808793,1.0,5/12,17.47%,CNNM4;NIPAL2;NIPAL1;NIPA2;MRS2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4762486974881313,1.0983811569952626,0.3611556982343499,0.8952683588322363,1.0,3/20,1.47%,KCNJ2;SLC12A2;ATP1B1
prerank,myoblast fusion (GO:0007520),0.5148458307612487,1.0977090720284972,0.4057724957555178,0.896312000664244,1.0,4/12,12.53%,CD9;ADAM12;ADAMTS5;PTGFRN
prerank,mesoderm development (GO:0007498),-0.4098241355186128,-1.0974562073068002,0.3434065934065934,0.7687155487405609,1.0,11/18,28.72%,TBX3;TIE1;TBX1;BMX;IKZF1;HCK;VEGFA;BTK;GDF11;MEST;TCF15
prerank,protein O-linked mannosylation (GO:0035269),0.49232503821892604,1.0971333482571193,0.36319218241042345,0.8970552323291453,1.0,6/18,12.90%,TMTC1;LARGE1;POMGNT2;B4GAT1;DPM1;LARGE2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.39798098842338875,1.097056186463546,0.35182679296346414,0.8963757659218904,1.0,10/59,9.94%,SOX9;TCF7L2;TNRC6C;MED15;NFKB1;MOV10;BCLAF1;JUN;CBFB;MED14
prerank,positive regulation of developmental process (GO:0051094),0.34990998728245165,1.096990200906151,0.3196448390677026,0.8956844879788004,1.0,17/164,6.02%,BMP4;SOX9;BMP5;COBL;FOXD1;ZBTB16;PHLDB2;FGFR1;ISL1;BMP1;LMNA;DDHD1;BMPR1A;TLE6;TRPM4;GDNF;FOXO6
prerank,prostanoid biosynthetic process (GO:0046457),-0.4216638806326166,-1.0968214991437757,0.3448275862068966,0.7690145297473902,1.0,7/15,17.32%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;MIF;CD74
prerank,negative regulation of type I interferon production (GO:0032480),0.42204948467670356,1.096643704566933,0.3562043795620438,0.8957533523488485,1.0,10/40,13.63%,TAX1BP1;IL10;NPLOC4;MAVS;RNF135;UFD1;ACOD1;TRIM25;IKBKE;REL
prerank,histone H3 acetylation (GO:0043966),0.4198646847815462,1.0965135034500382,0.35131396957123096,0.8952621613228993,1.0,15/40,18.84%,KAT6B;SGF29;TADA3;KAT2A;TAF6L;BRD1;BRCA2;TAF9;KAT2B;TRIM16;TAF12;LDB1;KAT14;YEATS2;TADA1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5208754790430085,1.0964424838940863,0.37823834196891193,0.8945962616110377,1.0,5/13,22.51%,PKD1;GOPC;FLNA;MDFI;SUFU
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5158771665102733,1.0962204853278736,0.37603993344425957,0.8943704580016939,1.0,5/14,12.11%,EZR;PATJ;CDC42;RHOA;MYO9A
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.3251705697663668,-1.095902785410347,0.30344827586206896,0.770142973283444,1.0,11/41,18.18%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;TRIM27;CHRNA7;NR1H4;TNFAIP3;VSIR
prerank,regulation of telomere capping (GO:1904353),0.4696399875812365,1.0956501448728253,0.37111801242236025,0.895078211973505,1.0,8/23,18.02%,NEK7;SMG6;TNKS2;ATM;USP7;MAPK1;MAPK15;NBN
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.38226956478719426,1.0953645474391094,0.3341708542713568,0.8950194872822679,1.0,22/80,19.16%,PLPP3;ERGIC1;ARF4;ERGIC2;RAB6A;ARF3;GOLPH3;KIF1C;KLC1;PITPNB;NSF;SEC22B;KIF2C;COG3;ATP9A;NBAS;ARCN1;GBF1;ATP9B;KIF18A;KIF2A;COPA
prerank,response to lipid (GO:0033993),0.3653328078772487,1.0950223574083808,0.32779097387173395,0.8951469304430164,1.0,21/105,14.68%,FOXP1;SOX9;ANXA1;FOXO3;LBP;SMAD6;SOCS2;SLPI;RARG;SCD;CYP27B1;STRN3;FOXA1;CYP19A1;TLR4;CD36;RXRA;STAT3;TRIM16;ERBIN;CDKN2D
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4036988375259192,1.0948578379408227,0.3459915611814346,0.8947466589649371,1.0,17/48,18.62%,ELOF1;POLR1G;EP300;TAF1C;KAT2A;SF3B1;CHEK1;POLR1A;ZMIZ1;KAT2B;POLR1H;POLR1F;TAF1D;ZMIZ2;ARID1A;ATAD2;POLR2H
prerank,microtubule polymerization (GO:0046785),0.44551730352627855,1.0946661327332177,0.36350148367952523,0.8943993701148218,1.0,10/28,19.71%,HDGFL3;NDEL1;MAP7D3;SLAIN2;FGF13;TUBGCP4;TUBGCP5;CSNK1D;AKAP9;TUBGCP6
prerank,cardiac muscle cell action potential (GO:0086001),0.44478847066916843,1.0945832868535552,0.34379671150971597,0.8937379155133145,1.0,5/30,4.50%,KCNJ2;ANK2;ATP1B1;CACNA1C;DMD
prerank,positive regulation of glucose import (GO:0046326),-0.388196899700553,-1.094556983733285,0.3435897435897436,0.7723968135070061,1.0,5/21,4.91%,IGF1;PIK3R1;OSBPL8;OCLN;INSR
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4563195529949049,-1.0944715978092305,0.3700980392156863,0.7711390431445891,1.0,4/13,8.05%,ENTPD1;ENPP1;ENTPD5;ENPP3
prerank,regulation of monooxygenase activity (GO:0032768),0.4646751642085786,1.0943392589488319,0.35365853658536583,0.8935936508275292,1.0,2/23,5.17%,EGFR;GDNF
prerank,cytoplasmic microtubule organization (GO:0031122),0.40419210845382525,1.0940811109541526,0.33921302578018997,0.8934326576234484,1.0,11/54,12.19%,CLIP4;EZR;LIMK2;CLIP1;DLG1;PLK3;SLAIN2;PCM1;TUBGCP4;RHOA;TUBGCP5
prerank,skeletal muscle tissue development (GO:0007519),0.4337145791368817,1.0940629975286498,0.3613086770981508,0.8926051467623433,1.0,6/32,9.98%,SIX1;CSRP3;MYOG;EGR2;SIX4;SKI
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5007376288671797,1.0937341950937745,0.3946932006633499,0.8926461935348012,1.0,3/16,7.31%,SMG6;TNKS2;ATM
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.39411313391200387,1.0928984911609732,0.3597315436241611,0.8941559055868674,1.0,9/60,9.94%,SOX9;TCF7L2;TNRC6C;MED15;NFKB1;MOV10;HNF1A;CBFB;MED14
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5081467294445943,1.0923399644842287,0.3884007029876977,0.8949120586832505,1.0,7/13,21.17%,XPO1;SDAD1;ABCE1;LSG1;RAN;LTV1;EIF6
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4616911383301368,1.0922656872015428,0.3471337579617834,0.8942426868693447,1.0,5/23,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,regulation of proteolysis (GO:0030162),0.40622697493173743,1.0921712730042645,0.3393854748603352,0.8936671469945399,1.0,8/48,11.21%,CYFIP2;PERP;SERPINE2;FBXW11;TBC1D10A;LTBP4;PARL;IST1
prerank,Golgi to plasma membrane transport (GO:0006893),0.408398016377907,1.0916766997345275,0.34173669467787116,0.8942426605863157,1.0,12/47,11.59%,STXBP6;EXOC4;KIF13A;RABEP1;GOLPH3;EXOC5;ARL3;NSF;OSBPL5;CCDC22;COMMD1;GGA2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.37668356049217744,-1.0909954684229157,0.3072289156626506,0.7795111057222827,1.0,11/25,18.67%,GRIN2A;GRIN2B;MEF2C;GRID2;LRRK2;GLRA1;GRIN1;AKT1;GSK3A;INSYN2A;ARRB2
prerank,regulation of vasculogenesis (GO:2001212),-0.4397239854801906,-1.0907761239690963,0.3399503722084367,0.778575242301559,1.0,6/14,16.87%,RAPGEF2;KDR;CD34;HEY2;HEY1;RIN2
prerank,regulation of microglial cell activation (GO:1903978),-0.4242165551633453,-1.0907590905103504,0.348780487804878,0.7771356225110171,1.0,6/15,25.70%,GRN;SYT11;SPHK1;TTBK1;TREM2;PTPRC
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.46856412201941894,1.0905171540925849,0.3836477987421384,0.896661890428971,1.0,5/18,14.95%,NPLOC4;UFD1;BIRC3;PUM2;PUM1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.40652602138013383,1.0904130640230814,0.3468286099865047,0.8960608761480889,1.0,14/48,16.35%,HIPK1;ABL1;EP300;ATM;DYRK2;TNFRSF1B;CDIP1;CHEK2;MOAP1;IKBKE;SFN;SNW1;PML;PRKDC
prerank,tRNA wobble uridine modification (GO:0002098),0.5046712515491913,1.0902929532784178,0.40747330960854095,0.8955313931403809,1.0,8/14,23.15%,CTU2;MOCS3;MTO1;ELP4;GTPBP3;ALKBH8;KTI12;URM1
prerank,cardiac muscle contraction (GO:0060048),0.42402499602041926,1.0888060572351306,0.34458509142053445,0.898958058522725,1.0,6/34,5.96%,ATP1B1;CAMK2D;CSRP3;GSN;DMD;TNNI3
prerank,regulation of protein export from nucleus (GO:0046825),0.44989416298788065,1.088179861600467,0.3574730354391371,0.8998777292705111,1.0,2/23,3.93%,TCF7L2;GSK3B
prerank,insulin secretion (GO:0030073),0.4800995821937055,1.0879450265613524,0.3502454991816694,0.8996563417394914,1.0,3/19,11.13%,ANXA1;SNX19;SELENOT
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.41349294417896,-1.0879236787105504,0.335632183908046,0.784014200956438,1.0,5/16,15.27%,APOE;HIF1A;SCARB1;NOS1AP;AKT1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4047577679918391,-1.0877491221691717,0.33,0.7830007507256984,1.0,9/18,33.77%,CORO2B;CEP120;CCT5;CCT2;TREM2;CEP135;DKC1;PTP4A3;CCT8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5146225618416012,1.0876959375079858,0.3628472222222222,0.8994669723525477,1.0,4/13,11.08%,DDIT3;GATA1;PER2;TAF1
prerank,regulation of mast cell activation (GO:0033003),-0.47192053649631777,-1.08755918496325,0.37383177570093457,0.7820245735021906,1.0,3/10,12.34%,LYN;NECTIN2;CD84
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4116135791373715,-1.0866873735621612,0.3625,0.7830179368850476,1.0,12/16,44.95%,TNFRSF21;VSIR;JAK3;DLL1;TYROBP;LILRB1;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,negative regulation of transport (GO:0051051),-0.31414562987262257,-1.086653521627344,0.2889733840304182,0.7816260779839993,1.0,9/51,7.47%,PRKD1;MCTP1;DYSF;SNCA;NR1H3;BST2;NDFIP2;SIRPA;SYT11
prerank,motile cilium assembly (GO:0044458),0.5088712144651216,1.086258153710948,0.3787878787878788,0.9027374751656587,1.0,3/12,11.52%,DNAAF3;CCDC40;RSPH6A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.37639958217219516,-1.0858704415204221,0.3575418994413408,0.7823361267696316,1.0,11/26,25.29%,LGR4;GPS2;FLOT1;TLR3;LRRC14;APPL2;TYRO3;SMPDL3B;IRF7;NFKBIL1;TREM2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.47032840226222505,1.0858075268781582,0.36437908496732024,0.9031218410219567,1.0,9/19,22.98%,LBP;PIK3AP1;TLR4;PRKCE;TICAM2;IRAK1;LY96;ITGAM;RAB11FIP2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4423861107413611,1.085754748527539,0.38366718027734975,0.9023981628947706,1.0,5/27,4.65%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.41592471862401253,-1.085685565296668,0.3559322033898305,0.7813704934961352,1.0,7/16,21.66%,CXCL12;TPT1;BCL2L1;RPS3;NACC2;TRIM32;CCAR2
prerank,gastrulation (GO:0007369),0.4874870874685624,1.0856666131597197,0.3613861386138614,0.9017879823957419,1.0,7/15,23.83%,GPC3;NR4A3;MEGF8;LRP5;LMBRD1;SMAD2;TASOR
prerank,fatty acid transport (GO:0015908),-0.4172103975080287,-1.0855949774160871,0.33695652173913043,0.7801476835266464,1.0,6/17,16.03%,ACSL1;APOE;PPARD;MFSD2A;FABP5;SLC27A1
prerank,icosanoid metabolic process (GO:0006690),0.4145789634712993,1.0853993022405233,0.3659942363112392,0.9016731103496134,1.0,6/40,8.51%,CYP1B1;PTGIS;PON3;MGLL;DAGLB;CYP2S1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39619210429842666,-1.085340774049732,0.3189873417721519,0.7793823823307789,1.0,3/18,2.68%,SLC2A1;PRKAG2;OCLN
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.40249180030803705,1.0853359019091595,0.3469656992084433,0.900992182856331,1.0,5/48,4.50%,ANK2;PTK2B;CAMK2D;DIAPH1;DMD
prerank,regulation of type I interferon production (GO:0032479),0.3748759367428222,1.085185732223674,0.33705080545229243,0.9005410181151853,1.0,39/84,27.10%,TAX1BP1;POLR3D;NFKB1;EP300;NPLOC4;MAVS;RNF135;CREBBP;UFD1;NFKB2;ACOD1;TRIM25;IRF1;CRCP;IKBKE;POLR3GL;XRCC5;POLR3B;DHX9;PRKDC;MYD88;STAT6;POLA1;IRAK1;POLR2H;MRE11;TRAF3IP1;OTUD5;TRAF3;RNF26;UBE2L6;PTPN22;IFIH1;POLR3K;IRF3;POLR1C;ILRUN;POLR3G;TBK1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3983058305695292,1.084910094604177,0.3598937583001328,0.900419843180892,1.0,14/52,14.65%,MBNL1;DDX5;RBFOX2;MBNL2;CELF1;SRSF6;RBM25;SRSF12;RBMX;REST;RBM8A;DDX17;HNRNPL;FXR2
prerank,plasma membrane organization (GO:0007009),0.3872665909649669,1.0848519587815497,0.34641407307171856,0.8997088162090041,1.0,11/61,9.97%,AHNAK2;ANK2;ANO6;DMKN;PLSCR1;CAVIN2;A4GALT;BIN2;SYTL4;NSF;CXCR4
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.42446818642982037,1.084056387144737,0.3533834586466165,0.9011773421409409,1.0,13/33,22.28%,DDX5;DDRGK1;EP300;KDM1A;CBFB;CARM1;UFL1;PRMT2;AR;UFSP2;UBA5;RNF14;SAFB2
prerank,"phagocytosis, engulfment (GO:0006911)",0.42975994025422437,1.0838335835690152,0.3855072463768116,0.9009152599931645,1.0,8/36,12.28%,THBS1;GULP1;GSN;BIN2;XKR4;RHOBTB1;CDC42;CD36
prerank,cellular response to growth factor stimulus (GO:0071363),0.345681151896126,1.0836784478841712,0.33295454545454545,0.9005004857527678,1.0,18/151,7.98%,EGFR;BMP4;SMAD9;SOX9;NTRK3;ANXA1;CD44;SHC1;BMP6;KLF4;GAREM1;RAP1A;BMPR1A;TGFBR1;TGFBR2;KIDINS220;NRP1;IQGAP1
prerank,Golgi organization (GO:0007030),0.36021422938425834,1.0835115589620206,0.3511543134872418,0.90013817283063,1.0,38/112,22.13%,ARHGAP21;ATL3;GOLGB1;RAB43;STX5;FBXW8;ATP8B1;TMED5;GOLPH3;GAK;PLK3;NPLOC4;ATL2;LMAN2L;BCAS3;SEC22B;VTI1A;CDC42;TRIP11;RAB30;TRAPPC12;CSNK1A1;COG3;STX16;CSNK1D;TICAM2;GBF1;ARL1;HUWE1;VPS51;PLEKHM2;VCPIP1;SYNE1;LYSMD3;BET1;CUL7;TBC1D20;CDK1
prerank,neuromuscular synaptic transmission (GO:0007274),0.4760648475368905,1.0831340376283842,0.38699186991869916,0.900308301141388,1.0,6/18,16.23%,ERC2;FCHSD1;KIF1B;ERC1;FCHSD2;CHRNB1
prerank,regulation of monocyte differentiation (GO:0045655),0.49958991355619237,1.0828202756542677,0.3875432525951557,0.9003126999820791,1.0,1/14,0.32%,FOXP1
prerank,Notch signaling pathway (GO:0007219),-0.29767711029126415,-1.0822430413630764,0.3347457627118644,0.7868165576878624,1.0,15/59,10.66%,SORBS2;NOTCH3;MAML2;MAML3;DTX4;NOTCH1;PLXND1;NOTCH4;RBPJ;JAG2;BMP2;MDK;HEY2;YBX1;DTX1
prerank,amino acid import (GO:0043090),0.4672030808547709,1.0818793679583336,0.37360890302066774,0.9021104926617852,1.0,3/21,5.72%,SLC47A1;SFXN1;SFXN2
prerank,response to iron ion (GO:0010039),-0.4532191868799375,-1.0817086006376824,0.36879432624113473,0.7867538948313807,1.0,4/12,4.67%,B2M;BCL2;HIF1A;SNCA
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.394153849932547,-1.0815589601222348,0.3763157894736842,0.7856778270353283,1.0,6/20,13.61%,IL1R1;B2M;CD81;MALT1;IL18;TRAF2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4757117881509353,-1.0815345333087307,0.3787878787878788,0.7842673549588485,1.0,4/10,6.83%,NEXMIF;NOTCH1;NOTCH4;RGCC
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.321099225016445,-1.0812327721369603,0.3210332103321033,0.7836468020844469,1.0,11/43,18.18%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;TRIM27;CHRNA7;NR1H4;TNFAIP3;VSIR
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4886458031468461,1.0810711617979327,0.3886178861788618,0.9035950685588461,1.0,5/14,16.96%,PPP3CA;PPTC7;PPP2R2D;PPP5C;PPP2CB
prerank,wound healing (GO:0042060),0.39337713733554547,1.0809569771179037,0.36136662286465177,0.9030617501078411,1.0,16/62,13.07%,AHNAK2;PPP3CA;DSP;COL3A1;FZD7;PDGFA;TGFBR1;FGF2;TSKU;GATA4;SYTL4;HPSE;NOG;TGFB2;PLEC;ITGB3
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.38823892035355667,-1.0809179597079677,0.35014005602240894,0.7830684601025009,1.0,11/22,18.42%,LYN;PICALM;EPHA4;LRRTM3;CASP3;CHRNA7;RANBP9;GSAP;GSK3A;ABCG1;RELA
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.48026608399200665,1.0806457957529108,0.4105960264900662,0.9031274780971751,1.0,5/16,17.88%,MRAP;SLC39A14;ACP3;PRKCA;PDE6H
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3158855401646271,-1.0804047179305711,0.30798479087452474,0.7830713049629796,1.0,8/55,9.17%,IGF1;IGFBP2;VCAM1;TFRC;IL6ST;IGF2;RPS3;IL18
prerank,regulation of B cell proliferation (GO:0030888),-0.3289994072712118,-1.0803884945636486,0.3333333333333333,0.781650965667239,1.0,14/44,17.32%,LYN;BCL2;AHR;TFRC;TNFRSF21;CD81;MEF2C;VAV3;CD300A;CD38;NCKAP1L;TIRAP;MIF;CD74
prerank,base-excision repair (GO:0006284),0.40407129076820325,1.0801965244618559,0.36083916083916084,0.9035213450159636,1.0,22/48,27.90%,MPG;APEX2;SMUG1;MBD4;RPA1;USP47;XPA;RFC5;POLD3;PRMT6;POLB;WRN;HUWE1;TDG;UNG;APEX1;RFC1;ERCC5;XRCC1;LIG3;NTHL1;POLQ
prerank,cellular response to inorganic substance (GO:0071241),-0.3796358838531305,-1.0801333612490975,0.3526170798898072,0.7808470374642124,1.0,6/21,14.84%,FOXO1;GUCY1B1;KCNC2;NSMCE3;BLM;RTF2
prerank,positive regulation of secretion by cell (GO:1903532),0.37649809359943315,1.0801174439096792,0.34404283801874164,0.902868692851758,1.0,12/70,9.35%,SLC12A2;TGFB3;EZR;BMP6;ADAM9;KCNB1;GOLPH3;P2RX4;EXPH5;SYTL4;UNC13B;RAB27B
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4563916703013893,1.0795605822987555,0.3877221324717286,0.903588730527221,1.0,2/22,1.47%,ANK2;ATP1B1
prerank,protein modification by small protein removal (GO:0070646),0.33842883353748915,1.079449763309975,0.3187633262260128,0.9030135341606088,1.0,95/252,26.02%,CCNA2;USP13;ADRB2;FOXK1;USP46;VCP;USP24;TGFBR1;TRRAP;BECN1;EP300;JOSD1;OTUD1;USP2;OTUD7B;USP49;TADA3;KAT2A;BAP1;USP7;MDM4;USP32;USP10;UFD1;USP33;FOXK2;GATA3;ASXL2;USP22;USP34;USP3;USP25;USP21;RHOA;USP47;MYSM1;BIRC3;KAT2B;COPS7B;COPS5;RAD23B;PSMC6;USP4;HCFC1;STAMBP;USP1;PSMD8;POLB;OTUD3;DESI2;DESI1;ACTR8;ZRANB1;YY1;OTUB1;CLSPN;AR;INO80;TNIP1;PSMB1;VCPIP1;SENP3;USP9X;PSMD13;USP48;PSMD1;HGS;PSMD7;OTUD5;STAM2;PSMA8;USP31;USP37;PSMD3;TRAF3;PSMD2;CDK1;SENP8;SENP1;PSMC2;SMAD2;USP36;PSMB2;RHOT1;IFIH1;INO80D;UIMC1;USP28;YOD1;PSMD14;APC;UCHL3;TOMM20;COPS6;MCRS1
prerank,regulation of protein kinase activity (GO:0045859),0.3624366923468446,1.0793812968169936,0.3462940461725395,0.9023574334988677,1.0,17/106,13.21%,PLCE1;RASSF2;PTK2B;CCN1;DDR2;LRP6;RAP1A;RAP2C;SMCR8;IQGAP1;WWTR1;PAK2;MRNIP;RB1;CEP85;SFN;XRCC5
prerank,cellular response to estrogen stimulus (GO:0071391),0.4883223447110171,1.079215774932312,0.398989898989899,0.9019791704428683,1.0,4/14,17.97%,SERPINB9;BCAS3;NCOA4;AR
prerank,platelet degranulation (GO:0002576),0.3598116357244013,1.0790689435742813,0.34522439585730724,0.9015188205109418,1.0,20/118,12.28%,PCDH7;THBS1;FN1;CD109;TGFB3;LHFPL2;CD9;PDGFA;CLU;VCL;ABCC4;FAM3C;SYTL4;GTPBP2;RAB27B;WDR1;ISLR;SERPING1;TGFB2;CD36
prerank,regulation of protein dephosphorylation (GO:0035304),-0.33174461180952214,-1.079053728421998,0.34098360655737703,0.7823762374354095,1.0,14/37,23.49%,MFHAS1;PPIA;CALM1;PPP1R16B;CALM3;PPP2R5A;TIPRL;HSP90B1;ENSA;PPP1R7;CDCA2;HTT;SMPD1;PIN1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3503834698944857,1.0789060658473797,0.3395565927654609,0.9011324473945664,1.0,23/133,15.85%,SLC35G1;SLC24A3;ANK2;ATP1B1;CAMK2D;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;MCUB;MICU1;DRD3;HTR2B;TRPC5;MCU;RMDN3;STOML2;SLC8B1;PRKACA;TRPC7;PML
prerank,positive regulation of B cell proliferation (GO:0030890),-0.36384910108335644,-1.078887786082089,0.3125,0.7814356587396001,1.0,10/29,17.32%,BCL2;TFRC;CD81;MEF2C;VAV3;CD38;NCKAP1L;TIRAP;MIF;CD74
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34273066876895364,-1.0787592882803945,0.3157894736842105,0.7803444018239085,1.0,7/32,3.72%,IL1RAPL1;NEDD4L;RAPGEF2;HECW2;RAP2A;TNIK;OBSL1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.37025060145219435,-1.0785881842217013,0.33692722371967654,0.7794307520965585,1.0,7/25,13.61%,B2M;KIT;WNT5A;SLC7A5;MALT1;LACC1;TRAF2
prerank,dopamine metabolic process (GO:0042417),-0.40215512773271056,-1.0784978807968169,0.3673469387755102,0.7782275714835999,1.0,5/18,8.37%,MOXD1;MAOA;MAOB;SNCA;COMT
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.36837334977221226,1.0784836736753112,0.3492462311557789,0.9014608341874613,1.0,5/80,2.79%,THBS1;MAP3K5;NGF;CD44;KLF4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.41303744038775525,-1.0780203076400785,0.3404761904761905,0.7780949045661384,1.0,7/16,10.01%,IGF1;TGFBR3;NOTCH1;RBPJ;MEF2C;ERBB4;EDN1
prerank,catecholamine metabolic process (GO:0006584),0.504021410684098,1.0776875301250486,0.39723661485319517,0.902760223327544,1.0,1/14,1.15%,SNCAIP
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3018659923618107,-1.0774079385637845,0.311787072243346,0.7783043805359134,1.0,26/57,28.48%,DCN;KDR;TNFSF10;PPARGC1A;PDCD5;BMF;CHCHD10;BOK;HIP1R;SPIRE1;GSK3A;PARK7;RALA;BIK;CAMKK2;MLLT11;DNM1L;HTT;BAD;PLAUR;GPER1;TREM2;HRK;BAK1;PMAIP1;TP53
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3695176093914654,1.0771058763911505,0.35128205128205126,0.9035689302508491,1.0,16/80,11.62%,PLCE1;DPYSL3;TGFB3;ARAP1;CDC42EP5;PALM;NDEL1;NRP1;NCKAP1;RHOQ;FUZ;ENTR1;BCAS3;WASHC1;CDC42;BRK1
prerank,negative regulation of anoikis (GO:2000811),-0.43037133394646165,-1.0770529036249987,0.34536082474226804,0.777852348106906,1.0,5/14,9.09%,TLE1;BCL2;PTK2;NOTCH1;SRC
prerank,regulation of chromatin organization (GO:1902275),0.5016844852013645,1.076725097837769,0.398989898989899,0.9037350157302033,1.0,4/14,12.51%,MLLT3;TLK1;SETD5;METTL4
prerank,regulation of cell cycle process (GO:0010564),0.36592298741126233,1.0760288694156168,0.3556085918854415,0.9048620071511442,1.0,17/104,12.16%,SOX9;KIF13A;KLHL13;BIRC6;BECN1;PLK3;RAB11FIP3;IHO1;TXLNG;ENTR1;ZFYVE26;CDC42;CHEK1;CSNK2A2;CSNK2A1;SETD2;CEP85
prerank,positive regulation of cell differentiation (GO:0045597),0.33789029549633837,1.0754667634782342,0.3408119658119658,0.9055937613945179,1.0,29/237,5.37%,BMP4;CDON;BOC;SOX9;NGF;HOXA5;TGFB3;ZBTB16;VWC2;CCN1;AGTR1;CTNNA1;FGFR1;BMP6;ISL1;DDR2;RAP1A;GDF6;MYOG;GDF5;GCNT2;BAMBI;MEF2A;ABL1;BMPR1A;TRPM4;GDNF;TGFBR1;NFKB1
prerank,positive regulation of actin nucleation (GO:0051127),0.5179856846529686,1.075397472869294,0.3902877697841727,0.904915601148666,1.0,6/11,18.12%,GSN;NCKAP1;BRK1;FCHSD2;WHAMM;CYFIP1
prerank,organic hydroxy compound transport (GO:0015850),-0.33837181204587485,-1.0751973359405997,0.321656050955414,0.7816676178512472,1.0,9/36,14.43%,SLCO2B1;NCOA1;SLCO1C1;RBP4;NPC2;OSBP;SLC5A3;STARD5;NR1H4
prerank,positive regulation of proteolysis (GO:0045862),0.393502236465476,1.0742541867516568,0.3782312925170068,0.9073300080870392,1.0,10/55,12.29%,CYFIP2;PERP;TANK;ADAM9;FBXW11;TNFRSF1B;TBC1D10A;IST1;SH3D19;ADAM8
prerank,neuron fate commitment (GO:0048663),0.480773069944468,1.0738105230822124,0.38422818791946306,0.9077178361582446,1.0,2/14,5.26%,ISL1;TGFBR1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.41184576537363493,-1.073741745668871,0.37,0.7843876426633557,1.0,4/15,3.55%,ATP1A2;ATP1B3;NEDD4L;ATP1B2
prerank,superoxide metabolic process (GO:0006801),0.4357243970879976,1.073668192332133,0.3851963746223565,0.9072520892695021,1.0,1/29,0.16%,SH3PXD2A
prerank,regulation of cation transmembrane transport (GO:1904062),-0.35573792486575406,-1.0731944335781474,0.3768996960486322,0.7844798629559371,1.0,7/29,8.92%,CACNA1D;KCNIP4;FGF12;KCNIP3;KCNAB1;KCNIP1;CD63
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.27857208395754157,-1.0731087698104673,0.2916666666666667,0.7833110491457628,1.0,17/90,9.98%,LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;GNAS;PRDM16;ELOVL6;EBF2;PPARGC1A;GJA1;MFN2;ACADL;IL18;LPIN1;IL4R
prerank,protein deubiquitination (GO:0016579),0.33803773253733505,1.0729681174969767,0.3483386923901393,0.9083485119053459,1.0,90/242,25.76%,CCNA2;USP13;ADRB2;FOXK1;USP46;VCP;USP24;TGFBR1;TRRAP;BECN1;EP300;JOSD1;OTUD1;USP2;OTUD7B;USP49;TADA3;KAT2A;BAP1;USP7;MDM4;USP32;USP10;UFD1;USP33;FOXK2;GATA3;ASXL2;USP22;USP34;USP3;USP25;USP21;RHOA;USP47;MYSM1;BIRC3;KAT2B;COPS5;RAD23B;PSMC6;USP4;HCFC1;STAMBP;USP1;PSMD8;POLB;OTUD3;DESI2;ACTR8;ZRANB1;YY1;OTUB1;CLSPN;AR;INO80;TNIP1;PSMB1;VCPIP1;USP9X;PSMD13;USP48;PSMD1;MINDY2;HGS;PSMD7;OTUD5;STAM2;PSMA8;USP31;USP37;PSMD3;TRAF3;PSMD2;CDK1;SENP8;PSMC2;SMAD2;USP36;PSMB2;RHOT1;IFIH1;INO80D;UIMC1;USP28;YOD1;PSMD14;APC;UCHL3;TOMM20
prerank,negative regulation of neurogenesis (GO:0050768),-0.3420783456593564,-1.0727762221966815,0.32386363636363635,0.7828452139644888,1.0,12/34,23.81%,B2M;RAPGEF2;NOTCH1;ARHGDIA;LINGO1;EFNB3;MAG;APPL2;OMG;RTN4;PTN;RTN4R
prerank,negative regulation of cytokine production (GO:0001818),0.34147391244057257,1.0724078908996721,0.3637400228050171,0.9090234393111277,1.0,27/163,12.79%,THBS1;FN1;ANXA1;EZR;TAX1BP1;INHBA;HDAC9;KLF4;IL10;ANXA4;PDCD4;DDIT3;NPLOC4;OTUD7B;MAVS;TLR6;RNF135;UFD1;KAT5;ASB1;ACOD1;TRIM25;TLR4;IKBKE;CMKLR1;PIBF1;INHBB
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5085389320433855,1.0723089791068787,0.4099485420240137,0.9084456507934934,1.0,2/12,5.52%,ISL1;CD80
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3466976682626021,-1.0723010356475844,0.3606060606060606,0.7827886507114573,1.0,4/32,2.82%,APOE;PPARA;PRKAG2;ZBTB20
prerank,long-chain fatty acid transport (GO:0015909),-0.3475295364620586,-1.0720635566823222,0.36036036036036034,0.7820133113333504,1.0,10/30,13.42%,ACSL1;APOE;PRKAG2;CPT1A;ACACA;ACACB;MFSD2A;PRKAA2;FABP5;RPS6KB1
prerank,protein sumoylation (GO:0016925),0.39444669899987256,1.071920039656083,0.3558368495077356,0.908676832884935,1.0,17/49,21.10%,NUP93;EGR2;TRPM4;PIAS3;PIAS2;NUP188;RANBP2;NSMCE2;SAE1;NUP107;AAAS;RNF212B;RAE1;NUP54;PIAS1;SUMO1;NUP98
prerank,positive regulation of cell growth (GO:0030307),0.3610189627260244,1.0717080296504407,0.3601953601953602,0.9084248183945789,1.0,15/96,12.09%,EGFR;NTN1;NGF;EIF4G1;TGFBR1;KLHL22;SHTN1;MMP14;ADAM10;ISLR2;ZFYVE27;CDC42;CSNK2A1;TGFB2;USP47
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.37374327484482744,1.071624175548218,0.37869062901155326,0.9078293041484661,1.0,19/72,16.52%,PLAGL1;NDRG1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;USP10;CHEK2;CDKN1B;PCBP4;KAT5;RBL2;SFN;FOXM1;CARM1;PML;ATRX
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.44292902577167664,-1.0716225160036543,0.37122969837587005,0.7818306782306917,1.0,4/12,8.48%,GJD3;CALM1;PDE4D;CALM3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3549342332019372,1.0712649749248246,0.3516355140186916,0.9080604143594335,1.0,16/107,11.12%,THBS1;MAP3K5;TMEM117;GSK3B;DDIT3;NIBAN1;RNF185;VCP;DDRGK1;ERP27;JUN;CREB3L3;OS9;AGR2;QRICH1;EIF2AK3
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.39487120070442083,-1.0712511473513049,0.351010101010101,0.7815316384833848,1.0,4/17,10.04%,CLDN5;F11R;S1PR3;TNFRSF1A
prerank,negative regulation of phosphatase activity (GO:0010923),0.45221353662001457,1.0709684074253947,0.40425531914893614,0.9080565333622356,1.0,11/25,22.44%,CRY2;GSK3B;BOD1L1;PPP1R36;TGFB2;STYXL1;CHP1;FKBP1B;URI1;MASTL;PPP1R1B
prerank,diterpenoid metabolic process (GO:0016101),0.3928867431177735,1.07069852656898,0.36712328767123287,0.9079307632956676,1.0,8/55,7.50%,GPC6;ADH7;GPC3;STRA6;RBP1;RLBP1;GPC4;PECR
prerank,regulation of telomere maintenance (GO:0032204),0.4398337761990494,1.0705428972382136,0.37519142419601836,0.9075201221594827,1.0,10/26,19.95%,SMG6;SMG1;USP7;ERCC1;HDAC8;XRCC5;PML;ATRX;NBN;MRE11
prerank,cellular response to arsenic-containing substance (GO:0071243),0.48142428146049754,1.069748041293429,0.3790322580645161,0.9088692722861911,1.0,2/15,4.82%,MKNK2;VCP
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.45397195966222537,1.0697315338180986,0.39461883408071746,0.9080627543295651,1.0,4/23,3.96%,ANK2;PTK2B;CAMK2D;DIAPH1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.459966659796618,-1.0694188680433543,0.3888888888888889,0.785156197791825,1.0,2/10,1.82%,ST3GAL1;ST6GAL1
prerank,protein localization to vacuole (GO:0072665),-0.42816802645924634,-1.0691430831022195,0.3864734299516908,0.7845580190298059,1.0,5/13,20.12%,CD81;MFSD1;GLMP;SH3BP4;RTN4
prerank,regulation of kinase activity (GO:0043549),0.3643175954818377,1.0690377893346685,0.3645200486026732,0.9092149684613424,1.0,7/89,2.74%,EGFR;PLCE1;MET;NTRK3;LMO4;FGFR1;DDR2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.35214811552912617,1.068718451346497,0.35160905840286055,0.9092608312991455,1.0,28/112,14.78%,SMAD9;SOX9;TGFB3;ITGB1;SMAD6;COL3A1;ADAM9;GDF5;GCNT2;BAMBI;BMPR1A;LTBP2;TGFBR1;TGFBR2;ID1;JUN;ITGB5;SKI;PARD3;ACVR1;TGFB2;RHOA;ZMIZ1;NLK;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,engulfment of apoptotic cell (GO:0043652),0.495165987567757,1.0684546586370758,0.39267015706806285,0.9091506204067202,1.0,3/15,10.66%,THBS1;XKR4;RHOBTB1
prerank,positive regulation of lipid localization (GO:1905954),0.5190798208185027,1.0684519658744394,0.404553415061296,0.9083195955731275,1.0,4/11,13.93%,NFKB1;HILPDA;IKBKE;LRP1
prerank,amino acid import across plasma membrane (GO:0089718),0.4555001347858398,1.0683324149647935,0.40186915887850466,0.9078390246530041,1.0,2/24,3.15%,SLC47A1;SLC7A2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4645784453499706,1.0682237800031158,0.3817891373801917,0.9072909316955922,1.0,6/18,17.08%,EZR;NELL1;RDX;RGP1;AMER1;FAF1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4544925988063768,-1.0681564223045152,0.38636363636363635,0.7860595689205859,1.0,5/12,15.27%,PPARA;FUT9;MDK;ASS1;AKT1
prerank,protein autophosphorylation (GO:0046777),0.34006129200493124,1.068138611379768,0.35795454545454547,0.9067073350931861,1.0,28/157,11.12%,STK39;EGFR;GRK5;PTK2B;CAMK2D;FGFR1;DDR2;MKNK2;GSK3B;ABL1;RIPK3;ULK2;SIK2;STK16;ATM;MAP3K3;MARK2;SMG1;EIF2AK4;CLK2;CHEK2;CAD;MARK3;MTOR;PAK2;PIM2;TAF1;EIF2AK3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.44191781299075783,-1.0680463291617894,0.4039408866995074,0.7849605811183292,1.0,4/11,30.28%,BLM;DONSON;FBH1;GMNN
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.36895223644151665,1.0679544449517593,0.38125,0.9063493010880445,1.0,7/80,6.17%,THBS1;SAMD4A;SLC2A13;PRKCD;NIBAN1;LARP4B;CLU
prerank,sphingolipid metabolic process (GO:0006665),-0.2693646534895445,-1.0678619479748677,0.26618705035971224,0.7840923738434535,1.0,21/108,9.35%,ST6GALNAC3;CERS4;PRKD1;ENPP2;SGMS1;ACER2;ELOVL7;UGCG;CERK;ELOVL6;DEGS2;SPTSSA;SMPD3;GM2A;SERINC1;CERT1;CTSA;GAL3ST1;SPNS2;SPHK1;ELOVL4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3560596037809655,-1.0678549259358785,0.34662576687116564,0.7827104463247191,1.0,14/29,37.83%,NR1H3;PNPLA8;DBI;TMEM86B;PLA2G4E;MBOAT7;PLA2G4C;LPCAT3;PLA2G5;PLBD1;LPCAT2;PLB1;NR1H2;PLA2G3
prerank,nucleoside salvage (GO:0043174),0.5185222940815257,1.0675321534803228,0.39649122807017545,0.9066638381957551,1.0,3/10,7.43%,UPP2;TK2;TK1
prerank,axon guidance (GO:0007411),0.3359404867511131,1.0674967996227591,0.34951456310679613,0.9059311734776856,1.0,31/201,9.97%,SLIT3;SLIT2;NTN1;SMO;NFIB;ALCAM;EFNA5;SEMA3D;EZR;SEMA3C;SPTAN1;GRB10;UNC5C;PDLIM7;SHC1;SEMA3E;NTN5;NOTCH2;KLF7;GDNF;EPHB6;PLXNA2;GAB2;NRP1;NTN3;TMEFF1;GAB1;PTPRA;USP33;EMB;CXCR4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.5271899911132378,1.0671029046092708,0.3932384341637011,0.9061727589933208,1.0,1/11,2.21%,AGTR1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3697372348591514,1.0669520531743166,0.3778054862842893,0.9057764542077713,1.0,20/76,19.08%,CYP1B1;PTGIS;TAX1BP1;KLF4;IL10;ANXA4;DDIT3;CHUK;USP7;CCDC22;ACOD1;COMMD1;CMKLR1;MAP2K5;ERBIN;UFL1;PRMT2;FAF1;IRAK1;CHP1
prerank,cellular iron ion homeostasis (GO:0006879),-0.30632278443317756,-1.0669089979297715,0.326007326007326,0.7839888913224693,1.0,13/55,16.33%,CP;FTH1;TFRC;SLC40A1;FTL;ATP6AP1;CAND1;SLC22A17;ATP6V1A;SLC11A2;BOLA2;NUBP1;GLRX3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3744044471443174,1.0668688734060654,0.36910994764397903,0.9051788293189797,1.0,5/76,3.28%,PLCE1;GPR4;ADRA1B;AGTR1;LPAR4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.31359616366737236,-1.0656422392747813,0.34099616858237547,0.7861773488532715,1.0,11/46,7.50%,ALDH1A1;NOVA1;LGR4;NOVA2;NOTCH1;PLCL1;NR1H3;MAP2K6;ACVR2B;RBPJ;PLCL2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4650421779742532,1.0654121700170787,0.38996763754045305,0.9083125419322212,1.0,5/20,7.71%,SLIT2;BMPR1A;IGFBP5;PDGFA;NRP1
prerank,regulation of actin nucleation (GO:0051125),0.5215282905221632,1.0653281336338964,0.40418118466898956,0.9077146207996865,1.0,4/12,17.14%,GSN;ARFIP1;WASHC5;WHAMM
prerank,histone mRNA metabolic process (GO:0008334),-0.35195778558609186,-1.0651157563066749,0.3652173913043478,0.7863756770609872,1.0,9/27,18.89%,LSM1;SNRPB;UPF1;SNRPF;TENT4B;SLBP;LSM10;DCP2;SNRPG
prerank,positive regulation of cell adhesion (GO:0045785),0.3670276331142808,1.0646574481944822,0.3647959183673469,0.9086823754926086,1.0,18/74,17.84%,VIT;ZFHX3;PPP3CA;ADAM9;FOXC2;ITGAV;ATM;MAGI1;AGR2;TGFB2;ADAM8;RSU1;CHRD;TFE3;PRKCA;CITED2;NPNT;TPM1
prerank,anion transmembrane transport (GO:0098656),0.3791218334538383,1.0645327015105275,0.38451612903225807,0.9082336382792213,1.0,7/67,5.72%,SLC23A1;SLC23A2;SLC5A6;LRRC8D;SLC7A2;SFXN1;SFXN2
prerank,N-terminal protein amino acid modification (GO:0031365),0.48929054021506263,1.0634272062905088,0.4095394736842105,0.9104309304597271,1.0,4/14,19.65%,NAA40;NAA35;METAP1D;METAP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.41313533703516353,1.0630357156953112,0.3997050147492625,0.9106546196585138,1.0,5/39,4.43%,THBS1;ANO6;IL10;PDCD4;NFE2L2
prerank,regulation of axon guidance (GO:1902667),0.5159405560452555,1.0627771206817118,0.4080267558528428,0.910595728964322,1.0,3/10,13.58%,MYCBP2;NRP1;TUBB2B
prerank,Golgi ribbon formation (GO:0090161),0.5015760220408705,1.0626439537098953,0.4214162348877375,0.9101302464274167,1.0,5/13,13.81%,TMED5;GOLPH3;VTI1A;TRIP11;STX16
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.42197141586308046,1.0622179806597538,0.4116766467065868,0.9104514876964687,1.0,6/35,7.71%,MET;SEMA3D;SEMA3C;SEMA3E;PLXNA2;NRP1
prerank,hippo signaling (GO:0035329),-0.3560815758961333,-1.0621820806076756,0.4,0.7933284058890266,1.0,12/26,30.08%,TJP1;TEAD2;AMOTL1;CASP3;STK3;TEAD4;YAP1;TJP2;TEAD3;YWHAB;DCHS1;LATS2
prerank,negative regulation of protein metabolic process (GO:0051248),0.3977821814242866,1.0620751276904672,0.390625,0.9099768318257453,1.0,11/48,17.79%,EGFR;NFKB1;CLU;ITGAV;MDM4;SNX12;INHBB;ITGB3;FLNA;HMGCR;AZIN1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.27060009895454357,-1.0620319169219563,0.3333333333333333,0.7923072636867935,1.0,28/117,16.35%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;CD81;PRKAR1B;PTH1R;CYSLTR1;PRKAR1A;SRC;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;SYK
prerank,striated muscle contraction (GO:0006941),-0.3053041090990998,-1.0618738539736152,0.32510288065843623,0.7912965767908047,1.0,12/53,16.64%,ATP1A2;DTNA;STAC;KCNQ1;ALDOA;SLC8A1;RYR2;RCSD1;MYH14;ARHGEF11;CASQ2;NOS1
prerank,establishment of spindle orientation (GO:0051294),0.42609788636643303,1.0616744415701507,0.3823088455772114,0.9102266509647866,1.0,5/28,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.37714468074966917,1.0616434545481124,0.38193548387096776,0.9094822944099117,1.0,19/69,18.88%,UBE4B;RNF185;VCP;NPLOC4;ANKZF1;ERLIN1;OS9;UFD1;TRIM25;EDEM2;FBXO17;UBXN4;FAF2;ECPAS;PSMC6;UBE4A;TMUB1;WFS1;SEL1L2
prerank,protein phosphorylation (GO:0006468),0.31958353690752117,1.0608458152426243,0.3319672131147541,0.9108500708870727,1.0,107/479,16.56%,STK39;EGFR;BMP4;DCLK1;MAP3K5;GRK5;STK19;PKD1;MARK1;PTK2B;ABI1;CCNA2;CAMK2D;LIMK2;WNT11;FGFR1;WNK1;CIT;DDR2;PRKCD;HIPK1;EFEMP1;MKNK2;NEK7;GDF6;BCR;GSK3B;ABL1;CDC25B;RIPK3;BMPR1A;SGK3;ULK2;SIK3;BIRC6;TLK1;TGFBR1;TGFBR2;SIK2;STK16;ERC1;CHUK;ATM;MAP3K3;MARK2;DYRK2;SMG1;IP6K3;ADAM10;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;CSNK1G3;FRK;CAD;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A2;CSNK2A1;TLR4;TGFB2;CSK;IKBKE;NLK;PRKCE;AAK1;CSNK1A1;MAPK1;SRPK1;MORC3;CAB39;VRK3;CAMK4;ILK;RIOK2;AMHR2;HTATIP2;CDK12;STK11;PPP4R1;FAM20A;MAPK15;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;CSNK1D;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;MAP4K1;TOP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4081463723769848,1.06069620570734,0.3948087431693989,0.9104484767966833,1.0,9/41,10.12%,CD44;PTPRU;PLPP3;IL10;GCNT2;TNFSF11;DENND6A;MAGI1;FOXA1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4277374407066677,-1.0604326438032299,0.3904761904761905,0.7926293983758456,1.0,4/13,10.34%,PLCB1;IL15RA;STAT5B;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4277374407066677,-1.0604326438032299,0.3904761904761905,0.7926293983758456,1.0,4/13,10.34%,PLCB1;IL15RA;STAT5B;GRB2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.43027013015179105,1.0601864592967947,0.38198757763975155,0.9110395568375297,1.0,5/27,7.07%,GRB10;PRKCD;PID1;IRS1;PTPN2
prerank,heart contraction (GO:0060047),0.40256743276725737,1.060015656037613,0.3800277392510402,0.9106917398637036,1.0,5/41,5.96%,SGCD;ATP1B1;CSRP3;DMD;TNNI3
prerank,regulation of cellular localization (GO:0060341),-0.31996442395366653,-1.0599931006270547,0.3333333333333333,0.7924553342421604,1.0,13/46,15.66%,LYN;ADCY5;PARD6G;MAP2;PARP1;LRRK2;HSP90AB1;BRSK2;FES;STXBP4;TRIM46;NR1H4;PPM1F
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.3969137810323037,-1.0599447826408908,0.3784530386740331,0.7911729973786136,1.0,6/19,15.66%,TEK;KDR;MAP4K4;RAC1;MYOC;PPM1F
prerank,positive regulation of type 2 immune response (GO:0002830),-0.42118535879582897,-1.0597465684356813,0.39086294416243655,0.7903664142792245,1.0,4/14,17.76%,CD81;IL18;CD74;PRKCZ
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.40250956475137223,1.0596109887156226,0.38686131386861317,0.9109624831320702,1.0,11/36,20.83%,FHIT;F8A1;GIPC1;DDRGK1;USP7;USP25;TAF9;TLK2;MAP1A;HFE;N4BP1
prerank,regulation of inclusion body assembly (GO:0090083),0.5033849728472682,1.0595453579511984,0.3936731107205624,0.9103231619434539,1.0,1/11,1.15%,SNCAIP
prerank,acetyl-CoA metabolic process (GO:0006084),-0.4036714711489216,-1.0594824784462507,0.3950617283950617,0.7897149535051078,1.0,8/15,25.42%,ACLY;ACACA;ACACB;ACSS1;HMGCS2;PPCS;MVK;DIP2A
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4660922563832135,1.0594519640473148,0.4112627986348123,0.9097600351025432,1.0,6/17,20.30%,DHDDS;MVD;ALG13;ALG14;ALG9;ALG3
prerank,regulation of ERAD pathway (GO:1904292),0.5227284436033417,1.059368343970881,0.4117647058823529,0.9091823772811669,1.0,3/11,11.86%,USP13;RNF185;USP25
prerank,regulation of neuron death (GO:1901214),-0.2786259925543892,-1.058876238330689,0.3218884120171674,0.7900624176541283,1.0,22/82,13.61%,EFNB2;PICALM;WNT5A;DCC;CSF1;TRIM2;CD34;SNCA;EPHB1;CTSZ;GRIN2B;PPARGC1A;MEF2C;GRID2;LRRK2;MAPT;EGR1;C1QA;UBB;FAIM2;CHRNA7;TRAF2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3873093143064406,1.0579815787161302,0.38492063492063494,0.9121045374679407,1.0,24/58,26.80%,HERC2;ATM;KAT5;RNF168;ERCC1;ERCC8;IFFO1;XRCC5;NSMCE2;PRKDC;POLB;UBE2N;KDM2A;ZBTB7A;POLA1;NBN;SMC5;MRE11;SUMO1;HMGB2;UIMC1;PSMD14;LIG4;LIG3
prerank,icosanoid secretion (GO:0032309),0.5026439796214554,1.0579373829357075,0.43079584775086505,0.9114199390069175,1.0,3/12,11.48%,ANXA1;ABCC4;DRD3
prerank,positive regulation of vascular permeability (GO:0043117),-0.4395502755625226,-1.057704777028251,0.3738532110091743,0.7919195797497396,1.0,4/12,12.07%,TJP1;OCLN;PDE2A;PDE3A
prerank,regulation of protein sumoylation (GO:0033233),0.4638045355908147,1.0577003790461592,0.3913764510779436,0.9112563406833145,1.0,4/17,15.57%,HDAC4;PIAS3;ZMIZ1;SAE1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.42719951382587573,1.0576873370221258,0.3964757709251101,0.9104735121072499,1.0,3/30,3.02%,KCNJ2;ANK2;CACNA1C
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5017847668184596,1.0575141899637226,0.41450777202072536,0.910120812118087,1.0,6/12,21.11%,UPP2;TK2;TK1;CAD;UCK2;UMPS
prerank,regulation of Notch signaling pathway (GO:0008593),0.3643761672903963,1.0574177261210922,0.39766839378238344,0.9095704864494747,1.0,19/76,15.67%,EGFR;CCN3;TCIM;WWP2;EP300;MMP14;JAG1;CREBBP;CD46;NIBAN2;TGFB2;ZMIZ1;STAT3;AAK1;KAT2B;GALNT11;YJEFN3;ITGB1BP1;SNW1
prerank,negative regulation of cell development (GO:0010721),-0.3603479543133747,-1.0572274197134437,0.36813186813186816,0.7917973887688412,1.0,3/25,3.99%,IGF1;B2M;NOTCH1
prerank,carboxylic acid catabolic process (GO:0046395),0.4943908171545337,1.0569336218106744,0.41333333333333333,0.9100433434033498,1.0,3/12,16.48%,PON3;ACOT8;GNPDA2
prerank,hyaluronan catabolic process (GO:0030214),0.4717375481014864,1.0566416946304797,0.41080196399345337,0.9100414791070421,1.0,9/18,21.05%,CD44;HEXA;FGF2;SPAM1;HYAL3;SLC9A1;CEMIP2;CHP1;TGFB1
prerank,cellular glucose homeostasis (GO:0001678),-0.32353220640453567,-1.056328565567782,0.3829787234042553,0.7929880300131193,1.0,13/41,16.11%,IGF1R;PIK3R1;FOXO1;ZBTB20;HIF1A;ERN1;PPARGC1A;GAS6;PRKAA2;HK2;LRRC8A;ADCY8;HK1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.460856411959427,1.056286131380357,0.4006677796327212,0.9101729471751242,1.0,5/18,11.71%,ITGB8;FN1;ITGAV;CD46;TGFB2
prerank,cellular response to retinoic acid (GO:0071300),0.4029724759775538,1.0561666293892624,0.4034582132564842,0.9096671280041322,1.0,5/42,4.04%,SOX9;WNT9A;PTK2B;WNT11;FZD7
prerank,zinc ion transmembrane transport (GO:0071577),-0.36337969400505327,-1.056042186583592,0.3972222222222222,0.7924349679554601,1.0,7/22,14.69%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4773576547898424,1.0559678887368076,0.41379310344827586,0.909451932850686,1.0,5/17,10.75%,EIF4G1;SPRED2;PPEF2;DMTN;PARD3
prerank,membrane assembly (GO:0071709),-0.33824183897055676,-1.055552453030944,0.38153846153846155,0.7924699309258483,1.0,7/34,8.81%,NRXN1;PICALM;IL1RAPL1;UGCG;RFTN1;ANK3;FLOT1
prerank,prostaglandin metabolic process (GO:0006693),-0.3596478590851593,-1.0551050510992945,0.36904761904761907,0.7923793956369216,1.0,10/26,21.55%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;HPGDS;MIF;CD74;ACOX1;PTGS2
prerank,hyaluronan metabolic process (GO:0030212),0.44444162118393543,1.0544909101079822,0.40923566878980894,0.9127251789315112,1.0,11/23,22.22%,CD44;HEXA;FGF2;ABCC5;SPAM1;HYAL3;SLC9A1;CEMIP2;CHP1;TGFB1;HAS1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.33332216094608463,1.0542849285857712,0.37816979051819183,0.9124742083910292,1.0,30/182,12.77%,BMP4;FOXP1;SLC24A3;ITGB8;SMO;LRPAP1;WWP2;KLF4;NOTCH2;ZNF148;BMPR1A;TNRC6C;DDRGK1;NFKB1;MOV10;CNOT7;CELF1;ATP2B4;FGF2;SMCR8;ADAM10;ATOH8;CD46;TAF1;RB1;RBL2;TGFB2;REST;SNX12;RBMS3
prerank,cyclooxygenase pathway (GO:0019371),-0.45594354139730797,-1.0536587579950738,0.4039301310043668,0.7950944424436961,1.0,6/10,21.55%,PTGDS;PTGS1;PTGES3;HPGDS;CBR1;PTGS2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4326940348203977,1.053492334840553,0.4141732283464567,0.9137930502254621,1.0,4/27,5.02%,PDGFC;FN1;DDR2;PDGFA
prerank,protein modification process (GO:0036211),0.3686361738052432,1.0534062831391005,0.39203084832904883,0.9132167957850285,1.0,23/76,16.72%,WWP2;TGM3;ABL1;RIPK3;PLOD2;PHKA2;PHEX;TGM1;ATG3;BAP1;UBE2D3;CSNK1G3;B4GALT7;GNMT;FBXW2;USP25;YES1;DUSP12;CPE;PRKDC;PPP4R2;UBE2S;PIGH
prerank,negative regulation of protein depolymerization (GO:1901880),-0.35740079681100007,-1.0531259082829885,0.37637362637362637,0.7952812369343533,1.0,11/24,29.56%,PLEKHH2;NAV3;CLASP2;ATXN7;CIB1;ARHGEF2;TPX2;CAMSAP2;STMN2;CAMSAP1;TAOK1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44605893997987495,1.0531154527194098,0.415748031496063,0.9132004135341073,1.0,6/22,11.24%,DUSP10;KAT2A;CBFB;BCL6;CD46;IRF1
prerank,positive regulation of growth (GO:0045927),0.3728343332435656,1.0529914519387562,0.39210526315789473,0.9127427793713535,1.0,11/64,12.09%,EGFR;EIF4G1;TGFBR1;KLHL22;MMP14;ADAM10;AGR2;CDC42;CSNK2A1;TGFB2;USP47
prerank,nervous system development (GO:0007399),0.3200775508743365,1.0525561117031104,0.3710819009100101,0.9131623373594817,1.0,46/429,8.39%,CDH1;WWP1;CRIM1;PCDHB16;DCLK1;MET;MBNL1;NGF;PDGFC;FN1;SMO;ZIC4;PKD1;HDAC4;ZBTB16;EFNA5;RBFOX2;INHBA;NTN5;PCDHB13;GSN;ZIC1;NOTCH2;PMP22;EGR2;GLRB;ADGRG6;GDNF;TGFBR1;SDK1;DAGLB;EP300;JAG1;STIL;ECRG4;NAGLU;FGF13;FGF2;NELL1;NCKAP1;GLIS2;HES1;WWTR1;SDCBP2;BTBD3;TEAD1
prerank,defense response to virus (GO:0051607),-0.27183259609770394,-1.052313679757057,0.288135593220339,0.7962490290787041,1.0,22/100,13.66%,SERINC3;SERINC5;BCL2;ABCC9;IRF2;SAMHD1;BST2;IFITM1;BCL2L1;NLRC5;IFIT2;AGBL4;TLR3;IFNAR2;IFITM3;ZDHHC1;MLKL;OAS2;RTP4;IFIT3;TLR7;CGAS
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.40982668674628053,1.0517646203913935,0.38944365192582026,0.9144702454409531,1.0,10/37,10.61%,TGFB3;IL10;PDCD4;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;CDKN1B;HTR1B
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4681686734665798,1.051568401559949,0.4026186579378069,0.9141824596074604,1.0,4/17,8.98%,TGFB3;IL10;PDCD4;CDKN1B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3577680947239987,-1.051505942598274,0.4046920821114369,0.7970773584420011,1.0,6/26,10.08%,MFHAS1;NR1H3;CYBA;FLOT1;TLR3;NINJ1
prerank,ethanol metabolic process (GO:0006067),0.49177123885499374,1.051180130509312,0.418848167539267,0.91445246339431,1.0,2/12,3.41%,ADH7;SULT1A1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.38523372759651897,1.0510758376226044,0.38959212376933894,0.9139024962532589,1.0,6/47,5.37%,FOXO3;AGTR1;INHBA;KLF4;EIF4G1;NFKB1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3713458340827237,-1.0506482973373108,0.3729281767955801,0.7982293461238873,1.0,14/23,40.71%,ELOVL6;ACOT7;ALOX12;PTGS2;ASAH2;GPX4;ACSBG1;ALOX5;LTA4H;CYP2E1;HPGD;CYP1A1;LTC4S;GSTP1
prerank,positive regulation of viral genome replication (GO:0045070),-0.34806616930288514,-1.0503878127507646,0.3869047619047619,0.7975739595543958,1.0,8/29,16.75%,PPARA;TOP2B;PPIA;ADARB1;DDB1;PPIE;NR5A2;TARBP2
prerank,glycolytic process (GO:0006096),-0.3425742238933215,-1.050348250069135,0.3850415512465374,0.7963278555283533,1.0,11/28,18.13%,GAPDH;ALDOC;PGAM1;PGAM4;ENO2;ALDOA;HK2;PFKM;PGM1;HK1;PKM
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.42677126036669666,-1.0502670290910496,0.40048543689320387,0.7952146166878279,1.0,8/13,22.61%,DCN;IDS;NCAN;CSPG5;CSPG4;HEXB;VCAN;BGN
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5154276857783882,1.050197794333886,0.4375,0.9154873238111036,1.0,2/10,2.92%,GRB10;PID1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.35798673061090075,1.0499444482047045,0.3935790725326992,0.9153697105571863,1.0,14/100,7.51%,EGFR;SOX9;PDGFC;NTRK3;FN1;NEDD4;FGFR1;WNT16;PDGFA;PIP5K1A;BECN1;HCLS1;PIK3AP1;FGF2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.42811788195532113,-1.0499140130791251,0.42822966507177035,0.7947784119328184,1.0,4/13,6.57%,PPARA;NOS3;TMSB4X;PPARGC1A
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.40707208273401957,1.0491557287694424,0.39705882352941174,0.9166687753478164,1.0,11/32,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TAF1;POLR1A;POLR1H;POLR1F;RRN3;TAF1D;POLR2H
prerank,positive regulation of multicellular organismal process (GO:0051240),0.32120241062011456,1.0490615007536614,0.39026915113871635,0.9161089657958703,1.0,53/308,12.79%,BMP4;SOX9;PDGFC;SMO;SIX1;TGFB3;FOXD1;ZBTB16;ADRA1B;LRPAP1;GRB10;LBP;INHBA;BMP1;ADRB2;IL10;GCNT2;ZBTB7B;BAMBI;BMPR1A;TLE6;TRPM4;GDNF;TGFBR1;TGFBR2;HILPDA;FGF2;DECR1;TGFB1I1;TSKU;KDM1A;KAT2A;SCD;WWTR1;CYP27B1;SIX4;PER2;CXCR4;MTOR;SHLD1;NIBAN2;BCL9L;NOG;ACVR1;OMA1;TGFB2;REST;CD36;SNX4;FOXC1;CMKLR1;HTR2B;INHBB
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.48496673143697333,1.0490504520275101,0.435,0.9153314359038218,1.0,2/14,6.07%,CD55;TGFBR2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.42393523243108383,1.0486018100886925,0.40923076923076923,0.9157200700668773,1.0,4/27,7.08%,MAP3K5;NFKB1;FBXW11;CHUK
prerank,protein monoubiquitination (GO:0006513),0.4120299822420138,1.048574672800428,0.3938053097345133,0.9149861256947461,1.0,10/36,18.69%,UBE2B;KLHL22;UBE2D3;CTR9;TRIM25;PAF1;UBE2W;UBE3D;HUWE1;PEX12
prerank,protein stabilization (GO:0050821),0.3360586254842945,1.0483767576479344,0.37599093997734995,0.9147484855108471,1.0,32/168,13.40%,RASSF2;ANK2;ATP1B1;PARVA;USP13;PLPP3;PRKCD;UBE2B;COA8;CLU;EP300;USP2;TRIM44;TBL1X;USP7;MDM4;TELO2;CHEK2;SWSAP1;CTNND1;USP33;P3H1;HPS4;PIM2;TAF1;GTPBP4;TAF9;NLK;WIZ;AAK1;COG3;MORC3
prerank,male gonad development (GO:0008584),0.41046847786784907,1.048040773569174,0.4121122599704579,0.9149293462083946,1.0,8/34,11.71%,SOX9;INHBA;GATA1;GATA4;SIX4;GATA3;WNT2B;TGFB2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.33613605727093304,-1.047505537738067,0.3527397260273973,0.8001477093702928,1.0,17/33,21.03%,LRRC4C;NRG3;GRIK1;GRID2;LRP8;GRIK2;LRRC4;CACNA1B;FABP5;CX3CR1;ABR;NTF3;NLGN1;PSMC5;EIF4EBP2;GRIK3;NLGN2
prerank,signal transduction by p53 class mediator (GO:0072331),0.42546487015400913,1.0466293852991957,0.4287833827893175,0.9179432739030797,1.0,5/30,8.84%,NDRG1;DDX5;FHIT;MDM4;USP10
prerank,diol metabolic process (GO:0034311),-0.38366338313443926,-1.0466020782107746,0.3932291666666667,0.8011580729675122,1.0,10/19,24.41%,NOS3;CALM1;DEGS2;SPHK1;AKT1;PLPP2;SGPP1;PTS;SPHK2;ASAH2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4495415925265456,1.046450105558157,0.41411042944785276,0.9176308586051364,1.0,3/23,9.81%,CCN3;IFI35;PPM1A
prerank,regulation of actomyosin structure organization (GO:0110020),0.4809754890368676,1.0462204640588744,0.41127694859038144,0.9174627172093401,1.0,4/13,12.17%,AKAP13;CDC42;ASAP3;SLC9A1
prerank,regulation of lamellipodium organization (GO:1902743),0.48721279655780375,1.0460277759524754,0.42810457516339867,0.9171796317288562,1.0,3/14,10.90%,CD44;DMTN;CDC42
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4395937726866154,1.0457494124556217,0.41479099678456594,0.9171343985525112,1.0,5/25,10.36%,EXT1;B3GNT2;B4GAT1;B3GNT6;NDST1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.34570976169432566,-1.0457483722046366,0.3669724770642202,0.8020241697086256,1.0,13/30,19.11%,NOS3;TNFSF10;FAS;BCL2L1;CFLAR;FAIM;RFFL;FAIM2;TRAF2;TNFAIP3;PARK7;BRCA1;ARHGEF2
prerank,peptidyl-arginine modification (GO:0018195),-0.4065690653186995,-1.0457386468234589,0.40816326530612246,0.8006932656219689,1.0,4/15,18.00%,ART3;PADI2;PRMT1;PARK7
prerank,positive regulation of cyclase activity (GO:0031281),-0.40703678266328713,-1.045377755431667,0.41353383458646614,0.8003494203757355,1.0,5/14,16.64%,CACNA1D;NOS3;MAPK3;STIM1;NOS1
prerank,regulation of hormone secretion (GO:0046883),0.47882842857911,1.0452098964694274,0.4256410256410256,0.9177599964584157,1.0,1/15,1.33%,ANXA1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3137209426988355,-1.044973437641356,0.3581081081081081,0.8001044994884345,1.0,13/44,19.21%,CYP7B1;PRKAG2;CYP27A1;SC5D;INSIG2;OSBP;HSD17B4;OSBPL1A;ALOX12;SCP2;PARK7;CH25H;HSD17B10
prerank,excitatory postsynaptic potential (GO:0060079),-0.3834155346023745,-1.0449526225561676,0.4087193460490463,0.7988274689488144,1.0,9/19,18.67%,GRIN2A;GRIN2B;MEF2C;GRID2;LRRK2;GRIN1;AKT1;GSK3A;ARRB2
prerank,glucose metabolic process (GO:0006006),-0.2990538604130353,-1.0449411517398548,0.37109375,0.7975092607885452,1.0,13/58,15.19%,APOD;RBP4;PPARD;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3183283996550984,1.0445409245279043,0.3742393509127789,0.9186948353239677,1.0,67/509,9.97%,EGFR;F3;NR3C2;THBS1;MET;SOX9;TCF7L2;PDGFC;NTRK3;FN1;TNFAIP8L3;TRAF3IP2;ADRA1B;AKAP13;NEDD4;TCIM;ITGB1;WNT11;FGFR1;SHC1;NFAT5;ALPK1;ADRB2;P2RX2;STRN;GCNT2;WNT16;PDCD4;DDIT3;PDGFA;TGFBR1;GOLPH3;CD80;BECN1;TNFSF11;TAB3;IRS1;BCLAF1;ITGAV;EP300;TRIP6;HCLS1;FGF22;TRIM44;GOLT1B;MAVS;CHUK;P2RX4;PIK3AP1;RIPK2;IFI35;TLR6;FGF2;GAB2;MAP3K3;SMCR8;IQGAP1;IRAK4;BCAR3;BCL10;SEC13;MLST8;GAB1;VAPA;HPSE;PPM1A;CCDC22
prerank,negative regulation of ion transport (GO:0043271),0.4365992930536563,1.044490708023185,0.40902021772939345,0.9180371185420957,1.0,3/24,2.51%,PTK2B;NEDD4;WNK1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4405314086551262,1.0443585344619908,0.4161490683229814,0.9175782444919227,1.0,2/21,1.83%,CXADR;AKAP13
prerank,response to interleukin-1 (GO:0070555),0.3668049052009514,1.0439732016151124,0.3944954128440367,0.9178168102583917,1.0,11/73,11.95%,SOX9;ANXA1;HDAC4;PTGIS;TANK;NFKB1;USP10;ACOD1;HYAL3;RBMX;TAF9
prerank,regulation of macrophage migration (GO:1905521),0.5047099316967351,1.0439436700902378,0.42018348623853213,0.9170849116403225,1.0,2/10,3.13%,PTK2B;MTUS1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5078779767140676,1.0439354829189469,0.41379310344827586,0.9163129062469489,1.0,5/11,11.71%,GDF6;TGFBR1;TGFBR2;ACVR1;TGFB2
prerank,positive regulation of immune system process (GO:0002684),0.4750463951033668,1.0437486516826917,0.42810457516339867,0.9160286216694303,1.0,1/16,1.33%,ANXA1
prerank,cristae formation (GO:0042407),-0.36069092095948496,-1.0436229066998444,0.39457831325301207,0.7997945613991458,1.0,10/27,16.02%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;MICOS13;ATP5F1D;APOO;ATP5MC2;ATP5F1A
prerank,regulation of glycolytic process (GO:0006110),0.3631336699489196,1.0431285607824274,0.4105960264900662,0.9169303013665313,1.0,10/68,12.14%,SLC4A4;HDAC4;NUP93;PFKFB2;EP300;GAPDHS;SEC13;NUP188;RANBP2;PRXL2C
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4208245213315752,-1.0431214576360943,0.41131105398457585,0.7998856206946642,1.0,4/14,6.96%,SEMA7A;KIT;WNT5A;GPRC5B
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4533616721735179,1.0428661151921503,0.4138486312399356,0.9169102586792149,1.0,10/19,27.10%,MAVS;CHUK;RIPK2;TLR4;SETD2;DHX9;IFIH1;IRF3;TLR8;TBK1
prerank,peptidyl-tyrosine modification (GO:0018212),0.3791964999430242,1.0427674401335711,0.40135135135135136,0.9163831928260135,1.0,7/56,4.13%,EGFR;PTK2B;ABI1;FGFR1;DDR2;EFEMP1;ABL1
prerank,inositol phosphate metabolic process (GO:0043647),0.38829417162471647,1.0425405783460275,0.4161931818181818,0.9162155267780147,1.0,11/46,9.62%,PLCE1;INPP4A;IP6K2;PLCB3;NUDT4;PLCD3;OCRL;FGF2;IP6K3;PPIP5K2;PLCD1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4242503111933562,1.0423293578185573,0.4263565891472868,0.9160323860365138,1.0,9/29,14.70%,ISL1;DDRGK1;KANK2;STRN3;CBFB;FOXA1;KMT2D;CARM1;UFL1
prerank,positive regulation of axon extension (GO:0045773),0.44125125524569725,1.041974845594511,0.4185692541856925,0.9162153095372139,1.0,6/22,11.91%,NTN1;SHTN1;NRP1;ISLR2;ZFYVE27;MEGF8
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.48937439958446066,1.041865038481804,0.4312080536912752,0.9156836600504964,1.0,3/13,7.31%,DDX5;SPRED2;ATM
prerank,myeloid leukocyte differentiation (GO:0002573),0.36475296908769284,1.041710072202099,0.4007682458386684,0.9153372313348562,1.0,6/65,7.52%,BMP4;FOXP1;TNFSF11;TGFBR2;EP300;GAB2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4277030593729228,1.0416611221637673,0.4062968515742129,0.9146754638533925,1.0,6/30,6.37%,NGF;STK19;SHC1;NOTCH2;SHOC2;ITGAV
prerank,regulation of protein polymerization (GO:0032271),-0.32398262115729776,-1.041624691580639,0.36482084690553745,0.8028056193006433,1.0,9/35,19.34%,ARHGAP28;ESAM;MAP2;COTL1;MAPT;PFN1;TTBK1;TPPP;RASA1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.44075844529186103,-1.0414713121250445,0.4227053140096618,0.8018896188648392,1.0,2/11,1.62%,SLC30A10;PPARA
prerank,positive regulation of biosynthetic process (GO:0009891),0.4036118224236704,1.0413808325732052,0.42196531791907516,0.9146697004466046,1.0,3/40,1.57%,BMP4;TGFB3;SORBS1
prerank,ribosomal small subunit assembly (GO:0000028),-0.39999218891941535,-1.0410373719569692,0.3798449612403101,0.8017995869353538,1.0,5/16,7.23%,RPS14;RPS27;RPS15;RPS5;RPS19
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.44596712929740756,-1.0410187396689454,0.4304932735426009,0.8005249635186871,1.0,4/11,19.34%,NOVA1;NOVA2;PCBP1;RASA1
prerank,negative regulation of protein modification process (GO:0031400),0.35832831566862877,1.0408060229648919,0.40234375,0.9154602682750176,1.0,8/79,4.57%,SLIT2;NTRK3;PLPP3;PID1;LRP6;GSK3B;DMD;NIBAN1
prerank,eye morphogenesis (GO:0048592),0.456324305653522,1.040355816416388,0.41158059467918623,0.9158890942246255,1.0,7/19,12.38%,COL5A2;MFAP5;EFEMP1;RARG;SKI;IFT122;STAT3
prerank,regulation of protein secretion (GO:0050708),0.34264036562962114,1.040265573178197,0.41466346153846156,0.9153360993042584,1.0,19/119,9.73%,SLC12A2;TGFB3;EZR;DISP1;BMP6;KCNS3;CACNA1C;ADAM9;RAP1A;KCNB1;ITPR2;GOLPH3;HNF4A;EXPH5;ARFIP1;SYTL4;UNC13B;P3H1;PER2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.430545513185595,-1.0400213529380524,0.4060324825986079,0.801926985210279,1.0,4/13,6.47%,ENG;KDR;COL4A1;NOTCH4
prerank,retinoid metabolic process (GO:0001523),0.36615463870745973,1.039801788728458,0.4116883116883117,0.9157669053897184,1.0,10/71,8.51%,GPC6;CYP1B1;ADH7;GPC3;STRA6;RBP1;SCPEP1;RLBP1;GPC4;CYP2S1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4690661935432937,1.0397301284554932,0.4600326264274062,0.9151837014823081,1.0,4/17,5.12%,KCNJ2;ANK2;CACNA1C;TRPM4
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3870576497710937,-1.0391002643995702,0.40641711229946526,0.8031016245978835,1.0,6/19,8.81%,TJP1;NEXMIF;NOTCH1;NOTCH4;RGCC;FLOT1
prerank,calcium ion transport (GO:0006816),0.34171174534520093,1.038793276961962,0.41874258600237246,0.9168631482552944,1.0,17/113,9.48%,SLC24A3;PKD1;ANK2;RAMP1;ATP2C2;TRPM6;ANO6;CACNA1C;NALCN;STIM2;MCOLN3;TRPM4;ITGAV;P2RX4;ATP2B4;CYP27B1;CACNB2
prerank,positive regulation of cellular process (GO:0048522),0.31261668217854655,1.0386255182091062,0.3921765295887663,0.9165357078739006,1.0,63/565,8.32%,EGFR;BMP4;THBS1;ACER3;SOX9;GRK5;ZFHX3;PDGFC;BMP5;NTRK3;FN1;TGFB3;HDAC4;PTK2B;PPP3CA;LBP;FGFR1;SHC1;KRAS;BMP6;PGF;ISL1;PRKCD;LRP6;GAREM1;EIF4G1;P2RX2;GCNT2;LMNA;BAMBI;FZD7;CDC25B;EGR2;DDRGK1;PDGFA;TRPM4;GDNF;TGFBR1;KLHL22;TGFBR2;IRS1;BCLAF1;HILPDA;ITGAV;MMP14;TGM1;CEP131;HCLS1;FGF22;CNOT7;CELF1;P2RX4;CLCF1;RIPK2;ATM;FGF2;GAB2;MVD;HES1;WWTR1;CAPN10;ADAM10;TNFRSF1B
prerank,lamellipodium organization (GO:0097581),0.4242266536667537,1.0383439392235492,0.4330357142857143,0.9165145423432335,1.0,8/29,9.56%,ABLIM3;ITGB1;ARHGEF6;GOLPH3;VCL;ABLIM2;SPEF1;DMTN
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4581613620886855,1.038236869628496,0.42673107890499196,0.916052101248537,1.0,4/20,9.07%,SMAD9;NFE2L2;EP300;CARF
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.40181272915790456,1.037906680800576,0.4219409282700422,0.916155018031142,1.0,16/40,26.30%,PRKCD;SMYD2;ABL1;BCLAF1;SMG1;FXR2;ARMT1;USP1;UBE2N;FEM1B;FMR1;WDR76;SIRT7;KMT5A;CASP9;UBE2V1
prerank,apoptotic process (GO:0006915),0.32978018322177644,1.0377948812387698,0.4,0.9156737997221641,1.0,36/203,12.87%,CYFIP2;EGLN3;PLAGL1;PTK2B;ZBTB16;EFNA5;PAWR;CIT;PRKCD;GDF6;NOTCH2;PDCD4;MAGI3;ARHGEF6;DIABLO;PLSCR1;RFK;TGFBR2;BCLAF1;EP300;PLK3;YARS1;NCKAP1;CDIP1;ERCC3;BCL2L13;CXCR4;MTOR;PAK4;AIFM2;IRF1;CHEK1;BNIP3;PRKCE;TRPC5;TRADD
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4347109914390083,-1.0374028723795978,0.4198645598194131,0.8051837192718179,1.0,1/12,0.18%,IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4347109914390083,-1.0374028723795978,0.4198645598194131,0.8051837192718179,1.0,1/12,0.18%,IGF1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.32022096480374784,1.0372976321865879,0.4123173277661795,0.916231723542729,1.0,38/291,10.44%,SLIT2;EGFR;SOX9;WNT9A;PTK2B;EZR;LBP;WNT11;PRKCD;PID1;ADAM9;RAP1A;MYOG;IL10;CAPN2;IP6K2;FZD7;PDCD4;IGFBP5;VCP;NR4A3;NFKB1;CD80;SHPK;IRS1;CHUK;JUN;P2RX4;ATM;ATP2B4;TNFRSF1B;BCL10;KAT5;CTR9;DMTN;SLC26A6;ACOD1;MTOR
prerank,regulation of cell division (GO:0051302),0.36240458039365636,1.0372572659318595,0.41947565543071164,0.9155632574148398,1.0,14/72,12.74%,MLLT3;KIF13A;KLHL13;TLE6;BIRC6;BECN1;PLK3;RAB11FIP3;ENTR1;ZFYVE26;PRDM15;SETD2;SFN;HTR2B
prerank,regulation of translation (GO:0006417),0.32753342459982865,1.037027468907306,0.40444444444444444,0.9154042979262661,1.0,51/173,24.36%,THBS1;SAMD4A;FOXO3;EIF4G3;EIF4G1;NIBAN1;IGFBP5;SYNCRIP;LARP4B;CNOT7;PAIP2;TOB1;EIF2AK4;PLD1;MTRF1;EIF2B2;MTOR;EIF2AK3;NANOS2;ETF1;TRAP1;DDX1;FXR2;EIF4E2;DHX9;GSPT1;PRKDC;YTHDF3;MTIF2;CYFIP1;ZCCHC4;ATXN2;RBM4B;UPF3A;METAP1;EIF4G2;PUM3;METTL18;EIF6;EIF4ENIF1;PUS7;EIF3E;CSDE1;FMR1;LARP1;CAPRIN1;MTG2;PCIF1;RBM4;NCBP2;IMPACT
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3785891839860546,1.0369098657937814,0.3986394557823129,0.9149726957852709,1.0,14/54,15.85%,PLAGL1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;CHEK2;CDKN1B;PCBP4;RBL2;SFN;CARM1;PML
prerank,membrane lipid biosynthetic process (GO:0046467),0.3780451215669637,1.0365530770030547,0.4072164948453608,0.9151284750801979,1.0,11/58,12.98%,ST3GAL4;ACER3;PLPP3;SGMS2;SPTSSB;CERS6;CERS5;VAPA;ELOVL5;PLPP1;ST3GAL2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.2461420508941894,-1.0365355808509096,0.3969465648854962,0.8063089024977619,1.0,41/148,16.83%,IL34;PRKAG2;RAPGEF2;PAK1;CALM1;TNIK;CCDC88A;CSF1;PTK2;GRM5;NRK;ACE;SNCA;INSR;PAK5;IL6R;DAB2IP;NEDD9;EPHA4;ADRA2A;MAP4K4;GPRC5B;LRP8;GAS6;CALM3;SRC;HSP90AB1;TAB2;EGR1;ETAA1;CIB1;AGT;MMD;ALS2;TTBK1;INCENP;SLC27A1;PIH1D1;CCL19;CENPE;STK3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43446597949524735,1.036438981177907,0.4116719242902208,0.9146385326720825,1.0,5/23,8.89%,HDAC4;C1QTNF12;ERFE;EP300;CLK2
prerank,post-translational protein modification (GO:0043687),0.3170378989711088,1.0362189622288978,0.3987538940809969,0.9144310843488594,1.0,42/332,11.70%,FBXL7;MSLN;BMP4;FSTL1;FN1;PTP4A2;ZBTB16;CCN1;FBXO40;FBXO10;GPC3;ASB9;ASB16;DCAF6;KLHL13;IGFBP5;SOCS2;FBXW8;ASB11;DNAJC3;KLHL22;PRKCSH;BMP15;FBXW11;WDTC1;UBE2F;KTN1;LRRC41;HIF3A;ADAM10;ASB14;FBXO32;FBXO4;PRSS23;ASB1;CCDC22;FBXL20;COMMD1;FBXO17;FBXW2;ERCC8;GOLM1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4396758903933527,1.0361856675763617,0.4234375,0.9137606582696008,1.0,5/22,12.11%,SOX9;GSK3B;HES1;EIF2AK4;REST
prerank,apoptotic cell clearance (GO:0043277),0.4203689892669872,1.0354231521291495,0.42,0.9150545594671393,1.0,7/30,13.93%,THBS1;ANXA1;ITGAV;XKR4;RHOBTB1;ITGB3;LRP1
prerank,establishment of protein localization to membrane (GO:0090150),0.36804545885998313,1.0352358110834574,0.4283854166666667,0.9147787594462194,1.0,15/66,18.50%,EGFR;NECTIN3;ZDHHC11;RAB3GAP2;FRMPD1;ATG3;SEC63;PARD3;ZDHHC23;ZDHHC15;NPC1;GOLGA7;CHM;VPS37A;ZDHHC7
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.47503641818723785,1.0351540396406598,0.44089456869009586,0.9142295524107205,1.0,6/15,23.49%,TLR6;TLR4;CD36;MYD88;NLRP2B;PYDC1
prerank,regulation of steroid metabolic process (GO:0019218),-0.3581586489683177,-1.0348939602033667,0.37960339943342775,0.8095777572486144,1.0,8/23,26.17%,APOE;ACADL;NR1H4;ABCG1;LAMTOR1;STUB1;RORC;ABCA2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.37206892649485623,-1.0347981140818308,0.40437158469945356,0.808510024079424,1.0,6/20,16.45%,NR2F2;MYOCD;INCA1;IPO5;CDKN1C;HHEX
prerank,regulation of anoikis (GO:2000209),-0.3727171858737689,-1.0344661980019794,0.4160206718346253,0.8081565953308996,1.0,5/19,9.09%,TLE1;BCL2;PTK2;NOTCH1;SRC
prerank,regulation of postsynapse organization (GO:0099175),-0.3467275835717701,-1.0343942439427476,0.42120343839541546,0.8070345006434004,1.0,9/28,10.81%,SHANK3;IL1RAPL1;PPFIA2;WNT5A;EPHA4;ABHD17C;CDKL5;LRRK2;ABI3
prerank,protein localization to cell-cell junction (GO:0150105),-0.3990724349507738,-1.0343241267382495,0.40865384615384615,0.8058955206164545,1.0,4/15,4.83%,TJP1;F11R;CGNL1;ACTB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.44046254926099104,1.0341165677967326,0.43146417445482865,0.9162261303662549,1.0,4/20,8.30%,ADAM9;NFKB1;SPPL2A;ADAM10
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4232046492670849,1.0339939757909111,0.4375,0.9157928297801927,1.0,7/26,12.28%,KLF4;CLU;P2RX4;TLR6;AGTR2;TLR4;CD36
prerank,negative regulation of protein phosphorylation (GO:0001933),0.33622586641183516,1.033849105233748,0.4330254041570439,0.9153875749661777,1.0,23/150,11.30%,SLIT2;RASSF2;NTRK3;PLPP3;PRKCD;PID1;LRP6;SMAD6;EIF4G1;DMD;NIBAN1;SPRED2;DNAJC3;NCK2;PPEF2;SMCR8;WWTR1;DMTN;CNKSR3;PARD3;PAK2;NOG;RB1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.322531798142149,-1.0337756742111737,0.41697416974169743,0.8060485839543383,1.0,7/34,10.30%,MFHAS1;PICALM;NEDD4L;GPM6B;RIPOR2;MAPT;ANKRD13A
prerank,phosphorylation (GO:0016310),0.3128881598197972,1.0334491223878919,0.4155578300921187,0.9156594100112158,1.0,93/385,17.53%,STK39;DCLK1;MAP3K5;GRK5;STK19;MARK1;PTK2B;CAMK2D;LIMK2;WNT11;FGFR1;WNK1;PRKCD;HIPK1;MKNK2;NEK7;BCR;GSK3B;ABL1;CDC25B;BMPR1A;SGK3;SIK3;BIRC6;TLK1;TGFBR1;SHPK;TGFBR2;SIK2;CHUK;ATM;MARK2;DYRK2;IP6K3;ADAM10;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;FRK;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A1;DGKA;TGFB2;CSK;IKBKE;NLK;STAT3;PRKCE;AAK1;CSNK1A1;HTR2B;MAPK1;SRPK1;MORC3;CAMK4;ILK;AMHR2;CDK12;STK11;PPP4R1;FAM20A;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;CSNK1D;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;MAP4K1;TOP1;TAOK3;MAPK8;VRK2;MAPKAPK2;GMFG;TLK2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.46067797920898323,1.0331033088642954,0.42673107890499196,0.9158165863746229,1.0,2/18,3.03%,MET;CCDC125
prerank,substrate-dependent cell migration (GO:0006929),0.4758184542296686,1.0328513324611721,0.42602495543672014,0.9157333631660016,1.0,3/14,7.71%,NTN1;SHTN1;NRP1
prerank,protein homotetramerization (GO:0051289),-0.30175720990791194,-1.0327793161638017,0.37992831541218636,0.8075315024274772,1.0,17/49,16.55%,ALDH1A2;B2M;HCN1;SAMHD1;AQP4;ACACA;ACACB;ALDH9A1;ALDOA;UPB1;RYR3;CRYZ;APPL2;KCNJ12;GBP5;CBY1;ALDH1A3
prerank,cellular response to interleukin-12 (GO:0071349),-0.30721790108950786,-1.0327580628112878,0.4037735849056604,0.8062729571020459,1.0,19/48,21.10%,PLCB1;CD47;PPIA;CNN2;LMNB1;SIRPA;HSPA9;AIP;PSME2;BOLA2;CFL1;MIF;RPLP0;SNRPA1;RALA;SOD2;HNRNPDL;LCP1;TALDO1
prerank,regulation of organelle assembly (GO:1902115),0.35908687164419273,1.0325992487284357,0.41836734693877553,0.9156621909268379,1.0,19/72,15.17%,EZR;RABEP2;GSN;PDCD6IP;TBC1D13;ATG3;STIL;SGSM3;CEP295NL;RDX;NPRL3;TBC1D10A;TRAPPC12;KIF9;TBC1D2B;TSG101;RAB5A;IFT88;MAPK15
prerank,7-methylguanosine mRNA capping (GO:0006370),0.408484434171837,1.0325665685882939,0.4279210925644917,0.9142239990518638,1.0,4/31,13.96%,RNMT;MNAT1;ERCC3;GTF2F2
prerank,7-methylguanosine RNA capping (GO:0009452),0.408484434171837,1.0325665685882939,0.4279210925644917,0.9142239990518638,1.0,4/31,13.96%,RNMT;MNAT1;ERCC3;GTF2F2
prerank,positive regulation of protein secretion (GO:0050714),0.3605946135016215,1.0319944527168108,0.4175531914893617,0.9149647771837011,1.0,15/69,12.29%,TCF7L2;TGFB3;EZR;BMP6;ISL1;ADAM9;GOLPH3;EXPH5;CAPN10;SYTL4;AACS;UNC13B;TLR4;TGFB2;ADAM8
prerank,vacuolar acidification (GO:0007035),0.45210821628393894,1.0317499415931226,0.42022116903633494,0.9147766119515304,1.0,7/21,19.06%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;TMEM199;CLN3
prerank,embryonic axis specification (GO:0000578),0.4742992426873911,1.0317187686614013,0.44310344827586207,0.9141074999433152,1.0,3/15,7.19%,COBL;SMAD6;STIL
prerank,plasma membrane repair (GO:0001778),0.4815966277860721,1.031439323018595,0.44873949579831934,0.9140769798873973,1.0,1/13,0.50%,AHNAK2
prerank,cell cycle G2/M phase transition (GO:0044839),0.33377691223032097,1.0314102339422158,0.4195804195804196,0.9133841868786229,1.0,34/129,21.08%,FBXL7;CCNA2;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;CHEK2;MNAT1;FBXL6;PCM1;HAUS5;CSNK1E;CEP70;PPP1R12A;CEP63;CEP57;FOXM1;PRKACA;CSNK1D;PPME1;DCTN3;CNTRL;AKAP9;FBXL17;CEP192;FBXL8;DCTN1;AURKA;ODF2;MASTL
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4185161796087661,-1.0313041864704842,0.41766109785202865,0.8087860585782743,1.0,6/13,15.89%,CALM1;ANK3;PDE4D;CALM3;SLC8A1;CASQ2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.41851060965233183,1.0312125677103168,0.43390357698289267,0.9131742962325408,1.0,3/28,4.13%,MAPRE2;GAS2L2;ABL1
prerank,negative regulation of axonogenesis (GO:0050771),-0.34973595372505784,-1.0310995561711778,0.3877551020408163,0.8080252318579848,1.0,11/27,20.12%,MAP2;DCC;ARHGDIA;LINGO1;EFNB3;MAG;SEMA3G;TRIM46;RNF6;OMG;RTN4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.36420607458964877,1.0310428142428538,0.4302477183833116,0.9128634173026393,1.0,10/65,12.40%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;HILPDA;MDM4;MTOR;ADAM8;BNIP3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4901599727941542,1.0302577587474304,0.4496527777777778,0.9141376613368697,1.0,2/11,4.74%,LRP6;NR4A2
prerank,acute-phase response (GO:0006953),0.48754233445800255,1.0301434876066093,0.40574506283662476,0.9136595704907059,1.0,3/12,13.86%,LBP;PLSCR1;CEBPB
prerank,polarized epithelial cell differentiation (GO:0030859),0.4977084794081083,1.0301378326761736,0.44045676998368677,0.9129186082935664,1.0,4/13,12.11%,EZR;CDC42;RHOA;MYO9A
prerank,regulation of protein modification process (GO:0031399),-0.29389658019435866,-1.0298288264136473,0.4089068825910931,0.8101671600990957,1.0,19/50,23.49%,LYN;PPP1R16B;CCDC88A;PTK2;GRM5;IGF2;ASPSCR1;NDUFS4;PPIB;SPRED1;FLCN;FNIP2;PLXNB2;HPF1;ATG14;ROPN1L;CCAR2;SOCS1;PIN1
prerank,negative regulation of response to stimulus (GO:0048585),0.36807863162419574,1.0297529860720096,0.42159383033419023,0.9131653197308087,1.0,8/60,7.56%,SLIT2;HHIP;KLF4;COL3A1;VPS13C;KLF7;CLU;MAP3K3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4061729629253978,1.029602452203308,0.4318840579710145,0.9128077979353332,1.0,5/33,11.55%,UBASH3A;EZR;PTPN2;BCL10;PHPT1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.41557922704746736,1.0295559953888573,0.4203125,0.9121710515079866,1.0,5/28,7.07%,GRB10;PRKCD;PID1;IRS1;PTPN2
prerank,neutrophil migration (GO:1990266),-0.2895680570114108,-1.0291998009728855,0.39271255060728744,0.8105119529134299,1.0,13/58,19.63%,PECAM1;PDE4B;BSG;PPIA;PIP5K1C;EDN1;PPIB;EDN3;NCKAP1L;SYK;CCL19;ITGB2;PIK3CD
prerank,retinoic acid metabolic process (GO:0042573),-0.4137124621679867,-1.0290065000135884,0.41414141414141414,0.8097816838070951,1.0,2/14,1.91%,ALDH1A2;CYP26B1
prerank,positive regulation of cell aging (GO:0090343),-0.4256529209631964,-1.0289134901991275,0.4325581395348837,0.8087062353720427,1.0,4/11,13.66%,B2M;YPEL3;ABI3;CGAS
prerank,regulation of neuron migration (GO:2001222),-0.3456506029390505,-1.0284460231273753,0.375,0.8086036033319199,1.0,9/26,13.35%,SEMA6A;CTNNA2;RAPGEF2;NEXMIF;DAB2IP;MDK;CAMK2A;ADGRG1;CAMK2B
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.41427436501799497,-1.0280974140048469,0.4346846846846847,0.8083117813779054,1.0,5/13,15.73%,NOTCH1;RBPJ;HEY2;RYR2;GSK3A
prerank,bile acid metabolic process (GO:0008206),-0.3463311317957255,-1.027742235687132,0.3982808022922636,0.8079557564156402,1.0,12/27,26.94%,CYP7B1;CYP27A1;OSBP;HSD17B4;OSBPL1A;SCP2;CH25H;HSD17B10;SLC27A2;CYP46A1;OSBPL6;OSBPL7
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.37767995578368163,-1.027665093028245,0.41935483870967744,0.8068622557126796,1.0,4/18,9.09%,ST18;IL6ST;IL6R;SRC
prerank,T cell differentiation (GO:0030217),-0.3125403403531172,-1.0275936682706994,0.40894568690095845,0.8057738001974178,1.0,9/40,11.38%,LEPR;CHD7;SOX13;KIT;JAG2;RHOH;LFNG;NHEJ1;TCF7
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3937667680437811,1.027316259216112,0.42962962962962964,0.9171816205471295,1.0,13/37,20.83%,FHIT;GIPC1;DDRGK1;USP7;TAF1;CSNK2A2;CSNK2A1;TAF9;PML;TLK2;MAP1A;HFE;N4BP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.36457172447802866,-1.0271446877681605,0.39080459770114945,0.8056782158190859,1.0,7/20,15.73%,BCL2;DCC;FAS;BCL2L1;CASP3;BOK;GSK3A
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3849672628387028,-1.0268494915502704,0.39950980392156865,0.8051791801670837,1.0,3/17,12.27%,KCNAB1;ANK3;NOS1AP
prerank,cellular protein localization (GO:0034613),0.3169087306592131,1.0264334386310003,0.4281217208814271,0.9186899011306247,1.0,72/285,19.23%,EGFR;ANK2;PTPRU;SGSM2;KIF13A;CSRP3;WNT11;CNTLN;GRTP1;WIPI2;ARF4;RAB43;DMD;STX19;STX5;STX11;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;AP3B1;HERC2;ID1;TBC1D25;VCL;STX8;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;NSF;SEC13;PIGU;RIC3;SAR1B;TBC1D10A;GGA2;EHD1;COG3;TBC1D2B;CTTN;VIPAS39;STX16;ZDHHC15;SMURF1;RAB5A;CPE;USP4;EMP2;SNX17;RAB17;ARCN1;VPS26C;RRAGB;FLNA;RAB22A;AMOT;TICAM2;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;ACD;ANGPT1;COPA;SNX13;NPHP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.299305206719657,-1.0263973362311467,0.41697416974169743,0.8052310140608034,1.0,13/54,8.46%,APOE;PRKD1;NOS3;KDR;AKT3;HIF1A;ETS1;TMSB4X;ATP5F1B;ANGPT2;MEF2C;RGCC;GATA2
prerank,regulation of sodium ion transport (GO:0002028),0.40827548475532144,1.0263395714276544,0.44822485207100593,0.9181663913146885,1.0,10/34,15.77%,SLMAP;NEDD4;WNK1;DLG1;P2RX4;ATP2B4;CNKSR3;ATP1A1;SNTA1;WNK3
prerank,positive regulation of interferon-beta production (GO:0032728),0.4035449484110277,1.0261151969014184,0.43023255813953487,0.9179888015183864,1.0,14/33,27.10%,POLR3D;MAVS;RIPK2;RNF135;IRF1;TLR4;POLR3B;DHX9;PTPN11;IFIH1;IRF3;POLR3G;TLR8;TBK1
prerank,negative regulation of cell cycle process (GO:0010948),0.3700161919774149,1.0260298220737645,0.4295125164690382,0.9174432992704132,1.0,20/61,22.56%,BMP4;E2F6;RRM2;RNF2;WAPL;CHEK1;NANOS2;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;NME6;YAF2;PHC3;EED
prerank,neural crest cell migration (GO:0001755),0.39810262909595984,1.0257005504381067,0.42380261248185774,0.9174881735398615,1.0,6/36,7.71%,FN1;SEMA3D;SEMA3C;SEMA3E;GDNF;NRP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4264990115674727,-1.0255011108415064,0.44711538461538464,0.8064486240750279,1.0,3/11,6.99%,LYN;ANK3;PRKCQ
prerank,iron ion homeostasis (GO:0055072),-0.29437924163800144,-1.0251415070507994,0.38910505836575876,0.8060734391709188,1.0,15/58,16.33%,CP;B2M;FTH1;PICALM;TFRC;SLC40A1;FTL;ATP6AP1;CAND1;SLC22A17;ATP6V1A;SLC11A2;BOLA2;NUBP1;GLRX3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.37106691537824377,1.0238628879957545,0.42953929539295393,0.92159411505392,1.0,3/57,1.22%,CYFIP2;MAP3K5;PERP
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4251918501868301,1.0238350953530004,0.4439252336448598,0.9209134335173813,1.0,7/25,12.28%,KLF4;CLU;P2RX4;TLR6;AGTR2;TLR4;CD36
prerank,protein dephosphorylation (GO:0006470),0.3359157432355365,1.0237307899135835,0.4426419466975666,0.9203915104724055,1.0,38/135,18.96%,EYA2;PTPN3;PPP3CA;PTPRU;PPTC7;PPM1H;DUSP16;PPEF2;EYA4;FBXW11;EYA3;PTPN2;PTPN21;PPP2R2D;DUSP10;PTPRF;DAPP1;PTPRA;PPM1A;DUSP5;PPP1R12A;PHPT1;PTPN14;PPP5C;DUSP11;PPP2R1B;PPP3CC;DUSP12;STK11;PPP4R1;PTPN9;DUSP22;PPP4R2;PPP2CB;PPP2R5C;PTPRD;PTPN1;ILKAP
prerank,response to sterol (GO:0036314),0.4789104666702397,1.023613606649863,0.4288354898336414,0.9199371149925367,1.0,5/11,22.94%,TGFBR1;TGFBR2;RORA;TGFB1;SMAD2
prerank,DNA repair (GO:0006281),0.31523643711989985,1.0232845771611827,0.4338235294117647,0.9200771909377148,1.0,87/284,22.37%,MPG;FTO;ABL1;UBE2B;IGHMBP2;VCP;APEX2;TRRAP;HERC2;EYA3;ATM;BAP1;APLF;CHEK2;FAAP24;MNAT1;KAT5;RNF168;EID3;RAD17;SMUG1;ERCC3;RAD52;BRCA2;ERCC1;COMMD1;RAD51C;CSNK1E;SLC30A9;MBD4;CHEK1;RPA1;ERCC8;SETD2;USP3;RAD51AP1;FANCM;USP47;XPA;RFC5;CHD1L;ASCC1;PPP5C;SMC1A;CHRNA4;XRCC5;EXD2;INTS3;RAD23B;POLD3;DDX1;CDKN2D;PRMT6;RBBP8;XPC;CENPX;PRKDC;USP1;POLB;UBE2N;MAPK8;ACTR8;WRN;HUWE1;POLA1;NBN;INO80;REXO4;VCPIP1;ALKBH5;PWWP3A;MRE11;PMS2;RMI2;WDHD1;TDG;SUMO1;XRCC2;RECQL5;UNG;ATR;MTA1;FANCA;CDK1;RNASEH2A;RAD9B;APEX1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3880932205734744,-1.023155043440127,0.4146341463414634,0.8103468937584769,1.0,7/16,13.28%,IGF1;TRPC3;IL6ST;PARP1;PDE9A;EDN1;AGT
prerank,regulation of striated muscle contraction (GO:0006942),-0.34607652308615133,-1.0231334388297046,0.4117647058823529,0.8091442001403579,1.0,2/27,3.34%,ATP1A2;CALM1
prerank,regulation of potassium ion transport (GO:0043266),0.41733806139195273,1.0230493937720684,0.4510948905109489,0.9199574425728122,1.0,3/31,1.57%,FHL1;ANK2;PTK2B
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4241943306580128,-1.0230379905297604,0.44226044226044225,0.808134585921242,1.0,5/12,19.74%,APOE;PFDN2;PFDN5;IAPP;PFDN6
prerank,amino sugar biosynthetic process (GO:0046349),0.4920354700283616,1.0229840751579813,0.4661016949152542,0.9193714998220178,1.0,8/12,31.38%,NANP;GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,protein tetramerization (GO:0051262),-0.27876405456425185,-1.0226943748412387,0.415929203539823,0.8077636809863568,1.0,22/67,16.55%,ALDH1A2;B2M;HCN1;SNCA;SAMHD1;CPSF6;AQP4;GRIN2B;ACACA;ACACB;ALDH9A1;ALDOA;KCNC1;UPB1;GRIN1;RYR3;CRYZ;APPL2;KCNJ12;GBP5;CBY1;ALDH1A3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.40580107982392666,1.021847779720651,0.4510703363914373,0.9215883842775938,1.0,11/30,24.06%,FHIT;GIPC1;DDRGK1;USP7;TAF9;TLK2;MAP1A;HFE;N4BP1;SVIP;WAC
prerank,regulation of dendrite development (GO:0050773),0.39319795227505305,1.0213838420606896,0.43490701001430615,0.9220918538842472,1.0,5/37,3.93%,BMP5;COBL;MARK1;NEDD4;GSK3B
prerank,positive regulation of cell death (GO:0010942),0.36835444062330724,1.0213025063238794,0.4327784891165173,0.9215545338962217,1.0,9/59,8.98%,BMP4;MAP3K5;EIF4G1;GSK3B;RARG;CLU;CELF1;RIPK2;CDKN1B
prerank,lymphocyte chemotaxis (GO:0048247),0.3948648535443102,1.0212250506185678,0.45021645021645024,0.9209832866496162,1.0,1/34,0.48%,SLC12A2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4241686456983468,-1.020551293515247,0.4401041666666667,0.8120745065025673,1.0,3/12,9.48%,LYN;ELF2;CD300A
prerank,UV protection (GO:0009650),0.4805810973708641,1.0204227527963174,0.44223826714801445,0.9223562156149375,1.0,1/10,1.25%,SCARA3
prerank,protein mannosylation (GO:0035268),0.442210703403487,1.0202469715556313,0.43898573692551507,0.9220648718649864,1.0,6/22,12.90%,TMTC1;LARGE1;POMGNT2;B4GAT1;DPM1;LARGE2
prerank,regulation of immune response (GO:0050776),0.33259570560399526,1.0200102087850604,0.4380733944954128,0.9219847909173913,1.0,19/135,12.39%,FOXP1;CXADR;ITGB1;RAET1E;COL3A1;RIPK3;TREML1;PVR;PLSCR1;RNF135;SPPL2A;BCL6;ERAP1;GPR108;PDCD1;IRF1;TGFB2;CSK;BIRC3
prerank,regulation of transmembrane transport (GO:0034762),0.40543274909349036,1.0197290361246139,0.4365994236311239,0.9218949286492389,1.0,3/31,2.62%,KCNJ2;NEDD4;WWP2
prerank,regulation of cell differentiation (GO:0045595),0.3270075726034492,1.0193529583740502,0.4151376146788991,0.9221270721995293,1.0,26/148,16.36%,ZFHX3;NGF;SIX1;DDX5;PHLDB2;FGFR1;ISL1;KLF4;GDNF;TGFBR1;TFAP2A;SMOC1;CREBBP;CBFB;BCL6;GATA3;LTBP4;GNB3;REST;DDX17;CEBPB;EMP2;SUZ12;PRKACA;PTHLH;CDK5RAP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.33031969278880763,1.018727916539795,0.4372093023255814,0.923052338365608,1.0,34/128,21.08%,FBXL7;CCNA2;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;CHEK2;MNAT1;FBXL6;PCM1;HAUS5;CSNK1E;CEP70;PPP1R12A;CEP63;CEP57;FOXM1;PRKACA;CSNK1D;PPME1;DCTN3;CNTRL;AKAP9;FBXL17;CEP192;FBXL8;DCTN1;AURKA;ODF2;MASTL
prerank,response to organophosphorus (GO:0046683),-0.3909236975488717,-1.0186765809640854,0.44155844155844154,0.8160329839479444,1.0,5/16,15.51%,TRPC3;ABCC9;NDUFS4;VGF;P2RX7
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.25957463552822685,-1.0183468718198194,0.43333333333333335,0.8156665950661786,1.0,27/116,16.35%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;PRKAR1B;PTH1R;CYSLTR1;PRKAR1A;SRC;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;SYK
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.40338127149226616,-1.01816929161343,0.43287037037037035,0.8148379225802677,1.0,2/15,6.76%,IGF1;BCL2L1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.41974216624759103,-1.017240822483677,0.4343675417661098,0.8161363640501844,1.0,4/13,13.91%,TPST1;ENPP1;SULT4A1;TPST2
prerank,histone ubiquitination (GO:0016574),0.4362267412501919,1.0168677004365085,0.440809968847352,0.9271186285498618,1.0,8/21,24.06%,UBE2B;CTR9;USP22;PAF1;UBE2N;HUWE1;LEO1;WAC
prerank,regulation of complement activation (GO:0030449),0.3894023656301183,1.0167598360161076,0.4406528189910979,0.9266733610330131,1.0,6/40,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.35574224658280196,-1.016652235271552,0.41944444444444445,0.8165732090865134,1.0,6/22,16.45%,NR2F2;MYOCD;INCA1;IPO5;CDKN1C;HHEX
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.45463516669683535,1.0164290093164905,0.4464579901153213,0.9267034606054665,1.0,5/17,7.71%,DOCK5;DOCK7;IGFBP5;NR4A3;NRP1
prerank,negative regulation of developmental growth (GO:0048640),-0.3357754086419719,-1.0163542945217128,0.4305177111716621,0.8161283717841162,1.0,8/30,15.87%,NKD1;MAP2;PTCH1;DCC;MAG;SEMA3G;TRIM46;RNF6
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.42735556893494586,1.0162488673085703,0.4608,0.9264392548185069,1.0,1/23,0.15%,SLIT2
prerank,translational termination (GO:0006415),0.34548452748737934,1.0158298000972632,0.42560975609756097,0.9268234674683566,1.0,36/95,26.26%,MRPL33;MRPL48;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;ETF1;MRPL57;ABCE1;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;GSPT1;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.494926836778645,1.0157595189695954,0.463768115942029,0.9262814013688914,1.0,2/10,2.51%,CYP1B1;WNK1
prerank,regulation of inflammatory response (GO:0050727),0.319225654782426,1.0156696626267565,0.46145374449339205,0.9257582486344403,1.0,29/190,12.87%,FOXP1;CCN3;GPR4;ANXA1;AGTR1;PTGIS;ISL1;PRKCD;KLF4;IL10;PDCD4;MGLL;SHPK;DAGLB;NLRP6;CELF1;PTPN2;PIK3AP1;IFI35;IL17RA;TNFRSF1B;BCL6;ACOD1;GATA3;RB1;TLR4;IL16;BIRC3;TRADD
prerank,microtubule-based transport (GO:0099111),0.4714627524515666,1.0154247315362142,0.4620573355817875,0.9256259242773827,1.0,3/12,9.10%,DYNC1I1;CCDC40;SPAG17
prerank,axonal fasciculation (GO:0007413),-0.42214167118843615,-1.015409982441542,0.44835680751173707,0.8174112104843397,1.0,6/12,20.67%,CNTN4;EPHA4;NRCAM;RTN4;CDK5R1;AMIGO1
prerank,regulation of nervous system process (GO:0031644),-0.3773301601896382,-1.0153679649627398,0.4435695538057743,0.8162391431271168,1.0,6/18,14.12%,NOS3;APP;DLGAP2;NPTXR;CHRNA7;TMEM108
prerank,negative regulation of endothelial cell migration (GO:0010596),0.38832359254232,1.0153172554700116,0.43731778425655976,0.9251499854164411,1.0,6/36,9.66%,SLIT2;THBS1;ATP2B4;FGF2;JUP;AGTR2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.32739561310398,-1.015254860858335,0.4166666666666667,0.8152837688496354,1.0,15/32,29.56%,NAV3;MAP2;SNCA;CLASP2;ATXN7;CIB1;TUBB4A;ARHGEF2;TPX2;CAMSAP2;FKBP4;STMN2;STMN1;CAMSAP1;TAOK1
prerank,T cell proliferation (GO:0042098),-0.4036831901192782,-1.0151068387451896,0.4459770114942529,0.8143613179313371,1.0,3/13,12.41%,CADM1;CTPS1;PPP3CB
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4335176328921183,-1.0148314450917497,0.45537757437070936,0.8138874501272764,1.0,5/10,18.00%,KLF15;MYOCD;PRKAA2;FLCN;PARK7
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3868292496546614,1.0148218330329577,0.4287769784172662,0.9256809259171911,1.0,12/46,17.42%,PNPLA3;DDHD1;PLD1;DGKA;ABHD4;ABHD5;GPAT3;GNPAT;AGPAT4;PLA2G4A;LCLAT1;AGPAT5
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.34296825959446753,-1.0147526764876988,0.4670487106017192,0.8128341078614066,1.0,12/25,28.48%,TNFSF10;PDCD5;BMF;BIK;MLLT11;DNM1L;BAD;PLAUR;GPER1;HRK;PMAIP1;TP53
prerank,protein glycosylation (GO:0006486),0.3344479965564138,1.014085433552019,0.4605263157894737,0.9267994839171884,1.0,19/125,12.98%,ST3GAL4;MGAT4C;FUT8;MGAT3;B3GNT2;LARGE1;GCNT2;PLOD2;MPI;POMGNT2;B4GAT1;B3GNT6;GCNT4;B4GALT1;B4GALT7;DPM1;COG3;LARGE2;ST3GAL2
prerank,positive regulation of mRNA processing (GO:0050685),0.4369745895789453,1.0139490340993302,0.4599358974358974,0.9264070490568108,1.0,9/21,28.22%,RBMX;PAF1;SNW1;TRA2B;NUP98;LEO1;NCBP2;CELF3;CIRBP
prerank,negative regulation of DNA binding (GO:0043392),0.4155390709232689,1.0138611224737522,0.4722222222222222,0.9258928427485659,1.0,5/28,9.73%,SMO;GATA1;JUN;KDM1A;PER2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3595734326019137,-1.013830530521402,0.45042492917847027,0.8140654187908648,1.0,5/22,9.89%,CACNA1D;ADGRV1;GRM3;CAP2;EDNRB
prerank,organelle assembly (GO:0070925),0.3088928163341363,1.0138053228244537,0.47052845528455284,0.9252897721344053,1.0,97/384,20.75%,MAPRE2;ABLIM3;PKD1;BBS9;PARVA;EXOC4;TMOD3;NEK7;GSN;WIPI2;EHD3;ARF4;ULK2;RAB43;CFAP70;PDCD6IP;PDE6D;PRRC2C;DZIP1;EXOC5;CEP164;ZFYVE1;BECN1;ATAT1;ARL3;ABCC4;ATG3;CEP131;BIN2;RAB11FIP3;SSTR3;OCRL;MKS1;TMEM237;CDS1;FUZ;TMEM231;PCM1;PTPDC1;DISC1;HAUS5;HPS4;KIF27;ARMC9;TUBGCP4;IFT122;IST1;CEP63;EHD1;TUBGCP5;DNAH5;PIBF1;POC1B;RB1CC1;CCDC66;TSG101;GALNT11;ATP6V0D1;AMBRA1;IFT88;RAB17;CSNK1D;DYNC2I2;RILPL1;BSCL2;FLNA;CEP89;ATG2A;CEP20;IFT80;GBF1;NUDCD3;EDC3;VPS37A;TMOD4;YTHDF3;DZIP1L;INO80;ATXN2;CDC14A;YTHDF2;RAB7A;EHD2;ATG7;ULK1;TEKT2;TUBGCP6;HYLS1;TRAF3IP1;HGS;STAM2;EXOC7;EXOC1;CHMP4A;CHMP4B;LZTFL1;ATG16L1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4731465015126935,1.0136503674483537,0.4540636042402827,0.9249369665943681,1.0,2/14,5.52%,ANXA1;CD80
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.498205160060268,1.0131129997012704,0.45266781411359724,0.9255721675202885,1.0,4/10,24.36%,JUN;CITED2;HSPA1A;IMPACT
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.32922962768699987,-1.0128377881160435,0.4548611111111111,0.8154477719889757,1.0,15/32,32.75%,CEMIP;TRPC3;SNCA;GRIN1;PLCG1;P2RX7;APLNR;CASQ1;GPER1;AKAP6;CAPN3;P2RX5;TRPC1;P2RX3;RAMP3
prerank,T cell mediated immunity (GO:0002456),0.47975318236869335,1.0126997762818521,0.4674657534246575,0.925848457078029,1.0,4/13,10.17%,CD55;GNL1;JAG1;CD46
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3766692831263285,1.0126024223804748,0.46089385474860334,0.9253944575493481,1.0,18/49,25.19%,ISL1;SMAD6;GSK3B;ANKRD27;CLU;EP300;PPM1A;CDC42;LDLRAD4;ULK1;PMEPA1;TRAF3IP1;PTGER4;NLRP2B;PYDC1;SVIP;IMPACT;DACT1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.41102204685217675,-1.0123737084923305,0.4423963133640553,0.8153601586645904,1.0,8/12,44.82%,IL18;TTBK1;NUPR1;TREM2;STAP1;TNF;TAFA3;CCL3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3380689386965313,-1.0122097166690214,0.43243243243243246,0.8145247570300218,1.0,7/29,9.04%,APOE;PPARA;ZBTB20;LPGAT1;NR1H3;SCARB1;MFSD2A
prerank,bone development (GO:0060348),-0.30625288493640374,-1.0121141852387465,0.445578231292517,0.8135244559796578,1.0,10/39,11.07%,RANBP3L;TGM2;CYP26B1;GNAS;RPL13;NOTUM;GJA1;DYM;PPIB;MYOC
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.37878359549039214,1.0120109879548667,0.4336870026525199,0.9261633914656764,1.0,9/47,8.89%,PTGIS;C1QTNF12;ERFE;NFKB1;EP300;WDTC1;ATP2B4;ERLIN1;CLK2
prerank,positive regulation of cation channel activity (GO:2001259),-0.31202601842000127,-1.0117055464992362,0.4083044982698962,0.8134446296058088,1.0,7/40,8.48%,SHANK3;CALM1;TMSB4X;ANK3;STAC;CTSS;CALM3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.37804949176231667,1.0110016910144317,0.45861601085481685,0.928030613261093,1.0,20/52,23.62%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;CSNK2A2;SFN;PPP3CC;RNF31;HSPA1L;SAE1;MAPK8;HUWE1;NMT1;BBC3;SH3GLB1;PPP1R13B;YWHAH;USP36
prerank,double-strand break repair (GO:0006302),0.3253627088763073,1.010966715875897,0.453318335208099,0.9273667724573961,1.0,41/158,18.20%,REV3L;RNF138;VCP;HERC2;EYA3;ATM;BAP1;APLF;CHEK2;SWSAP1;KAT5;RNF168;ZFYVE26;RAD52;BRCA2;ERCC1;RAD51C;RPA1;IFFO1;RAD51AP1;KDM4D;PPP5C;XRCC5;EXD2;NSMCE2;AP5S1;DDX1;RBBP8;PRKDC;POLB;UBE2N;MAPK8;ACTR8;WRN;KDM2A;YY1;MCM9;POLA1;NBN;INO80;SMC5
prerank,regulation of cellular component organization (GO:0051128),0.33501860250413745,1.0109031772405728,0.45497076023391814,0.9267979678030627,1.0,28/135,15.41%,PLCE1;SNCAIP;MLLT3;NEDD4;CAMK2D;AGTR1;STON1;FAM107A;RAP1A;ABL1;SGK3;SOCS2;ANGPTL7;BAP1;MTOR;PAK4;SETD5;LTBP4;CD36;METTL4;SNX12;WFDC1;STON2;RAB5A;STK11;SNX17;HCFC1;RAB17
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32724906306115187,1.010885434847898,0.46524663677130046,0.926102975477155,1.0,26/151,13.11%,ST3GAL4;ACER3;PCSK5;PLPP3;INHBA;SGMS2;LARGE1;NFS1;DMD;SPTSSB;GOLPH3;NANP;CDO1;B3GNT6;CERS6;CERS5;TYW1;VAPA;MOCS3;CSNK2A2;CSNK2A1;TYW5;ELOVL5;PLPP1;ST3GAL2;LPIN2
prerank,regulation of immune effector process (GO:0002697),0.3831900078832699,1.0105058147545753,0.45588235294117646,0.9263198745077869,1.0,6/41,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2631513146231724,-1.0101817381948637,0.4223300970873786,0.8162962735837506,1.0,25/94,23.03%,PLCB1;RPS6KA5;IL1R1;ST18;PELI2;NOD1;MAPK3;RPS27A;UBC;IRAK2;TAB2;EGR1;PSMB10;UBB;BTRC;PSME2;RELA;PSMB3;TNIP2;PSMB4;PSMB8;PSMC5;TAB1;PSME1;PSMA7
prerank,hexose metabolic process (GO:0019318),-0.3061426878741058,-1.0100380340338668,0.42857142857142855,0.8154011118463805,1.0,8/39,16.95%,APOD;PPARD;ALDOC;ALDOA;CHST1;PGM1;HK1;FUCA2
prerank,cellular response to interleukin-7 (GO:0098761),0.4491095845607624,1.0098369647461383,0.42857142857142855,0.9265475127546815,1.0,7/17,16.64%,SOCS2;IRS1;SMARCA4;STAT3;STAT5A;BRWD1;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4491095845607624,1.0098369647461383,0.42857142857142855,0.9265475127546815,1.0,7/17,16.64%,SOCS2;IRS1;SMARCA4;STAT3;STAT5A;BRWD1;IRS2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3431581159798788,1.0096868252526945,0.45387453874538747,0.9261970690605651,1.0,23/84,17.85%,MBNL1;DDX5;RBFOX2;MBNL2;SON;CELF1;PCBP4;SRSF6;RBM25;SRSF12;RBMX;REST;RBM8A;SRPK1;RBM39;DDX17;HNRNPL;FXR2;SNW1;JMJD6;SFSWAP;ZBTB7A;TRA2B
prerank,regulation of exocytosis (GO:0017157),0.3715199198894957,1.009624744550265,0.454421768707483,0.9256480244991405,1.0,6/46,9.35%,STXBP6;ANXA1;EXPH5;SYTL4;NSF;RAB27B
prerank,negative regulation of JNK cascade (GO:0046329),-0.32058974538014584,-1.0095887786340532,0.43260188087774293,0.8153011146377509,1.0,4/31,8.89%,MECOM;GPS2;SIRPA;DUSP3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3658986223771816,-1.0093216723921323,0.4470284237726098,0.8147763934909319,1.0,3/20,7.38%,SHANK3;APOE;LRP8
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4909414055982982,1.008795584742673,0.4778761061946903,0.9270221630813406,1.0,3/12,10.93%,STX19;STX11;SNAP23
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3904280099120924,-1.008143309048514,0.4309133489461358,0.8166894278231351,1.0,5/15,16.39%,TNK2;DGKD;HIP1R;SNAP91;WASL
prerank,organelle organization (GO:0006996),0.30555872810424395,1.007965751925508,0.4593202883625129,0.9284094211579025,1.0,94/388,20.65%,MICAL2;PLCE1;FMNL2;ABCD3;ARHGAP21;ARHGAP10;CXADR;MARK1;STRIP2;ATL3;PNPLA3;GOLGB1;TMEM135;VPS13C;DIAPH1;RAB43;SPTSSB;PDCD6IP;FBXW8;ATP8B1;MTX3;TMED5;GOLPH3;GAK;HILPDA;NPLOC4;DOP1B;ATL2;FAM161B;RAB18;FGD6;MTX2;TTC17;PITPNB;NCKIPSD;DYRK3;FMNL3;LMAN2L;HPS3;VAPA;DMTN;BCAS3;PAK4;SAR1B;GABPB1;CDC42;EIF2AK3;SH3D19;TRIP11;RAB30;PEX2;TRAPPC12;KIF9;FAF2;CSNK1A1;COG3;VPS13D;MTFR1;BRWD1;STOML2;MAPK15;HCFC1;PRDX3;CSNK1D;YME1L1;AGTPBP1;BSCL2;POLG2;TICAM2;GBF1;ZRANB1;PCLO;ARL1;HUWE1;YTHDF3;TPM1;TMCC1;VPS51;MCOLN1;YTHDF2;PEX12;PLEKHM2;RAB7A;LONP1;PEX16;LONP2;SLC25A36;VAPB;SYNE1;LYSMD3;ODF2;PEX7;CHMP4A;CHMP4B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.33053558211347184,-1.0079644975553719,0.4479495268138801,0.814703587833631,1.0,5/29,9.63%,ACBD6;ACLY;ACOT7;DBI;ACSF2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.33053558211347184,-1.0079644975553719,0.4479495268138801,0.814703587833631,1.0,5/29,9.63%,ACBD6;ACLY;ACOT7;DBI;ACSF2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.454493280432149,1.0079403127534425,0.4703891708967851,0.9277328360185422,1.0,2/17,7.72%,CD44;KDM1A
prerank,sensory perception of taste (GO:0050909),0.4901181388416501,1.0075859245893977,0.4575971731448763,0.9278924197380072,1.0,2/10,12.28%,PKD2L1;CD36
prerank,central nervous system neuron differentiation (GO:0021953),-0.3281981746206791,-1.00699609009444,0.44744744744744747,0.8160540327548224,1.0,20/33,28.27%,MAP2;OPHN1;GRID2;ZC4H2;NTRK2;MAPT;SPOCK1;TOX;MDGA1;FAIM2;PROX1;ATP7A;KNDC1;LHX1;CBLN1;NPY;CEND1;LMX1A;WNT2;MDGA2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3589200884721641,1.0069640582830615,0.45278137128072443,0.9287809824254628,1.0,13/64,12.43%,THBS1;PTK2B;EFNA5;SEMA3E;GSK3B;VCL;JAG1;JUP;PTPRA;RHOA;SLC9A1;CD36;CASK
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4623448945950531,1.0069028861604088,0.44041450777202074,0.9282044115805277,1.0,3/14,13.35%,EHHADH;ACOT8;ACOX3
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.44186092874157556,1.0066603208394076,0.46875,0.928088210877443,1.0,5/18,11.36%,CTNNA1;GSK3B;MDFIC;OTUD7B;POLR1A
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.38159144294430336,-1.0061756746669945,0.45103092783505155,0.8170997246300024,1.0,9/18,21.03%,SHANK3;NRXN1;RIMS1;RIMS2;GRIN1;CHRNA7;PRKCZ;NLGN1;NLGN2
prerank,response to peptide (GO:1901652),0.39908320474575687,1.0049832804339505,0.46402349486049926,0.9316121325918973,1.0,12/33,23.82%,ANXA1;IRS1;EIF2B2;STAT3;STAT5A;ERBIN;EIF2B3;STAT6;NOD2;PRNP;STAT4;AGER
prerank,ribosome assembly (GO:0042255),-0.29620167310806855,-1.004516619826121,0.40492957746478875,0.8203472733783194,1.0,14/47,17.79%,RPS14;RPS27;RPS15;RPS5;RPL5;RPS19;RPL3;RPL24;RPL23A;TRAF7;RPL11;MRPS11;RPLP0;RPS28
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.29608255662673705,-1.0044805482277244,0.425,0.819177293811132,1.0,12/48,21.87%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18;TLR3;TRIM27;TLR7;TXK;IL27;CD276;FZD5
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.40374386360674325,-1.0042128230188332,0.44471744471744473,0.8186254493752737,1.0,8/13,35.74%,NOS3;ALDH4A1;NOS1;GLUD1;NOS2;GAD1;DAO;ARG1
prerank,glycolipid metabolic process (GO:0006664),0.37798706883346694,1.0040890191861622,0.4666666666666667,0.9331066173008479,1.0,5/47,5.93%,ST3GAL4;ESYT3;ESYT2;NAGA;HEXA
prerank,positive regulation of lyase activity (GO:0051349),-0.396379174371612,-1.0039957560953814,0.45012787723785164,0.8179577463440598,1.0,5/14,18.00%,CACNA1D;NOS3;STIM1;NOS1;PARK7
prerank,brain morphogenesis (GO:0048854),-0.42246580414276863,-1.0039851895461414,0.45566502463054187,0.8167589469900391,1.0,2/12,1.99%,SHANK3;CTNNA2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3592431004881019,1.003961235908697,0.44312169312169314,0.9327028486259421,1.0,15/63,16.35%,PLAGL1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;CHEK2;CDKN1B;PCBP4;RBL2;SFN;CARM1;PML;PRKDC
prerank,negative regulation of cell cycle (GO:0045786),0.3548585142438333,1.0038989547829633,0.43886743886743884,0.932129457595852,1.0,12/73,13.89%,BMP4;PTPN3;INHBA;IL10;PDCD4;IPO7;CDKN1B;GATA3;RB1;FOXC1;HECA;BTG3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3457404396723769,1.0038652810523516,0.45905707196029777,0.9314786946470407,1.0,20/87,11.89%,PTK2B;EFNA5;EZR;ARHGDIB;PRKCD;SEMA3E;ARHGAP44;FAM107A;NOTCH2;ABL1;PDGFA;ARHGEF5;IQGAP1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;PHPT1;RHOA
prerank,regulation of macrophage activation (GO:0043030),0.3989705232375456,1.0034378036455465,0.46199701937406856,0.9317986141828309,1.0,4/30,7.33%,THBS1;LBP;SHPK;TLR6
prerank,regulation of T cell cytokine production (GO:0002724),0.45434303138188825,1.0030479847280653,0.4691151919866444,0.9320797543389536,1.0,3/15,8.32%,CD55;TRPM4;TNFRSF1B
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.31100899030743734,1.002588978686477,0.4656084656084656,0.932531770974242,1.0,54/248,16.18%,EGFR;SOX9;TCF7L2;MLLT3;CTNND2;GLI3;PTPRU;WNT11;WNK1;GPC3;LRP6;TMEM198;GSK3B;BAMBI;FZD7;UBE2B;DDIT3;TLE6;PLEKHA4;VCP;TRPM4;NFKB1;PRICKLE1;TNKS2;TBL1X;JUP;WWTR1;FUZ;TLE4;CTNND1;CSNK1G3;PPM1A;PRDM15;CSNK1E;NOG;UBR5;TLE3;TLE2;USP34;USP47;IGFBP6;CSNK1A1;RBMS3;AMER1;PSMC6;INVS;ILK;STK11;RNF146;CSNK1D;JRK;LRP4;LMBR1L;FRZB
prerank,RNA metabolic process (GO:0016070),-0.25167526375056454,-1.0016256076413093,0.42857142857142855,0.821793676349279,1.0,34/127,22.88%,RBPMS;RBMS1;ATXN1;NOVA1;SETX;APOBEC1;HNRNPA0;AGO1;ADARB2;CELF2;METTL14;ADARB1;ELAVL4;FASTKD2;LSM1;AGO4;HNRNPH3;PABPN1;RNASE4;POLR2K;METTL3;PAPOLG;DDX54;PCBP1;RNASEL;POLR2C;DDX24;POLR2G;HNRNPU;MRPL44;POLR2L;NUFIP1;TP53RK;TFIP11
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2823803432055279,-1.0013556131242638,0.4694835680751174,0.8213033257163496,1.0,15/59,19.21%,ALDH1A2;CYP7B1;CYP27A1;GATM;ACLY;ACACA;ELOVL4;OSBP;HSD17B4;OSBPL1A;SCP2;ALDH1A3;PARK7;CH25H;HSD17B10
prerank,negative regulation of metabolic process (GO:0009892),-0.29324966277085074,-1.000987653992704,0.44,0.8211144061426663,1.0,11/54,7.50%,ALDH1A1;NOVA1;LGR4;NOVA2;NOTCH1;PLCL1;NR1H3;MAP2K6;ACVR2B;RBPJ;PLCL2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4817687557337,1.0008151566111787,0.48,0.9356000380285763,1.0,3/12,15.61%,EFNA5;DMTN;ITGB1BP1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4817687557337,1.0008151566111787,0.48,0.9356000380285763,1.0,3/12,15.61%,EFNA5;DMTN;ITGB1BP1
prerank,insulin receptor signaling pathway (GO:0008286),0.3554283876839733,1.0005203633980948,0.470074812967581,0.9356134017301773,1.0,18/69,14.09%,SORBS1;GRB10;ATP6V0A4;SHC1;GSK3B;FOXC2;IRS1;PTPN2;IDE;SLC39A14;BCAR3;ATP6V0A1;RHOQ;GAB1;ATP6V0E1;C2CD5;ATP6V1H;ATP6V0D1
prerank,calcium import into the mitochondrion (GO:0036444),0.48026998063945914,1.00047730316319,0.47794117647058826,0.9349992208318632,1.0,5/10,26.17%,MCUB;MICU1;MCU;MICU3;SLC25A23
prerank,plasma membrane invagination (GO:0099024),0.4094912479652688,1.0002167291232367,0.48672566371681414,0.9349400110275717,1.0,7/29,12.28%,GULP1;SNX18;GSN;BIN2;CDC42;RHOA;CD36
prerank,mitochondrial translational termination (GO:0070126),0.34394994539995866,1.0000669470185997,0.4600997506234414,0.9345961726287934,1.0,33/88,26.26%,MRPL33;MRPL48;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;MRPL57;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,negative regulation of immune response (GO:0050777),-0.2464935853160109,-1.000057231160167,0.45689655172413796,0.8223012509568973,1.0,35/154,16.70%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;PRKAR1B;PTH1R;ENPP3;CYSLTR1;PRKAR1A;SRC;CD300A;ADORA2A;HAVCR2;ADM;CYSLTR2;TRIM21;ADCY4;TRIM27;SAMSN1;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;TNFAIP3;SYK;TYRO3
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3780448057161617,-0.9998519084269454,0.46,0.8216225367491333,1.0,5/17,7.31%,IL34;TENM4;NOTCH1;BMP2;MDK
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.30169160182925564,-0.9998080342384095,0.467680608365019,0.8205079443127116,1.0,8/46,8.89%,SEMA6A;TIMP3;LYN;DAB2IP;FBLN1;SIRPA;WNK2;DUSP3
prerank,limb development (GO:0060173),0.41094772538507907,0.9997342303120994,0.47938931297709925,0.9346815999834353,1.0,9/28,12.88%,PCSK5;GLI3;SMOC1;KAT2A;IFT122;NOG;MEGF8;IQCE;KAT2B
prerank,intracellular protein transport (GO:0006886),0.30499691607172763,0.999693810962585,0.48544698544698545,0.9340597639531485,1.0,74/304,19.24%,PKD1;SGSM2;KIF13A;GRTP1;NUP93;GIPC1;XPO1;EGR2;ARF4;RAB43;STX19;STX5;STX11;LTBP2;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;AP3B1;AP4E1;IPO7;HERC2;PRICKLE1;TBC1D25;STX8;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;NSF;SEC13;E2F3;HPS4;NUP188;AP4B1;SAR1B;TBC1D10A;TNPO2;GGA2;EHD1;STAT3;TBC1D2B;CTTN;C2CD5;HEATR3;VIPAS39;STX16;SMURF1;FAM53A;RAN;RAB5A;SNX17;RAB17;ARCN1;VPS26C;RAB22A;TICAM2;DESI1;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;ACD;RAB7A;NUP107;CHP1;COPA;SNX13;IPO8
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2773723634790663,-0.9992992803428089,0.4801762114537445,0.8206496185478585,1.0,12/68,13.91%,TPST1;ENPP1;ACBD6;ACLY;PDE9A;ACOT7;LRRK2;HINT1;DBI;ACSF2;SULT4A1;TPST2
prerank,positive regulation of myelination (GO:0031643),0.4696176234042593,0.99929774992647,0.44939965694682676,0.9343029331482774,1.0,4/11,11.22%,EGR2;TNFRSF1B;PARD3;RNF10
prerank,cardiac cell development (GO:0055006),0.47210023584019195,0.9988685383176102,0.46195652173913043,0.9346690620938912,1.0,2/11,6.86%,CXADR;JAG1
prerank,glycoprotein metabolic process (GO:0009100),0.3657397660878064,0.9987445320808234,0.4574898785425101,0.9342525087732035,1.0,11/53,12.98%,ST3GAL4;FUT8;LARGE1;GOLPH3;PRKCSH;B3GNT6;HPSE;B4GALT7;FBXO17;GANC;ST3GAL2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.42655260323609256,0.9980661431002305,0.4960254372019078,0.9352393662010353,1.0,7/21,10.61%,IL10;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;HTR1B
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4337480356464532,0.9979990214085039,0.4767255216693419,0.9346699919555479,1.0,1/21,0.32%,FOXP1
prerank,mRNA destabilization (GO:0061157),0.38719457780491284,0.9977468248967359,0.4700139470013947,0.9345862288208523,1.0,10/38,18.68%,FTO;MOV10;CELF1;ZC3H12D;DIS3L2;PUM1;YTHDF3;ZFP36L1;YTHDF2;RC3H2
prerank,phosphatidic acid metabolic process (GO:0046473),0.37719729390000717,0.9974150320356228,0.4526166902404526,0.934679010163014,1.0,12/48,17.42%,PNPLA3;DDHD1;PLD1;DGKA;ABHD4;ABHD5;GPAT3;GNPAT;AGPAT4;PLA2G4A;LCLAT1;AGPAT5
prerank,negative regulation of cellular component movement (GO:0051271),-0.39076263603826444,-0.9972230069858151,0.4864864864864865,0.8249993889532307,1.0,4/15,7.95%,FRMD5;TGFBR3;FBLN1;SPOCK3
prerank,cytoskeleton organization (GO:0007010),0.3321889061657963,0.9969652284315504,0.4728323699421965,0.9350667564213713,1.0,7/114,2.15%,MICAL2;PLCE1;FMNL2;ARHGAP10;MARK1;STRIP2;PPP2R3C
prerank,response to reactive oxygen species (GO:0000302),0.3701902289185304,0.9966822220540592,0.46328437917222964,0.93506701995733,1.0,6/54,7.13%,EGFR;ADAM9;COA8;PLK3;CHUK;JUN
prerank,inositol lipid-mediated signaling (GO:0048017),0.3730863777590436,0.9966589649576918,0.4797843665768194,0.9343978327825868,1.0,9/50,7.52%,PLCE1;NGF;TNFAIP8L3;EZR;FGFR1;PLCB3;PLCD3;IRS1;GAB2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3008375635130418,-0.9965900593766253,0.45390070921985815,0.8255156364557843,1.0,20/40,27.34%,UNC13C;RIMS1;RIMS2;SNCA;PIP5K1C;SYT7;CPLX1;BLOC1S6;SNAP25;UNC13A;STX3;SYT1;STX1B;SNAPIN;SYT5;DOC2B;CDK5;SNAP29;RAB3A;SYT2
prerank,dendritic spine morphogenesis (GO:0060997),-0.3812813368355844,-0.9965662211867999,0.45073891625615764,0.8243476438947162,1.0,3/15,5.10%,DOCK10;SHANK3;EPHB1
prerank,protein localization to cell junction (GO:1902414),0.4186231141254449,0.9964822008139257,0.4700162074554295,0.9341136091599813,1.0,3/22,2.68%,BSN;DSP;NPHS1
prerank,muscle contraction (GO:0006936),0.3300183315311689,0.9962905937345932,0.49026345933562426,0.9338839565330367,1.0,12/126,6.53%,EDNRA;SORBS3;CALD1;SORBS1;MYBPC2;MYOM3;TMOD3;DMD;TNNI3;VCL;CHRNG;CHRNE
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.33582124868324237,-0.9959800288278089,0.48342541436464087,0.824759295031373,1.0,6/25,9.60%,EPHA4;RPL5;RPL23;OPHN1;RPS7;HSP90AB1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.32740818569025515,-0.9955385811465098,0.46938775510204084,0.8247015550629969,1.0,3/28,3.83%,ARHGAP28;ESAM;CXCL12
prerank,cellular response to fatty acid (GO:0071398),0.4880762141735622,0.9952059509406073,0.5026642984014209,0.9358167158844413,1.0,2/12,6.10%,PID1;IRS1
prerank,Golgi inheritance (GO:0048313),0.4682883438475429,0.9951370713222887,0.46619217081850534,0.9352484947796711,1.0,5/11,22.13%,STX5;PLK3;GBF1;VCPIP1;CDK1
prerank,hemopoiesis (GO:0030097),0.33932108571432784,0.9950935787328091,0.460880195599022,0.9346247930260964,1.0,12/87,6.86%,BMP4;ZBTB16;MFAP5;INHBA;HIPK1;MKNK2;IL10;NOTCH2;TNFRSF13B;PRRC2C;TGFBR2;JAG1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3919482002361506,0.9950708953576012,0.4732142857142857,0.9339731126215309,1.0,6/33,9.52%,HOXA5;FOXO3;INHBA;GATA1;BRD1;RAB7B
prerank,ERAD pathway (GO:0036503),0.3442124330888974,0.9950123704572014,0.4801980198019802,0.933416997000295,1.0,17/83,14.43%,USP13;UBE4B;RNF185;VCP;NPLOC4;ANKZF1;ERLIN1;OS9;UFD1;TRIM25;FBXO17;UBXN4;UGGT2;FAF2;ECPAS;PSMC6;UBE4A
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2748451288094509,-0.994826274781573,0.4739583333333333,0.8253786121950498,1.0,9/75,6.30%,PLCB1;GPCPD1;PDGFRB;SERINC5;PLA1A;ABHD3;ENPP6;ABHD12;SERINC1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4163205325286796,-0.9946748993356923,0.45454545454545453,0.8245709764329191,1.0,2/11,8.02%,PRKCQ;MALT1
prerank,neural crest cell development (GO:0014032),-0.3023357371247839,-0.994568079824107,0.46503496503496505,0.8236424496337066,1.0,11/44,12.02%,SEMA6A;CDH2;SEMA7A;SEMA6D;TBX1;RADIL;TAPT1;SEMA5B;ERBB4;SEMA3G;SEMA6B
prerank,protein deacetylation (GO:0006476),0.37744796029985933,0.9945453281256171,0.4870689655172414,0.9338769210952851,1.0,14/41,24.73%,HDAC4;HDAC9;RCOR3;TBL1X;HDAC10;BAZ2A;FLNA;MORF4L2;BRMS1L;MIER2;MTA1;PRDM5;SIRT7;HDAC5
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.46986449468440183,0.9944714651064881,0.47739602169981915,0.933331876953375,1.0,3/13,9.48%,ANK2;CACNA1C;CACNB2
prerank,translesion synthesis (GO:0019985),0.3803245148207686,0.9942144286953206,0.47124824684431976,0.93327031184665,1.0,10/42,14.34%,REV3L;VCP;NPLOC4;USP10;UFD1;TRIM25;RPA1;RFC5;REV1;POLD3
prerank,response to interleukin-6 (GO:0070741),0.4998277697725318,0.9942082346626173,0.4883720930232558,0.932563732466085,1.0,3/10,5.37%,PTGIS;PID1;NFKB1
prerank,regulation of endocytosis (GO:0030100),-0.28451933443969374,-0.9936912958989668,0.47413793103448276,0.8247962525347644,1.0,14/61,11.10%,APOE;PRKD1;PICALM;NEDD4L;MCTP1;SNCA;OPHN1;SYT11;RIT2;FLOT1;SRC;SPHK1;CDH13;HIP1
prerank,regulation of vasculature development (GO:1901342),0.4109555310670387,0.9934293621471785,0.47913446676970634,0.9338730452369958,1.0,1/26,0.36%,BMPER
prerank,steroid biosynthetic process (GO:0006694),-0.2813662916560117,-0.9932296439371038,0.4826254826254826,0.824833527015269,1.0,19/56,26.94%,CYP7B1;PRKAG2;CYP27A1;SC5D;INSIG2;OSBP;HSD17B4;OSBPL1A;SCP2;HSD11B1;CH25H;HSD17B10;SRD5A1;SLC27A2;PRLR;CYP46A1;OSBPL6;FDXR;OSBPL7
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.35189579098450696,-0.992980984891758,0.4369747899159664,0.824285305838966,1.0,6/22,14.43%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1;NR1H4
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3181628634497311,-0.9929332326056691,0.45098039215686275,0.823230209262254,1.0,6/35,9.28%,SASH1;PHLPP1;MFHAS1;DAB2IP;BMP2;SPHK1
prerank,alanine transport (GO:0032328),-0.43124959161917276,-0.9928595691901061,0.4701834862385321,0.8222527268939359,1.0,3/10,23.33%,SLC6A6;SLC6A17;SLC36A2
prerank,positive regulation of TORC1 signaling (GO:1904263),0.44406030722336753,0.9928416087300242,0.4870967741935484,0.9345774629989908,1.0,5/16,16.13%,SIK3;KLHL22;TELO2;CLEC16A;RRAGB
prerank,positive regulation of autophagy (GO:0010508),-0.2653323454204854,-0.9927466508861974,0.44495412844036697,0.8213469026202779,1.0,16/81,12.87%,RNF152;PRKD1;FOXO1;DCN;KDR;GPSM1;TRIM14;DAPK1;LRRK2;PRKAA2;OPTN;PIK3C2A;TRIM21;ORMDL3;TRIM27;SH3BP4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.46391450216083435,0.9926772929236864,0.4761061946902655,0.9342718296751874,1.0,8/13,27.20%,UPP2;SMUG1;MBD4;TDG;UNG;NT5M;NT5C;NTHL1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4247471670201625,-0.9923830148455756,0.4717391304347826,0.8211266675624763,1.0,5/10,27.30%,CALM1;CALM3;CBARP;GPR35;CRHR1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3759401217735126,0.9920984827186027,0.4735376044568245,0.9350261310898131,1.0,7/43,8.00%,BMP4;CCN1;BMP6;DDR2;BMPR1A;NELL1;WWTR1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4080343575676625,0.9920251168889396,0.4583333333333333,0.9344862267098618,1.0,2/24,1.57%,PKD1;PTK2B
prerank,regulation of JUN kinase activity (GO:0043506),0.3894833286375707,0.9919534492071295,0.47058823529411764,0.9339463704317167,1.0,6/33,7.68%,MAP3K5;PDCD4;ARHGEF5;PPEF2;TLR6;DUSP10
prerank,negative regulation of developmental process (GO:0051093),0.34995304733195237,0.9917825673983615,0.4669211195928753,0.9336622988879805,1.0,5/69,4.56%,BMP4;SOX9;NFIB;WNT11;KLF7
prerank,glycerol metabolic process (GO:0006071),-0.428107747878698,-0.9915215788456051,0.4780600461893764,0.8222640091828506,1.0,2/10,8.29%,GK;COQ2
prerank,nucleic acid metabolic process (GO:0090304),0.34644309445004046,0.9915051706048643,0.4706649282920469,0.9336295558024441,1.0,17/69,21.63%,NT5E;RBFOX2;DXO;HNRNPH1;RBMX;EXD2;DUSP11;GTF2F2;HNRNPL;DDX1;RAN;WRN;ATXN2;POLR2H;HNRNPM;HNRNPA3;RECQL5
prerank,membrane depolarization during action potential (GO:0086010),-0.3435479896652308,-0.9903684288226401,0.47941176470588237,0.8241741279660884,1.0,3/26,1.75%,ATP1A2;CACNA1D;SCN7A
prerank,regulation of secretion (GO:0051046),-0.39268544209132683,-0.9901285006952723,0.45161290322580644,0.8235988940232268,1.0,4/13,11.09%,MYO6;SGK1;KCNQ1;OAS2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4272437337833066,-0.989537034407576,0.5,0.8239274239101038,1.0,7/11,24.78%,ST18;FAS;PIH1D1;PARK7;CAAP1;PRR7;PLAUR
prerank,protein ubiquitination (GO:0016567),0.3001113056066305,0.9893745217548597,0.5299492385786801,0.9381451430571799,1.0,108/471,19.48%,FBXL7;WWP1;NEDD4;FBXO40;FBXO10;UBE4B;NPEPPS;WWP2;ASB9;BIRC7;RNF138;KLHL13;RNF115;UBE2B;RNF19A;NFE2L2;RNF185;VCP;FBXW8;BIRC6;ASB11;KLHL22;HERC2;MYCBP2;ATG3;FBXW11;ARIH1;TRIM44;TRIP12;TNKS2;TRIM26;RNF141;LRSAM1;RNF135;TRIM7;ANAPC16;USP7;HIF3A;OS9;FBXO32;UBE2D3;BCL10;CDC16;FBXO4;CBFB;CTR9;RNF168;ASB1;MKRN1;CCDC22;FBXL20;UHRF2;COMMD1;UBE2Z;TRIM25;ARIH2;TAF1;FBXO17;RNF10;UBR5;FBXW2;ERCC8;USP22;PEX2;PAF1;RNF111;CUL4A;RTF1;UBE2W;BFAR;RNF31;SMURF1;PSMC6;UBE4A;PPIL2;TRIM41;FBXL14;RNF146;FBXL19;FBXO25;HERC6;UBE3D;PRKDC;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;UBE2N;RNF122;UBE2G1;RNF114;HUWE1;RNF144A;GAN;PCNP;NUB1;DTX3;TRIM47;RC3H2;PEX12;PSMB1;FBXL17;VCPIP1;UNKL;USP9X;CHFR;PSMD13
prerank,regulation of acute inflammatory response (GO:0002673),-0.35928596422465986,-0.9893181312111049,0.44923857868020306,0.8233277499020109,1.0,2/18,5.30%,OSMR;IL6ST
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.24208416530960605,-0.9893170524316466,0.4444444444444444,0.8221514473056561,1.0,40/163,21.15%,PIK3R1;PDE4B;FYB1;BCL2;PAK1;INPP5D;RFTN1;TNFRSF21;TEC;MEF2C;PRKCQ;MALT1;PDE4D;VAV3;CD38;MOG;PAG1;TAB2;PSMB10;BMX;BTRC;PSME2;PLCG1;BLNK;EIF2B5;NCKAP1L;LAT2;SYK;THEMIS;RELA;PSMB3;TXK;PIK3CD;PSMB4;PSMB8;LCP2;FYB2;ICOSLG;PSMC5;CD276
prerank,cellular response to DNA damage stimulus (GO:0006974),0.30475202356922293,0.9891355235303707,0.5170278637770898,0.9380479586073492,1.0,104/336,22.40%,FOXP1;TANK;GNL1;ABL1;UBE2B;DDIT3;IGHMBP2;VCP;TRRAP;SUSD6;HERC2;PLK3;TRIP12;ATM;DYRK2;MCM7;BOD1L1;TNFRSF1B;APLF;USP10;CHEK2;MNAT1;MACROD2;RNF168;EID3;BCL6;MOAP1;RAD17;ERCC3;RAD52;ERCC1;RAD51C;CSNK1E;MBD4;NRDE2;TAF1;MRNIP;UBR5;CHEK1;RPA1;ERCC8;CEP63;USP3;RAD51AP1;TAF9;IKBKE;USP47;XPA;RFC5;CHD1L;CUL4A;SFN;ZBTB4;SMC1A;CHRNA4;XRCC5;INTS3;DDX11;UFL1;STK11;RBBP8;MAPK15;AATF;XPC;PML;PRKDC;CBX1;POLB;TAOK3;ALKBH7;WRN;ASH2L;ATF2;MAPKAPK2;ZBTB40;TLK2;YY1;OTUB1;MCM9;POLA1;NBN;CBX5;INO80;SMC5;REXO4;VCPIP1;PWWP3A;MRE11;ZBTB38;RMI2;WDHD1;SUMO1;MASTL;XRCC2;ALKBH8;RECQL5;UNG;ATR;PIDD1;FANCA;CDK1;RAD9B;APEX1;FMR1
prerank,manganese ion transport (GO:0006828),-0.38869671722447235,-0.9886667865639248,0.4643734643734644,0.822663893365862,1.0,7/14,14.74%,SLC30A10;TRPC3;SLC39A8;ATP2C1;TRPC4;TRPC6;SLC11A2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.32906953339894507,0.9886103662022927,0.48098159509202454,0.9386369944948895,1.0,37/100,24.42%,FHIT;GSK3B;GIPC1;XPO1;RNF19A;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;USP7;COMMD1;CSNK1E;ARIH2;TAF1;TAF9;CSNK1A1;RAD23B;UFL1;CSNK1D;COP1;DESI1;TLK2;RNF144A;NUB1;MAP1A;HFE;PIAS1;N4BP1;RNF14;SUMO1;TRIB2;WAC;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,regulation of rRNA processing (GO:2000232),0.4499002816367122,0.9883239931205263,0.4838709677419355,0.9386592469073856,1.0,11/16,29.88%,WDR43;KAT2B;RIOK2;WDR75;YTHDF2;METTL18;SIRT7;USP36;HEATR1;UTP15;NUDT16
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.42677232072605165,0.9881405484002214,0.4865293185419968,0.9384307501737166,1.0,4/21,12.24%,SMO;ARMC9;TTC23;KIF7
prerank,polyol metabolic process (GO:0019751),0.3673571301983859,0.9881015680519506,0.4943820224719101,0.937808697054437,1.0,10/46,9.62%,PLCE1;INPP4A;IP6K2;PLCB3;NUDT4;PLCD3;OCRL;IP6K3;PPIP5K2;PLCD1
prerank,defense response to protozoan (GO:0042832),-0.40126022181280646,-0.9880740904407567,0.46436781609195404,0.8228892942054972,1.0,6/12,26.46%,GBP7;GBP4;GBP2;CD40;BATF;BATF2
prerank,replicative senescence (GO:0090399),0.4675388641316274,0.9879926234127089,0.48713550600343053,0.9373601253742421,1.0,4/12,11.29%,WNT16;ATM;CHEK2;CHEK1
prerank,chromatin remodeling (GO:0006338),0.3291259029700238,0.9875469785968592,0.48292682926829267,0.9377942861238079,1.0,28/100,19.09%,SOX9;HDAC4;BPTF;BAZ2B;KAT2A;TAF6L;SMARCA4;FOXA1;RB1;BAZ1A;MYSM1;KDM4D;CHD1L;GATAD2B;BAZ2A;KAT2B;PBRM1;HCFC1;SRCAP;ATRX;TOP1;ACTR8;KDM6B;ZBTB7A;INO80;ARID1A;SMARCD2;RBBP4
prerank,regulation of cell size (GO:0008361),0.4253565778998068,0.9874901105421537,0.4688427299703264,0.9372279629090898,1.0,6/23,11.89%,EZR;RARG;VAV2;RDX;MTOR;RHOA
prerank,positive regulation of cellular catabolic process (GO:0031331),0.32242774361181414,0.9870793791476833,0.4878048780487805,0.9375055583833264,1.0,28/132,15.22%,SLC4A4;FOXO3;EZR;PRKCD;ADAM9;GSK3B;DXO;PFKFB2;DAGLB;MOV10;IRS1;CNOT7;GAPDHS;TNFRSF1B;KAT5;RDX;PIM2;SH3D19;PRXL2C;MTDH;ADAM8;BNIP3;ABHD5;AMER1;TFEB;UFL1;STK11;PRKAA1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4133058117616243,0.9869327370133977,0.4796747967479675,0.9371683857122803,1.0,4/20,8.54%,MRAP;PID1;PPFIA1;RHOQ
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3384376753298793,0.9865961916481905,0.49146341463414633,0.9372906011361875,1.0,16/86,13.61%,MET;BAIAP2L1;PTK2B;CDC42EP5;NCK2;FCHSD1;CLU;CLIP1;SLAIN2;NCKAP1;WDR1;RB1;TOGARAM1;PRKCE;CTTN;FCHSD2
prerank,cellular response to sterol (GO:0036315),0.46716703976173757,0.9864864102975394,0.48404255319148937,0.9368781881338482,1.0,3/13,9.05%,SMO;LRP6;GRAMD1C
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.28888677004453733,-0.9861248689879676,0.4576923076923077,0.8268959548635625,1.0,13/46,20.13%,MFN2;HK2;AIP;TIMM44;GRPEL1;TIMM13;AKT1;HK1;TSPO;TOMM7;TOMM40L;RALA;CHCHD4
prerank,receptor internalization (GO:0031623),-0.29796728867744604,-0.9859284062469807,0.505338078291815,0.8262175313668432,1.0,12/44,11.12%,DNM3;PICALM;GRK3;TFRC;CALCRL;SNCA;RAMP2;CD81;ARRB1;GTF2H2;GRB2;ADM
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.414041893612891,-0.9856653919084136,0.5089686098654709,0.8257204909626404,1.0,5/12,20.47%,ACSL1;FADS2;HSD17B4;SCP2;ACOX1
prerank,negative regulation of locomotion (GO:0040013),-0.40058554364515675,-0.9854968075326387,0.4922737306843267,0.8250070853910694,1.0,4/12,8.89%,FRMD5;FBLN1;SPOCK3;DUSP3
prerank,transcription by RNA polymerase II (GO:0006366),0.3008293749885867,0.9854539353582754,0.5162644281217209,0.9387037004652955,1.0,63/305,17.12%,NR3C2;RNMT;RARB;MLLT3;DDX5;ESR2;NR2F1;HDAC9;ELOF1;ZBTB7B;NOTCH2;NR4A2;NR4A3;NFKB1;RPAP1;HNF4A;RARG;PRRX1;TBL1X;TAF1C;TTF2;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;CBFB;MNAT1;SCAF8;NFYA;CTR9;E2F3;ERCC3;MBD1;TAF1;RBMX;TRIP11;SETD2;TAF9;PAF1;RXRA;RTF1;KAT2B;SNAPC5;INTS3;INTS8;GTF2F2;SNRPD3;CDK12;TAF15;TAF12;ELP4;SNW1;SNAPC4;MED27;NFIX;ELOA;MED17;EAF2;RORA;NR4A1;GTF2E1;AFF4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.27045557771539713,-0.9852200811756672,0.4782608695652174,0.8245544776848175,1.0,18/72,14.84%,PLEKHH2;SHANK3;APOE;KANK3;NAV3;SSH2;MAP2;HSPA8;SNCA;PFDN2;MYADM;CLASP2;PFDN5;ATXN7;CIB1;PFN1;IAPP;HIP1R
prerank,cardiac myofibril assembly (GO:0055003),0.4435778793697326,0.9850840420995861,0.49743589743589745,0.9388903272642526,1.0,4/15,8.89%,CSRP3;NEBL;MEF2A;FHOD3
prerank,regulation of axonogenesis (GO:0050770),0.3621195088731873,0.9850705196804921,0.47690217391304346,0.9382106401520983,1.0,7/51,7.56%,SLIT2;NGF;SIPA1L1;GSK3B;TIAM2;PLXNA2;MARK2
prerank,positive regulation of inflammatory response (GO:0050729),-0.26003343420865643,-0.9846601112934372,0.5053763440860215,0.8248673538464146,1.0,20/86,13.32%,OSMR;WNT5A;CD47;ETS1;SNCA;IL6ST;CD81;GRN;GPRC5B;RPS19;MDK;PDE2A;IL18;TLR3;TNFRSF1A;NINJ1;APP;NAPEPLD;AGT;TLR7
prerank,negative regulation of DNA replication (GO:0008156),0.46548154870022407,0.9845732812698754,0.49376114081996436,0.9387490139893437,1.0,3/13,11.60%,RAD17;WAPL;GTPBP4
prerank,response to muscle stretch (GO:0035994),0.4535631350433512,0.983999962349773,0.503448275862069,0.9394790809669706,1.0,3/15,4.50%,CSRP3;GSN;DMD
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.27386827152348614,-0.9836839172306753,0.47533632286995514,0.8261853845985062,1.0,20/75,15.39%,DCDC2;CTNNA2;MAP2;DCC;ACTB;BAIAP2;CNTN4;ANK3;MEF2C;OPHN1;MFSD2A;PLPPR4;APP;ZDHHC17;SDC2;BRSK2;APBB1;ADGRB1;S100A6;SLITRK4
prerank,DNA metabolic process (GO:0006259),0.3028921686920857,0.9835166668416088,0.5153439153439153,0.9399866878480777,1.0,75/270,22.37%,NT5E;TCF7L2;MPG;UBE2B;IGHMBP2;VCP;TRRAP;ATM;MCM7;USP7;MNAT1;KAT5;EID3;NOC3L;TOP3A;RAD17;SMUG1;ERCC3;RAD52;DFFB;ERCC1;UHRF2;RAD51C;CSNK1E;STN1;MBD4;CHEK1;RPA1;USP3;RAD51AP1;XPA;RFC5;CHD1L;SMC1A;CHRNA4;XRCC5;EXD2;INTS3;POLD3;RAN;RBBP8;LRWD1;ORC5;XPC;PRKDC;TOP1;POLB;UBE2N;WRN;POLA1;NBN;INO80;REXO4;ACD;TOP1MT;LONP1;PRIM2;PWWP3A;MRE11;RMI2;WDHD1;TDG;SUMO1;XRCC2;ZNF445;RECQL5;UNG;ATR;RNASEH1;MCM6;FANCA;CDK1;RNASEH2A;RAD9B;APEX1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.30165461072780125,-0.9834636063041157,0.46774193548387094,0.8256220166235064,1.0,20/38,33.39%,PHLPP1;PPARA;CIB1;AKT1;FLCN;THEM4;ARRB2;PHLDA3;INPP5K;TRIB3;SH2B3;PIK3CB;GPER1;PLEKHA1;EPHA2;HYAL2;SFRP5;PKHD1;DAG1;RACK1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.348762925521154,0.9834430109529255,0.48695652173913045,0.9394752603343929,1.0,12/72,7.51%,SOX9;PDGFC;NTRK3;FN1;NEDD4;FGFR1;WNT16;PDGFA;BECN1;HCLS1;PIK3AP1;FGF2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3429909900606493,0.9832330113302052,0.5063775510204082,0.9392915745322455,1.0,9/73,12.38%,THBS1;LBP;ISL1;CLU;MAVS;BCL10;TLR4;ADAM8;STAT3
prerank,Ras protein signal transduction (GO:0007265),0.32332082391099726,0.9828381510629339,0.49189814814814814,0.939527048566855,1.0,22/137,9.75%,PLCE1;NTN1;ARHGDIB;CCNA2;CDC42EP5;MRAS;AGTR1;SHC1;NRAS;KRAS;RAP1A;RAPGEF6;SHTN1;SHOC2;RAP2C;JUN;FGF2;NCKAP1;SGSM3;PLD1;GNA13;RIT1
prerank,negative regulation of blood pressure (GO:0045776),-0.40238316924712814,-0.9827199753521059,0.47794117647058826,0.8262509380594,1.0,5/13,16.64%,NOS3;BMPR2;GPR37L1;PRCP;NOS1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.4693409973927697,0.9822160128018042,0.5127272727272727,0.9402834813939678,1.0,2/10,14.11%,KLF4;MAP2K5
prerank,retinal metabolic process (GO:0042574),0.4675816542108907,0.9819297362009686,0.4950166112956811,0.9402653855289559,1.0,1/12,1.68%,CYP1B1
prerank,regulation of RNA export from nucleus (GO:0046831),0.4664656271870318,0.9818574441392743,0.49740932642487046,0.9397169059435281,1.0,7/11,28.54%,NRDE2;SETD2;DHX9;NCBP2;AKAP8L;NUP153;KHDRBS1
prerank,establishment of mitotic spindle localization (GO:0040001),0.4009532938632448,0.9816480641714308,0.4670750382848392,0.9395010742488162,1.0,5/28,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,regulation of insulin secretion (GO:0050796),0.33176854881239015,0.9811392751070159,0.48444976076555024,0.940034467360338,1.0,13/101,8.37%,CCN3;TCF7L2;EFNA5;ISL1;KCNS3;CACNA1C;RAP1A;KCNB1;ITPR2;HNF4A;IRS1;CAPN10;AACS
prerank,membrane depolarization (GO:0051899),-0.3140894046206033,-0.9809909078187216,0.48338368580060426,0.8295936683173153,1.0,10/32,18.10%,SCN7A;CACNA1E;SCN1A;CACNG4;CACNA1B;SCN3A;CACNB4;CACNA1I;P2RX7;SCN2A
prerank,pyruvate metabolic process (GO:0006090),0.3550520031430692,0.9808830811463523,0.5054347826086957,0.9399756683213805,1.0,5/52,7.08%,ME1;SLC16A1;PFKFB2;NR4A3;GAPDHS
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4141873504504422,0.9807655825091078,0.48220064724919093,0.9395782936927524,1.0,5/20,11.79%,MRAP;PID1;PPFIA1;RHOQ;CSK
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4183152240634068,0.9803124723681669,0.4828150572831424,0.9400468437876801,1.0,3/21,5.12%,SOX9;PTK2B;TRPM4
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.33633519244576726,-0.980243892003512,0.4515235457063712,0.8303748788653923,1.0,8/23,16.30%,PARP1;RPS27A;UBC;DDB1;UBB;COPS8;DDB2;CETN2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.34620835085844537,-0.9800269594395412,0.5,0.8297733468764001,1.0,5/23,19.13%,IGF1;GAS6;CX3CR1;TNFAIP3;GIT1
prerank,histone H4 acetylation (GO:0043967),0.3663297584970563,0.9800115466297162,0.4964838255977497,0.9400721392205039,1.0,16/47,17.41%,NAA40;TRRAP;EP300;MSL1;TADA3;KANSL2;BRCA2;ZZZ3;KANSL1;BRD8;TRIM16;HCFC1;DMAP1;EPC1;MORF4L2;ATF2
prerank,T cell homeostasis (GO:0043029),0.48575793492489494,0.9797991798370039,0.5080500894454383,0.9398978273106592,1.0,2/10,4.22%,PPP2R3C;RIPK3
prerank,positive regulation of telomere maintenance (GO:0032206),0.39477709552511003,0.9792255387230506,0.4962962962962963,0.9406294802051499,1.0,10/31,19.95%,NEK7;TNKS2;ATM;ERCC1;MAPK1;MAPK15;PML;ATRX;NBN;MRE11
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3786258791510636,-0.9791091242295042,0.5037783375314862,0.8310624422696328,1.0,8/16,25.15%,SLC30A10;PPARA;ASXL3;PARK7;ABCB7;SLC18A2;EMILIN1;GPER1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4445669999847596,0.97895212844791,0.46598639455782315,0.9405946556982823,1.0,7/16,31.01%,RBMX;SNW1;TRA2B;NUP98;CELF3;CIRBP;PRDX6
prerank,regulation of brown fat cell differentiation (GO:0090335),0.440403464124829,0.9788586005945565,0.49759229534510435,0.9401473006872771,1.0,3/16,3.83%,SIX1;FTO;ZBTB7B
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.33822627122490906,0.9788265791951886,0.48429319371727747,0.9395265031897087,1.0,29/73,27.73%,HDAC4;POLR1G;CTCFL;EP300;TAF1C;KAT2A;SF3B1;POLR1A;KAT2B;POLR1H;POLR1F;SUZ12;TAF1D;EPC1;POLR2H;RBBP4;MPHOSPH8;TDG;MTA1;EED;TASOR;EZH2;HDAC5;DDX21;SMARCA5;POLR1C;PHF19;GLMN;CTCF
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4498375198394985,0.9788040646934785,0.49917081260364843,0.9389021065152844,1.0,2/14,5.52%,ISL1;CD80
prerank,brain development (GO:0007420),0.3187464793809151,0.978598435784396,0.5056818181818182,0.9386910527788551,1.0,14/136,7.20%,SLC23A1;PBX3;ZFHX3;NFIB;PBX1;ADGRL2;ZIC1;EGR2;BPTF;GRIN2C;PAFAH1B1;TGFBR2;FBXW11;RAB18
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.45354018413425523,0.9784719638163907,0.5039494470774092,0.9382877910548397,1.0,5/15,15.27%,EDA;LRP6;FOXC1;AMELX;ANKRD11
prerank,regulation of humoral immune response (GO:0002920),0.3678918490294445,0.9784548260007124,0.4805194805194805,0.9376288720484582,1.0,6/44,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4584216663793549,0.9784272789722458,0.48186528497409326,0.9370047177881197,1.0,2/13,1.91%,SOAT1;RAMP1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3364530296962442,-0.9782080658342233,0.46467391304347827,0.8323044238797777,1.0,2/24,0.90%,ERRFI1;PRKCH
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.46513464794588527,0.9782075760898247,0.4850615114235501,0.9368264524226387,1.0,2/11,7.14%,P2RX2;P2RX4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.31574528106829447,0.9781018378441184,0.5125570776255708,0.9363845155852055,1.0,38/149,18.85%,SLCO3A1;CARD14;EDA;RIPK3;DDRGK1;NFKB1;TNFSF11;TAB3;CLU;EP300;ERC1;IL18RAP;CHUK;RIPK2;TLR6;BCL10;RAB7B;NFKB2;TRIM25;TLR4;MTDH;CD36;ADAM8;STAT3;TRADD;TRAF5;RNF31;PRDX3;DHX9;MYD88;UBE2N;ROR1;CARD16;ZBTB7A;EDA2R;AR;IRAK1;PRKD2
prerank,protein-containing complex disassembly (GO:0032984),0.365274258223129,0.9775234735674743,0.5,0.9370836054623847,1.0,10/54,13.70%,LRP6;WIPI2;GSK3B;VCP;FZD2;LIX1;CSNK1A1;TSG101;VIPAS39;AMER1
prerank,response to molecule of bacterial origin (GO:0002237),0.3449360384043497,0.9775133558111772,0.49605263157894736,0.9364182660331987,1.0,11/69,15.51%,FOXP1;LBP;SMAD6;IL10;SLPI;CYP27B1;ACOD1;TLR4;CYRIB;ERBIN;PRDX3
prerank,positive regulation of neuron death (GO:1901216),0.36792354838067437,0.9774416446235215,0.4805755395683453,0.9358870779629467,1.0,10/46,12.11%,MAP3K5;FOXO3;GSK3B;DDIT3;CLU;TFAP2A;TLR6;TLR4;TGFB2;REST
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.32328495004135954,0.9767959563532009,0.5269320843091335,0.9367786220434753,1.0,18/118,11.45%,BMPER;FMNL2;EFNA5;PHLDB2;NEDD4;SIPA1L1;ARHGAP44;PID1;GSK3B;PDLIM5;GDNF;FGF2;MARK2;TANC2;BCL6;PAK2;BCL9L;SH3D19
prerank,cellular response to cytokine stimulus (GO:0071345),0.29461378494289336,0.9766318715880437,0.5634517766497462,0.9364862616045244,1.0,59/416,12.93%,STK39;F3;SLC12A2;SOX9;DPYSL3;FN1;ANXA1;FOXO3;IL22RA1;GRB10;PTGIS;LBP;ITGB1;SHC1;NFAT5;WNK1;TANK;PID1;IL10;YBX3;GSK3B;NFE2L2;SOCS2;SYNCRIP;NFKB1;CD80;IL5;SHPK;TNFSF11;HCLS1;IL18BP;PTPN2;CHUK;CLCF1;FGF2;GAB2;IRAK4;TNFRSF1B;USP10;CDKN1B;BCL6;SLC26A6;CXCR4;ACOD1;GATA3;HYAL3;RBMX;IRF1;TLR4;CSK;RHOA;IL16;CD36;STAT3;PTPN14;FOXC1;STAT5A;TRADD;DUOX1
prerank,RNA export from nucleus (GO:0006405),0.3318234766574636,0.9765402536532055,0.5193236714975845,0.9360390562934677,1.0,36/100,26.23%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;RAN;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37;XPO5
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.30999734821056363,-0.9758383162587301,0.5159235668789809,0.8371581776951488,1.0,12/33,16.35%,LYN;ACER2;NEXMIF;PTK2;JAM3;EPHA8;DPP4;CIB1;P2RY12;PDE3B;NCKAP1L;SYK
prerank,protein K48-linked deubiquitination (GO:0071108),0.4147537351195571,0.975582732720553,0.4818181818181818,0.9376610620247178,1.0,11/23,20.84%,OTUD7B;BAP1;USP33;USP34;USP25;OTUD3;OTUB1;VCPIP1;MINDY2;OTUD5;USP37
prerank,neutrophil chemotaxis (GO:0030593),-0.275417383190071,-0.9752753107074776,0.5205992509363296,0.837504550933206,1.0,12/53,19.63%,PDE4B;BSG;PPIA;PIP5K1C;EDN1;PPIB;EDN3;NCKAP1L;SYK;CCL19;ITGB2;PIK3CD
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3697303704184333,0.9752492188821484,0.49653259361997226,0.9377697314129665,1.0,3/44,4.05%,BMP4;PRKCD;PDCD4
prerank,protein processing (GO:0016485),0.32833903256616365,0.9749826996502122,0.5030450669914738,0.9377359714448038,1.0,18/102,16.09%,F3;PCSK5;DDI2;PHEX;TMPRSS2;MMP16;MMP14;ADAM10;MYRFL;PRSS12;PARL;OMA1;SPG7;PITRM1;CPE;STOML2;XPNPEP3;YME1L1
prerank,ribosomal large subunit assembly (GO:0000027),-0.34159955973840384,-0.9748789209218374,0.5103857566765578,0.8372869900489461,1.0,8/24,17.45%,RPL5;RPL3;RPL24;FASTKD2;RPL23A;TRAF7;RPL11;RPLP0
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.37271474482358696,0.9744265568155455,0.5069637883008357,0.938328982149844,1.0,11/39,20.05%,TCF7L2;ISL1;TNFSF11;CAPN10;AACS;SELENOT;MCU;IRS2;TM7SF3;ADCYAP1;HFE
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3385343224213194,0.9744187355172038,0.4917825537294564,0.9376619056666223,1.0,19/84,22.76%,FZR1;ANAPC5;ECRG4;ANAPC16;CDC16;RB1;PSMC6;UBE2S;PSMD8;PSMB1;PSMD13;PSMD1;AURKA;PSMD7;PSMA8;PSMD3;PSMD2;CDK1;PSMC2
prerank,muscle tissue morphogenesis (GO:0060415),0.4329683937499971,0.9743451965179631,0.4843205574912892,0.9371466814152668,1.0,1/16,0.27%,BMP4
prerank,regulation of ion transport (GO:0043269),0.3375366937188738,0.9740378804052512,0.5169385194479298,0.937189229930398,1.0,13/76,13.19%,KCNJ2;NEDD4;WNK1;WWP2;SYT8;GDNF;P2RX4;KCNJ15;DRD3;ATP1A1;ITGB3;KCNJ9;CHRNA4
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3404619468115175,-0.9737879118909076,0.4753623188405797,0.8389417071737109,1.0,5/24,5.83%,VTN;EPN2;HIF1A;TMEM204;DAB2IP
prerank,positive regulation of intracellular transport (GO:0032388),0.37433229926974604,0.9733171150609466,0.4992947813822285,0.938275181069748,1.0,8/38,14.93%,NEDD4;PLK3;CEP131;CAPN10;PCM1;BCAS3;EHD1;STK11
prerank,protein neddylation (GO:0045116),0.4423101632959719,0.9731574960105654,0.4973913043478261,0.9379712541402085,1.0,2/13,7.97%,UBE2F;DCUN1D4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.43304721999743817,0.9729455306322915,0.5074135090609555,0.9377663324903067,1.0,7/17,23.94%,MPG;SMUG1;MBD4;ACD;TDG;UNG;ERCC5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4317783658530632,-0.9728795237051401,0.5063829787234042,0.8400560512902417,1.0,2/10,5.06%,LPGAT1;NR1H3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.41360403795299505,0.9723673438242993,0.49013657056145676,0.9384503449943798,1.0,7/22,15.02%,NOL11;SMARCA4;MTOR;WDR43;EIF2AK3;DDX11;WDR75
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.46536277169185153,0.9722951240672262,0.499184339314845,0.9372709289072834,1.0,7/12,21.35%,GSK3B;ATP2B4;DYRK2;RCAN1;HOMER2;CHP1;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.46536277169185153,0.9722951240672262,0.499184339314845,0.9372709289072834,1.0,7/12,21.35%,GSK3B;ATP2B4;DYRK2;RCAN1;HOMER2;CHP1;PRNP
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.31812914814909127,-0.9718401418219591,0.5299401197604791,0.841566181487548,1.0,15/31,27.34%,SYT7;ADRA2A;SYT11;SYT12;SYT9;CACNA1I;SYT13;CBARP;SYT15;SYT1;SYT5;DOC2B;STXBP3;SYT17;SYT2
prerank,embryonic hemopoiesis (GO:0035162),-0.39699671974818646,-0.9709940315927127,0.4953051643192488,0.8426899151978449,1.0,3/12,9.54%,KIT;KDR;TAL1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.27396345597933575,-0.9706646266885556,0.5317460317460317,0.8424008058236925,1.0,15/55,13.99%,BCL2;TPD52L1;TNFSF10;FAS;DAB2IP;WWOX;BCL2L1;RPS3;TNFSF12;GSDME;BMF;AGT;TRAF7;TRAF2;BOK
prerank,regulation of focal adhesion assembly (GO:0051893),0.3561614786934419,0.9703863077925806,0.5020463847203275,0.9410683376328869,1.0,13/54,13.08%,THBS1;EFNA5;PHLDB2;FAM107A;ABL1;VCL;NRP1;PTPRA;DMTN;BCAS3;RHOA;SLC9A1;S100A10
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4125902546944287,0.9696939845674405,0.5042016806722689,0.942051438794733,1.0,3/20,5.26%,BMP4;PDCD4;TGFBR1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.47358316522591026,0.9695029942200037,0.493006993006993,0.9418621566805692,1.0,1/11,1.25%,SCARA3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3333004988742091,-0.9691690757605185,0.5138121546961326,0.845168236396072,1.0,5/24,8.91%,NR1H3;AQP11;BCL2L1;TMBIM6;LRRK2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.419092218990047,-0.9688533956226627,0.5069444444444444,0.8447692804547592,1.0,7/10,18.39%,GPR37;LRRK2;GPR37L1;STK26;PDE8A;PARK7;TXN
prerank,positive regulation of developmental growth (GO:0048639),-0.2821634597884072,-0.9687678636954615,0.5057034220532319,0.8438481606875076,1.0,20/49,22.18%,PLCB1;SEMA7A;NEDD4L;RIMS1;RIMS2;INSR;GHR;MACF1;CDKL5;MAPT;PPIB;LIMK1;RNF157;TWF2;UNC13A;CPNE5;DLL1;SYT1;CPNE9;ITSN2
prerank,regulation of defense response (GO:0031347),0.3389063618685269,0.9686711865178587,0.5111989459815547,0.9431993759863944,1.0,12/76,9.44%,FOXP1;ANXA1;AGTR1;MGLL;SHPK;DAGLB;NLRP6;CELF1;PIK3AP1;RNF135;BCL6;ERAP1
prerank,tRNA modification (GO:0006400),0.34753547850692074,0.9683049702563628,0.5039893617021277,0.9433793966023019,1.0,21/62,23.15%,TRMT13;METTL6;CTU2;TYW1;MOCS3;PUS10;METTL1;ELP5;TYW5;MTO1;GTPBP3;QTRT2;QTRT1;TRDMT1;ALKBH8;TRMT61A;PUS7;TRMT12;AARS1;DUS2;URM1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.36004535820935496,-0.9681548440991866,0.5062972292191436,0.8442967597117903,1.0,7/18,28.01%,MFHAS1;PPP1R16B;ENSA;SH2D4A;INPP5K;PPP1R35;YWHAB
prerank,arachidonate transport (GO:1903963),0.4760940884230652,0.9678509376144478,0.5070671378091873,0.943105948112984,1.0,1/10,1.33%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.4760940884230652,0.9678509376144478,0.5070671378091873,0.943105948112984,1.0,1/10,1.33%,ANXA1
prerank,cellular response to interferon-gamma (GO:0071346),-0.256971077904574,-0.9676400055193796,0.5129533678756477,0.8444892134169056,1.0,35/88,25.93%,B2M;VCAM1;WNT5A;CD47;GBP7;IRF2;GBP4;NCAM1;AQP4;TRIM62;GAPDH;SIRPA;DAPK1;RPL13A;CAMK2A;MT2A;OAS2;TRIM21;CAMK2B;SP100;GBP5;GBP2;CCL19;HCK;FCGR1A;CASP1;TRIM8;STAT1;IRF7;AIF1;GBP3;CCL2;PTAFR;OASL;CCL25
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3510346578600127,0.9675171058187133,0.516260162601626,0.9432069820375018,1.0,15/55,12.99%,GPC6;CD44;GPC3;HEXA;NAGLU;GPC4;FGF2;SGSH;HPSE;SPAM1;HYAL3;GLB1;SLC9A1;ARSB;SDC4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3352448309752039,0.9672581830790344,0.4968314321926489,0.9431624104478451,1.0,3/78,1.94%,EGFR;PKD1;CCNA2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.34081424815167094,0.9671882859061139,0.5179948586118251,0.9426612845821648,1.0,15/67,13.07%,CYFIP2;PTK2B;SULF1;ABI1;PGF;NCK2;ITGAV;VAV2;NRP1;NCKAP1;PAK2;CDC42;BRK1;RHOA;ITGB3
prerank,negative regulation of gene expression (GO:0010629),0.2969937066828789,0.9671043358020747,0.5380604796663191,0.9421880244463013,1.0,44/302,13.13%,BMP4;FOXP1;SLC24A3;SAMD4A;ITGB8;SMO;WWP2;HDAC9;KLF4;IL10;DXO;NOTCH2;ZNF148;BMPR1A;TNRC6C;IGFBP5;DDRGK1;SYNCRIP;NFKB1;MOV10;CNOT7;PAIP2;CELF1;ATP2B4;FGF2;ZC3H12D;SMCR8;ADAM10;TOB1;ASB1;ATOH8;DIS3L2;CD46;TAF1;EIF2AK3;RB1;RBL2;NANOS2;TGFB2;REST;SNX12;RBMS3;KAT2B;LSM2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3188156152539704,0.9671026136587347,0.5359628770301624,0.941513123551784,1.0,39/129,21.58%,EGFR;WNK1;GPC3;TMEM198;BAMBI;UBE2B;PLEKHA4;VCP;TRPM4;NFKB1;TNKS2;TBL1X;JUP;CSNK1G3;PPM1A;PRDM15;CSNK1E;UBR5;USP34;USP47;AMER1;PSMC6;ILK;RNF146;CSNK1D;JRK;PSMD8;FZD9;CSNK1G1;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;SFRP4;TGFB1;EGF;CAPRIN2;PSMD3
prerank,C-terminal protein amino acid modification (GO:0018410),-0.40535170807314524,-0.9669655836798827,0.5239234449760766,0.8450543051168409,1.0,4/11,14.60%,AGBL4;ATG12;LCMT1;ICMT
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4260722270652342,0.9668157219421077,0.5120772946859904,0.9414677031890506,1.0,5/18,15.69%,EZR;RDX;SNX12;MAPK1;MAP2K2
prerank,amyloid fibril formation (GO:1990000),-0.2883916312030708,-0.9667997781424155,0.516245487364621,0.8443295188824512,1.0,16/51,17.91%,HSPG2;B2M;CST3;SNCA;TSPAN5;ITM2B;RPS27A;UBC;MAPT;APP;TGFBI;UBB;IAPP;GGA3;APH1B;PSENEN
prerank,regulation of cellular respiration (GO:0043457),-0.3718632930886211,-0.9665406214922702,0.511166253101737,0.8438273537799043,1.0,3/17,3.90%,CBFA2T3;IFNAR1;PRDM16
prerank,response to organic cyclic compound (GO:0014070),0.352424455548773,0.9664860215712872,0.49865229110512127,0.9416053480989338,1.0,13/52,15.73%,ANXA1;CYP1B1;IGFBP5;SOCS2;CYP27B1;STRN3;FOXA1;CYP19A1;DRD3;STAT3;CDKN2D;ARL6IP5;TRPM2
prerank,fatty acid transmembrane transport (GO:1902001),-0.3510545170575649,-0.9664305175640109,0.49635036496350365,0.8429522826261744,1.0,6/19,11.01%,SLC2A1;PRKAG2;CPT1A;ACACA;ACACB;PRKAA2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4301358168325304,-0.9661878246466609,0.5302325581395348,0.8423990416516371,1.0,2/10,4.67%,APOD;SNCA
prerank,negative regulation of protein kinase activity (GO:0006469),-0.25858606883806257,-0.9659740454881839,0.5,0.8417890772279071,1.0,24/88,21.99%,PTPRB;PPM1E;PRKAG2;PPIA;PTPRT;SNCA;DAB2IP;GSKIP;ADARB1;DUSP3;SLC8A1;SPRED1;TRIM27;AKT1;CDKN1C;PPM1F;TARBP2;DUSP26;PARK7;RTRAF;PTPRO;INPP5K;TRIB3;TAB1
prerank,UV-damage excision repair (GO:0070914),0.4559582966487761,0.965922265215435,0.5034722222222222,0.9422745757363621,1.0,6/12,18.17%,ERCC1;XPA;POLD3;XPC;POLA1;INO80
prerank,regulation of DNA recombination (GO:0000018),0.384049480136733,0.9649188114297103,0.5067873303167421,0.9439800549566285,1.0,9/32,20.84%,IL10;KDM1A;KPNA1;CHEK1;SETD2;RAD51AP1;PPP4R2;MRE11;SHLD2
prerank,protein heterooligomerization (GO:0051291),0.4352675027622479,0.964363450434665,0.4700162074554295,0.9445998680906049,1.0,2/17,2.08%,PKD1;TMEM120A
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3030356604411977,-0.9640515162745427,0.5223880597014925,0.8454766543541792,1.0,7/40,8.52%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;BMP2;ZC4H2
prerank,cellular response to UV-A (GO:0071492),-0.4085596559923728,-0.9640391040436946,0.5067264573991032,0.8443533116320311,1.0,7/11,46.93%,MMP2;CERS1;MMP3;MME;OPN5;MMP9;OPN1SW
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3949425600537514,0.9638045211465648,0.5053435114503817,0.9452625851809613,1.0,11/29,21.61%,TANK;CHUK;TLR6;UBE2D3;TLR4;IKBKE;BIRC3;TICAM2;LY96;FADD;TRAF3
prerank,receptor catabolic process (GO:0032801),0.4033730568688994,0.9637508324267813,0.5023328149300156,0.9447194256858351,1.0,4/24,7.36%,NEDD4;AP2A2;BECN1;AP2A1
prerank,mismatch repair (GO:0006298),0.3904411888562259,0.9636017911864423,0.4917293233082707,0.9444102772676639,1.0,10/27,22.16%,ABL1;ERCC1;RPA1;SETD2;POLD3;XPC;MCM9;PMS2;TDG;RNASEH2A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.33085511588812067,0.9634492728145021,0.5325953259532595,0.944067340292275,1.0,34/96,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,focal adhesion assembly (GO:0048041),0.42633421942881017,0.9633620229819406,0.5250783699059561,0.9435953445166126,1.0,4/21,6.45%,SORBS1;BCR;PIP5K1A;TRIP6
prerank,regulation of double-strand break repair (GO:2000779),0.3712849160187255,0.9628780759120675,0.4972451790633609,0.9441051342117163,1.0,12/39,17.74%,TRIP12;KDM1A;MRNIP;UBR5;CHEK1;SETD2;RAD51AP1;DDX11;FOXM1;PML;PPP4R2;OTUB1
prerank,ruffle organization (GO:0031529),-0.3604398063265404,-0.9627686613932807,0.48293963254593175,0.8465140348038146,1.0,9/16,28.73%,PLEK;RAC1;AIF1L;CSF1R;ARF6;INPP5K;AIF1;CORO1B;PLEKHA1
prerank,axon development (GO:0061564),-0.26106942896440455,-0.9627305177109154,0.5046728971962616,0.845466058288377,1.0,23/78,20.67%,NREP;CTNNA2;DCC;PLP1;GRM7;ACTB;BAIAP2;CNTN4;ANK3;MAPT;PLPPR4;APP;ZDHHC17;BRSK2;APBB1;ADGRB1;S100A6;SLITRK4;NRCAM;NEFH;RTN4;CDK5R1;AMIGO1
prerank,organophosphate biosynthetic process (GO:0090407),0.3693321569733858,0.9625660318255918,0.5112359550561798,0.944173047433992,1.0,12/37,18.17%,IP6K2;NFS1;PIP5K1A;FGF2;IP6K3;PPIP5K2;MOCS3;PNPO;GNPAT;AGPAT4;AGPAT5;MBOAT1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3400605033294335,0.9624255240353692,0.509829619921363,0.9438523209223145,1.0,16/62,18.62%,MLLT3;ELOF1;MNAT1;CTR9;ERCC3;SETD2;PAF1;RTF1;GTF2F2;CDK12;ELP4;ELOA;EAF2;AFF4;NELFE;POLR2H
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3772907359132275,-0.9621798812576753,0.5080213903743316,0.8458065360149244,1.0,7/16,22.48%,PARP14;INPP5F;BCL3;NF2;LEPROT;SH2B3;SOCS1
prerank,endocytic recycling (GO:0032456),0.3505069265255998,0.9617100834994603,0.5087956698240866,0.944938516398109,1.0,20/50,21.16%,EHD3;ANKRD27;RAB11FIP3;SNX31;VPS53;ENTR1;CCDC22;WASHC1;EHD1;SNX4;SNX12;SNX17;RAB17;VPS26C;VPS51;RAB7A;EHD2;VPS50;VPS29;VPS26A
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3193300153029412,-0.9613117405996274,0.5147058823529411,0.8468694563823724,1.0,12/27,23.49%,PPIA;CALM1;PPP1R16B;BMP2;CALM3;SRC;PPP2R5A;MTMR9;PPP1R7;CDCA2;SMPD1;PIN1
prerank,regulation of cell motility (GO:2000145),0.31800441261766843,0.9612787535249755,0.5198598130841121,0.9452660410011887,1.0,19/121,11.89%,EGFR;NTN1;LMO4;CCDC125;MGAT3;LMNA;DIAPH1;ABL1;SGK3;MEMO1;SERPINE2;PLXNA2;FGF22;FGF2;GATA3;PKN2;BEX4;PHPT1;RHOA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3404661101681601,0.9612158469578772,0.5201560468140443,0.9447336102676831,1.0,7/67,4.13%,EGFR;PTK2B;ABI1;FGFR1;DDR2;EFEMP1;ABL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.27180090164994525,-0.9611169416561727,0.5256410256410257,0.8461871121572994,1.0,16/61,24.09%,PPARA;PRKAG2;PSMB10;NR1H4;PSME2;PDK2;OAZ1;SIRT5;FGFR4;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5
prerank,negative regulation of protein localization to membrane (GO:1905476),0.39689496841934135,0.9610755653302511,0.503125,0.9443721200434575,1.0,5/24,9.56%,MRAP;PID1;PPFIA1;RHOQ;DMTN
prerank,DNA duplex unwinding (GO:0032508),0.3548908721509404,0.960937926476413,0.5358592692828146,0.9440270649942268,1.0,19/50,22.29%,ANXA1;MCM7;ERCC3;RPA1;XPA;CHD1L;CUL4A;DDX11;RAD23B;DDX1;XPC;DHX9;WRN;MCM9;NBN;MRE11;RECQL5;MCM6;MCMDC2
prerank,positive regulation of signaling (GO:0023056),-0.2966379035590696,-0.9608771806093402,0.542319749216301,0.845621832821346,1.0,8/37,11.16%,WLS;RIMS1;RIMS2;SNCA;INPP5F;GRIK2;EDN1;EDN3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2677495317999975,-0.9605160383869177,0.5201612903225806,0.8453535778472425,1.0,24/62,28.57%,PPIA;BCL2;CXCL12;TPT1;BCL2L1;TMBIM6;LRRK2;SRC;NOC2L;NME5;NDUFS3;AKT1;PARK7;ARHGEF2;SOD2;TRIM32;CCAR2;PLAUR;SELENOS;RTKN2;DNAJA1;HYOU1;ENO1;XBP1
prerank,regulation of T cell proliferation (GO:0042129),0.34515153218237804,0.9604565241606132,0.5237467018469657,0.9444504848624528,1.0,10/61,15.37%,ANXA1;IL10;RIPK3;CD80;NCK2;TNFRSF1B;CD46;SDC4;CEBPB;TNFRSF13C
prerank,negative regulation of platelet activation (GO:0010544),0.4240350980605065,0.9597186755364671,0.5082508250825083,0.9454976594004306,1.0,5/16,6.41%,CD9;PRKCD;THBD;PDGFA;SERPINE2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.33062927957909566,0.9595529808217558,0.5224787363304981,0.9452045329242093,1.0,18/88,11.45%,STXBP6;VPS13A;EXOC4;GOLGB1;VPS13C;RABEP1;CLINT1;EXOC5;AP4E1;ARL3;DOP1B;AP2A1;OSBPL5;CCDC22;AP4B1;COMMD1;SNAP23;SH3D19
prerank,response to insulin (GO:0032868),-0.2538610079032963,-0.9594257340021822,0.5436893203883495,0.8468683706386987,1.0,21/80,19.53%,TBC1D4;PIK3R1;SORT1;FOXO1;ENPP1;CPEB2;INSR;LPIN3;PARP1;MYO5A;INSIG2;LPIN1;RPS6KB1;PDE3B;AKT1;GSK3A;SLC27A1;PKM;PRKCI;SLC25A33;RAB15
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4747102903573942,0.9591488042134889,0.5174953959484346,0.9448034071478337,1.0,2/10,7.36%,AP2A2;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4747102903573942,0.9591488042134889,0.5174953959484346,0.9448034071478337,1.0,2/10,7.36%,AP2A2;AP2A1
prerank,positive regulation of DNA binding (GO:0043388),0.3831678013072398,0.9582091654931131,0.5135542168674698,0.9463388028286471,1.0,7/31,12.50%,NGF;HES1;SKI;GATA3;NIBAN2;RB1;FOXC1
prerank,B cell proliferation (GO:0042100),-0.35921616692708414,-0.9581732855291438,0.5135869565217391,0.8488824068904759,1.0,3/17,6.59%,BCL2;CTPS1;MEF2C
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.33705743621776985,0.9581666646501312,0.5373891001267427,0.9457838033696191,1.0,6/73,5.66%,F3;NGF;EGLN3;VCP;DIABLO;CRADD
prerank,regulation of histone methylation (GO:0031060),0.440496026355739,0.9581660044764116,0.5094991364421416,0.9451144588520184,1.0,6/13,19.35%,CTCFL;CTR9;PAF1;MTHFR;CHTOP;NNMT
prerank,negative regulation of histone methylation (GO:0031061),-0.41996391402834427,-0.958155608281943,0.5475113122171946,0.8477748224409813,1.0,4/10,18.30%,JARID2;BCOR;MTF2;BRCA1
prerank,regulation of hydrolase activity (GO:0051336),0.33889810239438567,0.9580002523871572,0.5284450063211125,0.9448379474058767,1.0,13/71,7.45%,EFNA5;SIPA1L1;ARHGAP44;RAPGEF6;ADAP1;RAB3GAP2;ARHGEF5;PAFAH1B1;FBXW11;PLXNA2;VAV2;OCRL;FGD6
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4620921862691661,0.957924119831364,0.5258467023172906,0.9443520103863773,1.0,3/12,4.50%,ATP1B1;WNK1;DMD
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3663516498537975,0.9575465144090053,0.5322128851540616,0.9445316664927297,1.0,13/44,19.11%,FTO;TNRC6C;MOV10;CNOT7;CELF1;TOB1;NANOS2;PUM1;YTHDF3;TNRC6A;ZFP36L1;YTHDF2;PABPC1
prerank,mitotic nuclear division (GO:0140014),0.3383740039015464,0.9570731533389992,0.5210727969348659,0.9449844499144995,1.0,21/71,19.32%,SMC4;NDEL1;ARHGEF10;KLHL22;PPP2R2D;CHEK2;MISP;TOGARAM1;RHOA;PIBF1;SMC1A;RAN;UBE2S;FLNA;STAG2;INO80;KIF18A;KIF2A;SPICE1;AAAS;CEP192
prerank,acylglycerol metabolic process (GO:0006639),-0.29599740089483484,-0.9568388657378277,0.5506756756756757,0.8499031600116599,1.0,13/37,20.74%,APOE;DGKB;DGKI;GK;ABHD12;DGKD;DGKG;PGS1;DGKE;PNPLA2;DGAT1;AWAT2;LPL
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3349433299486142,-0.9567724150419487,0.4861878453038674,0.84892185720564,1.0,18/24,39.55%,HSCB;HSPA9;CIAO3;ISCA1;BOLA2;NUBP1;GLRX3;LYRM4;ABCB7;ISCA2;IBA57;MMS19;GLRX5;FXN;NUBPL;CIAO1;CIAPIN1;NDOR1
prerank,organophosphate ester transport (GO:0015748),0.4005979488118384,0.9567629399277394,0.5147744945567652,0.9450128305039196,1.0,5/24,8.53%,TNFAIP8L3;PITPNA;PITPNC1;PITPNB;OSBPL5
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.26521956835470584,-0.9564953284976246,0.5564853556485355,0.8484723515744156,1.0,15/70,18.40%,ENPP2;ABHD3;NR1H3;LPIN3;SLC44A1;PNPLA8;MFSD2A;DBI;LPIN1;SLC44A2;STARD7;SLC27A1;TMEM86B;PLA2G4E;MBOAT7
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3187959876996996,0.9563506116162266,0.5341317365269461,0.9452804900463124,1.0,8/108,5.66%,F3;MAP3K5;NGF;EGLN3;GSN;VCP;DIABLO;CRADD
prerank,positive regulation of receptor internalization (GO:0002092),-0.3419872111996352,-0.9560553214073508,0.4986072423398329,0.8484411148211607,1.0,7/22,20.96%,INSR;ARRB1;CD63;NTF3;ARRB2;GREM1;VEGFA
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4345245959079417,0.9556442900166934,0.5251299826689775,0.9462587796884441,1.0,6/14,18.86%,DDRGK1;AGR2;BFAR;COPS5;UFL1;PTPN1
prerank,response to metal ion (GO:0010038),0.3421049050453325,0.955379245634381,0.5219638242894057,0.9462096434363723,1.0,5/67,3.16%,THBS1;NDRG1;NEDD4;PPP3CA;ADAM9
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.23889234404795912,-0.9553372981424623,0.56875,0.8490799922081568,1.0,36/109,25.46%,PLCB1;INPP4B;PIK3R1;PDGFRB;PIP5K1B;LPGAT1;INPP5D;PLEKHA2;INPP5F;PIP5K1C;PIK3R6;PLEK;BMX;PIK3C2A;MTMR10;PLCG1;SLC27A1;PIK3R5;MTMR9;PLA2G4E;MBOAT7;CSF1R;PIK3CD;PITPNM1;RAB14;PTPN13;MTMR2;INPP5K;MTMR1;INPP5J;PIK3CG;TPTE;PLA2G4C;CDIPT;PIK3CB;PIP4K2B
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.30613975681662686,-0.9552769353853003,0.5352564102564102,0.8481024539706069,1.0,16/33,25.15%,TGFA;CCDC88A;ADRA2A;DGKD;HBEGF;HIP1;AGT;HIP1R;AKT1;CNOT9;DOK1;AFAP1L2;NUP62;HAP1;PLAUR;GPER1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.40625635361562185,-0.9544853579744682,0.5125,0.8489580945340718,1.0,3/11,6.59%,LYN;RAPGEF2;MEF2C
prerank,cellular response to leucine (GO:0071233),0.4564142993681014,0.954079825166052,0.5017301038062284,0.9478592688191922,1.0,2/10,10.44%,KLHL22;MTOR
prerank,response to leucine (GO:0043201),0.4564142993681014,0.954079825166052,0.5017301038062284,0.9478592688191922,1.0,2/10,10.44%,KLHL22;MTOR
prerank,cytoplasmic translational initiation (GO:0002183),0.4172905294955553,0.9540666945077154,0.5136876006441223,0.9472214836194445,1.0,10/17,29.07%,EIF4G1;EIF2D;EIF2B3;EIF2S2;EIF3A;DHX29;RBM4;EIF4B;EIF4A1;EIF4A2
prerank,long-term synaptic potentiation (GO:0060291),0.40552395526837237,0.953911703578968,0.5025041736227045,0.9469149472382815,1.0,5/21,14.36%,PTK2B;GRIN2C;NFATC4;CRHR2;MPP2
prerank,negative regulation of defense response (GO:0031348),0.32939318653885247,0.9534367533199467,0.5326370757180157,0.9473154302392314,1.0,11/77,11.53%,CCN3;PTGIS;ISL1;PRKCD;KLF4;IL10;PTPN2;ACOD1;GATA3;RB1;TRAFD1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29212430272584855,0.9533536282849878,0.6026831785345718,0.9468225808487495,1.0,49/390,8.54%,EGFR;MET;CYFIP2;ARHGEF28;NGF;PDGFC;NTRK3;PTK2B;SORBS1;EFNA5;SULF1;ABI1;RBFOX2;GRB10;FGFR1;ATP6V0A4;SHC1;SIPA1L1;PGF;DDR2;ADRB2;GSK3B;POLR1G;AP2A2;SOCS2;SPRED2;FOXC2;PDGFA;NR4A3;FLRT2;NCK2;EPHB6;IRS1;SHOC2;ITGAV;FGF22;HNRNPH1;VAV2;PTPN2;IDE;AP2A1;FGF2;NRP1;NCKAP1;NFATC4;SLC39A14;BCAR3;ATP6V0A1;RHOQ
prerank,mRNA transport (GO:0051028),0.3226834177381768,0.9533296579740437,0.5457788347205708,0.9462186364820597,1.0,36/101,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZFP36L1;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FMR1;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,regulation of synapse organization (GO:0050807),-0.32441650192100396,-0.9531576153059909,0.514792899408284,0.8511732089060949,1.0,10/26,15.39%,IL1RAPL1;CTNNA2;WNT5A;EPHA4;MEF2C;ABHD17C;CDKL5;MDGA1;CAMK2B;SLITRK4
prerank,negative regulation of TOR signaling (GO:0032007),-0.30107382860031145,-0.9530843874216683,0.5263157894736842,0.8501942151641548,1.0,9/36,16.65%,RNF152;SPAAR;TMEM127;PRKAA2;TNFAIP8L1;SH3BP4;MINAR1;GSK3A;FLCN
prerank,positive regulation of organelle assembly (GO:1902117),-0.2846801656254758,-0.9530267558539366,0.5542635658914729,0.8492011214962933,1.0,6/44,6.86%,ASAP1;CNOT6L;CEP120;CCDC88A;TAPT1;SDCBP
prerank,protein secretion (GO:0009306),0.3410167785663425,0.9529976417236329,0.5134770889487871,0.9463512383633824,1.0,5/56,5.51%,PCSK5;ANXA1;LTBP2;SNX19;GOLPH3
prerank,smooth muscle cell differentiation (GO:0051145),0.4627313619063811,0.952987573511773,0.5252173913043479,0.9457164727401121,1.0,1/12,0.27%,BMP4
prerank,regulation of biomineral tissue development (GO:0070167),0.39176397949494585,0.9529296523047132,0.5232919254658385,0.9451841979581889,1.0,5/26,8.58%,SOX9;DDR2;SGMS2;TXLNG;CYP27B1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.26737420577650295,-0.9529201422679072,0.55,0.8483428339381852,1.0,13/54,18.55%,RNF152;NEDD4L;UBE2E2;KLHL3;UBE2A;RFFL;RNF187;RNF6;TNFAIP3;TOPORS;ZNRF1;KBTBD7;HACE1
prerank,intracellular lipid transport (GO:0032365),-0.3368962612706522,-0.9526400690616125,0.5012853470437018,0.8479494396720524,1.0,7/21,11.01%,PRKAG2;NPC2;CPT1A;ACACA;ACACB;CERT1;PRKAA2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2902084051480053,-0.9524868739984123,0.5305466237942122,0.8472435391364952,1.0,13/42,16.87%,TEK;KDR;CSF1;PLEKHA2;CDK6;MAP4K4;RAC1;EFEMP2;CDH13;MYOC;CIB1;PPM1F;RIN2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.38475350411771764,0.9524511051014934,0.519650655021834,0.9456410131062163,1.0,4/27,5.97%,CD44;NFAT5;NR4A3;TNFSF11
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.40033568942113307,-0.9520012665412024,0.531615925058548,0.8473459849140327,1.0,3/12,4.91%,IGF1R;SETX;INSR
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.27338883057946683,-0.951860294678798,0.5142857142857142,0.8465597800151268,1.0,15/54,17.45%,NSA2;RPL14;RPL5;RPL3;RPL24;NOC2L;RPL23A;TRAF7;SNU13;RPL7A;RPL35A;RPL26;LAS1L;RPL11;RPLP0
prerank,RNA splicing (GO:0008380),0.3218342722767441,0.951778515605131,0.5440097799511002,0.9465278715032318,1.0,29/95,22.20%,MBNL1;SNRNP48;SYNCRIP;FUS;TCERG1;RSRC1;PRPF3;PPIG;NRDE2;SF3B2;SF3B1;SRRM1;RBM8A;SRPK1;SRSF11;SNRPD3;CDK12;SCNM1;SCAF11;TRA2B;NOL3;GEMIN2;DDX47;PRPF6;TXNL4A;ZCRB1;RNPC3;SNRPD2;SNRPD1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4566578791269497,0.9516579823444785,0.5439856373429084,0.9461400772832399,1.0,3/11,11.95%,CD44;KDM1A;TAF9
prerank,regulation of tumor necrosis factor production (GO:0032680),0.31569708353626463,0.9516344099642821,0.5368171021377672,0.9455317607171932,1.0,7/112,7.04%,FOXP1;THBS1;LBP;ISL1;IL10;CLU;MAVS
prerank,regulation of intracellular signal transduction (GO:1902531),0.2913888371789172,0.9513853655242392,0.624618514750763,0.9454418695713462,1.0,85/420,15.41%,EGFR;MOB3B;RASSF2;NTRK3;ARHGAP21;ARHGAP10;ARHGAP20;EZR;ARHGDIB;ARAP1;AKAP13;RHOJ;HIPK1;ARHGAP44;ARHGAP31;SMYD2;ARAP2;BCR;TIAM2;ARHGEF6;TRIO;ARHGEF5;PIP5K1A;TNFSF11;ITGAV;EP300;DLG1;PLK3;USP2;VAV2;OCRL;ATM;DYRK2;GATA4;CASTOR2;USP7;AKAP12;SRGAP2;SRGAP3;RHOQ;MDM4;TELO2;CHEK2;MLST8;KAT5;TOP3A;GNA13;RAD17;MTOR;PAK4;PAK2;CDC42;TAF1;ULK4;CHEK1;RPA1;CSNK2A2;CSNK2A1;SQSTM1;PAK1IP1;RHOA;TAF9;MYO9A;RFC5;NEK8;BIRC3;CMKLR1;PRKAR2A;INPP5B;MAPK1;GPAT3;EHMT2;TRAF5;STYXL1;EHMT1;ARHGAP5;ARHGEF18;ARHGAP17;UFL1;STK11;TAF15;RBBP8;PRKAA1;TAF12;STARD13
prerank,epithelium development (GO:0060429),0.3210012302712103,0.9510403339634037,0.5379146919431279,0.9455976228879426,1.0,10/107,7.19%,SOX9;SMO;SIX1;PKD1;BDH2;ANXA4;MEOX2;KANK2;VCL;STIL
prerank,peptide metabolic process (GO:0006518),0.3348905256254144,0.9508544525372692,0.5432569974554707,0.9453579149787215,1.0,11/75,11.06%,PCSK5;NPEPPS;MGAT3;DMD;CPQ;IDE;NLN;CARNMT1;MMACHC;ERAP1;PARL
prerank,regulation of fatty acid oxidation (GO:0046320),0.42654616319782906,0.9508007328187178,0.5184563758389261,0.9448239025491086,1.0,3/16,9.61%,SOX9;NR4A3;FABP3
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.23369894624611826,-0.950567332470017,0.5578231292517006,0.8486973172879111,1.0,34/132,18.89%,RPS14;RPL38;SETX;RPS27;RPS15;RPS5;CPSF6;RPL5;CELF2;RPS19;SF1;PTGES3;RPL3;RPL24;HSP90AB1;WDR77;EIF4H;SRSF9;RPL23A;SNRPB;TRAF7;YTHDC1;SNRPF;XAB2;RPL11;MRPS11;GEMIN7;TARBP2;RPLP0;CDC73;GEMIN5;RPS28;CELF6;SNRPG
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4046278973839313,-0.9503678417917488,0.5203836930455635,0.8480705342475856,1.0,4/11,16.03%,NR1H3;SCARB1;MFSD2A;SLC27A1
prerank,anterior/posterior axis specification (GO:0009948),-0.36979163465777565,-0.9503449690415502,0.5061425061425061,0.8470194918159458,1.0,2/15,2.38%,WLS;TBX3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40771272669224845,0.9502637742824217,0.49842271293375395,0.9453892837381295,1.0,4/20,8.81%,PLOD2;GCLC;PLSCR1;FPGS
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3266648764055573,-0.9502356449647484,0.5409356725146199,0.8461781725807929,1.0,2/26,0.73%,IGF1;FHL2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2595460007982344,-0.9501016053481195,0.5622119815668203,0.8454062672649095,1.0,15/71,12.51%,ADAMTS12;CTSH;OTUD7A;CTSC;CTSZ;CTSB;RPS27A;UBC;ATXN3;MALT1;RSPRY1;CTSS;DDB1;UBB;CTSL
prerank,endomembrane system organization (GO:0010256),0.3027353639244222,0.9498001070955268,0.542825361512792,0.9458296973451051,1.0,43/178,18.72%,ARHGAP21;ATL3;GOLGB1;NUP93;SUN3;RAB43;SPTSSB;FBXW8;ATP8B1;TMED5;GOLPH3;GAK;A4GALT;NPLOC4;DOP1B;ATL2;LMAN2L;VAPA;BCAS3;WASHC5;CDC42;EIF2AK3;TRIP11;SQSTM1;RAB30;TLCD2;TRAPPC12;CSNK1A1;COG3;MAPK15;HOOK2;CSNK1D;TMEM170A;RAB22A;TICAM2;GBF1;ARL1;HUWE1;LEMD3;TMCC1;VPS51;PLEKHM2;SYNGR2
prerank,regulation of cellular response to heat (GO:1900034),0.3336504130024547,0.9492924478067778,0.5430038510911425,0.9463773796819175,1.0,24/77,21.73%,CAMK2D;NUP93;GSK3B;EP300;ATM;CREBBP;SEC13;MLST8;NUP188;MTOR;RPA1;RANBP2;DNAJB6;MAPK1;HSPA1L;MAPKAPK2;NUP107;AAAS;CHORDC1;RAE1;NUP54;NUP98;AKT1S1;ATR
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.41996631695586034,-0.9492139520082811,0.5448275862068965,0.8464523609918903,1.0,3/10,12.33%,RPS27A;UBC;UBB
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3745866279326041,-0.9491588543533596,0.5587467362924282,0.8454898810745967,1.0,2/14,6.00%,ERN1;CPSF6
prerank,protein alkylation (GO:0008213),0.40730385103722605,0.9489554740345979,0.5447647951441578,0.9464705362941529,1.0,10/22,20.93%,METTL22;ETF1;METTL21C;SNRPD3;PRMT2;GSPT1;EEF1AKMT1;CAMKMT;PRMT8;METTL21A
prerank,ear morphogenesis (GO:0042471),0.41902908796859983,0.9488711055832721,0.5333333333333333,0.9459875948469134,1.0,5/20,11.02%,SIX1;ZIC1;TFAP2A;TIFAB;NOG
prerank,regulation of programmed cell death (GO:0043067),0.3059603211008336,0.9487816118569812,0.5650224215246636,0.945545428817338,1.0,22/161,12.40%,ACER3;SOX9;PERP;NDRG1;FBXO10;ABL1;RIPK3;VCP;KANK2;CRADD;RARG;CLU;ATM;DDX42;CREBBP;BCL6;MOAP1;AIFM2;RBM25;OMA1;BIRC3;BNIP3
prerank,mitotic cell cycle phase transition (GO:0044772),0.2965600300485101,0.9486509868090247,0.5888767720828789,0.9451699699644464,1.0,40/203,16.57%,FBXL7;CCNA2;INHBA;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;PPP2R2D;CDC16;CHEK2;CDKN1B;MNAT1;FBXL6;E2F3;PCM1;TACC3;HAUS5;CSNK1E;PIM2;CEP70;PPP1R12A;RB1;ACVR1;CEP63;CEP57;CUL4A;FOXM1;CDKN2D;PRKACA;CSNK1D;CDKN3;PPME1;DCTN3;GSPT1;UBE2S;CCND3
prerank,cellular response to amino acid starvation (GO:0034198),0.33327785987192593,0.9483529046554469,0.5338345864661654,0.9451962482375384,1.0,19/71,17.41%,MAP3K5;DAPL1;CASTOR2;EIF2AK4;SEC13;MLST8;NPRL3;MTOR;EIF2AK3;ATP6V0E1;MAPK1;ATP6V1H;CEBPB;ATP6V0D1;TFEB;MIOS;RRAGB;MAPK8;ATF2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.38695071270983594,0.9479185573474089,0.5151515151515151,0.9455468943920156,1.0,11/30,21.61%,TANK;CHUK;TLR6;UBE2D3;TLR4;IKBKE;BIRC3;TICAM2;LY96;FADD;TRAF3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.33589315737090053,-0.9478754650342899,0.5415472779369628,0.8474564274825652,1.0,7/24,11.07%,PIK3R1;TEK;KDR;MAP4K4;DUSP3;RAC1;MYOC
prerank,DNA replication (GO:0006260),0.3173226652133409,0.9476146991569805,0.5575326215895611,0.9455960320023431,1.0,35/105,23.39%,REV3L;IGHMBP2;MCMBP;ATM;MCM7;KAT5;TOP3A;RAD17;CHEK1;RPA1;BAZ1A;RFC5;REV1;RBBP8;ORC5;TOP1;POLG2;POLB;WRN;MCM9;POLA1;CLSPN;NBN;TOP1MT;MRE11;RMI2;WDHD1;RECQL5;ATR;MCM6;CDK1;RNASEH2A;RAD9B;NT5M;RFC1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.42045778842304504,0.9474383504840421,0.5265700483091788,0.9453337668038705,1.0,7/18,20.94%,SMYD2;SETD2;EHMT2;EHMT1;KMT2D;SETD1B;KMT2A
prerank,positive regulation of GTPase activity (GO:0043547),0.30181837523688554,0.9470346364206648,0.5883644346871569,0.9455819885515007,1.0,29/188,10.06%,NTRK3;MAPRE2;ARAP1;SGSM2;ITGB1;WNT11;SIPA1L1;GRTP1;CCDC125;DOCK7;RAP1A;SNX18;BCR;RAPGEF6;GSK3B;TIAM2;NDEL1;ARHGEF10;TBC1D13;ARHGEF5;PIP5K1A;TBC1D25;PKP4;SGSM3;BCAR3;SRGAP2;ARHGAP42;BCAS3;RGP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3703605199283625,0.9469251172712204,0.5334281650071123,0.945201753849957,1.0,9/38,12.28%,PTGIS;KLF4;CLU;P2RX4;TLR6;ATP2B4;AGTR2;TLR4;CD36
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2970864697859387,0.9466671385182575,0.5767543859649122,0.9451537274661664,1.0,41/198,15.95%,PLCE1;PLPPR2;TNFAIP8L3;PPP3CA;LIMK2;PLPP3;INPP4A;IP6K2;PFKFB2;PLCB3;NUDT4;DUSP16;PLCD3;SHPK;PFKP;OCRL;DUSP10;IP6K3;PPIP5K2;ACP3;PLA2G4F;PLCD1;PPM1A;DUSP5;MTOR;PAK2;GPI;STAT3;PLPP1;ACYP1;HTR2B;INPP5B;DUSP12;SLC20A1;G6PC3;LCAT;PLCH2;SYNJ1;PLA2G4A;COQ8A;PLA2G15
prerank,blood circulation (GO:0008015),0.34996012544770866,0.9463503808975086,0.5378151260504201,0.9452470208937259,1.0,6/49,6.31%,SGCD;AGTR1;MEOX2;GCLC;TNNI3;SCPEP1
prerank,regulation of TORC1 signaling (GO:1903432),0.3697645484867901,0.9461679042382709,0.5365853658536586,0.9450152462267685,1.0,10/33,16.13%,SIK3;KLHL22;ATM;SMCR8;CASTOR2;DYRK3;TELO2;CLEC16A;STK11;RRAGB
prerank,negative regulation of cell adhesion (GO:0007162),0.3349711315038315,0.9459816583855588,0.5400788436268068,0.9447698236226534,1.0,11/72,11.89%,CDH1;CYP1B1;ARHGDIB;GCNT2;FZD7;PLXNA2;JAG1;ADAM10;DMTN;GTPBP4;RHOA
prerank,body fluid secretion (GO:0007589),-0.367299151538118,-0.945904823674445,0.5121951219512195,0.8512569766947108,1.0,4/15,12.08%,NPR1;SLC22A4;ERBB4;SLC22A2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.429421636157226,0.9455236054437225,0.5215146299483648,0.9451534882903856,1.0,4/14,12.50%,PGF;NRP1;GAB1;FOXC1
prerank,positive regulation of phospholipase activity (GO:0010518),0.40479760834682377,0.945096180018395,0.5377358490566038,0.9454689829878598,1.0,6/22,9.69%,NTRK3;AGTR1;FGFR1;ARF4;FGF2;GNA13
prerank,negative regulation of cyclase activity (GO:0031280),-0.37895216781932795,-0.9446374662824316,0.5470297029702971,0.8532322922121507,1.0,3/14,9.89%,ADGRV1;GRM3;EDNRB
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3774852531774393,-0.9445835782181312,0.5463659147869674,0.8522760621850864,1.0,5/15,13.28%,AEBP1;TIE1;NOTCH1;EFEMP2;AGT
prerank,triglyceride catabolic process (GO:0019433),0.41107496162917434,0.9440869565156099,0.5323624595469255,0.9471903481756494,1.0,2/19,9.61%,PNPLA3;FABP3
prerank,negative regulation of cellular component organization (GO:0051129),0.3318264332500414,0.944026273793785,0.5538656527249683,0.9466683328735425,1.0,11/74,13.21%,TMEFF2;BMP6;ISL1;GSK3B;CLU;EP300;LRSAM1;RDX;CDC42;DNAJB6;XRCC5
prerank,positive regulation of hormone secretion (GO:0046887),-0.35262250349056823,-0.9438646500399316,0.5298701298701298,0.8529582692445601,1.0,4/17,11.16%,C1QTNF3;SPP1;EDN1;EDN3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.33143392059080773,0.9438349732895489,0.5556978233034571,0.9464511516556945,1.0,5/69,7.04%,THBS1;LBP;ISL1;CLU;MAVS
prerank,regulation of immunoglobulin production (GO:0002637),0.38970113587830985,0.9437502708556268,0.5252365930599369,0.9459873829370679,1.0,4/23,12.13%,IL10;CLCF1;TNFRSF4;GPI
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.43574736193134356,0.9435867465795268,0.5088652482269503,0.9457035515654754,1.0,2/14,7.33%,CARD14;TLR6
prerank,regulation of chemokine production (GO:0032642),0.37543448043925576,0.9433463564580068,0.5297450424929179,0.9455923438216823,1.0,1/36,0.32%,FOXP1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.36125139901649567,-0.9433165897390441,0.5587467362924282,0.8532120525090622,1.0,5/15,15.27%,PPARA;PPARD;PPM1K;ADM;AKT1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.316537085754513,-0.943106628012985,0.5572289156626506,0.8526468177734507,1.0,5/29,7.50%,RPS14;RPS21;RPS16;RPS19;RPS8
prerank,neural crest cell differentiation (GO:0014033),-0.3440016539798705,-0.9427512750459726,0.5382585751978892,0.8523984524390833,1.0,3/18,6.59%,CDH2;TAPT1;MEF2C
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3887609299457733,-0.9427043302867578,0.5346534653465347,0.8514194865881722,1.0,10/13,45.69%,ISCA1;BOLA2;GLRX3;ISCA2;MMS19;GLRX5;CIAO1;YAE1;CIAO2A;LTO1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4568337170904764,0.9426600936433075,0.5289115646258503,0.9464792965018035,1.0,4/11,13.66%,NOL11;SMARCA4;MTOR;DDX11
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.44317728029058623,0.9426523627323341,0.5345132743362832,0.9458482408378369,1.0,3/13,7.51%,ZFPM2;BMPR1A;FGF2
prerank,nuclear pore complex assembly (GO:0051292),0.4636751166668079,0.9424909495131382,0.5273722627737226,0.9456013183461057,1.0,4/10,21.10%,NUP93;TMEM170A;NUP107;NUP98
prerank,keratan sulfate metabolic process (GO:0042339),0.37569978772722046,0.9423333133354149,0.5392592592592592,0.9453090201893392,1.0,8/31,12.98%,ST3GAL4;B3GNT2;CHST5;HEXA;B4GAT1;B4GALT1;GLB1;ST3GAL2
prerank,ubiquinone metabolic process (GO:0006743),0.42913629359087957,0.9421779233334276,0.5426731078904992,0.9450053536815535,1.0,7/15,24.75%,COQ7;COQ10B;AIFM2;COQ8A;PDSS2;UBIAD1;COQ6
prerank,cellular response to organic cyclic compound (GO:0071407),0.30647533813914385,0.9421679613813537,0.5847554038680318,0.9443825511766417,1.0,16/141,9.87%,CDH1;EGFR;EZR;CYP1B1;CTNNA1;RAP1A;MYOG;DIAPH1;IGFBP5;NR4A3;GOLPH3;P2RX4;JUP;KAT5;DMTN;SLC26A6
prerank,positive regulation of T cell differentiation (GO:0045582),0.3652762630459599,0.942167105099508,0.5436337625178826,0.9437419331911941,1.0,8/36,12.29%,GLI3;VNN1;DUSP10;BCL6;CD46;GATA3;ZMIZ1;ADAM8
prerank,histone H2B ubiquitination (GO:0033523),0.4714847876518512,0.9420979548756508,0.525089605734767,0.9432693410757035,1.0,4/10,24.06%,CTR9;PAF1;LEO1;WAC
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4115668841893752,0.941448841248866,0.534453781512605,0.9441213019064585,1.0,3/20,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.40473582229411836,0.9413952434485964,0.5484375,0.9435890821119532,1.0,4/20,8.89%,C1QTNF12;ERFE;EP300;CLK2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.43847355531558974,0.9408549050117478,0.5279605263157895,0.9442211564652954,1.0,3/14,11.83%,FUS;MRNIP;RAD51AP1
prerank,dephosphorylation (GO:0016311),0.30427919690522676,0.9407234339538025,0.5743243243243243,0.9439182894390106,1.0,36/147,18.96%,PLPPR2;PTPN3;PPP3CA;PTPRU;PLPP3;PPM1H;DUSP16;PPEF2;FBXW11;PTPN21;DUSP10;ACP3;PTPRF;DAPP1;PTPRA;PPM1A;DUSP5;PPP1R12A;PHPT1;PTPN14;PLPP1;PPP5C;DUSP11;PPP2R1B;PPP3CC;DUSP12;STK11;PPP4R1;PTPN9;PPP4R2;PSPH;PPP2CB;PPP2R5C;PTPRD;PTPN1;ILKAP
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4454474920497857,0.9405655642305272,0.5246179966044142,0.9436213396181331,1.0,1/11,1.04%,BMP5
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.3107876871934402,-0.9401815289170584,0.5498575498575499,0.8565288700240937,1.0,12/30,29.54%,HSPA8;ENTPD5;HSPA9;PTGES3;DNAJB5;ERO1A;CHCHD4;CCT2;SDF2L1;DNAJB14;HSPE1;ST13
prerank,negative regulation of transposition (GO:0010529),0.4202098113663998,0.9401219235343132,0.5077452667814114,0.9439824441345771,1.0,2/16,6.23%,MOV10;TDRD9
prerank,response to amino acid starvation (GO:1990928),0.32916073895036024,0.9401177220011718,0.5469336670838548,0.9433572485662262,1.0,19/72,17.41%,MAP3K5;DAPL1;CASTOR2;EIF2AK4;SEC13;MLST8;NPRL3;MTOR;EIF2AK3;ATP6V0E1;MAPK1;ATP6V1H;CEBPB;ATP6V0D1;TFEB;MIOS;RRAGB;MAPK8;ATF2
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2715711669072061,-0.9400153273795925,0.5827067669172933,0.855806427557113,1.0,16/56,13.32%,NOD1;UNC93B1;CTSB;RPS27A;UBC;CTSS;TLR3;IRAK2;LACC1;TAB2;SFTPA2;SFTPA1;HSP90B1;UBB;CTSL;TLR7
prerank,regulation of pH (GO:0006885),0.45512750020458503,0.939949850705783,0.5265866209262435,0.9431079951684399,1.0,3/11,12.17%,ATP6V0A4;ATP1A4;SLC9A1
prerank,membrane repolarization (GO:0086009),0.43469304537561815,0.9399186847637567,0.5320945945945946,0.9425473948674383,1.0,2/15,1.47%,KCNJ2;ATP1B1
prerank,negative regulation of response to external stimulus (GO:0032102),0.31063436952533785,0.9398157317398249,0.5566502463054187,0.9421494622867177,1.0,15/105,12.43%,CCN3;CD109;PTGIS;ISL1;PRKCD;KLF4;IL10;PTPN2;FGF2;ACOD1;GATA3;RB1;DRD3;TRAFD1;CASK
prerank,generation of neurons (GO:0048699),0.2982051026029275,0.9396743682216603,0.5769230769230769,0.9418288537530897,1.0,30/190,11.87%,MET;WNT9A;SIX1;MARK1;WNT11;FGFR1;CIT;DOCK7;LHX2;WNT16;FZD7;NR4A2;ACSL3;PAFAH1B1;FGF13;MARK2;NRP1;BHLHE40;HES1;POMGNT2;ITM2C;FZD2;SIX4;PER2;CEP85L;ATOH8;DISC1;WNT2B;TGFB2;THOC2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.36609297510342975,0.9394701290468006,0.5602836879432624,0.9416367984274304,1.0,11/38,15.78%,BMP6;POLR3D;PLSCR1;IFI35;ACOD1;ADAM8;POLR3B;PUM2;PUM1;PRKCA;DHX9
prerank,regulation of exosomal secretion (GO:1903541),0.40499879801877486,0.9392512772241715,0.5392320534223706,0.9414963526354636,1.0,7/19,20.26%,PDCD6IP;SDC4;ATP9A;TSG101;SDC1;RAB7A;HGS
prerank,synaptic vesicle cycle (GO:0099504),-0.3079914754537515,-0.9391220271589151,0.5501519756838906,0.8569050196886723,1.0,16/30,33.91%,RIMS1;SNCA;PIP5K1C;SYT7;CPLX1;SNAP25;NLGN1;SLC18A2;SNAPIN;SLC32A1;CDK5;RAB3A;WNT7A;SLC17A8;PLD2;OTOF
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3999038334031155,0.9390557697191613,0.5401574803149606,0.9413725170901901,1.0,3/20,7.14%,NT5E;ANO6;P2RX4
prerank,regulation of hemopoiesis (GO:1903706),0.4512497693741916,0.938045478031841,0.5373665480427047,0.9430190960771616,1.0,3/10,12.09%,CREBBP;CBFB;MYSM1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.35710437371349774,-0.9377751123110544,0.5628140703517588,0.859075214083349,1.0,4/18,6.42%,APOE;CTSC;CD81;VGLL4
prerank,chromosome organization (GO:0051276),0.31704362125403057,0.9377683114962704,0.5710843373493976,0.9430488289563409,1.0,23/99,19.82%,TCF7L1;TCF7L2;ABL1;HDAC10;SMARCA4;HMG20A;HDAC8;XPA;CUL4A;EHMT1;COPS7B;COPS5;RAD23B;BRWD1;LRWD1;XPC;LDB1;ZBTB7A;FAM50A;MTHFR;HMGN2;PWWP3A;RAE1
prerank,cellular protein catabolic process (GO:0044257),-0.26650853255816914,-0.9374401431139797,0.5753968253968254,0.8588192594877865,1.0,9/59,8.45%,ADAMTS12;CTSH;CTSC;DAB2IP;CTSZ;CTSB;MALT1;RSPRY1;CTSS
prerank,regulation of secretion by cell (GO:1903530),0.3423099243011754,0.9365664931398122,0.5511596180081856,0.9451297702966878,1.0,6/54,9.71%,SNCAIP;ANXA1;DISP1;ARFIP1;NSF;P3H1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3003534580659821,-0.9362630199579713,0.5853658536585366,0.8605931919670101,1.0,6/31,16.62%,PLCB1;MDK;TLR3;SYK;TIRAP;CCL19
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4018086806347496,-0.9360987474042157,0.5501113585746102,0.8598862738874253,1.0,5/10,32.44%,CX3CR1;ARRB2;PTPRC;LILRB1;FCGR2B
prerank,establishment of vesicle localization (GO:0051650),0.41629159338568056,0.9360643825387653,0.5357142857142857,0.9456029589438184,1.0,3/18,9.26%,LIMK2;F8A1;SPG11
prerank,negative regulation of T cell proliferation (GO:0042130),0.3769586039983684,0.9360564830240632,0.5398230088495575,0.9449851178814832,1.0,5/28,13.86%,IL10;CD80;TNFRSF14;SDC4;CEBPB
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.29133129080094244,-0.9359753994898282,0.5425867507886435,0.8590883772780274,1.0,5/37,7.45%,APOD;PPARA;HIF1A;ADCY7;SIRPA
prerank,proteasomal protein catabolic process (GO:0010498),0.2945090556095405,0.9359010427679472,0.6050054406964092,0.9446904384485888,1.0,45/201,20.59%,WWP1;NEDD4;UBE4B;WWP2;DDI2;UBE2B;DDIT3;NFE2L2;RNF185;VCP;KLHL22;FBXW11;TBL1X;UBE2D3;KAT5;ERCC8;CUL4A;UBE2W;BFAR;APPBP2;RAD23B;SMURF1;PSMC6;FBXL19;PML;UBE3D;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;FEM1C;HUWE1;PPP2R5C;PCNP;PSMB1;FBXL17;PSMD13;PSMD1;PSMD7;KCTD17;PSMA8
prerank,regulation of urine volume (GO:0035809),-0.4117315033177999,-0.9358326881428979,0.5526881720430108,0.8583468878209042,1.0,4/10,21.53%,NPR1;ADM;HAS2;INPP5K
prerank,positive regulation of histone modification (GO:0031058),-0.299617323490614,-0.9358282847247529,0.5597667638483965,0.8572580635011272,1.0,13/33,25.34%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;RUVBL2;NOS1;BRCA1;ING2;APLNR;CTBP1;TET1;TADA2B;SART3
prerank,proteoglycan metabolic process (GO:0006029),0.39169152053258444,0.9357733389528379,0.536,0.9443927487159001,1.0,8/26,14.86%,HS3ST4;SULF1;CHST13;HPSE;SULF2;B4GALT7;B3GALT6;FOXL1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3482957291878307,0.9351436478522369,0.5628491620111732,0.9451843434854044,1.0,15/50,24.18%,NXN;ABL1;PER2;HDAC8;TAF1;GTPBP4;SQSTM1;UFL1;USP4;PINX1;CHP1;N4BP1;SVBP;SIRT7;HSPA1A
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4372142865120139,0.9348218173113818,0.5324232081911263,0.9452614559147134,1.0,3/12,17.64%,PAICS;PFAS;GMPS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3953871264443306,-0.9342641473498776,0.5442359249329759,0.8599531738088607,1.0,5/12,15.07%,CYBA;SLC5A3;GRIN1;ADGRB1;RAB27A
prerank,regulation of coagulation (GO:0050818),-0.39854174732403724,-0.9342316727257745,0.5550122249388753,0.8589327757470157,1.0,8/11,46.07%,HS3ST5;HRG;F2R;EPHB2;FOXA2;GP1BA;F2RL1;F2
prerank,smooth muscle contraction (GO:0006939),0.43216878288532007,0.9340551244921771,0.524390243902439,0.9463898743837876,1.0,1/14,0.48%,EDNRA
prerank,regulation of adaptive immune response (GO:0002819),-0.3524888387072173,-0.9338094071442898,0.5358974358974359,0.8589144065053076,1.0,5/18,12.89%,ADCY7;AHR;IL6ST;TRIM27;SAMSN1
prerank,glutathione biosynthetic process (GO:0006750),0.4469658227569713,0.9337197602583438,0.5131348511383538,0.9464898501393855,1.0,3/11,21.36%,GCLC;MGST2;GSS
prerank,regulation of mRNA stability (GO:0043488),0.3024571670803814,0.9332782920081822,0.5697940503432495,0.9468415036611586,1.0,44/145,22.77%,SAMD4A;PRKCD;EIF4G1;FTO;XPO1;GDNF;CELF1;FUS;PCBP4;EXOSC7;SERBP1;TENT5D;ZC3H14;PUM2;PSMC6;VIP;FXR2;PUM1;TAF15;PRKCA;PSMD8;MAPKAPK2;EXOSC5;YTHDF3;TENT5C;ZFP36L1;YTHDF2;RC3H2;FASTKD1;PSMB1;PABPC1;PSMD13;PSMD1;PSMD7;PSMA8;EIF4ENIF1;PSMD3;EXOSC4;PSMD2;DCP1A;APEX1;FMR1;PSMC2;LARP1
prerank,granulocyte differentiation (GO:0030851),-0.3474548998636946,-0.933145897462355,0.5691489361702128,0.859481721698926,1.0,4/18,11.06%,LEF1;CBFA2T3;TAL1;DEK
prerank,positive regulation of peptidase activity (GO:0010952),0.4009680901932363,0.9328943117469962,0.549520766773163,0.9470787363343269,1.0,3/20,4.86%,TANK;VCP;DDRGK1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.41063540582664015,0.9328022151136438,0.5431472081218274,0.9466622231044285,1.0,5/16,17.13%,ANK2;DDRGK1;VAPA;BCAP29;GBF1
prerank,actin filament organization (GO:0007015),0.30598828502772557,0.9327120870936388,0.5849056603773585,0.9462401684360454,1.0,22/151,11.89%,DPYSL3;BAIAP2L1;COBL;VILL;ABI1;SHROOM3;TMOD3;NEBL;GAS2L2;GSN;TLE6;FAT1;MPRIP;DLG1;POF1B;FHOD3;DMTN;RHOBTB1;CDC42;TRIOBP;PLS1;RHOA
prerank,negative regulation of nervous system development (GO:0051961),-0.3546641827003473,-0.9321189990097327,0.5291375291375291,0.8609844092551424,1.0,4/17,14.88%,B2M;NOTCH1;ROBO2;APPL2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.29612234308611884,0.9320326534721857,0.6065934065934065,0.9471001022714117,1.0,30/186,14.41%,TRABD2B;SOX9;NXN;TCF7L2;MLLT3;GLI3;PTPRU;GRB10;WNT11;LRP6;GSK3B;DDIT3;TLE6;PRICKLE1;TSKU;WWTR1;FUZ;TLE4;CTNND1;NOG;TLE3;TLE2;NLK;IGFBP6;CSNK1A1;RBMS3;AMER1;LRP1;PSMC6;INVS
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4200338956173808,0.9316495565280927,0.5399361022364217,0.9473060899961889,1.0,3/16,5.21%,RAET1E;KLRC2;PVR
prerank,regulation of translational initiation (GO:0006446),0.3361676050016771,0.9313847195840564,0.5651595744680851,0.9472664053523774,1.0,24/63,25.75%,EIF4G3;EIF4G1;DNAJC3;NCK2;PAIP2;EIF2AK4;EIF2B2;EIF2AK3;CEBPB;DDX1;YTHDF3;MTIF2;YTHDF2;EIF4G2;EIF3E;CSDE1;FMR1;LARP1;RBM4;NCBP2;IMPACT;EIF4B;GLE1;YTHDF1
prerank,negative regulation of receptor internalization (GO:0002091),0.43708419163765383,0.9312198092708667,0.518796992481203,0.947008561236174,1.0,5/12,20.34%,LRPAP1;RIN3;ANKRD13D;ATXN2;DLG4
prerank,acylglycerol catabolic process (GO:0046464),0.37805135684557967,0.9310753397780074,0.555052790346908,0.9467038003721681,1.0,4/30,9.61%,PNPLA3;MGLL;ABHD6;FABP3
prerank,positive regulation of histone methylation (GO:0031062),-0.33026509048587827,-0.9310584776001738,0.6010498687664042,0.862522476195233,1.0,3/24,5.45%,AUTS2;JARID2;RIF1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.44446522846314884,0.9309621203761755,0.5212765957446809,0.9463218554226783,1.0,3/11,12.11%,IL10;NR4A3;REST
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4040226599376174,0.930224621707041,0.5450081833060556,0.9473428270890727,1.0,3/19,4.66%,EXT1;GLCE;HS6ST2
prerank,mononuclear cell differentiation (GO:1903131),0.3944908350683462,0.9299600123409482,0.558599695585997,0.9473180729466161,1.0,1/24,0.27%,BMP4
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3493303850670704,-0.9296914892916444,0.5488721804511278,0.864747695006157,1.0,7/17,29.85%,ADRA2A;MFSD2A;PDE3B;AKT1;APOC1;GPLD1;SORL1
prerank,sterol metabolic process (GO:0016125),-0.26163712629801084,-0.9295438134972728,0.61328125,0.864013595298611,1.0,12/60,12.34%,CYP7B1;APOE;PRKAG2;CYP26B1;CYP27A1;ABCA1;PPARD;SC5D;INSIG2;ABCA5;LIPA;OSBPL1A
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4537844853054086,0.9292732794535469,0.5504424778761062,0.9482360311993546,1.0,2/10,9.01%,NPLOC4;UFD1
prerank,energy reserve metabolic process (GO:0006112),-0.3347458145825506,-0.9288078008541553,0.5498721227621484,0.8647575507622328,1.0,3/19,2.81%,LEPR;PRKAG2;GBE1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.292113716004536,0.9285621092624866,0.6278814489571899,0.9492180454221758,1.0,48/184,23.72%,FZR1;PKD1;SFI1;CEP164;ANAPC5;PAFAH1B1;CEP131;ANAPC16;CDC16;ERCC3;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;PSMC6;RIOK2;XPC;PRKACA;CSNK1D;DCTN3;UBE2S;PSMD8;CNTRL;INO80;AKAP9;ZFP36L1;MAD2L1BP;CDC14A;PSMB1;CEP192;PSMD13;PSMD1;DCTN1;AURKA;PSMD7;PSMA8;ODF2;KLHL18;PSMD3;PSMD2;CDK1;NEK6;PSMC2;HAUS1;ERCC2;PSMB2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.41359830539012765,0.9284734462545068,0.5284280936454849,0.9487973708986566,1.0,4/16,4.50%,ANK2;CAMK2D;CACNA1C;DMD
prerank,adenine nucleotide transport (GO:0051503),0.41502472350772707,0.9282829662097503,0.5507487520798668,0.9486017029478363,1.0,4/17,10.63%,LRRC8D;ABCC4;SLC25A17;ABCC5
prerank,error-free translesion synthesis (GO:0070987),0.39769340215924515,0.9278462152011988,0.5506329113924051,0.9489737647179121,1.0,6/22,13.24%,VCP;NPLOC4;UFD1;RPA1;RFC5;REV1
prerank,regulation of lipid metabolic process (GO:0019216),-0.2456099489792825,-0.9274938938541594,0.6285714285714286,0.8667997295999753,1.0,16/88,11.78%,NCOA1;PPARA;PRKAG2;TBL1XR1;NPC2;ELOVL6;PPARD;C1QTNF2;GPS2;ACACA;SC5D;ACACB;GGPS1;PSAP;NR1D2;GPAM
prerank,bone morphogenesis (GO:0060349),0.42292099608840106,0.9272639816286955,0.555735056542811,0.9496352592975579,1.0,4/14,13.44%,LRP6;TFAP2A;SKI;LRP5
prerank,regulation of stem cell proliferation (GO:0072091),-0.34504118353224444,-0.9272090137242148,0.5561224489795918,0.8664649715569973,1.0,3/17,7.25%,ACE;FBLN1;GJA1
prerank,reticulophagy (GO:0061709),0.4437064407750444,0.9271260856925336,0.5277280858676208,0.9493160211711245,1.0,7/12,20.89%,ULK2;DDRGK1;RB1CC1;UFL1;ATG2A;ULK1;UBA5
prerank,dendritic cell differentiation (GO:0097028),-0.3278497290873752,-0.9271105134576211,0.5472222222222223,0.8656424659315166,1.0,9/22,27.95%,LYN;GAS6;CCL19;BATF;AXL;PRTN3;TREM2;BATF2;LILRB1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.31048466041332673,-0.9269998183865481,0.5885885885885885,0.8648280962555092,1.0,7/27,16.06%,C1QTNF3;ARRB1;SIRPA;SYT11;GAS6;TNFAIP3;NCKAP1L
prerank,N-glycan processing (GO:0006491),-0.3454027165975022,-0.9269668076932965,0.5367847411444142,0.8638072464082791,1.0,4/18,5.07%,ST8SIA4;MAN1C1;MAN2A2;ST8SIA6
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4105692913145454,0.9268653602490686,0.5531914893617021,0.9493041717960936,1.0,5/19,16.64%,PRKCD;DAGLB;IRS1;ABHD5;IRS2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.39466092578563966,-0.9267959643267298,0.5727272727272728,0.8631606793402579,1.0,2/10,6.09%,PCGF5;IGF2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2969906633105037,-0.9267412105393726,0.5907590759075908,0.8622073559557524,1.0,6/36,6.21%,MYLK;CACNA1D;PDGFRB;TRPC3;CXCL12;ATP2B1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.39554843947638846,-0.9267271604932866,0.5493273542600897,0.861158583987985,1.0,3/11,18.50%,PRDX4;CAT;PRDX1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4141447861981705,0.9266921267451153,0.5509554140127388,0.9490840320989371,1.0,3/17,5.21%,RAET1E;KLRC2;PVR
prerank,regulation of cell-cell adhesion (GO:0022407),0.3615167702136628,0.9266873369425818,0.5625879043600562,0.9484726107123251,1.0,2/39,1.64%,CDH1;EFNA5
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3849537608948418,-0.9266105793297438,0.5407407407407407,0.8603681648491667,1.0,3/13,9.89%,ADGRV1;GRM3;EDNRB
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3710330573880596,-0.9265515005009988,0.5603864734299517,0.8594459852336922,1.0,2/13,8.38%,RNF152;SPAAR
prerank,mitotic spindle assembly (GO:0090307),0.35740248121884316,0.9265139345842412,0.5637393767705382,0.9482466186254059,1.0,13/42,19.32%,ARHGEF10;CHEK2;MISP;TOGARAM1;RHOA;PIBF1;SMC1A;FLNA;STAG2;KIF2A;SPICE1;AAAS;CEP192
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4203198206551171,0.9263041452192794,0.5434412265758092,0.9480830916813582,1.0,9/14,31.25%,SEC24B;SEC13;SEC24A;SEC23A;TBC1D20;SEC24D;SEC31A;SEC24C;RAB1A
prerank,oxoacid metabolic process (GO:0043436),-0.315818619207909,-0.9261664558890639,0.5380116959064327,0.8592829711089371,1.0,8/27,17.21%,TPST1;ENPP1;DDO;SULT4A1;AGXT;PPA1;TPST2;MIF
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3654993456210399,0.9256018186283222,0.5798561151079137,0.9490267114628879,1.0,4/39,7.07%,EGFR;PTPN3;RNF115;PTPN2
prerank,calcium ion transport into cytosol (GO:0060402),-0.3359667455649409,-0.9255247946759007,0.5597826086956522,0.859686406604745,1.0,11/21,21.95%,GRIN2A;GRIN2B;SLC8A1;RYR2;CACNA2D1;GRIN1;JPH2;JPH1;TRPV4;JPH4;JPH3
prerank,regulation of wound healing (GO:0061041),0.3596001185222726,0.9254578977046755,0.5774456521739131,0.9487340412054727,1.0,9/42,12.93%,CD109;ANXA1;ITGB1;FGF2;DMTN;SRSF6;CASK;PRKCE;DUOX1
prerank,snRNA metabolic process (GO:0016073),0.4208867366780523,0.925127127338374,0.553921568627451,0.9488060227602715,1.0,8/17,31.08%,ZCCHC8;INTS3;INTS8;MEPCE;INTS9;INTS1;INTS2;INTS12
prerank,negative regulation of JUN kinase activity (GO:0043508),0.449876082839907,0.9250007818393979,0.5497382198952879,0.9484578766056169,1.0,2/10,7.68%,PDCD4;DUSP10
prerank,regulation of GTPase activity (GO:0043087),0.2956943248691521,0.9248481015415994,0.6146993318485523,0.9482008011744146,1.0,28/177,10.06%,MAPRE2;EFNA5;ARAP1;SGSM2;ITGB1;WNT11;WNK1;SIPA1L1;ARHGAP44;RAP1A;SNX18;RAPGEF6;GSK3B;NDEL1;ADAP1;RAB3GAP2;ARHGEF5;PKP4;PLXNA2;VAV2;OCRL;FGD6;SGSM3;BCAR3;SRGAP2;RDX;BCAS3;RGP1
prerank,purine ribonucleotide transport (GO:0015868),0.4179384622375464,0.9248066510529364,0.5557404326123128,0.9476730630078601,1.0,4/16,10.63%,LRRC8D;ABCC4;SLC25A17;ABCC5
prerank,membrane lipid metabolic process (GO:0006643),-0.31916492922822615,-0.9239525875501536,0.5747126436781609,0.8623706086733993,1.0,11/22,25.40%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1;ST6GALNAC4;SMPDL3B;SPHK2;AGMO;B4GALT4;TEX2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4071680691248706,0.9236959944115111,0.5762439807383628,0.9495055613418967,1.0,3/18,4.69%,USP13;DDIT3;RNF185
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4608115603388633,0.9235100347701636,0.5418894830659536,0.9493068229304665,1.0,4/10,23.96%,GALNT13;POGLUT3;POGLUT2;GALNT4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.40167836886637254,0.9234586673891554,0.5644891122278057,0.9488013264981422,1.0,7/19,21.13%,KLF4;NFKB1;GATA3;MAP2K5;MAPK8;WFS1;EGF
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.41288478525970956,-0.9233691083391019,0.5862831858407079,0.8627632182224508,1.0,5/10,25.64%,RAPGEF3;PIH1D1;BRCA1;SPHK2;SMARCB1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3252736904433118,0.9233335623305879,0.564875491480996,0.9484392733451071,1.0,8/69,7.90%,NGF;SIX1;TGFB3;PTK2B;ISL1;GDNF;CLCF1;NFATC4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.37720470212809654,-0.922699174938732,0.540948275862069,0.8633344534428634,1.0,7/12,38.31%,CCT5;GNL3;CCT2;GNL3L;DKC1;CCT8;CCT7
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.43905002960599254,0.9225165754271045,0.5416666666666666,0.9496253786716302,1.0,4/10,24.35%,PAF1;NUDT21;LEO1;NCBP2
prerank,lipid transport (GO:0006869),0.3145610884972907,0.9221228136891343,0.6070559610705596,0.9499039503965924,1.0,14/97,10.01%,SLCO3A1;ABCD3;TNFAIP8L3;PITPNA;LBP;SLCO2A1;PITPNC1;ATP8B1;ABCC4;PITPNB;SLC27A3;OSBPL5;FABP3;SLC25A17
prerank,regulation of cell-substrate adhesion (GO:0010810),0.34462597489995717,0.9221033795705863,0.5631205673758866,0.9493344276433231,1.0,7/42,12.77%,VIT;GCNT2;FZD7;DMTN;AGR2;RHOA;RSU1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.35913752227040796,0.9213863304406834,0.5835734870317003,0.9502831505518922,1.0,18/36,24.78%,E2F6;RRM2;RNF2;CHEK1;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;YAF2;PHC3;EED;EZH2;RING1
prerank,nuclear envelope organization (GO:0006998),0.396962352578302,0.9210079490671026,0.5608974358974359,0.9504859501863441,1.0,3/20,4.72%,NUP93;SUN3;TOR1AIP1
prerank,regulation of macrophage differentiation (GO:0045649),-0.362145938759246,-0.9207601848655341,0.5883838383838383,0.8668520269833561,1.0,3/15,10.55%,IL34;CSF1;C1QC
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.324607874721224,0.9206903624617309,0.5721784776902887,0.9505350146412538,1.0,16/64,18.62%,MLLT3;ELOF1;MNAT1;CTR9;ERCC3;SETD2;PAF1;RTF1;GTF2F2;CDK12;ELP4;ELOA;EAF2;AFF4;NELFE;POLR2H
prerank,cell cycle G1/S phase transition (GO:0044843),0.3264113479746243,0.9205764244226491,0.5651006711409396,0.9501681934164333,1.0,13/61,16.33%,CCNA2;INHBA;PLK3;CDKN1B;MNAT1;E2F3;PIM2;RB1;ACVR1;CUL4A;CDKN2D;CDKN3;GSPT1
prerank,mitochondrial translation (GO:0032543),0.3115519582515938,0.9204056829706436,0.6014669926650367,0.9499234093223038,1.0,36/104,26.26%,MRPL33;MRPL48;EARS2;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;MRPL57;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;NDUFA7;MRPS27;MTIF2;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2400032442294684,-0.9202196462149556,0.642512077294686,0.8670322104721191,1.0,29/91,21.82%,PICALM;RIMS2;INPP5F;SYT7;MAPK3;SCARB1;OPHN1;RIT2;LRRK2;SRC;SPHK1;CDH13;HIP1;CPLX1;LGI3;ABL2;FES;SCFD1;RNF139;HIP1R;DNAJC13;SYK;HCK;RALA;AP2S1;RAB15;SYT1;RAB3C;RUFY2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4613598768180276,0.9201807950219321,0.5388513513513513,0.9497905212414823,1.0,4/10,16.70%,TLR6;TLR4;CD36;MYD88
prerank,negative regulation of B cell activation (GO:0050869),0.4055617356707512,0.9197070208594558,0.5855572998430141,0.950210715578996,1.0,4/21,7.31%,INHBA;IL10;TNFRSF13B;ATM
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3715986181142341,0.9196241808144391,0.5757121439280359,0.9497672506469994,1.0,6/28,15.96%,NGF;DIABLO;CRADD;MOAP1;TRADD;CASP8AP2
prerank,acyl-CoA metabolic process (GO:0006637),-0.28933288908749527,-0.9196095977380435,0.613013698630137,0.8674696133049545,1.0,6/35,9.63%,ACBD6;ACACA;ACACB;ACOT7;DBI;ACSF2
prerank,positive regulation of insulin secretion (GO:0032024),0.36025090471869015,0.9195601071927089,0.5724852071005917,0.949286800837643,1.0,5/36,8.37%,TCF7L2;ISL1;TRPM4;CAPN10;AACS
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.44640474301224303,0.9193339062391362,0.5636672325976231,0.9491744247902161,1.0,2/11,13.20%,IL10;CIITA
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3782278342407726,0.9191070064293495,0.5476575121163166,0.9490694331908825,1.0,4/24,11.71%,FOXO3;DDIT3;TFAP2A;TGFB2
prerank,negative regulation of angiogenesis (GO:0016525),0.31268863212508297,0.9190123865123117,0.6042446941323346,0.9486600793581177,1.0,6/84,2.85%,THBS1;SLC12A2;HOXA5;SULF1;KLF4;SEMA3E
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3354932763797196,0.9186693607133509,0.5773333333333334,0.9481700514563419,1.0,16/50,22.40%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;PUM2;PUM1;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;NUP98;FMR1
prerank,regulation of gene silencing by RNA (GO:0060966),0.3354932763797196,0.9186693607133509,0.5773333333333334,0.9481700514563419,1.0,16/50,22.40%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;PUM2;PUM1;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;NUP98;FMR1
prerank,regulation of actin filament-based process (GO:0032970),0.32590753495613795,0.9185688385070395,0.5677749360613811,0.9477699477273431,1.0,18/70,14.97%,EFNA5;EZR;PRKCD;ARHGAP44;FAM107A;ABL1;PDGFA;ARHGEF5;IQGAP1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;RHOA;LRP1;ARHGAP17;RND3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.39790714959197204,0.9184042823863433,0.5741324921135647,0.947528448065939,1.0,2/17,2.92%,HDAC4;PID1
prerank,synapse organization (GO:0050808),0.30240759745818524,0.9182254345693881,0.6272189349112426,0.9472892264452815,1.0,14/125,9.48%,CDH1;PCDHB16;GPC6;CTNND2;NEDD4;SEMA3E;PCDHB13;CAST;SDK1;GPC4;PPFIA1;UNC13B;PTPRF;CACNB2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.33798534533884383,-0.9182098077850277,0.5621761658031088,0.869808633796324,1.0,8/21,22.29%,CYP26B1;PPARD;LPIN3;LPIN1;AGXT;NUDT19;ACOX1;HOGA1
prerank,myofibril assembly (GO:0030239),0.35475417231675765,0.9179889622830607,0.5826330532212886,0.9471905089249315,1.0,7/42,10.00%,KRT19;CSRP3;TMOD3;CSRP2;FHOD3;SIX4;WDR1
prerank,response to ionizing radiation (GO:0010212),0.3259859851577473,0.9177972438839141,0.5984848484848485,0.9469910949152769,1.0,15/70,18.17%,ANXA1;TANK;EYA3;ATM;CLK2;KAT5;RNF168;MRNIP;RAD51AP1;KDM4D;INTS3;STK11;PRKAA1;COP1;INO80
prerank,regulation of chemotaxis (GO:0050920),0.369274703767379,0.9177004749558809,0.5720858895705522,0.9465989256784352,1.0,5/30,9.97%,THBS1;MYCBP2;PTPN2;P2RX4;CXCR4
prerank,microtubule nucleation (GO:0007020),0.40292846672419097,0.9176357994493386,0.5654281098546042,0.9461399135910615,1.0,7/19,19.71%,NDEL1;SLAIN2;TUBGCP4;TUBGCP5;CSNK1D;AKAP9;TUBGCP6
prerank,negative regulation of neuron death (GO:1901215),0.30896282669532693,0.9175961295960483,0.5862068965517241,0.9456174547103604,1.0,11/93,8.32%,NGF;SIX1;TGFB3;PTK2B;ISL1;EIF4G1;GSK3B;GDNF;CLCF1;NFATC4;TNFRSF1B
prerank,protein autoubiquitination (GO:0051865),0.32863665296904715,0.9173786418723389,0.5968992248062015,0.9454737637164214,1.0,14/61,17.04%,WWP2;RNF115;UBE2B;RNF185;RNF141;LRSAM1;UBE2D3;UHRF2;RNF10;ERCC8;BFAR;RNF146;UBE3D;RNF122
prerank,cellular response to lipid (GO:0071396),0.29262135214773616,0.9171537807767796,0.6350606394707828,0.9453400461444107,1.0,27/191,12.06%,EGFR;SOX9;WNT9A;PTK2B;LBP;WNT11;PID1;ADAM9;MYOG;IL10;FZD7;PDCD4;NFKB1;CD80;SHPK;IRS1;ATM;TNFRSF1B;BCL10;KAT5;CTR9;ACOD1;TLR4;RHOA;ATP1A3;ATP1A1;PAF1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4511588132244328,0.9170536364813888,0.5653710247349824,0.9449567155014577,1.0,3/10,10.06%,ANXA2;NELL1;RGP1
prerank,positive regulation of innate immune response (GO:0045089),0.36989815652373437,0.9170499464951541,0.5620542082738944,0.9443574916280064,1.0,8/30,15.78%,LBP;POLR3D;PLSCR1;MAVS;IFI35;ADAM8;POLR3B;DHX9
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.37718629037956575,-0.9168270318100273,0.5357142857142857,0.8719871994123845,1.0,2/14,8.05%,ENPP1;ENPP3
prerank,calcium ion homeostasis (GO:0055074),0.307955725120901,0.9166841282723608,0.6195121951219512,0.9445634447904724,1.0,10/95,8.58%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;CYP27B1
prerank,proton transmembrane transport (GO:1902600),-0.28626167954957826,-0.9166128766002339,0.6039603960396039,0.8714280713335903,1.0,2/36,4.76%,ATP1A2;ATP5F1B
prerank,regulation of protein ubiquitination (GO:0031396),0.30669869363168223,0.9164664048437123,0.609375,0.9444215394637429,1.0,27/108,19.08%,NXN;FAM107A;BIRC7;TGFBR1;MYCBP2;PRICKLE1;RIPK2;BCL10;FBXO4;PER2;COMMD1;HDAC8;WASHC1;GTPBP4;SQSTM1;BIRC3;AMER1;UFL1;USP4;TSPYL5;CENPX;UBE2N;HUWE1;WFS1;PINX1;ANGPT1;CHP1
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.29303148020528647,-0.9158252037104787,0.609375,0.8721926663817496,1.0,8/34,9.96%,RUNX1T1;FOXO1;ENPP1;WNT5A;CCDC85B;GPS2;GATA2;LRP3
prerank,RNA destabilization (GO:0050779),0.4064387346591081,0.9153753850023907,0.5842696629213483,0.9461675960380572,1.0,9/18,25.75%,FTO;DXO;CELF1;PUM1;YTHDF3;YTHDF2;ZC3H18;ROCK1;YTHDF1
prerank,histone H3-K9 demethylation (GO:0033169),0.4406280031400042,0.915252989926411,0.5714285714285714,0.9458096653314266,1.0,4/11,12.60%,JMJD1C;KDM1A;KDM4D;KDM3B
prerank,cell junction assembly (GO:0034329),0.31296494899443844,0.915195091753554,0.6200241254523522,0.9453255046819974,1.0,6/100,3.05%,CDH1;PCDHB16;CDH11;FN1;CTNND2;PCDHB13
prerank,activation of GTPase activity (GO:0090630),0.3148316249506851,0.915127902927173,0.6156670746634026,0.9448536491235969,1.0,17/89,10.66%,NTRK3;SGSM2;SIPA1L1;GRTP1;CCDC125;DOCK7;BCR;TIAM2;ARHGEF10;TBC1D13;ARHGEF5;PIP5K1A;TBC1D25;SGSM3;ARHGAP42;BCAS3;TBC1D10A
prerank,positive regulation of stem cell differentiation (GO:2000738),0.40712057412939073,0.9150433884455808,0.5497470489038786,0.9444375480201521,1.0,5/16,12.50%,SOX9;LTBP3;GATA4;TGFB2;FOXC1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4223606027039398,0.9142593559632216,0.5569823434991974,0.9455302392654533,1.0,5/15,11.71%,FGFR1;MFRP;CELF1;USP22;TGFB2
prerank,response to peptide hormone (GO:0043434),0.34425831592802736,0.9141423611885502,0.5906593406593407,0.9451757994779945,1.0,11/43,18.37%,ANXA1;ZBTB7B;IGFBP5;IRS1;EIF2B2;STAT3;STAT5A;TRIM16;EIF2B3;STAT6;ZFP36L1
prerank,positive regulation of cell cycle process (GO:0090068),-0.23664996891757475,-0.9141216853404056,0.6632653061224489,0.8752577652939322,1.0,9/91,6.83%,IGF1;TGFA;PDGFRB;MAP3K20;CEP120;INSR;IGF2;SVIL;RGCC
prerank,negative regulation of reproductive process (GO:2000242),0.4054279025388265,0.9139280178151118,0.5604026845637584,0.9450154465184406,1.0,2/17,1.79%,SULF1;ARHGDIB
prerank,mitochondrial fission (GO:0000266),-0.34559982184221194,-0.9138449001054292,0.5670886075949367,0.8748257537311905,1.0,5/16,21.94%,DNM3;SLC25A46;DNM1;DNM1L;MTFP1
prerank,nuclear pore organization (GO:0006999),0.42292432263499224,0.9137181034399988,0.5630397236614854,0.94484494253995,1.0,5/14,21.10%,NUP93;TMEM170A;NUP107;NUP54;NUP98
prerank,regulation of glucose metabolic process (GO:0010906),0.36011283333779237,0.9135207833713601,0.5762463343108505,0.9446979397767652,1.0,10/34,17.48%,FOXK1;IRS1;USP7;FOXK2;GNMT;GNB3;SLC45A3;IRS2;RORA;ADIPOR1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.413377109033437,0.913516846194197,0.576068376068376,0.9441090036747151,1.0,7/15,29.88%,ZC3H12D;LACTB2;NYNRIN;RNASEH1;POP1;ZC3H12A;NUDT16
prerank,response to interleukin-4 (GO:0070670),-0.39688359440271403,-0.9133765968970613,0.5755555555555556,0.8748359354132831,1.0,1/10,0.37%,LEF1
prerank,regulation of DNA binding (GO:0051101),0.34738191227640564,0.9131246871286527,0.5762942779291553,0.9443528174989586,1.0,13/44,21.13%,NGF;SMO;JUN;KDM1A;HES1;SKI;FOXC1;MAPK8;ZBTB7A;MDFI;SUMO1;TGFB1;EGF
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.44645589240476036,0.9127768048796228,0.5811808118081181,0.9444923875507443,1.0,6/11,20.71%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A;CDCA4
prerank,monocyte chemotaxis (GO:0002548),-0.295288987694989,-0.9126074336083662,0.5676470588235294,0.8755690010453171,1.0,3/32,7.23%,FLT1;IL6R;RPS19
prerank,carbohydrate homeostasis (GO:0033500),0.32156001658188055,0.912091695964948,0.5984455958549223,0.9453136979244103,1.0,17/67,18.27%,TCF7L2;CRY2;KCNB1;KLF7;HNF4A;HNF1A;IRS1;PTPN2;SELENOT;STAT3;MCU;STK11;PRKAA1;SLC8B1;PAX6;ADIPOR1;WFS1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45991155567729375,0.9119723296412936,0.5657439446366782,0.944969575051621,1.0,1/10,1.26%,SMOX
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3419511443206011,-0.9115959197663778,0.597911227154047,0.8768559535337848,1.0,6/16,16.65%,PPARA;TMSB4X;PPARGC1A;PARP1;DNAJC30;FLCN
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3179733181157654,-0.9115156429579583,0.603448275862069,0.8759904702693805,1.0,6/24,16.62%,ITPR1;RYR2;HTR2A;RYR3;ERO1A;CCL19
prerank,protein export from nucleus (GO:0006611),0.3713673675423695,0.9114193668205821,0.5676100628930818,0.9455627391293765,1.0,4/27,5.16%,PKD1;XPO1;EGR2;DUSP16
prerank,Rho protein signal transduction (GO:0007266),0.33196990504731394,0.9109528248781115,0.5699067909454061,0.9459497418934997,1.0,5/53,2.21%,NTN1;ARHGDIB;CDC42EP5;RHOJ;AGTR1
prerank,positive regulation of cell projection organization (GO:0031346),0.30211068594698104,0.910618862956059,0.6272189349112426,0.9460479618777269,1.0,13/115,7.56%,SLIT2;DPYSL3;NGF;NTRK3;PTK2B;CUX1;RAP1A;TIAM2;FBXW8;EP300;PLXNA2;KIDINS220;MARK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.32537181998373016,-0.9104212715494696,0.5887096774193549,0.8775597627894373,1.0,8/22,16.30%,PARP1;RPS27A;UBC;GTF2H2;DDB1;UBB;DDB2;CETN2
prerank,lymphocyte differentiation (GO:0030098),0.323064233849104,0.9101553103458808,0.5982028241335045,0.9464772561284224,1.0,10/68,10.39%,HDAC4;PBX1;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3;GATA3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4326547695239306,0.910021100724614,0.5347091932457786,0.9461675483394656,1.0,1/11,0.82%,SOAT1
prerank,tRNA metabolic process (GO:0006399),-0.3322931680803237,-0.9098815893435174,0.5760598503740648,0.8777217192672857,1.0,7/17,28.50%,DTD2;POP5;SARS1;DTD1;POP7;DARS2;RPP21
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.31780193351306896,0.909643754366073,0.5984354628422425,0.9463932605818488,1.0,8/75,10.47%,PLCE1;GRK5;MRAP;MGLL;FRMPD1;SLC39A14;USP33;KCTD8
prerank,negative regulation of binding (GO:0051100),0.31664072747325855,0.9096073252723796,0.6074534161490683,0.9458715326272059,1.0,13/81,11.60%,SMO;LRPAP1;PRKCD;BTAF1;GSK3B;SLPI;JUN;KDM1A;USP33;DISC1;WAPL;CSNK1E;GTPBP4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4334048526904595,0.9095263395734174,0.5681415929203539,0.9454402703361307,1.0,1/11,0.45%,THBS1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.411659837406046,0.9089646007119911,0.5731292517006803,0.9460128365672382,1.0,4/16,19.15%,PAICS;PFAS;GMPS;AMPD3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.386539355907728,0.9089346815580803,0.5753424657534246,0.9454859278532762,1.0,2/21,3.79%,FOXP1;ELF1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4112276821360179,0.9087889227031741,0.5721649484536082,0.9452029850009614,1.0,3/15,11.95%,CD44;KDM1A;TAF9
prerank,DNA strand elongation (GO:0022616),0.39136962634281,0.9085220661085803,0.555379746835443,0.9451840231240451,1.0,8/18,25.54%,MCM7;GINS3;POLD3;POLA1;NBN;MRE11;MCMDC2;TERT
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.30392329375563604,-0.907875911266464,0.6342182890855457,0.8813643323345198,1.0,8/28,15.58%,SHANK3;APOE;ADCY1;EPHA4;NSG1;APP;CHRNA7;ADCY8
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3412443791431904,-0.9077828614792292,0.598404255319149,0.8805292399180724,1.0,10/18,31.14%,BCL2;BCL2L1;CAMK2A;THEM4;SLC25A4;BAD;BAK1;PMAIP1;NAIF1;HEBP2
prerank,mRNA export from nucleus (GO:0006406),0.3084100181684678,0.9070787738059711,0.6047904191616766,0.9476091153809958,1.0,34/102,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,muscle cell development (GO:0055001),0.3598242447739629,0.9068608176992906,0.6024464831804281,0.9474928057351355,1.0,6/30,7.89%,CXADR;ANK2;NEBL;DMD;KDM1A;HES1
prerank,negative regulation of viral process (GO:0048525),-0.2632189904412201,-0.9067189696015143,0.6666666666666666,0.8819319948643074,1.0,16/57,21.79%,PPIA;TRIM14;BST2;TRIM62;IFITM1;IFITM3;OAS2;TRIM21;TRIM27;PROX1;TRIM6;LARP7;RNASEL;TRIM8;TRIM32;STAT1
prerank,negative regulation of translation (GO:0017148),0.3113988038806125,0.9065187131502231,0.5980392156862745,0.9476206104641139,1.0,25/87,24.24%,SAMD4A;FTO;IGFBP5;SYNCRIP;CNOT7;PAIP2;CELF1;TOB1;EIF2AK4;EIF2AK3;NANOS2;FXR2;PUM1;EIF4E2;YTHDF3;YTHDF2;EIF4ENIF1;PUS7;EIF3E;FMR1;LARP1;CAPRIN1;PCIF1;ROCK1;RBM4
prerank,negative regulation by host of viral process (GO:0044793),0.4384442128063524,0.9064961866458027,0.5630550621669627,0.9470716997262247,1.0,2/10,9.46%,EIF2AK4;VAPA
prerank,regulation of protein localization to cell surface (GO:2000008),-0.291552464568434,-0.9064862114882904,0.631578947368421,0.8814210973780464,1.0,4/33,9.60%,PICALM;NEDD4L;GPM6B;HSP90AB1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3452906519816923,0.9063120140889355,0.6182336182336182,0.9468947116641687,1.0,7/46,8.44%,TMEFF2;FN1;PARVA;ANTXR1;ITGAV;NRP1;SRGAP2
prerank,activation of adenylate cyclase activity (GO:0007190),0.3499895363800014,0.9057859831077707,0.5973254086181278,0.9473828153898408,1.0,3/35,5.09%,EDNRA;ADRB2;ADCY9
prerank,regulation of autophagosome assembly (GO:2000785),0.362790212132269,0.9054814280578439,0.5761494252873564,0.947456855707116,1.0,15/33,23.77%,RAB3GAP2;LRSAM1;SMCR8;NPRL3;SEC22B;FEZ2;RAB5A;IFT88;CHMP4A;CHMP4B;SH3GLB1;TMEM39A;NPRL2;PIKFYVE;PHF23
prerank,calcium ion import (GO:0070509),-0.2986571232513823,-0.9054012711305555,0.5734072022160664,0.8828894836265816,1.0,9/28,19.09%,CACNA1D;CACNA1E;SLC8A1;CACNA1B;TRPC4;CACNA1I;MCUR1;ATP2A2;TRPV4
prerank,regulation of small molecule metabolic process (GO:0062012),-0.3052058681316636,-0.9051698580778187,0.599406528189911,0.8823716620591306,1.0,6/28,14.64%,APOE;PPARA;PDK1;ACADL;NR1H4;PDK2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.40870059351170973,0.904621034967423,0.5787728026533997,0.948713082398942,1.0,1/15,1.26%,SMOX
prerank,lipid modification (GO:0030258),0.3488405450744557,0.9043801073199995,0.60431654676259,0.9486144067484964,1.0,2/37,2.52%,PLPPR2;PLPP3
prerank,regulated exocytosis (GO:0045055),0.288784477785871,0.9042584070311422,0.6471238938053098,0.9482608728662223,1.0,19/173,10.12%,PCDH7;THBS1;FN1;CD109;TGFB3;LHFPL2;CD9;SYT8;DNAJC5;PDGFA;CLU;VCL;ABCC4;FAM3C;SYTL4;GTPBP2;RAB27B;WDR1;ISLR
prerank,positive regulation of neurogenesis (GO:0050769),0.32046215783631793,0.9038152419151263,0.6070496083550914,0.9486366616160792,1.0,7/68,7.72%,SLIT2;NGF;CUX1;TIAM2;FBXW8;PLXNA2;KDM1A
prerank,myelination (GO:0042552),0.33663138186181113,0.9037511505237865,0.5865384615384616,0.9481800390419506,1.0,9/46,10.75%,ACER3;PMP22;MARVELD1;ADGRG6;ARHGEF10;CXCR4;SKI;EIF2B2;PARD3
prerank,neutrophil degranulation (GO:0043312),0.27374732030123694,0.9036902265399165,0.7390862944162436,0.947720178491166,1.0,67/425,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.36979353585248625,-0.9036243997598784,0.5882352941176471,0.8847701301766172,1.0,3/13,13.25%,CD81;SEC16B;BRSK2
prerank,retrograde axonal transport (GO:0008090),0.411047165754275,0.9036137917846938,0.5883361921097771,0.9472862628017492,1.0,5/16,19.64%,PAFAH1B1;FBXW11;KIF1C;DLG2;MAP1A
prerank,regulation of mitochondrial fission (GO:0090140),-0.3169203651343794,-0.9035845685109972,0.6102150537634409,0.88380891517825,1.0,5/24,9.36%,DCN;KDR;INF2;LRRK2;MAPT
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3530878709288254,-0.9033683754289789,0.6004728132387707,0.8832499977751048,1.0,3/15,16.77%,GNAS;ADCY3;UBR3
prerank,Fc receptor signaling pathway (GO:0038093),-0.23250959328391824,-0.902765358127361,0.703030303030303,0.8836098882451258,1.0,35/110,24.09%,LYN;PIK3R1;KIT;PAK1;CALM1;TEC;MAPK3;PPP3R1;PRKCQ;MALT1;VAV3;RAC1;TAB2;GRB2;PSMB10;PPP3CB;BTRC;MAPK9;PSME2;PLCG1;VAV1;LAT2;SYK;RELA;PSMB3;PSMB4;PSMB8;LCP2;PSMC5;TAB1;PSME1;PSMA7;BTK;MAP3K1;PSMD5
prerank,neuron development (GO:0048666),0.2925849194604397,0.9021002424098383,0.6372881355932203,0.9499234142648562,1.0,12/141,6.52%,VSX1;PBX3;RP1;PBX1;NEDD4;WNK1;DOCK7;GSK3B;HDGFL3;GDNF;CDNF;ARL3
prerank,prostanoid metabolic process (GO:0006692),-0.36462304392813155,-0.9020054007573405,0.6053268765133172,0.8842913815853781,1.0,3/13,20.47%,PTGS1;HPGDS;ACOX1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3696980852137056,0.9018697679053415,0.5964391691394659,0.9497978084034655,1.0,2/29,2.77%,SLIT2;PRKCD
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3309082643358301,0.9017979671197406,0.5968379446640316,0.9493589779482413,1.0,3/51,2.81%,THBS1;PGF;ANO6
prerank,cell chemotaxis (GO:0060326),0.32281101560851805,0.9016708977701393,0.5915678524374176,0.9490693779065038,1.0,7/60,7.71%,CCN3;PARVA;AGTR1;PRKCD;PIP5K1A;BIN2;NRP1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3516432096449653,-0.9014986636731902,0.6115107913669064,0.8844081794017068,1.0,6/15,13.28%,IGF1;IL6ST;PARP1;PDE9A;EDN1;AGT
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3198249528335545,0.9014282520537383,0.6127388535031847,0.9489761527780302,1.0,9/66,7.51%,EGFR;MAP3K5;PDGFC;FGFR1;PDGFA;ARHGEF5;TNFSF11;TLR6;FGF2
prerank,platelet aggregation (GO:0070527),-0.29195301954983693,-0.9012005076482564,0.6141479099678456,0.8840352125487755,1.0,9/33,9.38%,PPIA;GNAS;TLN1;ACTB;MYH9;PDGFRA;PLEK;MYL12A;MYL9
prerank,diacylglycerol metabolic process (GO:0046339),0.3788698204025618,0.9010591792316579,0.5792880258899676,0.949136440461397,1.0,1/23,0.44%,PLCE1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.26957995713615346,0.9009486835873354,0.7591093117408907,0.9487717358622691,1.0,71/532,13.26%,TNFRSF11B;F3;CARD14;FN1;EDA;TRAF3IP2;ANXA1;IL17RE;FOXO3;PTK2B;CD44;CAMK2D;IL22RA1;GRB10;PITPNA;LBP;ITGB1;SHC1;ANXA2;PRKCD;MID1;IL10;IP6K2;PDCD4;TNFRSF13B;SOCS2;NFKB1;CD80;IL5;TNFSF11;TAB3;IRS1;FBXW11;IL18RAP;IL18BP;TRIM26;CHUK;CLCF1;RIPK2;IFI35;IL17RA;FGF2;GAB2;MAP3K3;IRAK4;TNFRSF4;TNFRSF1B;CDIP1;SMARCA4;CDKN1B;CTR9;BCL6;GATA3;TRIM25;PAK2;CDC42;IRF1;SQSTM1;CSK;IL16;TNFRSF14;CD36;STAT3;BIRC3;FOXC1;STAT5A;TRADD;CAPZA1;DUOX1;CIITA;TRAF5
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.3030922232182879,-0.9006429830476923,0.6133333333333333,0.8842445006113681,1.0,4/28,7.45%,CD47;SH3KBP1;PRKCQ;SIRPA
prerank,regulation of autophagy (GO:0010506),0.28302364902791144,0.9005265190067999,0.6990185387131952,0.949080266534532,1.0,43/216,15.22%,MET;FOXO3;EIF4G3;DAPL1;NEDD4;EXOC4;USP13;EIF4G1;FOXK1;IL10;GSK3B;ABL1;DDIT3;KLHL22;TAB3;EP300;ATM;SMCR8;ATP6V0A1;USP10;MLST8;KAT5;USP33;FOXK2;MTOR;WASHC1;PIM2;CSNK2A2;ATP6V0E1;MTDH;STAT3;BNIP3;HTR2B;RB1CC1;ATP6V1H;ATP6V0D1;WDR41;TFEB;UFL1;SNX32;STK11;MAPK15;PRKAA1
prerank,cellular response to leucine starvation (GO:1990253),0.44686009517778347,0.900501759605677,0.5694682675814752,0.9485432274597118,1.0,3/10,16.13%,EIF2AK4;MTOR;RRAGB
prerank,inner dynein arm assembly (GO:0036159),0.44361420366359594,0.9002207300605131,0.5746924428822495,0.9485168037830197,1.0,1/10,4.71%,CCDC40
prerank,endoplasmic reticulum organization (GO:0007029),0.31916201066345234,0.900010338538312,0.6292134831460674,0.9484003292913536,1.0,12/72,11.12%,ATL3;TLE6;STX5;SPTSSB;GAK;SHTN1;DOP1B;ATL2;RAB18;LMAN2L;VAPA;EIF2AK3
prerank,neutrophil activation involved in immune response (GO:0002283),0.2725731332548087,0.8999243294077797,0.75,0.9479811783301201,1.0,67/428,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.30562224700467006,-0.8998865277206548,0.6270718232044199,0.8849104348180645,1.0,15/25,25.15%,CCDC88A;RBPJ;DGKD;HIP1;AGT;HIP1R;AKT1;CNOT9;DOK1;RTN4;AFAP1L2;NUP62;HAP1;PLAUR;GPER1
prerank,regulation of DNA metabolic process (GO:0051052),0.34377484512626916,0.8998511732677011,0.5918958031837916,0.9475417833350339,1.0,17/44,26.33%,PDGFA;SMG6;SMG1;KPNA1;HDAC8;XRCC5;USP1;UBE2N;NBN;MPHOSPH8;MPV17;SIRT7;ALYREF;YLPM1;WDR18;UBE2V1;WDR70
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3154054373013265,-0.8997247668950744,0.5946666666666667,0.8831545529211372,1.0,3/23,6.32%,TFDP2;BCL2;PPP3R1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3154054373013265,-0.8997247668950744,0.5946666666666667,0.8831545529211372,1.0,3/23,6.32%,TFDP2;BCL2;PPP3R1
prerank,RNA catabolic process (GO:0006401),0.3355521056247228,0.899594512713394,0.6133518776077886,0.9474820898903001,1.0,20/46,30.02%,DXO;PABPC4;ZC3H12D;RNASE6;EXOSC7;DIS3L2;NANOS2;LSM2;YTHDF2;RNASEH1;RNASEH2A;SIDT2;HSPA1A;AGO3;PNPT1;ZFP36L2;NUDT16L1;DNA2;NUDT16;ZFP36
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.36511270037787924,0.8992436043840849,0.5969465648854961,0.9476480649651151,1.0,4/30,3.28%,GPR4;AKAP13;COL3A1;LPAR4
prerank,response to retinoic acid (GO:0032526),0.3270010584193625,0.8992372772974128,0.6331994645247657,0.9470809479833336,1.0,7/59,7.31%,SOX9;WNT9A;PTK2B;WNT11;FZD7;RARG;ATM
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3319173615029363,0.8991496486777112,0.5947712418300654,0.9466645327525974,1.0,7/51,8.44%,DCLK1;NGF;TRIO;ANKRD27;SHTN1;NCKAP1;SRGAP2
prerank,negative regulation of blood coagulation (GO:0030195),0.3506411856223441,0.8991180764330907,0.5887445887445888,0.9461451375880685,1.0,4/38,6.41%,F3;THBD;PDGFA;SERPINE2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4183345701652119,0.898411746128154,0.5734767025089605,0.9470142241092843,1.0,2/13,10.89%,KCNB1;HYAL3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.32539016952875716,-0.8980853410087385,0.6236842105263158,0.8857898476241338,1.0,13/19,38.80%,SRC;TENT4B;DCP2;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;PIF1;HNRNPC;NAT10;TERF2
prerank,recombinational repair (GO:0000725),0.3115356108510161,0.8980424400363536,0.6182728410513142,0.94721568444968,1.0,37/77,30.32%,REV3L;RNF138;SWSAP1;ZFYVE26;RAD52;BRCA2;RAD51C;RPA1;RAD51AP1;KDM4D;EXD2;NSMCE2;AP5S1;RBBP8;UBE2N;WRN;YY1;MCM9;NBN;INO80;SMC5;MRE11;XRCC2;RECQL5;ERCC5;ZSWIM7;PSMD14;MEIOB;XRCC1;LIG3;RFWD3;POLQ;RAD51B;SPIDR;SEM1;NSMCE1;TONSL
prerank,neutrophil mediated immunity (GO:0002446),0.2721499803805254,0.8979911684606081,0.7565922920892495,0.9467344739349675,1.0,68/432,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;IRAK4;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,bicellular tight junction assembly (GO:0070830),0.3345517554739354,0.8977079866794498,0.6034236804564908,0.9467049786315691,1.0,10/46,10.80%,MPP7;CLDN16;STRN;PDCD6IP;CLDN11;DLG1;POF1B;PATJ;PARD3;PAK2
prerank,response to steroid hormone (GO:0048545),0.35439106709672985,0.8973252843979289,0.6008836524300442,0.9468950019567156,1.0,2/31,1.44%,THBS1;TGFB3
prerank,leukotriene biosynthetic process (GO:0019370),-0.3557655241236517,-0.8972846454091168,0.6088082901554405,0.8865426904974569,1.0,8/14,31.51%,GGT5;MGST3;GGT7;GGT1;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,myeloid cell differentiation (GO:0030099),-0.2692444234361594,-0.8972568114089581,0.6455223880597015,0.8855620853746242,1.0,14/47,18.62%,LYN;MFHAS1;RPS14;KIT;SNRK;RPS19;HSPA9;TAL1;CASP3;IKZF1;SLC25A38;TIRAP;KMT2E;JAK3
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.32680545697913077,-0.8967074943233199,0.6123456790123457,0.8857620933734047,1.0,9/18,27.12%,ADAMTS9;STT3B;SAMHD1;FBXO6;AOAH;FUCA1;NEU2;FBXO44;FBXO2
prerank,actin nucleation (GO:0045010),-0.3284008064074396,-0.8956449174904343,0.5853658536585366,0.8870709727250625,1.0,15/21,41.19%,IQGAP2;LMOD1;TRIM27;SPIRE1;ARPC3;ARPC5L;ARPC1A;SPIRE2;ACTR2;SCIN;ARPC4;LMOD3;JMY;ARPC5;MAGEL2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3289390520346384,-0.895598217779264,0.6047120418848168,0.8861355326278623,1.0,4/19,16.13%,DDO;ALDH7A1;ASPA;GCDH
prerank,regulation of interferon-gamma production (GO:0032649),-0.2463372326228186,-0.8954259364157287,0.6864864864864865,0.8854752727395352,1.0,13/71,14.43%,IL1R1;PDE4B;CD47;SLC7A5;SIRPA;GAS6;PDE4D;IL18;TLR3;HAVCR2;TRIM27;TLR7;NR1H4
prerank,cellular amino acid catabolic process (GO:0009063),-0.237396700263255,-0.8944613916401258,0.7219512195121951,0.8866212863257354,1.0,22/87,24.02%,NOS3;DDO;BCKDHB;ALDH7A1;QDPR;IVD;ACAD8;BCKDHA;ASPA;SLC25A44;ALDH4A1;ABAT;GCDH;SARDH;NOS1;GSTZ1;HSD17B10;HOGA1;HIBADH;SHMT2;KYNU;GLUD1
prerank,regulation of cellular metabolic process (GO:0031323),0.3305162334477484,0.8943339018956843,0.6097560975609756,0.9525803514263356,1.0,7/45,11.20%,CYP1B1;PID1;COQ7;ARF4;MKLN1;PARL;GNB3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.31141111443188274,-0.894322780401663,0.5895953757225434,0.8858982024696582,1.0,8/23,24.90%,PARP14;NR1H3;NLRC5;HSP90AB1;TXK;STAT1;SOCS1;CDC37
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2702098960700421,-0.8939865955241924,0.6206896551724138,0.8856901019071935,1.0,17/46,21.10%,PLCB1;PPIA;CNN2;LMNB1;HSPA9;AIP;PSME2;BOLA2;CFL1;MIF;RPLP0;SNRPA1;RALA;SOD2;HNRNPDL;LCP1;TALDO1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.38977026623212635,0.8939783134181518,0.5944625407166124,0.9527452980761965,1.0,8/22,24.00%,CRY2;GSK3B;BOD1L1;STYXL1;FKBP1B;MASTL;PPP1R1B;ROCK1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.39515921094614787,0.8937938642543846,0.5938009787928222,0.9525548984385745,1.0,9/18,25.78%,PTK2B;SHTN1;BCAS3;CYRIB;LLGL1;RAP1B;ROCK1;RUFY3;ARFGEF1
prerank,regulation of response to external stimulus (GO:0032101),0.29334949843647246,0.8937745245857053,0.6440281030444965,0.952006687668319,1.0,18/121,12.39%,FOXP1;ANXA1;CD55;AGTR1;MGLL;SHPK;DAGLB;NLRP6;CELF1;P2RX4;PIK3AP1;RNF135;BCL6;ERAP1;CXCR4;IRF1;CD36;BIRC3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3844604832757336,0.8935524528443323,0.6006655574043261,0.9518973915318127,1.0,5/21,11.22%,ADAM9;SPPL2A;ADAM10;ERAP1;RBMX
prerank,oligosaccharide metabolic process (GO:0009311),0.340033997032958,0.8934725241216133,0.605890603085554,0.9514785948979232,1.0,3/46,5.11%,ST3GAL4;FUT8;NAGA
prerank,regulation of MAP kinase activity (GO:0043405),0.3026912235030155,0.8930737146149814,0.6293206197854588,0.9517302561202479,1.0,9/92,7.51%,EGFR;BMP4;PDGFC;FGFR1;PRKCD;PDGFA;TNFSF11;PPEF2;FGF2
prerank,regulation of interferon-beta production (GO:0032648),0.33003737358844143,0.8926861127838186,0.6238030095759234,0.9519424079167308,1.0,19/46,29.05%,POLR3D;MAVS;RIPK2;RNF135;IRF1;TLR4;REL;POLR3B;DHX9;YY1;PTPN11;TRAF3;IFIH1;IRF3;POLR3G;TLR8;TBK1;RNF216;PPM1B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.36092236669349465,-0.892331327358466,0.5985401459854015,0.8884823848174569,1.0,4/14,8.99%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,regulation of mRNA catabolic process (GO:0061013),0.2948875155605065,0.8922066126818835,0.6318874560375146,0.9523694650706174,1.0,35/121,22.76%,SAMD4A;PRKCD;EIF4G1;XPO1;MOV10;CNOT7;PCBP4;EXOSC7;SERBP1;ZC3H14;PUM2;PSMC6;FXR2;PUM1;PRKCA;PSMD8;MAPKAPK2;EXOSC5;YTHDF3;ZFP36L1;YTHDF2;RC3H2;PSMB1;PABPC1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;EXOSC4;PSMD2;DCP1A;APEX1;FMR1;PSMC2
prerank,negative regulation of secretion by cell (GO:1903531),0.34197944686994053,0.8921991500160981,0.5851528384279476,0.9518065981396722,1.0,2/38,1.33%,STXBP6;ANXA1
prerank,peptide hormone secretion (GO:0030072),0.36675933034801506,0.8921927854410996,0.6030769230769231,0.9512357234333925,1.0,4/26,14.53%,ANXA1;SNX19;LTBP4;VIP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3675290180524294,-0.8919027444813901,0.6039119804400978,0.8883500805432234,1.0,5/12,12.51%,CTSH;LMO2;CTSB;CTSS;CTSL
prerank,neurotransmitter transport (GO:0006836),0.3096983321477635,0.891849213325851,0.6282051282051282,0.9513787586096775,1.0,7/73,9.04%,SLC38A2;SLC38A1;DNAJC5;SLC17A7;PPFIA1;SLC6A16;UNC13B
prerank,regulation of glucose import (GO:0046324),0.36263838566246953,0.8917431008762214,0.6015503875968993,0.9510197592347829,1.0,8/30,8.54%,SORBS1;GRB10;PID1;C1QTNF12;ERFE;IRS1;CAPN10;RHOQ
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.33478667976994647,-0.8905776780907465,0.6155844155844156,0.8902685135535346,1.0,8/18,29.17%,PLCB1;CHRM3;CHRM2;CDK5R1;GRK2;AGRN;RGS8;GNA15
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.440322187981934,0.8905554189018831,0.5876106194690266,0.9529085811595026,1.0,2/11,9.48%,CAMK2D;CACNB2
prerank,peptidyl-lysine methylation (GO:0018022),0.36931074253343177,0.8904164707986824,0.5923076923076923,0.9526252966493771,1.0,8/26,20.97%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;METTL21A;METTL18
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4463093197202089,0.889712995409214,0.5701107011070111,0.9535058578945688,1.0,3/10,16.01%,MLLT3;UFL1;LMBR1L
prerank,positive regulation of cytokine production (GO:0001819),0.274838581488639,0.8893581116479857,0.7182952182952183,0.9536266545005735,1.0,44/292,14.25%,F3;FOXP1;ANXA1;CYP1B1;SULF1;LBP;ISL1;IL10;ZBTB7B;DDIT3;POLR3D;NFKB1;CD80;HILPDA;EP300;MAVS;RIPK2;TLR6;IL17RA;KAT2A;CREBBP;GATA4;BCL10;RAB7B;HPSE;NFKB2;NOX1;CD46;SULF2;GATA3;EIF2AK3;IRF1;TLR4;IL16;CRCP;TNFRSF14;POLR3GL;STAT3;PIBF1;HTR2B;XRCC5;CEBPB;CYRIB;POLR3B
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.34537583135016164,0.8892246022157401,0.6123348017621145,0.9533205671500552,1.0,1/36,0.19%,EGFR
prerank,synapse assembly (GO:0007416),0.3147280701617565,0.8890802913848646,0.6141235813366961,0.953031540195633,1.0,3/67,3.05%,CDH1;PCDHB16;PCDHB13
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.3345387345360501,-0.8890192730327736,0.6020408163265306,0.8928655003742123,1.0,6/16,25.42%,ACLY;ACACA;GCDH;ACSS1;PPCS;DIP2A
prerank,gonad development (GO:0008406),0.3374330961392017,0.8889096722859504,0.611271676300578,0.9527916633566164,1.0,9/41,11.71%,SOX9;INHBA;GATA1;GATA4;SIX4;GATA3;CYP19A1;WNT2B;TGFB2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4348063277724491,0.8884523858538529,0.5885328836424958,0.9531249627412963,1.0,2/10,11.44%,DDIT3;TLR4
prerank,neuropeptide signaling pathway (GO:0007218),-0.25448627744016183,-0.8884322791408842,0.6904761904761905,0.8931335802236106,1.0,7/58,11.17%,SORT1;RAPGEF2;GPR37;SORCS2;CYSLTR1;GLRA1;CYSLTR2
prerank,regulation of mitochondrion organization (GO:0010821),0.3359912525028015,0.8884205455462009,0.6385372714486639,0.9526181773791015,1.0,16/47,24.07%,PID1;GSK3B;GOLPH3;EP300;PARL;CSNK2A2;OMA1;SQSTM1;CYRIB;PRMT6;FIS1;RHOT2;SIRT7;USP36;RHOT1;MUL1
prerank,positive regulation of response to external stimulus (GO:0032103),0.29079357924387905,0.8882922835099024,0.6621004566210046,0.9523043809348883,1.0,21/128,15.78%,THBS1;GPR4;AGTR1;BMP6;PDCD4;THBD;POLR3D;PLSCR1;LRSAM1;IFI35;IL17RA;ACOD1;TLR4;IL16;ADAM8;TRADD;POLR3B;PUM2;PUM1;PRKCA;DHX9
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2102310450476232,-0.8879774314187674,0.819047619047619,0.8930676516204452,1.0,59/159,27.40%,TCF4;FMOD;SGIP1;PICALM;RPL38;PDE4DIP;SNCA;CYBA;DNAI4;SRC;PTGES3;MAPT;HSP90AB1;NSG1;IMMP2L;HIP1;PIK3C2A;EIF4H;COX7A2;HOPX;TRAF2;SMAD1;POMP;SMAD3;HIP1R;CASQ2;CENPE;EPS15;NUP205;PTGES3L;AP2S1;ADRM1;BIN1;PFDN6;RTN4;CHCHD4;HIGD1B;AP2M1;EID2;OTUD6B;RAB5IF;NSG2;MAPK8IP2;HIGD2A;DRC1;CCT2;CENPA;UVRAG;PRLR;CASQ1;SHQ1;FKBP1A;NRG1;GPX4;VAMP3;DNAJB14;MKKS;DNAJC28;DNAAF2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.2995563333575908,-0.8877463500085583,0.6211340206185567,0.8925695519778443,1.0,8/26,18.00%,APOE;HIF1A;SCARB1;NOS1AP;AKT1;ATP7A;CDH3;PARK7
prerank,regulation of tube diameter (GO:0035296),0.41201855616000604,0.8875268006827814,0.6041666666666666,0.9527260834245577,1.0,3/13,6.31%,AGTR1;GCLC;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.41201855616000604,0.8875268006827814,0.6041666666666666,0.9527260834245577,1.0,3/13,6.31%,AGTR1;GCLC;SCPEP1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3890006104180422,0.8874477216768213,0.6066115702479339,0.9523075470871223,1.0,5/19,11.02%,ZFPM2;BMPR1A;TGFBR1;FGF2;NOG
prerank,response to growth factor (GO:0070848),0.3352418363508757,0.88730456264253,0.6134094151212554,0.9520174563088889,1.0,9/41,14.78%,SHC1;KLF4;BMPR1A;TGFBR1;TGFBR2;ACVR1;CPNE3;MAP2K5;AMHR2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3820632641478725,0.8869350407480024,0.5925925925925926,0.9521985920161703,1.0,5/20,10.88%,TNRC6C;MOV10;CNOT7;CELF1;NRDE2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3575121797000122,0.8861420722913673,0.6026587887740029,0.9532561845898702,1.0,11/31,14.55%,EZR;PDCD6IP;DLG1;MARK2;WDR1;PARD3;CDC42;RHOA;MYO9A;DLG2;ERBIN
prerank,amide biosynthetic process (GO:0043604),0.33148669190644386,0.8861098147263566,0.6180555555555556,0.9527529961815594,1.0,7/47,8.67%,PCSK5;SGMS2;DMD;SPTSSB;NANP;CERS6;CERS5
prerank,negative regulation of catalytic activity (GO:0043086),-0.30791733712182856,-0.8860616779685395,0.6187845303867403,0.8953930108733846,1.0,10/24,32.19%,NOTCH1;NES;CAMK2A;CAND1;NOS1;CCAR2;TP53;MT3;PLN;HP
prerank,cellular respiration (GO:0045333),-0.27068852445625274,-0.8860500462656075,0.6105263157894737,0.8943775831481798,1.0,22/41,34.95%,SDHA;PPARGC1A;UQCR10;UQCRH;ME3;NDUFS4;ATP5F1D;MTLN;COX10;CYCS;UQCRC2;UQCRB;UQCRFS1;NDUFA5;COX4I2;ETFRF1;NDUFS1;MTFR2;SIRT3;SDHB;LYRM7;BLOC1S1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.30184526807506673,-0.8859953673143496,0.635593220338983,0.8934511326118058,1.0,10/26,25.22%,PRKAG2;LPGAT1;NR1H3;ACADL;PRKAA2;BRCA1;TRIB3;ERLIN2;APOC1;ADIPOR2
prerank,response to interferon-beta (GO:0035456),-0.31347138332308944,-0.8857210294977068,0.6381766381766382,0.8930223159598252,1.0,5/22,10.24%,BST2;IFITM1;AIM2;IFNAR2;IFITM3
prerank,axonemal dynein complex assembly (GO:0070286),0.37300105479329626,0.8851440574849849,0.6068111455108359,0.9540777376535555,1.0,4/27,12.37%,DNAAF3;CCDC40;DNAH8;DNAH5
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3041943303165367,0.8848937014290498,0.6453558504221955,0.9539990208674692,1.0,21/87,20.29%,CD44;RBFOX2;FGFR1;SPRED2;FLRT2;SHOC2;FGF22;HNRNPH1;FGF2;KLB;CEP57;MAPK1;GTF2F2;DSTYK;ITGB1BP1;FGF18;NR4A1;ZFP36L1;POLR2H;PTPN11;HNRNPM
prerank,negative regulation of innate immune response (GO:0045824),-0.2850696785032627,-0.8848784969951864,0.654434250764526,0.8937863047380181,1.0,10/34,16.70%,SAMHD1;GRN;RPS19;NLRC5;A2M;USP18;TRIM21;TNFAIP3;METTL3;TYRO3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.36521083258620973,0.884841821586522,0.6115444617784711,0.9535159063845858,1.0,5/26,10.17%,ST3GAL4;B3GNT2;CHST5;B4GAT1;B4GALT1
prerank,protein deacylation (GO:0035601),0.3665004291619913,0.8847841365190637,0.5922480620155038,0.9530480739281888,1.0,3/23,12.73%,HDAC4;HDAC10;ABHD17B
prerank,piRNA metabolic process (GO:0034587),0.38380418944297234,0.8846574452340092,0.6028938906752411,0.9527209824680141,1.0,4/19,17.80%,TDRD9;TDRD12;MAEL;PIWIL4
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4002790193610208,0.8845807714280891,0.6081771720613288,0.9523080262754583,1.0,5/14,17.29%,PCBP4;SRSF6;SRSF12;RBMX;SFSWAP
prerank,positive regulation of MAPK cascade (GO:0043410),0.27596646407604636,0.8844534114635731,0.7033898305084746,0.9519964466406445,1.0,16/245,4.00%,EGFR;BMPER;PDGFC;NTRK3;TNFAIP8L3;PTK2B;CD44;ADRA1B;FGFR1;SHC1;ADRB2;GAREM1;MID1;RAP1A;GCNT2;NOTCH2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.34937410510670547,0.8843544570289181,0.5985074626865672,0.9510495395743769,1.0,14/32,28.43%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NUP37;NUP153;NUP88
prerank,tRNA export from nucleus (GO:0006409),0.34937410510670547,0.8843544570289181,0.5985074626865672,0.9510495395743769,1.0,14/32,28.43%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NUP37;NUP153;NUP88
prerank,positive regulation of TOR signaling (GO:0032008),0.34002287939710757,0.8841843540772789,0.6330935251798561,0.9508234967654143,1.0,10/40,16.13%,SIK3;KLHL22;GOLPH3;SMCR8;SEC13;TELO2;MLST8;CLEC16A;MIOS;RRAGB
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39372176111459,0.8841776450530346,0.603225806451613,0.950267754976714,1.0,8/16,30.02%,MOV10;ZC3H12D;ZFP36L1;ZC3H12A;KHSRP;ZFP36L2;TARDBP;ZFP36
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.43660930352805205,0.8841546871670726,0.5901926444833625,0.9497407193384925,1.0,2/10,7.28%,LBP;IFI35
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.394994343033096,-0.8840267110691167,0.6178489702517163,0.894615776667949,1.0,5/10,22.48%,PARP14;INPP5F;NF2;SH2B3;SOCS1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.30289039695645587,0.8839465827035289,0.6632782719186785,0.949585315319178,1.0,13/98,10.39%,THBS1;AGTR1;INHBA;ANXA2;KLF4;PID1;EIF4G1;TGFBR2;LIPT2;NSF;STARD4;ACOD1;GATA3
prerank,response to lipopolysaccharide (GO:0032496),0.288261624201526,0.8838525336193955,0.6861397479954181,0.9492103095248423,1.0,27/138,17.43%,FOXP1;LBP;SMAD6;ADAM9;IL10;PDCD4;SLPI;NFKB1;CD80;SHPK;TNFRSF1B;CYP27B1;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;ERBIN;TRIM41;SBNO2;PRDX3;MYD88;TICAM2;CARD16;MAPK8;MAPKAPK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4210416069719228,0.8836328151954583,0.6294964028776978,0.9490803560482056,1.0,3/12,11.95%,CD44;KDM1A;TAF9
prerank,protein heterotetramerization (GO:0051290),0.4223571619293404,0.883427726229453,0.6006655574043261,0.9489079908470056,1.0,5/13,21.49%,PKD1;FARSA;CBR4;CPSF7;NUDT21
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.29879212526163706,-0.882750031474424,0.641399416909621,0.8964341990704981,1.0,6/26,16.62%,ITPR1;RYR2;HTR2A;RYR3;ERO1A;CCL19
prerank,regulation of phosphate metabolic process (GO:0019220),0.40684406317371,0.8823476951277461,0.6275510204081632,0.950526838436726,1.0,4/16,11.20%,SMG6;MCM7;RAD17;GNB3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.35751419246494764,-0.8820697163519802,0.6423357664233577,0.8968974642286688,1.0,10/14,37.49%,CD81;RPS3;NECTIN2;RELA;KCNN4;TRAT1;CD226;TESPA1;LCK;RAB29
prerank,negative regulation of kinase activity (GO:0033673),-0.24994594464415773,-0.8818031577736143,0.6909871244635193,0.896428045634418,1.0,19/62,21.99%,PPM1E;PRKAG2;PPIA;SNCA;GSKIP;MAPT;PPP2R5A;SPRED1;TRIM27;AKT1;CDKN1C;PPM1F;TARBP2;PARK7;RTRAF;HNRNPU;INPP5K;TRIB3;TAB1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.347281536382714,-0.8813871720529479,0.6225,0.8962765846088355,1.0,3/14,8.92%,PRKD1;LOXL3;CD63
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4131339255878018,0.8809966107295477,0.6013513513513513,0.9526824943613379,1.0,1/13,2.25%,PTGIS
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.3841749730761437,0.8806396144033074,0.5914332784184514,0.9527984397050635,1.0,2/17,2.58%,CD55;BMP6
prerank,ovarian follicle development (GO:0001541),0.4089426773580672,0.8806262709133525,0.6362038664323374,0.9522517836566137,1.0,4/13,13.86%,INHBA;EIF2B2;INHBB;CEBPB
prerank,protein homooligomerization (GO:0051260),0.2912643743840087,0.8803897736703068,0.6623067776456599,0.9521726223766491,1.0,22/114,15.73%,KCNJ2;DISP1;TMEM120A;ATL3;EHD3;PDCD6IP;TRPM4;ATL2;RNF135;TK1;FUS;PKD2L1;BCL10;GNMT;MICU1;RBMX;EHD1;APIP;MPP2;CLYBL;JMJD6;TRPM2
prerank,neuron projection regeneration (GO:0031102),-0.39051396250428655,-0.8803306673582876,0.6040268456375839,0.8976522896307114,1.0,3/10,23.06%,NREP;OMG;PTN
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.36973692736593816,-0.8797574549014433,0.6492890995260664,0.8978426268506067,1.0,2/12,9.03%,CYP26B1;CALR
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.38105618325310353,-0.8796575269874657,0.6032110091743119,0.8960185151057506,1.0,7/10,50.96%,CEP250;CACNA2D4;GNAT1;REEP6;TULP1;GNAT2;CACNA1F
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.38105618325310353,-0.8796575269874657,0.6032110091743119,0.8960185151057506,1.0,7/10,50.96%,CEP250;CACNA2D4;GNAT1;REEP6;TULP1;GNAT2;CACNA1F
prerank,mitochondrial transport (GO:0006839),-0.25414931293918874,-0.8793429487505184,0.684,0.8956387589804359,1.0,14/53,18.27%,BCL2;BCL2L1;MFN2;TMEM14A;AIP;TIMM44;TMEM14C;TIMM13;STARD3;COX18;TSPO;SLC25A4;SLC25A24;TOMM7
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3759815658985557,0.8792488528211471,0.6026058631921825,0.953899221079995,1.0,4/21,4.50%,ANK2;CAMK2D;CACNA1C;DMD
prerank,positive regulation of translation (GO:0045727),0.29952474067846074,0.8792097205437402,0.6573849878934624,0.953406176078862,1.0,22/94,22.77%,THBS1;SAMD4A;YBX3;NIBAN1;LARP4B;PLD1;MTOR;MPV17L2;FXR2;DHX9;PRKDC;JMJD4;MRPS27;YTHDF3;ZCCHC4;YTHDF2;UPF3A;TRUB2;EIF6;EIF3E;FMR1;LARP1
prerank,glycoprotein biosynthetic process (GO:0009101),0.3074179125249109,0.8790186330003712,0.6392405063291139,0.9532205578437547,1.0,7/79,5.51%,ST3GAL4;B3GNT2;LARGE1;GCNT2;CHST13;MPI;GOLPH3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.39962764670416806,0.8789380147256536,0.5970394736842105,0.9528016896275956,1.0,1/14,0.45%,THBS1
prerank,camera-type eye morphogenesis (GO:0048593),-0.3854021052627903,-0.8789083094496761,0.6401869158878505,0.8955601620268553,1.0,3/10,5.12%,SHROOM2;KDM2B;TENM3
prerank,positive regulation of bone resorption (GO:0045780),-0.37329342609826877,-0.8782527684049732,0.6045977011494252,0.8959632053802363,1.0,5/11,16.35%,SPP1;ATP6AP1;TNFRSF11A;PLEKHM1;SYK
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.29621062222768674,-0.8780297823329017,0.6617210682492581,0.8954344627731116,1.0,15/30,22.61%,DCN;UGDH;NDNF;IDS;CSGALNACT1;CHST3;CHSY3;NCAN;CSPG5;CSPG4;HEXB;CHSY1;VCAN;BGN;DSEL
prerank,ketone body metabolic process (GO:1902224),0.43134539153676194,0.8778814869352718,0.6153846153846154,0.9543448800904991,1.0,2/10,8.37%,BDH2;AACS
prerank,protein acetylation (GO:0006473),0.35533835100413447,0.8777799888643572,0.617339312406577,0.95399712868635,1.0,6/30,12.88%,NAA40;EP300;CREBBP;KAT5;NAA35;KAT2B
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3482907280310903,-0.8777719098458073,0.6279620853080569,0.894957725385285,1.0,4/13,7.31%,AKT3;ITGA4;IGF2;MDK
prerank,positive regulation of stress fiber assembly (GO:0051496),0.33187010637967795,0.8777598053380344,0.6382393397524071,0.953473489689336,1.0,8/44,7.71%,SORBS3;TGFB3;WNT11;ABL1;TGFBR1;ARHGEF10;ARHGEF5;NRP1
prerank,positive regulation of cilium assembly (GO:0045724),-0.3299507811873208,-0.8771042322445944,0.6459948320413437,0.8953997846966502,1.0,3/18,5.34%,CEP120;CCDC88A;TAPT1
prerank,arachidonic acid metabolic process (GO:0019369),0.34242404367281315,0.8769875057527369,0.6198581560283688,0.9544897733150314,1.0,5/35,8.51%,CYP1B1;PTGIS;MGLL;DAGLB;CYP2S1
prerank,glycerolipid catabolic process (GO:0046503),-0.3192491810580564,-0.8769106941482968,0.6456043956043956,0.8947886579375869,1.0,3/19,4.59%,GPCPD1;ENPP6;ABHD12
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2720436353092894,-0.8767148512262414,0.6690391459074733,0.8942306468688379,1.0,16/37,28.48%,BCL2;BCL2L1;RPS7;RPS3;GSDME;BMF;UBB;BOK;NACC2;NUPR1;DNM1L;BAD;MSX1;FBH1;PMAIP1;TP53
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.39470582114807967,0.8766681538924489,0.6064516129032258,0.9545327300121604,1.0,4/17,18.30%,ANK2;SNTA1;KCNE4;AKAP9
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.338183965232285,0.876439854386407,0.6185852981969486,0.9544086891318079,1.0,3/43,4.22%,EGFR;PTPN3;RNF115
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.40798945316805973,0.8764268518791035,0.5837742504409171,0.9538691816936644,1.0,5/13,20.89%,SAE1;DESI2;DESI1;ATG7;UBA5
prerank,negative regulation of cholesterol transport (GO:0032375),0.43324527727302853,0.8755400095824791,0.6174377224199288,0.9551188010871879,1.0,1/10,5.37%,NFKB1
prerank,protein kinase A signaling (GO:0010737),0.433334156626549,0.8754622939234324,0.6230088495575221,0.9547004386836977,1.0,3/12,15.65%,EZR;RDX;PRKACA
prerank,mitotic spindle organization (GO:0007052),0.2817231764355878,0.8752751192436744,0.6681766704416761,0.9544996295014561,1.0,39/153,22.38%,TBCE;XPO1;NDEL1;DYNC1I1;VCP;ARHGEF10;PAFAH1B1;CLIP1;CENPQ;DCTN6;STIL;SEC13;CHEK2;DYNC1LI2;RMDN1;MISP;KIF2C;RANBP2;TOGARAM1;RHOA;NEK9;PIBF1;SMC1A;SPC24;RAN;FLNA;STAG2;KIF18A;KIF2A;SPICE1;NUP107;AAAS;CEP192;AURKA;SKA2;NUP98;CENPU;SUN2;NEK6
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2778742699229057,-0.8752394864562705,0.6936936936936937,0.8964077406409683,1.0,13/32,23.86%,BCL2;BCL2L1;IFIT2;ERBB4;CAMK2A;HK2;BOK;THEM4;SOD2;BIK;DNM1L;CCAR2;BAD
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.30703618977666364,0.8751428623058721,0.6542893725992317,0.9541896912478575,1.0,11/70,12.87%,NGF;INHBA;HIPK1;GSK3B;DIABLO;CRADD;ITGAV;TNFRSF1B;MOAP1;TGFB2;TRADD
prerank,positive regulation of fat cell differentiation (GO:0045600),0.32734569064690744,0.875078000291129,0.6180371352785146,0.9537630100259277,1.0,15/47,18.37%,SIX1;ZBTB16;ZBTB7B;TRPM4;CDS1;ASXL2;CMKLR1;LRP5;CEBPB;TFE3;CARM1;FRZB;SYAP1;CREBL2;ZFP36L1
prerank,mitochondrial translational elongation (GO:0070125),0.3027078246880359,0.8749498076612295,0.6628787878787878,0.9534628756125648,1.0,30/88,26.26%,MRPL33;MRPL48;MRPL32;MRPL14;MRPL21;MRPS31;MRPL38;GFM2;MRPL57;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,negative regulation of signaling (GO:0023057),-0.2950959657116916,-0.8749491034400155,0.6647727272727273,0.8960028780566072,1.0,5/25,11.03%,IGFBP3;SOCS5;KIF26A;GLRA1;OPTN
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3983464784717531,0.8748607700069592,0.5993485342019544,0.9530713181509355,1.0,6/15,21.13%,TLR6;IL17RA;TLR4;STAT3;MYD88;NOD2
prerank,tight junction assembly (GO:0120192),0.32081143482450947,0.8747667498604332,0.6337448559670782,0.9526832199177152,1.0,10/49,10.80%,MPP7;CLDN16;STRN;PDCD6IP;CLDN11;DLG1;POF1B;PATJ;PARD3;PAK2
prerank,regulation of chromosome organization (GO:0033044),0.36966417452987516,0.8746439548432824,0.5962732919254659,0.952392041254583,1.0,6/22,13.21%,SMG6;SMG1;WAPL;HDAC8;RB1;XRCC5
prerank,positive regulation of response to stimulus (GO:0048584),0.3322221833612753,0.8745577612591728,0.6386066763425254,0.9519814473376079,1.0,12/40,18.54%,PRKCD;CD80;BCLAF1;MAVS;GATA3;TGFB2;TAF9;ILK;FXR2;DHX9;HOMER1;IL15
prerank,glucose homeostasis (GO:0042593),0.30350575225463783,0.8741507454631983,0.6801517067003793,0.9522709115559465,1.0,18/83,16.20%,TCF7L2;LRRC8D;CRY2;FOXK1;KCNB1;KLF7;HNF4A;HNF1A;IRS1;PTPN2;FOXK2;SELENOT;STAT3;MCU;STK11;PRKAA1;SLC8B1;PAX6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.29004263621085413,0.8740902936789343,0.671021377672209,0.9512713962017614,1.0,12/104,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,cellular response to lectin (GO:1990858),0.29004263621085413,0.8740902936789343,0.671021377672209,0.9512713962017614,1.0,12/104,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,heterocycle biosynthetic process (GO:0018130),0.40269927348576084,0.8735014392523507,0.5938566552901023,0.9519293532153377,1.0,3/14,9.49%,NFS1;PYCR1;MOCS3
prerank,histone H3-K36 demethylation (GO:0070544),-0.3860726631282098,-0.8733791681339921,0.6412037037037037,0.8983660467217092,1.0,2/10,4.79%,KDM7A;KDM2B
prerank,regulation of G0 to G1 transition (GO:0070316),0.33743050179623213,0.8729690125960993,0.6411347517730497,0.952432502997381,1.0,18/38,24.78%,E2F6;RRM2;RNF2;CHEK1;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;YAF2;PHC3;EED;EZH2;RING1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3439033722884606,-0.8725642658196897,0.6223776223776224,0.8990904494820033,1.0,2/14,5.30%,OSMR;IL6ST
prerank,signal transduction in response to DNA damage (GO:0042770),0.32450805190661536,0.8723170232041529,0.645466847090663,0.9532137130409774,1.0,9/49,11.74%,NDRG1;ABL1;ATM;MDM4;USP10;CHEK2;RAD17;CHEK1;CEP63
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.33956365598389987,0.8722605993044035,0.6220238095238095,0.9527518456483177,1.0,6/36,6.05%,TCF7L2;PPP3CA;WNT11;PLCB3;TNRC6C;MOV10
prerank,response to axon injury (GO:0048678),0.37833318514213693,0.8721497861327976,0.6147540983606558,0.9524061404534226,1.0,2/18,7.14%,DPYSL3;P2RX4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2985408245376988,0.8720868140036445,0.6521739130434783,0.9519726864660316,1.0,19/80,18.89%,FAM107A;BIRC7;MYCBP2;PRICKLE1;RIPK2;KDM1A;DCUN1D4;BCL10;FBXO4;COMMD1;FANCM;BIRC3;AMER1;TSPYL5;CENPX;UBE2N;HUWE1;WFS1;ANGPT1
prerank,response to thyroid hormone (GO:0097066),-0.3529020007548771,-0.8719164196057986,0.6428571428571429,0.8994236511460074,1.0,5/13,12.51%,CTSH;LMO2;CTSB;CTSS;CTSL
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4278427058369174,0.8717464372685294,0.6313799621928167,0.9521022846441471,1.0,1/10,1.76%,DSE
prerank,positive regulation of JNK cascade (GO:0046330),0.31124255742077556,0.8716324056381396,0.660574412532637,0.951761730945818,1.0,5/70,4.04%,MAP3K5;RASSF2;PTK2B;WNT16;FZD7
prerank,regulation of neuron differentiation (GO:0045664),0.30587447176776394,0.8712633935509322,0.6553459119496855,0.9519216249549531,1.0,5/76,2.40%,ZFHX3;NGF;SIX1;VWC2;FGFR1
prerank,DNA conformation change (GO:0071103),0.38544694299032073,0.8711640338807024,0.6120689655172413,0.9515786037116953,1.0,5/17,18.62%,ABL1;TOP3A;ERCC3;TOP1;TOP1MT
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.28905985343956914,0.8710613333359479,0.6757719714964371,0.9512294503552813,1.0,12/105,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,regulation of mitochondrial fusion (GO:0010635),0.412618978812281,0.8707843592274902,0.5890909090909091,0.9511923172177148,1.0,4/11,17.63%,PID1;OMA1;BNIP3;HUWE1
prerank,intermediate filament organization (GO:0045109),0.3848403008866457,0.8707655983226859,0.6087662337662337,0.9506652430085519,1.0,2/17,3.51%,DSP;KRT14
prerank,regulation of cation channel activity (GO:2001257),0.29551520920845475,0.8702018787680738,0.6588957055214724,0.9511916949443326,1.0,10/89,7.50%,ANK2;PTK2B;SLMAP;AHNAK;CAMK2D;ITGB1;DMD;CNIH2;DLG1;FGF13
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3367510826715165,0.8697507191792272,0.6302158273381295,0.9515563705588841,1.0,4/35,4.55%,HOXA5;FOXO3;INHBA;GATA1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3425215600854536,0.8696976887223572,0.6200294550810015,0.9511093553516909,1.0,6/33,10.59%,TCF7L2;IL10;CAST;NFE2L2;GATA3;PAK4
prerank,DNA modification (GO:0006304),0.36975745489285816,0.8690143586056643,0.6188976377952756,0.9518997649816255,1.0,8/22,21.90%,MPG;SMUG1;MBD4;EXOSC5;ACD;TDG;UNG;EXOSC4
prerank,cellular response to interleukin-4 (GO:0071353),-0.3766660131171241,-0.868994053155462,0.6333333333333333,0.9048190264218242,1.0,1/10,0.37%,LEF1
prerank,chromatin assembly or disassembly (GO:0006333),0.42267176191588884,0.868927412268183,0.6113989637305699,0.9515092603205105,1.0,2/11,10.68%,CHAF1B;HDAC8
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36039944034882765,0.8689173318895815,0.6439393939393939,0.9509785202837466,1.0,10/25,24.10%,SCAF8;SETD5;WDR43;THOC5;EAF2;LDB1;ZNF326;HTATSF1;CCNT1;ALYREF
prerank,cellular response to oxidative stress (GO:0034599),0.28486915789303796,0.8683628170220711,0.6818713450292397,0.9515088626809033,1.0,13/118,8.02%,EGFR;FOXO3;PRKCD;MGAT3;WNT16;ABL1;NFE2L2;VKORC1L1;CHUK;JUN;PYCR1;GPX8;ETV5
prerank,regulation of microtubule nucleation (GO:0010968),-0.37572243820145146,-0.8683453237244955,0.6493212669683258,0.9051646544768321,1.0,5/10,33.48%,PAK1;GIT1;ARHGEF7;MECP2;HSPA1B
prerank,neuron projection extension (GO:1990138),0.3514604738532482,0.8676072152258194,0.6561561561561562,0.9524560341433779,1.0,11/32,19.28%,ALCAM;ULK2;NRP1;IQGAP1;EIF2AK4;SPG11;MAP1B;LLPH;CYFIP1;ULK1;USP9X
prerank,blood vessel endothelial cell migration (GO:0043534),0.37350573053865765,0.8675592321624972,0.6334405144694534,0.9519929404429737,1.0,4/22,7.71%,SLIT2;ID1;FGF2;NRP1
prerank,regulation of viral genome replication (GO:0045069),-0.24653451605570606,-0.8674815149157349,0.7240143369175627,0.9059315511260577,1.0,14/56,18.76%,PPARA;PPIA;BST2;IFITM1;ADARB1;IFITM3;OAS2;DDB1;PROX1;PPIE;NR5A2;TARBP2;TRIM6;RNASEL
prerank,regulation of catecholamine secretion (GO:0050433),-0.2863563175632875,-0.867349092149905,0.6863905325443787,0.9051683803747324,1.0,14/29,27.34%,SNCA;SYT7;SYT11;SYT12;SYT9;SYT13;KCNA2;GRK2;SYT15;SYT1;CHGA;SYT5;SYT17;SYT2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.389295826344711,0.8672242418106502,0.6094276094276094,0.952108939132717,1.0,3/17,7.71%,SLIT2;FGF2;NRP1
prerank,embryonic digit morphogenesis (GO:0042733),-0.3228088017607541,-0.8667827760063375,0.6339522546419099,0.9053470547632808,1.0,4/18,6.37%,TBX3;MAP3K20;SALL1;OSR1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3048301657092317,-0.8663814364281435,0.6472148541114059,0.9052025222926257,1.0,16/22,39.55%,HSCB;HSPA9;CIAO3;ISCA1;NUBP1;LYRM4;ABCB7;ISCA2;IBA57;MMS19;GLRX5;FXN;NUBPL;CIAO1;CIAPIN1;NDOR1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.34102395881787256,0.8659915293144281,0.622356495468278,0.9540797040426221,1.0,9/32,18.45%,NEK7;TNKS2;ATM;FBXO4;MAPK1;XRCC5;MAPK15;TCP1;ACD
prerank,TOR signaling (GO:0031929),-0.29694195017567276,-0.8658109186099406,0.6332288401253918,0.9053058459921823,1.0,11/26,24.12%,CCDC88A;PRR5L;RICTOR;EIF4EBP1;TIPRL;RPS6KB1;AKT1;FLCN;EIF4EBP2;PRR5;MEAK7
prerank,exit from mitosis (GO:0010458),-0.3518355374427813,-0.8657266906425143,0.6492027334851936,0.9044633013220962,1.0,1/12,0.78%,EPS8
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3543592609284839,-0.8656308800888644,0.6571428571428571,0.9036648917245107,1.0,5/12,21.35%,PRKD1;ING2;APLNR;VEGFA;CTBP1
prerank,axonogenesis (GO:0007409),0.2705940504549536,0.8655692051263963,0.7510822510822511,0.9543369159905497,1.0,29/237,9.97%,SLIT3;SLIT2;EFNA5;SEMA3D;EZR;SEMA3C;SPTAN1;GRB10;UNC5C;PDLIM7;SHC1;ISL1;SEMA3E;DOCK7;NOTCH2;ULK2;KLF7;GDNF;EPHB6;SHTN1;GAB2;NRP1;NTN3;GAB1;SPG11;PTPRA;USP33;EMB;CXCR4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3208097694330858,0.8654442486042812,0.6527196652719666,0.9540133362456178,1.0,8/45,13.20%,CD44;CAMK2D;PRKCD;MID1;TRIM26;TRIM25;IRF1;CIITA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3500413624967549,-0.8651594987232469,0.6352657004830918,0.9036776187638963,1.0,4/14,15.27%,PPARA;MFSD2A;MTLN;AKT1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.28092595656518815,-0.8651075571488788,0.6826347305389222,0.9027846015826662,1.0,8/32,16.03%,ABHD3;LPIN3;SLC44A1;MFSD2A;LPIN1;SLC44A2;STARD7;SLC27A1
prerank,neurotrophin signaling pathway (GO:0038179),0.3730380199287576,0.8646422761285473,0.6342229199372057,0.9550605039555422,1.0,4/21,10.38%,NGF;RAP1A;KIDINS220;ZFYVE27
prerank,apical protein localization (GO:0045176),-0.37715122578701177,-0.8642339583625652,0.654627539503386,0.9035842316562023,1.0,4/10,6.79%,SHROOM2;MAL;ACTB;JAM3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2753017268621738,0.864223974172725,0.7250821467688937,0.9552867115381507,1.0,21/190,11.48%,SLIT2;CCN3;THBS1;CIT;TANK;PDE10A;UBE2B;DDIT3;PHLPP2;PPEF2;OTUD7B;IFI35;ATP2B4;USP10;PPM1A;CCDC22;NPRL3;PRDM15;MARK3;CARD19;DRD3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2498958521877026,-0.8635585468548298,0.6911196911196911,0.9040186581075974,1.0,10/49,14.02%,SGMS1;BCL2;DAPK2;BCL2L1;SRC;GSDME;BMF;NOC2L;BOK;NDUFS3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.34767790970947865,0.8630131893725581,0.6462882096069869,0.9569872350397494,1.0,6/31,13.86%,IL10;TNFRSF13B;CD80;ATM;SDC4;CEBPB
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.36231880428705554,0.8622295379064737,0.6191222570532915,0.9579357150181956,1.0,3/22,7.89%,CYP1B1;IL10;HES1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.3845453536072283,0.862200307338411,0.611764705882353,0.9574360546767011,1.0,2/16,4.89%,CLDN16;CLDN11
prerank,cellular copper ion homeostasis (GO:0006878),-0.33848240622485115,-0.8621430890769278,0.6790123456790124,0.9060905244307704,1.0,5/14,16.91%,ATOX1;MT2A;APP;SLC31A1;ATP7A
prerank,protein import into nucleus (GO:0006606),0.30654549452614005,0.8613901236232593,0.665359477124183,0.9584606251703915,1.0,15/66,15.05%,NUP93;IPO7;PRICKLE1;KPNA1;SEC13;E2F3;RGPD1;NUP188;TNPO2;RANBP2;STAT3;HEATR3;FAM53A;RAN;KPNA4
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.30552401138359137,0.8611667695885228,0.6620253164556962,0.9583324039558941,1.0,13/72,13.96%,RBFOX2;FGFR1;SPRED2;FLRT2;SHOC2;FGF22;HNRNPH1;FGF2;KLB;NOG;CEP57;MAPK1;GTF2F2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.28219940790277076,-0.8601574875895228,0.6887608069164265,0.9091982607131502,1.0,13/31,28.48%,TFDP2;BCL2;PPP3R1;CHCHD10;BOK;HIP1R;GSK3A;BAD;TFDP1;BAK1;YWHAB;PMAIP1;TP53
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3421924743532002,-0.859994214120566,0.6632911392405063,0.9085523470838909,1.0,2/14,7.42%,ENTPD1;ENTPD5
prerank,heterochromatin assembly (GO:0031507),-0.30375788108073587,-0.8597727192165465,0.6710182767624021,0.9080130817168957,1.0,9/20,32.53%,MBD2;SMCHD1;ZNFX1;HELLS;SUV39H1;CENPV;RRP8;BEND3;HMGA2
prerank,quinone biosynthetic process (GO:1901663),0.3961420254699701,0.8596430500825362,0.6098360655737705,0.9606703089927752,1.0,6/14,24.75%,COQ7;COQ10B;COQ8A;PDSS2;UBIAD1;COQ6
prerank,positive regulation of B cell activation (GO:0050871),-0.25489724921100343,-0.8596209135591771,0.7622641509433963,0.9073216588373465,1.0,14/50,18.59%,BCL2;TFRC;SH3KBP1;RIF1;CD81;MEF2C;VAV3;CD38;NCKAP1L;SYK;TIRAP;MIF;CD74;TNIP2
prerank,receptor signaling pathway via STAT (GO:0097696),0.3558741072285606,0.8591249805527484,0.6440944881889764,0.9611084903614107,1.0,10/25,20.96%,PKD1;SOCS2;CLCF1;CTR9;STAT3;STAT5A;STAMBP;STAT6;PIAS1;THPO
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.33737687062009525,0.8591048344328677,0.6438152011922503,0.9606049296414555,1.0,9/35,18.45%,NEK7;TNKS2;ATM;FBXO4;MAPK1;XRCC5;MAPK15;TCP1;ACD
prerank,negative regulation of mRNA processing (GO:0050686),0.38610189643006926,0.8582890314766306,0.6346801346801347,0.9616364294898075,1.0,5/15,17.29%,PCBP4;SRSF6;SRSF12;RBMX;SFSWAP
prerank,negative regulation of lyase activity (GO:0051350),-0.3330488791313024,-0.8582279772794759,0.6506329113924051,0.9092498319886184,1.0,2/16,1.74%,ADGRV1;GRM3
prerank,histone H3-K4 trimethylation (GO:0080182),0.40469222023215534,0.8582131807347516,0.6217162872154116,0.9612302001285316,1.0,4/11,20.94%,CTR9;KMT2D;SETD1B;KMT2A
prerank,negative regulation of cell activation (GO:0050866),-0.3468838444474047,-0.8580893831091309,0.6515837104072398,0.9085275399055434,1.0,3/14,7.21%,APOE;NOS3;PDGFRA
prerank,regulation of leukocyte migration (GO:0002685),0.3867326805604518,0.8578229156634958,0.6227347611202636,0.961438576435278,1.0,1/16,1.33%,ANXA1
prerank,"transcription, DNA-templated (GO:0006351)",0.26825393183561985,0.8574224733707134,0.7657952069716776,0.9616350333287856,1.0,42/207,18.62%,RNMT;MLLT3;FOXO3;DDX5;ZBTB7B;MEF2A;NR4A2;NFKB1;RPAP1;TAF1C;TTF2;CBFB;MNAT1;NFYA;CTR9;ERCC3;MBD1;TTF1;TAF1;RBMX;TRIP11;TAF9;PAF1;CRCP;POLR3GL;RTF1;BAZ2A;PPP5C;GTF2F2;THAP1;TAF15;TAF12;NFIX;ELOA;EAF2;GTF2E1;AFF4;EPC1;NELFE;CREBL2;BRF1;POLR2H
prerank,regulation of cardiac muscle contraction (GO:0055117),0.34030055588140795,0.8573343988561006,0.6488888888888888,0.961251683692729,1.0,4/34,7.14%,ANK2;ATP1B1;TNNI3;P2RX4
prerank,B cell activation (GO:0042113),0.3012929055325591,0.8566923551317713,0.6636713735558408,0.9618942711984853,1.0,8/68,9.43%,HDAC4;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3
prerank,regulation of lipid kinase activity (GO:0043550),-0.3676247252501197,-0.8562809190935115,0.6574074074074074,0.91131695105164,1.0,3/11,13.00%,PIK3R1;PPP2R5A;WDR91
prerank,cellular response to glucose stimulus (GO:0071333),-0.2821735425253909,-0.856240184805898,0.6863905325443787,0.9103964522254819,1.0,5/30,11.01%,IGF1R;ZBTB20;ERN1;GAS6;PRKAA2
prerank,selective autophagy (GO:0061912),0.309502191416544,0.8559923414509362,0.6829931972789116,0.9627238469226671,1.0,17/56,19.21%,ULK2;DYNC1I1;DDRGK1;BECN1;ATM;DYNC1LI2;SQSTM1;RB1CC1;ACBD5;UFL1;AMBRA1;IFT88;LGALS8;UBE2N;ATG2A;RAB7A;ULK1
prerank,positive regulation of exosomal secretion (GO:1903543),0.38967567749011944,0.8558998869019734,0.6492146596858639,0.9623364537360497,1.0,8/15,26.75%,PDCD6IP;SDC4;TSG101;SDC1;RAB7A;HGS;SNF8;ATP13A2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3737382738670159,-0.8557884539760671,0.6484018264840182,0.9103461091333882,1.0,2/10,5.45%,JARID2;RIF1
prerank,positive regulation of T cell activation (GO:0050870),-0.23914375840379487,-0.8556409319479307,0.7406015037593985,0.9096321856684201,1.0,9/62,7.45%,VCAM1;CD47;TFRC;IL6ST;CD81;PRKCQ;RHOH;MDK;SIRPA
prerank,positive regulation of viral process (GO:0048524),-0.23858244175582172,-0.8553918969773028,0.767175572519084,0.909164587374475,1.0,18/60,22.89%,PPARA;PPIA;ADARB1;DDB1;KPNA2;NELFCD;PPIE;NELFA;POLR2K;NR5A2;TYRO3;TARBP2;POLR2C;HACD3;POLR2G;SUPT4H1;POLR2L;AXL
prerank,histone H4-K16 acetylation (GO:0043984),0.38105063572364695,0.8549822401528708,0.6272577996715928,0.9635561513652,1.0,9/19,26.02%,MSL1;KANSL2;KANSL1;HCFC1;KMT2A;KANSL3;PHF20;WDR5;MCRS1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3289542339537659,-0.8549446839859371,0.6597938144329897,0.9090721837950161,1.0,4/15,16.03%,NR1H3;SCARB1;MFSD2A;SLC27A1
prerank,nitric oxide biosynthetic process (GO:0006809),0.405337162491941,0.8543069567913497,0.6410684474123539,0.964291977843735,1.0,1/13,1.68%,CYP1B1
prerank,positive regulation of protein acetylation (GO:1901985),-0.35919553771343005,-0.8541404898944356,0.6706730769230769,0.9097338635675948,1.0,6/12,29.56%,RAPGEF3;PRKAA2;TERF2IP;DIP2A;FAM161A;TAOK1
prerank,mitotic cytokinesis (GO:0000281),0.3217986691065834,0.8539495589263139,0.6593406593406593,0.9644144710550064,1.0,5/47,6.58%,CIT;SNX18;PDCD6IP;ARL3;SON
prerank,cellular lipid catabolic process (GO:0044242),-0.2867383804131662,-0.8539382269183401,0.6871345029239766,0.9091425382594734,1.0,6/27,9.71%,ENPP2;PPARD;ABHD12;LPIN3;ACADL;LPIN1
prerank,membrane protein proteolysis (GO:0033619),0.32781022670029175,0.8537719756682866,0.648068669527897,0.9642199989944481,1.0,12/37,21.05%,ADAM9;NFKB1;SPPL2A;ADAM10;ERAP1;PARL;RBMX;NAPSA;MBTPS1;CLPP;BACE2;TGFB1
prerank,glycogen metabolic process (GO:0005977),0.34420065785230636,0.8537502837096989,0.6330275229357798,0.9637032950465734,1.0,4/27,4.99%,PPP1R3C;PYGB;GSK3B;PHKA2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2777663277210554,0.8534956259826405,0.7275862068965517,0.9636331332620138,1.0,39/148,20.49%,HIPK1;SMYD2;EP300;PLK3;USP2;ATM;DYRK2;USP7;MDM4;CHEK2;MLST8;KAT5;TOP3A;RAD17;MTOR;TAF1;CHEK1;RPA1;CSNK2A2;CSNK2A1;PAK1IP1;TAF9;RFC5;EHMT2;EHMT1;STK11;TAF15;RBBP8;PRKAA1;TAF12;PML;WRN;PPP2R5C;NBN;RBBP4;MRE11;AURKA;NOP2;RMI2
prerank,MAPK cascade (GO:0000165),0.26273417995979165,0.8534576187687555,0.7885416666666667,0.9631632006096168,1.0,27/295,7.56%,EGFR;MET;SOX9;MAP3K5;PTPN3;MRAS;SPTAN1;FGFR1;SHC1;NRAS;KRAS;MEF2A;PDE6D;PDGFA;GDNF;NFKB1;IL5;IRS1;SHOC2;ITGAV;DLG1;FBXW11;FGF22;CHUK;FGF13;FGF2;MAP3K3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.34253912774072864,0.85336974638524,0.6823529411764706,0.9627790647154588,1.0,3/35,3.03%,MET;ARHGAP44;CCDC125
prerank,serine family amino acid metabolic process (GO:0009069),0.3925466985896715,0.8531893651006034,0.6575809199318569,0.9625715875718609,1.0,4/16,16.83%,GCLC;CDO1;SEPSECS;PSPH
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2885853094882355,-0.8528552187730888,0.6761658031088082,0.9104097688270919,1.0,9/26,15.94%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;TAB2;UBB;AAMP;TNFAIP3
prerank,calcium ion import across plasma membrane (GO:0098703),-0.33417883464989684,-0.8527297333066289,0.6862302483069977,0.9096909425285453,1.0,5/14,24.30%,SLC24A2;SLC8A1;CACNA2D1;TRPV4;TRPV2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.25799985335306636,-0.8523748773641968,0.7422680412371134,0.909402894633058,1.0,4/42,5.25%,CECR2;MBD2;ACTB;SMARCA2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.40498690802655235,0.8522750092797917,0.6524953789279113,0.9637715714686985,1.0,6/13,20.71%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A;CDCA4
prerank,Golgi to lysosome transport (GO:0090160),0.41452065298681284,0.8516760665884358,0.6371841155234657,0.9643743839925227,1.0,5/11,19.06%,EHD3;GAK;RBSN;AP4M1;CLN3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2933947907404455,0.8514148848655886,0.719059405940594,0.9643040798526767,1.0,7/93,4.04%,MAP3K5;RASSF2;PTK2B;MID1;GDF6;WNT16;FZD7
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3943466823261206,0.8511000146083452,0.6309314586994728,0.9643119335584884,1.0,5/13,20.25%,PRPF3;SRSF12;LSM2;USP4;PRPF6
prerank,"base-excision repair, gap-filling (GO:0006287)",0.33706683438839125,0.8506726844646827,0.656203288490284,0.964537116016028,1.0,14/35,27.20%,MPG;SMUG1;MBD4;RPA1;RFC5;POLD3;POLB;TDG;UNG;APEX1;RFC1;XRCC1;LIG3;NTHL1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3050965374506775,-0.8502281484814462,0.6684782608695652,0.9128473838493447,1.0,5/23,11.01%,IGF1R;ZBTB20;ERN1;GAS6;PRKAA2
prerank,negative regulation of macroautophagy (GO:0016242),0.35722742467427226,0.8500335134575466,0.663093415007657,0.9651791400529617,1.0,11/26,23.77%,SMG1;SMCR8;MTOR;SEC22B;FEZ2;CLEC16A;CHMP4A;CHMP4B;TMEM39A;USP36;PHF23
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.30752030090828136,-0.8499304667994481,0.6772486772486772,0.9124658020418073,1.0,6/20,19.35%,FAR2;ACLY;ACACA;HSD17B4;GCDH;DGAT1
prerank,negative regulation of cell communication (GO:0010648),-0.29620977069773646,-0.8497919159339048,0.6666666666666666,0.9117436543783269,1.0,4/21,9.15%,IGFBP3;SOCS5;KIF26A;GLRA1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4103832699736544,0.8493712868369594,0.6210720887245841,0.965353659070584,1.0,3/11,15.53%,OCRL;INPP5B;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4103832699736544,0.8493712868369594,0.6210720887245841,0.965353659070584,1.0,3/11,15.53%,OCRL;INPP5B;SYNJ1
prerank,protein K63-linked deubiquitination (GO:0070536),0.34401105305473806,0.8491678757945419,0.6505139500734214,0.9651942247360868,1.0,8/31,17.36%,USP13;OTUD1;OTUD7B;USP7;USP33;USP25;STAMBP;ZRANB1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3582788340415418,0.8491490330867,0.6639741518578353,0.9646845276551504,1.0,3/24,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3732738585895085,0.8491267098531196,0.609717868338558,0.9641828969248966,1.0,1/17,0.27%,BMP4
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3652877662928031,0.8485357572180536,0.6236220472440945,0.9647624881244773,1.0,3/20,7.77%,BMP5;WDTC1;ERLIN1
prerank,kinetochore organization (GO:0051383),-0.35610736642117574,-0.8482984747952466,0.6716791979949874,0.9136039326370862,1.0,8/13,41.06%,CENPE;CENPA;DLGAP5;NUF2;NDC80;POGZ;MIS12;CDT1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3077321052997646,0.8482731256699775,0.6736842105263158,0.9647447244152006,1.0,8/65,10.90%,EGFR;PTPN3;ARAP1;RNF115;PTPN2;BCAR3;AGR2;CDC42
prerank,regulation of AMPA receptor activity (GO:2000311),-0.29739910952549764,-0.8480777872528822,0.6873156342182891,0.9130566513012582,1.0,10/25,22.39%,SHANK3;MEF2C;CACNG4;CACNG7;GSG1L;NLGN1;SHISA9;NLGN2;SHISA6;MAPK8IP2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3189202278709615,-0.8479070741352535,0.6548223350253807,0.912388729332372,1.0,4/18,11.15%,SHANK3;NRXN1;CACNG4;CACNG7
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2984859419455248,0.8476837636034539,0.6952506596306068,0.9653106903600822,1.0,8/64,8.50%,CYP1B1;PNPLA3;MGLL;ACSL3;DAGLB;HACL1;ACOT8;SLC27A3
prerank,calcium ion import into cytosol (GO:1902656),-0.32517636431618,-0.8471077824380172,0.6782407407407407,0.9129927439335113,1.0,5/15,24.30%,SLC24A2;SLC8A1;CACNA2D1;TRPV4;TRPV2
prerank,zinc ion transport (GO:0006829),-0.30004492194982507,-0.8471020628873038,0.676056338028169,0.9120129930280076,1.0,6/21,14.69%,SLC30A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,regulation of intracellular transport (GO:0032386),-0.26259520463105074,-0.8467671380662485,0.7363013698630136,0.911651958693892,1.0,11/38,21.10%,MAP2;INPP5F;LAMP1;LRRK2;SCFD1;RNF139;DNAJC30;NEFH;LCP1;DYNLT2B;SPAG5
prerank,T cell receptor signaling pathway (GO:0050852),-0.21015502965066904,-0.845998991939636,0.8387096774193549,0.9121993866703797,1.0,31/138,21.15%,PIK3R1;PDE4B;FYB1;PAK1;INPP5D;RFTN1;TNFRSF21;TEC;PRKCQ;MALT1;PDE4D;MOG;PAG1;TAB2;PSMB10;BTRC;PSME2;PLCG1;EIF2B5;THEMIS;RELA;PSMB3;TXK;PIK3CD;PSMB4;PSMB8;LCP2;FYB2;ICOSLG;PSMC5;CD276
prerank,regulation of actin filament-based movement (GO:1903115),0.42562372686687117,0.8458967872029153,0.6319702602230484,0.9680997559883537,1.0,1/10,1.46%,ANK2
prerank,cellular response to nutrient levels (GO:0031669),0.30569359003802526,0.8455005137264627,0.6730523627075351,0.968274869880868,1.0,18/62,19.21%,EIF4G1;FAM107A;WIPI2;KCNB1;ZFYVE1;KLF10;USP33;MTOR;VPS41;INHBB;EHMT2;CLEC16A;TFEB;PRKAA1;RRAGB;WRN;ATG7;ULK1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3546523858497992,0.8454364388961934,0.6464968152866242,0.9678527125078755,1.0,5/25,12.38%,FOXO3;INHBA;GATA1;BRD1;STAT3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.346811765482316,0.8453553396906612,0.6621823617339312,0.9674717703563619,1.0,3/28,4.38%,MAP3K5;TMEM117;DDIT3
prerank,nitric oxide metabolic process (GO:0046209),0.39962251204364585,0.8450980519732643,0.645,0.9674209982990748,1.0,1/14,1.68%,CYP1B1
prerank,cardiac muscle cell development (GO:0055013),0.35968451327530965,0.8448596518458108,0.6379310344827587,0.9673146890697548,1.0,4/20,8.89%,CXADR;CSRP3;PDLIM5;FHOD3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.39078203029986575,0.8447825476167474,0.652027027027027,0.966916363783907,1.0,4/15,12.29%,ADAM9;TNFRSF1B;SH3D19;ADAM8
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.38749158526536226,0.8447785792805783,0.6517412935323383,0.9663776538228335,1.0,1/15,1.02%,NGF
prerank,glycerolipid metabolic process (GO:0046486),0.4066834356895838,0.8446798982071037,0.6397188049209139,0.9660060518425274,1.0,4/11,15.95%,PNPLA3;PIP5K1A;DGKA;PLA2G15
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3198066770816894,0.8446265922930963,0.6736401673640168,0.9655719644864436,1.0,15/45,23.67%,FOXO3;GCNT2;ZC3H7A;PUM2;PUM1;MATR3;CYFIP1;ATXN2;RBM4B;METAP1;PUM3;METTL18;NUDT21;LARP1;PCIF1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3588486385371636,0.8443670771196542,0.6470588235294118,0.9655007135315323,1.0,3/23,11.44%,INHBA;DDIT3;TLR4
prerank,lipid droplet formation (GO:0140042),0.40460500120824777,0.8442557446971481,0.6469565217391304,0.9651627892713738,1.0,3/10,16.58%,ZFYVE1;CDS1;BSCL2
prerank,toll-like receptor signaling pathway (GO:0002224),0.28958100285677446,0.8442379188931842,0.6971214017521903,0.9646437028605925,1.0,13/84,12.39%,SCARA3;LBP;TAB3;CHUK;PIK3AP1;RIPK2;TLR6;IRAK4;UBE2D3;BCL10;TLR4;CD36;BIRC3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3517436480180254,0.844067306478221,0.6540880503144654,0.964409911102678,1.0,3/26,6.56%,MET;CLIP1;SLAIN2
prerank,regulation of calcium ion transport (GO:0051924),-0.2417931804333576,-0.8439358357126056,0.7715355805243446,0.9152912840865941,1.0,13/54,16.64%,MYLK;CACNA1D;BCL2;EPB41;ADRA2A;ATP2B1;CAMK2A;CACNA2D1;CD84;CAMK2B;TRPC6;STIM1;NOS1
prerank,response to cAMP (GO:0051591),-0.2581081993448894,-0.8437891989059291,0.735191637630662,0.9145710169469958,1.0,8/37,9.90%,RAPGEF3;RAPGEF2;HCN1;AHR;RAPGEF1;PDE2A;KCNQ1;NDUFS4
prerank,regulation of dopamine secretion (GO:0014059),-0.2880072973316963,-0.8435279571255581,0.711484593837535,0.9140628546588246,1.0,12/25,27.34%,SNCA;SYT7;SYT11;SYT12;SYT9;SYT13;KCNA2;SYT15;SYT1;SYT5;SYT17;SYT2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3168807302765421,-0.8434945159943594,0.7009569377990431,0.9131486752697545,1.0,6/18,18.62%,PPARA;DUSP3;PAG1;ASS1;AKT1;JAK3
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3059216982620939,-0.8432543659116359,0.6649874055415617,0.9116856975989036,1.0,7/20,22.49%,BCKDHB;IVD;ACAD8;BCKDHA;SLC25A44;HSD17B10;HIBADH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3059216982620939,-0.8432543659116359,0.6649874055415617,0.9116856975989036,1.0,7/20,22.49%,BCKDHB;IVD;ACAD8;BCKDHA;SLC25A44;HSD17B10;HIBADH
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.32460548199217315,0.842995710240358,0.646551724137931,0.9658836958871277,1.0,5/37,10.07%,ENTPD6;PABPC4;RNASE6;EXOSC7;DFFB
prerank,positive regulation of immune effector process (GO:0002699),0.33629828547279816,0.8427736261158789,0.6506024096385542,0.9657588968817393,1.0,3/27,10.17%,LBP;IL10;CD46
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3227621253858224,-0.8427419519998707,0.6892230576441103,0.9116965548777847,1.0,6/15,16.67%,PRKCH;CSF1;IL18;AGT;MAPK9;MSR1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.3985068458290634,0.8425116491406444,0.6434494195688225,0.9651453741942033,1.0,2/14,6.80%,ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),0.3985068458290634,0.8425116491406444,0.6434494195688225,0.9651453741942033,1.0,2/14,6.80%,ABCG2;HMOX2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.34820235388655846,0.8422299828918507,0.6550079491255962,0.9651241812204416,1.0,4/24,11.62%,PLCE1;NCKAP1;CDC42;BRK1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3551709064864315,0.8421776945026971,0.6693163751987281,0.9641361606526608,1.0,6/21,12.56%,ERCC3;ERCC1;RPA1;XPA;CHD1L;CUL4A
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3551709064864315,0.8421776945026971,0.6693163751987281,0.9641361606526608,1.0,6/21,12.56%,ERCC3;ERCC1;RPA1;XPA;CHD1L;CUL4A
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2848734296937658,0.8420233738390795,0.7175757575757575,0.9638809767073726,1.0,39/95,28.28%,REV3L;RNF138;MCM7;SWSAP1;ZFYVE26;RAD52;BRCA2;RAD51C;RPA1;RAD51AP1;FANCM;KDM4D;EXD2;NSMCE2;AP5S1;RBBP8;UBE2N;WRN;YY1;MCM9;NBN;INO80;SMC5;MRE11;XRCC2;RECQL5;MCM6;MCMDC2;ERCC5;ZSWIM7;PSMD14;MEIOB;XRCC1;LIG3;FANCB;MCM2;RFWD3;POLQ;RAD51B
prerank,protein targeting to membrane (GO:0006612),0.28900025914389477,0.8418361344631337,0.7032418952618454,0.9636800090438304,1.0,23/83,20.96%,ABCD3;ZDHHC11;PXMP2;ATG3;SEC63;SLC25A17;PARD3;ZDHHC23;PEX2;ACBD5;ZDHHC15;GOLGA7;CHM;VPS37A;ZDHHC7;PEX12;FIS1;PEX16;RABGEF1;GET3;CHMP4A;CHMP4B;SIL1
prerank,membrane raft organization (GO:0031579),0.37758822675623976,0.8417713468273463,0.6446700507614214,0.9632585543483876,1.0,6/15,19.06%,ANXA2;S100A10;EMP2;YJEFN3;NPC1;CLN3
prerank,cellular response to interleukin-1 (GO:0071347),-0.20259168575383613,-0.8416675986139426,0.9029850746268657,0.9129784310795055,1.0,18/143,10.53%,PLCB1;RPS6KA5;IL1R1;ADAMTS12;ST18;CD47;HIF1A;PELI2;NOD1;DAB2IP;MAPK3;SIRPA;RPS27A;UBC;IRAK2;TAB2;EGR1;PSMB10
prerank,carbohydrate catabolic process (GO:0016052),-0.2535029316246189,-0.8412530241343957,0.799373040752351,0.912800430853555,1.0,12/38,18.13%,GAPDH;ALDOC;PGAM1;PGAM4;ENO2;ALDOA;HK2;PFKM;MAN2C1;PGM1;HK1;PKM
prerank,protein complex oligomerization (GO:0051259),0.29002188611222884,0.8411524082447543,0.71625,0.9638860726879972,1.0,23/85,19.65%,LRRC8D;TMEM120A;ATL3;EHD3;PDCD6IP;ATL2;RNF135;FUS;BCL10;MICU1;RBMX;EHD1;SLC9A1;MCU;MPP2;STOML2;JMJD6;YME1L1;HOMER1;NOL3;CUTC;CPSF7;PRMT8
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.28490330101603056,0.8410834314396844,0.7115613825983313,0.963476307954417,1.0,21/95,17.10%,LBP;ADAM9;IL10;PDCD4;NFKB1;CD80;SHPK;TNFRSF1B;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;CYRIB;TRIM41;SBNO2;MYD88;TICAM2;CARD16;MAPK8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35018280321426837,0.8408739162208507,0.6438569206842923,0.963329258276854,1.0,5/27,11.26%,MARK1;GSK3B;NDEL1;DISC1;ULK4
prerank,phasic smooth muscle contraction (GO:0014821),0.4139187404072284,0.8407871535101819,0.656140350877193,0.9629547930581265,1.0,3/10,12.74%,GDNF;TIFAB;HTR2B
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.29193444972626564,0.8389810267154443,0.6952141057934509,0.9658058194885092,1.0,20/72,21.56%,TAX1BP1;HIPK1;ELF1;TRIM44;PTPN2;CHUK;SPPL2A;CBFB;BIRC3;TRADD;ABCE1;RNF31;VRK2;IRAK1;PTPN1;PTPN11;PIAS1;SUMO1;FADD;IFNGR2
prerank,negative regulation of response to wounding (GO:1903035),0.3631387964125238,0.8386863462259264,0.6413223140495867,0.9658166216610474,1.0,3/19,12.43%,CD109;FGF2;CASK
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.27923070172232956,0.8385766505113488,0.7319098457888493,0.9654775693711386,1.0,19/113,12.56%,TRABD2B;MPP7;EIF4G1;GSK3B;VCP;IL5;CLU;ATM;TLR6;UNC13B;ERCC3;ERCC1;RPA1;TLR4;BRK1;XPA;CD36;CHD1L;CUL4A
prerank,positive regulation of microtubule polymerization (GO:0031116),0.34103039237844635,0.8383963677577877,0.6546310832025117,0.9652902761805466,1.0,3/28,6.56%,MET;CLIP1;SLAIN2
prerank,regulation of cilium assembly (GO:1902017),-0.23140206403254399,-0.8383963299019986,0.8099173553719008,0.9173898761253352,1.0,16/62,15.11%,DCDC2;USP6NL;CEP120;CCDC88A;TAPT1;TBC1D8;CDKL5;CDK10;TBC1D2;TBC1D16;ODF2L;DYNC2LI1;TBC1D1;RABGAP1;TBC1D14;CCP110
prerank,histone H4-K5 acetylation (GO:0043981),0.38730308518879497,0.8383399625003277,0.6447811447811448,0.964315405611473,1.0,7/15,26.02%,KANSL2;KANSL1;HCFC1;KANSL3;PHF20;WDR5;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),0.38730308518879497,0.8383399625003277,0.6447811447811448,0.964315405611473,1.0,7/15,26.02%,KANSL2;KANSL1;HCFC1;KANSL3;PHF20;WDR5;MCRS1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.3516973913341824,0.8381797313712862,0.6792168674698795,0.9640890303274904,1.0,3/23,5.21%,RAET1E;KLRC2;PVR
prerank,oligodendrocyte differentiation (GO:0048709),0.3629171070796146,0.8374670940423787,0.652991452991453,0.9648790896984998,1.0,1/19,0.76%,SOX9
prerank,nucleocytoplasmic transport (GO:0006913),-0.2607933429560485,-0.8372518472938093,0.7466216216216216,0.9186532829397832,1.0,11/40,18.89%,ATXN1;BACH2;ANP32A;MALT1;SNRPB;SNRPF;PHAX;GEMIN7;GEMIN5;NUP205;SNRPG
prerank,regulation of stem cell population maintenance (GO:2000036),0.37093866577486045,0.8372283318459671,0.6509433962264151,0.9647737613586771,1.0,6/18,21.20%,KAT2A;TAF6L;WDR43;REST;CNOT3;NCOA3
prerank,methylguanosine-cap decapping (GO:0110156),-0.3640681846795868,-0.8371393526204441,0.6682464454976303,0.9178741482545464,1.0,5/10,30.24%,LSM1;DCP1B;DCP2;PATL2;PATL1
prerank,regulation of fibroblast proliferation (GO:0048145),0.31507840702469153,0.8367589519083527,0.6741889985895627,0.965108802364831,1.0,8/45,13.40%,PDGFC;FN1;DDR2;PDGFA;SKI;B4GALT7;PEX2;MORC3
prerank,nuclear export (GO:0051168),0.2878795046255365,0.8364958246435973,0.7061021170610212,0.9650456638373464,1.0,22/80,19.82%,PKD1;XPO1;EGR2;U2AF1L4;CASC3;SRSF5;NUP188;SRSF6;NXF1;SRRM1;THOC2;RBM8A;SRSF11;SMURF1;LSG1;RAN;THOC5;DESI1;ZC3H11A;CHP1;CHTOP;RAE1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.33895505167240725,0.8361242561460571,0.677710843373494,0.9651923555183135,1.0,9/29,18.54%,PKD1;SOCS2;CLCF1;CTR9;STAT3;STAT5A;STAMBP;STAT6;IL15
prerank,negative regulation of bone mineralization (GO:0030502),0.39039962456243665,0.8358779033686623,0.6527050610820244,0.965105634535134,1.0,2/13,5.12%,PTK2B;TRPM4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3646727044755014,0.8348727579361226,0.6610738255033557,0.9664014486497333,1.0,4/20,19.15%,PAICS;PFAS;GMPS;AMPD3
prerank,inositol phosphate catabolic process (GO:0071545),0.39993513912591033,0.8341329444126198,0.6505576208178439,0.9672955330861154,1.0,3/12,15.53%,OCRL;INPP5B;SYNJ1
prerank,positive regulation of viral life cycle (GO:1903902),-0.29935397280072984,-0.8336204880114033,0.7012658227848101,0.9237221812212154,1.0,9/22,31.38%,LGALS1;DDB1;KPNA2;TYRO3;CD74;AXL;CHMP2B;VPS4A;P4HB
prerank,regulation of astrocyte differentiation (GO:0048710),0.39412643505090905,0.8335333258470434,0.632688927943761,0.967892921059126,1.0,4/12,11.02%,SERPINE2;CLCF1;HES1;NOG
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.26732958585705613,-0.833486467987783,0.7477477477477478,0.9230278931127347,1.0,12/31,20.52%,SHANK3;PPFIA2;EPHA4;LRP8;LRRK2;ABI3;CAMK2B;LZTS3;CFL1;NLGN1;ABI2;CDK5R1
prerank,primary alcohol metabolic process (GO:0034308),0.342242718444778,0.8332910830149481,0.6602870813397129,0.9678161180374617,1.0,5/25,12.92%,CYP1B1;ADH7;PECR;GDPD3;NAAA
prerank,phospholipid translocation (GO:0045332),0.3397237948468717,0.8328524384802226,0.6621621621621622,0.9680779417910258,1.0,4/28,5.80%,ATP10A;ANO6;ATP8B1;PLSCR1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28711796125620026,0.8327577340544887,0.7270471464019851,0.9677030996652828,1.0,12/88,11.40%,SAMD4A;IGFBP5;SYNCRIP;NFKB1;SERPINE2;CNOT7;PAIP2;NELL1;TOB1;RGP1;EIF2AK3;NANOS2
prerank,determination of left/right symmetry (GO:0007368),0.32846506452037516,0.8327390332985285,0.6901408450704225,0.9671998973011845,1.0,8/36,18.79%,SMO;CCDC40;STIL;MEGF8;DNAH5;GALNT11;CITED2;PKD1L1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.28490039191501243,0.8327177315447263,0.7376847290640394,0.9667045232912533,1.0,25/98,19.97%,EGFR;SORBS1;ITGB1;KCNB1;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;SFN;C2CD5;PPP3CC;LRP1;ITGB1BP1;PTPN9;WNK3;TCAF2;MAPK8;NMT1;CHP1;MIEF1;FIS1;BBC3
prerank,histone H2A acetylation (GO:0043968),0.37900885289778163,0.8326822212787224,0.6740237691001698,0.9662426909965217,1.0,6/16,17.34%,NAA40;TRRAP;BRD8;DMAP1;EPC1;MORF4L2
prerank,histone lysine demethylation (GO:0070076),0.34451719799973013,0.8326388385778053,0.6714285714285714,0.9657942225568207,1.0,8/25,18.95%,JMJD1C;RIOX2;KDM1A;KDM4D;KDM3B;KDM6B;KDM2A;RIOX1
prerank,regulation of cell adhesion (GO:0030155),0.27528574811990125,0.8321904137526384,0.7514518002322881,0.9660775228763443,1.0,31/129,19.69%,ZFHX3;GPR4;PTK2B;EFNA5;ARHGDIB;PPP3CA;ABL1;PKP4;ITGAV;PLXNA2;ATM;ADAM10;CXCR4;PPP1R12A;ADAM8;RSU1;CHRD;TFE3;ITGB1BP1;PRKCA;PLAU;TPM1;EPHB3;YTHDF2;PRKD2;ANGPT1;PRKX;PLXNA3;DSCAM;CELSR2;PTPN11
prerank,intestinal lipid absorption (GO:0098856),-0.35793100269778017,-0.8316979972033278,0.6886363636363636,0.9254663628880645,1.0,1/11,3.65%,UGCG
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2631564321166133,-0.831666713420472,0.738562091503268,0.9245352758287232,1.0,8/37,11.59%,CEMIP;PRKAG2;CALM1;BMP7;CALM3;SPHK1;APP;SPRED1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.38130332565969877,0.831499392469543,0.6479591836734694,0.9668110969266797,1.0,4/15,17.91%,IGSF1;SKI;ACVR1;LEMD3
prerank,regulation of trophoblast cell migration (GO:1901163),0.3757808141626101,0.8313692561065422,0.6194539249146758,0.966491403940597,1.0,1/14,1.79%,ARHGDIB
prerank,microtubule depolymerization (GO:0007019),-0.31743701666985114,-0.8313140095488689,0.6693548387096774,0.9242376641479715,1.0,7/17,28.23%,STMN4;STMN3;NCKAP5;KIF18B;STMN2;KIF19;STMN1
prerank,dendritic cell chemotaxis (GO:0002407),0.3792245960990972,0.8312804805790656,0.664983164983165,0.9661017873270928,1.0,4/14,19.53%,TRPM4;CXCR4;TRPM2;CCR1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.39155385255755115,0.8309669800303698,0.65625,0.966170245691527,1.0,2/13,2.75%,ITGB1;CD9
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.26097212370888057,-0.8309668721472093,0.7516129032258064,0.9239170924699007,1.0,15/39,28.28%,ABCA1;TANGO2;OLFM2;STEAP3;RCN3;NECAB3;RAB15;RAB3C;CANX;MIA2;COPG2;MIA3;RAB13;RAB3A;SEL1L
prerank,phospholipid transport (GO:0015914),0.30555146882304307,0.8309042262192607,0.703851261620186,0.9657600614037157,1.0,7/52,8.53%,TNFAIP8L3;ATP10A;PITPNA;PITPNC1;ATP8B1;PITPNB;OSBPL5
prerank,glutathione derivative metabolic process (GO:1901685),-0.29661070016455776,-0.8303696160552305,0.6965699208443272,0.9231715363763165,1.0,8/20,28.31%,MGST3;ESD;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.29661070016455776,-0.8303696160552305,0.6965699208443272,0.9231715363763165,1.0,8/20,28.31%,MGST3;ESD;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3520959546249099,-0.8300608979523497,0.6898148148148148,0.9227672224831236,1.0,3/11,10.06%,WIPI1;MFN2;PACS2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3519349895970709,0.8295602270582878,0.6661608497723824,0.967736285940523,1.0,1/21,1.02%,NGF
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.31385164776224533,0.8294650865261973,0.6959459459459459,0.9673729970266174,1.0,6/42,13.56%,WARS2;EARS2;YARS1;CARS2;NARS2;FARSA
prerank,negative regulation of chemokine production (GO:0032682),0.3759081600238885,0.8294152083947061,0.6616161616161617,0.9669394672329389,1.0,2/14,3.51%,KLF4;IL10
prerank,positive regulation of behavior (GO:0048520),0.4050295829417201,0.8293513356767087,0.6684303350970018,0.9665203090859971,1.0,2/10,5.36%,STRA6;NR4A3
prerank,genitalia development (GO:0048806),0.39517684104194184,0.8290810461033835,0.6483333333333333,0.9664955291609947,1.0,4/12,12.29%,PKD1;STRA6;TIFAB;DNAJC19
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3343816035258839,0.8285229411271283,0.677037037037037,0.9669400015688073,1.0,10/29,26.08%,RAB6A;TRAPPC3L;NSF;VTI1A;COG3;COG5;COPA;TRAPPC10;COPB1;NAPG
prerank,regulation of protein processing (GO:0070613),-0.29123596015463815,-0.8282055074247713,0.7540106951871658,0.9252972135683207,1.0,4/21,14.48%,CCBE1;NKD2;LRRK2;RNF139
prerank,sensory perception of smell (GO:0007608),-0.35332883182613584,-0.8280798540225411,0.665938864628821,0.9245721494608141,1.0,3/11,26.77%,ADCY3;UBR3;MKKS
prerank,negative regulation of axon extension (GO:0030517),0.3268288847577303,0.8278483086975765,0.6809160305343511,0.9676181958173983,1.0,3/30,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,endothelial cell differentiation (GO:0045446),0.38831575717692535,0.8274351009770139,0.663003663003663,0.9678646557320055,1.0,2/12,6.86%,FSTL1;JAG1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.39714005588594425,0.8272962963619374,0.6649305555555556,0.9676013644574339,1.0,4/12,13.66%,WAPL;HDAC8;RB1;DDX11
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3548970707799887,-0.8268167522353607,0.6968325791855203,0.9259441754701471,1.0,2/11,9.42%,PAK1;RAC1
prerank,pore complex assembly (GO:0046931),0.36223965147975923,0.8265208158277624,0.6758508914100486,0.9685030483271796,1.0,3/19,8.30%,ANO6;NUP93;ADAM10
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.3868173659489156,0.8263240251440198,0.6558219178082192,0.9683327318537895,1.0,2/13,3.83%,SIX1;ZBTB7B
prerank,negative regulation of protein binding (GO:0032091),0.28848800215211257,0.8255181430731073,0.7031446540880503,0.9692557286815244,1.0,10/71,10.71%,LRPAP1;PRKCD;ADRB2;GSK3B;SLPI;KDM1A;PTPRF;USP33;DISC1;CSNK1E
prerank,nuclear membrane disassembly (GO:0051081),0.3749376984861337,0.8252213402297907,0.6792452830188679,0.9693042478338841,1.0,7/14,26.21%,CNEP1R1;NEK9;PRKCA;DCTN1;CDK1;NEK6;AKAP8L
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.41132911898945057,0.8251167003717694,0.6590509666080844,0.9679124940781512,1.0,5/10,29.76%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.41132911898945057,0.8251167003717694,0.6590509666080844,0.9679124940781512,1.0,5/10,29.76%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,t-circle formation (GO:0090656),0.41132911898945057,0.8251167003717694,0.6590509666080844,0.9679124940781512,1.0,5/10,29.76%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,myelin assembly (GO:0032288),0.4010563323308519,0.8246180562895746,0.687170474516696,0.9682906172174172,1.0,2/10,4.17%,CD9;PMP22
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4051446573275925,0.8243723818584265,0.6860068259385665,0.968196091453795,1.0,7/11,31.38%,GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,regulation of phospholipase C activity (GO:1900274),0.377902975004241,0.8236680138798412,0.6693944353518821,0.9688951060396118,1.0,4/15,7.51%,NTRK3;FGFR1;ABL1;FGF2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.32245601070311036,-0.8229055197526368,0.706855791962175,0.9322157862107054,1.0,1/15,0.37%,LEF1
prerank,myotube cell development (GO:0014904),0.3998249203799688,0.8227649303899394,0.672945205479452,0.9700072258758013,1.0,2/10,9.98%,SIX1;SKI
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.382834023144267,0.8226238375216363,0.6719298245614035,0.9697208017689468,1.0,2/13,7.52%,KLRC2;GAB2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29322707014151994,0.8223876272739555,0.7114882506527415,0.9696202015308177,1.0,20/62,23.33%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;STAT3;PUM2;PUM1;DHX9;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;TGFB1;NUP98;FMR1;PPARG
prerank,endodermal cell fate commitment (GO:0001711),0.41036954623176386,0.8215457486125816,0.6538461538461539,0.9706101826415728,1.0,3/10,12.61%,CTR9;PAF1;RTF1
prerank,cellular response to UV (GO:0034644),0.2836934700529334,0.8213284284681386,0.7157232704402515,0.970472917448521,1.0,17/76,18.17%,NEDD4;PRKCD;EP300;KDM1A;CREBBP;EIF2AK4;ERCC1;HYAL3;TAF1;CHEK1;USP47;XPA;STK11;XPC;CARD16;YY1;INO80
prerank,cellular response to interleukin-6 (GO:0071354),-0.2820433509922553,-0.8201018657516468,0.7278481012658228,0.9364898398682013,1.0,6/26,9.09%,ST3GAL6;ST18;PTPRT;IL6ST;IL6R;SRC
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.39396457845302857,0.81992799383475,0.6733333333333333,0.9724522837965185,1.0,1/11,1.61%,CD44
prerank,T cell activation (GO:0042110),0.2878270759215116,0.819804775683038,0.7252475247524752,0.972133453271345,1.0,8/69,10.39%,CXADR;CD44;PPP3CA;NCK2;PTPN2;TNFRSF4;EIF2AK4;GATA3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.33201675340467995,0.8195039130201143,0.6696562032884903,0.9721196618433505,1.0,3/26,5.12%,EFNA5;KLF7;TRPM4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.34476640236711154,0.8186180908752909,0.6822289156626506,0.9732197530840674,1.0,4/23,7.44%,F8A1;DYNC1I1;KIF1B;KIF1C
prerank,positive regulation of cell killing (GO:0031343),-0.33188952451922576,-0.818455599613047,0.7097560975609756,0.9384871345253776,1.0,4/13,16.35%,WNT5A;CYBA;RAC1;SYK
prerank,fibrinolysis (GO:0042730),-0.3323154416596995,-0.818419474923601,0.7024390243902439,0.9375601963300177,1.0,8/13,46.07%,PLAT;PLAUR;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,positive regulation of telomere capping (GO:1904355),0.3642044249206767,0.8183920255970727,0.6751592356687898,0.9730781600980122,1.0,4/17,15.17%,NEK7;TNKS2;MAPK1;MAPK15
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3473568530948286,0.817572234728306,0.7027863777089783,0.9740055376806352,1.0,7/26,8.54%,SORBS1;C1QTNF12;ERFE;NR4A3;IRS1;CAPN10;RHOQ
prerank,positive regulation of macrophage migration (GO:1905523),0.351901451890373,0.8171659666642545,0.6886035313001605,0.9742153720451638,1.0,4/19,12.93%,THBS1;P2RX4;CMKLR1;MAPK1
prerank,ncRNA export from nucleus (GO:0097064),0.31653444116421364,0.8170469434216912,0.6880466472303207,0.973909215231683,1.0,14/36,26.95%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NCBP2;NUP37;NUP153
prerank,positive regulation of hydrolase activity (GO:0051345),0.2660203026510971,0.8169282739241812,0.771264367816092,0.9735793099966678,1.0,21/137,13.08%,MAPRE2;ARAP1;SGSM2;ITGB1;WNT11;RAP1A;SNX18;RAPGEF6;GSK3B;RIPK3;NDEL1;PKP4;SGSM3;BCAR3;SRGAP2;BCAS3;RGP1;ASAP3;RHOA;RSU1;S100A10
prerank,cellular response to starvation (GO:0009267),0.26676138554937295,0.8168577478753495,0.7575757575757576,0.9731671729001222,1.0,32/147,17.41%,MAP3K5;FOXO3;DAPL1;WIPI2;ZFYVE1;BECN1;SIK2;KLF10;CASTOR2;EIF2AK4;SEC13;MLST8;USP33;NPRL3;MTOR;VPS41;EIF2AK3;ATP6V0E1;INHBB;MAPK1;EHMT2;ATP6V1H;CLEC16A;CEBPB;ATP6V0D1;TFEB;PRKAA1;MIOS;RRAGB;MAPK8;WRN;ATF2
prerank,receptor metabolic process (GO:0043112),0.3052927272995957,0.8164127379073285,0.7262872628726287,0.9734147247864002,1.0,6/53,5.88%,NEDD4;RAMP1;ITGB1;CD9;EHD3;BECN1
prerank,mitochondrion morphogenesis (GO:0070584),0.3876060312130758,0.8163190278686925,0.6783831282952548,0.9730440948936617,1.0,1/11,2.92%,PID1
prerank,regulation of embryonic development (GO:0045995),-0.26258550841232225,-0.8162713703949351,0.7756410256410257,0.9404535279437279,1.0,11/34,20.75%,PLCB1;INSR;SOX17;CLASP2;NR2C2;CFL1;RBM19;B4GALT5;RAB14;NPHP3;POGLUT1
prerank,regulation of microtubule polymerization (GO:0031113),0.31396441184484364,0.8162271086087812,0.7155172413793104,0.9726853301743456,1.0,4/40,6.56%,MET;ABL1;CLIP1;SLAIN2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2760292765928076,0.8161852225321445,0.7771010962241169,0.9722407208266562,1.0,28/94,23.70%,SFI1;CEP164;PAFAH1B1;CEP131;MKS1;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;CEP97;PRKACA;CSNK1D;DCTN3;CEP89;CNTRL;AKAP9;NPHP1;CEP192;DCTN1;ODF2;C2CD3;CDK1;B9D1;HAUS1;NPHP4;IQCB1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2635017760667004,-0.8161478235537516,0.7572254335260116,0.9396905504503907,1.0,7/29,23.67%,DDO;ALDH4A1;SARDH;GSTZ1;HSD17B10;HOGA1;KYNU
prerank,protein-containing complex subunit organization (GO:0043933),0.27547829179557803,0.8161365393685329,0.7420118343195267,0.9718085887638996,1.0,13/109,10.75%,REPS2;SOX9;PTK2B;MATN1;MAGI1;CREBBP;HES1;TEAD1;MDM4;MNAT1;DMTN;TUBGCP4;PARD3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.21494817643153288,-0.8161008077822273,0.8627450980392157,0.9387966288694227,1.0,12/84,9.28%,IGF1;APOE;RTN1;GAPDH;CNOT8;DAPK1;RPL13A;RPS3;CALR;NTRK2;YBX1;SPHK1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.36279297579976644,0.8160544301573709,0.680921052631579,0.9714368891227078,1.0,6/16,21.68%,FOXK1;FOXK2;GNB3;RORA;ADIPOR1;PDK3
prerank,protein localization to chromatin (GO:0071168),0.35501818462681906,0.8160311539691808,0.6605960264900662,0.9709538873402902,1.0,5/18,17.80%,SGF29;WAPL;MRNIP;LRWD1;MCM9
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.29025632668633056,0.8159300219099757,0.7477707006369426,0.9705999259244601,1.0,13/69,13.40%,PLCE1;NGF;EZR;FGFR1;PLCB3;PLCD3;IRS1;GAB2;PLCD1;GATA3;RHOA;HTR2B;PI4KB
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.29888383307833044,0.8155207541037818,0.7163781624500666,0.970815134124646,1.0,14/52,24.73%,SAMD4A;PAN3;CNOT7;EXOSC7;LSM2;PNLDC1;EDC3;EXOSC5;RC3H2;CNOT3;EXOSC4;DCP1A;CNOT11;EXOSC1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.30599516792624404,-0.8154397672296104,0.7034313725490197,0.939104292851714,1.0,10/18,26.60%,RGCC;BMP2;EFEMP2;FSCN1;CLASP2;SMAD3;COLGALT1;EMILIN1;RUNX1;IER3IP1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3814269842804149,0.8152050889261192,0.6892561983471074,0.970838077899797,1.0,7/13,23.77%,SMCR8;SEC22B;FEZ2;CHMP4A;CHMP4B;TMEM39A;PHF23
prerank,maturation of SSU-rRNA (GO:0030490),-0.26716438730802,-0.8151865994051195,0.7342192691029901,0.9385652220303309,1.0,11/34,18.62%,RPS14;RPS16;RPS19;RPS8;SNU13;RIOK1;TSR3;MRPS11;RPS28;NGDN;NOB1
prerank,response to cytokine (GO:0034097),0.26326714909215443,0.8148396199783501,0.7881257275902211,0.9709507101324821,1.0,33/141,18.58%,DPYSL3;ANXA1;HDAC4;NFAT5;PID1;COL3A1;ADAM9;AFF3;PLSCR1;HCLS1;IL18BP;PTPN2;TIMP2;ADAM10;CYP27B1;CXCR4;SETD2;RHOA;TAF9;IKBKE;STAT3;PTPN14;CIITA;REL;PRKCA;PTPN9;PML;MYD88;MAPK8;MAPKAPK2;NUB1;IRAK1;DDOST
prerank,neuron projection morphogenesis (GO:0048812),0.2696899876307776,0.8143080965226357,0.7793103448275862,0.9713441724482103,1.0,16/137,8.44%,DCLK1;NGF;ALCAM;CTNND2;ISL1;DOCK7;MEF2A;KLF7;TRIO;ANKRD27;SHTN1;NCKAP1;IQGAP1;BTBD3;EIF2AK4;SRGAP2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.28353316398000156,0.8141768316121176,0.7468671679197995,0.9710414594405559,1.0,6/85,7.14%,PIEZO2;ATP6V0A4;P2RX2;TFAP2A;TBL1X;P2RX4
prerank,regulation of necroptotic process (GO:0060544),0.339430187960716,0.8140103183452513,0.7043618739903069,0.9708194106214735,1.0,3/23,4.80%,YBX3;RIPK3;PDCD6IP
prerank,granulocyte chemotaxis (GO:0071621),0.2912264687681779,0.813747011581164,0.7247956403269755,0.9707744715754705,1.0,2/55,1.33%,CXADR;ANXA1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.31452291009254485,0.8137416592616911,0.7164179104477612,0.9702664859646309,1.0,11/37,20.34%,LRPAP1;NFKB1;ITGAV;TFAP2A;ITGB3;TRAP1;RIN3;AATF;ANKRD13D;ATXN2;DLG4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3400715221337213,0.8136934287818036,0.7189952904238619,0.9698370864845137,1.0,4/22,11.48%,AHNAK;DMD;CACNB2;DRD3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2839678701481776,0.8136588292817765,0.7372986369268897,0.9693843102958845,1.0,14/73,12.93%,CYFIP2;ABI1;PRKCD;ABL1;NR4A3;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.20827037478455374,-0.8133064014387497,0.8698224852071006,0.9410157649311307,1.0,34/109,24.09%,LYN;PIK3R1;PAK1;CALM1;TEC;MAPK3;PPP3R1;PRKCQ;MALT1;VAV3;RAC1;TAB2;GRB2;PSMB10;PPP3CB;BTRC;MAPK9;PSME2;PLCG1;VAV1;LAT2;SYK;RELA;PSMB3;PSMB4;PSMB8;LCP2;PSMC5;TAB1;PSME1;PSMA7;BTK;MAP3K1;PSMD5
prerank,regulation of response to oxidative stress (GO:1902882),-0.35632496005689984,-0.8131268937361363,0.7185354691075515,0.9403619719483249,1.0,5/11,31.14%,MCTP1;GGT7;STOX1;ALOX5;HEBP2
prerank,mRNA catabolic process (GO:0006402),0.30675381699670545,0.8130093173794941,0.7405329593267882,0.9700083174770048,1.0,7/44,13.42%,DDX5;DXO;ZC3H12D;DIS3L2;NANOS2;LSM2;NBAS
prerank,regulation of fat cell differentiation (GO:0045598),0.28427790429670957,0.8122921220767868,0.7452711223203027,0.970781007062682,1.0,19/74,18.37%,ZFPM2;ZBTB16;FTO;TRPM4;TRIO;WWTR1;CDS1;GATA3;GNB3;ASXL2;CMKLR1;LRP5;CEBPB;CARM1;FRZB;RORA;SYAP1;CREBL2;ZFP36L1
prerank,positive regulation of heart rate (GO:0010460),0.36147056073633876,0.8121199266240385,0.7077922077922078,0.9705469438069556,1.0,2/17,5.12%,ADRA1B;TRPM4
prerank,cardiac ventricle development (GO:0003231),0.35195596630928505,0.8117922246926236,0.6915739268680445,0.9706158293071543,1.0,6/20,10.39%,STRA6;TMEM65;HES1;GATA4;MDM4;GATA3
prerank,organonitrogen compound catabolic process (GO:1901565),0.29891586328409314,0.8117033608317644,0.7458492975734355,0.970262707684153,1.0,13/57,19.78%,NPEPPS;PDXDC1;CPQ;LRSAM1;IDE;GADL1;ERAP1;MTOR;PLA2G4A;PLA2G15;GNPDA2;TPP1;SMPD2
prerank,regulation of cilium movement (GO:0003352),0.3979195949158373,0.8115646048363373,0.6728813559322034,0.9699823159498089,1.0,1/10,4.71%,CCDC40
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.31234792585441884,-0.8114153863571036,0.7473684210526316,0.9424743991264541,1.0,6/15,21.18%,SPCS3;SRP14;RYR2;SEC61G;SPCS1;ZFAND2A
prerank,response to light stimulus (GO:0009416),0.29645681466383944,0.8113457495611122,0.7567934782608695,0.9698549498349105,1.0,9/55,17.10%,UBE4B;CRY2;UBE2B;ERCC3;ERCC8;REV1;CDKN2D;USP1;MAPK8
prerank,regulation of protein localization (GO:0032880),-0.23457633943357314,-0.8107727841933077,0.8577235772357723,0.9426147573064353,1.0,12/58,15.66%,RABGAP1L;PICALM;MAP2;TRIM14;PARP1;HSP90AB1;TRIM21;CTSD;TRIM27;MMD;TRIM46;PPM1F
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.40263434181163926,0.8105617603745006,0.6968085106382979,0.9707174967240458,1.0,5/10,28.32%,OS9;UBAC2;SVIP;YOD1;DERL2
prerank,striated muscle cell development (GO:0055002),-0.3198143305103691,-0.8104320224007575,0.7135416666666666,0.942240566567305,1.0,3/14,7.80%,PGM5;TMOD1;LMOD1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3179048711246003,-0.8102541462127634,0.717391304347826,0.941590224105898,1.0,2/15,7.42%,ENTPD1;ENTPD5
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2836822918828677,0.8102404838533817,0.7526178010471204,0.9707521457132167,1.0,25/68,26.41%,POLR1G;TAF1C;TTF2;MNAT1;SCAF8;ERCC3;TTF1;POLR1A;POLR1H;SNRPD3;POLR1F;TAF1D;POLR2H;CPSF7;NUDT21;CPSF4;ERCC2;MAZ;NCBP2;CSTF2;SNRPE;CSTF1;POLR3K;FIP1L1;POLR1C
prerank,ceramide metabolic process (GO:0006672),0.3020182124558104,0.8101623604862566,0.7359009628610729,0.9703804901152316,1.0,6/49,8.67%,ACER3;PLPP3;SGMS2;SPTSSB;CERS6;CERS5
prerank,regulation of axon extension (GO:0030516),0.31011071681861235,0.8101369264359598,0.7244755244755244,0.9699090613789676,1.0,6/37,10.38%,NTN1;GSK3B;ABL1;SHTN1;ISLR2;ZFYVE27
prerank,phagosome maturation (GO:0090382),0.31336689270748097,0.809894065527214,0.7111756168359942,0.9698057540073105,1.0,9/35,19.26%,ATP6V0A4;RAB43;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;MCOLN1;RAB7A;ATP6V1G1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3829656791464857,0.8097721921340684,0.6677577741407529,0.9695261045737735,1.0,7/13,28.32%,OS9;EDEM2;UBAC2;BCAP31;SVIP;YOD1;DERL2
prerank,synaptic vesicle membrane organization (GO:0048499),0.3677063216061683,0.8096043808106791,0.6824104234527687,0.9693182619560328,1.0,3/17,10.93%,STX19;STX11;SNAP23
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.3877131470495652,0.8095178092868222,0.6740994854202401,0.9684536752797199,1.0,1/10,1.51%,HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.3877131470495652,0.8095178092868222,0.6740994854202401,0.9684536752797199,1.0,1/10,1.51%,HDAC4
prerank,GPI anchor metabolic process (GO:0006505),0.33393826818705075,0.8092700202174542,0.7149187592319055,0.9683632192086837,1.0,7/26,17.19%,PIGB;PIGL;PIGU;PIGN;DPM1;PIGH;PGAP2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.26674772874964287,0.8092524195845862,0.7654761904761904,0.9678881579154591,1.0,10/107,8.27%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;SLC39A14
prerank,ubiquinone biosynthetic process (GO:0006744),0.36784421393335776,0.8090400277304167,0.6634615384615384,0.9677192654402129,1.0,2/15,5.43%,COQ7;COQ10B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.37322245364158024,0.8088899741723619,0.6748251748251748,0.9674776582329014,1.0,6/15,24.46%,DDRGK1;DYRK3;PAF1;ATAD5;KLHL18;EZH2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.348257466346732,0.8085325203578474,0.6982892690513219,0.9675770070276827,1.0,5/20,12.45%,LBP;BCL10;TLR4;MTDH;PRKCE
prerank,positive regulation of JUN kinase activity (GO:0043507),0.335168014150167,0.8084525906648449,0.6891679748822606,0.9672083011460102,1.0,3/23,7.33%,MAP3K5;ARHGEF5;TLR6
prerank,glycogen catabolic process (GO:0005980),0.35915839009990264,0.8084182612731862,0.6757215619694398,0.9667613192432196,1.0,6/15,21.05%,PYGB;PHKA2;RB1CC1;PHKB;PHKA1;GAA
prerank,positive regulation of reproductive process (GO:2000243),0.3257575970210151,0.8084176895714449,0.7237410071942446,0.9662527651562952,1.0,6/31,14.53%,LHFPL2;INHBA;HYAL3;INHBB;TACR3;VIP
prerank,regulation of innate immune response (GO:0045088),0.2912049915373176,0.8083177185788561,0.75,0.9659163419783234,1.0,13/57,15.78%,POLR3D;PLSCR1;IFI35;RNF135;ERAP1;ACOD1;IRF1;TRAFD1;ADAM8;BIRC3;ABCE1;POLR3B;DHX9
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3370852176290102,0.8082516113822619,0.7034700315457413,0.9655279122905059,1.0,3/23,5.96%,ISL1;DSG2;TNNI3
prerank,renal filtration (GO:0097205),0.39377091617430376,0.8081500149846921,0.6648936170212766,0.9651927572041905,1.0,4/10,17.49%,SULF1;SULF2;XPNPEP3;TBC1D8B
prerank,GPI anchor biosynthetic process (GO:0006506),0.3256144045084342,0.8077193822586497,0.7291361639824304,0.9654237031359508,1.0,8/30,18.91%,PIGB;PIGL;PIGU;PIGN;DPM1;PIGH;PGAP2;GPAA1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3796972884463974,0.8075299030150002,0.6808873720136519,0.9652308509347006,1.0,3/12,12.58%,WDTC1;ERLIN1;PIBF1
prerank,negative regulation of DNA recombination (GO:0045910),-0.2447515446625247,-0.8074322995821187,0.8391608391608392,0.9456040449009342,1.0,12/43,26.27%,RIF1;SMCHD1;CGAS;BLM;POLR2K;TERF2IP;POLR2C;H1-0;POLR2G;POLR2L;SHLD3;FBH1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.28682718791544426,-0.8071853927969677,0.7052023121387283,0.9450496908492351,1.0,4/20,10.06%,TGM2;BCL2;SELENOK;PACS2
prerank,regulation of Golgi organization (GO:1903358),0.3597172703650938,0.8071553165209735,0.6798107255520505,0.9653836924667806,1.0,7/17,18.30%,EHD3;STX5;RBSN;MAPK1;MAP2K2;ARMH3;AKAP9
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3546737322736828,0.8069875162927832,0.6608695652173913,0.9651708137026295,1.0,2/17,6.88%,KCNB1;SLC4A8
prerank,cellular response to light stimulus (GO:0071482),0.2849317083241337,0.8068583195368361,0.73828125,0.9648766690515685,1.0,19/66,25.39%,NEDD4;PRKCD;EP300;KDM1A;CREBBP;EIF2AK4;TAF1;USP47;YY1;INO80;N4BP1;ATR;SAG;FMR1;RHO;GNB1;PDE6A;USP28;CASP9
prerank,cellular response to ATP (GO:0071318),-0.3238182124938648,-0.806767154716289,0.7293233082706767,0.9448155640823066,1.0,5/14,15.51%,P2RY1;HSP90B1;P2RY12;RYR3;P2RX7
prerank,glucan catabolic process (GO:0009251),0.35727985086323544,0.8064601516245021,0.6773109243697479,0.9650246649981309,1.0,6/15,21.05%,PYGB;PHKA2;MGAM;PHKB;PHKA1;GAA
prerank,cardiac atrium morphogenesis (GO:0003209),0.3615640662290664,0.806427952264427,0.7113752122241087,0.9645707576590469,1.0,5/16,11.71%,ISL1;NOTCH2;GATA4;NOG;TGFB2
prerank,response to organonitrogen compound (GO:0010243),0.31600687122783583,0.8062844178117795,0.7013574660633484,0.9643162076953787,1.0,5/38,11.48%,GLRB;RNF185;VCP;MTOR;DRD3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.38901546026569045,0.8062575822060739,0.7061855670103093,0.9638530468661942,1.0,2/12,4.00%,PTK2B;NOTCH2
prerank,ncRNA 3'-end processing (GO:0043628),0.37090542654628794,0.805963148700174,0.7012089810017271,0.9638674019145728,1.0,8/14,33.58%,INTS8;TOE1;ELAC2;INTS2;PTCD1;INTS12;SSB;INTS6
prerank,C4-dicarboxylate transport (GO:0015740),0.3749066783281196,0.8058683608073608,0.700507614213198,0.9635095540587121,1.0,2/14,8.98%,LRRC8D;SLC25A14
prerank,cell proliferation in forebrain (GO:0021846),0.3897451319976677,0.80529845633559,0.6587155963302752,0.9639618690749455,1.0,2/10,9.89%,DOCK7;PCM1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2944582321795026,-0.8052388451441396,0.708994708994709,0.9466183217205243,1.0,7/21,21.81%,SLC30A10;PPARA;SIRT5;PARK7;BRCA1;ABCB7;SLC18A2
prerank,receptor-mediated endocytosis (GO:0006898),0.2619679502926772,0.8051308889208676,0.7846506300114547,0.9637496706643081,1.0,16/132,7.73%,NEDD4;RAMP1;PDLIM7;ITGB1;CD9;COLEC11;LRP6;ADRB2;HPX;AP2A2;CLTB;GPR107;AP4E1;GAK;AP2A1;IGF2R
prerank,negative regulation of translational initiation (GO:0045947),0.3862779082681712,0.8051018044861871,0.6947368421052632,0.9632901330521956,1.0,6/13,24.24%,PAIP2;EIF2AK4;EIF3E;FMR1;LARP1;RBM4
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2706574218133661,0.8049890093148533,0.7661574618096357,0.9629921432524424,1.0,14/110,12.46%,TRABD2B;ISL1;MPP7;GSN;GSK3B;VCP;CLU;EP300;SAR1B;CDC42;RB1;BRK1;CD36;KIF9
prerank,mitochondrial membrane organization (GO:0007006),0.32175397007624074,0.8044804934809859,0.7290419161676647,0.9633564087101352,1.0,8/32,13.10%,MTX3;SAMM50;DNAJC11;MTX2;MICOS10;IMMT;BNIP3;SPG7
prerank,regulation of cell development (GO:0060284),0.3195408666442605,0.804461593834792,0.721030042918455,0.9628919713867166,1.0,6/36,9.73%,HDAC9;DOCK7;NOTCH2;BHLHE40;HES1;PER2
prerank,sphingolipid biosynthetic process (GO:0030148),0.28244083119270086,0.8041999246726514,0.7496839443742098,0.9628401121147678,1.0,9/71,9.46%,ACER3;PLPP3;SGMS2;LARGE1;SPTSSB;A4GALT;CERS6;CERS5;VAPA
prerank,tRNA transport (GO:0051031),0.3149724323018181,0.8037198945034326,0.6991150442477876,0.9631526015701017,1.0,14/35,26.95%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;TOMM20;NUP37;NUP153
prerank,natural killer cell activation (GO:0030101),0.34103104212584856,0.8033232682973472,0.6935975609756098,0.9633310670941857,1.0,4/23,15.50%,PBX1;NFIL3;IL21R;ELF4
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3496300693191162,-0.8031346174988689,0.7209821428571429,0.9493546482589197,1.0,3/10,10.88%,PODXL;PIEZO1;DPP4
prerank,protein acylation (GO:0043543),-0.24923872044779044,-0.8031275899588253,0.8028169014084507,0.9483868879313779,1.0,8/38,14.41%,FOXO1;ZDHHC14;SELENOK;SPHK1;PORCN;ZDHHC1;ZDHHC17;ZDHHC13
prerank,filopodium assembly (GO:0046847),0.36395331427362,0.8029449236729957,0.6814449917898193,0.9634787127356876,1.0,4/16,8.44%,EZR;FGD6;SPEF1;SRGAP2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.37464038583470405,0.8027730411191007,0.7047781569965871,0.9632635335170029,1.0,3/13,11.02%,FSTL1;CD46;NOG
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.3606441294510615,0.8022581972881742,0.6977848101265823,0.9636321388666211,1.0,1/16,2.68%,RAET1E
prerank,regulation of histone modification (GO:0031056),-0.3226485768268944,-0.8015174693891128,0.7183098591549296,0.9501425355168243,1.0,5/13,18.92%,IGF2;MYOCD;FLCN;PARK7;HPF1
prerank,cellular amide metabolic process (GO:0043603),-0.2041600476612328,-0.8005084853254452,0.9487179487179487,0.9509004632668699,1.0,14/102,12.58%,AEBP1;ST3GAL1;PCCA;ST6GAL1;CERK;SMPD3;ACBD6;MTHFS;ACOT7;DBI;ACSF2;ALDH1L1;NAPEPLD;ORMDL3
prerank,cobalamin metabolic process (GO:0009235),0.350889575968905,0.8005004585953996,0.7286689419795221,0.9661192885147766,1.0,7/17,25.04%,MMACHC;CD320;MMADHC;LMBRD1;MMAB;ABCC1;MTRR
prerank,cholesterol transport (GO:0030301),0.2999000309936215,0.800344332901421,0.7268965517241379,0.9658983312951852,1.0,8/45,15.76%,SOAT1;CLU;TSKU;OSBPL5;STARD4;CD36;LCAT;NPC1
prerank,iron ion transmembrane transport (GO:0034755),-0.34093319478875844,-0.8002048406940074,0.7074235807860262,0.9504281547872823,1.0,4/10,20.15%,SLC40A1;SLC39A8;SLC11A2;ABCB7
prerank,peptidyl-amino acid modification (GO:0018193),-0.3499590545479815,-0.8001170119461786,0.7588832487309645,0.9496013040390859,1.0,3/10,16.91%,TTLL4;FKBP7;ATP7A
prerank,female gonad development (GO:0008585),-0.28978102149560847,-0.8000824733426398,0.7222222222222222,0.9486898441971342,1.0,2/19,2.57%,NR2F2;KIT
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2858238389847682,-0.7985289987971316,0.7540106951871658,0.9503390581385066,1.0,8/21,20.53%,COX17;SCO1;PET100;COX20;COX10;COX18;COA3;COA6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.29318477427849965,0.7983904684349904,0.7383177570093458,0.9686646274738837,1.0,6/53,12.74%,ANXA1;CHRM5;SSTR3;AGTR2;HTR1B;HTR2B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3395278552490205,0.7977489548170145,0.6863057324840764,0.9692155405804337,1.0,3/21,10.71%,CDC25B;DYRK3;RAD51C
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3424492523037821,0.7973002680369249,0.7106164383561644,0.9694580173557771,1.0,6/18,19.06%,MMP14;STX8;MISP;AR;ZDHHC7;CLN3
prerank,autophagosome assembly (GO:0000045),0.2922738678096403,0.7972883040424076,0.75,0.9689791048447528,1.0,13/52,20.75%,WIPI2;ULK2;RAB43;BECN1;ATG3;RB1CC1;SMURF1;AMBRA1;ATG2A;RAB7A;ATG7;ULK1;ATG16L1
prerank,epithelial cell development (GO:0002064),-0.28791255049444076,-0.7971613430357407,0.7642487046632125,0.9516463122256744,1.0,4/20,15.00%,WNT5B;ACTA2;DACT2;RILPL2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.35187167884363335,0.7962885577715832,0.6996699669966997,0.9701803709387876,1.0,1/17,1.46%,ANK2
prerank,adipose tissue development (GO:0060612),-0.34208560114451614,-0.7959787144800622,0.7173396674584323,0.9526215573774871,1.0,6/11,28.57%,ARID5B;SH3PXD2B;PGRMC2;RORC;DYRK1B;XBP1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2941007950180437,0.7955744191456314,0.7345013477088949,0.9708980315826827,1.0,10/53,17.01%,PKD1;F8A1;XPO1;DDRGK1;COMMD1;RAD23B;PSMC6;UFL1;PRKACA;DESI1
prerank,melanosome organization (GO:0032438),0.3266873105341737,0.7954078091301552,0.7010785824345146,0.9706628006143655,1.0,4/26,11.60%,KIF13A;AP3B1;HPS4;PMEL
prerank,stress-activated MAPK cascade (GO:0051403),0.2828218564200829,0.7952847767416763,0.7619047619047619,0.9703868696838281,1.0,7/61,7.24%,MAP3K5;ARHGEF6;NFKB1;TAB3;FBXW11;CHUK;RIPK2
prerank,positive regulation of immune response (GO:0050778),0.28192423224729013,0.7951281679464917,0.7721354166666666,0.970149522042331,1.0,15/64,22.29%,IL10;POLR3D;PLSCR1;IFI35;EIF2AK4;CD46;TGFB2;ADAM8;POLR3B;DHX9;IL15;NOD2;MYB;FADD;ITGAM
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.34395994984270567,0.7950533085411573,0.7121464226289518,0.9697703158032145,1.0,3/18,6.88%,RAP1A;GSK3B;SLC4A8
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2716629628822111,0.7940836245576094,0.772215269086358,0.9708694527472078,1.0,28/85,24.42%,USP13;GSK3B;RNF19A;RNF185;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;CSNK1E;ARIH2;TAF1;CSNK1A1;PSMC6;CSNK1D;COP1;RNF144A;NUB1;PIAS1;RNF14;SUMO1;FMR1;TRIB2;PSMC2;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,protein transport (GO:0015031),0.24112790336913364,0.7940435003889103,0.890625,0.9704352645483483,1.0,72/332,19.26%,RAMP1;SGSM2;KIF13A;ATP6V0A4;GRTP1;ARF4;RAB43;STX19;STX5;STX11;LTBP2;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;GOLPH3;AP3B1;HERC2;CLU;TBC1D25;STX8;LRSAM1;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;SLC10A7;NSF;ATP6V0A1;SEC13;LMAN2L;TANGO6;SAR1B;TBC1D10A;ATP6V0E1;GGA2;EHD1;CD36;TOM1;SNX4;TBC1D2B;CTTN;ATP6V1H;VIPAS39;STX16;LRP1;ATP6V0D1;ARL6IP5;RAB5A;SNX17;RAB17;ARCN1;VPS26C;GOLGA7;RAB22A;TICAM2;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;MCOLN1;ACD;RAB7A;RUFY1;COPA;SNX13;ATP6V1G1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.26374804833415744,-0.7936655117409425,0.8061538461538461,0.955599412250962,1.0,8/29,17.29%,AGO1;LIN28B;AGO4;SMAD1;SMAD3;METTL3;TARBP2;SPOUT1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.29133424994787793,-0.7935989731680759,0.728021978021978,0.9547279333171269,1.0,6/19,21.87%,GSK3A;PARK7;CAMKK2;DNM1L;HTT;FZD5
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.29868893902604665,0.7935507618786053,0.745269286754003,0.9707863351377184,1.0,5/41,7.78%,CYP1B1;MGLL;DAGLB;ACOT8;SCD
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2839914233565698,-0.7935010889964439,0.7367021276595744,0.9539065449570235,1.0,6/20,19.75%,HIF1A;HSP90AB1;EGR1;DCUN1D3;EPAS1;DNAJB2
prerank,fluid transport (GO:0042044),0.38062058078587835,0.7934412666149777,0.725314183123878,0.9704588639714035,1.0,4/12,19.46%,AQP6;SLC26A6;AQP9;PDPN
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3815009018726744,0.7932504457166966,0.6624548736462094,0.9702917732647647,1.0,3/11,7.46%,LMNA;P2RX4;ATP2B4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.29893485146670523,0.7931673221939376,0.7427385892116183,0.9699324826496665,1.0,11/52,19.90%,ME1;GCLC;ACOT8;FPGS;D2HGDH;OGDH;NIT2;MTHFD2;MTHFR;MTHFD2L;GOT1
prerank,protein N-linked glycosylation (GO:0006487),0.27775641070446644,0.7931609649906172,0.7584415584415585,0.9694476434651527,1.0,9/66,12.04%,MGAT4C;FUT8;MGAT3;ALG13;B4GALT1;B4GALT7;UGGT2;ASGR2;DPM1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.28124258463125223,0.7928785466989418,0.7721179624664879,0.9694265046022399,1.0,8/70,8.68%,TMEFF2;FN1;PARVA;ANTXR1;ITGAV;NRP1;SRGAP2;POF1B
prerank,regulation of metal ion transport (GO:0010959),-0.30644016352128955,-0.792843690939382,0.7575757575757576,0.9539900349735142,1.0,6/16,15.73%,SLC30A10;BCL2;EPB41;CACNA2D1;CAMK2B;STIM1
prerank,regulation of phospholipase activity (GO:0010517),0.3948828291077325,0.7922701146493992,0.7125645438898451,0.969904366092841,1.0,1/10,2.40%,FGFR1
prerank,spermatid development (GO:0007286),-0.25431374300618415,-0.7918703956188385,0.7914110429447853,0.9546666780309726,1.0,13/32,38.43%,NECTIN2;NME5;CIB1;CDYL;ZMYND15;ING2;MKKS;YTHDC2;DPY19L2;CCDC63;RSPH1;SOX30;JAM2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.33382085034987957,0.7915140601945746,0.7279752704791345,0.9706811794677355,1.0,9/21,22.13%,SOX9;ITGAV;HTR2B;MAPK1;MAP2K2;ZFP36L1;PTGER4;EGF;CDK1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3210574989364311,-0.7915136871636542,0.7488584474885844,0.9542665959234468,1.0,5/13,18.42%,FUT9;ETS1;MDK;ITGB2;RELA
prerank,negative regulation of B cell proliferation (GO:0030889),0.39088135266330104,0.7914795805150646,0.6851211072664359,0.9702370993608549,1.0,3/11,7.31%,IL10;TNFRSF13B;ATM
prerank,error-prone translesion synthesis (GO:0042276),0.3430268566095446,0.7907147516981585,0.7017543859649122,0.9710426509395484,1.0,4/21,13.24%,REV3L;RPA1;RFC5;REV1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.28915506653875694,-0.7906690496538212,0.760989010989011,0.9547186794964476,1.0,1/18,0.63%,LYN
prerank,regulation of amyloid-beta clearance (GO:1900221),0.35328618265002354,0.7901841730684269,0.680672268907563,0.9714728682938922,1.0,4/16,17.11%,LRPAP1;CLU;LRP1;HMGCR
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3080596074272312,0.7901209640752025,0.7576197387518142,0.9710904967031009,1.0,15/36,26.20%,NECTIN3;KIF13A;GOLPH3;NSF;GGA2;RILPL1;GOLGA7;RAB7A;ARFRP1;SYS1;VAMP4;GOLGA4;GORASP1;BBS2;RAB10
prerank,positive regulation of rRNA processing (GO:2000234),0.39352037828393926,0.7891779620778002,0.7160714285714286,0.9721649523450672,1.0,6/10,29.63%,WDR43;RIOK2;WDR75;SIRT7;HEATR1;UTP15
prerank,epithelial cell morphogenesis (GO:0003382),0.3433377782573501,0.7891293628755875,0.722972972972973,0.9717462126461979,1.0,1/17,0.68%,MET
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.34206618745773215,0.788893211992019,0.7093023255813954,0.9716158755439699,1.0,2/18,6.17%,SLC2A13;CLU
prerank,mRNA methylation (GO:0080009),-0.3051111489759389,-0.7885161573894437,0.7653061224489796,0.9572818417529773,1.0,5/15,29.33%,METTL14;METTL16;METTL3;TRMT61B;ZC3H13
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.33776075394565797,-0.7881818399169053,0.7184035476718403,0.9568381863428618,1.0,3/10,16.13%,ACADL;IVD;GCDH
prerank,cellular response to nitrogen compound (GO:1901699),0.3425428737180032,0.7880264836734615,0.7058823529411765,0.9725481387922005,1.0,4/20,16.52%,DDI2;ATP2B4;DDX11;ATRX
prerank,lysosome localization (GO:0032418),-0.24097899056953526,-0.7879999634170978,0.7880794701986755,0.956185930889135,1.0,14/37,27.22%,KIT;MYH9;ARL8B;KXD1;PLEKHM1;FLCN;LAMTOR1;PIK3CD;CHGA;BORCS6;PIK3CG;SNAPIN;KLC2;RAB3A
prerank,coenzyme A metabolic process (GO:0015936),-0.3104550038090659,-0.7879116103624574,0.7572115384615384,0.9553775415538859,1.0,5/14,22.09%,ACLY;ACOT7;PANK1;PPCS;DCAKD
prerank,regulation of lymphocyte differentiation (GO:0045619),0.34013038422207026,0.7878817347920095,0.7109243697478992,0.9722944562558113,1.0,7/18,28.23%,ABL1;PRKDC;ZFP36L1;IKZF3;CD2;CCR2;ZFP36L2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.26853150405302545,0.7875915656324762,0.7949367088607595,0.9722756267775878,1.0,21/82,20.61%,SFI1;CEP164;PAFAH1B1;CEP131;DYRK3;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;PRKACA;CSNK1D;DCTN3;ATAD5;CNTRL;AKAP9;CEP192;DCTN1;AURKA;ODF2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3742080489207137,0.7875849105064403,0.6917808219178082,0.9717873490136076,1.0,3/12,7.67%,SORBS1;IRS1;DYRK2
prerank,cellular response to gamma radiation (GO:0071480),0.34793666340213864,0.7874177239984372,0.7057851239669422,0.9715468861469736,1.0,8/17,23.69%,ATM;KDM1A;XRCC5;TSPYL5;WRN;TLK2;ATR;TMEM109
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.29997485225269116,-0.7874168395529954,0.7468354430379747,0.955199967104457,1.0,6/17,16.35%,PODXL;PIEZO1;CIB1;P2RY12;NCKAP1L;SYK
prerank,organelle fusion (GO:0048284),0.3359084556846727,0.7872002560723899,0.7199391171993912,0.9714015026280076,1.0,4/22,19.48%,EEA1;SPG7;MIEF1;FIS1
prerank,regulation of stem cell differentiation (GO:2000736),0.2701855527339681,0.7871894285127155,0.7938650306748466,0.9709201139000186,1.0,28/89,23.72%,ABL1;BMPR1A;GATA1;GDNF;JAG1;HES1;CBFB;TCF3;GATA3;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;NUDT21;PSMD3;PUS7;PSMD2;PSMC2;HOXB4;PSMB2
prerank,regulation of catabolic process (GO:0009894),0.35041431436150944,0.7868846117988574,0.7154471544715447,0.970933611343661,1.0,5/18,20.26%,ITGB1;CHEK2;FAF1;ZDHHC7;HGS
prerank,embryonic heart tube development (GO:0035050),0.3637640546653398,0.7868715024133343,0.714759535655058,0.9704570901205445,1.0,5/14,16.96%,HES1;IFT122;ACVR1;MEGF8;CITED2
prerank,sterol biosynthetic process (GO:0016126),-0.2507551739519058,-0.7868286100626455,0.8023598820058997,0.9551623195221429,1.0,11/33,24.01%,PRKAG2;ACLY;SC5D;GGPS1;INSIG2;HSD17B7;CH25H;ACAT2;IDI1;MVK;DHCR24
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.3356931379009779,0.7867219526006034,0.7387820512820513,0.970193608663124,1.0,7/20,16.20%,DDRGK1;EP300;GATA3;NIBAN2;RB1;FOXC1;PAX6
prerank,negative regulation of receptor binding (GO:1900121),0.39149349663075805,0.7865908292270709,0.7145299145299145,0.9699154049339463,1.0,3/10,11.02%,IL10;PTPRF;NOG
prerank,inner mitochondrial membrane organization (GO:0007007),-0.23917525628773995,-0.7860273822839594,0.862453531598513,0.955519629419201,1.0,12/47,16.02%,ATP5F1B;ATP5PF;ATP5F1E;HSPA9;ATP5ME;ATP5MC1;MICOS13;ATP5F1D;APOO;TIMM13;ATP5MC2;ATP5F1A
prerank,vesicle coating (GO:0006901),0.28416168054905955,0.7853487613647233,0.7820855614973262,0.970464645366756,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.28416168054905955,0.7853487613647233,0.7820855614973262,0.970464645366756,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,COPII vesicle coating (GO:0048208),0.28416168054905955,0.7853487613647233,0.7820855614973262,0.970464645366756,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.36542721651849336,0.7849744633730092,0.740484429065744,0.9705907820270552,1.0,8/14,33.54%,ZDHHC5;PUM2;PUM1;ZCCHC3;DDX60;USP15;ANKRD17;TLR5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2793913224499966,0.7848069619681838,0.7819843342036553,0.9703636102856433,1.0,27/67,24.11%,RABEP2;ATP8B1;TBC1D13;ATG3;P2RX4;SGSM3;PLD1;RDX;DMTN;TBC1D10A;CDC42;TBC1D2B;FXR2;RAB5A;IFT88;MAPK15;RAB17;TRPM2;TBC1D5;ABITRAM;TBC1D20;MYO10;FMR1;TBC1D17;ODAD3;TBC1D19;CAPZB
prerank,intraciliary retrograde transport (GO:0035721),0.37555704394742495,0.7846695852561296,0.6978653530377669,0.9700789517965408,1.0,7/12,26.18%,IFT122;TTC21A;DYNC2I2;DYNC2H1;WDR35;TTC21B;DYNC2I1
prerank,regulation of biosynthetic process (GO:0009889),-0.3325793014828922,-0.7846567570194574,0.745958429561201,0.9566924587309339,1.0,4/11,29.45%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,protein targeting to lysosome (GO:0006622),0.34237575698574346,0.784544754094567,0.7213930348258707,0.9697930365065784,1.0,8/20,25.05%,NEDD4;CLU;NCOA4;AP4M1;RAB7A;HGS;M6PR;LAMP2
prerank,regulation of multicellular organismal development (GO:2000026),0.3214704378387822,0.7843940224699506,0.7435508345978755,0.9695485954515126,1.0,6/25,13.37%,TRIP12;KAT2A;HPSE;GATA3;MYSM1;EHMT1
prerank,regulation of gastrulation (GO:0010470),0.36216955708525167,0.7839670744794597,0.7071917808219178,0.9697690388532112,1.0,1/14,1.84%,PHLDB2
prerank,lytic vacuole organization (GO:0080171),-0.2546323925061479,-0.7838040953572022,0.8173076923076923,0.9570961606584981,1.0,6/32,10.68%,ABCA1;CLVS2;GRN;CLVS1;LRRK2;AKTIP
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3278741863224155,-0.7828553838240251,0.7617977528089888,0.9576166711834062,1.0,6/11,20.52%,GRK3;ARRB1;GTF2H2;ADM;ARRB2;GRK2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.34307875196140464,0.7828083994035291,0.7281553398058253,0.9711453785751251,1.0,5/16,23.82%,RIPK3;CYRIB;KLRD1;FADD;AGER
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3404642409814912,-0.78274444587442,0.7461368653421634,0.956849432742104,1.0,7/10,41.18%,RIF1;TERF2IP;TFIP11;DCLRE1B;TERF2;DCLRE1A;DCLRE1C
prerank,aerobic respiration (GO:0009060),-0.27960615346058426,-0.7826036797378889,0.7746835443037975,0.9561147788247694,1.0,6/20,20.99%,UQCR10;UQCRH;ME3;ATP5F1D;UQCRC2;UQCRB
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.33602544501968934,0.7823982046333235,0.710236220472441,0.9713118469308287,1.0,5/19,16.35%,PPP2R3C;MMP14;GATA3;ZMIZ1;PRKDC
prerank,establishment of melanosome localization (GO:0032401),-0.28291124960218866,-0.7823039238785581,0.7897574123989218,0.9556510218780239,1.0,6/19,17.67%,SHROOM2;MYO5A;BLOC1S6;RAB27A;BLOC1S5;BBS7
prerank,triglyceride metabolic process (GO:0006641),-0.23071539818493575,-0.7821568190068753,0.8426966292134831,0.9549393727479865,1.0,11/48,20.74%,APOE;LPGAT1;GK;LPIN3;LPIN1;GPAM;FABP5;PNPLA2;DGAT1;FABP7;LPL
prerank,RNA 3'-end processing (GO:0031123),0.2818743815636895,0.7820819415808685,0.7938144329896907,0.9713522738397451,1.0,22/69,25.72%,U2AF1L4;CASC3;SRSF5;SRSF6;SRRM1;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;CPSF7;CHTOP;NUDT21;CPSF4;MTPAP;ALYREF;NCBP2;CSTF2;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,intracellular cholesterol transport (GO:0032367),-0.3037528184217807,-0.7814151729743377,0.7621483375959079,0.9551383239681139,1.0,5/15,16.99%,ABCA1;NPC2;OSBP;RELCH;ABCG1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.3737634682038634,0.7813233273279557,0.699825479930192,0.9720858967032342,1.0,3/12,7.98%,NPHS1;JAG1;IQGAP1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3654811427831125,0.780970098996168,0.7199312714776632,0.972158740029658,1.0,3/13,7.67%,SORBS1;IRS1;DYRK2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2923453889076294,-0.7805383963906384,0.7789203084832905,0.955562011416878,1.0,3/18,9.48%,FTH1;DAB2IP;CD300A
prerank,cholesterol efflux (GO:0033344),0.33525692012815134,0.7802071652254764,0.7582781456953642,0.9729132743066832,1.0,1/20,0.82%,SOAT1
prerank,pentose-phosphate shunt (GO:0006098),0.3730460471664253,0.7800469404842767,0.7075306479859895,0.9726856787879562,1.0,4/11,16.91%,SHPK;DERA;RPIA;RBKS
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3128584059799154,0.7799942056917603,0.7309417040358744,0.9722809968922586,1.0,5/31,12.13%,IL10;CLCF1;TNFRSF4;SHLD1;GPI
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2686047930651381,0.7798023937322617,0.8004895960832313,0.9720872432085018,1.0,26/85,23.72%,WNT11;FZD7;AP2A2;PRICKLE1;CELSR3;AP2A1;FZD2;CDC42;RHOA;DAAM1;SMURF1;PSMC6;PSMD8;FZD3;PSMB1;RYK;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2
prerank,regulation of mRNA processing (GO:0050684),0.3048287166733291,0.7793943019000493,0.7761194029850746,0.9722781646120952,1.0,10/32,22.28%,SLTM;SON;SRPK1;RBM39;JMJD6;DHX9;ZFP36L1;CWC22;CPSF4;SAFB2
prerank,mRNA stabilization (GO:0048255),0.3060576322537169,0.7793554919814057,0.7148876404494382,0.9718482021164896,1.0,15/40,22.77%,YBX3;GDNF;SYNCRIP;FUS;TENT5D;VIP;TAF15;DHX9;MYD88;MAPKAPK2;TENT5C;PABPC1;EIF4ENIF1;ANGEL2;LARP1
prerank,cellular response to hypoxia (GO:0071456),0.2559051263795965,0.7792765180355449,0.8395784543325527,0.9714918084275803,1.0,11/126,8.71%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;HILPDA;EP300;PLK3;CREBBP;HIF3A;MDM4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.27436768718038695,0.7789473546744113,0.788339670468948,0.9715457436051199,1.0,23/70,23.72%,ABL1;GATA1;CBFB;TCF3;GATA3;FOXC1;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;PSMD3;PUS7;PSMD2;PSMC2;PSMB2
prerank,regulation of myelination (GO:0031641),0.3199271784424315,0.7788721979015802,0.7638036809815951,0.9711821961657147,1.0,5/25,11.22%,EGR2;TNFRSF1B;PARD3;EIF2AK3;RNF10
prerank,lipid homeostasis (GO:0055088),-0.21888455823428724,-0.7782110465606576,0.8270042194092827,0.9581876113255687,1.0,13/57,18.12%,APOE;ABCA1;ZBTB20;NR1H3;PNPLA8;PRKAA2;NR1D2;ORMDL3;RCN3;ABCB4;ABCG1;PNPLA2;USF2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3128009424991854,-0.7781555851094462,0.7287735849056604,0.9573248745556563,1.0,7/12,34.26%,TAPT1;INSIG2;ANKRD13C;RER1;KDELR3;KDELR1;KDELR2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.24885313042843324,0.7780649102094913,0.8634850166481687,0.9720410512195554,1.0,28/161,16.18%,SOX9;TCF7L2;MLLT3;GLI3;PTPRU;WNT11;LRP6;GSK3B;DDIT3;TLE6;PRICKLE1;WWTR1;FUZ;TLE4;CTNND1;NOG;TLE3;TLE2;IGFBP6;CSNK1A1;RBMS3;AMER1;PSMC6;INVS;STK11;LRP4;LMBR1L;FRZB
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2768661260088082,0.7780077794122996,0.7930142302716688,0.9716413806524139,1.0,7/66,12.38%,FOXP1;ISL1;RIPK2;TLR6;TLR4;CD36;STAT3
prerank,mRNA processing (GO:0006397),0.23834063243538395,0.7777958223174174,0.8884165781083954,0.9715119853780341,1.0,82/287,24.40%,RNMT;DDX5;RBM6;SNRNP48;SYNCRIP;SON;HNRNPH1;ZCCHC8;CELF1;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;TCERG1;MNAT1;ERCC3;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;THOC2;PRPF40B;RBM8A;LSM2;ESS2;SRSF11;GTF2F2;SNRPD3;HNRNPL;THOC5;SNRNP70;PRKACA;SNW1;DHX9;PRCC;SCAF11;GPKOW;TRA2B;SRRT;GEMIN2;POLR2H;ZC3H11A;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;CHTOP;ALKBH5;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;ERCC2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3580312438769008,0.7775553980141439,0.7128712871287128,0.9714056655393,1.0,1/13,3.73%,BMS1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2897703646539801,-0.7772315679271091,0.7630922693266833,0.9578819105544754,1.0,1/17,2.96%,LPGAT1
prerank,carnitine metabolic process (GO:0009437),-0.3198209229521446,-0.7772096419410879,0.7641277641277642,0.9569499799073453,1.0,3/12,8.69%,CPT1A;ALDH9A1;ACADL
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.33029427911457354,0.7771285795409798,0.714516129032258,0.9716169628446472,1.0,5/22,8.05%,CAMK2D;MEF2A;NR4A3;P2RX4;LMCD1
prerank,tRNA methylation (GO:0030488),0.31137264218064453,0.7769278190600707,0.75,0.9714597577018225,1.0,11/34,22.52%,TRMT13;METTL6;METTL1;TRMT1L;MTO1;GTPBP3;DALRD3;TRDMT1;ALKBH8;TRMT61A;TRMT12
prerank,cardiocyte differentiation (GO:0035051),0.37752192339926904,0.7769031824659265,0.7054545454545454,0.9710130108470678,1.0,3/10,17.35%,AKAP13;TGFB2;KDM6B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.27277987791736014,0.7760942087992599,0.7747183979974969,0.9718175444411861,1.0,13/70,12.93%,CYFIP2;ABI1;PRKCD;ABL1;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,peptidyl-methionine modification (GO:0018206),0.3679849340866291,0.7754973702944772,0.7173553719008264,0.9723023633684109,1.0,12/12,63.23%,METAP1D;METAP1;NAA15;METAP2;NAA16;NAA20;NAA60;APOA2;APOA1;NAA25;PDF;NAA30
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3106745202925295,-0.7753440582394063,0.731829573934837,0.9588859378192292,1.0,2/13,10.01%,KDR;EDN1
prerank,regulation of nuclear division (GO:0051783),-0.278503930339428,-0.7751177979266761,0.7684210526315789,0.9582958315812712,1.0,5/20,26.33%,OBSL1;RCC1;MKI67;PIN1;L3MBTL1
prerank,determination of bilateral symmetry (GO:0009855),-0.2632613773989271,-0.7750806389924007,0.8065476190476191,0.9574036876930737,1.0,7/24,21.00%,NOTCH1;TBX1;ZIC3;BBS7;CFAP53;NPHP3;DLL1
prerank,mRNA 3'-end processing (GO:0031124),0.2710040413220134,0.774746143285082,0.8114355231143552,0.9730215661011044,1.0,28/78,25.72%,U2AF1L4;CASC3;SCAF8;SRSF5;SRSF6;SRRM1;THOC2;PAF1;RBM8A;SRSF11;THOC5;ZC3H11A;CPSF7;PABPC1;CHTOP;GRSF1;NUDT21;CPSF4;MTPAP;LEO1;ALYREF;NCBP2;CSTF2;AHCYL1;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,homotypic cell-cell adhesion (GO:0034109),0.2989357935266109,0.7745888202584404,0.7818696883852692,0.9728086667891923,1.0,5/39,6.28%,FN1;PLPP3;GATA1;DSC2;VCL
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.375484734498084,0.7744147108235088,0.717206132879046,0.9726107082715284,1.0,1/10,2.99%,LRP6
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3442989510083728,0.7743016853898054,0.6956521739130435,0.9723048260114237,1.0,7/16,19.06%,TBC1D25;MTRF1;ETF1;BNIP3;CLEC16A;GSPT1;CLN3
prerank,regulation of cell projection organization (GO:0031344),-0.3164190134496623,-0.7742958900242929,0.7399527186761229,0.9576616835797327,1.0,4/13,16.62%,MACF1;MFSD2A;ERMN;CCL19
prerank,spliceosomal complex assembly (GO:0000245),0.2853186319510413,0.773431664680676,0.765625,0.9731905277860321,1.0,16/46,22.20%,LUC7L2;CELF1;GCFC2;SRSF5;SRSF6;SF3B1;SRPK1;DDX1;SCAF11;NOL3;LUC7L;PRPF6;TXNL4A;RBM5;SNRPD2;SNRPD1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2608916525038946,-0.7732896586857753,0.7891566265060241,0.9582619968623699,1.0,9/29,18.76%,WNT5A;SAMHD1;NLRC5;HSP90AB1;IFNAR2;USP18;METTL3;TRIM6;RNASEL
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3705518546276628,0.772938216324465,0.7344827586206897,0.9734581982102081,1.0,4/11,26.96%,RESF1;MPHOSPH8;TASOR;TRIM28
prerank,second-messenger-mediated signaling (GO:0019932),0.2651187965339511,0.7729358464487038,0.8136882129277566,0.9729744454902006,1.0,12/82,12.74%,PLCE1;AGTR1;NUDT4;TRPM4;TNFSF11;P2RX4;AGTR2;RCAN1;CXCR4;EIF2AK3;CD36;HTR2B
prerank,sister chromatid segregation (GO:0000819),0.30996323302299933,0.772727892139167,0.7771260997067448,0.9728128661811078,1.0,7/31,18.33%,SMC4;KLHL22;RB1;SMC1A;RAN;INO80;KIF18A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3369082736785963,-0.7723503287862308,0.7429193899782135,0.9587310137194935,1.0,1/10,0.90%,PRKCH
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2614114905994335,0.7721046047050787,0.8245823389021479,0.9732980545264928,1.0,22/101,17.10%,LBP;ADAM9;IL10;PDCD4;NFKB1;CD80;SHPK;TNFRSF1B;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;MTDH;PRKCE;TRIM41;SBNO2;MYD88;TICAM2;CARD16;MAPK8
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.36560599965229873,0.772064692057591,0.7297297297297297,0.9728641952306487,1.0,5/12,22.38%,CNEP1R1;NEK9;PRKCA;CDK1;NEK6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3375068471531862,0.7720338624460149,0.7213930348258707,0.9724312734800202,1.0,6/16,21.05%,PYGB;PHKA2;MGAM;PHKB;PHKA1;GAA
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2822029990754023,0.7715657279286199,0.7863013698630137,0.9722019353844501,1.0,13/51,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,mitotic nuclear membrane organization (GO:0101024),0.2822029990754023,0.7715657279286199,0.7863013698630137,0.9722019353844501,1.0,13/51,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,positive regulation of protein deacetylation (GO:0090312),0.3536769028290398,0.7711013992742121,0.7271157167530224,0.9725119658428077,1.0,1/14,3.83%,ZBTB7B
prerank,dendrite morphogenesis (GO:0048813),0.30343546941363814,0.7708447369092309,0.7650513950073421,0.9724465924785772,1.0,4/35,4.56%,PHACTR1;CTNND2;MEF2A;KLF7
prerank,cellular response to pH (GO:0071467),0.3573808242555834,0.7707691709984974,0.7474916387959866,0.9720906406064941,1.0,5/17,24.36%,PKD2L1;SLC9A1;MCOLN1;CHP1;IMPACT
prerank,negative regulation of MAPK cascade (GO:0043409),0.2647226803240956,0.770353953875798,0.8177399756986634,0.9722434155071464,1.0,11/87,11.44%,BMP4;EZR;PRKCD;SPRED2;PPEF2;DLG1;PTPN2;DUSP10;PRDM15;CNKSR3;TLR4
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.27615593510038483,-0.7699257977940199,0.7774936061381074,0.9614785137881686,1.0,9/21,34.76%,DUSP3;PAG1;SAMSN1;TNFAIP3;JAK3;LAPTM5;GPNMB;FCGR2B;FOXJ1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.269632255868528,0.7699100133278021,0.7820672478206725,0.972482238120783,1.0,13/71,12.93%,CYFIP2;ABI1;PRKCD;ABL1;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3633654648395246,0.7698133820307135,0.7504363001745201,0.9721358668538662,1.0,4/12,18.64%,JAG1;HES1;REST;YTHDF2
prerank,melanosome localization (GO:0032400),-0.2719550577353555,-0.7693409292985408,0.8011204481792717,0.9613982439773929,1.0,6/21,17.67%,SHROOM2;MYO5A;BLOC1S6;RAB27A;BLOC1S5;BBS7
prerank,plasma membrane tubulation (GO:0097320),0.3478247397573511,0.7690621913284376,0.7162393162393162,0.9728337798258525,1.0,5/13,20.64%,CAVIN2;BIN2;WHAMM;EHD2;CHMP4A
prerank,autophagosome organization (GO:1905037),0.28319567331428214,0.7690507751286209,0.788135593220339,0.9723687891727844,1.0,12/50,20.75%,WIPI2;ULK2;RAB43;BECN1;ATG3;RB1CC1;AMBRA1;ATG2A;RAB7A;ATG7;ULK1;ATG16L1
prerank,DNA recombination (GO:0006310),0.2982667154837344,0.76900218789125,0.7524475524475525,0.9719590956182355,1.0,13/37,26.40%,IGHMBP2;HDAC10;RAD52;ERCC1;RAD51C;RPA1;WRN;MRE11;XRCC2;RECQL5;DMC1;LIG4;EXO1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3556104677579331,0.768761647891506,0.7221297836938436,0.9718620724174403,1.0,5/14,19.35%,IRS1;PTPN2;SLC45A3;IRS2;NNMT
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2662905555487486,-0.768367805704961,0.8262032085561497,0.9619524368932222,1.0,5/25,14.45%,HSPA8;HSPA9;PTGES3;DNAJB5;ERO1A
prerank,translational elongation (GO:0006414),0.2591113520009189,0.7681780382743811,0.8170731707317073,0.972309454240557,1.0,32/101,26.26%,MRPL33;MRPL48;MRPL32;MRPL14;MRPL21;GTPBP2;MRPS31;MRPL38;GFM2;MRPL57;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;EEFSEC;MRPS34;MRPS18C
prerank,cell junction organization (GO:0034330),0.26919225751545606,0.7677885025190475,0.8138020833333334,0.9724469491588478,1.0,12/71,12.92%,CXADR;TGFB3;CTNND2;SEMA3E;SDK1;PPFIA1;LIMS2;CDC42;TGFB2;RHOA;MYO9A;CAPZA1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.26506303513509133,-0.7676255890988655,0.8050139275766016,0.9620853076933342,1.0,15/24,38.80%,PARP1;SRC;TENT4B;DCP2;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;PIF1;ERCC4;HNRNPC;NAT10;TERF2
prerank,ncRNA metabolic process (GO:0034660),0.3041865883261662,0.767548251940464,0.7705627705627706,0.9723458120013749,1.0,9/37,20.41%,TDRD9;TDRD12;ZCCHC8;DDX17;RAN;DROSHA;MAEL;PIWIL4;MEPCE
prerank,NIK/NF-kappaB signaling (GO:0038061),0.26933485204425245,0.7668126986029047,0.7938144329896907,0.9729915268895333,1.0,19/72,23.72%,CARD14;FBXW11;CHUK;TLR6;NFKB2;BIRC3;REL;PSMC6;PSMD8;IRAK1;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2
prerank,DNA methylation (GO:0006306),0.3184936872702855,0.7663346017156893,0.7550077041602465,0.9732473614973862,1.0,6/23,16.54%,METTL4;BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,regulation of establishment of planar polarity (GO:0090175),0.2630534914667884,0.7663098153392924,0.8216482164821648,0.9728120770533373,1.0,26/88,23.72%,WNT11;FZD7;AP2A2;PRICKLE1;CELSR3;AP2A1;SPEF1;FZD2;CDC42;RHOA;DAAM1;SMURF1;PSMC6;PSMD8;FZD3;PSMB1;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2
prerank,cellular response to oxygen levels (GO:0071453),-0.33147655636631557,-0.766112582092719,0.7563805104408353,0.9633926371498909,1.0,4/10,21.13%,ATP6AP1;ATP6V1A;NDUFS2;CPEB4
prerank,metanephric mesenchyme development (GO:0072075),0.37621417401034446,0.7657467265818969,0.7310469314079422,0.9731779915945598,1.0,2/10,9.70%,SIX1;SIX4
prerank,apoptotic nuclear changes (GO:0030262),-0.262301435684694,-0.7657303103672916,0.793002915451895,0.962980793876055,1.0,7/24,20.27%,CECR2;CASP3;DFFA;BLCAP;ACVR1C;FOXL2;H1-0
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3271417291023734,0.7646192108665567,0.740340030911901,0.974455613027017,1.0,6/22,16.96%,DUSP16;DUSP10;PPM1A;DUSP5;PPP5C;PPP2CB
prerank,cardiolipin metabolic process (GO:0032048),-0.29957630657416834,-0.7645507573996456,0.7579462102689487,0.9637279194821117,1.0,5/13,29.68%,PNPLA8;PGS1;SLC27A1;PLA2G5;HADHA
prerank,superoxide anion generation (GO:0042554),-0.30930164240247116,-0.7645150646100051,0.7788235294117647,0.9628248931188403,1.0,5/13,23.44%,CYBA;ALOX12;NCF2;TAFA4;NOX4
prerank,cholesterol homeostasis (GO:0042632),0.27339519002836005,0.7640167680714304,0.8098318240620958,0.9749204808391873,1.0,13/64,16.81%,SOAT1;HDAC9;HNF4A;PLA2G12B;TSKU;FABP3;EHD1;LRP5;LCAT;TTC39B;NPC1;CYP39A1;RORA
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.37770489102640425,0.7638508753401139,0.7106227106227107,0.9746878788122624,1.0,2/10,4.00%,GRB10;ITGA5
prerank,negative regulation of bone remodeling (GO:0046851),-0.31879306263671314,-0.7638442041280061,0.7827102803738317,0.962862381524535,1.0,4/11,28.00%,P2RX7;TNFAIP3;GREM1;CARTPT
prerank,glycosphingolipid metabolic process (GO:0006687),0.28903333750305193,0.7637640914106684,0.7766714082503556,0.9743494798242955,1.0,5/42,6.49%,ESYT3;ESYT2;LARGE1;HEXA;A4GALT
prerank,sphingoid metabolic process (GO:0046519),0.3545056261150361,0.7633468818195239,0.7324185248713551,0.9745072903306247,1.0,3/12,12.92%,PLPP3;PLPP1;NAAA
prerank,DNA packaging (GO:0006323),0.34523852407282357,0.7633204927468485,0.745819397993311,0.9740673881185492,1.0,1/16,2.87%,CHAF1B
prerank,mammary gland development (GO:0030879),0.3309444123502776,0.7633021529589429,0.7764350453172205,0.9736149340277108,1.0,2/21,3.83%,TGFB3;ZBTB7B
prerank,aggrephagy (GO:0035973),-0.2599270828629715,-0.7627671801372874,0.8083333333333333,0.9634681734270276,1.0,8/27,18.86%,VIM;DYNLL2;RPS27A;UBC;DYNLL1;UBB;PARK7;DYNC1I2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.31731740717346496,-0.7626889412315455,0.7962529274004684,0.9626428178342868,1.0,4/11,15.17%,MAPK3;LRRK2;SRC;DNAJC13
prerank,positive regulation of DNA recombination (GO:0045911),-0.2553433600179755,-0.7626556880432102,0.8544303797468354,0.9617585691820619,1.0,3/27,7.55%,TFRC;RIF1;PARP1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2957299194931118,0.7618955305455397,0.8008415147265077,0.9752892587150095,1.0,11/38,23.43%,UBN1;CABIN1;CENPQ;CENPX;HIRA;ATRX;RBBP4;OIP5;CENPU;ASF1B;CENPC
prerank,sterol homeostasis (GO:0055092),0.2717835173696563,0.7617637995046657,0.8090322580645162,0.9749908075440621,1.0,13/65,16.81%,SOAT1;HDAC9;HNF4A;PLA2G12B;TSKU;FABP3;EHD1;LRP5;LCAT;TTC39B;NPC1;CYP39A1;RORA
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3281466256933343,-0.7616604016187583,0.771689497716895,0.9622635447606138,1.0,2/10,17.32%,CD81;CD74
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3209340590284646,0.7613767884647002,0.7475409836065574,0.9751254772910091,1.0,8/21,23.13%,FATE1;MCUB;MICU1;MCU;SLC8B1;FIS1;BCAP31;MICU3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.335701636993931,0.7609978129434355,0.7582236842105263,0.9752181489438377,1.0,7/17,24.35%,CTR9;ZC3H14;NELFE;CPSF7;NUDT21;CCNT1;NCBP2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.30575660948613104,0.7606144389391543,0.7658321060382917,0.9753401213055874,1.0,5/31,12.97%,NFS1;PYCR1;MOCS3;CYP19A1;FDFT1
prerank,nuclear body organization (GO:0030575),0.3567434795651515,0.760555000163251,0.7521815008726004,0.9749526047230715,1.0,3/12,15.85%,DYRK3;SERBP1;PML
prerank,leukotriene metabolic process (GO:0006691),-0.2748413652897746,-0.7604292400330898,0.7918781725888325,0.9630751459096437,1.0,8/19,31.51%,GGT5;MGST3;ALOX12;GGT1;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,positive regulation of nervous system process (GO:0031646),0.3330004985301734,0.7601960549871263,0.746218487394958,0.9750283040066832,1.0,5/18,11.22%,EGR2;TNFRSF1B;UNC13B;PARD3;RNF10
prerank,monocarboxylic acid metabolic process (GO:0032787),0.25133278943293547,0.7597524937733511,0.8534883720930233,0.975203912687103,1.0,11/117,9.73%,ME1;SLC5A6;SLC16A1;ADH7;VNN1;ACSL3;SCPEP1;HACL1;CYP2S1;CPT1C;PER2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3816458376070588,0.759729566669085,0.7325800376647834,0.9747548828267859,1.0,1/10,2.81%,ANO6
prerank,positive regulation of lipid storage (GO:0010884),0.32472481378768697,0.7595486034574201,0.7406832298136646,0.9745428372140721,1.0,4/21,12.07%,NFKB1;HILPDA;EHD1;IKBKE
prerank,response to tumor necrosis factor (GO:0034612),0.2530089666537672,0.7592372723707932,0.8333333333333334,0.9745341495561968,1.0,18/91,18.75%,TANK;PID1;ADAM9;YBX3;NFE2L2;AFF3;CHUK;ADAM10;ACOD1;GATA3;HYAL3;TRADD;ERBIN;DHX9;NPNT;ZFP36L1;NUB1;ADAMTS7
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.328919901775902,-0.7587711467297706,0.7742663656884876,0.9646232772313843,1.0,7/10,40.42%,SACS;DNAJA4;DNAJB2;SORL1;HSPA1B;DNAJB8;DNAJB1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2659396425632689,0.7574146408737669,0.8284250960307298,0.9767947828191884,1.0,10/68,12.38%,LBP;ISL1;MAVS;TLR6;IL17RA;BCL10;RAB7B;TLR4;IL16;STAT3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3126723996327855,0.7573737700996097,0.759375,0.97638257313891,1.0,7/26,20.94%,CTR9;SETD5;SETD2;METTL21C;KMT2D;SETD1B;KMT2A
prerank,cellular macromolecule catabolic process (GO:0044265),0.2739203827634997,0.7572292195218955,0.810368349249659,0.9761185659524381,1.0,7/49,11.16%,PABPC4;IDE;RNASE6;CHEK2;EXOSC7;DFFB;FBXO17
prerank,cholesterol metabolic process (GO:0008203),0.2681765793315387,0.7568579176500114,0.8042328042328042,0.9761973673437221,1.0,14/68,17.11%,SOAT1;FDX1;TSKU;MVD;FDPS;OSBPL5;LBR;EBP;RXRA;FDFT1;LCAT;SNX17;SULT2B1;HMGCR
prerank,neural tube development (GO:0021915),0.34714033394707305,0.7568147704761287,0.7516666666666667,0.9757865469382038,1.0,2/15,7.19%,PKD1;STIL
prerank,COPII-coated vesicle budding (GO:0090114),0.27021920161765123,0.7563913137276125,0.8219895287958116,0.9759456637106355,1.0,28/68,26.70%,SEC24B;STX5;CNIH2;NSF;SEC13;VAPA;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;VAPB;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG
prerank,placenta development (GO:0001890),-0.30850288752260147,-0.7563168514190799,0.8206896551724138,0.9671873699542458,1.0,4/12,30.61%,PTK2;E2F7;ADAM19;E2F8
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.24901420839399985,0.7558561175509635,0.869928400954654,0.9762546131003297,1.0,18/125,13.39%,TBCE;XPO1;NDEL1;DYNC1I1;PAFAH1B1;CLIP1;CENPQ;DCTN6;STIL;SEC13;DYNC1LI2;RMDN1;TACC3;KIF2C;RANBP2;SETD2;NEK9;SPC24
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3511025202837148,0.755814792564474,0.7455138662316476,0.9758438698082752,1.0,7/13,27.18%,CPSF7;NUDT21;CPSF4;NCBP2;CSTF2;FIP1L1;CPSF4L
prerank,positive regulation of catalytic activity (GO:0043085),-0.22849914412520378,-0.7554645537220903,0.8327868852459016,0.9673924919545855,1.0,9/37,17.91%,IGF2;MAPK3;NHEJ1;SLC5A3;CIB1;ABL2;ATP7A;FGFR4;PSENEN
prerank,peptide catabolic process (GO:0043171),0.32007575865692534,0.7551822022977639,0.7511737089201878,0.9763627421036697,1.0,5/23,11.32%,NPEPPS;CPQ;IDE;ERAP1;XPNPEP1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.332166364267217,-0.7551205659605743,0.7932692307692307,0.966944908281091,1.0,4/10,15.66%,CORO2B;NDFIP2;MAPT;PPM1F
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2991523991646749,0.7543406242492595,0.7716763005780347,0.9771460474587583,1.0,4/33,4.77%,TGFB3;IL10;PDCD4;IGFBP5
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.325338076498796,0.7542746801464635,0.7524271844660194,0.9767651125403789,1.0,4/21,9.94%,HNF1A;BCLAF1;JUN;MED14
prerank,positive regulation of defense response (GO:0031349),0.25882556909755666,0.7538788393526155,0.8567961165048543,0.9769015628984957,1.0,18/89,18.54%,GPR4;AGTR1;PDCD4;POLR3D;PLSCR1;LRSAM1;IFI35;IL17RA;TLR4;IL16;ADAM8;TRADD;POLR3B;DHX9;FEM1A;MGST2;TNIP1;IL15
prerank,regulation of oxidoreductase activity (GO:0051341),0.3516206387357822,0.753781302581571,0.726643598615917,0.9765729409995489,1.0,1/13,4.13%,ABL1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.2796888625125874,-0.753753618213997,0.7978723404255319,0.9679517814488929,1.0,5/19,13.35%,IL1RAPL1;OBSL1;LRP8;CDKL5;CAMK2B
prerank,positive regulation of cellular component organization (GO:0051130),0.252054224694136,0.7536339864191042,0.8691476590636255,0.9762964373487499,1.0,9/107,6.17%,TRABD2B;TGFB3;ATP10A;GPC3;MPP7;GSK3B;VCP;TGFBR1;CLU
prerank,homologous chromosome segregation (GO:0045143),0.3270342869164292,0.7536016300300126,0.779578606158833,0.9758722755116146,1.0,6/20,26.42%,IHO1;ANKRD31;RNF212B;CENPC;SIRT7;MEIOB
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3190417541207429,0.7534695154440288,0.7652582159624414,0.975609686475293,1.0,4/22,8.58%,RBP1;VKORC1L1;RLBP1;CYP27B1
prerank,regulation of protein localization to centrosome (GO:1904779),0.3734985819930265,0.752141239995065,0.7406749555950266,0.9771256744260424,1.0,1/10,3.93%,GSK3B
prerank,regulation of execution phase of apoptosis (GO:1900117),0.36789655617832767,0.752106085767517,0.7512776831345827,0.9767002501223496,1.0,1/11,2.25%,PTGIS
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3593063361828683,0.7520688021020024,0.7668918918918919,0.9762767140521915,1.0,7/13,31.38%,GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.32317575661417886,0.7517740864755202,0.7673343605546995,0.9762480877063339,1.0,3/22,7.31%,DDX5;SPRED2;ATM
prerank,dorsal/ventral pattern formation (GO:0009953),0.3245320915344011,0.7511546814518387,0.7681388012618297,0.9767116380005827,1.0,6/20,19.80%,BMPR1A;NOG;ACVR1;NBL1;MDFI;GLI2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.31257112176299356,0.7510950368336393,0.7884914463452566,0.9763226185004892,1.0,2/25,5.52%,ANXA1;CD80
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.36686694883279286,0.7509521648987958,0.7256637168141593,0.9760557880667511,1.0,4/10,18.17%,WIZ;STOML2;ATRX;INO80
prerank,cellular glucan metabolic process (GO:0006073),0.36242339438630067,0.7508167850952796,0.7549549549549549,0.975786760590236,1.0,2/11,3.93%,PPP1R3C;GSK3B
prerank,regulation of interleukin-17 production (GO:0032660),-0.24275085821917097,-0.7506861475998775,0.8214285714285714,0.9712756776973468,1.0,8/31,18.18%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1;NR1H4;NCKAP1L;VSIR
prerank,response to amino acid (GO:0043200),-0.24259623874717637,-0.7503880482449311,0.8254437869822485,0.9707150417817383,1.0,15/31,31.31%,SPAAR;TMBIM6;GLRA1;SLC38A9;IPO5;SH3BP4;GRIN1;LAMTOR1;GLRA3;CPEB4;MEAK7;LAMTOR2;XBP1;RPTOR;LAMTOR5
prerank,myeloid cell activation involved in immune response (GO:0002275),0.33075951719007046,0.7503696240425877,0.7724252491694352,0.9760033031554679,1.0,2/18,7.28%,LBP;IFI35
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2616337209919482,0.7501010110660448,0.8431618569636136,0.9759493870410627,1.0,5/75,5.88%,BMP4;PRKCD;LRP6;ABL1;IPO7
prerank,response to hydroxyurea (GO:0072710),0.3629750327973351,0.7500977370120504,0.753448275862069,0.9754817646190325,1.0,4/11,22.40%,DDI2;DDX11;ATRX;FMR1
prerank,protein oxidation (GO:0018158),0.3588261560441839,0.749753252815566,0.7418244406196214,0.9755286015482779,1.0,3/11,15.51%,LOXL1;LOXL4;PRDX3
prerank,stem cell differentiation (GO:0048863),0.2876475524415868,0.7495001846521185,0.7789165446559297,0.9754211181158848,1.0,9/39,16.01%,MLLT3;LRP6;TGFB2;SETD2;HTR2B;SOX21;UFL1;PUM1;LMBR1L
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2571557462569345,0.7493808397748019,0.8339622641509434,0.9746530731537054,1.0,21/78,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2571557462569345,0.7493808397748019,0.8339622641509434,0.9746530731537054,1.0,21/78,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.32531668458404406,-0.7492934399892773,0.8023529411764706,0.9713033715855828,1.0,4/10,22.71%,HK2;PFKM;HK1;PFKL
prerank,cellular response to fluid shear stress (GO:0071498),0.34777565301576346,0.7491851770863783,0.735191637630662,0.9744757418947988,1.0,2/12,4.43%,KLF4;NFE2L2
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.24251835531879623,-0.7490862365931302,0.8640483383685801,0.970633420230522,1.0,9/33,19.79%,SETX;PABPN1;SNRPB;SNRPF;SLBP;WDR33;LSM10;SNRPG;MED18
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2976423014327644,-0.748888576812696,0.7847222222222222,0.9699376651195991,1.0,1/14,1.31%,AUTS2
prerank,inorganic ion transmembrane transport (GO:0098660),0.3511955841400821,0.7487857322921649,0.7319078947368421,0.9745977394844851,1.0,2/12,8.41%,TRPM4;PKD2L1
prerank,negative regulation of hippo signaling (GO:0035331),0.348283931957499,0.7487673014592465,0.74822695035461,0.9741597003651216,1.0,2/12,10.41%,CIT;MARK3
prerank,histone mRNA catabolic process (GO:0071044),-0.2932912042332571,-0.7485071713166754,0.8086253369272237,0.969544796310928,1.0,4/15,16.61%,LSM1;UPF1;TENT4B;DCP2
prerank,regulation of interleukin-10 production (GO:0032653),-0.22768399420818639,-0.747856211708397,0.8698630136986302,0.9695173579383839,1.0,9/44,21.11%,CD47;CD34;TNFRSF21;SYK;PRKCZ;VSIR;JAK3;DLL1;TYROBP
prerank,hemidesmosome assembly (GO:0031581),0.3598992874665372,0.747650290539175,0.7275922671353251,0.9753375479505466,1.0,3/11,13.05%,KRT14;ITGB4;PLEC
prerank,defense response to bacterium (GO:0042742),0.24960802986524677,0.7476252340110416,0.8705035971223022,0.9748995742511412,1.0,8/105,8.70%,ANXA3;LBP;SHC1;PRKCD;SLPI;MAVS;TLR6;RNASE6
prerank,receptor recycling (GO:0001881),0.3718884583189203,0.747545285640196,0.7293497363796133,0.9745478882056455,1.0,1/10,3.89%,EHD3
prerank,regulation of synapse assembly (GO:0051963),0.2842246875202539,0.7450518256553189,0.8190743338008415,0.9777183375621442,1.0,4/46,7.41%,GPC6;EIF4G1;PDLIM5;GPC4
prerank,proteoglycan biosynthetic process (GO:0030166),0.299364146855159,0.7446756717129644,0.7943368107302533,0.9778052855846948,1.0,3/31,4.11%,EXT1;GLCE;CHST13
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.32602307967481503,-0.7436928016841599,0.80622009569378,0.9742121604413383,1.0,1/10,3.01%,KDR
prerank,fatty acid metabolic process (GO:0006631),0.24647259075288427,0.7435399903032806,0.875,0.978913282206899,1.0,21/115,17.48%,ABCD3;PNPLA3;PON3;ACSL3;ACADM;HACL1;ACOT8;SLC27A3;CPT1C;PER2;PEX2;CD36;NAAA;LPIN2;GNPAT;ACBD5;PLA2G15;MCAT;ALKBH7;CBR4;ADIPOR1
prerank,tetrapyrrole metabolic process (GO:0033013),0.32147683595637755,0.743391114552725,0.7852233676975945,0.9786591980466776,1.0,7/18,25.04%,MMACHC;CD320;MMADHC;LMBRD1;MMAB;ABCC1;MTRR
prerank,cellular response to insulin stimulus (GO:0032869),0.247733969351105,0.7432713166102849,0.8770685579196218,0.9783518185136594,1.0,23/124,14.09%,SORBS1;GRB10;ATP6V0A4;SHC1;HDAC9;GSK3B;FOXC2;IRS1;PTPN2;IDE;CAPN10;SLC39A14;BCAR3;ATP6V0A1;RHOQ;GAB1;ATP6V0E1;INHBB;KAT2B;LPIN2;C2CD5;ATP6V1H;ATP6V0D1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.30427399108795333,0.742530407325632,0.775,0.9789510490110758,1.0,11/29,22.77%,GDNF;FUS;TENT5D;NBAS;VIP;TAF15;TENT5C;PABPC1;EIF4ENIF1;FMR1;LARP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2962121688934576,0.7422375370507025,0.7808219178082192,0.9789166097644169,1.0,5/30,14.72%,CD44;CLU;KDM1A;CDKN2D;THOC5
prerank,amyloid-beta metabolic process (GO:0050435),0.33196337270832543,0.7421019647649945,0.7537437603993344,0.9786275306026587,1.0,2/16,7.32%,MGAT3;IDE
prerank,fatty acid biosynthetic process (GO:0006633),-0.20773609036815538,-0.7417151985249799,0.9248826291079812,0.9758428085529639,1.0,23/63,29.45%,ELOVL7;ABHD3;ELOVL6;ACLY;ACACA;ACOT7;ELOVL4;ALOX12;FADS3;TECRL;LPL;HACD3;PTGS2;HACD2;ASAH2;LIAS;DECR2;GPX4;ACSBG1;OXSM;XBP1;ELOVL2;ALOX5
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.27018416780447185,0.7416562861706846,0.8228021978021978,0.9788118819332535,1.0,8/54,14.89%,NXN;PIAS3;PER2;HDAC8;GTPBP4;SQSTM1;UFL1;USP4
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3558817605968083,0.7409792136438713,0.7783505154639175,0.9793087531077979,1.0,5/11,27.03%,ATL2;VCPIP1;VAPB;STX18;BNIP1
prerank,regulation of T cell differentiation (GO:0045580),0.29270608986488234,0.7407509644166863,0.7944199706314243,0.979176174052048,1.0,6/33,14.48%,ABL1;KAT2A;CBFB;GATA3;ZMIZ1;CAMK4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2886314430535698,-0.7404842482613657,0.7793764988009593,0.9765050068507718,1.0,3/15,8.81%,RAPGEF3;RIPOR2;FLOT1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.322618403977183,0.7404572389098747,0.7925117004680188,0.9791329779446738,1.0,5/22,11.97%,EDEM3;RNF185;OS9;EDEM2;UGGT2
prerank,negative regulation of organelle assembly (GO:1902116),0.28934263078888445,0.7400877275796393,0.8061797752808989,0.9792217044198328,1.0,8/35,13.88%,LIMK2;KAT2A;SMCR8;SEC22B;KAT2B;FEZ2;STYXL1;CEP97
prerank,mitochondrion organization (GO:0007005),-0.17834455462410143,-0.7400753329433023,0.9651162790697675,0.9761067830049913,1.0,43/165,22.07%,DNM3;NOS3;AKT3;ATP5F1B;PPARGC1A;BCL2L1;PARP1;IFIT2;CHCHD2;MFN2;PYROXD2;LRRK2;ALAS1;IMMP2L;HK2;AIP;RAB38;COX7A2;TIMM44;MYH14;ATP5F1D;CHCHD10;TRAK2;TIMM13;NIPSNAP2;GABPA;ATP7A;MGME1;SIRT5;PARK7;TSPO;SLC25A4;TOMM7;SLC25A33;HSD17B10;CYCS;CHCHD4;BIK;DNM1;DNM1L;HIGD1B;MTFP1;RAB5IF
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2377865980573818,0.7396135941942282,0.9051428571428571,0.9794436187178149,1.0,35/158,16.97%,TRAF3IP2;AKAP13;ALPK1;TAB3;GOLT1B;MAVS;CHUK;RIPK2;TLR6;MAP3K3;IRAK4;BCL10;VAPA;PPM1A;CCDC22;TRIM25;PIM2;RHOA;IKBKE;MTDH;BIRC3;HTR2B;TRADD;PPP5C;TRAF5;REL;RNF31;SLC20A1;DDX1;FLNA;MYD88;UBE2N;ROR1;TICAM2;CARD16
prerank,positive regulation of isotype switching (GO:0045830),-0.2867407000455202,-0.7396009592001709,0.8170103092783505,0.9757854354339236,1.0,2/15,5.45%,TFRC;RIF1
prerank,nuclear membrane reassembly (GO:0031468),0.267189950709185,0.7394811257020141,0.8342318059299192,0.9791799567342647,1.0,13/54,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2700472591616701,0.7392016023703188,0.8229598893499308,0.9791087595120455,1.0,12/51,18.57%,NEK7;SMG6;TNKS2;ATM;FBXO4;STN1;MAPK1;XRCC5;MAPK15;TCP1;ACD;PINX1
prerank,gas transport (GO:0015669),0.3670210345441111,0.7390701084599339,0.7413194444444444,0.9788309898485429,1.0,1/10,4.61%,AQP6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.25693646488710703,0.7390418370148103,0.8481012658227848,0.9784054708358728,1.0,25/76,24.42%,GSK3B;RNF19A;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;CCDC22;CSNK1E;ARIH2;TAF1;CSNK1A1;SMURF1;CSNK1D;COP1;RNF144A;NUB1;PIAS1;RNF14;SUMO1;TRIB2;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,cellular response to acid chemical (GO:0071229),-0.2467686460546433,-0.7389811621790268,0.84593837535014,0.9756575819161872,1.0,12/27,31.31%,SPAAR;GLRA1;SLC38A9;IPO5;SH3BP4;LAMTOR1;VEGFA;CPEB4;LAMTOR2;XBP1;RPTOR;LAMTOR5
prerank,centromere complex assembly (GO:0034508),-0.22929584540969905,-0.7387925310522958,0.8720538720538721,0.9749833943356985,1.0,20/36,39.69%,RUVBL1;CENPP;KNL1;CENPE;MIS18BP1;HELLS;CENPI;CENPV;CENPA;NPM1;DLGAP5;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;POGZ;CENPS;MIS12
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3137987533279544,-0.7386531372207634,0.8077803203661327,0.9742290527086972,1.0,1/11,3.62%,AHR
prerank,regulation of interleukin-2 production (GO:0032663),0.27925144744604646,0.7384804907797923,0.8326359832635983,0.9787577838171018,1.0,3/43,5.52%,ANXA1;EZR;CD80
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.24339238536229332,0.7379630702541423,0.8713789107763615,0.9790343756940171,1.0,38/124,23.77%,TCF7L2;PPP3CA;WNT11;FZD7;PLCB3;TNRC6C;AP2A2;MOV10;PRICKLE1;CELSR3;AP2A1;FZD2;CDC42;RHOA;NLK;DAAM1;SMURF1;PSMC6;FRZB;PSMD8;FZD9;FZD3;TNRC6A;PSMB1;RYK;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;NFATC1;SFRP4;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2;GNB1
prerank,cellular response to calcium ion (GO:0071277),0.257810109525986,0.7379603657274386,0.864516129032258,0.9785731403508532,1.0,7/67,9.56%,CLIC4;CAMK2D;MEF2A;SYT8;IQGAP1;CARF;DMTN
prerank,renal absorption (GO:0070293),0.3668920212399791,0.7377939934780366,0.7673611111111112,0.9783585638820873,1.0,2/10,6.07%,GSN;HNF1A
prerank,macrophage activation involved in immune response (GO:0002281),0.34319028773878824,0.7377236491071069,0.768581081081081,0.9779974938092605,1.0,2/13,7.28%,LBP;IFI35
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.29850347559071255,0.7371533644545166,0.8146487294469357,0.9783279422417623,1.0,3/29,5.21%,RAET1E;KLRC2;PVR
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3588491723475125,0.7368607991269643,0.7407407407407407,0.9782911997847945,1.0,5/10,31.47%,SAG;RHO;GNB1;PDE6A;CNGB1
prerank,cellular response to chemical stress (GO:0062197),0.24976500831156662,0.7368577636643782,0.8806888068880688,0.9778314096324481,1.0,13/96,10.46%,FOXO3;LRRC8D;MGAT3;ABL1;NFE2L2;VKORC1L1;PYCR1;ATM;GPX8;ETV5;RAD52;NOX1;CCS
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2997654412875309,0.7368490216815053,0.786910197869102,0.9773850594408703,1.0,2/25,2.18%,CNNM2;CNNM4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.31275487961065956,-0.736810570374085,0.7995444191343963,0.9747744943303868,1.0,3/11,10.50%,AGO1;NOTCH4;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.31275487961065956,-0.736810570374085,0.7995444191343963,0.9747744943303868,1.0,3/11,10.50%,AGO1;NOTCH4;AGO4
prerank,vasodilation (GO:0042311),-0.30530212711217997,-0.7367988073795583,0.8104265402843602,0.9738582434804958,1.0,6/13,25.15%,NOS3;KCNMA1;NOS1;SOD2;ADRB1;GPER1
prerank,negative regulation by host of viral transcription (GO:0043922),0.3430060915019504,0.7367962628465591,0.764102564102564,0.9769877547875738,1.0,2/12,12.11%,JUN;REST
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.2932238778483433,-0.7367938160308958,0.8164705882352942,0.9729372873017484,1.0,3/13,9.17%,LAMP1;GAS6;IL18
prerank,JNK cascade (GO:0007254),0.2812454005221392,0.7367712759796365,0.8231884057971014,0.9765643609285322,1.0,4/40,7.24%,MAP3K5;ARHGEF6;TAB3;RIPK2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.34117428223471946,0.73673443135069,0.7774086378737541,0.9761514677699847,1.0,5/15,22.36%,CHEK2;RAD17;ATF2;MRE11;RAD9B
prerank,neuron projection organization (GO:0106027),0.33810469485384403,0.7363709807222709,0.7698675496688742,0.9762124856604668,1.0,6/15,21.35%,GSK3B;PLS1;ATP1A3;MAP1A;DCTN1;PRNP
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.36734602243691017,0.7359154994927843,0.7779783393501805,0.976393571975882,1.0,3/10,16.85%,KDM1A;DISC1;FZD3
prerank,cellular response to hydroxyurea (GO:0072711),0.3633693573046552,0.735693262705193,0.7513227513227513,0.976270951885524,1.0,4/10,22.40%,DDI2;DDX11;ATRX;FMR1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2728102265266366,-0.7350068308178495,0.8369304556354916,0.9742480862665311,1.0,6/18,19.30%,PPIA;HIF1A;NME5;AKT1;PARK7;SOD2
prerank,lymphocyte migration (GO:0072676),-0.23842065540292462,-0.7342185675305648,0.8820058997050148,0.9743444463065408,1.0,19/32,46.10%,S1PR1;CCL19;CCL2;CCL25;MYO1G;CCL5;CCL11;ZAP70;CCL4;CRTAM;CX3CL1;CCL7;CCL8;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,positive regulation of transmembrane transport (GO:0034764),0.3475111437457093,0.7340215225224692,0.7787162162162162,0.9782097851053573,1.0,5/13,17.79%,ANO6;NR4A3;SLC26A6;C2CD5;AZIN1
prerank,protein-DNA complex disassembly (GO:0032986),-0.28738697580511885,-0.731916693883919,0.844559585492228,0.9763216209739622,1.0,9/16,35.86%,RPL23;SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.31042106506862344,0.731799640057717,0.7712,0.9798831316985758,1.0,2/20,7.31%,KLHL22;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.31042106506862344,0.731799640057717,0.7712,0.9798831316985758,1.0,2/20,7.31%,KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.31042106506862344,0.731799640057717,0.7712,0.9798831316985758,1.0,2/20,7.31%,KLHL22;ATM
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.24961090029885105,0.7297695811546913,0.8526448362720404,0.9822425685139222,1.0,21/79,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,lysosome organization (GO:0007040),-0.2292427647998843,-0.7295854084888785,0.8774834437086093,0.9782362540374739,1.0,6/36,10.68%,ABCA1;CLVS2;GRN;CLVS1;LRRK2;AKTIP
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30530462093638916,-0.7286592133970986,0.8073394495412844,0.9784625228375707,1.0,4/11,18.30%,CDK5RAP2;MDM1;RBM14;BRCA1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.349046003680214,0.7285442122699343,0.7464788732394366,0.9834896458870063,1.0,3/12,13.20%,GSN;TRIM26;CIITA
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.29712481462311885,-0.7282127356152472,0.8223844282238443,0.9780457295763371,1.0,6/13,22.36%,EAPP;NELFCD;NELFA;LARP7;HNRNPU;SUPT4H1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.3563098346800537,0.7281708663929678,0.7801418439716312,0.983549343813895,1.0,2/10,8.83%,ZBTB7B;CBFB
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2352580180813712,0.7279242468169002,0.9146757679180887,0.9834506122116423,1.0,43/172,20.42%,PNPLA3;INPP4A;DDHD1;PLEKHA4;ARF3;PLSCR1;PIP5K1A;MTMR12;PITPNM3;OCRL;FGF2;ETNK1;PLD1;CDS1;SELENOI;CSNK2A2;CSNK2A1;DGKA;ABHD4;VAC14;ABHD5;GPAT3;LPIN2;GNPAT;PI4KB;CPNE3;LCAT;RAB5A;AGPAT4;PIK3C2B;SYNJ1;PLA2G4A;LCLAT1;SLC44A5;AGPAT5;PITPNM2;CEPT1;SLC44A3;CLN3;RUFY1;FIG4;PIK3R2;AGK
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3362972128933748,0.7276150247385644,0.7400346620450606,0.9834251448609621,1.0,1/13,2.77%,PRKCD
prerank,sulfur amino acid metabolic process (GO:0000096),0.3086348288447302,0.7276083369481622,0.8134328358208955,0.9829723521016647,1.0,3/24,8.18%,GCLC;CDO1;GADL1
prerank,regulation of telomerase activity (GO:0051972),0.27158777593095923,0.7274766966839371,0.8454038997214485,0.9826948577889374,1.0,10/45,18.57%,KLF4;NEK7;SMG6;ATM;MAPK1;XRCC5;MAPK15;TCP1;ACD;PINX1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.30488677039948137,-0.7274594998397031,0.8303571428571429,0.9780409512471181,1.0,5/11,38.31%,CCT5;CCT2;DKC1;CCT8;CCT7
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3215756275367885,0.7272372593706913,0.77491961414791,0.9825499111457462,1.0,2/17,7.72%,LTBP3;KDM1A
prerank,regulation of defense response to virus (GO:0050688),0.32964051912055203,0.7271035596682008,0.7706896551724138,0.9822504404512671,1.0,8/14,29.05%,DHX9;IFNLR1;TRAF3IP1;TRAF3;RNF26;ILRUN;RNF216;PPM1B
prerank,mRNA metabolic process (GO:0016071),0.2470813304747797,0.7270916424907589,0.8783269961977186,0.9818076370522223,1.0,19/90,19.50%,DDX5;DXO;SON;CELF1;ZC3H12D;TCERG1;PRPF3;DIS3L2;SRSF5;SF3B2;NANOS2;LSM2;SRSF11;SNRPD3;PRKACA;SCAF11;GEMIN2;YTHDF2;ALKBH5
prerank,regulation of platelet aggregation (GO:0090330),0.32288024209281296,0.7270439853918225,0.7828947368421053,0.9814143695714931,1.0,7/17,15.64%,CD9;PRKCD;SERPINE2;DMTN;C1QTNF1;ADAMTS18;PRKCA
prerank,water transport (GO:0006833),-0.30509587860062415,-0.7264757026903694,0.8240740740740741,0.9783207472345621,1.0,2/12,6.29%,AQP4;AQP11
prerank,negative regulation of cilium assembly (GO:1902018),0.3464673642441539,0.7264469279450103,0.7793345008756567,0.9817798604011937,1.0,1/12,2.28%,LIMK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3073268336544593,-0.7264284618457285,0.7731481481481481,0.9756131689736651,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3073268336544593,-0.7264284618457285,0.7731481481481481,0.9756131689736651,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3073268336544593,-0.7264284618457285,0.7731481481481481,0.9756131689736651,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,multivesicular body assembly (GO:0036258),0.2870949012462053,0.726371143803719,0.8126843657817109,0.9814198496565207,1.0,8/30,20.65%,PDCD6IP;IST1;TSG101;VPS37A;HGS;STAM2;CHMP4A;CHMP4B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.30914897577942574,0.726158820175364,0.7867298578199052,0.9812544772802438,1.0,6/23,15.59%,MTMR12;OCRL;INPP5B;MTMR11;SYNJ1;PIP4P2
prerank,secondary alcohol metabolic process (GO:1902652),0.27514510185889274,0.7258921187817058,0.8220108695652174,0.9811644685822679,1.0,8/42,16.53%,SOAT1;FDX1;TSKU;OSBPL5;EBP;RXRA;LCAT;SULT2B1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3061573013829576,0.7257791962285037,0.7964743589743589,0.980866627151909,1.0,5/25,19.28%,PAICS;PRPS2;GMPS;AMPD3;ADA
prerank,regulation of cellular component size (GO:0032535),0.2993377863828336,0.7255267770103222,0.8202080237741456,0.9807630928206603,1.0,5/30,10.44%,EZR;RARG;VAV2;RDX;MTOR
prerank,cilium movement (GO:0003341),0.2672753105838876,0.7252805716948537,0.8515406162464986,0.9806472965160955,1.0,6/47,12.37%,CCDC40;CFAP70;SPEF1;SPAG17;RSPH6A;DNAH5
prerank,protein catabolic process (GO:0030163),-0.2061531660652415,-0.7250470336926406,0.9163179916317992,0.9764010201894195,1.0,5/59,5.83%,APOE;ADAMTS9;HSPA8;STT3B;DAB2IP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2969086180519303,0.7250212474834782,0.8246753246753247,0.980551088170209,1.0,5/24,14.68%,CD44;CLU;KDM1A;TAF9;CDKN2D
prerank,negative regulation of proteolysis (GO:0045861),0.2840431024521043,0.72399382817364,0.8088235294117647,0.9815363025240055,1.0,4/34,7.84%,PTPN3;IL10;SERPINE2;TIMP2
prerank,negative regulation of transferase activity (GO:0051348),0.2953235464164736,0.7238721890947662,0.8385650224215246,0.981233761351817,1.0,7/28,18.57%,GSK3B;ABL1;CDKN1B;PHPT1;PRDX3;IRS2;PINX1
prerank,phagosome acidification (GO:0090383),0.2973014523767096,0.7237562836981546,0.765990639625585,0.980931976983005,1.0,7/26,19.26%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;RAB7A;ATP6V1G1
prerank,establishment of protein localization to organelle (GO:0072594),0.25404915978132336,0.7235165000890253,0.8538754764930114,0.9807921862686834,1.0,13/72,14.62%,NUP93;IPO7;PRICKLE1;LRSAM1;SEC13;E2F3;NUP188;TNPO2;STAT3;HEATR3;ZDHHC15;FAM53A;RAN
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.35664995896799867,0.7234959901728649,0.7783687943262412,0.9803671730423761,1.0,3/10,18.30%,DLGAP4;CACNG5;AKAP9
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2842802580394819,0.7231715956863808,0.8215892053973014,0.9803485915287845,1.0,2/32,2.77%,FOXO3;PRKCD
prerank,negative regulation of RNA splicing (GO:0033119),-0.25834824563423675,-0.7223387974751975,0.8384615384615385,0.9787683421970934,1.0,5/19,12.56%,RPS13;TMBIM6;RNPS1;SRSF9;PTBP2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2756490735825009,0.7218966995743831,0.8361111111111111,0.9816062890623806,1.0,10/42,17.81%,VCP;USP10;TRIM25;RPA1;RFC5;REV1;POLD3;CDKN2D;WRN;POLA1
prerank,cranial nerve development (GO:0021545),0.35038064295238724,0.7205362421823523,0.7802768166089965,0.9829707384523327,1.0,3/11,10.99%,ISL1;TFAP2A;TIFAB
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3408534245303083,0.7204124182436127,0.7773913043478261,0.9826680421405377,1.0,5/12,23.09%,SEC63;GET3;CHMP4A;CHMP4B;SEC61A2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.29445941119902275,0.7201903520433746,0.8084772370486656,0.9825108094618554,1.0,8/25,20.34%,LRPAP1;ITGAV;ITGB3;NEU3;RIN3;ANKRD13D;ATXN2;DLG4
prerank,lipid biosynthetic process (GO:0008610),0.2528608943255966,0.7199980625328001,0.86875,0.9823225257111609,1.0,15/77,18.17%,ABCD3;PIP5K1A;SCD;MVD;CYP19A1;FDFT1;GNPAT;AGPS;AGPAT4;PRKAA1;MCAT;CBR4;HMGCR;AGPAT5;MBOAT1
prerank,digestive tract morphogenesis (GO:0048546),0.3358164702768072,0.7196042004600964,0.7929292929292929,0.9823531688022807,1.0,2/14,10.03%,STRA6;AGR2
prerank,regulation of cholesterol esterification (GO:0010872),0.34934603820842675,0.7194861312792395,0.7806563039723662,0.9820612388852947,1.0,2/10,9.08%,AGTR1;STARD4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.25734480900537704,-0.7193935049852629,0.8457142857142858,0.9813595736429668,1.0,8/21,28.57%,BCL2L1;TMBIM6;LRRK2;BOK;PARK7;SELENOS;PMAIP1;XBP1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.28167077531964785,0.7192727951833383,0.8218978102189781,0.9818984435414209,1.0,1/32,0.44%,PLCE1
prerank,regulation of protein kinase A signaling (GO:0010738),0.31364770499623656,0.7192669520019678,0.7952380952380952,0.981447996106,1.0,4/20,12.76%,TCIM;ADRB2;AKAP12;PRKAR2A
prerank,histone lysine methylation (GO:0034968),0.28458167334507145,0.7187259122655766,0.833095577746077,0.9817128964392127,1.0,9/33,25.39%,SMYD2;EHMT2;KMT2D;ASH2L;SETD1B;KMT2A;PRDM5;EZH2;WDR5
prerank,programmed necrotic cell death (GO:0097300),0.31690389972619265,0.7183390052944437,0.7931034482758621,0.9817682624199883,1.0,6/18,20.37%,RIPK3;TLR4;TRPM7;ALKBH7;TICAM2;LY96
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3206166977920176,0.7182376879920158,0.8010033444816054,0.9814405300318301,1.0,2/17,5.12%,NFE2L2;VNN1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24014817365059632,0.7178921931321862,0.9044205495818399,0.981433336607623,1.0,24/119,15.53%,TTC7A;INPP4A;IP6K2;PLEKHA4;SOCS2;ARF3;PIP5K1A;MTMR12;PITPNM3;OCRL;FGF2;SMG1;IP6K3;PIGB;CDS1;PIGL;PIGU;PIGN;DPM1;VAC14;PI4KB;RAB5A;PIK3C2B;SYNJ1
prerank,cell part morphogenesis (GO:0032990),0.3319842272281511,0.7178917851468539,0.7803163444639719,0.9809789693221566,1.0,1/13,2.92%,PID1
prerank,transcription preinitiation complex assembly (GO:0070897),0.3385099486007214,0.7173018417114525,0.799645390070922,0.9813032270969105,1.0,3/12,15.29%,TAF1;TAF7L;TAF12
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.26803407751874353,-0.7171468598764891,0.8414634146341463,0.9830969466984255,1.0,2/18,3.01%,DCN;KDR
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.27750958608453796,-0.7170484116456709,0.8421052631578947,0.9822846823043733,1.0,5/15,17.46%,CST3;DPP4;FSCN1;CLASP2;FGFR4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2500594955582829,0.7166014530241044,0.8609022556390977,0.9818209406388498,1.0,23/73,23.72%,ABL1;GATA1;CBFB;TCF3;GATA3;FOXC1;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;PSMD3;PUS7;PSMD2;PSMC2;PSMB2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.2773971874987142,-0.7162464852635122,0.8194774346793349,0.982254194161842,1.0,4/15,12.58%,SMPD3;SPHK1;TNFRSF1A;ORMDL3
prerank,lymphocyte proliferation (GO:0046651),-0.2495336357298905,-0.7146343696979588,0.882183908045977,0.9831356190846292,1.0,8/22,25.70%,BCL2;CTPS1;MEF2C;PPP3CB;HELLS;CD40;PIK3CG;PTPRC
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3061873361763597,-0.7146300244456322,0.8099352051835853,0.9822196507869261,1.0,3/10,24.95%,MMGT1;EMC3;EMC8
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.329568443914537,0.7145625805234097,0.805,0.9841126650912365,1.0,4/16,16.72%,PIGB;PIGL;PIGN;PIGH
prerank,maturation of LSU-rRNA (GO:0000470),-0.23561484080737227,-0.7145240775874241,0.8670360110803325,0.9814157736194816,1.0,5/26,15.71%,NSA2;SNU13;RPL7A;NIFK;LAS1L
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.350959468485554,0.7145166962233916,0.7699443413729128,0.9832683629185252,1.0,1/10,2.77%,PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.350959468485554,0.7145166962233916,0.7699443413729128,0.9832683629185252,1.0,1/10,2.77%,PRKCD
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3074755593630315,-0.7131078072087436,0.8365591397849462,0.982127388754874,1.0,5/10,38.31%,CCT5;CCT2;DKC1;CCT8;CCT7
prerank,protein trimerization (GO:0070206),0.3314971837374984,0.7122927893137739,0.7740213523131673,0.985275983683568,1.0,1/14,1.76%,DISP1
prerank,protein homotrimerization (GO:0070207),0.3314971837374984,0.7122927893137739,0.7740213523131673,0.985275983683568,1.0,1/14,1.76%,DISP1
prerank,I-kappaB phosphorylation (GO:0007252),0.3493343864580166,0.711445265018231,0.7754010695187166,0.9859498849752113,1.0,3/10,11.44%,ERC1;CHUK;TLR4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.25198993018144156,-0.7114097598142665,0.8582677165354331,0.9831645702245358,1.0,5/21,13.72%,MDK;NES;TOX;CX3CR1;PROX1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.31394504005895263,0.7107050311567578,0.8045602605863192,0.9864858172677456,1.0,2/18,10.71%,CDC25B;RAD51C
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2418641438807532,0.7104424214459528,0.8921568627450981,0.9863573243174207,1.0,6/88,6.17%,TRABD2B;MPP7;GSK3B;PDCD6IP;VCP;CLU
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.29187401536840335,-0.7103261555764898,0.8405797101449275,0.983499718728815,1.0,2/13,5.83%,EPN2;DAB2IP
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.27186084234573055,0.7100200312052171,0.8543417366946778,0.9864500021214071,1.0,8/40,17.04%,PID1;ABL1;VCP;PYCR1;ARL6IP5;STOML2;PRDX3;RNF122
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.21890905678768788,0.7100170297169047,0.9687836383207751,0.9859991122636358,1.0,74/264,24.40%,DDX5;RBM6;SNRNP48;SYNCRIP;HNRNPH1;ZCCHC8;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;PRPF40B;RBM8A;SRPK1;LSM2;ESS2;SRSF11;DDX17;GTF2F2;SNRPD3;HNRNPL;DDX1;SNRNP70;GEMIN8;SNW1;DHX9;SCNM1;PRCC;SCAF11;GPKOW;TRA2B;SRRT;GEMIN2;POLR2H;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.27384237076586426,-0.7098988796096547,0.853904282115869,0.9831167720296314,1.0,5/16,17.61%,NR1H3;SCARB1;MFSD2A;SLC27A1;PNPLA2
prerank,positive regulation of cellular component movement (GO:0051272),0.3017839332208269,0.709455046403871,0.8196457326892109,0.9862635890149396,1.0,8/24,19.46%,NTN1;TGFBR1;PHPT1;DUOX1;TUBB2B;STK11;CCDC25;PDPN
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3437680848506286,0.709170709294544,0.7890070921985816,0.9861667696012302,1.0,8/11,30.13%,STAT3;PUM2;PUM1;DHX9;FMR1;XPO5;ZFP36;FXR1
prerank,endoderm development (GO:0007492),-0.2925843358589231,-0.7091327946725215,0.8461538461538461,0.9830425115217054,1.0,6/13,29.33%,SOX17;SOX7;LHX1;DUSP4;LAMC1;TBX20
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.26403129123483726,-0.7090102050385368,0.8673218673218673,0.982257653439615,1.0,5/18,19.04%,MSRA;ASPG;ASS1;ASPA;SMS
prerank,triglyceride biosynthetic process (GO:0019432),0.31140845681770135,0.7085354699416898,0.8030050083472454,0.9865337694759114,1.0,4/18,13.11%,PNPLA3;MOGAT3;GPAT3;LPIN2
prerank,regulation of macrophage cytokine production (GO:0010935),0.3353887361265577,0.7084921675833424,0.8059964726631393,0.9861336662690109,1.0,1/13,1.44%,TGFB3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3017628409758255,0.7082668460500805,0.8126984126984127,0.9859450329666981,1.0,2/21,7.31%,KLHL22;ATM
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2713181861053247,-0.7081736629650952,0.8451443569553806,0.9822292717083413,1.0,5/16,24.15%,RIF1;SMCHD1;PNKP;SETMAR;SHLD3
prerank,erythrocyte development (GO:0048821),0.3443604455117304,0.7079769985914505,0.7806563039723662,0.9858788813251039,1.0,3/10,17.52%,GATA1;DMTN;ZBTB7A
prerank,response to histamine (GO:0034776),0.3457731371542814,0.7073652654040188,0.8103130755064457,0.986231341259457,1.0,2/10,11.48%,DIAPH1;DRD3
prerank,sulfur amino acid catabolic process (GO:0000098),0.34956497915825396,0.7069362240351547,0.7912280701754386,0.9863362869807367,1.0,4/10,27.32%,GADL1;MTRR;ADO;CTH
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.33723136299521944,0.7068837900335599,0.7982608695652174,0.9859539741915495,1.0,7/12,27.35%,STAT3;TGFB1;NCOR1;TERT;IL6;ESR1;ZC3H12A
prerank,regulation of centrosome duplication (GO:0010824),0.279894201025113,0.7062609331129298,0.8440944881889764,0.9862742291357518,1.0,4/29,8.76%,PDCD6IP;CEP131;STIL;CEP295NL
prerank,import into nucleus (GO:0051170),0.24877543690439108,0.7060654884169191,0.8835705045278137,0.9860785977941717,1.0,20/73,22.20%,NUP93;IPO7;PRICKLE1;SEC13;E2F3;NUP188;TNPO2;STAT3;HEATR3;SNRPD3;FAM53A;RAN;HTATIP2;GEMIN8;GEMIN2;NUP107;IPO8;EIF4ENIF1;SNRPD2;SNRPD1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3453709784934413,0.7055425127241991,0.81195079086116,0.9862816509509554,1.0,9/12,32.05%,FUZ;ZDHHC7;TRAF3IP1;CELSR1;RAB10;LAMA5;VANGL2;SCRIB;AHI1
prerank,muscle filament sliding (GO:0030049),0.2794585820049538,0.7054287769417474,0.8547249647390691,0.985521614980862,1.0,3/38,5.96%,MYBPC2;DMD;TNNI3
prerank,actin-myosin filament sliding (GO:0033275),0.2794585820049538,0.7054287769417474,0.8547249647390691,0.985521614980862,1.0,3/38,5.96%,MYBPC2;DMD;TNNI3
prerank,neutrophil activation (GO:0042119),0.3367196217279612,0.7045397253066558,0.8073555166374781,0.9862183734175675,1.0,1/12,2.77%,PRKCD
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2541639881975199,0.704269043454547,0.8764940239043825,0.9861170825537573,1.0,13/59,16.94%,TANK;TAB3;ERC1;CHUK;RIPK2;BCL10;TLR4;BIRC3;TRADD;REL;RNF31;NKIRAS2;TICAM2
prerank,regulation of centrosome cycle (GO:0046605),0.2967264354353495,0.704188966741816,0.8499184339314845,0.9857627424929258,1.0,5/21,20.65%,PDCD6IP;CEP131;FBXW5;AURKA;CHMP4B
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3349370588770333,0.7035894148120697,0.7905405405405406,0.9860763436584268,1.0,2/12,5.98%,EPHB6;MYCBP2
prerank,nuclear transport (GO:0051169),0.31134177040071687,0.7034447224255305,0.7757774140752864,0.9858197974589763,1.0,5/16,21.32%,XPO1;RSRC1;AAAS;NUP98;PSIP1
prerank,regulation of lymphocyte migration (GO:2000401),-0.3068275015301812,-0.703290849131154,0.8548387096774194,0.9866208662803636,1.0,7/10,44.75%,AKT1;WASL;MIA3;STK10;JAM2;CCR6;SPN
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2888947768221611,0.7032792994935957,0.8157894736842105,0.9855787922052497,1.0,9/27,20.37%,TAB3;TLR6;IRAK4;TLR4;CD36;MYD88;TNIP1;IRAK1;LY96
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23676864876429338,0.7027833457508086,0.9170731707317074,0.9857330221102485,1.0,20/104,17.01%,CCNA2;LRP6;ADRB2;ABL1;PPEF2;TELO2;CDKN1B;MNAT1;RB1;GTPBP4;RHOA;LRP5;TSG101;CAB39;CDKN2D;CDK12;MAP2K2;CDKN3;CCND3;SYAP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2345322455823683,-0.7022371953712508,0.8703703703703703,0.9868262332869615,1.0,4/28,7.75%,CTSC;PTK2;DAB2IP;ECSCR
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.31212119165697455,0.7019304273136171,0.8125,0.9863556307992746,1.0,6/16,21.22%,CTCFL;KDM1A;CTR9;SNW1;KMT2A;MYB
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.2986776319972393,-0.7017475647294317,0.850253807106599,0.9864503991423141,1.0,2/12,8.91%,GRN;LRRK2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3476039060713795,0.7015836461532055,0.8011049723756906,0.9863361254944686,1.0,3/10,12.74%,PARD3;PLPP1;HTR2B
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.32233785926089203,0.7015652450813092,0.8298217179902755,0.9859064202398053,1.0,6/16,22.29%,MCM7;RPA1;WRN;RECQL5;MCM6;MCMDC2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.34529676755674676,0.7013183540998514,0.8199643493761141,0.9857408958530575,1.0,3/10,11.95%,PIH1D2;ZNHIT3;TAF9
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.21970352219936978,0.7006374311149757,0.9714599341383096,0.9861107252721953,1.0,42/208,16.97%,TRAF3IP2;AKAP13;TANK;ALPK1;TAB3;OTUD7B;GOLT1B;MAVS;CHUK;RIPK2;TLR6;MAP3K3;IRAK4;BCL10;USP10;VAPA;PPM1A;CCDC22;TRIM25;CARD19;PIM2;SQSTM1;RHOA;IKBKE;MTDH;BIRC3;HTR2B;TRADD;PPP5C;TRAF5;REL;RNF31;SLC20A1;DDX1;UFL1;FLNA;MYD88;UBE2N;RORA;ROR1;TICAM2;CARD16
prerank,long-term memory (GO:0007616),0.2980578090045609,0.7004788991090406,0.8289902280130294,0.9858476988687038,1.0,7/19,21.35%,KAT2A;NFATC4;EIF2AK4;CAMK4;SHANK1;LDLR;PRNP
prerank,leukocyte tethering or rolling (GO:0050901),0.318339586996242,0.6994700347009186,0.826580226904376,0.9866561934993483,1.0,2/17,5.51%,ITGB1;GOLPH3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.29132596508196523,0.6992382415113495,0.7996820349761526,0.9860592542886578,1.0,5/24,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,canonical glycolysis (GO:0061621),0.29132596508196523,0.6992382415113495,0.7996820349761526,0.9860592542886578,1.0,5/24,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2907626074004667,0.698777109476374,0.8203592814371258,0.9861936433402315,1.0,3/26,11.44%,INHBA;PTPN2;TLR4
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3060846871655945,-0.6987192807925462,0.8407494145199064,0.9887545876656642,1.0,5/10,36.62%,IL18;PRKCZ;SPHK2;TSLP;IL4
prerank,mRNA modification (GO:0016556),-0.24291898443982274,-0.6981780963110048,0.8710601719197708,0.9883338252890919,1.0,8/22,32.71%,METTL14;METTL16;METTL3;TRUB1;RPUSD2;TRMT61B;ZC3H13;DKC1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.27170589507583376,0.6975507033359581,0.8485294117647059,0.9872616202958033,1.0,6/38,10.95%,TANK;OTUD7B;USP10;PPM1A;CCDC22;CARD19
prerank,mesoderm formation (GO:0001707),0.30740352604637033,0.6973152250524497,0.8170731707317073,0.9871094540344522,1.0,4/17,17.35%,ITGB1;ITGB4;ITGB3;KDM6B
prerank,cellular response to cAMP (GO:0071320),0.27952758130987526,0.6967131061417755,0.8672566371681416,0.9873915943376327,1.0,5/30,9.87%,EZR;RAP1A;IGFBP5;DMTN;SLC26A6
prerank,neuromuscular process controlling balance (GO:0050885),0.331290565906218,0.695428521499041,0.7979094076655052,0.9885759746335389,1.0,5/12,19.06%,PAFAH1B1;TIFAB;SHANK1;TPP1;CLN3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.28100353914228154,-0.6954071752002418,0.8795180722891566,0.9902744724937026,1.0,3/14,11.55%,GPS2;GAS6;RFFL
prerank,histone H2A ubiquitination (GO:0033522),0.29906792501257756,0.6952738290241298,0.8252427184466019,0.9883073780401783,1.0,3/17,9.20%,UBE2B;RNF2;RNF168
prerank,glutamine family amino acid metabolic process (GO:0009064),0.28146575078236846,0.6948384929316006,0.8411497730711044,0.9884182911623425,1.0,9/33,19.90%,GCLC;PYCR1;FPGS;KYAT1;CAD;GLUL;NIT2;OAT;GOT1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.3074438385902307,0.6947286591990267,0.8245614035087719,0.9880961811950101,1.0,1/17,2.81%,ANO6
prerank,synaptic vesicle recycling (GO:0036465),-0.22521105752207757,-0.6946600641916973,0.8879310344827587,0.9901218803136219,1.0,18/31,33.52%,SNCA;PIP5K1C;SYT7;OPHN1;NLGN1;NLGN2;SYT1;PACSIN1;CANX;SYT5;CDK5;RAB3A;SYT2;SNCB;WNT7A;SNCG;PLD2;NLGN3
prerank,regulation of cytokine production (GO:0001817),0.2291968273024144,0.6945875279131553,0.930151338766007,0.9878235674647436,1.0,11/126,10.39%,FOXP1;ANXA1;HDAC9;IL10;RIPK3;HILPDA;KAT2A;TNFRSF1B;BCL6;ASB1;GATA3
prerank,regulation of cellular catabolic process (GO:0031329),0.2464999787516837,0.6943650856070971,0.9041450777202072,0.9876233653765506,1.0,8/62,9.68%,USP13;ABL1;DDIT3;EP300;ATM;SMCR8;USP10;USP33
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.27689873762175177,0.6943345542345342,0.843108504398827,0.9872069465824194,1.0,1/30,0.90%,ABCD3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.31014030975607326,0.6942126138643754,0.8200636942675159,0.9869116828810254,1.0,4/18,11.97%,RNF185;OS9;EDEM2;UGGT2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.235224032332322,-0.693740466549042,0.8728323699421965,0.99016317498575,1.0,6/23,20.27%,CECR2;CASP3;DFFA;FOXL2;SETMAR;H1-0
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.256582846073829,-0.6929453346644031,0.8821989528795812,0.9900751453767888,1.0,7/17,27.53%,BCL2;BCL2L1;BOK;SOD2;DNM1L;BAD;BAK1
prerank,anterograde axonal transport (GO:0008089),0.26821174565541517,0.6926531273886893,0.8505747126436781,0.9883196801186023,1.0,6/37,14.37%,AP3B1;KIF1B;KIF1C;RAB27B;MAPK8IP3;DLG2
prerank,regulation of nervous system development (GO:0051960),0.26807653388620817,0.6922277884726914,0.8437956204379562,0.9883985786843293,1.0,6/37,13.29%,DOCK7;BHLHE40;HES1;TNFRSF1B;PER2;HES7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.18756839025378091,-0.6921382493937605,0.9855072463768116,0.989993511846684,1.0,23/74,24.74%,HIF1A;NOTCH1;ELOB;ELOC;RBPJ;BACH1;RPS27A;UBC;PSMB10;EGLN1;UBB;PSME2;EPAS1;EGLN2;PSMB3;PSMB4;PSMB8;PSMC5;VEGFA;PSME1;PSMA7;PSMD5;ARNT
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3094321229075646,0.6919461940669182,0.8176895306859205,0.9882971707625544,1.0,7/14,31.48%,DDX1;TSEN54;CPSF4;CSTF2;RTCB;TRPT1;TSEN2
prerank,sterol transport (GO:0015918),0.300656058692979,0.6916474743799542,0.8373205741626795,0.9882013551687076,1.0,6/19,19.78%,OSBPL5;CD36;LCAT;NPC1;ARV1;LDLR
prerank,global genome nucleotide-excision repair (GO:0070911),0.28262338163249207,0.6915527275484828,0.858034321372855,0.987872401791933,1.0,8/26,15.55%,ERCC3;ERCC1;XPA;CHD1L;RNF111;CUL4A;RAD23B;XPC
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.28740574934371954,0.6915199769166673,0.8264984227129337,0.9874649697541548,1.0,5/25,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,nucleotide-excision repair (GO:0006289),0.23036991155116682,0.6913246467002843,0.9205378973105135,0.9872547534748325,1.0,23/101,18.62%,EP300;USP7;MNAT1;ERCC3;BRCA2;ERCC1;COMMD1;SLC30A9;RPA1;ERCC8;XPA;RFC5;CHD1L;RNF111;CUL4A;COPS7B;COPS5;RAD23B;POLD3;XPC;POLB;POLA1;POLR2H
prerank,glucan biosynthetic process (GO:0009250),0.3229493585852972,0.6911340127595829,0.8113207547169812,0.9866057428255475,1.0,2/12,9.73%,PPP1R3C;PER2
prerank,glycogen biosynthetic process (GO:0005978),0.3229493585852972,0.6911340127595829,0.8113207547169812,0.9866057428255475,1.0,2/12,9.73%,PPP1R3C;PER2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.26972454076314945,0.6903064333782882,0.8633720930232558,0.9871756722333708,1.0,6/39,8.27%,F8A1;NDEL1;DYNC1I1;PAFAH1B1;FBXW11;TANC2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.290007775969453,0.6902845865191193,0.8248772504091653,0.9867585017482869,1.0,8/20,24.18%,CLU;PSMG2;PSMG1;LONP1;HSPA4;BBS12;TMEM35A;HSPA1A
prerank,dendritic cell migration (GO:0036336),-0.26341907036142453,-0.6901784484653815,0.883419689119171,0.9911069287803876,1.0,1/16,0.78%,EPS8
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.28645409316223114,0.6898285425536375,0.8484848484848485,0.98686378251902,1.0,2/24,4.50%,CAMK2D;DMD
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2892156553037021,0.6888362634326166,0.8472668810289389,0.9875853175700987,1.0,1/22,1.74%,CD55
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2923993109185142,0.6888109564625889,0.8421900161030595,0.9871712630409704,1.0,6/21,16.91%,SHPK;DERA;RPIA;GPI;G6PC3;RBKS
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3000870775938952,0.6881502139897594,0.8385579937304075,0.987502921021393,1.0,5/21,18.30%,ANK2;SNTA1;KCNE4;FLNA;AKAP9
prerank,regulation of aerobic respiration (GO:1903715),-0.2706787262140007,-0.688008574449011,0.8671679197994987,0.9924023006668565,1.0,6/15,23.47%,CBFA2T3;COX7A2;ATP7A;UQCC2;SLC25A33;SHMT2
prerank,receptor clustering (GO:0043113),-0.2353116361217613,-0.6879135665049121,0.9166666666666666,0.9915887440858722,1.0,8/27,24.31%,NRXN1;ITGA4;LRRC7;MUSK;ITGB2;NLGN1;PTN;AGRN
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2650266285986273,0.6874701051099624,0.8771186440677966,0.9878611820395973,1.0,7/42,11.83%,KDM1A;FUS;SHLD1;MRNIP;CHEK1;SETD2;RAD51AP1
prerank,positive regulation of chromosome organization (GO:2001252),0.3111020566068837,0.6873624344582531,0.8251748251748252,0.9875409865395717,1.0,5/15,19.95%,DDX11;PML;ATRX;NBN;MRE11
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2780749515995752,0.6861645247286874,0.8317901234567902,0.9884938341955356,1.0,5/26,12.11%,NFE2L2;VNN1;PYCR1;GATA4;REST
prerank,membrane organization (GO:0061024),0.21641193398357098,0.686094441587406,0.9694989106753813,0.9881445011729716,1.0,17/227,7.73%,EGFR;REPS2;ANK2;ADRB2;NUP93;SUN3;AP2A2;STX11;CLTB;TOR1AIP1;PDCD6IP;RABEP1;GAK;A4GALT;OCRL;AP2A1;IGF2R
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.23761039362814868,-0.6860519185559207,0.9150141643059491,0.9924527413932478,1.0,4/24,14.33%,JARID2;CREBZF;TRIM27;MTF2
prerank,ESCRT III complex disassembly (GO:1904903),-0.30580019093115374,-0.6858401525809187,0.838074398249453,0.9908415233640105,1.0,5/10,30.47%,CHMP1A;CHMP7;CHMP1B;CHMP2B;VPS4A
prerank,ESCRT complex disassembly (GO:1904896),-0.30580019093115374,-0.6858401525809187,0.838074398249453,0.9908415233640105,1.0,5/10,30.47%,CHMP1A;CHMP7;CHMP1B;CHMP2B;VPS4A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.2702284246836029,0.6856866120771828,0.8727015558698727,0.9881645865567011,1.0,5/35,12.14%,CYP1B1;IL10;HES1;PIGU;NLK
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2831893860655354,0.684542790007247,0.8423566878980892,0.9890521873384677,1.0,3/24,7.92%,DDIT3;NFE2L2;CREB3L3
prerank,regulation of myoblast fusion (GO:1901739),-0.2858029006970515,-0.6837901950466402,0.8454332552693209,0.9919020345832208,1.0,4/11,14.75%,RIPOR2;CFLAR;FLOT1;ADGRB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.25250341385217656,0.6832122174970886,0.8961384820239681,0.9901831772499793,1.0,18/54,26.45%,TAX1BP1;HIPK1;PTPN2;CHUK;SPPL2A;BIRC3;TRADD;RNF31;CARD16;FADD;NLRP2B;PYDC1;ADAM17;HSPA1A;UBE2K;CASP8;CLIP3;CPNE1
prerank,myeloid dendritic cell activation (GO:0001773),0.3235083769871142,0.6831419871070735,0.8399280575539568,0.9898209873051383,1.0,2/12,14.48%,TGFBR2;CAMK4
prerank,phospholipid homeostasis (GO:0055091),0.33606181107004596,0.6826695073576315,0.7978533094812165,0.9899475050093272,1.0,3/11,12.36%,HNF4A;FABP3;TLCD2
prerank,regulation of isotype switching (GO:0045191),0.31785700490622243,0.6820590312931423,0.8119935170178282,0.9901942482592536,1.0,2/14,10.63%,IL10;SHLD1
prerank,RNA processing (GO:0006396),0.21550685604133063,0.681993002395662,0.9658213891951488,0.9898293611125303,1.0,33/176,16.45%,MBNL1;RBM6;SNRNP48;SYNCRIP;SON;PABPC4;HNRNPH1;ZCCHC8;CELF1;FUS;TCERG1;RSRC1;PRPF3;PPIG;SRSF5;NRDE2;SF3B2;SF3B1;SRRM1;RBM8A;SRPK1;RBM39;SRSF11;DUSP11;DDX17;SNRPD3;HNRNPL;CDK12;TSEN54;DROSHA;PRKACA;SCNM1;SCAF11
prerank,protein insertion into ER membrane (GO:0045048),-0.2085799561696175,-0.6819461774908397,0.9267515923566879,0.9927440187718857,1.0,10/37,25.98%,CYB5A;UBE2J2;MMGT1;APP;SEC61G;TRAM1;EMC3;GET4;EMC8;TRAM1L1
prerank,protein-DNA complex assembly (GO:0065004),0.22307571549724012,0.6818969545836872,0.943728018757327,0.9895133457795111,1.0,36/116,26.36%,SOX9;CHAF1B;KAT6B;NAP1L2;MCM7;MNAT1;ERCC3;RPA1;XPA;CHD1L;CUL4A;RAD23B;PSMC6;ORC5;XPC;ATRX;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;MCM6;PSMD2;PSMC2;ERCC2;PSMB2;ERCC5;HMGB2;BRD2;DMC1;PSMD14;ORC2;CUL4B;SMARCA5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2483903030682823,0.6818123576034943,0.900804289544236,0.9891681348428799,1.0,7/56,11.89%,CIT;SNX18;PDCD6IP;ARL3;SON;IST1;RHOA
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.24080973591132446,-0.6817763421845303,0.8854748603351955,0.9920017363501608,1.0,3/20,14.43%,APOE;ACADL;NR1H4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2360460743773914,0.6816809303050897,0.9184993531694696,0.988872641194111,1.0,13/72,14.34%,EP300;USP7;MNAT1;ERCC3;ERCC1;RPA1;ERCC8;XPA;RFC5;CUL4A;COPS7B;COPS5;POLD3
prerank,innate immune response (GO:0045087),0.21287965748827117,0.6815581096161392,0.955386289445049,0.9885719737573723,1.0,28/217,13.63%,PTK2B;LBP;COLEC11;ALPK1;KLRC2;ZDHHC11;TREML1;VNN1;SLPI;TRIM26;MAVS;CHUK;RIPK2;RNF135;IRAK4;ANKHD1;CYP27B1;BCL10;RNASE6;FRK;TRIM25;TLR4;SETD2;YES1;CAPZA1;SRPK1;CIITA;REL
prerank,protein palmitoylation (GO:0018345),-0.2261988866282016,-0.6814207715446442,0.9174603174603174,0.9914099372872873,1.0,7/30,14.41%,ZDHHC14;SELENOK;PORCN;ZDHHC1;ZDHHC17;ZDHHC4;ZDHHC13
prerank,regulation of keratinocyte proliferation (GO:0010837),0.29371925924999587,0.6813873463119087,0.8615863141524106,0.9883395082933006,1.0,7/22,18.37%,NOTCH2;TGM1;KLF9;SRSF6;CASK;AREG;ZFP36L1
prerank,organelle fission (GO:0048285),-0.23359041833222166,-0.6804490042220058,0.9,0.9914433956692215,1.0,6/24,21.94%,DNM3;SEC16B;PEX19;DNM1;DNM1L;MTFP1
prerank,response to muramyl dipeptide (GO:0032495),-0.2867469108249978,-0.6803222951947556,0.8585365853658536,0.9906602886577723,1.0,2/12,5.54%,VIM;NOD1
prerank,Notch signaling involved in heart development (GO:0061314),0.3231102276983278,0.6799011201617814,0.8357142857142857,0.9896124523020781,1.0,4/11,19.33%,NOTCH2;JAG1;GALNT11;HEYL
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.2672882472713918,-0.6798746510741521,0.8693467336683417,0.9901690083430198,1.0,1/13,1.23%,APOD
prerank,regulation of phosphatase activity (GO:0010921),0.2825075418683918,0.6790148727117159,0.8470031545741324,0.9901747573960838,1.0,6/24,20.38%,RIPK3;PPP6R2;PPP1R36;PPP6R3;CHP1;URI1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28316607551765927,0.6786149635627131,0.8672699849170438,0.9901892916568094,1.0,9/25,23.82%,TCERG1;RNF168;WDR43;CDK12;EAF2;LDB1;NELFE;RECQL5;LEO1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3211573194349709,0.676788019188149,0.817531305903399,0.9917910961144388,1.0,5/13,20.60%,KPNA1;RGPD1;RANBP2;KPNA4;NUP54
prerank,regulation of superoxide anion generation (GO:0032928),0.30929416928862424,0.6763384035471715,0.831918505942275,0.991831560456486,1.0,4/14,22.29%,PRKCD;AATF;TGFB1;ITGAM
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.29324367758982056,0.6761118445579785,0.8328025477707006,0.9916465970654056,1.0,5/18,22.29%,MCM7;GINS3;POLD3;POLA1;MCMDC2
prerank,regulation of cholesterol transport (GO:0032374),-0.24318833929909206,-0.6756881757968201,0.8943089430894309,0.993136516056993,1.0,9/20,27.41%,NR1H3;ABCA5;ABCB4;TSPO;LAMTOR1;APOC1;ABCA2;OSBPL6;NAXE
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2813075098842219,0.675636517340554,0.8742331288343558,0.9917651967768308,1.0,6/24,18.57%,HDGFL3;MAP7D3;FGF13;KIF2C;KIF18A;KIF2A
prerank,telomere maintenance via telomerase (GO:0007004),0.27873314130969234,0.6752286624533116,0.8596491228070176,0.991776736431634,1.0,10/28,25.54%,TELO2;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3322134699303305,0.6744207364983451,0.8373382624768947,0.9922285255440438,1.0,4/10,23.56%,USP7;GNMT;ZNF692;SIRT7
prerank,negative regulation of secretion (GO:0051048),-0.2926050916855595,-0.6741098272525393,0.8695652173913043,0.9936672148227988,1.0,7/10,40.23%,NR1H3;CD74;NRG1;VAMP3;ERBB3;PTGER3;VAMP8
prerank,axonal transport (GO:0098930),0.26397039838517616,0.6740914993812204,0.8680851063829788,0.9921636498106502,1.0,4/36,6.61%,AP3B1;PAFAH1B1;KIF1B;FBXW11
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.30000982697401735,0.6738768648172486,0.8508474576271187,0.9919595696616157,1.0,6/17,18.12%,NCKAP1;ARFIP1;BRK1;FCHSD2;GMFG;CYFIP1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2089061081855721,0.6736851933463425,0.9761129207383279,0.9917106217372698,1.0,72/241,25.72%,DDX5;RBM6;SNRNP48;SYNCRIP;HNRNPH1;ZCCHC8;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;PRPF40B;RBM8A;LSM2;ESS2;SRSF11;GTF2F2;SNRPD3;HNRNPL;SNRNP70;SNW1;DHX9;PRCC;GPKOW;TRA2B;SRRT;POLR2H;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2;SNRPE;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,DNA damage checkpoint signaling (GO:0000077),0.2759914625263232,0.673399277738741,0.8616541353383459,0.9916127403490566,1.0,9/28,22.95%,ATM;CHEK2;RAD17;CHEK1;CEP63;CLSPN;NBN;ATR;HINFP
prerank,regulation of macroautophagy (GO:0016241),0.2242809705286122,0.6733036397149091,0.9430992736077481,0.9912709982838376,1.0,27/105,21.16%,NEDD4;EXOC4;TBC1D25;SMG1;SMCR8;ATP6V0A1;MLST8;MTOR;ATP6V0E1;BNIP3;RB1CC1;ATP6V1H;CLEC16A;ATP6V0D1;PAFAH1B2;SNX32;PRKAA1;PRKACA;RRAGB;MAPK8;CLN3;ULK1;ATP6V1G1;EXOC7;EXOC1;SH3GLB1;VPS26A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2820666234432793,0.6732012913850626,0.8625592417061612,0.9909421555143264,1.0,4/22,12.15%,IL10;TRPM4;TNFRSF1B;TNFRSF14
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2551225373876432,0.6730726633423217,0.8796561604584527,0.9906486793853707,1.0,12/41,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,lipid translocation (GO:0034204),0.2922058691606874,0.6722863020182264,0.8537360890302067,0.9910876826067819,1.0,2/21,4.95%,ATP10A;ATP8B1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.30838490610164837,0.6709089036591532,0.8455008488964346,0.9921535091657316,1.0,1/15,3.39%,USP46
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.27246816102147625,-0.6708186596521963,0.8661800486618005,0.9957819005809209,1.0,2/13,7.04%,CD81;SEC16B
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.24318495126466338,-0.6703229160271744,0.8796791443850267,0.9953245818155186,1.0,9/18,37.15%,TLR3;MAFB;LILRB1;LILRB3;CARTPT;LRRC17;FBN1;IL4;TMEM178A
prerank,copper ion homeostasis (GO:0055070),-0.25260587711403537,-0.6702477842360376,0.905511811023622,0.994503671409747,1.0,5/17,16.91%,ATOX1;MT2A;APP;SLC31A1;ATP7A
prerank,mitotic chromosome condensation (GO:0007076),0.2750723321600118,0.6701768501596048,0.875,0.9925128685654641,1.0,9/26,26.21%,SMC4;RB1;CSNK2A2;CSNK2A1;NCAPH2;CDK1;MCPH1;KMT5A;AKAP8L
prerank,regulation of B cell activation (GO:0050864),-0.22942731358670443,-0.6698947845774789,0.9261363636363636,0.993905678368112,1.0,5/25,18.59%,AHR;SH3KBP1;SAMSN1;TNFAIP3;TNIP2
prerank,lipoxygenase pathway (GO:0019372),0.30501965324018865,0.6697614516598184,0.8316151202749141,0.9925289548306705,1.0,1/14,3.86%,PON3
prerank,ncRNA transcription (GO:0098781),0.3141450251005609,0.669719949410777,0.858603066439523,0.9921299822179397,1.0,6/13,30.65%,POLR1G;BRF1;SNAPC2;SIRT7;ANG;SPIN1
prerank,regulation of centriole replication (GO:0046599),0.29519724339158177,0.6689255046430277,0.855,0.9926086256828013,1.0,4/17,12.88%,STIL;KAT2A;CEP295NL;KAT2B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.28003637560986605,0.6685854120258097,0.8501577287066246,0.9925466440270734,1.0,3/21,8.40%,HDGFL3;FGF13;SPEF1
prerank,macroautophagy (GO:0016236),0.21896622055325776,0.6683728543236743,0.954599761051374,0.992331913643634,1.0,28/118,21.28%,WIPI2;VCP;ZFYVE1;BECN1;ATG3;HDAC10;VPS41;LIX1;CSNK2A2;CSNK2A1;SQSTM1;RB1CC1;ACBD5;TSG101;VIPAS39;AMBRA1;PRKAA1;TBC1D5;VPS37A;CLN3;ATG7;ULK1;HGS;STAM2;CHMP4A;CHMP4B;ATG16L1;LIX1L
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3242977336526209,0.6679131238015271,0.822992700729927,0.9923995534163945,1.0,2/10,11.30%,CLU;RB1
prerank,necroptotic process (GO:0070266),0.3034429891698527,0.6667784628895682,0.842948717948718,0.9931637689295459,1.0,5/16,20.37%,RIPK3;TLR4;TRPM7;TICAM2;LY96
prerank,telomere capping (GO:0016233),0.3022078639905701,0.6666821292071965,0.8693548387096774,0.9928282222157693,1.0,5/16,19.95%,STN1;PRKDC;NBN;ACD;MRE11
prerank,miRNA metabolic process (GO:0010586),0.2895996973086866,0.6666121358175867,0.8653250773993808,0.9924634479490543,1.0,4/20,15.49%,DIS3L2;DDX17;RAN;DROSHA
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.31403706347385973,0.6662320294178639,0.8508474576271187,0.9924414872153293,1.0,4/13,18.44%,PIK3AP1;IRAK4;MYD88;IRAK1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.2794106055286279,0.6661691391830246,0.8676236044657097,0.9920722874819439,1.0,10/24,22.88%,SEC24B;IDE;SEC13;ERAP1;SAR1B;SEC24A;SEC23A;HFE;FCER1G;BCAP31
prerank,multivesicular body organization (GO:0036257),0.26181145984617943,0.6660954061238424,0.8774002954209749,0.9917168139428554,1.0,8/31,20.65%,PDCD6IP;IST1;TSG101;VPS37A;HGS;STAM2;CHMP4A;CHMP4B
prerank,DNA alkylation (GO:0006305),0.28978582018367693,0.6652777575416814,0.8666666666666667,0.9917191511135272,1.0,5/19,16.54%,BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,DNA methylation or demethylation (GO:0044728),0.28978582018367693,0.6652777575416814,0.8666666666666667,0.9917191511135272,1.0,5/19,16.54%,BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,regulation of vacuole organization (GO:0044088),0.28493421807102093,0.6652651771189274,0.8503184713375797,0.9912951491526585,1.0,5/20,16.99%,ANXA2;NPRL3;RAB5A;IFT88;ENO4
prerank,female gamete generation (GO:0007292),0.26996690939625895,0.6651976190756306,0.8809160305343512,0.9909348428581721,1.0,7/29,19.28%,TOB2;BMP15;IHO1;NANOS2;KMT2D;MCM9;USP9X
prerank,RNA interference (GO:0016246),0.2953718753305694,0.6640324200568424,0.8311036789297659,0.991719528960801,1.0,4/17,15.78%,CELF1;NRDE2;DROSHA;DHX9
prerank,tyrosine metabolic process (GO:0006570),-0.2813382712949595,-0.6638291291318413,0.8755555555555555,0.9982606430063373,1.0,11/11,71.89%,GSTZ1;DCT;IYD;IL4I1;HGD;TH;PAH;TAT;TYR;FAH;THAP4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3346373307613669,0.6637644560655538,0.8509532062391681,0.9915727713891594,1.0,4/10,16.64%,IRS1;SLC45A3;PRKCE;IRS2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.26347920099457856,0.6636135868244072,0.8967468175388967,0.9912952077778189,1.0,18/37,30.04%,CEP131;PCM1;IFT122;TRIP11;IFT88;DYNC2I2;IFT80;TRAF3IP1;IFT81;DYNC2H1;WDR35;TTC21B;DYNC2I1;IFT27;KIF17;CLUAP1;KIF3B;IFT46
prerank,outer dynein arm assembly (GO:0036158),0.30248916544300647,0.6635331682752554,0.8365695792880259,0.9909600163115281,1.0,2/14,12.37%,DNAH8;DNAH5
prerank,rRNA transcription (GO:0009303),0.29006008559270025,0.6620827618035887,0.8355704697986577,0.9920596885877129,1.0,8/17,32.19%,POLR1G;BRF1;GTF3C2;SIRT7;ANG;TAF1B;SPIN1;GTF3C3
prerank,regulation of transposition (GO:0010528),0.3070479765782378,0.6617585094882767,0.8360957642725598,0.9919721935972013,1.0,3/13,23.56%,TDRD9;PIWIL4;SIRT7
prerank,positive regulation of telomerase activity (GO:0051973),0.25759413877293846,0.6614251960998557,0.8774002954209749,0.9918843305449013,1.0,8/33,20.77%,KLF4;NEK7;MAPK1;XRCC5;MAPK15;TCP1;ACD;NVL
prerank,positive regulation of cellular protein localization (GO:1903829),0.23039840964855135,0.6605128532370655,0.9411764705882353,0.9924035708696309,1.0,9/69,12.41%,LIMK2;GSK3B;DDRGK1;CENPQ;WWTR1;ENTR1;RIC3;EIF2AK3;TRAPPC12
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.28130256029040146,-0.6600724106919998,0.8978622327790974,1.0,1.0,3/11,15.14%,ENPP3;SLC19A3;SLC25A19
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.23767749597179413,0.6595762640195137,0.9266304347826086,0.9929161388733759,1.0,7/63,10.17%,ANXA1;CD80;NCK2;CLCF1;TNFRSF4;CD320;CD46
prerank,defense response to tumor cell (GO:0002357),0.3190405702340462,0.6594902204366724,0.829136690647482,0.9925762338688725,1.0,2/10,12.77%,KLF4;RBMS3
prerank,antibacterial humoral response (GO:0019731),0.29607135222998027,0.6589618320471703,0.8640939597315436,0.9926861956546611,1.0,2/16,8.70%,SLPI;RNASE6
prerank,pre-replicative complex assembly (GO:0036388),-0.18217382277453364,-0.6587398683139789,0.9655172413793104,1.0,1.0,21/64,30.72%,RPS27A;UBC;PSMB10;UBB;ORC4;PSME2;ORC6;PSMB3;PSMB4;PSMB8;PSMC5;MCM4;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;MCM3;GMNN;CDC6;PSMA5
prerank,response to gamma radiation (GO:0010332),0.2779155214639002,0.6586173670739189,0.8783570300157978,0.9926110773600682,1.0,9/24,23.69%,ATM;KDM1A;XRCC5;PRKAA1;TSPYL5;WRN;TLK2;ATR;TMEM109
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3084739156633351,0.6584580558173324,0.8314049586776859,0.9923254031444132,1.0,5/12,26.66%,MAVS;DHX9;MUL1;IFIH1;ZCCHC3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2559266341386347,0.6584545647045392,0.8911465892597968,0.991895931404177,1.0,10/36,22.95%,ATM;CHEK2;RAD17;CHEK1;CEP63;CLSPN;NBN;ATR;RAD9B;HINFP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.2735749056432085,0.6574445335440791,0.8824404761904762,0.9924946569015685,1.0,1/25,1.46%,ANK2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.26147548335780946,0.6572495355902085,0.8989598811292719,0.9922629895959344,1.0,13/34,24.14%,DUSP16;PTPN2;DUSP10;PTPRF;DUSP5;PTPN9;DUSP22;PTPN1;PTPN11;PTPN12;PTPN22;UBASH3B;PTPRQ
prerank,cellular response to glucose starvation (GO:0042149),0.25567454926554634,0.6572055034491082,0.9169054441260746,0.9918836817762231,1.0,3/41,6.08%,FOXO3;BECN1;SIK2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.24449652956891438,-0.6571395169655823,0.9138888888888889,1.0,1.0,8/18,27.84%,AQP4;CABYR;CFAP53;SPEF2;NPHP3;ROPN1L;DNAAF2;ODAD4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.2793416301753271,-0.6571033012452475,0.8818181818181818,0.9992906973275845,1.0,6/11,38.31%,CCT5;LARP7;CCT2;DKC1;CCT8;CCT7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.2793416301753271,-0.6571033012452475,0.8818181818181818,0.9992906973275845,1.0,6/11,38.31%,CCT5;LARP7;CCT2;DKC1;CCT8;CCT7
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.25212626939933847,-0.6570763740471156,0.9020100502512562,0.9984103792381176,1.0,6/16,23.47%,COX7A2;ATP7A;UQCC2;SLC25A33;NUPR1;SHMT2
prerank,presynapse assembly (GO:0099054),0.29360111829200825,0.656623144398062,0.8406040268456376,0.9920356426100138,1.0,1/16,1.72%,BSN
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.27728978106585334,0.656001499272544,0.8783151326053042,0.9922511561573082,1.0,3/24,5.43%,PID1;NR4A3;COQ10B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2441848715949682,-0.6558220678710583,0.9247311827956989,0.9984683420234249,1.0,5/18,15.73%,TMEM14A;CHCHD10;BOK;HIP1R;GSK3A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.30591284055295054,0.6556893238450107,0.8522920203735145,0.9921565954095524,1.0,5/14,22.48%,ETNK1;SELENOI;LPIN2;CEPT1;CHKB
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.23973243150058277,-0.6554959028121395,0.9177718832891246,0.9978351604361589,1.0,1/17,0.63%,LYN
prerank,negative regulation of ATPase activity (GO:0032780),0.2923173345583847,0.6546732098740988,0.867741935483871,0.9926909005973312,1.0,1/16,5.96%,TNNI3
prerank,mitotic DNA replication (GO:1902969),0.32208749310281587,0.6541117557634187,0.8548387096774194,0.9928347381617404,1.0,5/10,27.65%,GINS3;POLA1;MCM6;MCMDC2;MCM2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2431612633179674,-0.6540188515854171,0.9072681704260651,0.998092161336982,1.0,6/17,32.77%,LPGAT1;PLA2G4E;MBOAT7;PLA2G4C;PLA2G5;PLBD1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.24801577272093794,0.6537281073904044,0.8946608946608947,0.992775366247497,1.0,12/41,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,megakaryocyte differentiation (GO:0030219),-0.2772672324491624,-0.6529804725402946,0.8802992518703242,0.9980133333298333,1.0,5/11,24.80%,KIT;TAL1;SH2B3;MED1;CDKN2B
prerank,postreplication repair (GO:0006301),0.24732588025322014,0.6520088677529725,0.9095890410958904,0.9940712676304816,1.0,9/45,16.77%,UBE2B;VCP;USP10;TRIM25;RPA1;RFC5;REV1;POLD3;UBE2N
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22385471579721583,-0.6514386186134102,0.9205479452054794,0.9982593243152745,1.0,8/25,25.99%,SORT1;CHMP1A;CHMP4C;LEPROT;CHMP7;CHMP1B;TMEM50A;CHMP2B
prerank,maturation of 5.8S rRNA (GO:0000460),0.2843964401236962,0.6504251848548352,0.8544520547945206,0.9952182743733341,1.0,8/17,23.16%,RPF1;RRP15;C1D;PRKDC;WDR12;EIF6;EXOSC4;FTSJ3
prerank,myelin maintenance (GO:0043217),0.32143815041776913,0.6502618170184286,0.8594594594594595,0.9949441028680366,1.0,2/10,9.97%,CLU;CXCR4
prerank,regulation of osteoclast differentiation (GO:0045670),0.2568941925707866,0.6496122373629454,0.8905109489051095,0.9951571676437975,1.0,9/33,24.01%,TNFSF11;MTOR;TLR4;CEBPB;CAMK4;PRXL2A;CCR1;TCTA;UBASH3B
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2837567687402649,-0.6495637090345783,0.9047619047619048,0.9987704397198233,1.0,5/11,32.71%,TENT4B;LARP7;EXOSC3;EXOSC10;DKC1
prerank,cellular response to amino acid stimulus (GO:0071230),0.25591599179102903,0.6493490437787486,0.8989598811292719,0.9949731286763068,1.0,4/33,10.44%,CAPN2;KLHL22;CASTOR2;MTOR
prerank,RNA modification (GO:0009451),0.23878814261389356,0.6493489501626278,0.9195088676671214,0.9945422178366896,1.0,17/54,23.16%,CTU2;METTL1;ELP5;TYW5;MRM2;JMJD6;QTRT2;NSUN4;NOP2;MEPCE;QTRT1;TRDMT1;TRMT61A;PUS7;AARS1;URM1;FTSJ3
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2567060882017931,0.6485978632712738,0.8982558139534884,0.9948704992709545,1.0,5/36,11.08%,ITGB1;ADRB2;IL10;NRP1;TAF1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.308266846441984,0.6479069317887236,0.8658318425760286,0.9950841070320366,1.0,5/13,25.56%,RHOQ;RAN;ENTPD7;GNAI3;AK3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2715623894432591,-0.6478567813977926,0.8932038834951457,0.9991051963276738,1.0,5/12,21.42%,EAPP;NELFCD;NELFA;LARP7;HNRNPU
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.20743266741825278,-0.647814840388944,0.9466666666666667,0.9982494708251057,1.0,14/39,27.57%,FAN1;PARP1;RPS27A;UBC;GTF2H2;DDB1;UBB;DDB2;GTF2H4;OGG1;POLD1;RFC2;RPA3;POLD2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.27740954725068795,0.6476641293635836,0.8826446280991735,0.9949109725418316,1.0,2/20,4.80%,RIPK3;PDCD6IP
prerank,tRNA processing (GO:0008033),0.2280642737320393,0.6471813289011822,0.9338624338624338,0.9949248090278379,1.0,27/61,31.48%,CTU2;METTL1;ELP5;TYW5;DDX1;TSEN54;QTRT2;TRMT10B;QTRT1;TRDMT1;TRMT61A;CPSF4;AARS1;URM1;POP1;CSTF2;RTCB;ELAC2;FARS2;KARS1;THG1L;TRPT1;ADAT1;PUS3;PTCD1;TRMT6;TSEN2
prerank,glutamate metabolic process (GO:0006536),0.2869211420301339,0.6471054453263219,0.869281045751634,0.994569546378992,1.0,7/19,24.70%,GCLC;FPGS;GLUL;OAT;GOT1;GLS2;PRODH
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2785207354252921,0.6469927223096742,0.8613707165109035,0.9942400642347766,1.0,3/21,7.70%,CRY2;GSK3B;BOD1L1
prerank,positive regulation of translational initiation (GO:0045948),-0.23716819937128542,-0.6457749709775537,0.9371584699453552,0.9988360076117102,1.0,9/18,34.00%,UHMK1;RPS6KB1;EIF2B5;HABP4;POLR2G;BOLL;CDC123;CCL5;POLR2D
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24287945422431623,0.645739228573806,0.9369250985545335,0.9949903923473481,1.0,15/52,22.45%,SHC1;LMNA;DNAJC3;DNAJB11;ADD1;DDX11;ATP6V0D1;ERN2;WFS1;TPP1;TATDN2;DCTN1;VAPB;CUL7;SRPRA
prerank,mitochondrial gene expression (GO:0140053),0.24537302287908255,0.6455081991790451,0.9192634560906515,0.9947685240161671,1.0,11/42,25.94%,FOXO3;GFM2;MRPL57;MRPS28;MRPL47;NDUFA7;MRPS24;MRPS18B;MRPS7;PTCD3;MRPS34
prerank,apoptotic DNA fragmentation (GO:0006309),0.29308220811159874,0.6453605467495805,0.8865131578947368,0.9944792978997108,1.0,3/16,10.07%,DNASE2B;KPNA1;DFFB
prerank,protein autoprocessing (GO:0016540),0.28405733437526287,0.6449000774041034,0.8796747967479674,0.9944893387540225,1.0,3/17,11.64%,TMPRSS2;MYRFL;OMA1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2564839861257797,-0.6446316763108738,0.912718204488778,0.9987871060572601,1.0,4/15,16.22%,SAMHD1;NLRC5;USP18;METTL3
prerank,response to UV-B (GO:0010224),-0.2701695181446103,-0.6444406733826673,0.8893905191873589,0.9980433216080151,1.0,2/12,7.63%,CRIP1;MFAP4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2984363858267446,0.6444205639612453,0.848585690515807,0.9945182158375743,1.0,5/15,17.60%,ATL2;RAB18;ZFYVE27;TMEM170A;RTN3
prerank,skeletal muscle contraction (GO:0003009),-0.24211350991902544,-0.6439787710617072,0.924791086350975,0.9974978957841947,1.0,3/19,13.17%,STAC;RCSD1;MYH14
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.28937175020886063,0.6439644281829023,0.8608247422680413,0.9945093945061074,1.0,4/13,15.78%,TRIM44;MAVS;TAF9;DHX9
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.22014411695986055,0.6434376709918206,0.9607843137254902,0.9945636348682994,1.0,21/86,24.36%,EGLN3;DDIT3;NFE2L2;EP300;CREBBP;HIF3A;CHEK1;PSMC6;PSMD8;INO80;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2;HSPA1A;IMPACT
prerank,intracellular pH reduction (GO:0051452),0.2575785240647873,0.6433188118768873,0.9079754601226994,0.9942501713106463,1.0,7/33,19.26%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;RAB7A;ATP6V1G1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2771548673959973,-0.6427213466378289,0.8926940639269406,0.9975036132267706,1.0,4/10,22.12%,MFSD2A;MTMR9;MTMR2;MTMR1
prerank,positive regulation of exocytosis (GO:0045921),0.2475007630697941,0.6422991292987992,0.9124629080118695,0.9947647253102734,1.0,10/35,20.26%,PDCD6IP;EXPH5;SYTL4;RAB27B;SDC4;TSG101;RAB5A;SDC1;RAB7A;HGS
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.26221219743990937,-0.6422759261915086,0.9014423076923077,0.996937305888706,1.0,2/12,11.27%,CXCL12;APP
prerank,modulation by host of viral genome replication (GO:0044827),0.29731650672434307,0.6421782279816536,0.8707360861759426,0.9944492583548632,1.0,4/13,22.40%,EIF2AK4;VAPA;TBC1D20;FMR1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3060040516144194,0.6415534377846119,0.863406408094435,0.9945733709188538,1.0,4/13,23.90%,MOAP1;BNIP3;RHOT2;RHOT1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.30343620562092877,0.6410929513026792,0.8327586206896552,0.9945496928469434,1.0,2/13,6.99%,MOV10;CNOT7
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.24196101675848597,-0.6408570278968979,0.9183098591549296,0.9970619313241998,1.0,6/17,26.88%,APOE;FGF1;ABCG1;ERLIN2;ABCA2;LPCAT3
prerank,serine family amino acid catabolic process (GO:0009071),-0.2778588516947092,-0.6407590260578748,0.8896396396396397,0.9962526742420311,1.0,5/10,34.51%,SHMT2;GLDC;SHMT1;CBS;DAO
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2364214121111498,-0.6404530684565964,0.922077922077922,0.994684676066544,1.0,5/19,22.66%,POLR2K;TERF2IP;POLR2C;POLR2G;POLR2L
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2364214121111498,-0.6404530684565964,0.922077922077922,0.994684676066544,1.0,5/19,22.66%,POLR2K;TERF2IP;POLR2C;POLR2G;POLR2L
prerank,DNA-dependent DNA replication (GO:0006261),0.2103569463197196,0.6402546687467755,0.9790697674418605,0.9948815472714392,1.0,33/128,23.72%,REV3L;MCMBP;MCM7;NOC3L;RPA1;BAZ1A;RFC5;GINS3;POLD3;PSMC6;LRWD1;ORC5;PSMD8;POLG2;POLB;WRN;POLA1;PSMB1;PRIM2;PSMD13;PSMD1;PSMD7;WDHD1;PSMA8;PSMD3;RECQL5;MCM6;PSMD2;MCMDC2;PSMC2;RFC1;SIRT7;PSMB2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.25601469475699834,0.6385437354907557,0.9281437125748503,0.9960067820598529,1.0,4/30,12.04%,FUT8;UGGT2;ASGR2;DPM1
prerank,oogenesis (GO:0048477),0.2825519587134972,0.6385385721450818,0.8872305140961857,0.9955823659435364,1.0,3/15,14.18%,IHO1;NANOS2;KMT2D
prerank,macrophage migration (GO:1905517),-0.25661007477487113,-0.6385233762592403,0.9178743961352657,0.995163146972228,1.0,6/13,34.83%,EDNRB;P2RY12;TAFA4;CCL2;CCL5;CXCL17
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3229911817803009,0.6380854443417873,0.8522920203735145,0.9955888285956439,1.0,3/10,21.23%,WDR1;CFL2;PDXP
prerank,cell cycle checkpoint signaling (GO:0000075),0.2899560577526681,0.6376098446407769,0.8604240282685512,0.9955699978222686,1.0,12/12,71.03%,PRCC;CHFR;ZWILCH;WEE1;NABP1;ZW10;ZWINT;NABP2;WEE2;PLK2;BUB1;BUB1B
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.247484733245873,-0.6374756723423011,0.9212598425196851,0.9950265125258695,1.0,3/16,13.66%,RIF1;SMCHD1;CGAS
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2604064160663104,0.6373974430953258,0.8916030534351145,0.9953402506204048,1.0,7/27,18.32%,ETNK1;SELENOI;ABHD4;NAAA;LPIN2;PLA2G15;CEPT1
prerank,gene silencing by miRNA (GO:0035195),0.25607833809466835,0.6357939846110058,0.9175108538350217,0.9963352404072008,1.0,8/32,17.88%,TNRC6C;MOV10;CNOT7;ZC3H7A;PUM2;RAN;PUM1;TNRC6A
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.27236977390554157,0.6355349596812672,0.8695652173913043,0.9957202961810777,1.0,5/22,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GOLGA7;ZDHHC7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.27236977390554157,0.6355349596812672,0.8695652173913043,0.9957202961810777,1.0,5/22,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GOLGA7;ZDHHC7
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.25576430756400337,0.6353794086607708,0.9155145929339478,0.9954260531914418,1.0,8/29,15.55%,MNAT1;ERCC3;RPA1;XPA;CHD1L;CUL4A;RAD23B;XPC
prerank,protein import into peroxisome matrix (GO:0016558),-0.2633294024488735,-0.6349394119223671,0.8968824940047961,0.9958794067710669,1.0,2/12,8.79%,PEX5L;PEX6
prerank,interstrand cross-link repair (GO:0036297),0.23800372715123383,0.6348981319291244,0.9375866851595007,0.9954064706068866,1.0,11/53,17.80%,VCP;FAAP24;RNF168;ERCC1;RPA1;RAD51AP1;FANCM;XPA;CENPX;USP1;MCM9
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.3102835010900316,0.6346190989071581,0.8700361010830325,0.9952260682990386,1.0,3/10,15.16%,TSKU;PLS1;IFT88
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.2858413944218657,0.6344138479482521,0.8924558587479936,0.9949806440727517,1.0,2/18,5.51%,ITGB1;GOLPH3
prerank,negative regulation of viral release from host cell (GO:1902187),0.2981952478515281,0.6344074787756462,0.8929219600725953,0.9945608321647758,1.0,5/13,26.96%,TRIM26;PML;TRIM35;MID2;TRIM28
prerank,synaptic vesicle localization (GO:0097479),-0.2525519476719371,-0.6341139136706535,0.9195121951219513,0.9955411166806655,1.0,5/13,25.16%,KIF5C;RAB27A;NLGN1;SNAPIN;CDK5
prerank,histone monoubiquitination (GO:0010390),0.25945075104610665,0.6339376991598422,0.9086687306501547,0.9945316673272973,1.0,9/24,26.06%,RNF2;CTR9;RNF168;PAF1;PCGF1;LEO1;WAC;RING1;CUL4B
prerank,autophagosome maturation (GO:0097352),0.25514665821158944,0.6333082926574296,0.8942857142857142,0.9946669948300881,1.0,5/32,13.64%,WIPI2;VCP;LIX1;TSG101;VIPAS39
prerank,defense response to fungus (GO:0050832),0.27818335638534725,0.6331715156609631,0.8707482993197279,0.9943484877244391,1.0,4/17,19.82%,BCL10;FAM3A;CLEC6A;RNASE7
prerank,cellular response to virus (GO:0098586),0.2562590205592954,0.6327152012508842,0.8954344624447718,0.9943285559496813,1.0,11/30,27.66%,VWCE;CHUK;LGALS8;GBF1;FMR1;IFIH1;MAPK14;IRF3;IL6;ZC3H12A;ARF1
prerank,DNA replication checkpoint signaling (GO:0000076),0.28412658545774194,0.6319398468439331,0.8805460750853242,0.9945769133638179,1.0,16/16,71.62%,RAD17;CLSPN;RAD9B;DNA2;ORC1;TIPIN;TIMELESS;CDC45;RAD9A;CDT1;NAE1;TOPBP1;HUS1;TICRR;CDC6;HUS1B
prerank,mitotic sister chromatid segregation (GO:0000070),0.2163814656425673,0.6316258932003788,0.9647630619684082,0.9944273710213886,1.0,19/98,20.65%,SMC4;PDCD6IP;KLHL22;BECN1;DIS3L2;KIF2C;RB1;CSNK2A2;CSNK2A1;PIBF1;SMC1A;RAN;NCAPH2;INO80;KIF18A;PINX1;TEX14;CHMP4A;CHMP4B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2521496047319043,0.6315027908906936,0.9159420289855073,0.9941112406795377,1.0,11/33,25.54%,TELO2;STN1;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,regulation of protein targeting to membrane (GO:0090313),0.265398775377534,0.6310719785684203,0.8838612368024132,0.9940654732881936,1.0,10/28,22.29%,KCNB1;DMTN;C2CD5;ITGB1BP1;TCAF2;CHP1;MIEF1;FIS1;PRNP;ITGAM
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.26740982960206633,-0.6306980651452075,0.9028436018957346,0.9968922146464303,1.0,5/12,27.98%,NINL;BICD2;CCDC68;CEP19;CCDC120
prerank,positive regulation of protein depolymerization (GO:1901881),-0.26238723235923733,-0.6299450424271714,0.9067599067599068,0.9964821179800016,1.0,2/11,8.53%,NES;PLEK
prerank,dicarboxylic acid catabolic process (GO:0043649),0.298535056649529,0.6297489900982883,0.8854337152209493,0.9947708398684546,1.0,2/13,6.89%,QPRT;ACOT8
prerank,regulation of neurogenesis (GO:0050767),-0.18203709222275055,-0.6290363730456767,0.9823321554770318,0.9962079830190064,1.0,14/55,22.59%,TGM2;B2M;NOTCH1;HEY2;FAIM;CX3CR1;APPL2;NUMBL;BHLHE41;HEY1;HES6;DLL1;TRIM32;YAP1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.29896555189510426,0.6288611124082644,0.8726655348047538,0.9950868119151342,1.0,4/12,23.81%,FDX1;AKR1B1;STARD3NL;TSPOAP1
prerank,mitochondrion distribution (GO:0048311),-0.2581152368008683,-0.6288220219666462,0.9128329297820823,0.9954643819621047,1.0,7/12,29.87%,LRRK2;MAPT;TRAK2;DNM1L;HAP1;CLUH;MTM1
prerank,peptidyl-asparagine modification (GO:0018196),0.2479571472815602,0.6279946702963978,0.9298245614035088,0.9954124579599504,1.0,4/31,12.04%,FUT8;UGGT2;ASGR2;DPM1
prerank,protein deneddylation (GO:0000338),0.30360599210900513,0.6261716502148372,0.881508078994614,0.9964983351740831,1.0,2/10,14.03%,COPS7B;COPS5
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.2964803332706533,0.6258139151203467,0.8729582577132486,0.9963795197558651,1.0,3/11,22.29%,MAVS;CAMK4;ITGAM
prerank,nucleus organization (GO:0006997),0.23338048341418502,0.6257801351906902,0.9403606102635229,0.9959857869728856,1.0,13/47,23.62%,NUP93;SUN3;PDCD6IP;PITPNB;TMEM170A;LEMD3;SYNE1;NUP54;CHMP4A;CHMP4B;NUP98;SUN2;USP36
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.24503482651924302,0.6255436669932765,0.9284649776453056,0.9957581061532342,1.0,5/39,7.95%,TTC7A;IP6K2;SOCS2;SMG1;IP6K3
prerank,negative regulation of hormone secretion (GO:0046888),0.3024695141274932,0.6250990032361987,0.8839779005524862,0.9957268934623008,1.0,1/10,6.93%,RAB11FIP3
prerank,cellular response to ionizing radiation (GO:0071479),0.23515923766136082,0.6250625543591714,0.9363762102351314,0.9953335071921928,1.0,16/47,26.21%,TANK;ATM;KDM1A;RAD51AP1;KDM4D;XRCC5;TSPYL5;WRN;TLK2;INO80;ATR;RAD9B;TMEM109;CDKN1A;MAPK14;LIG4
prerank,positive regulation of double-strand break repair (GO:2000781),0.24481573819640487,0.6240686359397042,0.9336043360433605,0.9957330777012628,1.0,8/39,16.35%,FUS;SHLD1;MRNIP;RAD51AP1;KDM4D;DDX11;FOXM1;PRKDC
prerank,mitochondrial fusion (GO:0008053),0.27718297151417026,0.6230003941200545,0.8868501529051988,0.9961934867588123,1.0,4/18,19.48%,SPG7;STOML2;MIEF1;FIS1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.2875296272897486,0.6229602802424555,0.8839137645107794,0.9957995414336135,1.0,3/13,21.30%,PVR;CYRIB;FADD
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.22339191164016103,-0.6224424206106345,0.9545454545454546,0.9985895985928386,1.0,2/23,8.27%,CALM1;NMT2
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2467427895906727,-0.6222618800106926,0.9378109452736318,0.9978290941200701,1.0,2/14,10.90%,CSF1;ATP6AP1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2548732434936008,0.622180901609685,0.9018126888217523,0.9959853292774894,1.0,12/27,30.64%,ZC3H12D;RNASE6;LACTB2;NYNRIN;RNASEH1;POP1;TOE1;ZC3H12A;PARN;NUDT16;PCF11;XRN1
prerank,regulation of protein acetylation (GO:1901983),0.29430264991269134,0.6218375981882005,0.8631051752921536,0.9958319006839587,1.0,2/12,9.16%,GSK3B;KAT5
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.22823365740513535,-0.6215058689594676,0.9073569482288828,0.9974259073573256,1.0,3/19,13.39%,APOE;CHRFAM7A;CHRNA7
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2741750276713395,0.6210330823908725,0.9244372990353698,0.996064398138606,1.0,2/18,9.16%,EZR;KAT5
prerank,membrane fusion (GO:0061025),0.2507810840543683,0.6208722608299054,0.9218523878437048,0.9957691941463634,1.0,9/33,19.08%,STX11;RABEP1;NSF;VAPA;SNAP23;RABIF;HUWE1;USO1;CHP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2487298305809095,0.6208361144975636,0.9212962962962963,0.9953801282568636,1.0,9/27,25.71%,CTPS2;RRM2;AK9;NUDT13;CMPK1;GSR;AK5;AK6;DTYMK
prerank,RNA stabilization (GO:0043489),0.2446511244893946,0.6197039630339456,0.915954415954416,0.9959467126033783,1.0,10/33,22.77%,GDNF;FUS;TENT5D;VIP;TAF15;TENT5C;PABPC1;TRDMT1;EIF4ENIF1;LARP1
prerank,histone H3-K4 methylation (GO:0051568),0.2556758728585163,0.6196960305436143,0.9076923076923077,0.9955295619554605,1.0,6/26,20.94%,CTR9;KMT2C;KMT2D;ASH2L;SETD1B;KMT2A
prerank,proteasome assembly (GO:0043248),0.2923646386927966,0.6194953273849927,0.8907014681892332,0.9952642669830539,1.0,3/11,19.48%,PSMG2;PSMG1;PSMD13
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.24622726433633432,0.6191693720147039,0.9314024390243902,0.9951043026758057,1.0,12/30,26.46%,KIF13A;GOLPH3;NSF;GGA2;GOLGA7;ARFRP1;SYS1;VAMP4;GOLGA4;BBS2;RAB10;SEC16A
prerank,regulation of receptor recycling (GO:0001919),0.2826040169059027,0.6183881655601053,0.9063545150501672,0.9953184098856499,1.0,2/16,8.34%,ANXA2;NSF
prerank,snRNA processing (GO:0016180),0.2841800685425899,0.618262024674373,0.8813008130081301,0.9950012447055674,1.0,7/16,31.08%,INTS3;INTS8;INTS9;TOE1;INTS1;INTS2;INTS12
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2621938341783355,0.6179377223065288,0.9077901430842608,0.9948347380293898,1.0,7/22,24.10%,TCERG1;SCAF8;THOC5;CDK12;CCNT1;LEO1;ALYREF
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21564030833271544,0.6178813439761448,0.9542566709021602,0.9944580839619318,1.0,13/72,14.44%,DXO;IHO1;RNASE6;ERCC3;ERCC1;RPA1;XPA;RFC5;CHD1L;CUL4A;EXD2;POLD3;DDX1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.24815295289498412,-0.617786716171548,0.9178743961352657,0.9988068658367982,1.0,10/15,41.19%,IQGAP2;TRIM27;ARPC3;ARPC5L;ARPC1A;ACTR2;ARPC4;JMY;ARPC5;MAGEL2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.18860648308372507,-0.6176061440755013,0.9728813559322034,0.9980388618861045,1.0,8/40,17.92%,GBP7;DEFA6;GBP4;PGLYRP1;RPL39;GBP2;TIRAP;GSDMD
prerank,chromosome condensation (GO:0030261),0.2440912898744472,0.6172074690676524,0.9273255813953488,0.9945595112779412,1.0,14/36,28.58%,SMC4;DFFB;RB1;CSNK2A2;CSNK2A1;ERN2;NCAPH2;CDK1;MCPH1;AIFM1;KMT5A;AKAP8L;NCAPD3;ACIN1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.26247436163492477,0.6169327357915672,0.8870703764320785,0.9943561713690505,1.0,9/22,29.85%,HNF1A;MED14;PSMC6;MED17;PSMC2;MED12;ESR1;PSMC4;MED13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.1705536183628778,-0.616594611103591,1.0,0.9977802602034359,1.0,18/70,24.09%,B2M;CYBA;CALR;TAP2;PSMB10;PDIA3;MFSD6;PSME2;PSMB3;LNPEP;NCF2;PSMB4;PSMB8;FCGR1A;PSMC5;PSME1;PSMA7;PSMD5
prerank,heme biosynthetic process (GO:0006783),0.26285010239025935,0.6160449695533866,0.941747572815534,0.9946564571405198,1.0,1/22,2.82%,ABCG2
prerank,neuron apoptotic process (GO:0051402),0.2754926790985235,0.6153035243884307,0.8932676518883416,0.9948218076855607,1.0,4/19,12.81%,CIT;DIABLO;BNIP3;TRPC5
prerank,regulation of neuroblast proliferation (GO:1902692),-0.23816283018907797,-0.6134893838420968,0.9181141439205955,0.9986758563187016,1.0,6/15,24.18%,LRRK2;CX3CR1;TAFA1;VEGFA;PTN;SMARCD3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.25305322530452273,0.6130446629796035,0.9192073170731707,0.9961871143861976,1.0,5/25,11.30%,GATA1;PER2;GATA3;NIBAN2;RB1
prerank,positive regulation of viral transcription (GO:0050434),0.24893208725880128,0.6127640487257608,0.9311424100156495,0.9959842867676897,1.0,5/25,18.62%,MDFIC;GTF2F2;DHX9;NELFE;POLR2H
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2351797860030436,0.6124904462189222,0.9348441926345609,0.9957654025587367,1.0,8/37,14.34%,ERCC3;ERCC1;RPA1;XPA;RFC5;CHD1L;CUL4A;POLD3
prerank,positive regulation of ATPase activity (GO:0032781),0.2354936459934603,0.6118421348626744,0.940771349862259,0.9958309816011386,1.0,3/41,5.80%,ATP1B1;TOR1AIP1;PLSCR1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2251256332040407,0.6114769223734562,0.9621109607577808,0.9956981054825036,1.0,8/51,14.20%,ISL1;RIPK2;TLR6;TLR4;IL16;CD36;STAT3;TRIM16
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2604152836972039,0.6113528275943128,0.8954758190327613,0.9953695828644223,1.0,6/23,24.24%,SAMM50;MOAP1;HSPA4;TIMM10B;AGK;TIMM29
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2685477690028253,-0.6112100991391417,0.9074550128534704,0.9991276957292279,1.0,1/10,8.99%,PRKAR1A
prerank,positive regulation of sodium ion transport (GO:0010765),-0.2530649600523514,-0.6111350951196198,0.9121951219512195,0.9982937979500277,1.0,5/12,26.19%,ANK3;NOS1;SCN3B;SCN4B;SCN1B
prerank,positive regulation of macroautophagy (GO:0016239),0.23127648118290292,0.6108321559002835,0.944141689373297,0.9953457204608279,1.0,14/48,25.00%,ADRB2;RAB3GAP2;LRSAM1;SMCR8;BNIP3;VPS13D;PAFAH1B2;FYCO1;SPTLC1;SH3GLB1;LARP1;WAC;SPTLC2;GNAI3
prerank,phagosome-lysosome fusion (GO:0090385),-0.2682715460937383,-0.6101449057126219,0.9101123595505618,0.9979811193813807,1.0,2/10,8.88%,SYT7;ARL8B
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.29690044176610886,0.6101211622465239,0.896797153024911,0.995449291068567,1.0,2/11,12.11%,GATA4;REST
prerank,midbody abscission (GO:0061952),-0.23095683610265538,-0.6096503946870228,0.9201030927835051,0.9974021751245489,1.0,8/17,30.47%,CHMP1A;CHMP4C;CHMP7;CEP55;CHMP1B;CHMP2B;KIF20A;VPS4A
prerank,chromatin disassembly (GO:0031498),-0.25098304414582373,-0.6088549116851302,0.9516539440203562,0.9960817859213871,1.0,8/14,35.86%,SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.25098304414582373,-0.6088549116851302,0.9516539440203562,0.9960817859213871,1.0,8/14,35.86%,SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3019914871169016,0.607476975862121,0.885036496350365,0.9969737505845951,1.0,2/11,13.73%,KAT5;FOXM1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.26090253445825506,-0.6068794327050254,0.9330143540669856,0.99624054536473,1.0,7/11,41.35%,IL6ST;STAT1;CANX;IL27RA;IL12A;JAK1;EBI3
prerank,protein prenylation (GO:0018342),-0.270911261598194,-0.6063631966450329,0.9116279069767442,0.9956407984731522,1.0,1/10,5.81%,PTAR1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.25231815531503166,0.6061775745685339,0.9152542372881356,0.9975317046444067,1.0,9/25,23.20%,PRPF3;SF3B1;SRRM1;SCAF11;TRA2B;GEMIN2;PRPF6;TXNL4A;SNRNP40
prerank,rRNA 3'-end processing (GO:0031125),0.29357978556571296,0.6054308749342673,0.91005291005291,0.9975989057581223,1.0,2/10,9.85%,ERI3;EXOSC7
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.22004897471673684,-0.6051524972897272,0.9643835616438357,0.9954183643834273,1.0,2/19,5.56%,UGDH;SLC35D1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2872049600347828,0.6050960328195056,0.8907849829351536,0.9974222865369408,1.0,5/11,24.49%,PAF1;ZFP36L1;LEO1;NCBP2;AHCYL1
prerank,mRNA splice site selection (GO:0006376),0.2420659475855322,0.6049103051377345,0.9401197604790419,0.9971365285388714,1.0,9/30,21.32%,LUC7L2;CELF1;SRSF5;SRSF6;SRSF12;SFSWAP;NOL3;LUC7L;PSIP1
prerank,ncRNA catabolic process (GO:0034661),0.24407345502492406,0.6048796634252254,0.922173274596182,0.9967409185204972,1.0,12/28,31.14%,ZCCHC8;EXOSC7;DIS3L2;ERN2;EXOSC5;EXOSC4;POP1;NUDT16L1;PARN;NUDT16;XRN1;DEDD2
prerank,regulation of receptor internalization (GO:0002090),0.23126312319432335,0.6044127866572467,0.9469026548672567,0.9966545297729729,1.0,11/35,22.40%,LRPAP1;MKLN1;RIN3;TBC1D5;ANKRD13D;ATXN2;ANGPT1;DLG4;SFRP4;EGF;FMR1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2547695293925887,-0.603818066694684,0.9223529411764706,0.9952800455092746,1.0,3/12,17.98%,PRPSAP2;PRPS1;PRPS1L1
prerank,regulation of store-operated calcium entry (GO:2001256),0.29840495007589274,0.6033762382119519,0.8845470692717584,0.9969861243640383,1.0,4/10,18.49%,HOMER2;SLC8B1;HOMER1;GRAMD2A
prerank,microtubule anchoring (GO:0034453),-0.25285733383485337,-0.6032646560883163,0.9330143540669856,0.9946935634422053,1.0,8/12,44.51%,CLASP2;BICD2;PEX14;DAG1;SAXO2;BCCIP;BICD1;SAXO1
prerank,RNA methylation (GO:0001510),0.2158662162503027,0.6024874314977082,0.9553571428571429,0.9972074890019734,1.0,16/60,23.67%,TRMT13;METTL6;METTL1;MRM2;MTO1;GTPBP3;NSUN4;ZCCHC4;NOP2;MEPCE;TRDMT1;ALKBH8;TRMT61A;TRMT12;FTSJ3;PCIF1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2369515937332884,0.6023192836708394,0.9531722054380665,0.9969198708635763,1.0,5/34,12.15%,IL10;CLCF1;TNFRSF4;GPI;TNFRSF14
prerank,tRNA aminoacylation (GO:0043039),0.2340819262480789,0.6017676935841002,0.9480337078651685,0.9968988745589296,1.0,2/37,7.64%,WARS2;YARS1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2401398000565703,0.6012831900860902,0.9346504559270516,0.9968248960112219,1.0,8/30,20.81%,MVD;FDPS;LBR;EBP;FDFT1;HMGCR;ARV1;DHCR7
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.30891401692103926,0.6006890956037663,0.8951310861423221,0.9968204858307271,1.0,2/10,13.73%,KAT5;FOXM1
prerank,P-body assembly (GO:0033962),0.288135593220339,0.5996432648682528,0.8877374784110535,0.997148640418728,1.0,12/12,71.21%,EDC3;ATXN2;EIF4ENIF1;DYNC1H1;LSM4;LSM14A;RC3H1;LIMD1;LSM3;DDX6;PATL1;PATL2
prerank,striated muscle cell differentiation (GO:0051146),0.26877205864760495,0.5991561837602142,0.8930921052631579,0.9970560176764957,1.0,5/16,18.13%,AKAP13;SKI;KDM6B;MYEF2;SDC1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.24066899164442856,-0.5987849708494937,0.9397590361445783,0.9961408796859531,1.0,7/14,33.73%,ABCG1;APH1B;PSENEN;ADAM19;APH1A;NCSTN;ABCA7
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2499044978451168,0.5987667474757833,0.9228395061728395,0.9969266456549549,1.0,4/23,18.17%,PLA2G4F;ABHD4;PLA2G4A;MBOAT1
prerank,chromatin remodeling at centromere (GO:0031055),-0.19583905387162048,-0.5964095039704459,0.9836065573770492,0.9964799871207891,1.0,16/31,39.48%,RUVBL1;CENPP;KNL1;MIS18BP1;HELLS;CENPI;CENPV;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,mitotic cytokinetic process (GO:1902410),-0.21800210753186972,-0.5963278389491402,0.9498680738786279,0.9956553484090734,1.0,9/20,30.47%,KLHDC8B;CHMP1A;CHMP4C;CHMP7;CEP55;CHMP1B;CHMP2B;KIF20A;VPS4A
prerank,presynaptic endocytosis (GO:0140238),0.24801112407562004,0.5947010541223909,0.9159935379644588,0.9992611846712597,1.0,2/24,4.30%,STON1;SYT8
prerank,regulation of microtubule depolymerization (GO:0031114),0.23839651293575886,0.5944557123379602,0.9282371294851794,0.9990159633625687,1.0,4/25,12.94%,HDGFL3;FGF13;SPEF1;MAP1B
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.25594543842048834,0.5929195868309663,0.9230769230769231,0.999584766577474,1.0,9/24,22.29%,KCNB1;C2CD5;ITGB1BP1;TCAF2;CHP1;MIEF1;FIS1;PRNP;ITGAM
prerank,mitochondrial genome maintenance (GO:0000002),0.28609772114530524,0.5927813563138634,0.8953687821612349,0.9992559421503053,1.0,5/11,21.86%,MEF2A;TOP3A;LONP1;SLC25A36;MPV17
prerank,regulation of cell aging (GO:0090342),-0.2509184321678385,-0.5908022218828483,0.9477272727272728,0.9974974236349027,1.0,5/11,22.31%,NUAK1;VASH1;MIF;ING2;NEK4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2577356636619584,0.5897070251123172,0.9151234567901234,1.0,1.0,8/18,29.63%,WDR43;EIF2AK3;WDR75;FLNA;SIRT7;HEATR1;ERBB2;UTP15
prerank,negative regulation of protein transport (GO:0051224),0.24628088255729347,0.5894664915276776,0.9564541213063764,1.0,1.0,4/25,12.65%,WWP2;DRD3;CSK;SNX12
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2594536093063745,0.5894043149111577,0.9250814332247557,1.0,1.0,3/18,13.66%,COA8;COX16;SCO2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2846631040742715,0.5892298848095188,0.9241379310344827,0.9998899591688968,1.0,2/12,6.10%,NR4A3;IRS1
prerank,protein lipidation (GO:0006497),0.2141888527866293,0.5890648192381523,0.9741935483870968,0.9995747631513462,1.0,14/59,19.16%,WIPI2;PIGB;PIGL;PIGU;PIGN;ZDHHC23;DPM1;ZDHHC5;ZDHHC15;GLUL;PIGH;PGAP2;ZDHHC7;ATG7
prerank,mitotic metaphase plate congression (GO:0007080),0.21637440388402057,0.5864273359354153,0.9740437158469946,1.0,1.0,16/51,29.13%,PDCD6IP;BECN1;RMDN1;KIF2C;PIBF1;KIF18A;PINX1;CHMP4A;CHMP4B;CENPC;SPDL1;CHAMP1;CHMP5;KIF14;NUDC;CUL3
prerank,replication fork processing (GO:0031297),0.23092836689783822,0.5859997301339719,0.9524475524475524,1.0,1.0,10/38,21.73%,BOD1L1;BRCA2;FANCM;EXD2;DDX11;CENPX;ATRX;WRN;MRE11;ATR
prerank,positive regulation of secretion (GO:0051047),0.28633326998162545,0.5852175591507688,0.9032815198618307,1.0,1.0,1/11,5.15%,ACSL3
prerank,alpha-amino acid metabolic process (GO:1901605),0.2219165521914104,0.5849966460197231,0.9701280227596017,1.0,1.0,14/45,25.87%,HNF4A;PYCR1;GADL1;KYAT1;GNMT;GLUL;MTHFR;SLC25A12;OAT;GOT1;FOLH1;GLS2;MTRR;DPEP1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.21101523109236067,-0.5841574688697961,0.9575596816976127,0.9997594697484474,1.0,6/20,24.58%,AGO1;AGO4;TARBP2;SPOUT1;MRPL44;ZC3H7B
prerank,phagolysosome assembly (GO:0001845),-0.24193351842498956,-0.5838438342475354,0.9440559440559441,0.9990398327839825,1.0,6/12,32.30%,SYT7;ARL8B;RAB14;RAB20;PLA2G5;RAB39A
prerank,establishment of spindle localization (GO:0051293),0.271388611323453,0.5838288560886041,0.9003378378378378,1.0,1.0,1/14,4.42%,TLE6
prerank,spliceosomal snRNP assembly (GO:0000387),0.22158868173836802,0.5837370934465664,0.9631811487481591,1.0,1.0,14/38,28.52%,PRPF3;SRSF12;LSM2;SNRPD3;USP4;GEMIN8;GEMIN2;PRPF6;SNRPD2;SNRPD1;SNRPE;COIL;SART1;PRPF31
prerank,positive regulation of interleukin-10 production (GO:0032733),0.2332172866464597,0.5834695364871356,0.9375,1.0,1.0,4/30,12.58%,CD46;TLR4;STAT3;PIBF1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.266728355461916,0.582766979491487,0.9103690685413005,1.0,1.0,4/13,20.30%,ALG13;ALG14;ALG9;ALG3
prerank,RNA transport (GO:0050658),0.20527890773362897,0.5826080447352172,0.9757653061224489,0.9998470191076105,1.0,26/71,27.49%,TGFBR2;U2AF1L4;CASC3;SRSF5;NUP188;SRSF6;NXF1;SRRM1;THOC2;RBM8A;SRSF11;THOC5;ZFP36L1;ATXN2;ZC3H11A;CHTOP;RAE1;FMR1;SIDT2;ALYREF;NCBP2;UPF3B;SRSF7;XPO5;NUP153;PNPT1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.23658361306964884,-0.5803976307653004,0.9454976303317536,0.999685979468851,1.0,1/12,4.92%,APOBEC1
prerank,regulation of ATP metabolic process (GO:1903578),0.21000150444696014,0.5801429924196271,0.9701897018970189,1.0,1.0,14/54,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;COX7A1;ZBTB7A;NUP107;AAAS;FIS1;RAE1;NUP54;NUP98;EIF6
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.21395646891912512,-0.580119229787255,0.9485294117647058,0.9989377338127228,1.0,4/17,24.95%,MMGT1;EMC3;GET4;EMC8
prerank,stress granule assembly (GO:0034063),0.24871949601515866,0.5784705552774322,0.9245585874799358,1.0,1.0,8/20,28.55%,PRRC2C;YTHDF3;ATXN2;YTHDF2;CSDE1;YTHDF1;CIRBP;DYNC1H1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2560938452897109,-0.5758190491357243,0.9325842696629213,0.9999132393344927,1.0,1/10,8.02%,MALT1
prerank,nucleic acid-templated transcription (GO:0097659),0.216225805026167,0.5755614614907698,0.9735376044568245,1.0,1.0,9/42,20.19%,MEF2A;NR4A2;BAZ2A;PPP5C;THAP1;EPC1;CREBL2;POLR2H;HOXD3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.21635749179508681,0.5753231614484006,0.9630642954856361,1.0,1.0,8/45,16.70%,ISL1;RIPK2;TLR6;TLR4;CD36;STAT3;TRIM16;MYD88
prerank,protein targeting (GO:0006605),0.1906083171416032,0.5751865060816397,0.9918032786885246,1.0,1.0,26/118,19.91%,ZDHHC11;GIPC1;LTBP2;AP4E1;HACL1;ATG3;SEC63;HPS4;AP4B1;PARD3;ZDHHC23;DNAJC19;PITRM1;ZDHHC15;TIMM17B;GOLGA7;CHM;VPS37A;AP4M1;ZDHHC7;PEX12;TIMM10B;FIS1;PEX16;RABGEF1;LONP2
prerank,isotype switching (GO:0045190),0.2761411647229851,0.5734347375511661,0.9150779896013865,1.0,1.0,1/10,9.20%,RNF168
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.22191953817602061,0.5734243549062568,0.9448373408769448,1.0,1.0,8/40,17.80%,BOD1L1;FANCM;EXD2;DDX11;CENPX;ATRX;WRN;MCM9
prerank,steroid catabolic process (GO:0006706),0.28094074598713037,0.573346760727234,0.9059040590405905,1.0,1.0,2/10,10.46%,CYP27B1;CYP19A1
prerank,mitotic recombination (GO:0006312),0.2632574505969671,0.5732103986365645,0.9208754208754208,1.0,1.0,4/15,18.20%,RAD52;ERCC1;NSMCE2;SMC5
prerank,synaptonemal complex assembly (GO:0007130),0.2516749277627881,0.5719352322023186,0.927487352445194,1.0,1.0,1/15,5.75%,P3H4
prerank,synaptonemal complex organization (GO:0070193),0.2516749277627881,0.5719352322023186,0.927487352445194,1.0,1.0,1/15,5.75%,P3H4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.26036093993211834,0.5717664756197067,0.9207419898819561,1.0,1.0,4/14,23.16%,ZNHIT3;WDR12;DDX18;FTSJ3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.2368324532002143,-0.5716268083952962,0.9564164648910412,1.0,1.0,2/13,6.29%,NR1H3;AQP11
prerank,regulation of DNA damage checkpoint (GO:2000001),0.27942419753513914,0.5711565951813709,0.9269162210338681,1.0,1.0,4/10,27.84%,THOC5;FEM1B;WDR76;RFWD3
prerank,regulation of interleukin-6 production (GO:0032675),0.19256374007999932,0.5689212019006554,0.9975786924939467,1.0,1.0,11/96,12.38%,LBP;ISL1;IL10;MAVS;TLR6;IL17RA;BCL10;RAB7B;TLR4;IL16;STAT3
prerank,covalent chromatin modification (GO:0016569),-0.2255818244422916,-0.5685336906374294,0.946949602122016,1.0,1.0,3/14,19.51%,MBD2;PARK7;HELLS
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.23774509594640317,0.5679893300584622,0.9503205128205128,1.0,1.0,1/24,2.82%,ABCG2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.2633465790533485,0.5675767488640229,0.9377162629757786,1.0,1.0,2/13,7.71%,PLXNA2;NRP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22882373984823973,0.5668591373291001,0.9640062597809077,1.0,1.0,2/29,6.99%,P3H4;IHO1
prerank,protein targeting to mitochondrion (GO:0006626),0.2113132952405284,0.56676966170811,0.9679572763684913,1.0,1.0,17/52,26.83%,SAMM50;PMPCB;DNAJC19;IMMP1L;PITRM1;TIMM17B;HSPA4;TIMM10B;FIS1;AGK;BCAP31;AIFM1;TIMM29;TOMM34;TIMM23;TOMM20;GRPEL2
prerank,positive regulation of cellular respiration (GO:1901857),0.27100035885745,0.566468837767335,0.9281867145421903,1.0,1.0,1/11,4.82%,VCP
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.23263456478348432,0.5657929448131213,0.9479674796747968,1.0,1.0,5/23,19.40%,PLK3;CHEK1;INTS3;PRCC;CHFR
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2569859970704635,0.5653982801338571,0.9368421052631579,1.0,1.0,7/16,29.56%,SRSF12;SFSWAP;PSIP1;NCBP2;SART1;SNRNP200;WBP4
prerank,cellular senescence (GO:0090398),0.2264219809360458,0.5652557932588043,0.9512555391432792,1.0,1.0,5/27,18.20%,PRKCD;ECRG4;NSMCE2;PML;SMC5
prerank,sensory perception of pain (GO:0019233),-0.2009255550404826,-0.5634308764005624,0.9690140845070423,1.0,1.0,1/21,1.34%,RETREG1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2693473993599329,0.5626601427112442,0.9210526315789473,1.0,1.0,3/12,17.86%,CHEK2;RAD17;CLSPN
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.24754971396555944,-0.5618903677318193,0.9629629629629629,1.0,1.0,3/11,25.57%,NOS1AP;TREM2;AKAP6
prerank,protein destabilization (GO:0031648),0.2249659692661042,0.56171590798354,0.9691629955947136,1.0,1.0,4/32,7.81%,GSN;EP300;FBXW11;CREBBP
prerank,regulation of primary metabolic process (GO:0080090),0.18473005138836554,0.560441905652484,0.9953488372093023,1.0,1.0,34/126,24.53%,TNFAIP8L3;CHD9;HNF4A;TBL1X;SCD;CREBBP;MVD;FDPS;NFYA;RXRA;PLPP1;FDFT1;CARM1;PSMC6;IRS2;PSMD8;HMGCR;ADIPOR1;AZIN1;LACTB;PSMB1;PSMD13;LDLR;PSMD1;PSMD7;PSMA8;DHCR7;PSMD3;PSMD2;PSMC2;PPARG;PSMB2;HMGCS1;NCOR1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21469609668602635,-0.5596418018449826,0.9548532731376975,1.0,1.0,4/15,25.80%,ERN1;RTRAF;TSEN15;TSEN34
prerank,2-oxoglutarate metabolic process (GO:0006103),0.26234133213903704,0.5594044132722414,0.9395973154362416,1.0,1.0,3/13,19.90%,D2HGDH;OGDH;GOT1
prerank,transferrin transport (GO:0033572),0.221968632001515,0.5593855074242072,0.956268221574344,1.0,1.0,8/33,20.05%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;MCOLN1;ATP6V1G1;HFE
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.23041772928577597,0.5585367031024197,0.9557926829268293,1.0,1.0,5/26,14.76%,ANAPC5;CDC16;RB1;NSMCE2;RIOK2
prerank,cellular response to interferon-beta (GO:0035458),0.2533314320191237,0.5584374357180515,0.9347079037800687,1.0,1.0,2/14,11.24%,ACOD1;IRF1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2643491120108874,0.5583655739994123,0.9312714776632303,1.0,1.0,4/12,25.11%,RMDN1;KIF2C;CENPC;CHAMP1
prerank,mucosal immune response (GO:0002385),-0.21406493193854298,-0.5578856970899762,0.972972972972973,1.0,1.0,2/15,10.80%,DEFA6;RPL39
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.27037010031606884,0.5571290176170477,0.9387387387387387,1.0,1.0,4/12,27.84%,PLK3;PRKDC;WAC;RFWD3
prerank,rRNA modification (GO:0000154),-0.19771142197518785,-0.5568402333216174,0.9801136363636364,1.0,1.0,12/21,39.98%,TSR3;THUMPD1;DIMT1;MTERF4;NOP10;TFB1M;TFB2M;DKC1;NHP2;NAT10;FBLL1;TRMT112
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2241748167960417,0.5511458719489991,0.9703703703703703,1.0,1.0,5/29,17.46%,ABL1;DCUN1D4;UBE2N;FEM1B;FEM1A
prerank,cellular response to dsRNA (GO:0071359),0.2491404715552216,0.550176339254197,0.9435215946843853,1.0,1.0,5/15,26.66%,MAVS;DHX9;MUL1;IFIH1;ZCCHC3
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2080963118957289,-0.5498915212756191,0.9629629629629629,1.0,1.0,1/16,2.87%,TOP2B
prerank,regulation of protein metabolic process (GO:0051246),0.20956252456257013,0.5498855450793971,0.9781659388646288,1.0,1.0,12/44,21.61%,KLF4;CHEK2;LTBP4;PARL;MAP2K5;SPOP;FAF1;MAPK8;WFS1;LDLR;HGS;TRAF3
prerank,nuclear membrane organization (GO:0071763),0.23810567893636153,0.5494275925809488,0.9537480063795853,1.0,1.0,8/19,29.47%,TOR1AIP1;DCTN1;CHMP4B;TOR1B;AKAP8L;TARDBP;NSFL1C;TMEM43
prerank,regulation of T cell activation (GO:0050863),0.20490975693140495,0.5473259637955605,0.9707927677329624,1.0,1.0,4/42,8.32%,ABL1;TNFSF11;KAT2A;TNFRSF1B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.26419704079253054,0.5472064651938605,0.950354609929078,1.0,1.0,1/11,8.83%,CBFB
prerank,protein localization to kinetochore (GO:0034501),-0.22143395278754396,-0.5464122141638251,0.9533169533169533,1.0,1.0,14/14,77.88%,KNL1;TTK;IK;AURKB;MIS12;MTBP;ZW10;RCC2;CENPT;BUB3;CHAMP1;ZWILCH;SPDL1;CDK1
prerank,negative regulation of viral genome replication (GO:0045071),0.2056496785936105,0.5462651832906282,0.9826338639652678,1.0,1.0,10/40,24.12%,SLPI;PLSCR1;MAVS;SRPK1;RESF1;TNIP1;MPHOSPH8;N4BP1;TASOR;IFIH1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.22479119430302433,0.5457371084017466,0.9657738095238095,1.0,1.0,4/30,12.58%,PRKCD;PTPN2;DMTN;PIBF1
prerank,regulation of response to interferon-gamma (GO:0060330),0.252982717105023,0.5455885302339969,0.9534883720930233,1.0,1.0,5/14,24.91%,PTPN2;PIAS1;SUMO1;IFNGR2;IFNGR1
prerank,RNA biosynthetic process (GO:0032774),-0.17415166995496395,-0.5441805628956935,0.9936305732484076,1.0,1.0,6/31,20.93%,SETX;TBPL1;POLA2;TAF10;TAF6;TCEA2
prerank,primary miRNA processing (GO:0031053),0.2689625168940008,0.5432393911144436,0.9511278195488722,1.0,1.0,4/10,22.94%,PUS10;DROSHA;SRRT;SMAD2
prerank,DNA replication initiation (GO:0006270),0.21030952627068117,0.543181984731841,0.9684361549497847,1.0,1.0,8/37,21.94%,MCM7;NOC3L;RPA1;LRWD1;ORC5;POLA1;PRIM2;MCM6
prerank,negative regulation of defense response to virus (GO:0050687),0.26504291432413474,0.5418152118417253,0.9345132743362832,1.0,1.0,6/10,32.33%,TRAF3IP1;RNF26;MUL1;ILRUN;PPM1B;ITCH
prerank,synaptic vesicle transport (GO:0048489),-0.22688365943308703,-0.5407040121229781,0.9616306954436451,1.0,1.0,4/11,25.16%,KIF5C;RAB27A;SNAPIN;CDK5
prerank,regulation of mitotic spindle assembly (GO:1901673),0.23414606295435908,0.5386906890740158,0.9608177172061328,1.0,1.0,6/19,27.02%,PDCD6IP;CEP97;CHMP4B;HSPA1A;CCSAP;CHMP5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.17667049745061236,-0.5376456468328757,0.9969788519637462,1.0,1.0,7/29,20.26%,CNOT8;EXOSC8;LSM1;DCP1B;DCP2;EXOSC3;HBS1L
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.18895097748575204,-0.5376277423416147,0.9746478873239437,1.0,1.0,5/22,21.53%,APOD;LRRK2;SP100;PARK7;INPP5K
prerank,pigment granule transport (GO:0051904),0.238078904423411,0.5361290158001365,0.9579967689822294,1.0,1.0,3/18,15.41%,MLPH;RAB27B;RAB17
prerank,melanosome transport (GO:0032402),0.238078904423411,0.5361290158001365,0.9579967689822294,1.0,1.0,3/18,15.41%,MLPH;RAB27B;RAB17
prerank,regulation of spindle assembly (GO:0090169),0.22130204258751146,0.5356320824847766,0.9597423510466989,1.0,1.0,11/25,31.78%,PDCD6IP;CEP97;CHMP4B;GPSM2;HSPA1A;CCSAP;CHMP5;DYNC1H1;RNF4;EML3;NUMA1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19950836563798627,0.5355122067680419,0.9858557284299858,1.0,1.0,12/48,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,snRNA 3'-end processing (GO:0034472),0.2356823747670029,0.535297545527494,0.94,1.0,1.0,7/19,28.61%,EXOSC7;INTS8;EXOSC5;EXOSC4;TOE1;INTS1;INTS2
prerank,regulation of cytoplasmic translation (GO:2000765),0.2498043243469327,0.5350112789233533,0.956989247311828,1.0,1.0,1/14,3.72%,YBX3
prerank,cholesterol biosynthetic process (GO:0006695),0.2125880816992107,0.5350008680933219,0.9682779456193353,1.0,1.0,8/31,20.81%,MVD;FDPS;LBR;EBP;FDFT1;HMGCR;ARV1;DHCR7
prerank,pinocytosis (GO:0006907),0.26079588250062774,0.534865149966191,0.9552772808586762,1.0,1.0,10/10,73.94%,MAPKAPK2;SNX33;CARMIL1;RAB34;MAPKAPK3;PPT1;PYCARD;SNX5;AHSG;DOCK2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.1829385900053203,0.5346146957480046,0.9937810945273632,1.0,1.0,14/83,16.33%,INHBA;PLK3;RRM2;CDKN1B;MNAT1;E2F3;PIM2;RB1;ACVR1;CUL4A;CDKN2D;CDK18;CDKN3;GSPT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22060948547040293,-0.5338516345755747,0.9647887323943662,1.0,1.0,1/12,6.99%,PRKCQ
prerank,positive regulation of chromatin organization (GO:1905269),0.24843250986152932,0.5316609701015282,0.9546247818499127,1.0,1.0,3/12,18.45%,ATRX;UBE2N;ACD
prerank,telomere maintenance via recombination (GO:0000722),0.2564150165637901,0.5309123362485526,0.9431616341030196,1.0,1.0,3/11,18.20%,ERCC1;NSMCE2;SMC5
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.18679806634440183,-0.5283789272853656,0.9731182795698925,1.0,1.0,8/24,27.57%,RPS27A;UBC;UBB;POLD1;RFC2;LIG1;RPA3;POLD2
prerank,indolalkylamine catabolic process (GO:0046218),0.2563550943378615,0.5259836619877578,0.9322638146167558,1.0,1.0,1/10,9.92%,KYAT1
prerank,protein localization to condensed chromosome (GO:1903083),-0.22140615191462648,-0.5254870406084101,0.9808153477218226,1.0,1.0,12/12,77.88%,KNL1;TTK;IK;AURKB;MIS12;MTBP;ZW10;BUB3;CHAMP1;ZWILCH;SPDL1;CDK1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19026892210108326,0.5247656119209371,0.9867724867724867,1.0,1.0,7/50,16.57%,CCNA2;CDKN1B;MNAT1;GTPBP4;CDKN2D;CDKN3;CCND3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.24662018198135446,0.5242234671163135,0.9686956521739131,1.0,1.0,1/12,5.12%,TRPM4
prerank,telomere maintenance (GO:0000723),0.19311407193842758,0.523844228758452,0.990578734858681,1.0,1.0,14/50,22.37%,ATM;STN1;RPA1;XRCC5;NSMCE2;POLD3;PRKDC;WRN;NBN;SMC5;ACD;MRE11;ATR;APEX1
prerank,telomere organization (GO:0032200),0.19883761726553079,0.5233489862442421,0.9902370990237099,1.0,1.0,12/43,22.37%,ATM;STN1;RPA1;XRCC5;POLD3;PRKDC;WRN;NBN;ACD;MRE11;ATR;APEX1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.25086755991711424,0.5225494432748943,0.9285714285714286,1.0,1.0,7/12,31.13%,TGFB1;PPARG;NCOR1;TERT;ESR1;ZC3H12A;NCOR2
prerank,regulation of viral release from host cell (GO:1902186),0.22100405351928665,0.5210214386515314,0.9642276422764228,1.0,1.0,4/21,15.85%,TRIM26;TRIM25;TSG101;PML
prerank,regulation of endocytic recycling (GO:2001135),0.2624836486826751,0.52034468069787,0.9411764705882353,1.0,1.0,4/11,22.63%,EHD1;ATP9A;EHD2;ARHGAP1
prerank,protein localization to lysosome (GO:0061462),0.20526974878116275,0.5203302122879246,0.9772382397572079,1.0,1.0,1/28,1.91%,NEDD4
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.1923114822245392,-0.5198457756952997,0.9901234567901235,1.0,1.0,3/18,12.56%,RPS13;TMBIM6;PTBP2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.237832075245818,0.5188991276386323,0.9682274247491639,1.0,1.0,3/15,14.76%,CDC16;TACC3;RIOK2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.21352553168937488,0.5188469827767405,0.9766081871345029,1.0,1.0,10/29,25.54%,TELO2;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.24650997089685975,0.5178097728722911,0.9537366548042705,1.0,1.0,1/11,8.41%,PKD2L1
prerank,aminoglycan metabolic process (GO:0006022),0.2503178161962276,0.5165628960086789,0.9473684210526315,1.0,1.0,4/10,24.85%,B4GALT7;B3GALT6;XYLT1;CHST9
prerank,endosome organization (GO:0007032),0.19874621350898536,0.5165050278176646,0.9798561151079137,1.0,1.0,11/41,24.96%,EEA1;WASHC5;SQSTM1;HOOK2;RAB22A;TMCC1;RNF26;RILP;CORO1C;ANXA8;ANXA8L1
prerank,regulation of TOR signaling (GO:0032006),0.1844940943995953,0.5163076132311807,0.9934810951760105,1.0,1.0,11/67,16.13%,GOLPH3;SMCR8;DYRK3;SEC13;TELO2;MLST8;NPRL3;GPAT3;PRKAA1;MIOS;RRAGB
prerank,steroid metabolic process (GO:0008202),0.18202470646163096,0.5157222260207076,0.9986962190352021,1.0,1.0,9/72,16.53%,CYP1B1;SULT1A1;FDX1;CYP27B1;CYP19A1;FDFT1;NPC1;CYP39A1;SULT2B1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.19337049160282577,-0.5154719804738118,0.9768637532133676,1.0,1.0,1/16,3.62%,AHR
prerank,regulation of mitotic spindle organization (GO:0060236),0.20261554070446333,0.5145555848708913,0.9862804878048781,1.0,1.0,11/35,28.55%,PDCD6IP;TACC3;CEP97;RAE1;DCTN1;CHMP4B;GPSM2;HSPA1A;CCSAP;CHMP5;DYNC1H1
prerank,modulation by host of symbiont process (GO:0051851),0.20063359880515003,0.5106938285592718,0.9758308157099698,1.0,1.0,6/31,16.77%,EP300;JUN;SMARCA4;REST;SNW1;SAP30
prerank,positive regulation of tissue remodeling (GO:0034105),-0.22188652731281386,-0.5102136472296775,0.9632183908045977,1.0,1.0,1/10,9.17%,IL18
prerank,aromatic amino acid family metabolic process (GO:0009072),0.24758121717541037,0.509545050895263,0.941712204007286,1.0,1.0,2/10,14.85%,KYAT1;PCBD1
prerank,icosanoid biosynthetic process (GO:0046456),-0.22397331344015217,-0.5086537756801865,0.9702970297029703,1.0,1.0,5/10,31.51%,MGST3;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,T cell activation involved in immune response (GO:0002286),-0.2078401519904411,-0.5058110264213413,0.969047619047619,1.0,1.0,4/12,27.95%,MDK;CD74;LCP1;LILRB1
prerank,transcription by RNA polymerase III (GO:0006383),0.20722128653454583,0.5042711237365214,0.9722650231124808,1.0,1.0,11/27,28.45%,CRCP;POLR3GL;SNAPC5;SNAPC4;BRF1;ICE2;GTF3C2;SNAPC2;POLR3K;POLR3G;SNAPC1
prerank,negative regulation of T cell activation (GO:0050868),0.19671202081874578,0.5037119368520909,0.9897209985315712,1.0,1.0,5/35,16.15%,IL10;CD80;SDC4;CEBPB;LAX1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.24166809929457345,0.5036338489724917,0.9565217391304348,1.0,1.0,3/11,24.24%,TIMM10B;AGK;TIMM29
prerank,phosphate ion transmembrane transport (GO:0035435),0.2429658698044332,0.5024768324682614,0.9625,1.0,1.0,2/12,14.30%,SLC25A14;SLC20A1
prerank,lipoprotein transport (GO:0042953),0.24381272656242917,0.49904767593885185,0.953405017921147,1.0,1.0,2/10,13.93%,CD36;LRP1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.19306803964157582,-0.4981052725009679,0.980722891566265,1.0,1.0,3/15,23.67%,QDPR;GSTZ1;KYNU
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2311241984789576,0.49801519764155644,0.9725363489499192,1.0,1.0,2/13,9.13%,HES1;PIGU
prerank,glycine metabolic process (GO:0006544),0.23471437539234163,0.4980018285726147,0.9778156996587031,1.0,1.0,12/12,76.55%,GCAT;DLD;GCSH;AMT;SDSL;SDS;BAAT;RIDA;GLYAT;SHMT1;GLDC;SHMT2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.19722403680440667,0.4961466039047721,0.9882697947214076,1.0,1.0,8/31,22.32%,CNOT7;EXOSC7;DIS3L2;LSM2;EDC3;EXOSC5;EXOSC4;DCP1A
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.14450248599660143,-0.4938828717704423,1.0,1.0,1.0,53/53,85.60%,PPM1K;PSMB10;PSME2;OAZ1;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;PSMA5;PSMF1;OAZ3;PSMA2;ODC1;PSMB9;PSMA4;PSMD10;PSMA1;NQO1;PSMB5;PSMB11;BCKDK;PSMD4;PSMB6;PSMA3;PSMC1;PSMC3;BHMT;PSMD6;OAZ2;PSMB7;PSMD12;PSME3;PSME4;PSMD11;PSMC4;PSMD14;PSMB2;PSMC2;PSMD2;PSMD3;PSMA8;PSMD7;PSMD1;PSMD13;PSMB1;AZIN1;PSMD8;PSMC6
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2295720196152331,0.4932981690433676,0.964765100671141,1.0,1.0,7/14,30.02%,YBX3;MYD88;MAPKAPK2;ANGEL2;MAPK14;TARDBP;ZFP36
prerank,tryptophan catabolic process (GO:0006569),0.23570397338522375,0.49314686972482,0.9562937062937062,1.0,1.0,11/11,76.45%,KYAT1;HAAO;IL4I1;KMO;ACMSD;IDO1;TDO2;IDO2;AADAT;KYNU;AFMID
prerank,B cell mediated immunity (GO:0019724),-0.20857393924177756,-0.4925083509649767,0.9611872146118722,1.0,1.0,10/10,79.16%,CD74;FCGR2B;CARD9;SLA2;CD19;MSH2;CD70;CD27;TLR8;FCER1G
prerank,GTP metabolic process (GO:0046039),0.2277017772208721,0.49231884707960405,0.9697508896797153,1.0,1.0,5/15,25.56%,RHOQ;RAN;ENTPD7;GNAI3;AK3
prerank,DNA biosynthetic process (GO:0071897),0.21703098821738182,0.48616874552447764,0.9743178170144462,1.0,1.0,4/16,17.81%,POLD3;CDKN2D;WRN;POLA1
prerank,male meiosis I (GO:0007141),0.22141754726903473,0.4853619713903171,0.9794168096054888,1.0,1.0,1/16,6.23%,TDRD9
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.14447520765164865,-0.48536051587158136,1.0,1.0,1.0,50/50,85.60%,PSMB10;PSME2;OAZ1;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;PSMA5;PSMF1;OAZ3;PSMA2;ODC1;PSMB9;PSMA4;PSMD10;PSMA1;NQO1;PSMB5;PSMB11;PSMD4;PSMB6;PSMA3;PSMC1;PSMC3;PSMD6;OAZ2;PSMB7;PSMD12;PSME3;PSME4;PSMD11;PSMC4;PSMD14;PSMB2;PSMC2;PSMD2;PSMD3;PSMA8;PSMD7;PSMD1;PSMD13;PSMB1;AZIN1;PSMD8;PSMC6
prerank,CENP-A containing chromatin organization (GO:0061641),-0.16007557175359613,-0.4835391366266283,0.9969604863221885,1.0,1.0,14/29,39.48%,RUVBL1;CENPP;KNL1;MIS18BP1;CENPI;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.16007557175359613,-0.4835391366266283,0.9969604863221885,1.0,1.0,14/29,39.48%,RUVBL1;CENPP;KNL1;MIS18BP1;CENPI;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,tRNA 5'-end processing (GO:0099116),-0.1941032406048802,-0.48273417899908383,0.9901960784313726,1.0,1.0,6/15,28.50%,POP5;PRORP;HSD17B10;RPP25L;POP7;RPP21
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.20321936230156612,0.4808397995372272,0.98,1.0,1.0,7/22,26.28%,ERI3;EXOSC7;WDR12;FTSJ3;ERI2;UTP20;KRI1
prerank,regulation of lipid catabolic process (GO:0050994),-0.1726859111111034,-0.4807668907881548,0.9897172236503856,1.0,1.0,2/19,13.96%,ADRA2A;PDE3B
prerank,lipoprotein localization (GO:0044872),0.23278249185748157,0.47869359586780047,0.9749552772808586,1.0,1.0,2/11,13.93%,CD36;LRP1
prerank,microtubule anchoring at centrosome (GO:0034454),0.24197226989984438,0.4781575353047778,0.9664902998236331,1.0,1.0,3/10,20.02%,PCM1;NIN;DCTN1
prerank,homocysteine metabolic process (GO:0050667),0.23444855941246623,0.477845567052659,0.9826388888888888,1.0,1.0,11/11,76.57%,MTHFR;MTRR;DPEP1;CTH;MPST;BLMH;CPS1;MMUT;TST;CBS;NOX4
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2100939276342226,0.4776097279832239,0.9773095623987034,1.0,1.0,6/19,25.04%,FPGS;MTHFD2;MTHFR;MTHFD2L;SLC19A1;MTRR
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.19523417258452752,-0.47559935683198706,0.9839816933638444,1.0,1.0,3/13,21.11%,HSP90AB1;STX3;TYROBP
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.16933416397258882,0.4755843991541169,0.9987080103359173,1.0,1.0,17/67,23.72%,ITGAV;CHUK;ITGB5;SEC22B;SNAP23;CD36;PSMC6;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.19454767302635492,-0.4755317457780872,0.9844961240310077,1.0,1.0,1/12,5.06%,CLCN2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.19221328271477145,0.47453504559934284,0.9878971255673222,1.0,1.0,1/29,2.81%,ANO6
prerank,histone exchange (GO:0043486),0.18595579878853413,0.47287842505423044,0.9915611814345991,1.0,1.0,10/37,23.43%,CENPQ;SRCAP;CENPX;VPS72;DMAP1;RBBP4;ZNHIT1;OIP5;CENPU;CENPC
prerank,folic acid metabolic process (GO:0046655),0.20990371093015936,0.4722703643114619,0.9822866344605475,1.0,1.0,6/18,25.04%,FPGS;MTHFD2;MTHFR;MTHFD2L;SLC19A1;MTRR
prerank,vitamin D metabolic process (GO:0042359),0.21589553644296566,0.4719375491882371,0.9737762237762237,1.0,1.0,13/13,78.43%,CYP27B1;LRP2;VDR;PIAS4;UGT1A4;CYP11A1;FGF23;CYP24A1;CYP2R1;GC;CYP1A1;LGMN;CUBN
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.18850038754414378,-0.47114991706230663,0.9974025974025974,1.0,1.0,4/14,24.91%,FASTKD2;UQCC2;COA3;RCC1L
prerank,tRNA 5'-leader removal (GO:0001682),0.22022879894169575,0.4687390709780167,0.9806338028169014,1.0,1.0,1/13,5.55%,RPP38
prerank,lysine metabolic process (GO:0006553),0.22082176969714068,0.46706651643864455,0.968421052631579,1.0,1.0,4/12,20.92%,OGDH;HYKK;DLD;PIPOX
prerank,lysine catabolic process (GO:0006554),0.22082176969714068,0.46706651643864455,0.968421052631579,1.0,1.0,4/12,20.92%,OGDH;HYKK;DLD;PIPOX
prerank,purine-containing compound salvage (GO:0043101),-0.19158819836785937,-0.45983580918126,0.986870897155361,1.0,1.0,12/12,80.86%,GMPR;APRT;AMPD1;PNP;DCK;GMPR2;ADK;DGUOK;AMPD2;HPRT1;ADA;AMPD3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.1723316394451629,-0.4578511044222305,0.9900990099009901,1.0,1.0,5/16,26.78%,RAD21;BOD1;PDS5B;REC8;DSCC1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.12542902428451674,-0.456365961491953,1.0,0.9997668059653857,1.0,14/69,22.66%,RPRD2;RPAP2;POLR2K;PHAX;ELL;TAF6;ZC3H8;CCNK;ELL2;POLR2C;INTS4;POLR2G;SNAPC3;POLR2L
prerank,DNA catabolic process (GO:0006308),0.21794930642437868,0.4558439069924735,0.9807355516637478,1.0,1.0,2/11,18.40%,DFFB;REXO4
prerank,snRNA transcription (GO:0009301),-0.12487428760925257,-0.4557605530219245,1.0,0.9990013038238282,1.0,14/70,22.66%,RPRD2;RPAP2;POLR2K;PHAX;ELL;TAF6;ZC3H8;CCNK;ELL2;POLR2C;INTS4;POLR2G;SNAPC3;POLR2L
prerank,phosphate ion transport (GO:0006817),0.2048876719857191,0.45465202393105836,0.9866666666666667,1.0,1.0,2/16,14.30%,SLC25A14;SLC20A1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2053311501145587,0.4517147862855879,0.9898305084745763,1.0,1.0,1/15,5.63%,AP3B1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2053311501145587,0.4517147862855879,0.9898305084745763,1.0,1.0,1/15,5.63%,AP3B1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22334457877232083,0.448065077545191,0.987410071942446,1.0,1.0,3/10,19.14%,MTHFD2;MTHFR;MTHFD2L
prerank,intracellular protein transmembrane transport (GO:0065002),0.1746266462824888,0.4472537752446806,0.9957983193277311,1.0,1.0,17/42,31.32%,SEC63;PEX2;DNAJC19;C2CD5;TIMM17B;PEX12;PEX16;PEX7;SEC61A2;AIFM1;TIMM23;TOMM20;GRPEL2;SEC61A1;DNAJC15;PEX5;HSPA5
prerank,negative regulation of interferon-beta production (GO:0032688),-0.19312524935626432,-0.44089305876641505,0.9930875576036866,0.9996659222927432,1.0,1/10,7.45%,SIRPA
prerank,regulation of mitochondrial translation (GO:0070129),-0.1584775949612281,-0.44071214954868965,0.9946949602122016,0.998853546135879,1.0,5/21,24.91%,FASTKD2;UQCC2;COA3;SHMT2;RCC1L
prerank,meiosis I (GO:0007127),0.187448960361832,0.4406740389787394,0.9984326018808778,1.0,1.0,23/23,81.28%,TDRD9;FOXJ2;MEIOB;FOXJ3;ZSCAN21;BCL2L11;SGO1;ZCWPW1;SYCP3;PTTG1;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;BRDT;MEIKIN;MOV10L1;SLC25A31;MYBL1;DDX4;HSF2BP;ING2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.16943369947162693,0.4387734788337962,0.9985955056179775,1.0,1.0,4/42,12.15%,LBP;RNASE6;TLR4;TNFRSF14
prerank,mRNA polyadenylation (GO:0006378),0.1814191178874795,0.4376781122511588,0.9926578560939795,1.0,1.0,9/26,27.49%,SCAF8;PAF1;PABPC1;GRSF1;MTPAP;LEO1;AHCYL1;FIP1L1;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.1814191178874795,0.4376781122511588,0.9926578560939795,1.0,1.0,9/26,27.49%,SCAF8;PAF1;PABPC1;GRSF1;MTPAP;LEO1;AHCYL1;FIP1L1;PNPT1
prerank,B cell activation involved in immune response (GO:0002312),0.19908279605382068,0.43458096854973793,0.994991652754591,1.0,1.0,1/13,9.20%,RNF168
prerank,protein import into mitochondrial matrix (GO:0030150),-0.16101273400970595,-0.4342116957012852,1.0,0.9986031491183647,1.0,6/18,31.80%,TIMM44;GRPEL1;TOMM40L;TOMM40;DNLZ;TIMM17A
prerank,cellular response to radiation (GO:0071478),-0.13120802117633523,-0.43311730728306047,1.0,0.9978491819223823,1.0,15/40,34.36%,NET1;RHOB;GRB2;NSMCE3;BLM;GPR88;RAD51;TP53;RRH;FIGNL1;HUS1;RHNO1;EEF1D;RAD1;INTS7
prerank,regulation of spindle organization (GO:0090224),0.1909518171603183,0.43296873502241545,0.9899159663865547,1.0,1.0,8/18,33.06%,TACC3;RAE1;DCTN1;GPSM2;DYNC1H1;RNF4;NUMA1;GNAI1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.21102184283203637,0.42924087100186764,0.9838187702265372,1.0,1.0,10/10,78.91%,CDC42;APC;SIRT2;RCC2;KNSTRN;ECT2;NEK2;CCNB1;RACGAP1;SPAG5
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.18866893927020684,0.42811175284152536,0.9891640866873065,1.0,1.0,4/19,20.56%,MTOR;ZNF76;AR;ICE2
prerank,regulation of lymphocyte activation (GO:0051249),0.20291701502617543,0.4275295010356085,0.9857397504456328,1.0,1.0,2/12,18.39%,KAT2A;IKZF3
prerank,rRNA catabolic process (GO:0016075),0.1911136929321417,0.42477520568316635,0.9932432432432432,1.0,1.0,4/16,21.90%,EXOSC7;ERN2;EXOSC5;EXOSC4
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.18190508929836482,0.42447613336820794,0.9921875,1.0,1.0,1/22,4.43%,NFE2L2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.20562390158172233,0.4220386979922379,0.9928952042628775,1.0,1.0,10/10,79.45%,PSMC6;PSMC2;ESR1;PSMC4;HMGB1;PSMC3;ATF7IP;TP53;THRA;PSMC5
prerank,double-strand break repair via break-induced replication (GO:0000727),0.19519656434113136,0.41940872884440866,0.9884297520661157,1.0,1.0,3/12,22.29%,MCM7;MCM6;MCMDC2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.1808946828233054,0.41903022272417495,0.9918831168831169,1.0,1.0,4/20,23.81%,FDX1;AKR1B1;STARD3NL;TSPOAP1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.1859445240251441,0.41275946555269505,0.9867986798679867,1.0,1.0,5/16,27.02%,TMEM50B;CHMP4A;CHMP4B;SNF8;CHMP5
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.16819151153295453,0.41111492144278994,0.9955290611028316,1.0,1.0,6/28,23.56%,SHLD1;MRNIP;KDM4D;PRKDC;SHLD2;SIRT7
prerank,glutathione metabolic process (GO:0006749),0.1592835181618534,0.40903375869187997,0.997134670487106,1.0,1.0,7/38,22.63%,GCLC;MMACHC;GSTM4;MGST2;GSTM5;GSS;GSR
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.167159331863874,0.4090104743776023,1.0,1.0,1.0,10/31,26.83%,PEX2;DNAJC19;TIMM17B;PEX12;PEX16;PEX7;AIFM1;TIMM23;TOMM20;GRPEL2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.20097862388074,0.40837085409299967,0.9897435897435898,1.0,1.0,1/10,8.44%,RPUSD1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.1764742824844563,0.40726942077461475,0.9916805324459235,1.0,1.0,19/19,82.37%,POLD3;AMPD3;ADA;TERT;HPRT1;AMPD2;DGUOK;ADK;TYMS;GMPR2;DCK;PNP;AMPD1;APRT;POLL;POLD2;POLD1;CDA;GMPR
prerank,negative regulation of double-strand break repair (GO:2000780),0.16378099785943767,0.40159702041791995,1.0,1.0,1.0,6/30,20.84%,TRIP12;SHLD1;UBR5;OTUB1;RMI2;SHLD2
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.1717747983888671,-0.39929853337055665,0.9932126696832579,0.9988894243529594,1.0,2/10,22.47%,TARBP2;MRPL44
prerank,tryptophan metabolic process (GO:0006568),0.19380564488330124,0.39896903744222467,0.9964093357271095,1.0,1.0,1/11,9.92%,KYAT1
prerank,regulation of exit from mitosis (GO:0007096),0.15361671306328598,0.39665814812475825,1.0,0.9999548067682567,1.0,6/38,18.60%,ANAPC5;ANAPC16;CDC16;UBE2S;MAD2L1BP;CDC14A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.15854871683111815,0.38645063904919796,0.9984051036682615,1.0,1.0,7/26,26.71%,ACOD1;TRAFD1;CARD16;TRAF3IP1;RNF26;MUL1;ILRUN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.1842959519788522,0.38530521956128877,0.9867330016583747,0.9999201440065812,1.0,2/12,18.02%,METTL4;NBN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.16530492707567157,0.3798060510442816,0.9967213114754099,0.9998096046037498,1.0,6/17,27.73%,RB1;CDK1;SPDL1;ZWILCH;CHAMP1;CTCF
prerank,rRNA methylation (GO:0031167),0.16017306439877477,0.379239767682676,0.9953775038520801,0.9994522331436977,1.0,7/22,26.08%,MRM2;MRM1;NSUN4;ZCCHC4;NOP2;FTSJ3;METTL15
prerank,cilium-dependent cell motility (GO:0060285),0.15966764103667702,0.3769281759408974,0.9953703703703703,0.9991735672276537,1.0,6/22,24.55%,DNAH8;TEKT2;DNAH2;RSPH9;GAS8;CCDC65
prerank,pseudouridine synthesis (GO:0001522),0.17866783853349247,0.37647515181768293,0.9983388704318937,0.9988091635099707,1.0,13/13,82.15%,PUS10;TRUB2;PUS7;PUS3;GAR1;PUSL1;PUS1;NHP2;DKC1;NOP10;RPUSD2;TRUB1;PUS7L
prerank,steroid hormone biosynthetic process (GO:0120178),0.153190835446126,0.37077040204500855,1.0,0.9986789445399358,1.0,8/29,28.09%,FDX1;CYP19A1;AKR1B1;STARD3NL;DHCR7;TSPOAP1;SRD5A3;HSD17B2
